DB00775	Tirofiban	blood coagulation disorders	40	-6.11
DB00775	Tirofiban	hematologic diseases	188	-3.89
DB00775	Tirofiban	collagen diseases	25	-3.58
DB00775	Tirofiban	myocardial ischemia	43	-3.20
DB00775	Tirofiban	coronary disease	37	-3.06
DB00775	Tirofiban	diabetes mellitus type 2	72	-2.46
DB00775	Tirofiban	multiple sclerosis	69	-2.17
DB00775	Tirofiban	anemia hemolytic	29	-1.60
DB00775	Tirofiban	coronary artery disease	31	-1.55
DB00775	Tirofiban	bone diseases	144	-1.55
DB00775	Tirofiban	diabetes mellitus	162	-1.47
DB00775	Tirofiban	pancreatic diseases	24	-1.42
DB00775	Tirofiban	arteriosclerosis	38	-1.33
DB00775	Tirofiban	arterial occlusive diseases	44	-1.31
DB00775	Tirofiban	heart diseases	167	-1.28
DB00775	Tirofiban	vascular diseases	181	-1.21
DB00775	Tirofiban	colitis ulcerative	55	-1.14
DB00775	Tirofiban	colitis	55	-1.08
DB00775	Tirofiban	eye diseases	231	-1.06
DB00775	Tirofiban	metabolism inborn errors	289	-0.95
DB00775	Tirofiban	autoimmune diseases	243	-0.94
DB00775	Tirofiban	prostatic neoplasms	61	-0.86
DB00775	Tirofiban	breast neoplasms	40	-0.84
DB00775	Tirofiban	endocrine system diseases	291	-0.82
DB00775	Tirofiban	skin diseases	278	-0.74
DB00775	Tirofiban	cardiovascular diseases	330	-0.68
DB00775	Tirofiban	crohn disease	71	-0.63
DB00775	Tirofiban	diabetes mellitus type 1	82	-0.63
DB00775	Tirofiban	leukemia myeloid acute	43	-0.62
DB00775	Tirofiban	anemia	58	-0.52
DB00775	Tirofiban	colorectal neoplasms	42	-0.47
DB00775	Tirofiban	leukemia lymphoid	66	-0.44
DB00775	Tirofiban	intestinal neoplasms	42	-0.44
DB00775	Tirofiban	lung diseases	71	-0.42
DB00775	Tirofiban	gastroenteritis	122	-0.37
DB00775	Tirofiban	inflammatory bowel diseases	119	-0.34
DB00775	Tirofiban	kidney diseases	144	-0.24
DB00775	Tirofiban	neoplasms	482	-0.16
DB00775	Tirofiban	varicose veins	20	-0.13
DB00775	Tirofiban	epilepsy	25	-0.12
DB00775	Tirofiban	arrhythmias cardiac	30	-0.08
DB00775	Tirofiban	gastrointestinal neoplasms	72	-0.08
DB00775	Tirofiban	insulin resistance	26	-0.06
DB00775	Tirofiban	hyperinsulinism	26	-0.06
DB00775	Tirofiban	macular degeneration	44	-0.02
DB00775	Tirofiban	bone diseases metabolic	27	-0.02
DB00775	Tirofiban	mycobacterium infections	22	0.14
DB00775	Tirofiban	keratosis	21	0.15
DB00775	Tirofiban	leukemia	117	0.22
DB00775	Tirofiban	malabsorption syndromes	34	0.23
DB00775	Tirofiban	thyroid diseases	30	0.25
DB00775	Tirofiban	bacterial infections	26	0.25
DB00775	Tirofiban	hypopigmentation	22	0.26
DB00775	Tirofiban	liver cirrhosis	24	0.30
DB00775	Tirofiban	kidney neoplasms	20	0.30
DB00775	Tirofiban	liver cirrhosis biliary	23	0.31
DB00775	Tirofiban	amyotrophic lateral sclerosis	21	0.34
DB00775	Tirofiban	asthma	36	0.37
DB00775	Tirofiban	cardiomyopathy dilated	29	0.39
DB00775	Tirofiban	parkinsonian disorders	31	0.39
DB00775	Tirofiban	neuroendocrine tumors	24	0.39
DB00775	Tirofiban	parkinson disease	30	0.42
DB00775	Tirofiban	alzheimer disease	29	0.46
DB00775	Tirofiban	hypersensitivity	45	0.47
DB00775	Tirofiban	lymphoma	24	0.51
DB00775	Tirofiban	sarcoma	25	0.51
DB00775	Tirofiban	arthritis rheumatoid	42	0.57
DB00775	Tirofiban	lymphoma non hodgkin	22	0.58
DB00775	Tirofiban	dementia	42	0.68
DB00775	Tirofiban	adenocarcinoma	32	0.69
DB00775	Tirofiban	motor neuron disease	31	0.70
DB00775	Tirofiban	psoriasis	54	0.72
DB00775	Tirofiban	head and neck neoplasms	35	0.73
DB00775	Tirofiban	rheumatic diseases	59	0.77
DB00775	Tirofiban	lupus erythematosus systemic	75	0.78
DB00775	Tirofiban	spinal cord diseases	59	0.87
DB00775	Tirofiban	joint diseases	79	0.92
DB00775	Tirofiban	arthritis	76	0.97
DB00678	Losartan	kidney diseases	144	-3.87
DB00678	Losartan	metabolism inborn errors	289	-3.07
DB00678	Losartan	blood coagulation disorders	40	-2.64
DB00678	Losartan	colitis ulcerative	55	-2.42
DB00678	Losartan	colitis	55	-2.40
DB00678	Losartan	thyroid diseases	30	-2.22
DB00678	Losartan	multiple sclerosis	69	-2.16
DB00678	Losartan	leukemia myeloid acute	43	-2.00
DB00678	Losartan	head and neck neoplasms	35	-1.89
DB00678	Losartan	lung diseases	71	-1.83
DB00678	Losartan	crohn disease	71	-1.81
DB00678	Losartan	gastroenteritis	122	-1.72
DB00678	Losartan	inflammatory bowel diseases	119	-1.61
DB00678	Losartan	vascular diseases	181	-1.26
DB00678	Losartan	eye diseases	231	-1.20
DB00678	Losartan	heart diseases	167	-1.19
DB00678	Losartan	leukemia	117	-1.13
DB00678	Losartan	autoimmune diseases	243	-1.03
DB00678	Losartan	hematologic diseases	188	-1.02
DB00678	Losartan	skin diseases	278	-0.97
DB00678	Losartan	endocrine system diseases	291	-0.87
DB00678	Losartan	cardiovascular diseases	330	-0.72
DB00678	Losartan	varicose veins	20	-0.43
DB00678	Losartan	insulin resistance	26	-0.37
DB00678	Losartan	neoplasms	482	-0.34
DB00678	Losartan	hyperinsulinism	26	-0.33
DB00678	Losartan	collagen diseases	25	-0.32
DB00678	Losartan	arrhythmias cardiac	30	-0.32
DB00678	Losartan	bone diseases metabolic	27	-0.31
DB00678	Losartan	coronary artery disease	31	-0.24
DB00678	Losartan	keratosis	21	-0.23
DB00678	Losartan	mycobacterium infections	22	-0.23
DB00678	Losartan	macular degeneration	44	-0.22
DB00678	Losartan	bacterial infections	26	-0.16
DB00678	Losartan	anemia hemolytic	29	-0.16
DB00678	Losartan	kidney neoplasms	20	-0.11
DB00678	Losartan	arteriosclerosis	38	-0.10
DB00678	Losartan	liver cirrhosis biliary	23	-0.10
DB00678	Losartan	coronary disease	37	-0.09
DB00678	Losartan	myocardial ischemia	43	-0.09
DB00678	Losartan	liver cirrhosis	24	-0.09
DB00678	Losartan	hypopigmentation	22	-0.08
DB00678	Losartan	pancreatic diseases	24	-0.08
DB00678	Losartan	amyotrophic lateral sclerosis	21	-0.04
DB00678	Losartan	parkinsonian disorders	31	-0.04
DB00678	Losartan	alzheimer disease	29	-0.03
DB00678	Losartan	neuroendocrine tumors	24	-0.02
DB00678	Losartan	parkinson disease	30	-0.01
DB00678	Losartan	asthma	36	-0.01
DB00678	Losartan	arterial occlusive diseases	44	0.00
DB00678	Losartan	malabsorption syndromes	34	0.00
DB00678	Losartan	lymphoma non hodgkin	22	0.02
DB00678	Losartan	sarcoma	25	0.03
DB00678	Losartan	cardiomyopathy dilated	29	0.03
DB00678	Losartan	lymphoma	24	0.05
DB00678	Losartan	hypersensitivity	45	0.09
DB00678	Losartan	motor neuron disease	31	0.14
DB00678	Losartan	adenocarcinoma	32	0.14
DB00678	Losartan	arthritis rheumatoid	42	0.16
DB00678	Losartan	dementia	42	0.17
DB00678	Losartan	psoriasis	54	0.20
DB00678	Losartan	diabetes mellitus type 2	72	0.21
DB00678	Losartan	breast neoplasms	40	0.21
DB00678	Losartan	rheumatic diseases	59	0.22
DB00678	Losartan	prostatic neoplasms	61	0.23
DB00678	Losartan	lupus erythematosus systemic	75	0.25
DB00678	Losartan	diabetes mellitus type 1	82	0.25
DB00678	Losartan	spinal cord diseases	59	0.28
DB00678	Losartan	colorectal neoplasms	42	0.31
DB00678	Losartan	joint diseases	79	0.32
DB00678	Losartan	intestinal neoplasms	42	0.33
DB00678	Losartan	anemia	58	0.33
DB00678	Losartan	arthritis	76	0.35
DB00678	Losartan	leukemia lymphoid	66	0.38
DB00678	Losartan	gastrointestinal neoplasms	72	0.52
DB00678	Losartan	diabetes mellitus	162	0.52
DB00678	Losartan	bone diseases	144	0.57
DB00678	Losartan	epilepsy	25	1.73
DB01169	Arsenic.trioxide	skin diseases	278	-3.38
DB01169	Arsenic.trioxide	breast neoplasms	40	-3.06
DB01169	Arsenic.trioxide	varicose veins	20	-3.05
DB01169	Arsenic.trioxide	diabetes mellitus type 2	72	-2.33
DB01169	Arsenic.trioxide	adenocarcinoma	32	-2.33
DB01169	Arsenic.trioxide	multiple sclerosis	69	-2.26
DB01169	Arsenic.trioxide	endocrine system diseases	291	-2.22
DB01169	Arsenic.trioxide	neuroendocrine tumors	24	-2.22
DB01169	Arsenic.trioxide	parkinsonian disorders	31	-2.21
DB01169	Arsenic.trioxide	parkinson disease	30	-2.17
DB01169	Arsenic.trioxide	intestinal neoplasms	42	-2.03
DB01169	Arsenic.trioxide	colorectal neoplasms	42	-1.98
DB01169	Arsenic.trioxide	lymphoma non hodgkin	22	-1.72
DB01169	Arsenic.trioxide	bone diseases	144	-1.70
DB01169	Arsenic.trioxide	lymphoma	24	-1.67
DB01169	Arsenic.trioxide	gastrointestinal neoplasms	72	-1.64
DB01169	Arsenic.trioxide	head and neck neoplasms	35	-1.63
DB01169	Arsenic.trioxide	thyroid diseases	30	-1.55
DB01169	Arsenic.trioxide	vascular diseases	181	-1.46
DB01169	Arsenic.trioxide	asthma	36	-1.43
DB01169	Arsenic.trioxide	arrhythmias cardiac	30	-1.41
DB01169	Arsenic.trioxide	eye diseases	231	-1.40
DB01169	Arsenic.trioxide	pancreatic diseases	24	-1.36
DB01169	Arsenic.trioxide	malabsorption syndromes	34	-1.26
DB01169	Arsenic.trioxide	hypersensitivity	45	-1.18
DB01169	Arsenic.trioxide	leukemia myeloid acute	43	-1.13
DB01169	Arsenic.trioxide	neoplasms	482	-1.11
DB01169	Arsenic.trioxide	anemia hemolytic	29	-1.11
DB01169	Arsenic.trioxide	autoimmune diseases	243	-1.06
DB01169	Arsenic.trioxide	hematologic diseases	188	-1.05
DB01169	Arsenic.trioxide	alzheimer disease	29	-1.04
DB01169	Arsenic.trioxide	leukemia lymphoid	66	-1.01
DB01169	Arsenic.trioxide	prostatic neoplasms	61	-0.94
DB01169	Arsenic.trioxide	kidney diseases	144	-0.92
DB01169	Arsenic.trioxide	colitis ulcerative	55	-0.91
DB01169	Arsenic.trioxide	inflammatory bowel diseases	119	-0.90
DB01169	Arsenic.trioxide	diabetes mellitus	162	-0.89
DB01169	Arsenic.trioxide	colitis	55	-0.87
DB01169	Arsenic.trioxide	gastroenteritis	122	-0.87
DB01169	Arsenic.trioxide	cardiovascular diseases	330	-0.86
DB01169	Arsenic.trioxide	lung diseases	71	-0.85
DB01169	Arsenic.trioxide	motor neuron disease	31	-0.77
DB01169	Arsenic.trioxide	heart diseases	167	-0.73
DB01169	Arsenic.trioxide	liver cirrhosis biliary	23	-0.65
DB01169	Arsenic.trioxide	liver cirrhosis	24	-0.61
DB01169	Arsenic.trioxide	sarcoma	25	-0.58
DB01169	Arsenic.trioxide	metabolism inborn errors	289	-0.48
DB01169	Arsenic.trioxide	dementia	42	-0.45
DB01169	Arsenic.trioxide	mycobacterium infections	22	-0.41
DB01169	Arsenic.trioxide	macular degeneration	44	-0.27
DB01169	Arsenic.trioxide	keratosis	21	-0.25
DB01169	Arsenic.trioxide	bone diseases metabolic	27	-0.17
DB01169	Arsenic.trioxide	bacterial infections	26	-0.11
DB01169	Arsenic.trioxide	leukemia	117	-0.08
DB01169	Arsenic.trioxide	psoriasis	54	-0.07
DB01169	Arsenic.trioxide	spinal cord diseases	59	-0.03
DB01169	Arsenic.trioxide	diabetes mellitus type 1	82	0.07
DB01169	Arsenic.trioxide	anemia	58	0.07
DB01169	Arsenic.trioxide	blood coagulation disorders	40	0.23
DB01169	Arsenic.trioxide	lupus erythematosus systemic	75	0.28
DB01169	Arsenic.trioxide	kidney neoplasms	20	0.31
DB01169	Arsenic.trioxide	coronary artery disease	31	0.38
DB01169	Arsenic.trioxide	arterial occlusive diseases	44	0.38
DB01169	Arsenic.trioxide	crohn disease	71	0.54
DB01169	Arsenic.trioxide	coronary disease	37	0.58
DB01169	Arsenic.trioxide	collagen diseases	25	0.59
DB01169	Arsenic.trioxide	myocardial ischemia	43	0.62
DB01169	Arsenic.trioxide	arteriosclerosis	38	0.84
DB01169	Arsenic.trioxide	hypopigmentation	22	0.90
DB01169	Arsenic.trioxide	insulin resistance	26	0.94
DB01169	Arsenic.trioxide	hyperinsulinism	26	0.97
DB01169	Arsenic.trioxide	amyotrophic lateral sclerosis	21	1.13
DB01169	Arsenic.trioxide	rheumatic diseases	59	1.30
DB01169	Arsenic.trioxide	epilepsy	25	1.46
DB01169	Arsenic.trioxide	cardiomyopathy dilated	29	1.57
DB01169	Arsenic.trioxide	arthritis rheumatoid	42	1.62
DB01169	Arsenic.trioxide	arthritis	76	1.90
DB01169	Arsenic.trioxide	joint diseases	79	1.98
DB00674	Galantamine	epilepsy	25	-5.15
DB00674	Galantamine	lung diseases	71	-1.36
DB00674	Galantamine	autoimmune diseases	243	-1.24
DB00674	Galantamine	macular degeneration	44	-1.14
DB00674	Galantamine	alzheimer disease	29	-0.67
DB00674	Galantamine	dementia	42	-0.40
DB00674	Galantamine	collagen diseases	25	-0.22
DB00674	Galantamine	hyperinsulinism	26	0.11
DB00674	Galantamine	coronary artery disease	31	0.14
DB00674	Galantamine	insulin resistance	26	0.16
DB00674	Galantamine	coronary disease	37	0.45
DB00674	Galantamine	eye diseases	231	0.54
DB00674	Galantamine	pancreatic diseases	24	0.57
DB00674	Galantamine	myocardial ischemia	43	0.59
DB00674	Galantamine	arteriosclerosis	38	0.69
DB00674	Galantamine	cardiomyopathy dilated	29	0.75
DB00674	Galantamine	prostatic neoplasms	61	0.77
DB00674	Galantamine	spinal cord diseases	59	0.78
DB00674	Galantamine	adenocarcinoma	32	0.87
DB00674	Galantamine	amyotrophic lateral sclerosis	21	0.96
DB00674	Galantamine	arterial occlusive diseases	44	1.04
DB00674	Galantamine	arrhythmias cardiac	30	1.08
DB00674	Galantamine	asthma	36	1.14
DB00674	Galantamine	psoriasis	54	1.21
DB00674	Galantamine	motor neuron disease	31	1.26
DB00674	Galantamine	vascular diseases	181	1.34
DB00674	Galantamine	diabetes mellitus type 2	72	1.41
DB00674	Galantamine	colitis ulcerative	55	1.43
DB00674	Galantamine	heart diseases	167	1.45
DB00674	Galantamine	hypersensitivity	45	1.50
DB00674	Galantamine	colitis	55	1.59
DB00674	Galantamine	crohn disease	71	1.73
DB00674	Galantamine	colorectal neoplasms	42	2.01
DB00674	Galantamine	bacterial infections	26	2.13
DB00674	Galantamine	intestinal neoplasms	42	2.16
DB00674	Galantamine	neoplasms	482	2.22
DB00674	Galantamine	cardiovascular diseases	330	2.31
DB00674	Galantamine	parkinson disease	30	2.39
DB00674	Galantamine	keratosis	21	2.40
DB00674	Galantamine	parkinsonian disorders	31	2.41
DB00674	Galantamine	inflammatory bowel diseases	119	2.45
DB00674	Galantamine	neuroendocrine tumors	24	2.45
DB00674	Galantamine	varicose veins	20	2.50
DB00674	Galantamine	lupus erythematosus systemic	75	2.55
DB00674	Galantamine	gastrointestinal neoplasms	72	2.56
DB00674	Galantamine	leukemia lymphoid	66	2.57
DB00674	Galantamine	gastroenteritis	122	2.62
DB00674	Galantamine	kidney neoplasms	20	2.64
DB00674	Galantamine	lymphoma	24	2.73
DB00674	Galantamine	lymphoma non hodgkin	22	2.74
DB00674	Galantamine	sarcoma	25	2.76
DB00674	Galantamine	diabetes mellitus	162	2.83
DB00674	Galantamine	bone diseases	144	3.03
DB00674	Galantamine	breast neoplasms	40	3.05
DB00674	Galantamine	bone diseases metabolic	27	3.08
DB00674	Galantamine	liver cirrhosis biliary	23	3.12
DB00674	Galantamine	anemia hemolytic	29	3.16
DB00674	Galantamine	diabetes mellitus type 1	82	3.18
DB00674	Galantamine	liver cirrhosis	24	3.19
DB00674	Galantamine	leukemia	117	3.20
DB00674	Galantamine	head and neck neoplasms	35	3.22
DB00674	Galantamine	blood coagulation disorders	40	3.48
DB00674	Galantamine	leukemia myeloid acute	43	3.53
DB00674	Galantamine	skin diseases	278	3.56
DB00674	Galantamine	arthritis rheumatoid	42	3.58
DB00674	Galantamine	endocrine system diseases	291	3.63
DB00674	Galantamine	hypopigmentation	22	3.68
DB00674	Galantamine	arthritis	76	3.80
DB00674	Galantamine	rheumatic diseases	59	3.81
DB00674	Galantamine	joint diseases	79	3.83
DB00674	Galantamine	malabsorption syndromes	34	3.89
DB00674	Galantamine	mycobacterium infections	22	3.96
DB00674	Galantamine	multiple sclerosis	69	4.04
DB00674	Galantamine	thyroid diseases	30	4.05
DB00674	Galantamine	hematologic diseases	188	4.35
DB00674	Galantamine	anemia	58	4.38
DB00674	Galantamine	kidney diseases	144	4.60
DB00674	Galantamine	metabolism inborn errors	289	4.61
DB00675	Tamoxifen	skin diseases	278	-2.66
DB00675	Tamoxifen	cardiovascular diseases	330	-2.57
DB00675	Tamoxifen	heart diseases	167	-2.51
DB00675	Tamoxifen	breast neoplasms	40	-2.48
DB00675	Tamoxifen	neoplasms	482	-2.17
DB00675	Tamoxifen	cardiomyopathy dilated	29	-2.04
DB00675	Tamoxifen	asthma	36	-1.96
DB00675	Tamoxifen	hypersensitivity	45	-1.91
DB00675	Tamoxifen	pancreatic diseases	24	-1.78
DB00675	Tamoxifen	sarcoma	25	-1.68
DB00675	Tamoxifen	prostatic neoplasms	61	-1.68
DB00675	Tamoxifen	colitis ulcerative	55	-1.43
DB00675	Tamoxifen	colorectal neoplasms	42	-1.38
DB00675	Tamoxifen	intestinal neoplasms	42	-1.32
DB00675	Tamoxifen	colitis	55	-1.28
DB00675	Tamoxifen	diabetes mellitus type 2	72	-1.28
DB00675	Tamoxifen	diabetes mellitus type 1	82	-1.26
DB00675	Tamoxifen	lung diseases	71	-1.23
DB00675	Tamoxifen	crohn disease	71	-1.18
DB00675	Tamoxifen	coronary artery disease	31	-1.16
DB00675	Tamoxifen	gastrointestinal neoplasms	72	-1.13
DB00675	Tamoxifen	myocardial ischemia	43	-1.03
DB00675	Tamoxifen	coronary disease	37	-0.95
DB00675	Tamoxifen	vascular diseases	181	-0.76
DB00675	Tamoxifen	arteriosclerosis	38	-0.76
DB00675	Tamoxifen	diabetes mellitus	162	-0.74
DB00675	Tamoxifen	inflammatory bowel diseases	119	-0.74
DB00675	Tamoxifen	gastroenteritis	122	-0.71
DB00675	Tamoxifen	bone diseases	144	-0.63
DB00675	Tamoxifen	kidney neoplasms	20	-0.60
DB00675	Tamoxifen	leukemia	117	-0.58
DB00675	Tamoxifen	arterial occlusive diseases	44	-0.58
DB00675	Tamoxifen	alzheimer disease	29	-0.57
DB00675	Tamoxifen	autoimmune diseases	243	-0.50
DB00675	Tamoxifen	thyroid diseases	30	-0.41
DB00675	Tamoxifen	neuroendocrine tumors	24	-0.40
DB00675	Tamoxifen	hematologic diseases	188	-0.31
DB00675	Tamoxifen	liver cirrhosis	24	-0.30
DB00675	Tamoxifen	liver cirrhosis biliary	23	-0.28
DB00675	Tamoxifen	arrhythmias cardiac	30	-0.13
DB00675	Tamoxifen	dementia	42	-0.11
DB00675	Tamoxifen	lymphoma	24	-0.11
DB00675	Tamoxifen	lymphoma non hodgkin	22	-0.10
DB00675	Tamoxifen	endocrine system diseases	291	-0.05
DB00675	Tamoxifen	varicose veins	20	-0.01
DB00675	Tamoxifen	collagen diseases	25	-0.01
DB00675	Tamoxifen	macular degeneration	44	0.01
DB00675	Tamoxifen	epilepsy	25	0.02
DB00675	Tamoxifen	adenocarcinoma	32	0.07
DB00675	Tamoxifen	motor neuron disease	31	0.08
DB00675	Tamoxifen	hyperinsulinism	26	0.08
DB00675	Tamoxifen	insulin resistance	26	0.10
DB00675	Tamoxifen	lupus erythematosus systemic	75	0.14
DB00675	Tamoxifen	bone diseases metabolic	27	0.16
DB00675	Tamoxifen	head and neck neoplasms	35	0.24
DB00675	Tamoxifen	parkinsonian disorders	31	0.30
DB00675	Tamoxifen	anemia hemolytic	29	0.31
DB00675	Tamoxifen	parkinson disease	30	0.32
DB00675	Tamoxifen	keratosis	21	0.44
DB00675	Tamoxifen	multiple sclerosis	69	0.44
DB00675	Tamoxifen	spinal cord diseases	59	0.55
DB00675	Tamoxifen	leukemia myeloid acute	43	0.56
DB00675	Tamoxifen	malabsorption syndromes	34	0.59
DB00675	Tamoxifen	leukemia lymphoid	66	0.63
DB00675	Tamoxifen	kidney diseases	144	0.68
DB00675	Tamoxifen	hypopigmentation	22	0.68
DB00675	Tamoxifen	mycobacterium infections	22	0.72
DB00675	Tamoxifen	blood coagulation disorders	40	0.78
DB00675	Tamoxifen	anemia	58	0.82
DB00675	Tamoxifen	eye diseases	231	0.91
DB00675	Tamoxifen	bacterial infections	26	0.92
DB00675	Tamoxifen	amyotrophic lateral sclerosis	21	0.92
DB00675	Tamoxifen	metabolism inborn errors	289	1.33
DB00675	Tamoxifen	arthritis rheumatoid	42	1.52
DB00675	Tamoxifen	psoriasis	54	1.64
DB00675	Tamoxifen	rheumatic diseases	59	1.88
DB00675	Tamoxifen	arthritis	76	2.21
DB00675	Tamoxifen	joint diseases	79	2.28
DB00672	Chlorpropamide	pancreatic diseases	24	-4.34
DB00672	Chlorpropamide	diabetes mellitus	162	-4.29
DB00672	Chlorpropamide	diabetes mellitus type 2	72	-4.17
DB00672	Chlorpropamide	endocrine system diseases	291	-3.70
DB00672	Chlorpropamide	arrhythmias cardiac	30	-1.12
DB00672	Chlorpropamide	bacterial infections	26	-0.85
DB00672	Chlorpropamide	alzheimer disease	29	-0.83
DB00672	Chlorpropamide	cardiomyopathy dilated	29	-0.77
DB00672	Chlorpropamide	dementia	42	-0.58
DB00672	Chlorpropamide	arthritis rheumatoid	42	-0.51
DB00672	Chlorpropamide	rheumatic diseases	59	-0.39
DB00672	Chlorpropamide	spinal cord diseases	59	-0.37
DB00672	Chlorpropamide	arthritis	76	-0.33
DB00672	Chlorpropamide	joint diseases	79	-0.32
DB00672	Chlorpropamide	kidney diseases	144	-0.11
DB00672	Chlorpropamide	heart diseases	167	-0.05
DB00672	Chlorpropamide	autoimmune diseases	243	0.11
DB00672	Chlorpropamide	metabolism inborn errors	289	0.14
DB00672	Chlorpropamide	skin diseases	278	0.25
DB00672	Chlorpropamide	cardiovascular diseases	330	0.32
DB00672	Chlorpropamide	neoplasms	482	0.50
DB00672	Chlorpropamide	varicose veins	20	0.65
DB00672	Chlorpropamide	epilepsy	25	0.66
DB00672	Chlorpropamide	collagen diseases	25	0.77
DB00672	Chlorpropamide	insulin resistance	26	0.78
DB00672	Chlorpropamide	hyperinsulinism	26	0.79
DB00672	Chlorpropamide	bone diseases metabolic	27	0.80
DB00672	Chlorpropamide	mycobacterium infections	22	0.83
DB00672	Chlorpropamide	coronary artery disease	31	0.85
DB00672	Chlorpropamide	keratosis	21	0.86
DB00672	Chlorpropamide	macular degeneration	44	0.88
DB00672	Chlorpropamide	kidney neoplasms	20	0.91
DB00672	Chlorpropamide	thyroid diseases	30	0.93
DB00672	Chlorpropamide	anemia hemolytic	29	0.94
DB00672	Chlorpropamide	hypopigmentation	22	0.95
DB00672	Chlorpropamide	liver cirrhosis biliary	23	0.95
DB00672	Chlorpropamide	coronary disease	37	0.97
DB00672	Chlorpropamide	amyotrophic lateral sclerosis	21	0.98
DB00672	Chlorpropamide	parkinson disease	30	0.98
DB00672	Chlorpropamide	arteriosclerosis	38	0.99
DB00672	Chlorpropamide	parkinsonian disorders	31	0.99
DB00672	Chlorpropamide	myocardial ischemia	43	0.99
DB00672	Chlorpropamide	liver cirrhosis	24	1.00
DB00672	Chlorpropamide	malabsorption syndromes	34	1.02
DB00672	Chlorpropamide	asthma	36	1.03
DB00672	Chlorpropamide	neuroendocrine tumors	24	1.04
DB00672	Chlorpropamide	sarcoma	25	1.13
DB00672	Chlorpropamide	lymphoma non hodgkin	22	1.14
DB00672	Chlorpropamide	arterial occlusive diseases	44	1.16
DB00672	Chlorpropamide	motor neuron disease	31	1.17
DB00672	Chlorpropamide	blood coagulation disorders	40	1.19
DB00672	Chlorpropamide	hypersensitivity	45	1.21
DB00672	Chlorpropamide	lymphoma	24	1.24
DB00672	Chlorpropamide	colitis	55	1.26
DB00672	Chlorpropamide	head and neck neoplasms	35	1.28
DB00672	Chlorpropamide	adenocarcinoma	32	1.35
DB00672	Chlorpropamide	colitis ulcerative	55	1.36
DB00672	Chlorpropamide	breast neoplasms	40	1.41
DB00672	Chlorpropamide	psoriasis	54	1.44
DB00672	Chlorpropamide	prostatic neoplasms	61	1.45
DB00672	Chlorpropamide	lupus erythematosus systemic	75	1.53
DB00672	Chlorpropamide	intestinal neoplasms	42	1.56
DB00672	Chlorpropamide	multiple sclerosis	69	1.59
DB00672	Chlorpropamide	diabetes mellitus type 1	82	1.62
DB00672	Chlorpropamide	colorectal neoplasms	42	1.64
DB00672	Chlorpropamide	leukemia myeloid acute	43	1.64
DB00672	Chlorpropamide	crohn disease	71	1.66
DB00672	Chlorpropamide	anemia	58	1.67
DB00672	Chlorpropamide	leukemia lymphoid	66	1.79
DB00672	Chlorpropamide	lung diseases	71	1.79
DB00672	Chlorpropamide	gastroenteritis	122	1.90
DB00672	Chlorpropamide	gastrointestinal neoplasms	72	1.98
DB00672	Chlorpropamide	inflammatory bowel diseases	119	1.99
DB00672	Chlorpropamide	leukemia	117	2.06
DB00672	Chlorpropamide	eye diseases	231	2.07
DB00672	Chlorpropamide	vascular diseases	181	2.19
DB00672	Chlorpropamide	bone diseases	144	2.19
DB00672	Chlorpropamide	hematologic diseases	188	2.40
DB01022	Phytonadione	prostatic neoplasms	61	-4.71
DB01022	Phytonadione	blood coagulation disorders	40	-4.63
DB01022	Phytonadione	hematologic diseases	188	-3.88
DB01022	Phytonadione	neoplasms	482	-3.37
DB01022	Phytonadione	insulin resistance	26	-2.69
DB01022	Phytonadione	hyperinsulinism	26	-2.59
DB01022	Phytonadione	diabetes mellitus type 1	82	-1.79
DB01022	Phytonadione	diabetes mellitus	162	-1.61
DB01022	Phytonadione	vascular diseases	181	-1.40
DB01022	Phytonadione	autoimmune diseases	243	-1.29
DB01022	Phytonadione	metabolism inborn errors	289	-1.26
DB01022	Phytonadione	thyroid diseases	30	-1.22
DB01022	Phytonadione	anemia hemolytic	29	-1.15
DB01022	Phytonadione	endocrine system diseases	291	-1.10
DB01022	Phytonadione	cardiovascular diseases	330	-1.07
DB01022	Phytonadione	diabetes mellitus type 2	72	-0.60
DB01022	Phytonadione	lupus erythematosus systemic	75	-0.54
DB01022	Phytonadione	anemia	58	-0.43
DB01022	Phytonadione	epilepsy	25	-0.22
DB01022	Phytonadione	kidney diseases	144	-0.14
DB01022	Phytonadione	bone diseases metabolic	27	-0.10
DB01022	Phytonadione	bone diseases	144	-0.10
DB01022	Phytonadione	heart diseases	167	-0.08
DB01022	Phytonadione	macular degeneration	44	0.02
DB01022	Phytonadione	mycobacterium infections	22	0.05
DB01022	Phytonadione	eye diseases	231	0.11
DB01022	Phytonadione	bacterial infections	26	0.17
DB01022	Phytonadione	arteriosclerosis	38	0.24
DB01022	Phytonadione	alzheimer disease	29	0.26
DB01022	Phytonadione	skin diseases	278	0.37
DB01022	Phytonadione	arterial occlusive diseases	44	0.44
DB01022	Phytonadione	hypersensitivity	45	0.46
DB01022	Phytonadione	arthritis rheumatoid	42	0.60
DB01022	Phytonadione	colitis	55	0.61
DB01022	Phytonadione	dementia	42	0.65
DB01022	Phytonadione	colitis ulcerative	55	0.66
DB01022	Phytonadione	rheumatic diseases	59	0.80
DB01022	Phytonadione	multiple sclerosis	69	0.86
DB01022	Phytonadione	colorectal neoplasms	42	0.91
DB01022	Phytonadione	intestinal neoplasms	42	0.91
DB01022	Phytonadione	varicose veins	20	0.96
DB01022	Phytonadione	arthritis	76	1.01
DB01022	Phytonadione	arrhythmias cardiac	30	1.05
DB01022	Phytonadione	lung diseases	71	1.07
DB01022	Phytonadione	joint diseases	79	1.08
DB01022	Phytonadione	collagen diseases	25	1.10
DB01022	Phytonadione	keratosis	21	1.23
DB01022	Phytonadione	coronary artery disease	31	1.26
DB01022	Phytonadione	inflammatory bowel diseases	119	1.27
DB01022	Phytonadione	gastroenteritis	122	1.28
DB01022	Phytonadione	gastrointestinal neoplasms	72	1.29
DB01022	Phytonadione	kidney neoplasms	20	1.38
DB01022	Phytonadione	hypopigmentation	22	1.39
DB01022	Phytonadione	parkinson disease	30	1.41
DB01022	Phytonadione	pancreatic diseases	24	1.43
DB01022	Phytonadione	coronary disease	37	1.44
DB01022	Phytonadione	liver cirrhosis biliary	23	1.45
DB01022	Phytonadione	amyotrophic lateral sclerosis	21	1.49
DB01022	Phytonadione	liver cirrhosis	24	1.50
DB01022	Phytonadione	malabsorption syndromes	34	1.50
DB01022	Phytonadione	parkinsonian disorders	31	1.52
DB01022	Phytonadione	asthma	36	1.54
DB01022	Phytonadione	neuroendocrine tumors	24	1.55
DB01022	Phytonadione	myocardial ischemia	43	1.55
DB01022	Phytonadione	cardiomyopathy dilated	29	1.56
DB01022	Phytonadione	lymphoma	24	1.68
DB01022	Phytonadione	sarcoma	25	1.71
DB01022	Phytonadione	lymphoma non hodgkin	22	1.76
DB01022	Phytonadione	motor neuron disease	31	1.79
DB01022	Phytonadione	adenocarcinoma	32	1.91
DB01022	Phytonadione	head and neck neoplasms	35	1.93
DB01022	Phytonadione	breast neoplasms	40	1.96
DB01022	Phytonadione	psoriasis	54	2.10
DB01022	Phytonadione	crohn disease	71	2.35
DB01022	Phytonadione	leukemia myeloid acute	43	2.43
DB01022	Phytonadione	leukemia lymphoid	66	2.45
DB01022	Phytonadione	spinal cord diseases	59	2.46
DB01022	Phytonadione	leukemia	117	3.18
DB00269	Chlorotrianisene	cardiovascular diseases	330	-6.67
DB00269	Chlorotrianisene	skin diseases	278	-5.18
DB00269	Chlorotrianisene	heart diseases	167	-4.64
DB00269	Chlorotrianisene	neoplasms	482	-3.07
DB00269	Chlorotrianisene	breast neoplasms	40	-2.95
DB00269	Chlorotrianisene	coronary artery disease	31	-1.33
DB00269	Chlorotrianisene	coronary disease	37	-1.28
DB00269	Chlorotrianisene	myocardial ischemia	43	-1.20
DB00269	Chlorotrianisene	thyroid diseases	30	-1.17
DB00269	Chlorotrianisene	arteriosclerosis	38	-1.05
DB00269	Chlorotrianisene	cardiomyopathy dilated	29	-1.01
DB00269	Chlorotrianisene	arterial occlusive diseases	44	-0.95
DB00269	Chlorotrianisene	alzheimer disease	29	-0.92
DB00269	Chlorotrianisene	kidney neoplasms	20	-0.87
DB00269	Chlorotrianisene	colitis ulcerative	55	-0.87
DB00269	Chlorotrianisene	colitis	55	-0.85
DB00269	Chlorotrianisene	diabetes mellitus type 2	72	-0.83
DB00269	Chlorotrianisene	dementia	42	-0.72
DB00269	Chlorotrianisene	sarcoma	25	-0.72
DB00269	Chlorotrianisene	liver cirrhosis biliary	23	-0.70
DB00269	Chlorotrianisene	liver cirrhosis	24	-0.70
DB00269	Chlorotrianisene	pancreatic diseases	24	-0.68
DB00269	Chlorotrianisene	asthma	36	-0.65
DB00269	Chlorotrianisene	neuroendocrine tumors	24	-0.64
DB00269	Chlorotrianisene	hypersensitivity	45	-0.55
DB00269	Chlorotrianisene	prostatic neoplasms	61	-0.53
DB00269	Chlorotrianisene	diabetes mellitus type 1	82	-0.52
DB00269	Chlorotrianisene	lymphoma non hodgkin	22	-0.52
DB00269	Chlorotrianisene	head and neck neoplasms	35	-0.51
DB00269	Chlorotrianisene	motor neuron disease	31	-0.51
DB00269	Chlorotrianisene	lymphoma	24	-0.51
DB00269	Chlorotrianisene	adenocarcinoma	32	-0.46
DB00269	Chlorotrianisene	lupus erythematosus systemic	75	-0.42
DB00269	Chlorotrianisene	crohn disease	71	-0.35
DB00269	Chlorotrianisene	diabetes mellitus	162	-0.29
DB00269	Chlorotrianisene	colorectal neoplasms	42	-0.28
DB00269	Chlorotrianisene	leukemia myeloid acute	43	-0.28
DB00269	Chlorotrianisene	spinal cord diseases	59	-0.27
DB00269	Chlorotrianisene	leukemia lymphoid	66	-0.26
DB00269	Chlorotrianisene	inflammatory bowel diseases	119	-0.25
DB00269	Chlorotrianisene	metabolism inborn errors	289	-0.24
DB00269	Chlorotrianisene	intestinal neoplasms	42	-0.22
DB00269	Chlorotrianisene	kidney diseases	144	-0.22
DB00269	Chlorotrianisene	multiple sclerosis	69	-0.22
DB00269	Chlorotrianisene	gastroenteritis	122	-0.22
DB00269	Chlorotrianisene	anemia	58	-0.19
DB00269	Chlorotrianisene	lung diseases	71	-0.14
DB00269	Chlorotrianisene	gastrointestinal neoplasms	72	-0.03
DB00269	Chlorotrianisene	bone diseases	144	0.01
DB00269	Chlorotrianisene	eye diseases	231	0.04
DB00269	Chlorotrianisene	vascular diseases	181	0.07
DB00269	Chlorotrianisene	leukemia	117	0.10
DB00269	Chlorotrianisene	endocrine system diseases	291	0.11
DB00269	Chlorotrianisene	autoimmune diseases	243	0.12
DB00269	Chlorotrianisene	hematologic diseases	188	0.17
DB00269	Chlorotrianisene	arrhythmias cardiac	30	0.45
DB00269	Chlorotrianisene	collagen diseases	25	0.48
DB00269	Chlorotrianisene	macular degeneration	44	0.49
DB00269	Chlorotrianisene	epilepsy	25	0.54
DB00269	Chlorotrianisene	varicose veins	20	0.55
DB00269	Chlorotrianisene	bone diseases metabolic	27	0.57
DB00269	Chlorotrianisene	parkinson disease	30	0.62
DB00269	Chlorotrianisene	parkinsonian disorders	31	0.63
DB00269	Chlorotrianisene	insulin resistance	26	0.66
DB00269	Chlorotrianisene	hyperinsulinism	26	0.66
DB00269	Chlorotrianisene	anemia hemolytic	29	0.77
DB00269	Chlorotrianisene	keratosis	21	0.86
DB00269	Chlorotrianisene	malabsorption syndromes	34	0.98
DB00269	Chlorotrianisene	blood coagulation disorders	40	0.98
DB00269	Chlorotrianisene	hypopigmentation	22	0.99
DB00269	Chlorotrianisene	mycobacterium infections	22	1.09
DB00269	Chlorotrianisene	amyotrophic lateral sclerosis	21	1.10
DB00269	Chlorotrianisene	bacterial infections	26	1.31
DB00269	Chlorotrianisene	psoriasis	54	1.77
DB00269	Chlorotrianisene	arthritis rheumatoid	42	1.93
DB00269	Chlorotrianisene	rheumatic diseases	59	2.33
DB00269	Chlorotrianisene	joint diseases	79	2.94
DB00269	Chlorotrianisene	arthritis	76	2.95
DB00810	Biperiden	epilepsy	25	-3.30
DB00810	Biperiden	lung diseases	71	-0.83
DB00810	Biperiden	hyperinsulinism	26	-0.74
DB00810	Biperiden	insulin resistance	26	-0.66
DB00810	Biperiden	macular degeneration	44	-0.50
DB00810	Biperiden	pancreatic diseases	24	-0.35
DB00810	Biperiden	eye diseases	231	-0.32
DB00810	Biperiden	arteriosclerosis	38	-0.29
DB00810	Biperiden	arterial occlusive diseases	44	-0.18
DB00810	Biperiden	colitis ulcerative	55	-0.03
DB00810	Biperiden	colitis	55	-0.02
DB00810	Biperiden	dementia	42	-0.01
DB00810	Biperiden	diabetes mellitus type 2	72	0.10
DB00810	Biperiden	psoriasis	54	0.11
DB00810	Biperiden	lupus erythematosus systemic	75	0.18
DB00810	Biperiden	crohn disease	71	0.22
DB00810	Biperiden	neoplasms	482	0.24
DB00810	Biperiden	diabetes mellitus type 1	82	0.25
DB00810	Biperiden	leukemia lymphoid	66	0.35
DB00810	Biperiden	collagen diseases	25	0.52
DB00810	Biperiden	gastroenteritis	122	0.52
DB00810	Biperiden	inflammatory bowel diseases	119	0.53
DB00810	Biperiden	arrhythmias cardiac	30	0.54
DB00810	Biperiden	kidney diseases	144	0.57
DB00810	Biperiden	bone diseases	144	0.67
DB00810	Biperiden	coronary artery disease	31	0.68
DB00810	Biperiden	diabetes mellitus	162	0.69
DB00810	Biperiden	liver cirrhosis	24	0.75
DB00810	Biperiden	thyroid diseases	30	0.76
DB00810	Biperiden	bacterial infections	26	0.76
DB00810	Biperiden	coronary disease	37	0.78
DB00810	Biperiden	amyotrophic lateral sclerosis	21	0.79
DB00810	Biperiden	leukemia	117	0.82
DB00810	Biperiden	liver cirrhosis biliary	23	0.83
DB00810	Biperiden	parkinsonian disorders	31	0.83
DB00810	Biperiden	vascular diseases	181	0.83
DB00810	Biperiden	myocardial ischemia	43	0.84
DB00810	Biperiden	parkinson disease	30	0.84
DB00810	Biperiden	alzheimer disease	29	0.86
DB00810	Biperiden	cardiomyopathy dilated	29	0.90
DB00810	Biperiden	lymphoma	24	0.94
DB00810	Biperiden	metabolism inborn errors	289	0.96
DB00810	Biperiden	lymphoma non hodgkin	22	0.98
DB00810	Biperiden	autoimmune diseases	243	1.04
DB00810	Biperiden	hematologic diseases	188	1.05
DB00810	Biperiden	motor neuron disease	31	1.07
DB00810	Biperiden	adenocarcinoma	32	1.11
DB00810	Biperiden	endocrine system diseases	291	1.13
DB00810	Biperiden	skin diseases	278	1.19
DB00810	Biperiden	prostatic neoplasms	61	1.21
DB00810	Biperiden	breast neoplasms	40	1.24
DB00810	Biperiden	cardiovascular diseases	330	1.29
DB00810	Biperiden	colorectal neoplasms	42	1.32
DB00810	Biperiden	leukemia myeloid acute	43	1.38
DB00810	Biperiden	intestinal neoplasms	42	1.40
DB00810	Biperiden	spinal cord diseases	59	1.44
DB00810	Biperiden	arthritis	76	1.47
DB00810	Biperiden	joint diseases	79	1.49
DB00810	Biperiden	anemia	58	1.55
DB00810	Biperiden	varicose veins	20	1.64
DB00810	Biperiden	gastrointestinal neoplasms	72	1.78
DB00810	Biperiden	bone diseases metabolic	27	1.79
DB00810	Biperiden	mycobacterium infections	22	1.84
DB00810	Biperiden	keratosis	21	1.86
DB00810	Biperiden	kidney neoplasms	20	1.88
DB00810	Biperiden	hypopigmentation	22	1.92
DB00810	Biperiden	anemia hemolytic	29	1.97
DB00810	Biperiden	heart diseases	167	2.02
DB00810	Biperiden	neuroendocrine tumors	24	2.03
DB00810	Biperiden	malabsorption syndromes	34	2.03
DB00810	Biperiden	asthma	36	2.04
DB00810	Biperiden	hypersensitivity	45	2.11
DB00810	Biperiden	sarcoma	25	2.14
DB00810	Biperiden	blood coagulation disorders	40	2.25
DB00810	Biperiden	arthritis rheumatoid	42	2.30
DB00810	Biperiden	head and neck neoplasms	35	2.37
DB00810	Biperiden	rheumatic diseases	59	2.62
DB00810	Biperiden	multiple sclerosis	69	2.68
DB00522	Bentiromide	blood coagulation disorders	40	-2.53
DB00522	Bentiromide	hematologic diseases	188	-2.13
DB00522	Bentiromide	insulin resistance	26	-1.10
DB00522	Bentiromide	hyperinsulinism	26	-1.10
DB00522	Bentiromide	mycobacterium infections	22	-1.02
DB00522	Bentiromide	thyroid diseases	30	-0.94
DB00522	Bentiromide	bacterial infections	26	-0.89
DB00522	Bentiromide	kidney neoplasms	20	-0.88
DB00522	Bentiromide	colitis ulcerative	55	-0.65
DB00522	Bentiromide	adenocarcinoma	32	-0.65
DB00522	Bentiromide	colitis	55	-0.62
DB00522	Bentiromide	diabetes mellitus type 2	72	-0.61
DB00522	Bentiromide	prostatic neoplasms	61	-0.54
DB00522	Bentiromide	diabetes mellitus type 1	82	-0.49
DB00522	Bentiromide	inflammatory bowel diseases	119	-0.32
DB00522	Bentiromide	gastrointestinal neoplasms	72	-0.32
DB00522	Bentiromide	gastroenteritis	122	-0.30
DB00522	Bentiromide	diabetes mellitus	162	-0.27
DB00522	Bentiromide	kidney diseases	144	-0.24
DB00522	Bentiromide	vascular diseases	181	-0.14
DB00522	Bentiromide	eye diseases	231	-0.08
DB00522	Bentiromide	autoimmune diseases	243	0.01
DB00522	Bentiromide	endocrine system diseases	291	0.03
DB00522	Bentiromide	skin diseases	278	0.03
DB00522	Bentiromide	cardiovascular diseases	330	0.07
DB00522	Bentiromide	neoplasms	482	0.35
DB00522	Bentiromide	varicose veins	20	0.47
DB00522	Bentiromide	bone diseases metabolic	27	0.57
DB00522	Bentiromide	arrhythmias cardiac	30	0.58
DB00522	Bentiromide	collagen diseases	25	0.60
DB00522	Bentiromide	keratosis	21	0.62
DB00522	Bentiromide	coronary artery disease	31	0.66
DB00522	Bentiromide	macular degeneration	44	0.69
DB00522	Bentiromide	coronary disease	37	0.75
DB00522	Bentiromide	parkinsonian disorders	31	0.77
DB00522	Bentiromide	anemia hemolytic	29	0.77
DB00522	Bentiromide	amyotrophic lateral sclerosis	21	0.78
DB00522	Bentiromide	malabsorption syndromes	34	0.78
DB00522	Bentiromide	pancreatic diseases	24	0.78
DB00522	Bentiromide	neuroendocrine tumors	24	0.80
DB00522	Bentiromide	liver cirrhosis	24	0.81
DB00522	Bentiromide	liver cirrhosis biliary	23	0.81
DB00522	Bentiromide	asthma	36	0.81
DB00522	Bentiromide	myocardial ischemia	43	0.81
DB00522	Bentiromide	parkinson disease	30	0.82
DB00522	Bentiromide	alzheimer disease	29	0.83
DB00522	Bentiromide	arteriosclerosis	38	0.84
DB00522	Bentiromide	sarcoma	25	0.87
DB00522	Bentiromide	lymphoma non hodgkin	22	0.87
DB00522	Bentiromide	cardiomyopathy dilated	29	0.87
DB00522	Bentiromide	lymphoma	24	0.90
DB00522	Bentiromide	hypersensitivity	45	0.95
DB00522	Bentiromide	arterial occlusive diseases	44	0.95
DB00522	Bentiromide	motor neuron disease	31	0.98
DB00522	Bentiromide	arthritis rheumatoid	42	1.04
DB00522	Bentiromide	head and neck neoplasms	35	1.06
DB00522	Bentiromide	breast neoplasms	40	1.06
DB00522	Bentiromide	dementia	42	1.07
DB00522	Bentiromide	psoriasis	54	1.11
DB00522	Bentiromide	rheumatic diseases	59	1.18
DB00522	Bentiromide	leukemia myeloid acute	43	1.22
DB00522	Bentiromide	intestinal neoplasms	42	1.23
DB00522	Bentiromide	lupus erythematosus systemic	75	1.23
DB00522	Bentiromide	crohn disease	71	1.25
DB00522	Bentiromide	multiple sclerosis	69	1.26
DB00522	Bentiromide	colorectal neoplasms	42	1.27
DB00522	Bentiromide	spinal cord diseases	59	1.29
DB00522	Bentiromide	arthritis	76	1.37
DB00522	Bentiromide	lung diseases	71	1.38
DB00522	Bentiromide	joint diseases	79	1.40
DB00522	Bentiromide	anemia	58	1.43
DB00522	Bentiromide	leukemia lymphoid	66	1.50
DB00522	Bentiromide	bone diseases	144	1.60
DB00522	Bentiromide	heart diseases	167	1.70
DB00522	Bentiromide	metabolism inborn errors	289	1.71
DB00522	Bentiromide	leukemia	117	1.76
DB00522	Bentiromide	epilepsy	25	2.15
DB00522	Bentiromide	hypopigmentation	22	2.49
DB00126	Vitamin.C	bone diseases	144	-2.94
DB00126	Vitamin.C	collagen diseases	25	-2.60
DB00126	Vitamin.C	bone diseases metabolic	27	-2.25
DB00126	Vitamin.C	hematologic diseases	188	-2.02
DB00126	Vitamin.C	neuroendocrine tumors	24	-1.84
DB00126	Vitamin.C	lupus erythematosus systemic	75	-1.72
DB00126	Vitamin.C	multiple sclerosis	69	-1.62
DB00126	Vitamin.C	vascular diseases	181	-1.62
DB00126	Vitamin.C	head and neck neoplasms	35	-1.52
DB00126	Vitamin.C	lymphoma non hodgkin	22	-1.49
DB00126	Vitamin.C	leukemia	117	-1.47
DB00126	Vitamin.C	adenocarcinoma	32	-1.46
DB00126	Vitamin.C	coronary disease	37	-1.43
DB00126	Vitamin.C	lymphoma	24	-1.39
DB00126	Vitamin.C	bacterial infections	26	-1.34
DB00126	Vitamin.C	amyotrophic lateral sclerosis	21	-1.25
DB00126	Vitamin.C	neoplasms	482	-1.24
DB00126	Vitamin.C	myocardial ischemia	43	-1.17
DB00126	Vitamin.C	autoimmune diseases	243	-1.14
DB00126	Vitamin.C	kidney diseases	144	-1.09
DB00126	Vitamin.C	kidney neoplasms	20	-1.01
DB00126	Vitamin.C	coronary artery disease	31	-0.94
DB00126	Vitamin.C	mycobacterium infections	22	-0.92
DB00126	Vitamin.C	intestinal neoplasms	42	-0.89
DB00126	Vitamin.C	leukemia myeloid acute	43	-0.88
DB00126	Vitamin.C	colorectal neoplasms	42	-0.88
DB00126	Vitamin.C	leukemia lymphoid	66	-0.85
DB00126	Vitamin.C	prostatic neoplasms	61	-0.84
DB00126	Vitamin.C	motor neuron disease	31	-0.81
DB00126	Vitamin.C	breast neoplasms	40	-0.76
DB00126	Vitamin.C	endocrine system diseases	291	-0.76
DB00126	Vitamin.C	spinal cord diseases	59	-0.68
DB00126	Vitamin.C	arteriosclerosis	38	-0.68
DB00126	Vitamin.C	dementia	42	-0.61
DB00126	Vitamin.C	cardiomyopathy dilated	29	-0.59
DB00126	Vitamin.C	cardiovascular diseases	330	-0.54
DB00126	Vitamin.C	lung diseases	71	-0.44
DB00126	Vitamin.C	gastrointestinal neoplasms	72	-0.42
DB00126	Vitamin.C	pancreatic diseases	24	-0.41
DB00126	Vitamin.C	metabolism inborn errors	289	-0.41
DB00126	Vitamin.C	liver cirrhosis	24	-0.40
DB00126	Vitamin.C	inflammatory bowel diseases	119	-0.39
DB00126	Vitamin.C	liver cirrhosis biliary	23	-0.39
DB00126	Vitamin.C	gastroenteritis	122	-0.37
DB00126	Vitamin.C	psoriasis	54	-0.34
DB00126	Vitamin.C	heart diseases	167	-0.29
DB00126	Vitamin.C	arthritis rheumatoid	42	-0.26
DB00126	Vitamin.C	arterial occlusive diseases	44	-0.24
DB00126	Vitamin.C	hypopigmentation	22	-0.20
DB00126	Vitamin.C	colitis ulcerative	55	-0.19
DB00126	Vitamin.C	alzheimer disease	29	-0.19
DB00126	Vitamin.C	asthma	36	-0.16
DB00126	Vitamin.C	colitis	55	-0.15
DB00126	Vitamin.C	rheumatic diseases	59	-0.15
DB00126	Vitamin.C	hypersensitivity	45	-0.12
DB00126	Vitamin.C	joint diseases	79	-0.11
DB00126	Vitamin.C	parkinson disease	30	-0.09
DB00126	Vitamin.C	parkinsonian disorders	31	-0.07
DB00126	Vitamin.C	arthritis	76	-0.04
DB00126	Vitamin.C	diabetes mellitus	162	0.03
DB00126	Vitamin.C	diabetes mellitus type 1	82	0.15
DB00126	Vitamin.C	crohn disease	71	0.18
DB00126	Vitamin.C	diabetes mellitus type 2	72	0.20
DB00126	Vitamin.C	skin diseases	278	0.20
DB00126	Vitamin.C	eye diseases	231	0.21
DB00126	Vitamin.C	keratosis	21	0.23
DB00126	Vitamin.C	macular degeneration	44	0.33
DB00126	Vitamin.C	sarcoma	25	0.35
DB00126	Vitamin.C	malabsorption syndromes	34	0.46
DB00126	Vitamin.C	thyroid diseases	30	0.53
DB00126	Vitamin.C	arrhythmias cardiac	30	0.62
DB00126	Vitamin.C	blood coagulation disorders	40	0.67
DB00126	Vitamin.C	varicose veins	20	0.86
DB00126	Vitamin.C	hyperinsulinism	26	0.88
DB00126	Vitamin.C	anemia	58	0.90
DB00126	Vitamin.C	insulin resistance	26	0.93
DB00126	Vitamin.C	anemia hemolytic	29	0.97
DB00126	Vitamin.C	epilepsy	25	1.18
DB00387	Procyclidine	thyroid diseases	30	-1.51
DB00387	Procyclidine	liver cirrhosis	24	-1.41
DB00387	Procyclidine	liver cirrhosis biliary	23	-1.40
DB00387	Procyclidine	pancreatic diseases	24	-1.38
DB00387	Procyclidine	arteriosclerosis	38	-1.37
DB00387	Procyclidine	arterial occlusive diseases	44	-1.18
DB00387	Procyclidine	epilepsy	25	-1.15
DB00387	Procyclidine	colitis	55	-1.03
DB00387	Procyclidine	hyperinsulinism	26	-1.01
DB00387	Procyclidine	insulin resistance	26	-0.99
DB00387	Procyclidine	head and neck neoplasms	35	-0.98
DB00387	Procyclidine	dementia	42	-0.97
DB00387	Procyclidine	colitis ulcerative	55	-0.97
DB00387	Procyclidine	psoriasis	54	-0.81
DB00387	Procyclidine	eye diseases	231	-0.76
DB00387	Procyclidine	lupus erythematosus systemic	75	-0.74
DB00387	Procyclidine	leukemia myeloid acute	43	-0.72
DB00387	Procyclidine	diabetes mellitus type 1	82	-0.65
DB00387	Procyclidine	crohn disease	71	-0.65
DB00387	Procyclidine	hypopigmentation	22	-0.61
DB00387	Procyclidine	arthritis	76	-0.57
DB00387	Procyclidine	leukemia lymphoid	66	-0.54
DB00387	Procyclidine	lung diseases	71	-0.51
DB00387	Procyclidine	joint diseases	79	-0.50
DB00387	Procyclidine	neuroendocrine tumors	24	-0.47
DB00387	Procyclidine	asthma	36	-0.38
DB00387	Procyclidine	gastrointestinal neoplasms	72	-0.34
DB00387	Procyclidine	skin diseases	278	-0.33
DB00387	Procyclidine	gastroenteritis	122	-0.32
DB00387	Procyclidine	lymphoma non hodgkin	22	-0.32
DB00387	Procyclidine	inflammatory bowel diseases	119	-0.29
DB00387	Procyclidine	lymphoma	24	-0.28
DB00387	Procyclidine	hypersensitivity	45	-0.22
DB00387	Procyclidine	diabetes mellitus	162	-0.18
DB00387	Procyclidine	kidney diseases	144	-0.13
DB00387	Procyclidine	bone diseases	144	-0.11
DB00387	Procyclidine	adenocarcinoma	32	-0.06
DB00387	Procyclidine	bone diseases metabolic	27	-0.03
DB00387	Procyclidine	mycobacterium infections	22	0.00
DB00387	Procyclidine	diabetes mellitus type 2	72	0.07
DB00387	Procyclidine	keratosis	21	0.07
DB00387	Procyclidine	leukemia	117	0.08
DB00387	Procyclidine	coronary artery disease	31	0.09
DB00387	Procyclidine	vascular diseases	181	0.18
DB00387	Procyclidine	anemia hemolytic	29	0.22
DB00387	Procyclidine	kidney neoplasms	20	0.23
DB00387	Procyclidine	intestinal neoplasms	42	0.25
DB00387	Procyclidine	neoplasms	482	0.26
DB00387	Procyclidine	bacterial infections	26	0.28
DB00387	Procyclidine	metabolism inborn errors	289	0.29
DB00387	Procyclidine	autoimmune diseases	243	0.30
DB00387	Procyclidine	parkinson disease	30	0.30
DB00387	Procyclidine	multiple sclerosis	69	0.31
DB00387	Procyclidine	coronary disease	37	0.32
DB00387	Procyclidine	colorectal neoplasms	42	0.33
DB00387	Procyclidine	amyotrophic lateral sclerosis	21	0.33
DB00387	Procyclidine	parkinsonian disorders	31	0.33
DB00387	Procyclidine	spinal cord diseases	59	0.33
DB00387	Procyclidine	malabsorption syndromes	34	0.33
DB00387	Procyclidine	hematologic diseases	188	0.34
DB00387	Procyclidine	myocardial ischemia	43	0.42
DB00387	Procyclidine	alzheimer disease	29	0.44
DB00387	Procyclidine	anemia	58	0.44
DB00387	Procyclidine	cardiomyopathy dilated	29	0.46
DB00387	Procyclidine	endocrine system diseases	291	0.47
DB00387	Procyclidine	varicose veins	20	0.56
DB00387	Procyclidine	sarcoma	25	0.57
DB00387	Procyclidine	cardiovascular diseases	330	0.62
DB00387	Procyclidine	blood coagulation disorders	40	0.66
DB00387	Procyclidine	motor neuron disease	31	0.75
DB00387	Procyclidine	arrhythmias cardiac	30	0.75
DB00387	Procyclidine	collagen diseases	25	0.86
DB00387	Procyclidine	heart diseases	167	0.92
DB00387	Procyclidine	breast neoplasms	40	1.04
DB00387	Procyclidine	prostatic neoplasms	61	1.07
DB00387	Procyclidine	macular degeneration	44	1.10
DB00387	Procyclidine	arthritis rheumatoid	42	1.80
DB00387	Procyclidine	rheumatic diseases	59	2.11
DB00819	Acetazolamide	anemia hemolytic	29	-2.49
DB00819	Acetazolamide	anemia	58	-2.45
DB00819	Acetazolamide	eye diseases	231	-2.37
DB00819	Acetazolamide	metabolism inborn errors	289	-2.30
DB00819	Acetazolamide	kidney diseases	144	-1.98
DB00819	Acetazolamide	bone diseases	144	-1.75
DB00819	Acetazolamide	hematologic diseases	188	-1.42
DB00819	Acetazolamide	neuroendocrine tumors	24	-1.42
DB00819	Acetazolamide	adenocarcinoma	32	-0.99
DB00819	Acetazolamide	head and neck neoplasms	35	-0.97
DB00819	Acetazolamide	hypopigmentation	22	-0.64
DB00819	Acetazolamide	kidney neoplasms	20	-0.64
DB00819	Acetazolamide	liver cirrhosis	24	-0.58
DB00819	Acetazolamide	liver cirrhosis biliary	23	-0.57
DB00819	Acetazolamide	cardiomyopathy dilated	29	-0.49
DB00819	Acetazolamide	neoplasms	482	-0.41
DB00819	Acetazolamide	asthma	36	-0.38
DB00819	Acetazolamide	blood coagulation disorders	40	-0.30
DB00819	Acetazolamide	hypersensitivity	45	-0.22
DB00819	Acetazolamide	epilepsy	25	-0.18
DB00819	Acetazolamide	arthritis rheumatoid	42	-0.14
DB00819	Acetazolamide	diabetes mellitus	162	-0.12
DB00819	Acetazolamide	insulin resistance	26	-0.09
DB00819	Acetazolamide	hyperinsulinism	26	-0.08
DB00819	Acetazolamide	prostatic neoplasms	61	0.00
DB00819	Acetazolamide	heart diseases	167	0.00
DB00819	Acetazolamide	bone diseases metabolic	27	0.02
DB00819	Acetazolamide	breast neoplasms	40	0.03
DB00819	Acetazolamide	diabetes mellitus type 2	72	0.05
DB00819	Acetazolamide	mycobacterium infections	22	0.13
DB00819	Acetazolamide	rheumatic diseases	59	0.13
DB00819	Acetazolamide	coronary artery disease	31	0.16
DB00819	Acetazolamide	multiple sclerosis	69	0.19
DB00819	Acetazolamide	keratosis	21	0.21
DB00819	Acetazolamide	lupus erythematosus systemic	75	0.22
DB00819	Acetazolamide	diabetes mellitus type 1	82	0.27
DB00819	Acetazolamide	bacterial infections	26	0.31
DB00819	Acetazolamide	coronary disease	37	0.34
DB00819	Acetazolamide	joint diseases	79	0.36
DB00819	Acetazolamide	pancreatic diseases	24	0.37
DB00819	Acetazolamide	lung diseases	71	0.42
DB00819	Acetazolamide	arthritis	76	0.44
DB00819	Acetazolamide	myocardial ischemia	43	0.46
DB00819	Acetazolamide	arteriosclerosis	38	0.52
DB00819	Acetazolamide	autoimmune diseases	243	0.52
DB00819	Acetazolamide	lymphoma	24	0.61
DB00819	Acetazolamide	lymphoma non hodgkin	22	0.63
DB00819	Acetazolamide	gastrointestinal neoplasms	72	0.64
DB00819	Acetazolamide	arterial occlusive diseases	44	0.65
DB00819	Acetazolamide	endocrine system diseases	291	0.65
DB00819	Acetazolamide	varicose veins	20	0.67
DB00819	Acetazolamide	skin diseases	278	0.71
DB00819	Acetazolamide	cardiovascular diseases	330	0.76
DB00819	Acetazolamide	motor neuron disease	31	0.78
DB00819	Acetazolamide	colitis	55	0.91
DB00819	Acetazolamide	arrhythmias cardiac	30	0.92
DB00819	Acetazolamide	dementia	42	0.94
DB00819	Acetazolamide	colitis ulcerative	55	0.94
DB00819	Acetazolamide	collagen diseases	25	0.96
DB00819	Acetazolamide	psoriasis	54	0.99
DB00819	Acetazolamide	vascular diseases	181	1.14
DB00819	Acetazolamide	macular degeneration	44	1.15
DB00819	Acetazolamide	colorectal neoplasms	42	1.15
DB00819	Acetazolamide	crohn disease	71	1.18
DB00819	Acetazolamide	leukemia myeloid acute	43	1.20
DB00819	Acetazolamide	intestinal neoplasms	42	1.22
DB00819	Acetazolamide	thyroid diseases	30	1.23
DB00819	Acetazolamide	spinal cord diseases	59	1.25
DB00819	Acetazolamide	amyotrophic lateral sclerosis	21	1.32
DB00819	Acetazolamide	malabsorption syndromes	34	1.35
DB00819	Acetazolamide	leukemia lymphoid	66	1.37
DB00819	Acetazolamide	parkinsonian disorders	31	1.37
DB00819	Acetazolamide	parkinson disease	30	1.40
DB00819	Acetazolamide	alzheimer disease	29	1.46
DB00819	Acetazolamide	inflammatory bowel diseases	119	1.48
DB00819	Acetazolamide	sarcoma	25	1.50
DB00819	Acetazolamide	gastroenteritis	122	1.55
DB00819	Acetazolamide	leukemia	117	2.00
DB00158	Folic.Acid	colitis ulcerative	55	-1.24
DB00158	Folic.Acid	colitis	55	-1.24
DB00158	Folic.Acid	psoriasis	54	-1.20
DB00158	Folic.Acid	leukemia myeloid acute	43	-1.17
DB00158	Folic.Acid	prostatic neoplasms	61	-1.15
DB00158	Folic.Acid	diabetes mellitus type 1	82	-1.07
DB00158	Folic.Acid	gastroenteritis	122	-0.84
DB00158	Folic.Acid	inflammatory bowel diseases	119	-0.80
DB00158	Folic.Acid	diabetes mellitus	162	-0.73
DB00158	Folic.Acid	leukemia	117	-0.64
DB00158	Folic.Acid	vascular diseases	181	-0.59
DB00158	Folic.Acid	metabolism inborn errors	289	-0.58
DB00158	Folic.Acid	eye diseases	231	-0.55
DB00158	Folic.Acid	autoimmune diseases	243	-0.51
DB00158	Folic.Acid	skin diseases	278	-0.51
DB00158	Folic.Acid	cardiovascular diseases	330	-0.45
DB00158	Folic.Acid	endocrine system diseases	291	-0.43
DB00158	Folic.Acid	neoplasms	482	-0.19
DB00158	Folic.Acid	varicose veins	20	-0.12
DB00158	Folic.Acid	insulin resistance	26	-0.06
DB00158	Folic.Acid	epilepsy	25	-0.05
DB00158	Folic.Acid	hyperinsulinism	26	-0.03
DB00158	Folic.Acid	arrhythmias cardiac	30	-0.03
DB00158	Folic.Acid	bone diseases metabolic	27	-0.02
DB00158	Folic.Acid	keratosis	21	0.01
DB00158	Folic.Acid	mycobacterium infections	22	0.02
DB00158	Folic.Acid	coronary artery disease	31	0.04
DB00158	Folic.Acid	thyroid diseases	30	0.07
DB00158	Folic.Acid	hypopigmentation	22	0.08
DB00158	Folic.Acid	macular degeneration	44	0.09
DB00158	Folic.Acid	kidney neoplasms	20	0.09
DB00158	Folic.Acid	anemia hemolytic	29	0.11
DB00158	Folic.Acid	bacterial infections	26	0.11
DB00158	Folic.Acid	liver cirrhosis biliary	23	0.11
DB00158	Folic.Acid	parkinsonian disorders	31	0.11
DB00158	Folic.Acid	coronary disease	37	0.13
DB00158	Folic.Acid	parkinson disease	30	0.13
DB00158	Folic.Acid	liver cirrhosis	24	0.13
DB00158	Folic.Acid	amyotrophic lateral sclerosis	21	0.14
DB00158	Folic.Acid	arteriosclerosis	38	0.16
DB00158	Folic.Acid	myocardial ischemia	43	0.17
DB00158	Folic.Acid	pancreatic diseases	24	0.17
DB00158	Folic.Acid	asthma	36	0.18
DB00158	Folic.Acid	cardiomyopathy dilated	29	0.20
DB00158	Folic.Acid	alzheimer disease	29	0.20
DB00158	Folic.Acid	neuroendocrine tumors	24	0.20
DB00158	Folic.Acid	malabsorption syndromes	34	0.20
DB00158	Folic.Acid	sarcoma	25	0.21
DB00158	Folic.Acid	hypersensitivity	45	0.23
DB00158	Folic.Acid	lymphoma	24	0.23
DB00158	Folic.Acid	motor neuron disease	31	0.26
DB00158	Folic.Acid	lymphoma non hodgkin	22	0.26
DB00158	Folic.Acid	arterial occlusive diseases	44	0.26
DB00158	Folic.Acid	blood coagulation disorders	40	0.27
DB00158	Folic.Acid	adenocarcinoma	32	0.29
DB00158	Folic.Acid	arthritis rheumatoid	42	0.30
DB00158	Folic.Acid	head and neck neoplasms	35	0.34
DB00158	Folic.Acid	dementia	42	0.36
DB00158	Folic.Acid	rheumatic diseases	59	0.43
DB00158	Folic.Acid	breast neoplasms	40	0.43
DB00158	Folic.Acid	intestinal neoplasms	42	0.45
DB00158	Folic.Acid	diabetes mellitus type 2	72	0.45
DB00158	Folic.Acid	colorectal neoplasms	42	0.45
DB00158	Folic.Acid	lupus erythematosus systemic	75	0.47
DB00158	Folic.Acid	spinal cord diseases	59	0.47
DB00158	Folic.Acid	multiple sclerosis	69	0.49
DB00158	Folic.Acid	crohn disease	71	0.51
DB00158	Folic.Acid	anemia	58	0.54
DB00158	Folic.Acid	joint diseases	79	0.55
DB00158	Folic.Acid	lung diseases	71	0.57
DB00158	Folic.Acid	arthritis	76	0.58
DB00158	Folic.Acid	leukemia lymphoid	66	0.58
DB00158	Folic.Acid	gastrointestinal neoplasms	72	0.71
DB00158	Folic.Acid	kidney diseases	144	0.75
DB00158	Folic.Acid	bone diseases	144	0.80
DB00158	Folic.Acid	heart diseases	167	0.81
DB00158	Folic.Acid	hematologic diseases	188	1.03
DB00158	Folic.Acid	collagen diseases	25	1.55
DB00380	Dexrazoxane	kidney neoplasms	20	-2.73
DB00380	Dexrazoxane	lymphoma non hodgkin	22	-2.14
DB00380	Dexrazoxane	lymphoma	24	-2.07
DB00380	Dexrazoxane	adenocarcinoma	32	-1.97
DB00380	Dexrazoxane	breast neoplasms	40	-1.68
DB00380	Dexrazoxane	leukemia myeloid acute	43	-1.64
DB00380	Dexrazoxane	head and neck neoplasms	35	-1.63
DB00380	Dexrazoxane	bone diseases metabolic	27	-1.60
DB00380	Dexrazoxane	coronary artery disease	31	-1.50
DB00380	Dexrazoxane	lung diseases	71	-1.38
DB00380	Dexrazoxane	coronary disease	37	-1.38
DB00380	Dexrazoxane	kidney diseases	144	-1.32
DB00380	Dexrazoxane	myocardial ischemia	43	-1.25
DB00380	Dexrazoxane	arteriosclerosis	38	-1.16
DB00380	Dexrazoxane	heart diseases	167	-1.08
DB00380	Dexrazoxane	neuroendocrine tumors	24	-1.06
DB00380	Dexrazoxane	gastrointestinal neoplasms	72	-0.99
DB00380	Dexrazoxane	cardiomyopathy dilated	29	-0.90
DB00380	Dexrazoxane	pancreatic diseases	24	-0.90
DB00380	Dexrazoxane	arterial occlusive diseases	44	-0.81
DB00380	Dexrazoxane	metabolism inborn errors	289	-0.81
DB00380	Dexrazoxane	leukemia	117	-0.74
DB00380	Dexrazoxane	vascular diseases	181	-0.73
DB00380	Dexrazoxane	sarcoma	25	-0.68
DB00380	Dexrazoxane	arthritis rheumatoid	42	-0.65
DB00380	Dexrazoxane	hematologic diseases	188	-0.57
DB00380	Dexrazoxane	autoimmune diseases	243	-0.54
DB00380	Dexrazoxane	lupus erythematosus systemic	75	-0.47
DB00380	Dexrazoxane	prostatic neoplasms	61	-0.45
DB00380	Dexrazoxane	rheumatic diseases	59	-0.39
DB00380	Dexrazoxane	cardiovascular diseases	330	-0.36
DB00380	Dexrazoxane	endocrine system diseases	291	-0.33
DB00380	Dexrazoxane	skin diseases	278	-0.33
DB00380	Dexrazoxane	multiple sclerosis	69	-0.29
DB00380	Dexrazoxane	diabetes mellitus type 1	82	-0.23
DB00380	Dexrazoxane	joint diseases	79	-0.14
DB00380	Dexrazoxane	spinal cord diseases	59	-0.14
DB00380	Dexrazoxane	arthritis	76	-0.11
DB00380	Dexrazoxane	colorectal neoplasms	42	-0.09
DB00380	Dexrazoxane	intestinal neoplasms	42	-0.06
DB00380	Dexrazoxane	leukemia lymphoid	66	0.06
DB00380	Dexrazoxane	varicose veins	20	0.14
DB00380	Dexrazoxane	epilepsy	25	0.20
DB00380	Dexrazoxane	insulin resistance	26	0.21
DB00380	Dexrazoxane	arrhythmias cardiac	30	0.23
DB00380	Dexrazoxane	hyperinsulinism	26	0.27
DB00380	Dexrazoxane	diabetes mellitus	162	0.28
DB00380	Dexrazoxane	collagen diseases	25	0.29
DB00380	Dexrazoxane	macular degeneration	44	0.31
DB00380	Dexrazoxane	neoplasms	482	0.33
DB00380	Dexrazoxane	mycobacterium infections	22	0.41
DB00380	Dexrazoxane	keratosis	21	0.44
DB00380	Dexrazoxane	anemia hemolytic	29	0.45
DB00380	Dexrazoxane	malabsorption syndromes	34	0.49
DB00380	Dexrazoxane	bone diseases	144	0.49
DB00380	Dexrazoxane	bacterial infections	26	0.54
DB00380	Dexrazoxane	hypopigmentation	22	0.54
DB00380	Dexrazoxane	thyroid diseases	30	0.59
DB00380	Dexrazoxane	parkinson disease	30	0.63
DB00380	Dexrazoxane	liver cirrhosis	24	0.63
DB00380	Dexrazoxane	asthma	36	0.63
DB00380	Dexrazoxane	liver cirrhosis biliary	23	0.64
DB00380	Dexrazoxane	parkinsonian disorders	31	0.65
DB00380	Dexrazoxane	blood coagulation disorders	40	0.70
DB00380	Dexrazoxane	amyotrophic lateral sclerosis	21	0.70
DB00380	Dexrazoxane	eye diseases	231	0.72
DB00380	Dexrazoxane	hypersensitivity	45	0.73
DB00380	Dexrazoxane	alzheimer disease	29	0.74
DB00380	Dexrazoxane	colitis ulcerative	55	0.89
DB00380	Dexrazoxane	colitis	55	0.92
DB00380	Dexrazoxane	dementia	42	0.95
DB00380	Dexrazoxane	motor neuron disease	31	0.96
DB00380	Dexrazoxane	diabetes mellitus type 2	72	0.96
DB00380	Dexrazoxane	psoriasis	54	1.00
DB00380	Dexrazoxane	crohn disease	71	1.11
DB00380	Dexrazoxane	anemia	58	1.33
DB00380	Dexrazoxane	inflammatory bowel diseases	119	1.56
DB00380	Dexrazoxane	gastroenteritis	122	1.58
DB01394	Colchicine	psoriasis	54	-1.25
DB01394	Colchicine	parkinson disease	30	-1.21
DB01394	Colchicine	arthritis rheumatoid	42	-1.20
DB01394	Colchicine	liver cirrhosis	24	-1.17
DB01394	Colchicine	parkinsonian disorders	31	-1.17
DB01394	Colchicine	lymphoma non hodgkin	22	-1.15
DB01394	Colchicine	liver cirrhosis biliary	23	-1.12
DB01394	Colchicine	lymphoma	24	-1.03
DB01394	Colchicine	leukemia myeloid acute	43	-0.80
DB01394	Colchicine	rheumatic diseases	59	-0.79
DB01394	Colchicine	leukemia lymphoid	66	-0.74
DB01394	Colchicine	diabetes mellitus	162	-0.64
DB01394	Colchicine	joint diseases	79	-0.56
DB01394	Colchicine	arthritis	76	-0.55
DB01394	Colchicine	anemia	58	-0.46
DB01394	Colchicine	amyotrophic lateral sclerosis	21	-0.42
DB01394	Colchicine	diabetes mellitus type 2	72	-0.41
DB01394	Colchicine	alzheimer disease	29	-0.29
DB01394	Colchicine	bone diseases	144	-0.29
DB01394	Colchicine	arterial occlusive diseases	44	-0.28
DB01394	Colchicine	mycobacterium infections	22	-0.26
DB01394	Colchicine	neuroendocrine tumors	24	-0.24
DB01394	Colchicine	leukemia	117	-0.23
DB01394	Colchicine	bacterial infections	26	-0.18
DB01394	Colchicine	dementia	42	-0.01
DB01394	Colchicine	skin diseases	278	0.00
DB01394	Colchicine	endocrine system diseases	291	0.10
DB01394	Colchicine	hematologic diseases	188	0.11
DB01394	Colchicine	prostatic neoplasms	61	0.11
DB01394	Colchicine	autoimmune diseases	243	0.12
DB01394	Colchicine	pancreatic diseases	24	0.15
DB01394	Colchicine	neoplasms	482	0.24
DB01394	Colchicine	motor neuron disease	31	0.35
DB01394	Colchicine	arrhythmias cardiac	30	0.36
DB01394	Colchicine	varicose veins	20	0.42
DB01394	Colchicine	diabetes mellitus type 1	82	0.46
DB01394	Colchicine	epilepsy	25	0.48
DB01394	Colchicine	macular degeneration	44	0.48
DB01394	Colchicine	collagen diseases	25	0.49
DB01394	Colchicine	bone diseases metabolic	27	0.56
DB01394	Colchicine	breast neoplasms	40	0.62
DB01394	Colchicine	crohn disease	71	0.68
DB01394	Colchicine	hyperinsulinism	26	0.74
DB01394	Colchicine	insulin resistance	26	0.74
DB01394	Colchicine	coronary artery disease	31	0.80
DB01394	Colchicine	blood coagulation disorders	40	0.84
DB01394	Colchicine	cardiomyopathy dilated	29	0.85
DB01394	Colchicine	coronary disease	37	0.85
DB01394	Colchicine	anemia hemolytic	29	0.88
DB01394	Colchicine	gastroenteritis	122	0.90
DB01394	Colchicine	myocardial ischemia	43	0.91
DB01394	Colchicine	thyroid diseases	30	0.92
DB01394	Colchicine	keratosis	21	0.93
DB01394	Colchicine	hypopigmentation	22	0.94
DB01394	Colchicine	arteriosclerosis	38	0.94
DB01394	Colchicine	kidney neoplasms	20	0.95
DB01394	Colchicine	inflammatory bowel diseases	119	0.97
DB01394	Colchicine	malabsorption syndromes	34	0.99
DB01394	Colchicine	colitis ulcerative	55	1.03
DB01394	Colchicine	colitis	55	1.04
DB01394	Colchicine	multiple sclerosis	69	1.10
DB01394	Colchicine	spinal cord diseases	59	1.21
DB01394	Colchicine	asthma	36	1.23
DB01394	Colchicine	heart diseases	167	1.30
DB01394	Colchicine	hypersensitivity	45	1.31
DB01394	Colchicine	sarcoma	25	1.31
DB01394	Colchicine	metabolism inborn errors	289	1.43
DB01394	Colchicine	lung diseases	71	1.49
DB01394	Colchicine	head and neck neoplasms	35	1.52
DB01394	Colchicine	adenocarcinoma	32	1.61
DB01394	Colchicine	lupus erythematosus systemic	75	1.73
DB01394	Colchicine	eye diseases	231	2.37
DB01394	Colchicine	vascular diseases	181	2.44
DB01394	Colchicine	kidney diseases	144	2.54
DB01394	Colchicine	colorectal neoplasms	42	2.56
DB01394	Colchicine	intestinal neoplasms	42	2.84
DB01394	Colchicine	cardiovascular diseases	330	3.89
DB01394	Colchicine	gastrointestinal neoplasms	72	4.01
DB00788	Naproxen	eye diseases	231	-1.92
DB00788	Naproxen	psoriasis	54	-1.64
DB00788	Naproxen	skin diseases	278	-1.33
DB00788	Naproxen	lung diseases	71	-1.21
DB00788	Naproxen	gastrointestinal neoplasms	72	-1.06
DB00788	Naproxen	bone diseases metabolic	27	-0.49
DB00788	Naproxen	keratosis	21	-0.41
DB00788	Naproxen	metabolism inborn errors	289	-0.40
DB00788	Naproxen	malabsorption syndromes	34	-0.21
DB00788	Naproxen	alzheimer disease	29	-0.14
DB00788	Naproxen	endocrine system diseases	291	-0.12
DB00788	Naproxen	lymphoma non hodgkin	22	0.01
DB00788	Naproxen	lymphoma	24	0.01
DB00788	Naproxen	adenocarcinoma	32	0.08
DB00788	Naproxen	dementia	42	0.14
DB00788	Naproxen	arthritis rheumatoid	42	0.17
DB00788	Naproxen	diabetes mellitus type 2	72	0.20
DB00788	Naproxen	head and neck neoplasms	35	0.22
DB00788	Naproxen	prostatic neoplasms	61	0.26
DB00788	Naproxen	multiple sclerosis	69	0.27
DB00788	Naproxen	breast neoplasms	40	0.27
DB00788	Naproxen	rheumatic diseases	59	0.30
DB00788	Naproxen	lupus erythematosus systemic	75	0.31
DB00788	Naproxen	diabetes mellitus type 1	82	0.33
DB00788	Naproxen	colorectal neoplasms	42	0.36
DB00788	Naproxen	arthritis	76	0.37
DB00788	Naproxen	intestinal neoplasms	42	0.37
DB00788	Naproxen	spinal cord diseases	59	0.39
DB00788	Naproxen	leukemia lymphoid	66	0.44
DB00788	Naproxen	joint diseases	79	0.45
DB00788	Naproxen	anemia	58	0.49
DB00788	Naproxen	neoplasms	482	0.64
DB00788	Naproxen	diabetes mellitus	162	0.67
DB00788	Naproxen	varicose veins	20	0.71
DB00788	Naproxen	heart diseases	167	0.76
DB00788	Naproxen	bone diseases	144	0.76
DB00788	Naproxen	leukemia	117	0.85
DB00788	Naproxen	arrhythmias cardiac	30	0.91
DB00788	Naproxen	hyperinsulinism	26	0.92
DB00788	Naproxen	vascular diseases	181	0.93
DB00788	Naproxen	collagen diseases	25	0.93
DB00788	Naproxen	insulin resistance	26	0.94
DB00788	Naproxen	hematologic diseases	188	0.99
DB00788	Naproxen	autoimmune diseases	243	1.10
DB00788	Naproxen	macular degeneration	44	1.15
DB00788	Naproxen	cardiovascular diseases	330	1.20
DB00788	Naproxen	coronary artery disease	31	1.22
DB00788	Naproxen	kidney neoplasms	20	1.37
DB00788	Naproxen	parkinsonian disorders	31	1.38
DB00788	Naproxen	coronary disease	37	1.38
DB00788	Naproxen	parkinson disease	30	1.42
DB00788	Naproxen	thyroid diseases	30	1.45
DB00788	Naproxen	pancreatic diseases	24	1.48
DB00788	Naproxen	myocardial ischemia	43	1.54
DB00788	Naproxen	arteriosclerosis	38	1.56
DB00788	Naproxen	neuroendocrine tumors	24	1.58
DB00788	Naproxen	amyotrophic lateral sclerosis	21	1.61
DB00788	Naproxen	sarcoma	25	1.65
DB00788	Naproxen	asthma	36	1.65
DB00788	Naproxen	arterial occlusive diseases	44	1.79
DB00788	Naproxen	hypersensitivity	45	1.83
DB00788	Naproxen	motor neuron disease	31	1.89
DB00788	Naproxen	colitis	55	2.01
DB00788	Naproxen	colitis ulcerative	55	2.06
DB00788	Naproxen	leukemia myeloid acute	43	2.07
DB00788	Naproxen	crohn disease	71	2.10
DB00788	Naproxen	epilepsy	25	2.22
DB00788	Naproxen	kidney diseases	144	2.26
DB00788	Naproxen	inflammatory bowel diseases	119	2.26
DB00788	Naproxen	gastroenteritis	122	2.28
DB00788	Naproxen	mycobacterium infections	22	2.92
DB00788	Naproxen	anemia hemolytic	29	2.99
DB00788	Naproxen	liver cirrhosis biliary	23	3.03
DB00788	Naproxen	hypopigmentation	22	3.11
DB00788	Naproxen	liver cirrhosis	24	3.14
DB00788	Naproxen	bacterial infections	26	3.17
DB00788	Naproxen	cardiomyopathy dilated	29	3.31
DB00788	Naproxen	blood coagulation disorders	40	3.83
DB00464	Sodium.Tetradecyl.Sulfate	blood coagulation disorders	40	-6.27
DB00464	Sodium.Tetradecyl.Sulfate	hematologic diseases	188	-4.23
DB00464	Sodium.Tetradecyl.Sulfate	vascular diseases	181	-2.49
DB00464	Sodium.Tetradecyl.Sulfate	bone diseases metabolic	27	-2.14
DB00464	Sodium.Tetradecyl.Sulfate	anemia hemolytic	29	-1.77
DB00464	Sodium.Tetradecyl.Sulfate	lupus erythematosus systemic	75	-1.75
DB00464	Sodium.Tetradecyl.Sulfate	prostatic neoplasms	61	-1.75
DB00464	Sodium.Tetradecyl.Sulfate	cardiovascular diseases	330	-1.70
DB00464	Sodium.Tetradecyl.Sulfate	anemia	58	-1.42
DB00464	Sodium.Tetradecyl.Sulfate	bone diseases	144	-1.15
DB00464	Sodium.Tetradecyl.Sulfate	kidney diseases	144	-1.11
DB00464	Sodium.Tetradecyl.Sulfate	insulin resistance	26	-0.81
DB00464	Sodium.Tetradecyl.Sulfate	hyperinsulinism	26	-0.79
DB00464	Sodium.Tetradecyl.Sulfate	coronary artery disease	31	-0.62
DB00464	Sodium.Tetradecyl.Sulfate	kidney neoplasms	20	-0.53
DB00464	Sodium.Tetradecyl.Sulfate	autoimmune diseases	243	-0.48
DB00464	Sodium.Tetradecyl.Sulfate	coronary disease	37	-0.44
DB00464	Sodium.Tetradecyl.Sulfate	thyroid diseases	30	-0.43
DB00464	Sodium.Tetradecyl.Sulfate	pancreatic diseases	24	-0.38
DB00464	Sodium.Tetradecyl.Sulfate	arteriosclerosis	38	-0.38
DB00464	Sodium.Tetradecyl.Sulfate	malabsorption syndromes	34	-0.36
DB00464	Sodium.Tetradecyl.Sulfate	myocardial ischemia	43	-0.35
DB00464	Sodium.Tetradecyl.Sulfate	neuroendocrine tumors	24	-0.32
DB00464	Sodium.Tetradecyl.Sulfate	asthma	36	-0.30
DB00464	Sodium.Tetradecyl.Sulfate	arterial occlusive diseases	44	-0.21
DB00464	Sodium.Tetradecyl.Sulfate	hypersensitivity	45	-0.19
DB00464	Sodium.Tetradecyl.Sulfate	arthritis rheumatoid	42	-0.11
DB00464	Sodium.Tetradecyl.Sulfate	motor neuron disease	31	-0.10
DB00464	Sodium.Tetradecyl.Sulfate	head and neck neoplasms	35	-0.08
DB00464	Sodium.Tetradecyl.Sulfate	adenocarcinoma	32	-0.07
DB00464	Sodium.Tetradecyl.Sulfate	dementia	42	-0.01
DB00464	Sodium.Tetradecyl.Sulfate	breast neoplasms	40	0.02
DB00464	Sodium.Tetradecyl.Sulfate	diabetes mellitus type 2	72	0.04
DB00464	Sodium.Tetradecyl.Sulfate	psoriasis	54	0.08
DB00464	Sodium.Tetradecyl.Sulfate	rheumatic diseases	59	0.08
DB00464	Sodium.Tetradecyl.Sulfate	crohn disease	71	0.11
DB00464	Sodium.Tetradecyl.Sulfate	spinal cord diseases	59	0.13
DB00464	Sodium.Tetradecyl.Sulfate	diabetes mellitus type 1	82	0.13
DB00464	Sodium.Tetradecyl.Sulfate	neoplasms	482	0.13
DB00464	Sodium.Tetradecyl.Sulfate	multiple sclerosis	69	0.17
DB00464	Sodium.Tetradecyl.Sulfate	leukemia myeloid acute	43	0.18
DB00464	Sodium.Tetradecyl.Sulfate	colorectal neoplasms	42	0.21
DB00464	Sodium.Tetradecyl.Sulfate	intestinal neoplasms	42	0.22
DB00464	Sodium.Tetradecyl.Sulfate	arthritis	76	0.25
DB00464	Sodium.Tetradecyl.Sulfate	joint diseases	79	0.26
DB00464	Sodium.Tetradecyl.Sulfate	leukemia lymphoid	66	0.28
DB00464	Sodium.Tetradecyl.Sulfate	lung diseases	71	0.34
DB00464	Sodium.Tetradecyl.Sulfate	gastroenteritis	122	0.39
DB00464	Sodium.Tetradecyl.Sulfate	inflammatory bowel diseases	119	0.39
DB00464	Sodium.Tetradecyl.Sulfate	varicose veins	20	0.42
DB00464	Sodium.Tetradecyl.Sulfate	gastrointestinal neoplasms	72	0.48
DB00464	Sodium.Tetradecyl.Sulfate	diabetes mellitus	162	0.53
DB00464	Sodium.Tetradecyl.Sulfate	epilepsy	25	0.54
DB00464	Sodium.Tetradecyl.Sulfate	heart diseases	167	0.56
DB00464	Sodium.Tetradecyl.Sulfate	eye diseases	231	0.71
DB00464	Sodium.Tetradecyl.Sulfate	leukemia	117	0.72
DB00464	Sodium.Tetradecyl.Sulfate	collagen diseases	25	0.73
DB00464	Sodium.Tetradecyl.Sulfate	metabolism inborn errors	289	0.74
DB00464	Sodium.Tetradecyl.Sulfate	mycobacterium infections	22	0.82
DB00464	Sodium.Tetradecyl.Sulfate	macular degeneration	44	0.86
DB00464	Sodium.Tetradecyl.Sulfate	skin diseases	278	0.87
DB00464	Sodium.Tetradecyl.Sulfate	keratosis	21	0.90
DB00464	Sodium.Tetradecyl.Sulfate	endocrine system diseases	291	0.94
DB00464	Sodium.Tetradecyl.Sulfate	liver cirrhosis	24	1.12
DB00464	Sodium.Tetradecyl.Sulfate	bacterial infections	26	1.12
DB00464	Sodium.Tetradecyl.Sulfate	hypopigmentation	22	1.12
DB00464	Sodium.Tetradecyl.Sulfate	liver cirrhosis biliary	23	1.17
DB00464	Sodium.Tetradecyl.Sulfate	amyotrophic lateral sclerosis	21	1.19
DB00464	Sodium.Tetradecyl.Sulfate	cardiomyopathy dilated	29	1.28
DB00464	Sodium.Tetradecyl.Sulfate	alzheimer disease	29	1.42
DB00464	Sodium.Tetradecyl.Sulfate	sarcoma	25	1.52
DB00464	Sodium.Tetradecyl.Sulfate	lymphoma non hodgkin	22	1.54
DB00464	Sodium.Tetradecyl.Sulfate	lymphoma	24	1.62
DB00464	Sodium.Tetradecyl.Sulfate	colitis ulcerative	55	1.69
DB00464	Sodium.Tetradecyl.Sulfate	colitis	55	1.75
DB00464	Sodium.Tetradecyl.Sulfate	arrhythmias cardiac	30	2.12
DB00464	Sodium.Tetradecyl.Sulfate	parkinson disease	30	2.76
DB00464	Sodium.Tetradecyl.Sulfate	parkinsonian disorders	31	2.92
DB00783	Estradiol	heart diseases	167	-3.14
DB00783	Estradiol	cardiomyopathy dilated	29	-3.05
DB00783	Estradiol	asthma	36	-2.96
DB00783	Estradiol	hypersensitivity	45	-2.86
DB00783	Estradiol	sarcoma	25	-2.69
DB00783	Estradiol	cardiovascular diseases	330	-2.36
DB00783	Estradiol	lung diseases	71	-2.19
DB00783	Estradiol	breast neoplasms	40	-2.12
DB00783	Estradiol	neoplasms	482	-1.95
DB00783	Estradiol	pancreatic diseases	24	-1.62
DB00783	Estradiol	prostatic neoplasms	61	-1.34
DB00783	Estradiol	colitis	55	-1.26
DB00783	Estradiol	colitis ulcerative	55	-1.20
DB00783	Estradiol	coronary artery disease	31	-1.16
DB00783	Estradiol	diabetes mellitus type 2	72	-1.14
DB00783	Estradiol	diabetes mellitus type 1	82	-1.07
DB00783	Estradiol	intestinal neoplasms	42	-1.07
DB00783	Estradiol	coronary disease	37	-1.05
DB00783	Estradiol	colorectal neoplasms	42	-1.04
DB00783	Estradiol	skin diseases	278	-0.95
DB00783	Estradiol	myocardial ischemia	43	-0.95
DB00783	Estradiol	crohn disease	71	-0.87
DB00783	Estradiol	arteriosclerosis	38	-0.76
DB00783	Estradiol	gastrointestinal neoplasms	72	-0.66
DB00783	Estradiol	kidney neoplasms	20	-0.64
DB00783	Estradiol	alzheimer disease	29	-0.60
DB00783	Estradiol	arterial occlusive diseases	44	-0.51
DB00783	Estradiol	neuroendocrine tumors	24	-0.46
DB00783	Estradiol	thyroid diseases	30	-0.45
DB00783	Estradiol	arrhythmias cardiac	30	-0.37
DB00783	Estradiol	liver cirrhosis	24	-0.36
DB00783	Estradiol	gastroenteritis	122	-0.36
DB00783	Estradiol	liver cirrhosis biliary	23	-0.36
DB00783	Estradiol	inflammatory bowel diseases	119	-0.33
DB00783	Estradiol	diabetes mellitus	162	-0.31
DB00783	Estradiol	vascular diseases	181	-0.20
DB00783	Estradiol	bone diseases	144	-0.15
DB00783	Estradiol	lymphoma	24	-0.12
DB00783	Estradiol	lymphoma non hodgkin	22	-0.12
DB00783	Estradiol	macular degeneration	44	-0.12
DB00783	Estradiol	bone diseases metabolic	27	-0.08
DB00783	Estradiol	leukemia	117	-0.07
DB00783	Estradiol	dementia	42	-0.04
DB00783	Estradiol	adenocarcinoma	32	0.00
DB00783	Estradiol	motor neuron disease	31	0.03
DB00783	Estradiol	metabolism inborn errors	289	0.04
DB00783	Estradiol	anemia hemolytic	29	0.13
DB00783	Estradiol	parkinsonian disorders	31	0.14
DB00783	Estradiol	parkinson disease	30	0.14
DB00783	Estradiol	autoimmune diseases	243	0.17
DB00783	Estradiol	lupus erythematosus systemic	75	0.23
DB00783	Estradiol	head and neck neoplasms	35	0.28
DB00783	Estradiol	hematologic diseases	188	0.33
DB00783	Estradiol	mycobacterium infections	22	0.40
DB00783	Estradiol	malabsorption syndromes	34	0.41
DB00783	Estradiol	multiple sclerosis	69	0.49
DB00783	Estradiol	leukemia myeloid acute	43	0.52
DB00783	Estradiol	bacterial infections	26	0.55
DB00783	Estradiol	endocrine system diseases	291	0.55
DB00783	Estradiol	spinal cord diseases	59	0.55
DB00783	Estradiol	blood coagulation disorders	40	0.56
DB00783	Estradiol	leukemia lymphoid	66	0.67
DB00783	Estradiol	amyotrophic lateral sclerosis	21	0.68
DB00783	Estradiol	kidney diseases	144	0.68
DB00783	Estradiol	varicose veins	20	0.77
DB00783	Estradiol	anemia	58	0.85
DB00783	Estradiol	epilepsy	25	0.87
DB00783	Estradiol	collagen diseases	25	0.91
DB00783	Estradiol	insulin resistance	26	0.93
DB00783	Estradiol	hyperinsulinism	26	0.96
DB00783	Estradiol	eye diseases	231	1.05
DB00783	Estradiol	keratosis	21	1.30
DB00783	Estradiol	arthritis rheumatoid	42	1.35
DB00783	Estradiol	psoriasis	54	1.44
DB00783	Estradiol	hypopigmentation	22	1.64
DB00783	Estradiol	rheumatic diseases	59	1.64
DB00783	Estradiol	arthritis	76	1.87
DB00783	Estradiol	joint diseases	79	1.92
DB01097	Leflunomide	sarcoma	25	-2.75
DB01097	Leflunomide	colitis ulcerative	55	-1.99
DB01097	Leflunomide	breast neoplasms	40	-1.94
DB01097	Leflunomide	leukemia myeloid acute	43	-1.92
DB01097	Leflunomide	spinal cord diseases	59	-1.88
DB01097	Leflunomide	crohn disease	71	-1.87
DB01097	Leflunomide	colitis	55	-1.87
DB01097	Leflunomide	gastrointestinal neoplasms	72	-1.75
DB01097	Leflunomide	coronary disease	37	-1.68
DB01097	Leflunomide	coronary artery disease	31	-1.67
DB01097	Leflunomide	myocardial ischemia	43	-1.59
DB01097	Leflunomide	arteriosclerosis	38	-1.57
DB01097	Leflunomide	keratosis	21	-1.56
DB01097	Leflunomide	parkinson disease	30	-1.56
DB01097	Leflunomide	parkinsonian disorders	31	-1.48
DB01097	Leflunomide	gastroenteritis	122	-1.38
DB01097	Leflunomide	alzheimer disease	29	-1.36
DB01097	Leflunomide	eye diseases	231	-1.35
DB01097	Leflunomide	inflammatory bowel diseases	119	-1.34
DB01097	Leflunomide	blood coagulation disorders	40	-1.34
DB01097	Leflunomide	heart diseases	167	-1.30
DB01097	Leflunomide	vascular diseases	181	-1.28
DB01097	Leflunomide	arterial occlusive diseases	44	-1.27
DB01097	Leflunomide	prostatic neoplasms	61	-1.16
DB01097	Leflunomide	bone diseases	144	-1.11
DB01097	Leflunomide	leukemia	117	-1.11
DB01097	Leflunomide	thyroid diseases	30	-1.04
DB01097	Leflunomide	hematologic diseases	188	-0.84
DB01097	Leflunomide	dementia	42	-0.83
DB01097	Leflunomide	cardiovascular diseases	330	-0.70
DB01097	Leflunomide	colorectal neoplasms	42	-0.69
DB01097	Leflunomide	intestinal neoplasms	42	-0.68
DB01097	Leflunomide	psoriasis	54	-0.66
DB01097	Leflunomide	multiple sclerosis	69	-0.61
DB01097	Leflunomide	skin diseases	278	-0.60
DB01097	Leflunomide	endocrine system diseases	291	-0.57
DB01097	Leflunomide	lung diseases	71	-0.56
DB01097	Leflunomide	diabetes mellitus type 1	82	-0.52
DB01097	Leflunomide	varicose veins	20	-0.45
DB01097	Leflunomide	insulin resistance	26	-0.40
DB01097	Leflunomide	epilepsy	25	-0.39
DB01097	Leflunomide	arrhythmias cardiac	30	-0.38
DB01097	Leflunomide	hyperinsulinism	26	-0.38
DB01097	Leflunomide	collagen diseases	25	-0.34
DB01097	Leflunomide	macular degeneration	44	-0.31
DB01097	Leflunomide	kidney diseases	144	-0.24
DB01097	Leflunomide	anemia hemolytic	29	-0.21
DB01097	Leflunomide	bone diseases metabolic	27	-0.17
DB01097	Leflunomide	mycobacterium infections	22	-0.06
DB01097	Leflunomide	neoplasms	482	-0.01
DB01097	Leflunomide	malabsorption syndromes	34	0.01
DB01097	Leflunomide	hypopigmentation	22	0.06
DB01097	Leflunomide	bacterial infections	26	0.11
DB01097	Leflunomide	diabetes mellitus	162	0.12
DB01097	Leflunomide	cardiomyopathy dilated	29	0.18
DB01097	Leflunomide	kidney neoplasms	20	0.21
DB01097	Leflunomide	asthma	36	0.25
DB01097	Leflunomide	neuroendocrine tumors	24	0.26
DB01097	Leflunomide	liver cirrhosis biliary	23	0.27
DB01097	Leflunomide	liver cirrhosis	24	0.33
DB01097	Leflunomide	pancreatic diseases	24	0.33
DB01097	Leflunomide	amyotrophic lateral sclerosis	21	0.36
DB01097	Leflunomide	hypersensitivity	45	0.36
DB01097	Leflunomide	metabolism inborn errors	289	0.47
DB01097	Leflunomide	lymphoma non hodgkin	22	0.52
DB01097	Leflunomide	lymphoma	24	0.53
DB01097	Leflunomide	arthritis rheumatoid	42	0.57
DB01097	Leflunomide	autoimmune diseases	243	0.58
DB01097	Leflunomide	adenocarcinoma	32	0.62
DB01097	Leflunomide	motor neuron disease	31	0.63
DB01097	Leflunomide	lupus erythematosus systemic	75	0.80
DB01097	Leflunomide	rheumatic diseases	59	0.84
DB01097	Leflunomide	head and neck neoplasms	35	0.89
DB01097	Leflunomide	diabetes mellitus type 2	72	0.92
DB01097	Leflunomide	joint diseases	79	0.95
DB01097	Leflunomide	arthritis	76	0.99
DB01097	Leflunomide	leukemia lymphoid	66	1.09
DB01097	Leflunomide	anemia	58	1.22
DB04895	Pegaptanib	thyroid diseases	30	-2.71
DB04895	Pegaptanib	colitis	55	-2.60
DB04895	Pegaptanib	macular degeneration	44	-2.59
DB04895	Pegaptanib	varicose veins	20	-2.56
DB04895	Pegaptanib	colitis ulcerative	55	-2.54
DB04895	Pegaptanib	breast neoplasms	40	-2.42
DB04895	Pegaptanib	inflammatory bowel diseases	119	-2.20
DB04895	Pegaptanib	gastroenteritis	122	-1.92
DB04895	Pegaptanib	kidney diseases	144	-1.71
DB04895	Pegaptanib	bone diseases	144	-1.50
DB04895	Pegaptanib	diabetes mellitus	162	-1.47
DB04895	Pegaptanib	vascular diseases	181	-1.29
DB04895	Pegaptanib	eye diseases	231	-1.22
DB04895	Pegaptanib	hematologic diseases	188	-1.17
DB04895	Pegaptanib	endocrine system diseases	291	-1.04
DB04895	Pegaptanib	cardiovascular diseases	330	-0.86
DB04895	Pegaptanib	skin diseases	278	-0.78
DB04895	Pegaptanib	epilepsy	25	-0.48
DB04895	Pegaptanib	neoplasms	482	-0.42
DB04895	Pegaptanib	collagen diseases	25	-0.36
DB04895	Pegaptanib	coronary artery disease	31	-0.29
DB04895	Pegaptanib	mycobacterium infections	22	-0.28
DB04895	Pegaptanib	bone diseases metabolic	27	-0.24
DB04895	Pegaptanib	keratosis	21	-0.23
DB04895	Pegaptanib	coronary disease	37	-0.19
DB04895	Pegaptanib	kidney neoplasms	20	-0.16
DB04895	Pegaptanib	parkinsonian disorders	31	-0.14
DB04895	Pegaptanib	myocardial ischemia	43	-0.09
DB04895	Pegaptanib	arteriosclerosis	38	-0.09
DB04895	Pegaptanib	hypopigmentation	22	-0.08
DB04895	Pegaptanib	parkinson disease	30	-0.06
DB04895	Pegaptanib	sarcoma	25	-0.04
DB04895	Pegaptanib	bacterial infections	26	-0.04
DB04895	Pegaptanib	malabsorption syndromes	34	-0.03
DB04895	Pegaptanib	arterial occlusive diseases	44	-0.02
DB04895	Pegaptanib	neuroendocrine tumors	24	0.04
DB04895	Pegaptanib	blood coagulation disorders	40	0.04
DB04895	Pegaptanib	adenocarcinoma	32	0.04
DB04895	Pegaptanib	diabetes mellitus type 2	72	0.15
DB04895	Pegaptanib	psoriasis	54	0.16
DB04895	Pegaptanib	prostatic neoplasms	61	0.17
DB04895	Pegaptanib	dementia	42	0.18
DB04895	Pegaptanib	lupus erythematosus systemic	75	0.23
DB04895	Pegaptanib	leukemia myeloid acute	43	0.24
DB04895	Pegaptanib	diabetes mellitus type 1	82	0.24
DB04895	Pegaptanib	multiple sclerosis	69	0.26
DB04895	Pegaptanib	intestinal neoplasms	42	0.26
DB04895	Pegaptanib	colorectal neoplasms	42	0.28
DB04895	Pegaptanib	crohn disease	71	0.28
DB04895	Pegaptanib	anemia	58	0.29
DB04895	Pegaptanib	joint diseases	79	0.33
DB04895	Pegaptanib	arthritis	76	0.33
DB04895	Pegaptanib	lung diseases	71	0.38
DB04895	Pegaptanib	gastrointestinal neoplasms	72	0.48
DB04895	Pegaptanib	heart diseases	167	0.54
DB04895	Pegaptanib	leukemia	117	0.62
DB04895	Pegaptanib	metabolism inborn errors	289	0.74
DB04895	Pegaptanib	autoimmune diseases	243	0.78
DB04895	Pegaptanib	arrhythmias cardiac	30	1.79
DB04895	Pegaptanib	hyperinsulinism	26	1.82
DB04895	Pegaptanib	insulin resistance	26	1.86
DB04895	Pegaptanib	cardiomyopathy dilated	29	2.28
DB04895	Pegaptanib	anemia hemolytic	29	2.31
DB04895	Pegaptanib	liver cirrhosis	24	2.40
DB04895	Pegaptanib	asthma	36	2.43
DB04895	Pegaptanib	amyotrophic lateral sclerosis	21	2.44
DB04895	Pegaptanib	liver cirrhosis biliary	23	2.46
DB04895	Pegaptanib	pancreatic diseases	24	2.55
DB04895	Pegaptanib	hypersensitivity	45	2.57
DB04895	Pegaptanib	leukemia lymphoid	66	2.63
DB04895	Pegaptanib	alzheimer disease	29	2.64
DB04895	Pegaptanib	lymphoma non hodgkin	22	2.73
DB04895	Pegaptanib	head and neck neoplasms	35	2.74
DB04895	Pegaptanib	motor neuron disease	31	2.76
DB04895	Pegaptanib	lymphoma	24	2.76
DB04895	Pegaptanib	arthritis rheumatoid	42	2.79
DB04895	Pegaptanib	rheumatic diseases	59	2.88
DB04895	Pegaptanib	spinal cord diseases	59	2.94
DB01014	Balsalazide	skin diseases	278	-2.51
DB01014	Balsalazide	psoriasis	54	-1.78
DB01014	Balsalazide	multiple sclerosis	69	-1.72
DB01014	Balsalazide	myocardial ischemia	43	-1.33
DB01014	Balsalazide	eye diseases	231	-1.27
DB01014	Balsalazide	alzheimer disease	29	-1.12
DB01014	Balsalazide	gastrointestinal neoplasms	72	-0.89
DB01014	Balsalazide	neoplasms	482	-0.81
DB01014	Balsalazide	arthritis rheumatoid	42	-0.71
DB01014	Balsalazide	bone diseases	144	-0.68
DB01014	Balsalazide	dementia	42	-0.62
DB01014	Balsalazide	heart diseases	167	-0.61
DB01014	Balsalazide	rheumatic diseases	59	-0.51
DB01014	Balsalazide	bone diseases metabolic	27	-0.49
DB01014	Balsalazide	coronary artery disease	31	-0.38
DB01014	Balsalazide	keratosis	21	-0.35
DB01014	Balsalazide	spinal cord diseases	59	-0.34
DB01014	Balsalazide	vascular diseases	181	-0.29
DB01014	Balsalazide	joint diseases	79	-0.26
DB01014	Balsalazide	arthritis	76	-0.26
DB01014	Balsalazide	coronary disease	37	-0.19
DB01014	Balsalazide	lung diseases	71	-0.19
DB01014	Balsalazide	malabsorption syndromes	34	-0.07
DB01014	Balsalazide	arteriosclerosis	38	-0.05
DB01014	Balsalazide	gastroenteritis	122	0.00
DB01014	Balsalazide	autoimmune diseases	243	0.02
DB01014	Balsalazide	amyotrophic lateral sclerosis	21	0.02
DB01014	Balsalazide	arterial occlusive diseases	44	0.17
DB01014	Balsalazide	endocrine system diseases	291	0.21
DB01014	Balsalazide	lymphoma non hodgkin	22	0.22
DB01014	Balsalazide	varicose veins	20	0.24
DB01014	Balsalazide	sarcoma	25	0.25
DB01014	Balsalazide	cardiovascular diseases	330	0.28
DB01014	Balsalazide	lymphoma	24	0.29
DB01014	Balsalazide	motor neuron disease	31	0.39
DB01014	Balsalazide	colitis	55	0.43
DB01014	Balsalazide	insulin resistance	26	0.43
DB01014	Balsalazide	colitis ulcerative	55	0.43
DB01014	Balsalazide	arrhythmias cardiac	30	0.45
DB01014	Balsalazide	hyperinsulinism	26	0.47
DB01014	Balsalazide	adenocarcinoma	32	0.47
DB01014	Balsalazide	head and neck neoplasms	35	0.53
DB01014	Balsalazide	prostatic neoplasms	61	0.55
DB01014	Balsalazide	leukemia	117	0.56
DB01014	Balsalazide	diabetes mellitus type 2	72	0.59
DB01014	Balsalazide	collagen diseases	25	0.62
DB01014	Balsalazide	breast neoplasms	40	0.66
DB01014	Balsalazide	lupus erythematosus systemic	75	0.68
DB01014	Balsalazide	crohn disease	71	0.79
DB01014	Balsalazide	diabetes mellitus type 1	82	0.80
DB01014	Balsalazide	macular degeneration	44	0.80
DB01014	Balsalazide	metabolism inborn errors	289	0.80
DB01014	Balsalazide	leukemia myeloid acute	43	0.81
DB01014	Balsalazide	intestinal neoplasms	42	0.81
DB01014	Balsalazide	colorectal neoplasms	42	0.86
DB01014	Balsalazide	anemia	58	0.99
DB01014	Balsalazide	thyroid diseases	30	1.01
DB01014	Balsalazide	kidney neoplasms	20	1.04
DB01014	Balsalazide	leukemia lymphoid	66	1.07
DB01014	Balsalazide	parkinsonian disorders	31	1.10
DB01014	Balsalazide	inflammatory bowel diseases	119	1.10
DB01014	Balsalazide	pancreatic diseases	24	1.13
DB01014	Balsalazide	asthma	36	1.20
DB01014	Balsalazide	parkinson disease	30	1.22
DB01014	Balsalazide	diabetes mellitus	162	1.24
DB01014	Balsalazide	neuroendocrine tumors	24	1.25
DB01014	Balsalazide	hypersensitivity	45	1.44
DB01014	Balsalazide	epilepsy	25	1.44
DB01014	Balsalazide	mycobacterium infections	22	1.89
DB01014	Balsalazide	hematologic diseases	188	2.01
DB01014	Balsalazide	anemia hemolytic	29	2.08
DB01014	Balsalazide	hypopigmentation	22	2.11
DB01014	Balsalazide	kidney diseases	144	2.13
DB01014	Balsalazide	bacterial infections	26	2.17
DB01014	Balsalazide	liver cirrhosis	24	2.21
DB01014	Balsalazide	liver cirrhosis biliary	23	2.23
DB01014	Balsalazide	cardiomyopathy dilated	29	2.35
DB01014	Balsalazide	blood coagulation disorders	40	2.55
DB01016	Glyburide	arrhythmias cardiac	30	-6.33
DB01016	Glyburide	endocrine system diseases	291	-5.55
DB01016	Glyburide	pancreatic diseases	24	-5.45
DB01016	Glyburide	heart diseases	167	-4.23
DB01016	Glyburide	diabetes mellitus type 2	72	-4.13
DB01016	Glyburide	kidney diseases	144	-3.93
DB01016	Glyburide	diabetes mellitus	162	-3.65
DB01016	Glyburide	cardiovascular diseases	330	-3.09
DB01016	Glyburide	cardiomyopathy dilated	29	-2.81
DB01016	Glyburide	metabolism inborn errors	289	-2.24
DB01016	Glyburide	lung diseases	71	-1.39
DB01016	Glyburide	varicose veins	20	-1.28
DB01016	Glyburide	epilepsy	25	-1.10
DB01016	Glyburide	amyotrophic lateral sclerosis	21	-0.79
DB01016	Glyburide	keratosis	21	-0.53
DB01016	Glyburide	rheumatic diseases	59	-0.35
DB01016	Glyburide	parkinson disease	30	-0.34
DB01016	Glyburide	parkinsonian disorders	31	-0.33
DB01016	Glyburide	gastrointestinal neoplasms	72	-0.32
DB01016	Glyburide	motor neuron disease	31	-0.18
DB01016	Glyburide	spinal cord diseases	59	-0.07
DB01016	Glyburide	joint diseases	79	-0.01
DB01016	Glyburide	arthritis	76	0.02
DB01016	Glyburide	macular degeneration	44	0.07
DB01016	Glyburide	coronary artery disease	31	0.13
DB01016	Glyburide	breast neoplasms	40	0.18
DB01016	Glyburide	coronary disease	37	0.42
DB01016	Glyburide	colitis ulcerative	55	0.43
DB01016	Glyburide	hyperinsulinism	26	0.45
DB01016	Glyburide	insulin resistance	26	0.46
DB01016	Glyburide	bacterial infections	26	0.46
DB01016	Glyburide	collagen diseases	25	0.49
DB01016	Glyburide	bone diseases metabolic	27	0.49
DB01016	Glyburide	colitis	55	0.51
DB01016	Glyburide	intestinal neoplasms	42	0.53
DB01016	Glyburide	arthritis rheumatoid	42	0.53
DB01016	Glyburide	myocardial ischemia	43	0.55
DB01016	Glyburide	arteriosclerosis	38	0.56
DB01016	Glyburide	colorectal neoplasms	42	0.58
DB01016	Glyburide	dementia	42	0.59
DB01016	Glyburide	crohn disease	71	0.59
DB01016	Glyburide	liver cirrhosis	24	0.60
DB01016	Glyburide	neuroendocrine tumors	24	0.60
DB01016	Glyburide	liver cirrhosis biliary	23	0.64
DB01016	Glyburide	autoimmune diseases	243	0.68
DB01016	Glyburide	head and neck neoplasms	35	0.69
DB01016	Glyburide	alzheimer disease	29	0.70
DB01016	Glyburide	bone diseases	144	0.73
DB01016	Glyburide	prostatic neoplasms	61	0.75
DB01016	Glyburide	arterial occlusive diseases	44	0.88
DB01016	Glyburide	skin diseases	278	0.88
DB01016	Glyburide	anemia hemolytic	29	0.97
DB01016	Glyburide	lymphoma	24	0.98
DB01016	Glyburide	hypopigmentation	22	0.99
DB01016	Glyburide	thyroid diseases	30	1.02
DB01016	Glyburide	lymphoma non hodgkin	22	1.04
DB01016	Glyburide	kidney neoplasms	20	1.06
DB01016	Glyburide	inflammatory bowel diseases	119	1.08
DB01016	Glyburide	gastroenteritis	122	1.09
DB01016	Glyburide	malabsorption syndromes	34	1.18
DB01016	Glyburide	diabetes mellitus type 1	82	1.21
DB01016	Glyburide	neoplasms	482	1.21
DB01016	Glyburide	multiple sclerosis	69	1.26
DB01016	Glyburide	mycobacterium infections	22	1.48
DB01016	Glyburide	psoriasis	54	1.52
DB01016	Glyburide	blood coagulation disorders	40	1.53
DB01016	Glyburide	sarcoma	25	1.56
DB01016	Glyburide	leukemia	117	1.71
DB01016	Glyburide	lupus erythematosus systemic	75	1.75
DB01016	Glyburide	eye diseases	231	1.80
DB01016	Glyburide	leukemia myeloid acute	43	1.88
DB01016	Glyburide	vascular diseases	181	1.89
DB01016	Glyburide	adenocarcinoma	32	1.98
DB01016	Glyburide	asthma	36	2.00
DB01016	Glyburide	hematologic diseases	188	2.15
DB01016	Glyburide	leukemia lymphoid	66	2.23
DB01016	Glyburide	anemia	58	2.27
DB01016	Glyburide	hypersensitivity	45	2.37
DB00255	Diethylstilbestrol	sarcoma	25	-2.76
DB00255	Diethylstilbestrol	cardiovascular diseases	330	-2.46
DB00255	Diethylstilbestrol	crohn disease	71	-2.36
DB00255	Diethylstilbestrol	colitis ulcerative	55	-2.29
DB00255	Diethylstilbestrol	colitis	55	-2.20
DB00255	Diethylstilbestrol	cardiomyopathy dilated	29	-1.94
DB00255	Diethylstilbestrol	breast neoplasms	40	-1.88
DB00255	Diethylstilbestrol	asthma	36	-1.78
DB00255	Diethylstilbestrol	inflammatory bowel diseases	119	-1.69
DB00255	Diethylstilbestrol	neoplasms	482	-1.65
DB00255	Diethylstilbestrol	heart diseases	167	-1.64
DB00255	Diethylstilbestrol	gastroenteritis	122	-1.64
DB00255	Diethylstilbestrol	hypersensitivity	45	-1.63
DB00255	Diethylstilbestrol	pancreatic diseases	24	-1.63
DB00255	Diethylstilbestrol	varicose veins	20	-1.50
DB00255	Diethylstilbestrol	vascular diseases	181	-1.47
DB00255	Diethylstilbestrol	prostatic neoplasms	61	-1.34
DB00255	Diethylstilbestrol	autoimmune diseases	243	-1.11
DB00255	Diethylstilbestrol	coronary artery disease	31	-1.08
DB00255	Diethylstilbestrol	diabetes mellitus type 1	82	-1.01
DB00255	Diethylstilbestrol	diabetes mellitus type 2	72	-0.91
DB00255	Diethylstilbestrol	intestinal neoplasms	42	-0.89
DB00255	Diethylstilbestrol	colorectal neoplasms	42	-0.88
DB00255	Diethylstilbestrol	coronary disease	37	-0.87
DB00255	Diethylstilbestrol	myocardial ischemia	43	-0.87
DB00255	Diethylstilbestrol	skin diseases	278	-0.84
DB00255	Diethylstilbestrol	lung diseases	71	-0.78
DB00255	Diethylstilbestrol	endocrine system diseases	291	-0.77
DB00255	Diethylstilbestrol	arteriosclerosis	38	-0.75
DB00255	Diethylstilbestrol	kidney neoplasms	20	-0.59
DB00255	Diethylstilbestrol	gastrointestinal neoplasms	72	-0.56
DB00255	Diethylstilbestrol	alzheimer disease	29	-0.52
DB00255	Diethylstilbestrol	arterial occlusive diseases	44	-0.49
DB00255	Diethylstilbestrol	thyroid diseases	30	-0.40
DB00255	Diethylstilbestrol	neuroendocrine tumors	24	-0.39
DB00255	Diethylstilbestrol	arrhythmias cardiac	30	-0.32
DB00255	Diethylstilbestrol	liver cirrhosis	24	-0.30
DB00255	Diethylstilbestrol	liver cirrhosis biliary	23	-0.28
DB00255	Diethylstilbestrol	diabetes mellitus	162	-0.26
DB00255	Diethylstilbestrol	epilepsy	25	-0.23
DB00255	Diethylstilbestrol	collagen diseases	25	-0.20
DB00255	Diethylstilbestrol	macular degeneration	44	-0.14
DB00255	Diethylstilbestrol	lymphoma non hodgkin	22	-0.09
DB00255	Diethylstilbestrol	bone diseases	144	-0.07
DB00255	Diethylstilbestrol	lymphoma	24	-0.04
DB00255	Diethylstilbestrol	dementia	42	-0.02
DB00255	Diethylstilbestrol	bone diseases metabolic	27	-0.02
DB00255	Diethylstilbestrol	adenocarcinoma	32	0.03
DB00255	Diethylstilbestrol	leukemia	117	0.09
DB00255	Diethylstilbestrol	motor neuron disease	31	0.12
DB00255	Diethylstilbestrol	parkinsonian disorders	31	0.20
DB00255	Diethylstilbestrol	anemia hemolytic	29	0.23
DB00255	Diethylstilbestrol	parkinson disease	30	0.24
DB00255	Diethylstilbestrol	keratosis	21	0.28
DB00255	Diethylstilbestrol	lupus erythematosus systemic	75	0.31
DB00255	Diethylstilbestrol	head and neck neoplasms	35	0.37
DB00255	Diethylstilbestrol	hematologic diseases	188	0.43
DB00255	Diethylstilbestrol	multiple sclerosis	69	0.52
DB00255	Diethylstilbestrol	malabsorption syndromes	34	0.52
DB00255	Diethylstilbestrol	mycobacterium infections	22	0.54
DB00255	Diethylstilbestrol	hypopigmentation	22	0.58
DB00255	Diethylstilbestrol	spinal cord diseases	59	0.61
DB00255	Diethylstilbestrol	leukemia myeloid acute	43	0.62
DB00255	Diethylstilbestrol	bacterial infections	26	0.68
DB00255	Diethylstilbestrol	blood coagulation disorders	40	0.68
DB00255	Diethylstilbestrol	leukemia lymphoid	66	0.77
DB00255	Diethylstilbestrol	kidney diseases	144	0.81
DB00255	Diethylstilbestrol	anemia	58	0.88
DB00255	Diethylstilbestrol	hyperinsulinism	26	1.03
DB00255	Diethylstilbestrol	eye diseases	231	1.10
DB00255	Diethylstilbestrol	insulin resistance	26	1.12
DB00255	Diethylstilbestrol	arthritis rheumatoid	42	1.45
DB00255	Diethylstilbestrol	metabolism inborn errors	289	1.50
DB00255	Diethylstilbestrol	psoriasis	54	1.52
DB00255	Diethylstilbestrol	rheumatic diseases	59	1.79
DB00255	Diethylstilbestrol	amyotrophic lateral sclerosis	21	2.01
DB00255	Diethylstilbestrol	joint diseases	79	2.06
DB00255	Diethylstilbestrol	arthritis	76	2.07
DB00541	Vincristine	parkinsonian disorders	31	-3.16
DB00541	Vincristine	parkinson disease	30	-3.03
DB00541	Vincristine	alzheimer disease	29	-2.10
DB00541	Vincristine	amyotrophic lateral sclerosis	21	-1.98
DB00541	Vincristine	dementia	42	-1.58
DB00541	Vincristine	pancreatic diseases	24	-1.53
DB00541	Vincristine	prostatic neoplasms	61	-1.40
DB00541	Vincristine	motor neuron disease	31	-1.30
DB00541	Vincristine	psoriasis	54	-1.29
DB00541	Vincristine	arthritis rheumatoid	42	-1.29
DB00541	Vincristine	diabetes mellitus type 1	82	-1.25
DB00541	Vincristine	lymphoma non hodgkin	22	-1.24
DB00541	Vincristine	lymphoma	24	-1.22
DB00541	Vincristine	breast neoplasms	40	-1.09
DB00541	Vincristine	rheumatic diseases	59	-0.96
DB00541	Vincristine	diabetes mellitus	162	-0.89
DB00541	Vincristine	arthritis	76	-0.82
DB00541	Vincristine	anemia hemolytic	29	-0.81
DB00541	Vincristine	joint diseases	79	-0.80
DB00541	Vincristine	spinal cord diseases	59	-0.80
DB00541	Vincristine	anemia	58	-0.71
DB00541	Vincristine	leukemia lymphoid	66	-0.71
DB00541	Vincristine	heart diseases	167	-0.69
DB00541	Vincristine	cardiomyopathy dilated	29	-0.67
DB00541	Vincristine	lung diseases	71	-0.65
DB00541	Vincristine	metabolism inborn errors	289	-0.60
DB00541	Vincristine	arterial occlusive diseases	44	-0.52
DB00541	Vincristine	bone diseases	144	-0.50
DB00541	Vincristine	mycobacterium infections	22	-0.41
DB00541	Vincristine	diabetes mellitus type 2	72	-0.40
DB00541	Vincristine	bacterial infections	26	-0.28
DB00541	Vincristine	eye diseases	231	-0.26
DB00541	Vincristine	leukemia	117	-0.16
DB00541	Vincristine	vascular diseases	181	-0.15
DB00541	Vincristine	neuroendocrine tumors	24	-0.11
DB00541	Vincristine	liver cirrhosis	24	-0.09
DB00541	Vincristine	hematologic diseases	188	-0.09
DB00541	Vincristine	liver cirrhosis biliary	23	-0.05
DB00541	Vincristine	autoimmune diseases	243	-0.03
DB00541	Vincristine	endocrine system diseases	291	-0.01
DB00541	Vincristine	skin diseases	278	0.05
DB00541	Vincristine	cardiovascular diseases	330	0.11
DB00541	Vincristine	adenocarcinoma	32	0.19
DB00541	Vincristine	neoplasms	482	0.36
DB00541	Vincristine	arrhythmias cardiac	30	0.36
DB00541	Vincristine	varicose veins	20	0.46
DB00541	Vincristine	bone diseases metabolic	27	0.46
DB00541	Vincristine	macular degeneration	44	0.49
DB00541	Vincristine	epilepsy	25	0.49
DB00541	Vincristine	collagen diseases	25	0.50
DB00541	Vincristine	leukemia myeloid acute	43	0.64
DB00541	Vincristine	hyperinsulinism	26	0.66
DB00541	Vincristine	insulin resistance	26	0.72
DB00541	Vincristine	multiple sclerosis	69	0.74
DB00541	Vincristine	colorectal neoplasms	42	0.75
DB00541	Vincristine	coronary artery disease	31	0.76
DB00541	Vincristine	intestinal neoplasms	42	0.79
DB00541	Vincristine	coronary disease	37	0.79
DB00541	Vincristine	keratosis	21	0.82
DB00541	Vincristine	thyroid diseases	30	0.87
DB00541	Vincristine	myocardial ischemia	43	0.88
DB00541	Vincristine	arteriosclerosis	38	0.88
DB00541	Vincristine	hypopigmentation	22	0.92
DB00541	Vincristine	blood coagulation disorders	40	0.92
DB00541	Vincristine	kidney neoplasms	20	0.93
DB00541	Vincristine	malabsorption syndromes	34	0.94
DB00541	Vincristine	colitis	55	0.98
DB00541	Vincristine	colitis ulcerative	55	1.02
DB00541	Vincristine	asthma	36	1.24
DB00541	Vincristine	sarcoma	25	1.26
DB00541	Vincristine	hypersensitivity	45	1.33
DB00541	Vincristine	gastrointestinal neoplasms	72	1.40
DB00541	Vincristine	head and neck neoplasms	35	1.48
DB00541	Vincristine	lupus erythematosus systemic	75	1.71
DB00541	Vincristine	crohn disease	71	1.92
DB00541	Vincristine	gastroenteritis	122	2.30
DB00541	Vincristine	kidney diseases	144	2.35
DB00541	Vincristine	inflammatory bowel diseases	119	2.36
DB00014	Goserelin	endocrine system diseases	291	-5.00
DB00014	Goserelin	neoplasms	482	-2.33
DB00014	Goserelin	thyroid diseases	30	-2.18
DB00014	Goserelin	bone diseases metabolic	27	-2.14
DB00014	Goserelin	intestinal neoplasms	42	-1.75
DB00014	Goserelin	colorectal neoplasms	42	-1.75
DB00014	Goserelin	gastrointestinal neoplasms	72	-1.33
DB00014	Goserelin	bone diseases	144	-1.18
DB00014	Goserelin	insulin resistance	26	-0.90
DB00014	Goserelin	hyperinsulinism	26	-0.84
DB00014	Goserelin	eye diseases	231	-0.84
DB00014	Goserelin	autoimmune diseases	243	-0.71
DB00014	Goserelin	keratosis	21	-0.70
DB00014	Goserelin	mycobacterium infections	22	-0.70
DB00014	Goserelin	arrhythmias cardiac	30	-0.67
DB00014	Goserelin	macular degeneration	44	-0.67
DB00014	Goserelin	metabolism inborn errors	289	-0.67
DB00014	Goserelin	coronary artery disease	31	-0.64
DB00014	Goserelin	kidney neoplasms	20	-0.63
DB00014	Goserelin	hypopigmentation	22	-0.56
DB00014	Goserelin	hematologic diseases	188	-0.56
DB00014	Goserelin	parkinson disease	30	-0.55
DB00014	Goserelin	bacterial infections	26	-0.53
DB00014	Goserelin	pancreatic diseases	24	-0.53
DB00014	Goserelin	parkinsonian disorders	31	-0.52
DB00014	Goserelin	myocardial ischemia	43	-0.49
DB00014	Goserelin	asthma	36	-0.49
DB00014	Goserelin	coronary disease	37	-0.48
DB00014	Goserelin	malabsorption syndromes	34	-0.46
DB00014	Goserelin	liver cirrhosis	24	-0.44
DB00014	Goserelin	neuroendocrine tumors	24	-0.42
DB00014	Goserelin	liver cirrhosis biliary	23	-0.42
DB00014	Goserelin	arteriosclerosis	38	-0.38
DB00014	Goserelin	cardiomyopathy dilated	29	-0.35
DB00014	Goserelin	sarcoma	25	-0.34
DB00014	Goserelin	alzheimer disease	29	-0.33
DB00014	Goserelin	lymphoma	24	-0.29
DB00014	Goserelin	lymphoma non hodgkin	22	-0.27
DB00014	Goserelin	hypersensitivity	45	-0.25
DB00014	Goserelin	blood coagulation disorders	40	-0.25
DB00014	Goserelin	arterial occlusive diseases	44	-0.22
DB00014	Goserelin	adenocarcinoma	32	-0.19
DB00014	Goserelin	arthritis rheumatoid	42	-0.16
DB00014	Goserelin	head and neck neoplasms	35	-0.13
DB00014	Goserelin	motor neuron disease	31	-0.12
DB00014	Goserelin	prostatic neoplasms	61	-0.09
DB00014	Goserelin	breast neoplasms	40	-0.09
DB00014	Goserelin	psoriasis	54	-0.09
DB00014	Goserelin	colitis	55	-0.09
DB00014	Goserelin	dementia	42	-0.08
DB00014	Goserelin	colitis ulcerative	55	-0.08
DB00014	Goserelin	diabetes mellitus type 2	72	-0.03
DB00014	Goserelin	lupus erythematosus systemic	75	0.02
DB00014	Goserelin	rheumatic diseases	59	0.03
DB00014	Goserelin	diabetes mellitus type 1	82	0.07
DB00014	Goserelin	leukemia myeloid acute	43	0.12
DB00014	Goserelin	multiple sclerosis	69	0.13
DB00014	Goserelin	crohn disease	71	0.13
DB00014	Goserelin	spinal cord diseases	59	0.16
DB00014	Goserelin	arthritis	76	0.16
DB00014	Goserelin	lung diseases	71	0.18
DB00014	Goserelin	joint diseases	79	0.19
DB00014	Goserelin	anemia	58	0.22
DB00014	Goserelin	leukemia lymphoid	66	0.24
DB00014	Goserelin	varicose veins	20	0.37
DB00014	Goserelin	gastroenteritis	122	0.39
DB00014	Goserelin	inflammatory bowel diseases	119	0.40
DB00014	Goserelin	kidney diseases	144	0.45
DB00014	Goserelin	diabetes mellitus	162	0.48
DB00014	Goserelin	epilepsy	25	0.51
DB00014	Goserelin	heart diseases	167	0.53
DB00014	Goserelin	leukemia	117	0.60
DB00014	Goserelin	collagen diseases	25	0.60
DB00014	Goserelin	vascular diseases	181	0.67
DB00014	Goserelin	skin diseases	278	0.89
DB00014	Goserelin	cardiovascular diseases	330	0.94
DB00014	Goserelin	amyotrophic lateral sclerosis	21	1.00
DB00014	Goserelin	anemia hemolytic	29	1.01
DB01250	Olsalazine	anemia	58	-4.97
DB01250	Olsalazine	gastroenteritis	122	-4.77
DB01250	Olsalazine	colitis ulcerative	55	-4.41
DB01250	Olsalazine	inflammatory bowel diseases	119	-4.39
DB01250	Olsalazine	colitis	55	-4.36
DB01250	Olsalazine	hematologic diseases	188	-3.37
DB01250	Olsalazine	cardiovascular diseases	330	-2.91
DB01250	Olsalazine	mycobacterium infections	22	-2.66
DB01250	Olsalazine	psoriasis	54	-2.52
DB01250	Olsalazine	joint diseases	79	-2.46
DB01250	Olsalazine	bacterial infections	26	-2.46
DB01250	Olsalazine	arthritis	76	-2.38
DB01250	Olsalazine	bone diseases	144	-2.09
DB01250	Olsalazine	skin diseases	278	-1.40
DB01250	Olsalazine	varicose veins	20	-0.90
DB01250	Olsalazine	hyperinsulinism	26	-0.77
DB01250	Olsalazine	insulin resistance	26	-0.74
DB01250	Olsalazine	keratosis	21	-0.66
DB01250	Olsalazine	collagen diseases	25	-0.66
DB01250	Olsalazine	macular degeneration	44	-0.60
DB01250	Olsalazine	anemia hemolytic	29	-0.58
DB01250	Olsalazine	coronary artery disease	31	-0.58
DB01250	Olsalazine	kidney neoplasms	20	-0.57
DB01250	Olsalazine	thyroid diseases	30	-0.56
DB01250	Olsalazine	amyotrophic lateral sclerosis	21	-0.53
DB01250	Olsalazine	coronary disease	37	-0.53
DB01250	Olsalazine	pancreatic diseases	24	-0.53
DB01250	Olsalazine	hypopigmentation	22	-0.52
DB01250	Olsalazine	malabsorption syndromes	34	-0.49
DB01250	Olsalazine	liver cirrhosis	24	-0.48
DB01250	Olsalazine	myocardial ischemia	43	-0.48
DB01250	Olsalazine	alzheimer disease	29	-0.48
DB01250	Olsalazine	cardiomyopathy dilated	29	-0.48
DB01250	Olsalazine	neuroendocrine tumors	24	-0.46
DB01250	Olsalazine	liver cirrhosis biliary	23	-0.43
DB01250	Olsalazine	sarcoma	25	-0.41
DB01250	Olsalazine	lymphoma	24	-0.39
DB01250	Olsalazine	arteriosclerosis	38	-0.36
DB01250	Olsalazine	lymphoma non hodgkin	22	-0.35
DB01250	Olsalazine	asthma	36	-0.31
DB01250	Olsalazine	arterial occlusive diseases	44	-0.31
DB01250	Olsalazine	motor neuron disease	31	-0.31
DB01250	Olsalazine	hypersensitivity	45	-0.29
DB01250	Olsalazine	arthritis rheumatoid	42	-0.27
DB01250	Olsalazine	adenocarcinoma	32	-0.25
DB01250	Olsalazine	blood coagulation disorders	40	-0.24
DB01250	Olsalazine	head and neck neoplasms	35	-0.23
DB01250	Olsalazine	breast neoplasms	40	-0.22
DB01250	Olsalazine	dementia	42	-0.21
DB01250	Olsalazine	diabetes mellitus type 2	72	-0.21
DB01250	Olsalazine	prostatic neoplasms	61	-0.15
DB01250	Olsalazine	diabetes mellitus type 1	82	-0.12
DB01250	Olsalazine	colorectal neoplasms	42	-0.09
DB01250	Olsalazine	lupus erythematosus systemic	75	-0.08
DB01250	Olsalazine	spinal cord diseases	59	-0.08
DB01250	Olsalazine	leukemia myeloid acute	43	-0.07
DB01250	Olsalazine	multiple sclerosis	69	-0.07
DB01250	Olsalazine	crohn disease	71	-0.05
DB01250	Olsalazine	intestinal neoplasms	42	-0.04
DB01250	Olsalazine	rheumatic diseases	59	-0.04
DB01250	Olsalazine	lung diseases	71	0.00
DB01250	Olsalazine	leukemia lymphoid	66	0.06
DB01250	Olsalazine	diabetes mellitus	162	0.16
DB01250	Olsalazine	gastrointestinal neoplasms	72	0.18
DB01250	Olsalazine	kidney diseases	144	0.23
DB01250	Olsalazine	heart diseases	167	0.27
DB01250	Olsalazine	vascular diseases	181	0.34
DB01250	Olsalazine	leukemia	117	0.34
DB01250	Olsalazine	eye diseases	231	0.35
DB01250	Olsalazine	metabolism inborn errors	289	0.42
DB01250	Olsalazine	autoimmune diseases	243	0.45
DB01250	Olsalazine	endocrine system diseases	291	0.53
DB01250	Olsalazine	neoplasms	482	0.80
DB01250	Olsalazine	epilepsy	25	1.12
DB01250	Olsalazine	arrhythmias cardiac	30	1.18
DB01250	Olsalazine	bone diseases metabolic	27	1.28
DB01250	Olsalazine	parkinsonian disorders	31	1.55
DB01250	Olsalazine	parkinson disease	30	1.61
DB01076	Atorvastatin	coronary artery disease	31	-3.06
DB01076	Atorvastatin	coronary disease	37	-3.04
DB01076	Atorvastatin	arteriosclerosis	38	-2.98
DB01076	Atorvastatin	arterial occlusive diseases	44	-2.94
DB01076	Atorvastatin	myocardial ischemia	43	-2.74
DB01076	Atorvastatin	vascular diseases	181	-2.15
DB01076	Atorvastatin	cardiovascular diseases	330	-1.62
DB01076	Atorvastatin	heart diseases	167	-1.27
DB01076	Atorvastatin	colitis ulcerative	55	-1.14
DB01076	Atorvastatin	colitis	55	-1.08
DB01076	Atorvastatin	multiple sclerosis	69	-0.94
DB01076	Atorvastatin	leukemia myeloid acute	43	-0.90
DB01076	Atorvastatin	spinal cord diseases	59	-0.87
DB01076	Atorvastatin	crohn disease	71	-0.85
DB01076	Atorvastatin	intestinal neoplasms	42	-0.79
DB01076	Atorvastatin	hematologic diseases	188	-0.76
DB01076	Atorvastatin	colorectal neoplasms	42	-0.72
DB01076	Atorvastatin	collagen diseases	25	-0.60
DB01076	Atorvastatin	bone diseases metabolic	27	-0.59
DB01076	Atorvastatin	skin diseases	278	-0.58
DB01076	Atorvastatin	mycobacterium infections	22	-0.49
DB01076	Atorvastatin	gastroenteritis	122	-0.48
DB01076	Atorvastatin	inflammatory bowel diseases	119	-0.47
DB01076	Atorvastatin	thyroid diseases	30	-0.38
DB01076	Atorvastatin	bacterial infections	26	-0.33
DB01076	Atorvastatin	gastrointestinal neoplasms	72	-0.33
DB01076	Atorvastatin	kidney neoplasms	20	-0.29
DB01076	Atorvastatin	liver cirrhosis biliary	23	-0.28
DB01076	Atorvastatin	parkinson disease	30	-0.27
DB01076	Atorvastatin	hypopigmentation	22	-0.27
DB01076	Atorvastatin	pancreatic diseases	24	-0.27
DB01076	Atorvastatin	anemia hemolytic	29	-0.27
DB01076	Atorvastatin	liver cirrhosis	24	-0.26
DB01076	Atorvastatin	malabsorption syndromes	34	-0.25
DB01076	Atorvastatin	parkinsonian disorders	31	-0.22
DB01076	Atorvastatin	bone diseases	144	-0.13
DB01076	Atorvastatin	asthma	36	-0.09
DB01076	Atorvastatin	leukemia	117	-0.03
DB01076	Atorvastatin	hypersensitivity	45	-0.03
DB01076	Atorvastatin	lymphoma	24	-0.03
DB01076	Atorvastatin	blood coagulation disorders	40	-0.01
DB01076	Atorvastatin	sarcoma	25	0.00
DB01076	Atorvastatin	lymphoma non hodgkin	22	0.02
DB01076	Atorvastatin	eye diseases	231	0.09
DB01076	Atorvastatin	metabolism inborn errors	289	0.10
DB01076	Atorvastatin	adenocarcinoma	32	0.20
DB01076	Atorvastatin	arthritis rheumatoid	42	0.20
DB01076	Atorvastatin	neoplasms	482	0.23
DB01076	Atorvastatin	prostatic neoplasms	61	0.25
DB01076	Atorvastatin	head and neck neoplasms	35	0.28
DB01076	Atorvastatin	diabetes mellitus type 2	72	0.29
DB01076	Atorvastatin	autoimmune diseases	243	0.29
DB01076	Atorvastatin	breast neoplasms	40	0.30
DB01076	Atorvastatin	varicose veins	20	0.34
DB01076	Atorvastatin	rheumatic diseases	59	0.42
DB01076	Atorvastatin	lupus erythematosus systemic	75	0.42
DB01076	Atorvastatin	epilepsy	25	0.47
DB01076	Atorvastatin	diabetes mellitus type 1	82	0.48
DB01076	Atorvastatin	endocrine system diseases	291	0.50
DB01076	Atorvastatin	arrhythmias cardiac	30	0.55
DB01076	Atorvastatin	lung diseases	71	0.56
DB01076	Atorvastatin	joint diseases	79	0.57
DB01076	Atorvastatin	arthritis	76	0.57
DB01076	Atorvastatin	hyperinsulinism	26	0.60
DB01076	Atorvastatin	insulin resistance	26	0.61
DB01076	Atorvastatin	anemia	58	0.63
DB01076	Atorvastatin	leukemia lymphoid	66	0.66
DB01076	Atorvastatin	macular degeneration	44	0.77
DB01076	Atorvastatin	kidney diseases	144	0.80
DB01076	Atorvastatin	keratosis	21	0.85
DB01076	Atorvastatin	diabetes mellitus	162	0.91
DB01076	Atorvastatin	amyotrophic lateral sclerosis	21	1.08
DB01076	Atorvastatin	alzheimer disease	29	1.21
DB01076	Atorvastatin	neuroendocrine tumors	24	1.21
DB01076	Atorvastatin	cardiomyopathy dilated	29	1.26
DB01076	Atorvastatin	motor neuron disease	31	1.50
DB01076	Atorvastatin	psoriasis	54	1.63
DB01076	Atorvastatin	dementia	42	1.70
DB01075	Diphenhydramine	arthritis	76	-2.42
DB01075	Diphenhydramine	arthritis rheumatoid	42	-2.36
DB01075	Diphenhydramine	joint diseases	79	-2.26
DB01075	Diphenhydramine	rheumatic diseases	59	-2.08
DB01075	Diphenhydramine	autoimmune diseases	243	-1.83
DB01075	Diphenhydramine	varicose veins	20	-0.99
DB01075	Diphenhydramine	epilepsy	25	-0.91
DB01075	Diphenhydramine	insulin resistance	26	-0.89
DB01075	Diphenhydramine	hyperinsulinism	26	-0.88
DB01075	Diphenhydramine	bone diseases metabolic	27	-0.88
DB01075	Diphenhydramine	collagen diseases	25	-0.88
DB01075	Diphenhydramine	arrhythmias cardiac	30	-0.85
DB01075	Diphenhydramine	coronary artery disease	31	-0.82
DB01075	Diphenhydramine	macular degeneration	44	-0.75
DB01075	Diphenhydramine	keratosis	21	-0.73
DB01075	Diphenhydramine	coronary disease	37	-0.70
DB01075	Diphenhydramine	anemia hemolytic	29	-0.68
DB01075	Diphenhydramine	parkinsonian disorders	31	-0.67
DB01075	Diphenhydramine	malabsorption syndromes	34	-0.65
DB01075	Diphenhydramine	amyotrophic lateral sclerosis	21	-0.64
DB01075	Diphenhydramine	kidney neoplasms	20	-0.63
DB01075	Diphenhydramine	myocardial ischemia	43	-0.63
DB01075	Diphenhydramine	bacterial infections	26	-0.63
DB01075	Diphenhydramine	pancreatic diseases	24	-0.62
DB01075	Diphenhydramine	parkinson disease	30	-0.62
DB01075	Diphenhydramine	hypopigmentation	22	-0.62
DB01075	Diphenhydramine	liver cirrhosis biliary	23	-0.62
DB01075	Diphenhydramine	liver cirrhosis	24	-0.61
DB01075	Diphenhydramine	cardiomyopathy dilated	29	-0.61
DB01075	Diphenhydramine	arteriosclerosis	38	-0.61
DB01075	Diphenhydramine	neuroendocrine tumors	24	-0.58
DB01075	Diphenhydramine	alzheimer disease	29	-0.57
DB01075	Diphenhydramine	asthma	36	-0.56
DB01075	Diphenhydramine	sarcoma	25	-0.55
DB01075	Diphenhydramine	lymphoma	24	-0.51
DB01075	Diphenhydramine	arterial occlusive diseases	44	-0.48
DB01075	Diphenhydramine	lymphoma non hodgkin	22	-0.47
DB01075	Diphenhydramine	blood coagulation disorders	40	-0.46
DB01075	Diphenhydramine	colitis	55	-0.42
DB01075	Diphenhydramine	hypersensitivity	45	-0.40
DB01075	Diphenhydramine	motor neuron disease	31	-0.40
DB01075	Diphenhydramine	breast neoplasms	40	-0.37
DB01075	Diphenhydramine	colitis ulcerative	55	-0.37
DB01075	Diphenhydramine	dementia	42	-0.36
DB01075	Diphenhydramine	head and neck neoplasms	35	-0.35
DB01075	Diphenhydramine	psoriasis	54	-0.31
DB01075	Diphenhydramine	adenocarcinoma	32	-0.31
DB01075	Diphenhydramine	diabetes mellitus type 2	72	-0.30
DB01075	Diphenhydramine	prostatic neoplasms	61	-0.27
DB01075	Diphenhydramine	intestinal neoplasms	42	-0.24
DB01075	Diphenhydramine	crohn disease	71	-0.24
DB01075	Diphenhydramine	spinal cord diseases	59	-0.23
DB01075	Diphenhydramine	lupus erythematosus systemic	75	-0.22
DB01075	Diphenhydramine	multiple sclerosis	69	-0.22
DB01075	Diphenhydramine	leukemia myeloid acute	43	-0.20
DB01075	Diphenhydramine	colorectal neoplasms	42	-0.20
DB01075	Diphenhydramine	diabetes mellitus type 1	82	-0.17
DB01075	Diphenhydramine	anemia	58	-0.14
DB01075	Diphenhydramine	leukemia lymphoid	66	-0.13
DB01075	Diphenhydramine	lung diseases	71	-0.07
DB01075	Diphenhydramine	gastrointestinal neoplasms	72	-0.07
DB01075	Diphenhydramine	gastroenteritis	122	-0.06
DB01075	Diphenhydramine	inflammatory bowel diseases	119	-0.05
DB01075	Diphenhydramine	diabetes mellitus	162	0.01
DB01075	Diphenhydramine	kidney diseases	144	0.05
DB01075	Diphenhydramine	bone diseases	144	0.09
DB01075	Diphenhydramine	heart diseases	167	0.11
DB01075	Diphenhydramine	eye diseases	231	0.16
DB01075	Diphenhydramine	leukemia	117	0.16
DB01075	Diphenhydramine	vascular diseases	181	0.17
DB01075	Diphenhydramine	metabolism inborn errors	289	0.26
DB01075	Diphenhydramine	hematologic diseases	188	0.27
DB01075	Diphenhydramine	skin diseases	278	0.36
DB01075	Diphenhydramine	endocrine system diseases	291	0.37
DB01075	Diphenhydramine	cardiovascular diseases	330	0.40
DB01075	Diphenhydramine	neoplasms	482	0.65
DB01075	Diphenhydramine	mycobacterium infections	22	1.07
DB01075	Diphenhydramine	thyroid diseases	30	1.20
DB00608	Chloroquine	psoriasis	54	-1.60
DB00608	Chloroquine	arthritis	76	-1.38
DB00608	Chloroquine	joint diseases	79	-1.28
DB00608	Chloroquine	keratosis	21	-1.21
DB00608	Chloroquine	liver cirrhosis	24	-1.09
DB00608	Chloroquine	liver cirrhosis biliary	23	-1.03
DB00608	Chloroquine	malabsorption syndromes	34	-1.01
DB00608	Chloroquine	bone diseases	144	-0.73
DB00608	Chloroquine	arthritis rheumatoid	42	-0.65
DB00608	Chloroquine	colitis	55	-0.64
DB00608	Chloroquine	adenocarcinoma	32	-0.63
DB00608	Chloroquine	colitis ulcerative	55	-0.62
DB00608	Chloroquine	head and neck neoplasms	35	-0.54
DB00608	Chloroquine	rheumatic diseases	59	-0.39
DB00608	Chloroquine	hyperinsulinism	26	-0.38
DB00608	Chloroquine	insulin resistance	26	-0.37
DB00608	Chloroquine	hematologic diseases	188	-0.37
DB00608	Chloroquine	multiple sclerosis	69	-0.33
DB00608	Chloroquine	arrhythmias cardiac	30	-0.32
DB00608	Chloroquine	lupus erythematosus systemic	75	-0.31
DB00608	Chloroquine	anemia	58	-0.21
DB00608	Chloroquine	skin diseases	278	-0.10
DB00608	Chloroquine	coronary artery disease	31	-0.09
DB00608	Chloroquine	macular degeneration	44	-0.09
DB00608	Chloroquine	thyroid diseases	30	0.01
DB00608	Chloroquine	hypopigmentation	22	0.02
DB00608	Chloroquine	bacterial infections	26	0.04
DB00608	Chloroquine	coronary disease	37	0.07
DB00608	Chloroquine	inflammatory bowel diseases	119	0.07
DB00608	Chloroquine	pancreatic diseases	24	0.10
DB00608	Chloroquine	gastroenteritis	122	0.12
DB00608	Chloroquine	myocardial ischemia	43	0.13
DB00608	Chloroquine	amyotrophic lateral sclerosis	21	0.14
DB00608	Chloroquine	arteriosclerosis	38	0.18
DB00608	Chloroquine	alzheimer disease	29	0.23
DB00608	Chloroquine	cardiomyopathy dilated	29	0.24
DB00608	Chloroquine	asthma	36	0.25
DB00608	Chloroquine	sarcoma	25	0.29
DB00608	Chloroquine	lymphoma non hodgkin	22	0.31
DB00608	Chloroquine	arterial occlusive diseases	44	0.31
DB00608	Chloroquine	hypersensitivity	45	0.32
DB00608	Chloroquine	lymphoma	24	0.33
DB00608	Chloroquine	blood coagulation disorders	40	0.36
DB00608	Chloroquine	motor neuron disease	31	0.43
DB00608	Chloroquine	eye diseases	231	0.58
DB00608	Chloroquine	prostatic neoplasms	61	0.59
DB00608	Chloroquine	breast neoplasms	40	0.61
DB00608	Chloroquine	dementia	42	0.62
DB00608	Chloroquine	neoplasms	482	0.62
DB00608	Chloroquine	diabetes mellitus type 2	72	0.68
DB00608	Chloroquine	varicose veins	20	0.69
DB00608	Chloroquine	epilepsy	25	0.78
DB00608	Chloroquine	colorectal neoplasms	42	0.79
DB00608	Chloroquine	intestinal neoplasms	42	0.80
DB00608	Chloroquine	leukemia myeloid acute	43	0.82
DB00608	Chloroquine	crohn disease	71	0.83
DB00608	Chloroquine	autoimmune diseases	243	0.85
DB00608	Chloroquine	bone diseases metabolic	27	0.87
DB00608	Chloroquine	diabetes mellitus type 1	82	0.87
DB00608	Chloroquine	spinal cord diseases	59	0.90
DB00608	Chloroquine	collagen diseases	25	0.91
DB00608	Chloroquine	mycobacterium infections	22	0.95
DB00608	Chloroquine	leukemia lymphoid	66	0.98
DB00608	Chloroquine	lung diseases	71	0.99
DB00608	Chloroquine	endocrine system diseases	291	1.00
DB00608	Chloroquine	kidney neoplasms	20	1.15
DB00608	Chloroquine	anemia hemolytic	29	1.20
DB00608	Chloroquine	cardiovascular diseases	330	1.20
DB00608	Chloroquine	kidney diseases	144	1.25
DB00608	Chloroquine	gastrointestinal neoplasms	72	1.28
DB00608	Chloroquine	parkinsonian disorders	31	1.29
DB00608	Chloroquine	parkinson disease	30	1.32
DB00608	Chloroquine	neuroendocrine tumors	24	1.38
DB00608	Chloroquine	diabetes mellitus	162	1.42
DB00608	Chloroquine	heart diseases	167	1.47
DB00608	Chloroquine	leukemia	117	1.62
DB00608	Chloroquine	vascular diseases	181	1.71
DB00608	Chloroquine	metabolism inborn errors	289	1.86
DB01073	Fludarabine	head and neck neoplasms	35	-2.45
DB01073	Fludarabine	asthma	36	-1.52
DB01073	Fludarabine	hypersensitivity	45	-1.33
DB01073	Fludarabine	adenocarcinoma	32	-1.16
DB01073	Fludarabine	eye diseases	231	-1.09
DB01073	Fludarabine	psoriasis	54	-1.05
DB01073	Fludarabine	diabetes mellitus type 2	72	-1.00
DB01073	Fludarabine	lupus erythematosus systemic	75	-0.87
DB01073	Fludarabine	lung diseases	71	-0.71
DB01073	Fludarabine	epilepsy	25	-0.68
DB01073	Fludarabine	arrhythmias cardiac	30	-0.66
DB01073	Fludarabine	hematologic diseases	188	-0.54
DB01073	Fludarabine	mycobacterium infections	22	-0.43
DB01073	Fludarabine	gastrointestinal neoplasms	72	-0.32
DB01073	Fludarabine	bacterial infections	26	-0.28
DB01073	Fludarabine	kidney neoplasms	20	-0.28
DB01073	Fludarabine	diabetes mellitus	162	-0.27
DB01073	Fludarabine	thyroid diseases	30	-0.24
DB01073	Fludarabine	anemia hemolytic	29	-0.23
DB01073	Fludarabine	hypopigmentation	22	-0.16
DB01073	Fludarabine	parkinson disease	30	-0.16
DB01073	Fludarabine	amyotrophic lateral sclerosis	21	-0.15
DB01073	Fludarabine	parkinsonian disorders	31	-0.14
DB01073	Fludarabine	alzheimer disease	29	-0.04
DB01073	Fludarabine	cardiomyopathy dilated	29	-0.01
DB01073	Fludarabine	sarcoma	25	0.03
DB01073	Fludarabine	lymphoma non hodgkin	22	0.04
DB01073	Fludarabine	lymphoma	24	0.11
DB01073	Fludarabine	vascular diseases	181	0.12
DB01073	Fludarabine	motor neuron disease	31	0.15
DB01073	Fludarabine	colitis ulcerative	55	0.21
DB01073	Fludarabine	colitis	55	0.23
DB01073	Fludarabine	arthritis rheumatoid	42	0.25
DB01073	Fludarabine	prostatic neoplasms	61	0.31
DB01073	Fludarabine	dementia	42	0.32
DB01073	Fludarabine	neoplasms	482	0.32
DB01073	Fludarabine	breast neoplasms	40	0.35
DB01073	Fludarabine	autoimmune diseases	243	0.37
DB01073	Fludarabine	rheumatic diseases	59	0.44
DB01073	Fludarabine	leukemia myeloid acute	43	0.52
DB01073	Fludarabine	multiple sclerosis	69	0.53
DB01073	Fludarabine	diabetes mellitus type 1	82	0.54
DB01073	Fludarabine	spinal cord diseases	59	0.56
DB01073	Fludarabine	endocrine system diseases	291	0.56
DB01073	Fludarabine	hyperinsulinism	26	0.57
DB01073	Fludarabine	intestinal neoplasms	42	0.58
DB01073	Fludarabine	colorectal neoplasms	42	0.59
DB01073	Fludarabine	joint diseases	79	0.59
DB01073	Fludarabine	crohn disease	71	0.60
DB01073	Fludarabine	arthritis	76	0.62
DB01073	Fludarabine	skin diseases	278	0.63
DB01073	Fludarabine	cardiovascular diseases	330	0.67
DB01073	Fludarabine	insulin resistance	26	0.67
DB01073	Fludarabine	collagen diseases	25	0.68
DB01073	Fludarabine	leukemia lymphoid	66	0.70
DB01073	Fludarabine	anemia	58	0.71
DB01073	Fludarabine	bone diseases metabolic	27	0.72
DB01073	Fludarabine	coronary artery disease	31	0.80
DB01073	Fludarabine	gastroenteritis	122	0.84
DB01073	Fludarabine	kidney diseases	144	0.88
DB01073	Fludarabine	macular degeneration	44	0.88
DB01073	Fludarabine	inflammatory bowel diseases	119	0.89
DB01073	Fludarabine	keratosis	21	0.91
DB01073	Fludarabine	heart diseases	167	1.05
DB01073	Fludarabine	bone diseases	144	1.06
DB01073	Fludarabine	coronary disease	37	1.09
DB01073	Fludarabine	myocardial ischemia	43	1.11
DB01073	Fludarabine	liver cirrhosis biliary	23	1.16
DB01073	Fludarabine	liver cirrhosis	24	1.18
DB01073	Fludarabine	malabsorption syndromes	34	1.20
DB01073	Fludarabine	pancreatic diseases	24	1.21
DB01073	Fludarabine	arteriosclerosis	38	1.23
DB01073	Fludarabine	leukemia	117	1.24
DB01073	Fludarabine	neuroendocrine tumors	24	1.26
DB01073	Fludarabine	blood coagulation disorders	40	1.35
DB01073	Fludarabine	metabolism inborn errors	289	1.36
DB01073	Fludarabine	arterial occlusive diseases	44	1.40
DB01073	Fludarabine	varicose veins	20	1.55
DB00603	Medroxyprogesterone	breast neoplasms	40	-3.35
DB00603	Medroxyprogesterone	heart diseases	167	-2.65
DB00603	Medroxyprogesterone	cardiovascular diseases	330	-2.38
DB00603	Medroxyprogesterone	skin diseases	278	-2.27
DB00603	Medroxyprogesterone	cardiomyopathy dilated	29	-2.17
DB00603	Medroxyprogesterone	asthma	36	-1.92
DB00603	Medroxyprogesterone	neoplasms	482	-1.87
DB00603	Medroxyprogesterone	sarcoma	25	-1.82
DB00603	Medroxyprogesterone	hypersensitivity	45	-1.77
DB00603	Medroxyprogesterone	prostatic neoplasms	61	-1.74
DB00603	Medroxyprogesterone	diabetes mellitus type 1	82	-1.53
DB00603	Medroxyprogesterone	multiple sclerosis	69	-1.47
DB00603	Medroxyprogesterone	lung diseases	71	-1.22
DB00603	Medroxyprogesterone	diabetes mellitus	162	-1.12
DB00603	Medroxyprogesterone	coronary artery disease	31	-0.98
DB00603	Medroxyprogesterone	coronary disease	37	-0.86
DB00603	Medroxyprogesterone	metabolism inborn errors	289	-0.83
DB00603	Medroxyprogesterone	bone diseases	144	-0.83
DB00603	Medroxyprogesterone	myocardial ischemia	43	-0.81
DB00603	Medroxyprogesterone	arteriosclerosis	38	-0.72
DB00603	Medroxyprogesterone	thyroid diseases	30	-0.70
DB00603	Medroxyprogesterone	autoimmune diseases	243	-0.55
DB00603	Medroxyprogesterone	arterial occlusive diseases	44	-0.51
DB00603	Medroxyprogesterone	alzheimer disease	29	-0.48
DB00603	Medroxyprogesterone	kidney neoplasms	20	-0.47
DB00603	Medroxyprogesterone	liver cirrhosis biliary	23	-0.43
DB00603	Medroxyprogesterone	colitis	55	-0.39
DB00603	Medroxyprogesterone	liver cirrhosis	24	-0.38
DB00603	Medroxyprogesterone	endocrine system diseases	291	-0.37
DB00603	Medroxyprogesterone	pancreatic diseases	24	-0.36
DB00603	Medroxyprogesterone	colitis ulcerative	55	-0.34
DB00603	Medroxyprogesterone	diabetes mellitus type 2	72	-0.28
DB00603	Medroxyprogesterone	neuroendocrine tumors	24	-0.24
DB00603	Medroxyprogesterone	lymphoma non hodgkin	22	-0.15
DB00603	Medroxyprogesterone	dementia	42	-0.10
DB00603	Medroxyprogesterone	lymphoma	24	-0.08
DB00603	Medroxyprogesterone	motor neuron disease	31	-0.04
DB00603	Medroxyprogesterone	head and neck neoplasms	35	-0.01
DB00603	Medroxyprogesterone	adenocarcinoma	32	0.01
DB00603	Medroxyprogesterone	lupus erythematosus systemic	75	0.16
DB00603	Medroxyprogesterone	crohn disease	71	0.21
DB00603	Medroxyprogesterone	leukemia myeloid acute	43	0.37
DB00603	Medroxyprogesterone	varicose veins	20	0.37
DB00603	Medroxyprogesterone	colorectal neoplasms	42	0.39
DB00603	Medroxyprogesterone	intestinal neoplasms	42	0.40
DB00603	Medroxyprogesterone	spinal cord diseases	59	0.41
DB00603	Medroxyprogesterone	epilepsy	25	0.43
DB00603	Medroxyprogesterone	arrhythmias cardiac	30	0.44
DB00603	Medroxyprogesterone	leukemia lymphoid	66	0.48
DB00603	Medroxyprogesterone	anemia	58	0.51
DB00603	Medroxyprogesterone	collagen diseases	25	0.51
DB00603	Medroxyprogesterone	macular degeneration	44	0.54
DB00603	Medroxyprogesterone	bone diseases metabolic	27	0.55
DB00603	Medroxyprogesterone	inflammatory bowel diseases	119	0.57
DB00603	Medroxyprogesterone	kidney diseases	144	0.57
DB00603	Medroxyprogesterone	hyperinsulinism	26	0.59
DB00603	Medroxyprogesterone	gastroenteritis	122	0.61
DB00603	Medroxyprogesterone	insulin resistance	26	0.62
DB00603	Medroxyprogesterone	parkinson disease	30	0.75
DB00603	Medroxyprogesterone	parkinsonian disorders	31	0.76
DB00603	Medroxyprogesterone	keratosis	21	0.78
DB00603	Medroxyprogesterone	gastrointestinal neoplasms	72	0.80
DB00603	Medroxyprogesterone	anemia hemolytic	29	0.87
DB00603	Medroxyprogesterone	mycobacterium infections	22	0.99
DB00603	Medroxyprogesterone	malabsorption syndromes	34	1.03
DB00603	Medroxyprogesterone	hypopigmentation	22	1.06
DB00603	Medroxyprogesterone	vascular diseases	181	1.07
DB00603	Medroxyprogesterone	blood coagulation disorders	40	1.07
DB00603	Medroxyprogesterone	leukemia	117	1.08
DB00603	Medroxyprogesterone	amyotrophic lateral sclerosis	21	1.09
DB00603	Medroxyprogesterone	eye diseases	231	1.09
DB00603	Medroxyprogesterone	bacterial infections	26	1.13
DB00603	Medroxyprogesterone	hematologic diseases	188	1.37
DB00603	Medroxyprogesterone	psoriasis	54	1.57
DB00603	Medroxyprogesterone	arthritis rheumatoid	42	1.73
DB00603	Medroxyprogesterone	rheumatic diseases	59	1.98
DB00603	Medroxyprogesterone	arthritis	76	2.14
DB00603	Medroxyprogesterone	joint diseases	79	2.25
DB00949	Felbamate	spinal cord diseases	59	-1.90
DB00949	Felbamate	keratosis	21	-1.57
DB00949	Felbamate	neuroendocrine tumors	24	-1.54
DB00949	Felbamate	asthma	36	-1.54
DB00949	Felbamate	hypersensitivity	45	-1.30
DB00949	Felbamate	parkinsonian disorders	31	-1.29
DB00949	Felbamate	parkinson disease	30	-1.24
DB00949	Felbamate	cardiomyopathy dilated	29	-1.22
DB00949	Felbamate	alzheimer disease	29	-1.15
DB00949	Felbamate	adenocarcinoma	32	-0.93
DB00949	Felbamate	multiple sclerosis	69	-0.90
DB00949	Felbamate	dementia	42	-0.86
DB00949	Felbamate	prostatic neoplasms	61	-0.84
DB00949	Felbamate	epilepsy	25	-0.82
DB00949	Felbamate	breast neoplasms	40	-0.81
DB00949	Felbamate	arrhythmias cardiac	30	-0.64
DB00949	Felbamate	collagen diseases	25	-0.61
DB00949	Felbamate	lung diseases	71	-0.49
DB00949	Felbamate	intestinal neoplasms	42	-0.43
DB00949	Felbamate	colorectal neoplasms	42	-0.41
DB00949	Felbamate	anemia hemolytic	29	-0.38
DB00949	Felbamate	hypopigmentation	22	-0.35
DB00949	Felbamate	liver cirrhosis biliary	23	-0.33
DB00949	Felbamate	liver cirrhosis	24	-0.33
DB00949	Felbamate	kidney neoplasms	20	-0.31
DB00949	Felbamate	pancreatic diseases	24	-0.25
DB00949	Felbamate	thyroid diseases	30	-0.24
DB00949	Felbamate	amyotrophic lateral sclerosis	21	-0.20
DB00949	Felbamate	myocardial ischemia	43	-0.15
DB00949	Felbamate	gastrointestinal neoplasms	72	0.02
DB00949	Felbamate	lymphoma	24	0.04
DB00949	Felbamate	lymphoma non hodgkin	22	0.06
DB00949	Felbamate	sarcoma	25	0.07
DB00949	Felbamate	arthritis rheumatoid	42	0.08
DB00949	Felbamate	heart diseases	167	0.09
DB00949	Felbamate	leukemia	117	0.15
DB00949	Felbamate	motor neuron disease	31	0.19
DB00949	Felbamate	colitis	55	0.26
DB00949	Felbamate	psoriasis	54	0.28
DB00949	Felbamate	varicose veins	20	0.28
DB00949	Felbamate	colitis ulcerative	55	0.29
DB00949	Felbamate	vascular diseases	181	0.33
DB00949	Felbamate	rheumatic diseases	59	0.37
DB00949	Felbamate	neoplasms	482	0.38
DB00949	Felbamate	head and neck neoplasms	35	0.39
DB00949	Felbamate	lupus erythematosus systemic	75	0.39
DB00949	Felbamate	hyperinsulinism	26	0.45
DB00949	Felbamate	autoimmune diseases	243	0.48
DB00949	Felbamate	crohn disease	71	0.49
DB00949	Felbamate	insulin resistance	26	0.49
DB00949	Felbamate	diabetes mellitus type 1	82	0.50
DB00949	Felbamate	anemia	58	0.52
DB00949	Felbamate	hematologic diseases	188	0.53
DB00949	Felbamate	leukemia myeloid acute	43	0.54
DB00949	Felbamate	arthritis	76	0.57
DB00949	Felbamate	joint diseases	79	0.62
DB00949	Felbamate	bone diseases metabolic	27	0.63
DB00949	Felbamate	mycobacterium infections	22	0.71
DB00949	Felbamate	macular degeneration	44	0.72
DB00949	Felbamate	endocrine system diseases	291	0.74
DB00949	Felbamate	leukemia lymphoid	66	0.75
DB00949	Felbamate	coronary artery disease	31	0.78
DB00949	Felbamate	skin diseases	278	0.80
DB00949	Felbamate	gastroenteritis	122	0.85
DB00949	Felbamate	inflammatory bowel diseases	119	0.89
DB00949	Felbamate	cardiovascular diseases	330	0.89
DB00949	Felbamate	kidney diseases	144	0.91
DB00949	Felbamate	coronary disease	37	0.91
DB00949	Felbamate	bacterial infections	26	0.91
DB00949	Felbamate	malabsorption syndromes	34	0.99
DB00949	Felbamate	diabetes mellitus	162	1.02
DB00949	Felbamate	arteriosclerosis	38	1.06
DB00949	Felbamate	bone diseases	144	1.15
DB00949	Felbamate	arterial occlusive diseases	44	1.27
DB00949	Felbamate	blood coagulation disorders	40	1.29
DB00949	Felbamate	eye diseases	231	1.37
DB00949	Felbamate	metabolism inborn errors	289	1.56
DB00949	Felbamate	diabetes mellitus type 2	72	1.60
DB00600	Monobenzone	hypopigmentation	22	-4.48
DB00600	Monobenzone	neuroendocrine tumors	24	-4.34
DB00600	Monobenzone	eye diseases	231	-4.13
DB00600	Monobenzone	metabolism inborn errors	289	-3.61
DB00600	Monobenzone	skin diseases	278	-3.47
DB00600	Monobenzone	neoplasms	482	-2.81
DB00600	Monobenzone	parkinsonian disorders	31	-2.59
DB00600	Monobenzone	parkinson disease	30	-2.53
DB00600	Monobenzone	prostatic neoplasms	61	-2.42
DB00600	Monobenzone	diabetes mellitus type 1	82	-2.41
DB00600	Monobenzone	diabetes mellitus	162	-2.23
DB00600	Monobenzone	autoimmune diseases	243	-1.73
DB00600	Monobenzone	endocrine system diseases	291	-1.65
DB00600	Monobenzone	cardiovascular diseases	330	-1.37
DB00600	Monobenzone	varicose veins	20	-0.96
DB00600	Monobenzone	epilepsy	25	-0.85
DB00600	Monobenzone	collagen diseases	25	-0.81
DB00600	Monobenzone	coronary artery disease	31	-0.78
DB00600	Monobenzone	mycobacterium infections	22	-0.74
DB00600	Monobenzone	amyotrophic lateral sclerosis	21	-0.73
DB00600	Monobenzone	macular degeneration	44	-0.72
DB00600	Monobenzone	anemia hemolytic	29	-0.71
DB00600	Monobenzone	bacterial infections	26	-0.70
DB00600	Monobenzone	coronary disease	37	-0.67
DB00600	Monobenzone	kidney neoplasms	20	-0.66
DB00600	Monobenzone	myocardial ischemia	43	-0.66
DB00600	Monobenzone	malabsorption syndromes	34	-0.66
DB00600	Monobenzone	alzheimer disease	29	-0.62
DB00600	Monobenzone	pancreatic diseases	24	-0.59
DB00600	Monobenzone	arteriosclerosis	38	-0.59
DB00600	Monobenzone	cardiomyopathy dilated	29	-0.55
DB00600	Monobenzone	blood coagulation disorders	40	-0.54
DB00600	Monobenzone	lymphoma non hodgkin	22	-0.50
DB00600	Monobenzone	sarcoma	25	-0.49
DB00600	Monobenzone	adenocarcinoma	32	-0.47
DB00600	Monobenzone	colitis	55	-0.47
DB00600	Monobenzone	arterial occlusive diseases	44	-0.47
DB00600	Monobenzone	lymphoma	24	-0.46
DB00600	Monobenzone	motor neuron disease	31	-0.46
DB00600	Monobenzone	arthritis rheumatoid	42	-0.45
DB00600	Monobenzone	dementia	42	-0.39
DB00600	Monobenzone	colitis ulcerative	55	-0.37
DB00600	Monobenzone	multiple sclerosis	69	-0.28
DB00600	Monobenzone	rheumatic diseases	59	-0.28
DB00600	Monobenzone	breast neoplasms	40	-0.27
DB00600	Monobenzone	leukemia myeloid acute	43	-0.27
DB00600	Monobenzone	lupus erythematosus systemic	75	-0.26
DB00600	Monobenzone	diabetes mellitus type 2	72	-0.24
DB00600	Monobenzone	intestinal neoplasms	42	-0.24
DB00600	Monobenzone	crohn disease	71	-0.23
DB00600	Monobenzone	spinal cord diseases	59	-0.19
DB00600	Monobenzone	arthritis	76	-0.19
DB00600	Monobenzone	leukemia lymphoid	66	-0.18
DB00600	Monobenzone	joint diseases	79	-0.17
DB00600	Monobenzone	colorectal neoplasms	42	-0.17
DB00600	Monobenzone	lung diseases	71	-0.17
DB00600	Monobenzone	anemia	58	-0.13
DB00600	Monobenzone	inflammatory bowel diseases	119	-0.02
DB00600	Monobenzone	gastrointestinal neoplasms	72	-0.02
DB00600	Monobenzone	kidney diseases	144	-0.01
DB00600	Monobenzone	gastroenteritis	122	0.00
DB00600	Monobenzone	bone diseases	144	0.04
DB00600	Monobenzone	leukemia	117	0.07
DB00600	Monobenzone	vascular diseases	181	0.12
DB00600	Monobenzone	heart diseases	167	0.12
DB00600	Monobenzone	hematologic diseases	188	0.25
DB00600	Monobenzone	hyperinsulinism	26	0.85
DB00600	Monobenzone	insulin resistance	26	0.90
DB00600	Monobenzone	arrhythmias cardiac	30	0.94
DB00600	Monobenzone	bone diseases metabolic	27	0.99
DB00600	Monobenzone	keratosis	21	1.00
DB00600	Monobenzone	thyroid diseases	30	1.10
DB00600	Monobenzone	liver cirrhosis biliary	23	1.20
DB00600	Monobenzone	liver cirrhosis	24	1.21
DB00600	Monobenzone	asthma	36	1.34
DB00600	Monobenzone	hypersensitivity	45	1.40
DB00600	Monobenzone	head and neck neoplasms	35	1.61
DB00600	Monobenzone	psoriasis	54	1.79
DB00829	Diazepam	epilepsy	25	-8.93
DB00829	Diazepam	vascular diseases	181	-3.14
DB00829	Diazepam	spinal cord diseases	59	-2.48
DB00829	Diazepam	collagen diseases	25	-2.39
DB00829	Diazepam	cardiovascular diseases	330	-1.99
DB00829	Diazepam	neuroendocrine tumors	24	-1.38
DB00829	Diazepam	colorectal neoplasms	42	-1.34
DB00829	Diazepam	intestinal neoplasms	42	-1.33
DB00829	Diazepam	varicose veins	20	-1.31
DB00829	Diazepam	keratosis	21	-1.07
DB00829	Diazepam	arrhythmias cardiac	30	-0.94
DB00829	Diazepam	lupus erythematosus systemic	75	-0.86
DB00829	Diazepam	bone diseases	144	-0.83
DB00829	Diazepam	multiple sclerosis	69	-0.78
DB00829	Diazepam	sarcoma	25	-0.73
DB00829	Diazepam	gastrointestinal neoplasms	72	-0.65
DB00829	Diazepam	amyotrophic lateral sclerosis	21	-0.57
DB00829	Diazepam	malabsorption syndromes	34	-0.56
DB00829	Diazepam	leukemia lymphoid	66	-0.50
DB00829	Diazepam	autoimmune diseases	243	-0.49
DB00829	Diazepam	motor neuron disease	31	-0.46
DB00829	Diazepam	asthma	36	-0.39
DB00829	Diazepam	cardiomyopathy dilated	29	-0.33
DB00829	Diazepam	thyroid diseases	30	-0.31
DB00829	Diazepam	adenocarcinoma	32	-0.26
DB00829	Diazepam	bacterial infections	26	-0.23
DB00829	Diazepam	kidney neoplasms	20	-0.21
DB00829	Diazepam	dementia	42	-0.12
DB00829	Diazepam	parkinsonian disorders	31	-0.06
DB00829	Diazepam	parkinson disease	30	-0.04
DB00829	Diazepam	breast neoplasms	40	-0.03
DB00829	Diazepam	pancreatic diseases	24	-0.03
DB00829	Diazepam	hypersensitivity	45	0.03
DB00829	Diazepam	diabetes mellitus type 2	72	0.08
DB00829	Diazepam	insulin resistance	26	0.09
DB00829	Diazepam	lung diseases	71	0.10
DB00829	Diazepam	macular degeneration	44	0.11
DB00829	Diazepam	hyperinsulinism	26	0.11
DB00829	Diazepam	bone diseases metabolic	27	0.17
DB00829	Diazepam	alzheimer disease	29	0.22
DB00829	Diazepam	endocrine system diseases	291	0.27
DB00829	Diazepam	leukemia myeloid acute	43	0.33
DB00829	Diazepam	crohn disease	71	0.35
DB00829	Diazepam	hypopigmentation	22	0.37
DB00829	Diazepam	diabetes mellitus type 1	82	0.38
DB00829	Diazepam	mycobacterium infections	22	0.40
DB00829	Diazepam	lymphoma non hodgkin	22	0.44
DB00829	Diazepam	lymphoma	24	0.47
DB00829	Diazepam	blood coagulation disorders	40	0.49
DB00829	Diazepam	coronary artery disease	31	0.51
DB00829	Diazepam	prostatic neoplasms	61	0.53
DB00829	Diazepam	psoriasis	54	0.60
DB00829	Diazepam	leukemia	117	0.65
DB00829	Diazepam	diabetes mellitus	162	0.74
DB00829	Diazepam	anemia hemolytic	29	0.79
DB00829	Diazepam	arthritis rheumatoid	42	0.81
DB00829	Diazepam	skin diseases	278	0.87
DB00829	Diazepam	coronary disease	37	0.87
DB00829	Diazepam	colitis ulcerative	55	0.90
DB00829	Diazepam	heart diseases	167	0.93
DB00829	Diazepam	colitis	55	0.98
DB00829	Diazepam	inflammatory bowel diseases	119	1.04
DB00829	Diazepam	arterial occlusive diseases	44	1.05
DB00829	Diazepam	kidney diseases	144	1.11
DB00829	Diazepam	gastroenteritis	122	1.11
DB00829	Diazepam	arteriosclerosis	38	1.12
DB00829	Diazepam	myocardial ischemia	43	1.17
DB00829	Diazepam	rheumatic diseases	59	1.27
DB00829	Diazepam	metabolism inborn errors	289	1.40
DB00829	Diazepam	liver cirrhosis biliary	23	1.44
DB00829	Diazepam	liver cirrhosis	24	1.48
DB00829	Diazepam	head and neck neoplasms	35	1.51
DB00829	Diazepam	arthritis	76	1.73
DB00829	Diazepam	neoplasms	482	1.75
DB00829	Diazepam	anemia	58	1.77
DB00829	Diazepam	joint diseases	79	1.79
DB00829	Diazepam	eye diseases	231	1.87
DB00829	Diazepam	hematologic diseases	188	2.17
DB00605	Sulindac	lung diseases	71	-2.57
DB00605	Sulindac	psoriasis	54	-2.16
DB00605	Sulindac	eye diseases	231	-1.58
DB00605	Sulindac	varicose veins	20	-1.46
DB00605	Sulindac	sarcoma	25	-1.37
DB00605	Sulindac	lymphoma	24	-1.29
DB00605	Sulindac	lymphoma non hodgkin	22	-1.21
DB00605	Sulindac	gastrointestinal neoplasms	72	-1.09
DB00605	Sulindac	adenocarcinoma	32	-1.05
DB00605	Sulindac	head and neck neoplasms	35	-0.96
DB00605	Sulindac	lupus erythematosus systemic	75	-0.86
DB00605	Sulindac	skin diseases	278	-0.82
DB00605	Sulindac	multiple sclerosis	69	-0.68
DB00605	Sulindac	malabsorption syndromes	34	-0.56
DB00605	Sulindac	alzheimer disease	29	-0.52
DB00605	Sulindac	vascular diseases	181	-0.51
DB00605	Sulindac	leukemia lymphoid	66	-0.41
DB00605	Sulindac	neuroendocrine tumors	24	-0.37
DB00605	Sulindac	arrhythmias cardiac	30	-0.36
DB00605	Sulindac	collagen diseases	25	-0.35
DB00605	Sulindac	bone diseases metabolic	27	-0.28
DB00605	Sulindac	colitis	55	-0.25
DB00605	Sulindac	colitis ulcerative	55	-0.22
DB00605	Sulindac	macular degeneration	44	-0.20
DB00605	Sulindac	diabetes mellitus type 2	72	-0.03
DB00605	Sulindac	dementia	42	0.01
DB00605	Sulindac	bone diseases	144	0.10
DB00605	Sulindac	keratosis	21	0.14
DB00605	Sulindac	heart diseases	167	0.15
DB00605	Sulindac	prostatic neoplasms	61	0.20
DB00605	Sulindac	cardiovascular diseases	330	0.21
DB00605	Sulindac	thyroid diseases	30	0.22
DB00605	Sulindac	neoplasms	482	0.23
DB00605	Sulindac	parkinson disease	30	0.25
DB00605	Sulindac	parkinsonian disorders	31	0.27
DB00605	Sulindac	breast neoplasms	40	0.28
DB00605	Sulindac	diabetes mellitus type 1	82	0.31
DB00605	Sulindac	leukemia	117	0.36
DB00605	Sulindac	kidney neoplasms	20	0.42
DB00605	Sulindac	crohn disease	71	0.44
DB00605	Sulindac	metabolism inborn errors	289	0.46
DB00605	Sulindac	spinal cord diseases	59	0.53
DB00605	Sulindac	leukemia myeloid acute	43	0.55
DB00605	Sulindac	intestinal neoplasms	42	0.55
DB00605	Sulindac	colorectal neoplasms	42	0.59
DB00605	Sulindac	pancreatic diseases	24	0.65
DB00605	Sulindac	asthma	36	0.66
DB00605	Sulindac	anemia	58	0.72
DB00605	Sulindac	autoimmune diseases	243	0.73
DB00605	Sulindac	hematologic diseases	188	0.79
DB00605	Sulindac	gastroenteritis	122	0.80
DB00605	Sulindac	inflammatory bowel diseases	119	0.82
DB00605	Sulindac	kidney diseases	144	0.89
DB00605	Sulindac	hypersensitivity	45	0.93
DB00605	Sulindac	diabetes mellitus	162	0.93
DB00605	Sulindac	endocrine system diseases	291	0.94
DB00605	Sulindac	motor neuron disease	31	1.11
DB00605	Sulindac	coronary artery disease	31	1.17
DB00605	Sulindac	mycobacterium infections	22	1.24
DB00605	Sulindac	arthritis rheumatoid	42	1.25
DB00605	Sulindac	anemia hemolytic	29	1.30
DB00605	Sulindac	myocardial ischemia	43	1.33
DB00605	Sulindac	coronary disease	37	1.37
DB00605	Sulindac	rheumatic diseases	59	1.48
DB00605	Sulindac	arteriosclerosis	38	1.49
DB00605	Sulindac	hypopigmentation	22	1.50
DB00605	Sulindac	bacterial infections	26	1.55
DB00605	Sulindac	liver cirrhosis biliary	23	1.60
DB00605	Sulindac	amyotrophic lateral sclerosis	21	1.66
DB00605	Sulindac	liver cirrhosis	24	1.68
DB00605	Sulindac	joint diseases	79	1.70
DB00605	Sulindac	hyperinsulinism	26	1.73
DB00605	Sulindac	arthritis	76	1.74
DB00605	Sulindac	blood coagulation disorders	40	1.74
DB00605	Sulindac	arterial occlusive diseases	44	1.82
DB00605	Sulindac	insulin resistance	26	1.86
DB00605	Sulindac	epilepsy	25	2.63
DB00605	Sulindac	cardiomyopathy dilated	29	2.73
DB00273	Topiramate	epilepsy	25	-4.20
DB00273	Topiramate	kidney diseases	144	-2.24
DB00273	Topiramate	bone diseases	144	-2.11
DB00273	Topiramate	anemia hemolytic	29	-2.01
DB00273	Topiramate	anemia	58	-1.66
DB00273	Topiramate	metabolism inborn errors	289	-1.63
DB00273	Topiramate	eye diseases	231	-1.55
DB00273	Topiramate	hematologic diseases	188	-1.48
DB00273	Topiramate	hypopigmentation	22	-1.04
DB00273	Topiramate	kidney neoplasms	20	-1.04
DB00273	Topiramate	heart diseases	167	-1.03
DB00273	Topiramate	cardiomyopathy dilated	29	-0.79
DB00273	Topiramate	arrhythmias cardiac	30	-0.65
DB00273	Topiramate	adenocarcinoma	32	-0.37
DB00273	Topiramate	mycobacterium infections	22	-0.34
DB00273	Topiramate	breast neoplasms	40	-0.21
DB00273	Topiramate	cardiovascular diseases	330	-0.20
DB00273	Topiramate	bacterial infections	26	-0.13
DB00273	Topiramate	crohn disease	71	-0.05
DB00273	Topiramate	varicose veins	20	-0.05
DB00273	Topiramate	pancreatic diseases	24	-0.04
DB00273	Topiramate	neuroendocrine tumors	24	0.04
DB00273	Topiramate	spinal cord diseases	59	0.06
DB00273	Topiramate	arterial occlusive diseases	44	0.24
DB00273	Topiramate	blood coagulation disorders	40	0.28
DB00273	Topiramate	motor neuron disease	31	0.38
DB00273	Topiramate	gastroenteritis	122	0.43
DB00273	Topiramate	arthritis rheumatoid	42	0.44
DB00273	Topiramate	inflammatory bowel diseases	119	0.44
DB00273	Topiramate	neoplasms	482	0.53
DB00273	Topiramate	gastrointestinal neoplasms	72	0.54
DB00273	Topiramate	keratosis	21	0.54
DB00273	Topiramate	head and neck neoplasms	35	0.56
DB00273	Topiramate	dementia	42	0.57
DB00273	Topiramate	skin diseases	278	0.60
DB00273	Topiramate	psoriasis	54	0.62
DB00273	Topiramate	prostatic neoplasms	61	0.64
DB00273	Topiramate	thyroid diseases	30	0.69
DB00273	Topiramate	parkinson disease	30	0.79
DB00273	Topiramate	rheumatic diseases	59	0.79
DB00273	Topiramate	lupus erythematosus systemic	75	0.81
DB00273	Topiramate	malabsorption syndromes	34	0.81
DB00273	Topiramate	amyotrophic lateral sclerosis	21	0.83
DB00273	Topiramate	multiple sclerosis	69	0.84
DB00273	Topiramate	parkinsonian disorders	31	0.85
DB00273	Topiramate	myocardial ischemia	43	0.87
DB00273	Topiramate	asthma	36	0.94
DB00273	Topiramate	diabetes mellitus type 1	82	0.94
DB00273	Topiramate	colorectal neoplasms	42	0.96
DB00273	Topiramate	intestinal neoplasms	42	0.98
DB00273	Topiramate	insulin resistance	26	1.04
DB00273	Topiramate	arthritis	76	1.04
DB00273	Topiramate	hyperinsulinism	26	1.05
DB00273	Topiramate	joint diseases	79	1.06
DB00273	Topiramate	lung diseases	71	1.12
DB00273	Topiramate	sarcoma	25	1.12
DB00273	Topiramate	collagen diseases	25	1.13
DB00273	Topiramate	lymphoma non hodgkin	22	1.13
DB00273	Topiramate	lymphoma	24	1.14
DB00273	Topiramate	hypersensitivity	45	1.17
DB00273	Topiramate	leukemia lymphoid	66	1.18
DB00273	Topiramate	coronary artery disease	31	1.37
DB00273	Topiramate	colitis	55	1.45
DB00273	Topiramate	colitis ulcerative	55	1.49
DB00273	Topiramate	diabetes mellitus	162	1.54
DB00273	Topiramate	liver cirrhosis	24	1.62
DB00273	Topiramate	coronary disease	37	1.64
DB00273	Topiramate	diabetes mellitus type 2	72	1.64
DB00273	Topiramate	liver cirrhosis biliary	23	1.67
DB00273	Topiramate	arteriosclerosis	38	1.77
DB00273	Topiramate	leukemia	117	1.84
DB00273	Topiramate	leukemia myeloid acute	43	1.88
DB00273	Topiramate	alzheimer disease	29	1.88
DB00273	Topiramate	bone diseases metabolic	27	1.92
DB00273	Topiramate	vascular diseases	181	1.98
DB00273	Topiramate	autoimmune diseases	243	2.15
DB00273	Topiramate	macular degeneration	44	2.22
DB00273	Topiramate	endocrine system diseases	291	2.37
DB00471	Montelukast	myocardial ischemia	43	-2.57
DB00471	Montelukast	psoriasis	54	-2.24
DB00471	Montelukast	multiple sclerosis	69	-2.08
DB00471	Montelukast	arthritis	76	-2.00
DB00471	Montelukast	joint diseases	79	-1.97
DB00471	Montelukast	gastroenteritis	122	-1.77
DB00471	Montelukast	mycobacterium infections	22	-1.59
DB00471	Montelukast	bone diseases	144	-1.53
DB00471	Montelukast	coronary artery disease	31	-1.52
DB00471	Montelukast	heart diseases	167	-1.51
DB00471	Montelukast	keratosis	21	-1.49
DB00471	Montelukast	bacterial infections	26	-1.47
DB00471	Montelukast	malabsorption syndromes	34	-1.43
DB00471	Montelukast	parkinson disease	30	-1.41
DB00471	Montelukast	vascular diseases	181	-1.38
DB00471	Montelukast	parkinsonian disorders	31	-1.36
DB00471	Montelukast	arteriosclerosis	38	-1.34
DB00471	Montelukast	coronary disease	37	-1.30
DB00471	Montelukast	asthma	36	-1.26
DB00471	Montelukast	sarcoma	25	-1.24
DB00471	Montelukast	arterial occlusive diseases	44	-1.19
DB00471	Montelukast	colitis	55	-1.13
DB00471	Montelukast	autoimmune diseases	243	-1.10
DB00471	Montelukast	hypersensitivity	45	-1.09
DB00471	Montelukast	dementia	42	-1.08
DB00471	Montelukast	skin diseases	278	-1.07
DB00471	Montelukast	arthritis rheumatoid	42	-0.99
DB00471	Montelukast	colitis ulcerative	55	-0.95
DB00471	Montelukast	cardiovascular diseases	330	-0.94
DB00471	Montelukast	prostatic neoplasms	61	-0.86
DB00471	Montelukast	rheumatic diseases	59	-0.85
DB00471	Montelukast	diabetes mellitus type 2	72	-0.83
DB00471	Montelukast	diabetes mellitus type 1	82	-0.78
DB00471	Montelukast	crohn disease	71	-0.74
DB00471	Montelukast	lupus erythematosus systemic	75	-0.73
DB00471	Montelukast	lung diseases	71	-0.63
DB00471	Montelukast	gastrointestinal neoplasms	72	-0.51
DB00471	Montelukast	inflammatory bowel diseases	119	-0.50
DB00471	Montelukast	neoplasms	482	-0.48
DB00471	Montelukast	epilepsy	25	-0.40
DB00471	Montelukast	varicose veins	20	-0.39
DB00471	Montelukast	kidney diseases	144	-0.36
DB00471	Montelukast	arrhythmias cardiac	30	-0.31
DB00471	Montelukast	collagen diseases	25	-0.28
DB00471	Montelukast	insulin resistance	26	-0.27
DB00471	Montelukast	diabetes mellitus	162	-0.27
DB00471	Montelukast	hyperinsulinism	26	-0.26
DB00471	Montelukast	bone diseases metabolic	27	-0.23
DB00471	Montelukast	eye diseases	231	-0.12
DB00471	Montelukast	macular degeneration	44	-0.10
DB00471	Montelukast	anemia hemolytic	29	-0.03
DB00471	Montelukast	hypopigmentation	22	-0.02
DB00471	Montelukast	thyroid diseases	30	-0.02
DB00471	Montelukast	kidney neoplasms	20	-0.01
DB00471	Montelukast	liver cirrhosis biliary	23	-0.01
DB00471	Montelukast	liver cirrhosis	24	0.00
DB00471	Montelukast	metabolism inborn errors	289	0.02
DB00471	Montelukast	pancreatic diseases	24	0.04
DB00471	Montelukast	neuroendocrine tumors	24	0.06
DB00471	Montelukast	hematologic diseases	188	0.06
DB00471	Montelukast	amyotrophic lateral sclerosis	21	0.07
DB00471	Montelukast	alzheimer disease	29	0.13
DB00471	Montelukast	cardiomyopathy dilated	29	0.14
DB00471	Montelukast	lymphoma non hodgkin	22	0.17
DB00471	Montelukast	lymphoma	24	0.18
DB00471	Montelukast	endocrine system diseases	291	0.23
DB00471	Montelukast	blood coagulation disorders	40	0.25
DB00471	Montelukast	motor neuron disease	31	0.29
DB00471	Montelukast	adenocarcinoma	32	0.37
DB00471	Montelukast	head and neck neoplasms	35	0.40
DB00471	Montelukast	breast neoplasms	40	0.42
DB00471	Montelukast	colorectal neoplasms	42	0.52
DB00471	Montelukast	intestinal neoplasms	42	0.55
DB00471	Montelukast	leukemia myeloid acute	43	0.55
DB00471	Montelukast	spinal cord diseases	59	0.58
DB00471	Montelukast	anemia	58	0.63
DB00471	Montelukast	leukemia lymphoid	66	0.67
DB00471	Montelukast	leukemia	117	1.10
DB01367	Rasagiline	keratosis	21	-3.45
DB01367	Rasagiline	diabetes mellitus type 2	72	-2.29
DB01367	Rasagiline	neoplasms	482	-2.19
DB01367	Rasagiline	head and neck neoplasms	35	-2.03
DB01367	Rasagiline	bone diseases metabolic	27	-1.70
DB01367	Rasagiline	leukemia lymphoid	66	-1.47
DB01367	Rasagiline	coronary artery disease	31	-1.45
DB01367	Rasagiline	arteriosclerosis	38	-1.39
DB01367	Rasagiline	coronary disease	37	-1.34
DB01367	Rasagiline	thyroid diseases	30	-1.33
DB01367	Rasagiline	myocardial ischemia	43	-1.33
DB01367	Rasagiline	diabetes mellitus	162	-1.28
DB01367	Rasagiline	heart diseases	167	-1.21
DB01367	Rasagiline	gastrointestinal neoplasms	72	-1.12
DB01367	Rasagiline	bone diseases	144	-1.12
DB01367	Rasagiline	arterial occlusive diseases	44	-1.05
DB01367	Rasagiline	amyotrophic lateral sclerosis	21	-1.00
DB01367	Rasagiline	hypopigmentation	22	-0.98
DB01367	Rasagiline	metabolism inborn errors	289	-0.97
DB01367	Rasagiline	cardiomyopathy dilated	29	-0.93
DB01367	Rasagiline	bacterial infections	26	-0.92
DB01367	Rasagiline	asthma	36	-0.90
DB01367	Rasagiline	leukemia	117	-0.89
DB01367	Rasagiline	vascular diseases	181	-0.86
DB01367	Rasagiline	alzheimer disease	29	-0.81
DB01367	Rasagiline	hypersensitivity	45	-0.76
DB01367	Rasagiline	lymphoma non hodgkin	22	-0.62
DB01367	Rasagiline	arthritis rheumatoid	42	-0.57
DB01367	Rasagiline	lymphoma	24	-0.56
DB01367	Rasagiline	dementia	42	-0.55
DB01367	Rasagiline	motor neuron disease	31	-0.53
DB01367	Rasagiline	prostatic neoplasms	61	-0.49
DB01367	Rasagiline	skin diseases	278	-0.46
DB01367	Rasagiline	adenocarcinoma	32	-0.44
DB01367	Rasagiline	cardiovascular diseases	330	-0.43
DB01367	Rasagiline	endocrine system diseases	291	-0.42
DB01367	Rasagiline	lupus erythematosus systemic	75	-0.29
DB01367	Rasagiline	rheumatic diseases	59	-0.26
DB01367	Rasagiline	multiple sclerosis	69	-0.22
DB01367	Rasagiline	arthritis	76	-0.14
DB01367	Rasagiline	spinal cord diseases	59	-0.13
DB01367	Rasagiline	leukemia myeloid acute	43	-0.08
DB01367	Rasagiline	joint diseases	79	-0.05
DB01367	Rasagiline	lung diseases	71	0.00
DB01367	Rasagiline	varicose veins	20	0.14
DB01367	Rasagiline	hyperinsulinism	26	0.20
DB01367	Rasagiline	insulin resistance	26	0.23
DB01367	Rasagiline	macular degeneration	44	0.30
DB01367	Rasagiline	anemia hemolytic	29	0.42
DB01367	Rasagiline	parkinsonian disorders	31	0.50
DB01367	Rasagiline	mycobacterium infections	22	0.51
DB01367	Rasagiline	parkinson disease	30	0.54
DB01367	Rasagiline	malabsorption syndromes	34	0.55
DB01367	Rasagiline	kidney neoplasms	20	0.61
DB01367	Rasagiline	eye diseases	231	0.65
DB01367	Rasagiline	blood coagulation disorders	40	0.71
DB01367	Rasagiline	liver cirrhosis biliary	23	0.74
DB01367	Rasagiline	pancreatic diseases	24	0.74
DB01367	Rasagiline	liver cirrhosis	24	0.75
DB01367	Rasagiline	colitis ulcerative	55	0.77
DB01367	Rasagiline	sarcoma	25	0.80
DB01367	Rasagiline	colitis	55	0.81
DB01367	Rasagiline	neuroendocrine tumors	24	0.83
DB01367	Rasagiline	diabetes mellitus type 1	82	1.05
DB01367	Rasagiline	psoriasis	54	1.08
DB01367	Rasagiline	autoimmune diseases	243	1.11
DB01367	Rasagiline	hematologic diseases	188	1.16
DB01367	Rasagiline	breast neoplasms	40	1.20
DB01367	Rasagiline	crohn disease	71	1.21
DB01367	Rasagiline	inflammatory bowel diseases	119	1.44
DB01367	Rasagiline	intestinal neoplasms	42	1.47
DB01367	Rasagiline	anemia	58	1.48
DB01367	Rasagiline	kidney diseases	144	1.51
DB01367	Rasagiline	colorectal neoplasms	42	1.54
DB01367	Rasagiline	gastroenteritis	122	1.58
DB01367	Rasagiline	collagen diseases	25	2.10
DB01367	Rasagiline	arrhythmias cardiac	30	2.13
DB01367	Rasagiline	epilepsy	25	2.14
DB00860	Prednisolone	coronary artery disease	31	-1.62
DB00860	Prednisolone	coronary disease	37	-1.60
DB00860	Prednisolone	myocardial ischemia	43	-1.48
DB00860	Prednisolone	arteriosclerosis	38	-1.42
DB00860	Prednisolone	malabsorption syndromes	34	-1.40
DB00860	Prednisolone	colitis	55	-1.24
DB00860	Prednisolone	kidney neoplasms	20	-1.22
DB00860	Prednisolone	colitis ulcerative	55	-1.21
DB00860	Prednisolone	alzheimer disease	29	-1.20
DB00860	Prednisolone	mycobacterium infections	22	-1.15
DB00860	Prednisolone	arterial occlusive diseases	44	-1.14
DB00860	Prednisolone	neuroendocrine tumors	24	-1.08
DB00860	Prednisolone	bacterial infections	26	-1.06
DB00860	Prednisolone	asthma	36	-1.04
DB00860	Prednisolone	hypersensitivity	45	-1.01
DB00860	Prednisolone	dementia	42	-0.96
DB00860	Prednisolone	sarcoma	25	-0.94
DB00860	Prednisolone	head and neck neoplasms	35	-0.87
DB00860	Prednisolone	prostatic neoplasms	61	-0.87
DB00860	Prednisolone	liver cirrhosis	24	-0.80
DB00860	Prednisolone	adenocarcinoma	32	-0.78
DB00860	Prednisolone	liver cirrhosis biliary	23	-0.77
DB00860	Prednisolone	arthritis rheumatoid	42	-0.75
DB00860	Prednisolone	diabetes mellitus type 1	82	-0.74
DB00860	Prednisolone	motor neuron disease	31	-0.73
DB00860	Prednisolone	lymphoma non hodgkin	22	-0.72
DB00860	Prednisolone	lupus erythematosus systemic	75	-0.71
DB00860	Prednisolone	lymphoma	24	-0.71
DB00860	Prednisolone	breast neoplasms	40	-0.64
DB00860	Prednisolone	rheumatic diseases	59	-0.62
DB00860	Prednisolone	crohn disease	71	-0.58
DB00860	Prednisolone	leukemia myeloid acute	43	-0.54
DB00860	Prednisolone	diabetes mellitus	162	-0.50
DB00860	Prednisolone	kidney diseases	144	-0.49
DB00860	Prednisolone	leukemia lymphoid	66	-0.48
DB00860	Prednisolone	joint diseases	79	-0.45
DB00860	Prednisolone	colorectal neoplasms	42	-0.44
DB00860	Prednisolone	intestinal neoplasms	42	-0.44
DB00860	Prednisolone	arthritis	76	-0.42
DB00860	Prednisolone	inflammatory bowel diseases	119	-0.41
DB00860	Prednisolone	gastroenteritis	122	-0.39
DB00860	Prednisolone	multiple sclerosis	69	-0.38
DB00860	Prednisolone	heart diseases	167	-0.38
DB00860	Prednisolone	spinal cord diseases	59	-0.36
DB00860	Prednisolone	metabolism inborn errors	289	-0.32
DB00860	Prednisolone	lung diseases	71	-0.32
DB00860	Prednisolone	bone diseases	144	-0.26
DB00860	Prednisolone	gastrointestinal neoplasms	72	-0.22
DB00860	Prednisolone	leukemia	117	-0.12
DB00860	Prednisolone	vascular diseases	181	-0.04
DB00860	Prednisolone	eye diseases	231	0.02
DB00860	Prednisolone	skin diseases	278	0.03
DB00860	Prednisolone	autoimmune diseases	243	0.09
DB00860	Prednisolone	hematologic diseases	188	0.13
DB00860	Prednisolone	endocrine system diseases	291	0.16
DB00860	Prednisolone	cardiovascular diseases	330	0.17
DB00860	Prednisolone	neoplasms	482	0.21
DB00860	Prednisolone	varicose veins	20	0.29
DB00860	Prednisolone	arrhythmias cardiac	30	0.30
DB00860	Prednisolone	macular degeneration	44	0.33
DB00860	Prednisolone	collagen diseases	25	0.34
DB00860	Prednisolone	bone diseases metabolic	27	0.39
DB00860	Prednisolone	epilepsy	25	0.39
DB00860	Prednisolone	parkinson disease	30	0.46
DB00860	Prednisolone	parkinsonian disorders	31	0.48
DB00860	Prednisolone	insulin resistance	26	0.56
DB00860	Prednisolone	hyperinsulinism	26	0.57
DB00860	Prednisolone	blood coagulation disorders	40	0.64
DB00860	Prednisolone	anemia hemolytic	29	0.67
DB00860	Prednisolone	cardiomyopathy dilated	29	0.67
DB00860	Prednisolone	keratosis	21	0.69
DB00860	Prednisolone	hypopigmentation	22	0.72
DB00860	Prednisolone	thyroid diseases	30	0.74
DB00860	Prednisolone	amyotrophic lateral sclerosis	21	0.77
DB00860	Prednisolone	diabetes mellitus type 2	72	0.87
DB00860	Prednisolone	psoriasis	54	1.19
DB00860	Prednisolone	pancreatic diseases	24	1.22
DB00860	Prednisolone	anemia	58	2.63
DB01083	Orlistat	macular degeneration	44	-4.26
DB01083	Orlistat	hyperinsulinism	26	-3.32
DB01083	Orlistat	insulin resistance	26	-3.28
DB01083	Orlistat	eye diseases	231	-2.56
DB01083	Orlistat	alzheimer disease	29	-1.76
DB01083	Orlistat	cardiomyopathy dilated	29	-1.69
DB01083	Orlistat	dementia	42	-1.50
DB01083	Orlistat	adenocarcinoma	32	-1.45
DB01083	Orlistat	metabolism inborn errors	289	-1.34
DB01083	Orlistat	intestinal neoplasms	42	-1.08
DB01083	Orlistat	colorectal neoplasms	42	-1.04
DB01083	Orlistat	coronary artery disease	31	-0.82
DB01083	Orlistat	gastrointestinal neoplasms	72	-0.67
DB01083	Orlistat	bacterial infections	26	-0.60
DB01083	Orlistat	coronary disease	37	-0.56
DB01083	Orlistat	myocardial ischemia	43	-0.53
DB01083	Orlistat	asthma	36	-0.49
DB01083	Orlistat	arteriosclerosis	38	-0.49
DB01083	Orlistat	heart diseases	167	-0.43
DB01083	Orlistat	sarcoma	25	-0.40
DB01083	Orlistat	arterial occlusive diseases	44	-0.36
DB01083	Orlistat	lymphoma non hodgkin	22	-0.34
DB01083	Orlistat	lymphoma	24	-0.28
DB01083	Orlistat	hypersensitivity	45	-0.28
DB01083	Orlistat	neoplasms	482	-0.23
DB01083	Orlistat	colitis ulcerative	55	-0.16
DB01083	Orlistat	arthritis rheumatoid	42	-0.16
DB01083	Orlistat	colitis	55	-0.13
DB01083	Orlistat	head and neck neoplasms	35	-0.08
DB01083	Orlistat	breast neoplasms	40	-0.07
DB01083	Orlistat	psoriasis	54	-0.06
DB01083	Orlistat	diabetes mellitus type 2	72	-0.02
DB01083	Orlistat	varicose veins	20	0.00
DB01083	Orlistat	epilepsy	25	0.01
DB01083	Orlistat	rheumatic diseases	59	0.04
DB01083	Orlistat	endocrine system diseases	291	0.06
DB01083	Orlistat	multiple sclerosis	69	0.14
DB01083	Orlistat	skin diseases	278	0.15
DB01083	Orlistat	lupus erythematosus systemic	75	0.15
DB01083	Orlistat	arrhythmias cardiac	30	0.15
DB01083	Orlistat	diabetes mellitus type 1	82	0.16
DB01083	Orlistat	cardiovascular diseases	330	0.19
DB01083	Orlistat	collagen diseases	25	0.20
DB01083	Orlistat	joint diseases	79	0.25
DB01083	Orlistat	arthritis	76	0.28
DB01083	Orlistat	lung diseases	71	0.30
DB01083	Orlistat	anemia	58	0.34
DB01083	Orlistat	mycobacterium infections	22	0.35
DB01083	Orlistat	leukemia lymphoid	66	0.39
DB01083	Orlistat	keratosis	21	0.40
DB01083	Orlistat	inflammatory bowel diseases	119	0.47
DB01083	Orlistat	thyroid diseases	30	0.48
DB01083	Orlistat	kidney diseases	144	0.51
DB01083	Orlistat	gastroenteritis	122	0.53
DB01083	Orlistat	kidney neoplasms	20	0.61
DB01083	Orlistat	liver cirrhosis biliary	23	0.61
DB01083	Orlistat	diabetes mellitus	162	0.62
DB01083	Orlistat	hypopigmentation	22	0.63
DB01083	Orlistat	pancreatic diseases	24	0.64
DB01083	Orlistat	parkinsonian disorders	31	0.67
DB01083	Orlistat	parkinson disease	30	0.67
DB01083	Orlistat	liver cirrhosis	24	0.67
DB01083	Orlistat	bone diseases	144	0.68
DB01083	Orlistat	malabsorption syndromes	34	0.69
DB01083	Orlistat	amyotrophic lateral sclerosis	21	0.70
DB01083	Orlistat	leukemia	117	0.85
DB01083	Orlistat	neuroendocrine tumors	24	0.85
DB01083	Orlistat	vascular diseases	181	0.90
DB01083	Orlistat	blood coagulation disorders	40	0.94
DB01083	Orlistat	autoimmune diseases	243	1.08
DB01083	Orlistat	hematologic diseases	188	1.11
DB01083	Orlistat	motor neuron disease	31	1.12
DB01083	Orlistat	prostatic neoplasms	61	1.35
DB01083	Orlistat	crohn disease	71	1.49
DB01083	Orlistat	leukemia myeloid acute	43	1.49
DB01083	Orlistat	spinal cord diseases	59	1.51
DB01083	Orlistat	anemia hemolytic	29	1.79
DB01083	Orlistat	bone diseases metabolic	27	2.58
DB01080	Vigabatrin	arteriosclerosis	38	-2.15
DB01080	Vigabatrin	coronary artery disease	31	-2.14
DB01080	Vigabatrin	coronary disease	37	-2.05
DB01080	Vigabatrin	bone diseases metabolic	27	-2.04
DB01080	Vigabatrin	keratosis	21	-2.04
DB01080	Vigabatrin	thyroid diseases	30	-2.01
DB01080	Vigabatrin	arterial occlusive diseases	44	-1.98
DB01080	Vigabatrin	myocardial ischemia	43	-1.93
DB01080	Vigabatrin	head and neck neoplasms	35	-1.69
DB01080	Vigabatrin	gastrointestinal neoplasms	72	-1.15
DB01080	Vigabatrin	kidney diseases	144	-1.11
DB01080	Vigabatrin	heart diseases	167	-0.91
DB01080	Vigabatrin	bone diseases	144	-0.86
DB01080	Vigabatrin	neoplasms	482	-0.85
DB01080	Vigabatrin	leukemia	117	-0.75
DB01080	Vigabatrin	epilepsy	25	-0.73
DB01080	Vigabatrin	hyperinsulinism	26	-0.69
DB01080	Vigabatrin	insulin resistance	26	-0.65
DB01080	Vigabatrin	varicose veins	20	-0.65
DB01080	Vigabatrin	vascular diseases	181	-0.64
DB01080	Vigabatrin	metabolism inborn errors	289	-0.47
DB01080	Vigabatrin	hematologic diseases	188	-0.32
DB01080	Vigabatrin	hypopigmentation	22	-0.31
DB01080	Vigabatrin	malabsorption syndromes	34	-0.29
DB01080	Vigabatrin	pancreatic diseases	24	-0.25
DB01080	Vigabatrin	cardiomyopathy dilated	29	-0.23
DB01080	Vigabatrin	parkinson disease	30	-0.20
DB01080	Vigabatrin	skin diseases	278	-0.19
DB01080	Vigabatrin	endocrine system diseases	291	-0.18
DB01080	Vigabatrin	parkinsonian disorders	31	-0.17
DB01080	Vigabatrin	neuroendocrine tumors	24	-0.17
DB01080	Vigabatrin	blood coagulation disorders	40	-0.11
DB01080	Vigabatrin	cardiovascular diseases	330	-0.11
DB01080	Vigabatrin	asthma	36	-0.11
DB01080	Vigabatrin	sarcoma	25	-0.10
DB01080	Vigabatrin	lymphoma	24	-0.05
DB01080	Vigabatrin	lymphoma non hodgkin	22	-0.04
DB01080	Vigabatrin	hypersensitivity	45	0.00
DB01080	Vigabatrin	colitis ulcerative	55	0.01
DB01080	Vigabatrin	colitis	55	0.02
DB01080	Vigabatrin	arthritis rheumatoid	42	0.05
DB01080	Vigabatrin	adenocarcinoma	32	0.07
DB01080	Vigabatrin	diabetes mellitus type 2	72	0.13
DB01080	Vigabatrin	psoriasis	54	0.16
DB01080	Vigabatrin	prostatic neoplasms	61	0.18
DB01080	Vigabatrin	rheumatic diseases	59	0.21
DB01080	Vigabatrin	multiple sclerosis	69	0.24
DB01080	Vigabatrin	leukemia myeloid acute	43	0.30
DB01080	Vigabatrin	lupus erythematosus systemic	75	0.30
DB01080	Vigabatrin	diabetes mellitus type 1	82	0.32
DB01080	Vigabatrin	spinal cord diseases	59	0.32
DB01080	Vigabatrin	intestinal neoplasms	42	0.32
DB01080	Vigabatrin	colorectal neoplasms	42	0.33
DB01080	Vigabatrin	crohn disease	71	0.35
DB01080	Vigabatrin	arthritis	76	0.39
DB01080	Vigabatrin	joint diseases	79	0.40
DB01080	Vigabatrin	lung diseases	71	0.45
DB01080	Vigabatrin	leukemia lymphoid	66	0.47
DB01080	Vigabatrin	anemia	58	0.49
DB01080	Vigabatrin	inflammatory bowel diseases	119	0.49
DB01080	Vigabatrin	gastroenteritis	122	0.53
DB01080	Vigabatrin	diabetes mellitus	162	0.59
DB01080	Vigabatrin	arrhythmias cardiac	30	0.81
DB01080	Vigabatrin	eye diseases	231	0.84
DB01080	Vigabatrin	collagen diseases	25	0.90
DB01080	Vigabatrin	autoimmune diseases	243	0.99
DB01080	Vigabatrin	mycobacterium infections	22	1.05
DB01080	Vigabatrin	macular degeneration	44	1.14
DB01080	Vigabatrin	anemia hemolytic	29	1.27
DB01080	Vigabatrin	kidney neoplasms	20	1.33
DB01080	Vigabatrin	liver cirrhosis biliary	23	1.35
DB01080	Vigabatrin	bacterial infections	26	1.37
DB01080	Vigabatrin	liver cirrhosis	24	1.40
DB01080	Vigabatrin	amyotrophic lateral sclerosis	21	1.42
DB01080	Vigabatrin	alzheimer disease	29	1.55
DB01080	Vigabatrin	motor neuron disease	31	1.67
DB01080	Vigabatrin	breast neoplasms	40	1.91
DB01080	Vigabatrin	dementia	42	1.91
DB01364	Ephedrine	head and neck neoplasms	35	-1.72
DB01364	Ephedrine	colitis	55	-1.70
DB01364	Ephedrine	dementia	42	-1.66
DB01364	Ephedrine	collagen diseases	25	-1.64
DB01364	Ephedrine	colitis ulcerative	55	-1.56
DB01364	Ephedrine	multiple sclerosis	69	-1.38
DB01364	Ephedrine	lung diseases	71	-1.36
DB01364	Ephedrine	crohn disease	71	-1.35
DB01364	Ephedrine	arthritis	76	-1.28
DB01364	Ephedrine	joint diseases	79	-1.27
DB01364	Ephedrine	parkinson disease	30	-1.13
DB01364	Ephedrine	amyotrophic lateral sclerosis	21	-1.12
DB01364	Ephedrine	parkinsonian disorders	31	-1.12
DB01364	Ephedrine	gastrointestinal neoplasms	72	-1.09
DB01364	Ephedrine	cardiomyopathy dilated	29	-1.04
DB01364	Ephedrine	inflammatory bowel diseases	119	-1.03
DB01364	Ephedrine	alzheimer disease	29	-1.02
DB01364	Ephedrine	neuroendocrine tumors	24	-1.01
DB01364	Ephedrine	gastroenteritis	122	-0.98
DB01364	Ephedrine	sarcoma	25	-0.96
DB01364	Ephedrine	asthma	36	-0.95
DB01364	Ephedrine	arterial occlusive diseases	44	-0.95
DB01364	Ephedrine	hypersensitivity	45	-0.83
DB01364	Ephedrine	bone diseases	144	-0.81
DB01364	Ephedrine	motor neuron disease	31	-0.79
DB01364	Ephedrine	heart diseases	167	-0.75
DB01364	Ephedrine	arrhythmias cardiac	30	-0.73
DB01364	Ephedrine	adenocarcinoma	32	-0.70
DB01364	Ephedrine	bone diseases metabolic	27	-0.68
DB01364	Ephedrine	breast neoplasms	40	-0.61
DB01364	Ephedrine	diabetes mellitus type 2	72	-0.51
DB01364	Ephedrine	psoriasis	54	-0.51
DB01364	Ephedrine	mycobacterium infections	22	-0.48
DB01364	Ephedrine	vascular diseases	181	-0.46
DB01364	Ephedrine	coronary artery disease	31	-0.43
DB01364	Ephedrine	intestinal neoplasms	42	-0.39
DB01364	Ephedrine	colorectal neoplasms	42	-0.38
DB01364	Ephedrine	autoimmune diseases	243	-0.29
DB01364	Ephedrine	coronary disease	37	-0.28
DB01364	Ephedrine	spinal cord diseases	59	-0.27
DB01364	Ephedrine	bacterial infections	26	-0.23
DB01364	Ephedrine	kidney neoplasms	20	-0.23
DB01364	Ephedrine	myocardial ischemia	43	-0.16
DB01364	Ephedrine	pancreatic diseases	24	-0.15
DB01364	Ephedrine	arteriosclerosis	38	-0.12
DB01364	Ephedrine	skin diseases	278	-0.05
DB01364	Ephedrine	cardiovascular diseases	330	-0.01
DB01364	Ephedrine	varicose veins	20	0.00
DB01364	Ephedrine	blood coagulation disorders	40	0.08
DB01364	Ephedrine	lymphoma	24	0.10
DB01364	Ephedrine	lymphoma non hodgkin	22	0.11
DB01364	Ephedrine	kidney diseases	144	0.11
DB01364	Ephedrine	epilepsy	25	0.15
DB01364	Ephedrine	diabetes mellitus	162	0.19
DB01364	Ephedrine	keratosis	21	0.47
DB01364	Ephedrine	leukemia	117	0.47
DB01364	Ephedrine	prostatic neoplasms	61	0.50
DB01364	Ephedrine	eye diseases	231	0.53
DB01364	Ephedrine	thyroid diseases	30	0.58
DB01364	Ephedrine	hypopigmentation	22	0.59
DB01364	Ephedrine	metabolism inborn errors	289	0.62
DB01364	Ephedrine	anemia hemolytic	29	0.66
DB01364	Ephedrine	neoplasms	482	0.67
DB01364	Ephedrine	diabetes mellitus type 1	82	0.69
DB01364	Ephedrine	lupus erythematosus systemic	75	0.71
DB01364	Ephedrine	leukemia myeloid acute	43	0.71
DB01364	Ephedrine	hematologic diseases	188	0.74
DB01364	Ephedrine	liver cirrhosis biliary	23	0.75
DB01364	Ephedrine	liver cirrhosis	24	0.77
DB01364	Ephedrine	endocrine system diseases	291	0.83
DB01364	Ephedrine	leukemia lymphoid	66	0.93
DB01364	Ephedrine	hyperinsulinism	26	1.11
DB01364	Ephedrine	insulin resistance	26	1.14
DB01364	Ephedrine	macular degeneration	44	1.47
DB01364	Ephedrine	malabsorption syndromes	34	1.77
DB01364	Ephedrine	anemia	58	1.97
DB01364	Ephedrine	arthritis rheumatoid	42	2.38
DB01364	Ephedrine	rheumatic diseases	59	2.90
DB01085	Pilocarpine	thyroid diseases	30	-1.20
DB01085	Pilocarpine	liver cirrhosis biliary	23	-1.17
DB01085	Pilocarpine	pancreatic diseases	24	-1.13
DB01085	Pilocarpine	liver cirrhosis	24	-1.13
DB01085	Pilocarpine	arteriosclerosis	38	-1.02
DB01085	Pilocarpine	arterial occlusive diseases	44	-0.82
DB01085	Pilocarpine	eye diseases	231	-0.78
DB01085	Pilocarpine	head and neck neoplasms	35	-0.75
DB01085	Pilocarpine	dementia	42	-0.74
DB01085	Pilocarpine	colitis	55	-0.70
DB01085	Pilocarpine	colitis ulcerative	55	-0.68
DB01085	Pilocarpine	psoriasis	54	-0.60
DB01085	Pilocarpine	epilepsy	25	-0.57
DB01085	Pilocarpine	lupus erythematosus systemic	75	-0.52
DB01085	Pilocarpine	diabetes mellitus type 1	82	-0.51
DB01085	Pilocarpine	leukemia myeloid acute	43	-0.48
DB01085	Pilocarpine	crohn disease	71	-0.47
DB01085	Pilocarpine	skin diseases	278	-0.47
DB01085	Pilocarpine	insulin resistance	26	-0.46
DB01085	Pilocarpine	bone diseases metabolic	27	-0.44
DB01085	Pilocarpine	hyperinsulinism	26	-0.43
DB01085	Pilocarpine	arthritis	76	-0.33
DB01085	Pilocarpine	leukemia lymphoid	66	-0.29
DB01085	Pilocarpine	joint diseases	79	-0.26
DB01085	Pilocarpine	lung diseases	71	-0.22
DB01085	Pilocarpine	inflammatory bowel diseases	119	-0.11
DB01085	Pilocarpine	hypopigmentation	22	-0.11
DB01085	Pilocarpine	gastrointestinal neoplasms	72	-0.10
DB01085	Pilocarpine	gastroenteritis	122	-0.10
DB01085	Pilocarpine	parkinson disease	30	-0.06
DB01085	Pilocarpine	parkinsonian disorders	31	-0.05
DB01085	Pilocarpine	diabetes mellitus	162	-0.01
DB01085	Pilocarpine	neuroendocrine tumors	24	0.04
DB01085	Pilocarpine	kidney diseases	144	0.06
DB01085	Pilocarpine	asthma	36	0.07
DB01085	Pilocarpine	bone diseases	144	0.09
DB01085	Pilocarpine	lymphoma non hodgkin	22	0.17
DB01085	Pilocarpine	neoplasms	482	0.18
DB01085	Pilocarpine	lymphoma	24	0.20
DB01085	Pilocarpine	leukemia	117	0.23
DB01085	Pilocarpine	hypersensitivity	45	0.23
DB01085	Pilocarpine	vascular diseases	181	0.34
DB01085	Pilocarpine	adenocarcinoma	32	0.39
DB01085	Pilocarpine	metabolism inborn errors	289	0.45
DB01085	Pilocarpine	hematologic diseases	188	0.45
DB01085	Pilocarpine	autoimmune diseases	243	0.48
DB01085	Pilocarpine	endocrine system diseases	291	0.56
DB01085	Pilocarpine	diabetes mellitus type 2	72	0.58
DB01085	Pilocarpine	colorectal neoplasms	42	0.68
DB01085	Pilocarpine	multiple sclerosis	69	0.69
DB01085	Pilocarpine	cardiovascular diseases	330	0.71
DB01085	Pilocarpine	mycobacterium infections	22	0.71
DB01085	Pilocarpine	spinal cord diseases	59	0.75
DB01085	Pilocarpine	intestinal neoplasms	42	0.75
DB01085	Pilocarpine	coronary artery disease	31	0.81
DB01085	Pilocarpine	keratosis	21	0.83
DB01085	Pilocarpine	anemia	58	0.89
DB01085	Pilocarpine	anemia hemolytic	29	0.96
DB01085	Pilocarpine	coronary disease	37	0.97
DB01085	Pilocarpine	kidney neoplasms	20	0.98
DB01085	Pilocarpine	myocardial ischemia	43	1.06
DB01085	Pilocarpine	bacterial infections	26	1.07
DB01085	Pilocarpine	malabsorption syndromes	34	1.11
DB01085	Pilocarpine	amyotrophic lateral sclerosis	21	1.12
DB01085	Pilocarpine	alzheimer disease	29	1.21
DB01085	Pilocarpine	cardiomyopathy dilated	29	1.24
DB01085	Pilocarpine	sarcoma	25	1.28
DB01085	Pilocarpine	heart diseases	167	1.29
DB01085	Pilocarpine	blood coagulation disorders	40	1.34
DB01085	Pilocarpine	motor neuron disease	31	1.44
DB01085	Pilocarpine	varicose veins	20	1.47
DB01085	Pilocarpine	collagen diseases	25	1.59
DB01085	Pilocarpine	arrhythmias cardiac	30	1.59
DB01085	Pilocarpine	breast neoplasms	40	1.64
DB01085	Pilocarpine	prostatic neoplasms	61	1.74
DB01085	Pilocarpine	macular degeneration	44	1.93
DB01085	Pilocarpine	arthritis rheumatoid	42	2.59
DB01085	Pilocarpine	rheumatic diseases	59	3.04
DB00175	Pravastatin	vascular diseases	181	-2.02
DB00175	Pravastatin	metabolism inborn errors	289	-1.58
DB00175	Pravastatin	cardiovascular diseases	330	-1.48
DB00175	Pravastatin	skin diseases	278	-1.42
DB00175	Pravastatin	hematologic diseases	188	-1.41
DB00175	Pravastatin	neoplasms	482	-0.79
DB00175	Pravastatin	insulin resistance	26	-0.65
DB00175	Pravastatin	arrhythmias cardiac	30	-0.62
DB00175	Pravastatin	epilepsy	25	-0.61
DB00175	Pravastatin	bone diseases metabolic	27	-0.60
DB00175	Pravastatin	hyperinsulinism	26	-0.60
DB00175	Pravastatin	collagen diseases	25	-0.59
DB00175	Pravastatin	coronary artery disease	31	-0.52
DB00175	Pravastatin	mycobacterium infections	22	-0.52
DB00175	Pravastatin	keratosis	21	-0.47
DB00175	Pravastatin	kidney neoplasms	20	-0.43
DB00175	Pravastatin	bacterial infections	26	-0.40
DB00175	Pravastatin	parkinson disease	30	-0.39
DB00175	Pravastatin	hypopigmentation	22	-0.38
DB00175	Pravastatin	malabsorption syndromes	34	-0.38
DB00175	Pravastatin	coronary disease	37	-0.37
DB00175	Pravastatin	arteriosclerosis	38	-0.35
DB00175	Pravastatin	amyotrophic lateral sclerosis	21	-0.35
DB00175	Pravastatin	liver cirrhosis biliary	23	-0.34
DB00175	Pravastatin	myocardial ischemia	43	-0.34
DB00175	Pravastatin	alzheimer disease	29	-0.34
DB00175	Pravastatin	pancreatic diseases	24	-0.33
DB00175	Pravastatin	parkinsonian disorders	31	-0.33
DB00175	Pravastatin	liver cirrhosis	24	-0.31
DB00175	Pravastatin	anemia hemolytic	29	-0.29
DB00175	Pravastatin	sarcoma	25	-0.26
DB00175	Pravastatin	cardiomyopathy dilated	29	-0.25
DB00175	Pravastatin	asthma	36	-0.24
DB00175	Pravastatin	neuroendocrine tumors	24	-0.21
DB00175	Pravastatin	blood coagulation disorders	40	-0.20
DB00175	Pravastatin	lymphoma	24	-0.18
DB00175	Pravastatin	arterial occlusive diseases	44	-0.18
DB00175	Pravastatin	arthritis rheumatoid	42	-0.14
DB00175	Pravastatin	motor neuron disease	31	-0.13
DB00175	Pravastatin	hypersensitivity	45	-0.12
DB00175	Pravastatin	dementia	42	-0.12
DB00175	Pravastatin	lymphoma non hodgkin	22	-0.10
DB00175	Pravastatin	adenocarcinoma	32	-0.09
DB00175	Pravastatin	colitis	55	-0.08
DB00175	Pravastatin	prostatic neoplasms	61	-0.08
DB00175	Pravastatin	diabetes mellitus type 2	72	-0.07
DB00175	Pravastatin	head and neck neoplasms	35	-0.06
DB00175	Pravastatin	colitis ulcerative	55	-0.04
DB00175	Pravastatin	breast neoplasms	40	-0.03
DB00175	Pravastatin	multiple sclerosis	69	0.03
DB00175	Pravastatin	lupus erythematosus systemic	75	0.06
DB00175	Pravastatin	intestinal neoplasms	42	0.07
DB00175	Pravastatin	rheumatic diseases	59	0.07
DB00175	Pravastatin	leukemia myeloid acute	43	0.07
DB00175	Pravastatin	crohn disease	71	0.09
DB00175	Pravastatin	diabetes mellitus type 1	82	0.09
DB00175	Pravastatin	spinal cord diseases	59	0.10
DB00175	Pravastatin	colorectal neoplasms	42	0.12
DB00175	Pravastatin	leukemia lymphoid	66	0.15
DB00175	Pravastatin	lung diseases	71	0.15
DB00175	Pravastatin	arthritis	76	0.16
DB00175	Pravastatin	anemia	58	0.18
DB00175	Pravastatin	joint diseases	79	0.19
DB00175	Pravastatin	gastroenteritis	122	0.28
DB00175	Pravastatin	gastrointestinal neoplasms	72	0.29
DB00175	Pravastatin	inflammatory bowel diseases	119	0.29
DB00175	Pravastatin	kidney diseases	144	0.29
DB00175	Pravastatin	diabetes mellitus	162	0.32
DB00175	Pravastatin	heart diseases	167	0.35
DB00175	Pravastatin	bone diseases	144	0.39
DB00175	Pravastatin	eye diseases	231	0.43
DB00175	Pravastatin	leukemia	117	0.43
DB00175	Pravastatin	autoimmune diseases	243	0.54
DB00175	Pravastatin	endocrine system diseases	291	0.58
DB00175	Pravastatin	varicose veins	20	1.18
DB00175	Pravastatin	macular degeneration	44	1.59
DB00175	Pravastatin	thyroid diseases	30	1.81
DB00175	Pravastatin	psoriasis	54	2.57
DB01003	Cromoglicic.acid	collagen diseases	25	-2.21
DB01003	Cromoglicic.acid	psoriasis	54	-1.81
DB01003	Cromoglicic.acid	multiple sclerosis	69	-1.42
DB01003	Cromoglicic.acid	kidney diseases	144	-1.21
DB01003	Cromoglicic.acid	hyperinsulinism	26	-0.83
DB01003	Cromoglicic.acid	epilepsy	25	-0.79
DB01003	Cromoglicic.acid	insulin resistance	26	-0.75
DB01003	Cromoglicic.acid	mycobacterium infections	22	-0.68
DB01003	Cromoglicic.acid	thyroid diseases	30	-0.55
DB01003	Cromoglicic.acid	keratosis	21	-0.53
DB01003	Cromoglicic.acid	bacterial infections	26	-0.51
DB01003	Cromoglicic.acid	autoimmune diseases	243	-0.50
DB01003	Cromoglicic.acid	endocrine system diseases	291	-0.49
DB01003	Cromoglicic.acid	kidney neoplasms	20	-0.48
DB01003	Cromoglicic.acid	anemia hemolytic	29	-0.47
DB01003	Cromoglicic.acid	malabsorption syndromes	34	-0.46
DB01003	Cromoglicic.acid	arteriosclerosis	38	-0.44
DB01003	Cromoglicic.acid	hypopigmentation	22	-0.44
DB01003	Cromoglicic.acid	liver cirrhosis biliary	23	-0.43
DB01003	Cromoglicic.acid	amyotrophic lateral sclerosis	21	-0.42
DB01003	Cromoglicic.acid	myocardial ischemia	43	-0.41
DB01003	Cromoglicic.acid	liver cirrhosis	24	-0.41
DB01003	Cromoglicic.acid	pancreatic diseases	24	-0.41
DB01003	Cromoglicic.acid	cardiomyopathy dilated	29	-0.38
DB01003	Cromoglicic.acid	neuroendocrine tumors	24	-0.37
DB01003	Cromoglicic.acid	skin diseases	278	-0.37
DB01003	Cromoglicic.acid	sarcoma	25	-0.32
DB01003	Cromoglicic.acid	alzheimer disease	29	-0.32
DB01003	Cromoglicic.acid	blood coagulation disorders	40	-0.25
DB01003	Cromoglicic.acid	lymphoma	24	-0.21
DB01003	Cromoglicic.acid	arterial occlusive diseases	44	-0.21
DB01003	Cromoglicic.acid	lymphoma non hodgkin	22	-0.20
DB01003	Cromoglicic.acid	motor neuron disease	31	-0.15
DB01003	Cromoglicic.acid	adenocarcinoma	32	-0.11
DB01003	Cromoglicic.acid	head and neck neoplasms	35	-0.10
DB01003	Cromoglicic.acid	dementia	42	-0.03
DB01003	Cromoglicic.acid	colitis	55	-0.01
DB01003	Cromoglicic.acid	colitis ulcerative	55	0.00
DB01003	Cromoglicic.acid	prostatic neoplasms	61	0.02
DB01003	Cromoglicic.acid	diabetes mellitus type 2	72	0.06
DB01003	Cromoglicic.acid	breast neoplasms	40	0.07
DB01003	Cromoglicic.acid	rheumatic diseases	59	0.07
DB01003	Cromoglicic.acid	lupus erythematosus systemic	75	0.10
DB01003	Cromoglicic.acid	leukemia myeloid acute	43	0.11
DB01003	Cromoglicic.acid	diabetes mellitus type 1	82	0.12
DB01003	Cromoglicic.acid	intestinal neoplasms	42	0.15
DB01003	Cromoglicic.acid	crohn disease	71	0.16
DB01003	Cromoglicic.acid	spinal cord diseases	59	0.19
DB01003	Cromoglicic.acid	colorectal neoplasms	42	0.24
DB01003	Cromoglicic.acid	anemia	58	0.24
DB01003	Cromoglicic.acid	arthritis	76	0.25
DB01003	Cromoglicic.acid	lung diseases	71	0.27
DB01003	Cromoglicic.acid	joint diseases	79	0.28
DB01003	Cromoglicic.acid	leukemia lymphoid	66	0.30
DB01003	Cromoglicic.acid	gastroenteritis	122	0.36
DB01003	Cromoglicic.acid	inflammatory bowel diseases	119	0.37
DB01003	Cromoglicic.acid	gastrointestinal neoplasms	72	0.44
DB01003	Cromoglicic.acid	varicose veins	20	0.45
DB01003	Cromoglicic.acid	diabetes mellitus	162	0.46
DB01003	Cromoglicic.acid	bone diseases	144	0.48
DB01003	Cromoglicic.acid	heart diseases	167	0.51
DB01003	Cromoglicic.acid	arrhythmias cardiac	30	0.57
DB01003	Cromoglicic.acid	vascular diseases	181	0.62
DB01003	Cromoglicic.acid	leukemia	117	0.65
DB01003	Cromoglicic.acid	eye diseases	231	0.70
DB01003	Cromoglicic.acid	metabolism inborn errors	289	0.74
DB01003	Cromoglicic.acid	bone diseases metabolic	27	0.74
DB01003	Cromoglicic.acid	coronary artery disease	31	0.80
DB01003	Cromoglicic.acid	hematologic diseases	188	0.84
DB01003	Cromoglicic.acid	macular degeneration	44	0.84
DB01003	Cromoglicic.acid	cardiovascular diseases	330	0.91
DB01003	Cromoglicic.acid	parkinsonian disorders	31	1.08
DB01003	Cromoglicic.acid	parkinson disease	30	1.12
DB01003	Cromoglicic.acid	coronary disease	37	1.13
DB01003	Cromoglicic.acid	asthma	36	1.20
DB01003	Cromoglicic.acid	neoplasms	482	1.43
DB01003	Cromoglicic.acid	hypersensitivity	45	1.53
DB01003	Cromoglicic.acid	arthritis rheumatoid	42	1.72
DB01001	Salbutamol	diabetes mellitus type 2	72	-3.00
DB01001	Salbutamol	diabetes mellitus	162	-2.04
DB01001	Salbutamol	arrhythmias cardiac	30	-1.92
DB01001	Salbutamol	pancreatic diseases	24	-1.71
DB01001	Salbutamol	breast neoplasms	40	-1.23
DB01001	Salbutamol	intestinal neoplasms	42	-1.09
DB01001	Salbutamol	endocrine system diseases	291	-1.08
DB01001	Salbutamol	colorectal neoplasms	42	-1.05
DB01001	Salbutamol	lung diseases	71	-0.78
DB01001	Salbutamol	gastrointestinal neoplasms	72	-0.55
DB01001	Salbutamol	neoplasms	482	-0.45
DB01001	Salbutamol	epilepsy	25	-0.43
DB01001	Salbutamol	varicose veins	20	-0.41
DB01001	Salbutamol	heart diseases	167	-0.37
DB01001	Salbutamol	bone diseases	144	-0.34
DB01001	Salbutamol	insulin resistance	26	-0.33
DB01001	Salbutamol	hyperinsulinism	26	-0.33
DB01001	Salbutamol	collagen diseases	25	-0.29
DB01001	Salbutamol	bone diseases metabolic	27	-0.23
DB01001	Salbutamol	coronary artery disease	31	-0.17
DB01001	Salbutamol	macular degeneration	44	-0.15
DB01001	Salbutamol	keratosis	21	-0.13
DB01001	Salbutamol	mycobacterium infections	22	-0.13
DB01001	Salbutamol	coronary disease	37	-0.07
DB01001	Salbutamol	bacterial infections	26	-0.05
DB01001	Salbutamol	kidney neoplasms	20	-0.03
DB01001	Salbutamol	myocardial ischemia	43	0.00
DB01001	Salbutamol	thyroid diseases	30	0.00
DB01001	Salbutamol	anemia hemolytic	29	0.00
DB01001	Salbutamol	hypopigmentation	22	0.01
DB01001	Salbutamol	parkinson disease	30	0.01
DB01001	Salbutamol	liver cirrhosis	24	0.03
DB01001	Salbutamol	parkinsonian disorders	31	0.05
DB01001	Salbutamol	liver cirrhosis biliary	23	0.05
DB01001	Salbutamol	malabsorption syndromes	34	0.06
DB01001	Salbutamol	amyotrophic lateral sclerosis	21	0.07
DB01001	Salbutamol	arteriosclerosis	38	0.10
DB01001	Salbutamol	neuroendocrine tumors	24	0.13
DB01001	Salbutamol	asthma	36	0.13
DB01001	Salbutamol	alzheimer disease	29	0.15
DB01001	Salbutamol	cardiomyopathy dilated	29	0.16
DB01001	Salbutamol	arterial occlusive diseases	44	0.22
DB01001	Salbutamol	sarcoma	25	0.24
DB01001	Salbutamol	lymphoma non hodgkin	22	0.26
DB01001	Salbutamol	blood coagulation disorders	40	0.26
DB01001	Salbutamol	lymphoma	24	0.27
DB01001	Salbutamol	skin diseases	278	0.28
DB01001	Salbutamol	hypersensitivity	45	0.28
DB01001	Salbutamol	motor neuron disease	31	0.34
DB01001	Salbutamol	colitis	55	0.35
DB01001	Salbutamol	cardiovascular diseases	330	0.38
DB01001	Salbutamol	adenocarcinoma	32	0.39
DB01001	Salbutamol	arthritis rheumatoid	42	0.40
DB01001	Salbutamol	colitis ulcerative	55	0.40
DB01001	Salbutamol	prostatic neoplasms	61	0.41
DB01001	Salbutamol	dementia	42	0.41
DB01001	Salbutamol	head and neck neoplasms	35	0.46
DB01001	Salbutamol	psoriasis	54	0.52
DB01001	Salbutamol	multiple sclerosis	69	0.52
DB01001	Salbutamol	rheumatic diseases	59	0.53
DB01001	Salbutamol	diabetes mellitus type 1	82	0.58
DB01001	Salbutamol	lupus erythematosus systemic	75	0.58
DB01001	Salbutamol	crohn disease	71	0.59
DB01001	Salbutamol	spinal cord diseases	59	0.63
DB01001	Salbutamol	leukemia myeloid acute	43	0.63
DB01001	Salbutamol	joint diseases	79	0.63
DB01001	Salbutamol	anemia	58	0.67
DB01001	Salbutamol	arthritis	76	0.69
DB01001	Salbutamol	leukemia lymphoid	66	0.73
DB01001	Salbutamol	inflammatory bowel diseases	119	0.87
DB01001	Salbutamol	gastroenteritis	122	0.90
DB01001	Salbutamol	kidney diseases	144	0.91
DB01001	Salbutamol	eye diseases	231	1.15
DB01001	Salbutamol	vascular diseases	181	1.22
DB01001	Salbutamol	leukemia	117	1.23
DB01001	Salbutamol	metabolism inborn errors	289	1.24
DB01001	Salbutamol	autoimmune diseases	243	1.47
DB01001	Salbutamol	hematologic diseases	188	1.47
DB01006	Letrozole	skin diseases	278	-2.64
DB01006	Letrozole	keratosis	21	-2.54
DB01006	Letrozole	anemia	58	-1.82
DB01006	Letrozole	eye diseases	231	-1.03
DB01006	Letrozole	hematologic diseases	188	-0.92
DB01006	Letrozole	metabolism inborn errors	289	-0.91
DB01006	Letrozole	endocrine system diseases	291	-0.79
DB01006	Letrozole	varicose veins	20	-0.27
DB01006	Letrozole	arrhythmias cardiac	30	-0.26
DB01006	Letrozole	bone diseases metabolic	27	-0.18
DB01006	Letrozole	macular degeneration	44	-0.11
DB01006	Letrozole	coronary artery disease	31	-0.05
DB01006	Letrozole	mycobacterium infections	22	-0.04
DB01006	Letrozole	anemia hemolytic	29	-0.01
DB01006	Letrozole	hypopigmentation	22	0.03
DB01006	Letrozole	bacterial infections	26	0.03
DB01006	Letrozole	pancreatic diseases	24	0.04
DB01006	Letrozole	thyroid diseases	30	0.04
DB01006	Letrozole	coronary disease	37	0.06
DB01006	Letrozole	malabsorption syndromes	34	0.07
DB01006	Letrozole	kidney neoplasms	20	0.07
DB01006	Letrozole	parkinson disease	30	0.08
DB01006	Letrozole	arteriosclerosis	38	0.09
DB01006	Letrozole	parkinsonian disorders	31	0.11
DB01006	Letrozole	myocardial ischemia	43	0.12
DB01006	Letrozole	asthma	36	0.13
DB01006	Letrozole	amyotrophic lateral sclerosis	21	0.13
DB01006	Letrozole	neuroendocrine tumors	24	0.13
DB01006	Letrozole	cardiomyopathy dilated	29	0.13
DB01006	Letrozole	arterial occlusive diseases	44	0.17
DB01006	Letrozole	alzheimer disease	29	0.17
DB01006	Letrozole	sarcoma	25	0.19
DB01006	Letrozole	blood coagulation disorders	40	0.19
DB01006	Letrozole	lymphoma	24	0.19
DB01006	Letrozole	hypersensitivity	45	0.24
DB01006	Letrozole	lymphoma non hodgkin	22	0.26
DB01006	Letrozole	colitis ulcerative	55	0.26
DB01006	Letrozole	dementia	42	0.28
DB01006	Letrozole	colitis	55	0.28
DB01006	Letrozole	motor neuron disease	31	0.28
DB01006	Letrozole	prostatic neoplasms	61	0.30
DB01006	Letrozole	head and neck neoplasms	35	0.31
DB01006	Letrozole	arthritis rheumatoid	42	0.33
DB01006	Letrozole	adenocarcinoma	32	0.34
DB01006	Letrozole	psoriasis	54	0.35
DB01006	Letrozole	lupus erythematosus systemic	75	0.36
DB01006	Letrozole	diabetes mellitus type 2	72	0.36
DB01006	Letrozole	breast neoplasms	40	0.37
DB01006	Letrozole	multiple sclerosis	69	0.38
DB01006	Letrozole	rheumatic diseases	59	0.39
DB01006	Letrozole	diabetes mellitus type 1	82	0.40
DB01006	Letrozole	crohn disease	71	0.41
DB01006	Letrozole	spinal cord diseases	59	0.44
DB01006	Letrozole	leukemia myeloid acute	43	0.46
DB01006	Letrozole	intestinal neoplasms	42	0.47
DB01006	Letrozole	arthritis	76	0.48
DB01006	Letrozole	colorectal neoplasms	42	0.50
DB01006	Letrozole	joint diseases	79	0.50
DB01006	Letrozole	leukemia lymphoid	66	0.52
DB01006	Letrozole	lung diseases	71	0.52
DB01006	Letrozole	gastroenteritis	122	0.53
DB01006	Letrozole	kidney diseases	144	0.57
DB01006	Letrozole	inflammatory bowel diseases	119	0.58
DB01006	Letrozole	diabetes mellitus	162	0.66
DB01006	Letrozole	gastrointestinal neoplasms	72	0.70
DB01006	Letrozole	heart diseases	167	0.71
DB01006	Letrozole	bone diseases	144	0.71
DB01006	Letrozole	leukemia	117	0.84
DB01006	Letrozole	vascular diseases	181	0.84
DB01006	Letrozole	autoimmune diseases	243	0.96
DB01006	Letrozole	cardiovascular diseases	330	1.12
DB01006	Letrozole	neoplasms	482	2.02
DB01006	Letrozole	epilepsy	25	2.19
DB01006	Letrozole	insulin resistance	26	2.34
DB01006	Letrozole	collagen diseases	25	2.46
DB01006	Letrozole	hyperinsulinism	26	2.48
DB01006	Letrozole	liver cirrhosis	24	2.74
DB01006	Letrozole	liver cirrhosis biliary	23	3.08
DB00268	Ropinirole	varicose veins	20	-3.45
DB00268	Ropinirole	epilepsy	25	-2.26
DB00268	Ropinirole	cardiovascular diseases	330	-2.26
DB00268	Ropinirole	heart diseases	167	-1.66
DB00268	Ropinirole	thyroid diseases	30	-1.36
DB00268	Ropinirole	vascular diseases	181	-1.29
DB00268	Ropinirole	colitis	55	-1.27
DB00268	Ropinirole	colitis ulcerative	55	-1.23
DB00268	Ropinirole	bone diseases	144	-1.14
DB00268	Ropinirole	arrhythmias cardiac	30	-1.04
DB00268	Ropinirole	leukemia myeloid acute	43	-0.68
DB00268	Ropinirole	spinal cord diseases	59	-0.58
DB00268	Ropinirole	inflammatory bowel diseases	119	-0.51
DB00268	Ropinirole	breast neoplasms	40	-0.49
DB00268	Ropinirole	gastroenteritis	122	-0.47
DB00268	Ropinirole	hematologic diseases	188	-0.28
DB00268	Ropinirole	liver cirrhosis biliary	23	-0.13
DB00268	Ropinirole	liver cirrhosis	24	-0.12
DB00268	Ropinirole	hyperinsulinism	26	-0.09
DB00268	Ropinirole	intestinal neoplasms	42	-0.09
DB00268	Ropinirole	colorectal neoplasms	42	-0.09
DB00268	Ropinirole	crohn disease	71	-0.09
DB00268	Ropinirole	insulin resistance	26	-0.07
DB00268	Ropinirole	psoriasis	54	0.03
DB00268	Ropinirole	neuroendocrine tumors	24	0.07
DB00268	Ropinirole	gastrointestinal neoplasms	72	0.10
DB00268	Ropinirole	alzheimer disease	29	0.15
DB00268	Ropinirole	anemia hemolytic	29	0.16
DB00268	Ropinirole	lung diseases	71	0.17
DB00268	Ropinirole	bacterial infections	26	0.28
DB00268	Ropinirole	mycobacterium infections	22	0.28
DB00268	Ropinirole	adenocarcinoma	32	0.29
DB00268	Ropinirole	amyotrophic lateral sclerosis	21	0.34
DB00268	Ropinirole	eye diseases	231	0.36
DB00268	Ropinirole	pancreatic diseases	24	0.37
DB00268	Ropinirole	keratosis	21	0.38
DB00268	Ropinirole	myocardial ischemia	43	0.39
DB00268	Ropinirole	malabsorption syndromes	34	0.40
DB00268	Ropinirole	multiple sclerosis	69	0.43
DB00268	Ropinirole	diabetes mellitus type 1	82	0.45
DB00268	Ropinirole	endocrine system diseases	291	0.49
DB00268	Ropinirole	collagen diseases	25	0.51
DB00268	Ropinirole	kidney neoplasms	20	0.68
DB00268	Ropinirole	hypopigmentation	22	0.70
DB00268	Ropinirole	anemia	58	0.73
DB00268	Ropinirole	cardiomyopathy dilated	29	0.73
DB00268	Ropinirole	leukemia	117	0.75
DB00268	Ropinirole	parkinsonian disorders	31	0.80
DB00268	Ropinirole	parkinson disease	30	0.84
DB00268	Ropinirole	dementia	42	1.00
DB00268	Ropinirole	blood coagulation disorders	40	1.02
DB00268	Ropinirole	arteriosclerosis	38	1.04
DB00268	Ropinirole	motor neuron disease	31	1.20
DB00268	Ropinirole	arthritis	76	1.23
DB00268	Ropinirole	joint diseases	79	1.24
DB00268	Ropinirole	diabetes mellitus type 2	72	1.30
DB00268	Ropinirole	arthritis rheumatoid	42	1.31
DB00268	Ropinirole	leukemia lymphoid	66	1.40
DB00268	Ropinirole	lymphoma non hodgkin	22	1.41
DB00268	Ropinirole	arterial occlusive diseases	44	1.49
DB00268	Ropinirole	diabetes mellitus	162	1.49
DB00268	Ropinirole	lymphoma	24	1.53
DB00268	Ropinirole	macular degeneration	44	1.54
DB00268	Ropinirole	skin diseases	278	1.57
DB00268	Ropinirole	asthma	36	1.60
DB00268	Ropinirole	metabolism inborn errors	289	1.70
DB00268	Ropinirole	autoimmune diseases	243	1.82
DB00268	Ropinirole	coronary artery disease	31	1.86
DB00268	Ropinirole	sarcoma	25	1.87
DB00268	Ropinirole	hypersensitivity	45	1.97
DB00268	Ropinirole	head and neck neoplasms	35	2.00
DB00268	Ropinirole	lupus erythematosus systemic	75	2.02
DB00268	Ropinirole	rheumatic diseases	59	2.02
DB00268	Ropinirole	prostatic neoplasms	61	2.22
DB00268	Ropinirole	coronary disease	37	2.35
DB00268	Ropinirole	neoplasms	482	2.45
DB00268	Ropinirole	kidney diseases	144	2.46
DB00268	Ropinirole	bone diseases metabolic	27	3.37
DB01005	Hydroxyurea	psoriasis	54	-2.56
DB01005	Hydroxyurea	hypopigmentation	22	-2.55
DB01005	Hydroxyurea	head and neck neoplasms	35	-2.51
DB01005	Hydroxyurea	multiple sclerosis	69	-2.39
DB01005	Hydroxyurea	lupus erythematosus systemic	75	-2.33
DB01005	Hydroxyurea	eye diseases	231	-1.48
DB01005	Hydroxyurea	autoimmune diseases	243	-1.31
DB01005	Hydroxyurea	vascular diseases	181	-1.31
DB01005	Hydroxyurea	skin diseases	278	-1.05
DB01005	Hydroxyurea	cardiovascular diseases	330	-1.02
DB01005	Hydroxyurea	neoplasms	482	-0.65
DB01005	Hydroxyurea	varicose veins	20	-0.51
DB01005	Hydroxyurea	epilepsy	25	-0.48
DB01005	Hydroxyurea	insulin resistance	26	-0.48
DB01005	Hydroxyurea	collagen diseases	25	-0.44
DB01005	Hydroxyurea	hyperinsulinism	26	-0.44
DB01005	Hydroxyurea	mycobacterium infections	22	-0.38
DB01005	Hydroxyurea	arrhythmias cardiac	30	-0.37
DB01005	Hydroxyurea	macular degeneration	44	-0.37
DB01005	Hydroxyurea	coronary artery disease	31	-0.34
DB01005	Hydroxyurea	keratosis	21	-0.34
DB01005	Hydroxyurea	kidney neoplasms	20	-0.29
DB01005	Hydroxyurea	bacterial infections	26	-0.28
DB01005	Hydroxyurea	coronary disease	37	-0.27
DB01005	Hydroxyurea	malabsorption syndromes	34	-0.26
DB01005	Hydroxyurea	anemia hemolytic	29	-0.24
DB01005	Hydroxyurea	arteriosclerosis	38	-0.23
DB01005	Hydroxyurea	thyroid diseases	30	-0.23
DB01005	Hydroxyurea	myocardial ischemia	43	-0.22
DB01005	Hydroxyurea	pancreatic diseases	24	-0.20
DB01005	Hydroxyurea	liver cirrhosis	24	-0.19
DB01005	Hydroxyurea	parkinsonian disorders	31	-0.17
DB01005	Hydroxyurea	cardiomyopathy dilated	29	-0.17
DB01005	Hydroxyurea	amyotrophic lateral sclerosis	21	-0.16
DB01005	Hydroxyurea	parkinson disease	30	-0.16
DB01005	Hydroxyurea	alzheimer disease	29	-0.15
DB01005	Hydroxyurea	neuroendocrine tumors	24	-0.15
DB01005	Hydroxyurea	liver cirrhosis biliary	23	-0.14
DB01005	Hydroxyurea	arterial occlusive diseases	44	-0.11
DB01005	Hydroxyurea	sarcoma	25	-0.10
DB01005	Hydroxyurea	asthma	36	-0.09
DB01005	Hydroxyurea	blood coagulation disorders	40	-0.09
DB01005	Hydroxyurea	lymphoma	24	-0.04
DB01005	Hydroxyurea	hypersensitivity	45	-0.03
DB01005	Hydroxyurea	lymphoma non hodgkin	22	-0.03
DB01005	Hydroxyurea	colitis ulcerative	55	-0.01
DB01005	Hydroxyurea	colitis	55	0.01
DB01005	Hydroxyurea	adenocarcinoma	32	0.03
DB01005	Hydroxyurea	arthritis rheumatoid	42	0.03
DB01005	Hydroxyurea	motor neuron disease	31	0.04
DB01005	Hydroxyurea	dementia	42	0.05
DB01005	Hydroxyurea	breast neoplasms	40	0.10
DB01005	Hydroxyurea	prostatic neoplasms	61	0.10
DB01005	Hydroxyurea	diabetes mellitus type 2	72	0.11
DB01005	Hydroxyurea	rheumatic diseases	59	0.13
DB01005	Hydroxyurea	diabetes mellitus type 1	82	0.20
DB01005	Hydroxyurea	leukemia myeloid acute	43	0.21
DB01005	Hydroxyurea	crohn disease	71	0.22
DB01005	Hydroxyurea	colorectal neoplasms	42	0.22
DB01005	Hydroxyurea	intestinal neoplasms	42	0.25
DB01005	Hydroxyurea	joint diseases	79	0.26
DB01005	Hydroxyurea	arthritis	76	0.27
DB01005	Hydroxyurea	lung diseases	71	0.28
DB01005	Hydroxyurea	spinal cord diseases	59	0.28
DB01005	Hydroxyurea	anemia	58	0.35
DB01005	Hydroxyurea	leukemia lymphoid	66	0.35
DB01005	Hydroxyurea	kidney diseases	144	0.37
DB01005	Hydroxyurea	inflammatory bowel diseases	119	0.37
DB01005	Hydroxyurea	gastroenteritis	122	0.38
DB01005	Hydroxyurea	gastrointestinal neoplasms	72	0.43
DB01005	Hydroxyurea	bone diseases	144	0.44
DB01005	Hydroxyurea	diabetes mellitus	162	0.44
DB01005	Hydroxyurea	heart diseases	167	0.50
DB01005	Hydroxyurea	leukemia	117	0.51
DB01005	Hydroxyurea	metabolism inborn errors	289	0.58
DB01005	Hydroxyurea	hematologic diseases	188	0.69
DB01005	Hydroxyurea	endocrine system diseases	291	0.71
DB01005	Hydroxyurea	bone diseases metabolic	27	1.72
DB00571	Propranolol	diabetes mellitus type 2	72	-2.25
DB00571	Propranolol	gastrointestinal neoplasms	72	-1.35
DB00571	Propranolol	diabetes mellitus	162	-1.30
DB00571	Propranolol	endocrine system diseases	291	-1.15
DB00571	Propranolol	bone diseases	144	-1.01
DB00571	Propranolol	intestinal neoplasms	42	-0.97
DB00571	Propranolol	colorectal neoplasms	42	-0.89
DB00571	Propranolol	lung diseases	71	-0.73
DB00571	Propranolol	epilepsy	25	-0.64
DB00571	Propranolol	hyperinsulinism	26	-0.57
DB00571	Propranolol	insulin resistance	26	-0.52
DB00571	Propranolol	arrhythmias cardiac	30	-0.49
DB00571	Propranolol	bone diseases metabolic	27	-0.41
DB00571	Propranolol	colitis ulcerative	55	-0.33
DB00571	Propranolol	colitis	55	-0.30
DB00571	Propranolol	mycobacterium infections	22	-0.25
DB00571	Propranolol	psoriasis	54	-0.15
DB00571	Propranolol	breast neoplasms	40	-0.15
DB00571	Propranolol	thyroid diseases	30	-0.09
DB00571	Propranolol	heart diseases	167	-0.09
DB00571	Propranolol	neoplasms	482	-0.08
DB00571	Propranolol	multiple sclerosis	69	-0.04
DB00571	Propranolol	kidney neoplasms	20	-0.01
DB00571	Propranolol	bacterial infections	26	0.00
DB00571	Propranolol	liver cirrhosis biliary	23	0.04
DB00571	Propranolol	liver cirrhosis	24	0.05
DB00571	Propranolol	amyotrophic lateral sclerosis	21	0.06
DB00571	Propranolol	pancreatic diseases	24	0.06
DB00571	Propranolol	crohn disease	71	0.08
DB00571	Propranolol	diabetes mellitus type 1	82	0.08
DB00571	Propranolol	malabsorption syndromes	34	0.10
DB00571	Propranolol	varicose veins	20	0.12
DB00571	Propranolol	spinal cord diseases	59	0.15
DB00571	Propranolol	leukemia myeloid acute	43	0.19
DB00571	Propranolol	asthma	36	0.19
DB00571	Propranolol	neuroendocrine tumors	24	0.21
DB00571	Propranolol	alzheimer disease	29	0.24
DB00571	Propranolol	metabolism inborn errors	289	0.31
DB00571	Propranolol	sarcoma	25	0.35
DB00571	Propranolol	hypersensitivity	45	0.38
DB00571	Propranolol	leukemia lymphoid	66	0.38
DB00571	Propranolol	inflammatory bowel diseases	119	0.51
DB00571	Propranolol	motor neuron disease	31	0.54
DB00571	Propranolol	gastroenteritis	122	0.58
DB00571	Propranolol	keratosis	21	0.64
DB00571	Propranolol	arthritis rheumatoid	42	0.64
DB00571	Propranolol	adenocarcinoma	32	0.68
DB00571	Propranolol	coronary artery disease	31	0.69
DB00571	Propranolol	macular degeneration	44	0.73
DB00571	Propranolol	skin diseases	278	0.73
DB00571	Propranolol	dementia	42	0.77
DB00571	Propranolol	hypopigmentation	22	0.85
DB00571	Propranolol	cardiovascular diseases	330	0.85
DB00571	Propranolol	anemia hemolytic	29	0.89
DB00571	Propranolol	coronary disease	37	0.97
DB00571	Propranolol	myocardial ischemia	43	1.00
DB00571	Propranolol	rheumatic diseases	59	1.02
DB00571	Propranolol	leukemia	117	1.04
DB00571	Propranolol	parkinsonian disorders	31	1.06
DB00571	Propranolol	lupus erythematosus systemic	75	1.10
DB00571	Propranolol	parkinson disease	30	1.11
DB00571	Propranolol	arteriosclerosis	38	1.11
DB00571	Propranolol	vascular diseases	181	1.12
DB00571	Propranolol	eye diseases	231	1.13
DB00571	Propranolol	arthritis	76	1.19
DB00571	Propranolol	anemia	58	1.22
DB00571	Propranolol	cardiomyopathy dilated	29	1.23
DB00571	Propranolol	joint diseases	79	1.25
DB00571	Propranolol	hematologic diseases	188	1.32
DB00571	Propranolol	arterial occlusive diseases	44	1.34
DB00571	Propranolol	lymphoma non hodgkin	22	1.34
DB00571	Propranolol	collagen diseases	25	1.35
DB00571	Propranolol	lymphoma	24	1.36
DB00571	Propranolol	blood coagulation disorders	40	1.38
DB00571	Propranolol	autoimmune diseases	243	1.43
DB00571	Propranolol	kidney diseases	144	1.53
DB00571	Propranolol	head and neck neoplasms	35	1.73
DB00571	Propranolol	prostatic neoplasms	61	1.77
DB00570	Vinblastine	mycobacterium infections	22	-2.55
DB00570	Vinblastine	parkinsonian disorders	31	-2.46
DB00570	Vinblastine	parkinson disease	30	-2.39
DB00570	Vinblastine	bacterial infections	26	-2.34
DB00570	Vinblastine	dementia	42	-1.92
DB00570	Vinblastine	lymphoma non hodgkin	22	-1.90
DB00570	Vinblastine	lymphoma	24	-1.85
DB00570	Vinblastine	macular degeneration	44	-1.80
DB00570	Vinblastine	prostatic neoplasms	61	-1.80
DB00570	Vinblastine	breast neoplasms	40	-1.64
DB00570	Vinblastine	arterial occlusive diseases	44	-1.45
DB00570	Vinblastine	leukemia lymphoid	66	-1.31
DB00570	Vinblastine	lung diseases	71	-1.25
DB00570	Vinblastine	asthma	36	-1.14
DB00570	Vinblastine	neuroendocrine tumors	24	-1.13
DB00570	Vinblastine	liver cirrhosis	24	-1.04
DB00570	Vinblastine	pancreatic diseases	24	-1.01
DB00570	Vinblastine	liver cirrhosis biliary	23	-0.99
DB00570	Vinblastine	hypersensitivity	45	-0.96
DB00570	Vinblastine	leukemia	117	-0.74
DB00570	Vinblastine	arrhythmias cardiac	30	-0.72
DB00570	Vinblastine	psoriasis	54	-0.72
DB00570	Vinblastine	motor neuron disease	31	-0.63
DB00570	Vinblastine	cardiomyopathy dilated	29	-0.61
DB00570	Vinblastine	adenocarcinoma	32	-0.56
DB00570	Vinblastine	bone diseases metabolic	27	-0.44
DB00570	Vinblastine	alzheimer disease	29	-0.40
DB00570	Vinblastine	skin diseases	278	-0.30
DB00570	Vinblastine	endocrine system diseases	291	-0.25
DB00570	Vinblastine	leukemia myeloid acute	43	-0.24
DB00570	Vinblastine	joint diseases	79	-0.04
DB00570	Vinblastine	spinal cord diseases	59	-0.02
DB00570	Vinblastine	arthritis	76	-0.02
DB00570	Vinblastine	intestinal neoplasms	42	-0.01
DB00570	Vinblastine	colorectal neoplasms	42	0.00
DB00570	Vinblastine	coronary artery disease	31	0.07
DB00570	Vinblastine	keratosis	21	0.13
DB00570	Vinblastine	anemia	58	0.17
DB00570	Vinblastine	myocardial ischemia	43	0.18
DB00570	Vinblastine	coronary disease	37	0.19
DB00570	Vinblastine	heart diseases	167	0.29
DB00570	Vinblastine	thyroid diseases	30	0.30
DB00570	Vinblastine	arteriosclerosis	38	0.32
DB00570	Vinblastine	neoplasms	482	0.42
DB00570	Vinblastine	gastrointestinal neoplasms	72	0.46
DB00570	Vinblastine	arthritis rheumatoid	42	0.46
DB00570	Vinblastine	metabolism inborn errors	289	0.51
DB00570	Vinblastine	malabsorption syndromes	34	0.52
DB00570	Vinblastine	amyotrophic lateral sclerosis	21	0.54
DB00570	Vinblastine	diabetes mellitus type 1	82	0.56
DB00570	Vinblastine	bone diseases	144	0.61
DB00570	Vinblastine	varicose veins	20	0.62
DB00570	Vinblastine	colitis ulcerative	55	0.70
DB00570	Vinblastine	epilepsy	25	0.71
DB00570	Vinblastine	colitis	55	0.72
DB00570	Vinblastine	collagen diseases	25	0.75
DB00570	Vinblastine	rheumatic diseases	59	0.83
DB00570	Vinblastine	diabetes mellitus type 2	72	0.84
DB00570	Vinblastine	eye diseases	231	0.89
DB00570	Vinblastine	crohn disease	71	0.91
DB00570	Vinblastine	insulin resistance	26	0.94
DB00570	Vinblastine	sarcoma	25	0.98
DB00570	Vinblastine	vascular diseases	181	0.99
DB00570	Vinblastine	hyperinsulinism	26	1.00
DB00570	Vinblastine	anemia hemolytic	29	1.23
DB00570	Vinblastine	multiple sclerosis	69	1.23
DB00570	Vinblastine	hematologic diseases	188	1.29
DB00570	Vinblastine	inflammatory bowel diseases	119	1.31
DB00570	Vinblastine	head and neck neoplasms	35	1.34
DB00570	Vinblastine	diabetes mellitus	162	1.39
DB00570	Vinblastine	blood coagulation disorders	40	1.40
DB00570	Vinblastine	hypopigmentation	22	1.44
DB00570	Vinblastine	gastroenteritis	122	1.52
DB00570	Vinblastine	cardiovascular diseases	330	1.53
DB00570	Vinblastine	kidney neoplasms	20	1.57
DB00570	Vinblastine	lupus erythematosus systemic	75	1.68
DB00570	Vinblastine	kidney diseases	144	2.49
DB00570	Vinblastine	autoimmune diseases	243	2.93
DB00572	Atropine	colitis	55	-1.47
DB00572	Atropine	colitis ulcerative	55	-1.46
DB00572	Atropine	thyroid diseases	30	-1.35
DB00572	Atropine	pancreatic diseases	24	-1.25
DB00572	Atropine	arteriosclerosis	38	-1.14
DB00572	Atropine	epilepsy	25	-1.09
DB00572	Atropine	arterial occlusive diseases	44	-1.01
DB00572	Atropine	insulin resistance	26	-0.99
DB00572	Atropine	hyperinsulinism	26	-0.97
DB00572	Atropine	gastroenteritis	122	-0.72
DB00572	Atropine	inflammatory bowel diseases	119	-0.70
DB00572	Atropine	head and neck neoplasms	35	-0.67
DB00572	Atropine	dementia	42	-0.64
DB00572	Atropine	hypopigmentation	22	-0.58
DB00572	Atropine	kidney diseases	144	-0.54
DB00572	Atropine	psoriasis	54	-0.51
DB00572	Atropine	bone diseases	144	-0.49
DB00572	Atropine	liver cirrhosis biliary	23	-0.45
DB00572	Atropine	liver cirrhosis	24	-0.41
DB00572	Atropine	leukemia myeloid acute	43	-0.39
DB00572	Atropine	lupus erythematosus systemic	75	-0.38
DB00572	Atropine	crohn disease	71	-0.32
DB00572	Atropine	asthma	36	-0.29
DB00572	Atropine	diabetes mellitus type 1	82	-0.28
DB00572	Atropine	eye diseases	231	-0.19
DB00572	Atropine	joint diseases	79	-0.18
DB00572	Atropine	arthritis	76	-0.16
DB00572	Atropine	leukemia lymphoid	66	-0.16
DB00572	Atropine	lung diseases	71	-0.15
DB00572	Atropine	bone diseases metabolic	27	-0.11
DB00572	Atropine	hypersensitivity	45	-0.04
DB00572	Atropine	metabolism inborn errors	289	-0.02
DB00572	Atropine	mycobacterium infections	22	-0.01
DB00572	Atropine	coronary artery disease	31	0.05
DB00572	Atropine	keratosis	21	0.07
DB00572	Atropine	adenocarcinoma	32	0.07
DB00572	Atropine	gastrointestinal neoplasms	72	0.12
DB00572	Atropine	neoplasms	482	0.13
DB00572	Atropine	skin diseases	278	0.23
DB00572	Atropine	coronary disease	37	0.27
DB00572	Atropine	kidney neoplasms	20	0.29
DB00572	Atropine	diabetes mellitus type 2	72	0.29
DB00572	Atropine	diabetes mellitus	162	0.29
DB00572	Atropine	bacterial infections	26	0.30
DB00572	Atropine	amyotrophic lateral sclerosis	21	0.34
DB00572	Atropine	intestinal neoplasms	42	0.38
DB00572	Atropine	myocardial ischemia	43	0.39
DB00572	Atropine	neuroendocrine tumors	24	0.39
DB00572	Atropine	colorectal neoplasms	42	0.42
DB00572	Atropine	leukemia	117	0.48
DB00572	Atropine	multiple sclerosis	69	0.48
DB00572	Atropine	alzheimer disease	29	0.50
DB00572	Atropine	spinal cord diseases	59	0.53
DB00572	Atropine	sarcoma	25	0.57
DB00572	Atropine	arrhythmias cardiac	30	0.58
DB00572	Atropine	vascular diseases	181	0.61
DB00572	Atropine	lymphoma	24	0.63
DB00572	Atropine	anemia	58	0.64
DB00572	Atropine	lymphoma non hodgkin	22	0.65
DB00572	Atropine	blood coagulation disorders	40	0.66
DB00572	Atropine	motor neuron disease	31	0.78
DB00572	Atropine	hematologic diseases	188	0.84
DB00572	Atropine	autoimmune diseases	243	0.86
DB00572	Atropine	macular degeneration	44	0.90
DB00572	Atropine	endocrine system diseases	291	0.92
DB00572	Atropine	anemia hemolytic	29	1.06
DB00572	Atropine	breast neoplasms	40	1.12
DB00572	Atropine	parkinson disease	30	1.12
DB00572	Atropine	cardiovascular diseases	330	1.13
DB00572	Atropine	parkinsonian disorders	31	1.13
DB00572	Atropine	varicose veins	20	1.14
DB00572	Atropine	malabsorption syndromes	34	1.14
DB00572	Atropine	heart diseases	167	1.22
DB00572	Atropine	cardiomyopathy dilated	29	1.25
DB00572	Atropine	collagen diseases	25	1.51
DB00572	Atropine	arthritis rheumatoid	42	1.57
DB00572	Atropine	prostatic neoplasms	61	1.85
DB00572	Atropine	rheumatic diseases	59	2.05
DB01240	Epoprostenol	lymphoma	24	-1.53
DB01240	Epoprostenol	lymphoma non hodgkin	22	-1.51
DB01240	Epoprostenol	psoriasis	54	-1.20
DB01240	Epoprostenol	metabolism inborn errors	289	-1.14
DB01240	Epoprostenol	endocrine system diseases	291	-1.13
DB01240	Epoprostenol	intestinal neoplasms	42	-1.10
DB01240	Epoprostenol	colorectal neoplasms	42	-1.08
DB01240	Epoprostenol	leukemia lymphoid	66	-0.98
DB01240	Epoprostenol	bone diseases metabolic	27	-0.98
DB01240	Epoprostenol	lung diseases	71	-0.92
DB01240	Epoprostenol	thyroid diseases	30	-0.81
DB01240	Epoprostenol	gastrointestinal neoplasms	72	-0.74
DB01240	Epoprostenol	pancreatic diseases	24	-0.67
DB01240	Epoprostenol	liver cirrhosis	24	-0.66
DB01240	Epoprostenol	arteriosclerosis	38	-0.65
DB01240	Epoprostenol	liver cirrhosis biliary	23	-0.65
DB01240	Epoprostenol	bone diseases	144	-0.52
DB01240	Epoprostenol	neoplasms	482	-0.50
DB01240	Epoprostenol	leukemia	117	-0.44
DB01240	Epoprostenol	arterial occlusive diseases	44	-0.39
DB01240	Epoprostenol	eye diseases	231	-0.36
DB01240	Epoprostenol	adenocarcinoma	32	-0.33
DB01240	Epoprostenol	varicose veins	20	-0.32
DB01240	Epoprostenol	head and neck neoplasms	35	-0.25
DB01240	Epoprostenol	colitis	55	-0.22
DB01240	Epoprostenol	colitis ulcerative	55	-0.21
DB01240	Epoprostenol	insulin resistance	26	-0.11
DB01240	Epoprostenol	prostatic neoplasms	61	-0.10
DB01240	Epoprostenol	arrhythmias cardiac	30	-0.08
DB01240	Epoprostenol	diabetes mellitus type 2	72	-0.08
DB01240	Epoprostenol	hyperinsulinism	26	-0.07
DB01240	Epoprostenol	collagen diseases	25	-0.06
DB01240	Epoprostenol	leukemia myeloid acute	43	-0.01
DB01240	Epoprostenol	skin diseases	278	-0.01
DB01240	Epoprostenol	diabetes mellitus type 1	82	0.02
DB01240	Epoprostenol	lupus erythematosus systemic	75	0.04
DB01240	Epoprostenol	crohn disease	71	0.06
DB01240	Epoprostenol	spinal cord diseases	59	0.08
DB01240	Epoprostenol	cardiovascular diseases	330	0.10
DB01240	Epoprostenol	joint diseases	79	0.12
DB01240	Epoprostenol	coronary artery disease	31	0.13
DB01240	Epoprostenol	keratosis	21	0.14
DB01240	Epoprostenol	arthritis	76	0.15
DB01240	Epoprostenol	anemia	58	0.18
DB01240	Epoprostenol	macular degeneration	44	0.20
DB01240	Epoprostenol	hypopigmentation	22	0.24
DB01240	Epoprostenol	bacterial infections	26	0.25
DB01240	Epoprostenol	kidney neoplasms	20	0.26
DB01240	Epoprostenol	coronary disease	37	0.31
DB01240	Epoprostenol	amyotrophic lateral sclerosis	21	0.32
DB01240	Epoprostenol	malabsorption syndromes	34	0.34
DB01240	Epoprostenol	myocardial ischemia	43	0.36
DB01240	Epoprostenol	asthma	36	0.42
DB01240	Epoprostenol	inflammatory bowel diseases	119	0.43
DB01240	Epoprostenol	gastroenteritis	122	0.44
DB01240	Epoprostenol	cardiomyopathy dilated	29	0.47
DB01240	Epoprostenol	alzheimer disease	29	0.52
DB01240	Epoprostenol	sarcoma	25	0.53
DB01240	Epoprostenol	diabetes mellitus	162	0.57
DB01240	Epoprostenol	blood coagulation disorders	40	0.62
DB01240	Epoprostenol	heart diseases	167	0.64
DB01240	Epoprostenol	motor neuron disease	31	0.67
DB01240	Epoprostenol	hypersensitivity	45	0.69
DB01240	Epoprostenol	epilepsy	25	0.75
DB01240	Epoprostenol	vascular diseases	181	0.76
DB01240	Epoprostenol	arthritis rheumatoid	42	0.82
DB01240	Epoprostenol	dementia	42	0.83
DB01240	Epoprostenol	breast neoplasms	40	0.91
DB01240	Epoprostenol	hematologic diseases	188	0.94
DB01240	Epoprostenol	autoimmune diseases	243	0.97
DB01240	Epoprostenol	rheumatic diseases	59	0.99
DB01240	Epoprostenol	mycobacterium infections	22	1.10
DB01240	Epoprostenol	multiple sclerosis	69	1.16
DB01240	Epoprostenol	anemia hemolytic	29	1.17
DB01240	Epoprostenol	parkinson disease	30	1.35
DB01240	Epoprostenol	parkinsonian disorders	31	1.35
DB01240	Epoprostenol	neuroendocrine tumors	24	1.48
DB01240	Epoprostenol	kidney diseases	144	1.49
DB00308	Ibutilide	arrhythmias cardiac	30	-5.49
DB00308	Ibutilide	heart diseases	167	-4.25
DB00308	Ibutilide	cardiovascular diseases	330	-2.85
DB00308	Ibutilide	epilepsy	25	-2.23
DB00308	Ibutilide	psoriasis	54	-2.21
DB00308	Ibutilide	liver cirrhosis biliary	23	-2.19
DB00308	Ibutilide	alzheimer disease	29	-2.16
DB00308	Ibutilide	diabetes mellitus type 2	72	-2.12
DB00308	Ibutilide	liver cirrhosis	24	-2.11
DB00308	Ibutilide	cardiomyopathy dilated	29	-2.11
DB00308	Ibutilide	lymphoma	24	-1.98
DB00308	Ibutilide	lymphoma non hodgkin	22	-1.93
DB00308	Ibutilide	spinal cord diseases	59	-1.92
DB00308	Ibutilide	varicose veins	20	-1.78
DB00308	Ibutilide	coronary artery disease	31	-1.71
DB00308	Ibutilide	dementia	42	-1.70
DB00308	Ibutilide	hypopigmentation	22	-1.64
DB00308	Ibutilide	head and neck neoplasms	35	-1.63
DB00308	Ibutilide	macular degeneration	44	-1.61
DB00308	Ibutilide	coronary disease	37	-1.60
DB00308	Ibutilide	parkinsonian disorders	31	-1.55
DB00308	Ibutilide	parkinson disease	30	-1.53
DB00308	Ibutilide	amyotrophic lateral sclerosis	21	-1.50
DB00308	Ibutilide	pancreatic diseases	24	-1.45
DB00308	Ibutilide	arteriosclerosis	38	-1.45
DB00308	Ibutilide	myocardial ischemia	43	-1.43
DB00308	Ibutilide	hyperinsulinism	26	-1.43
DB00308	Ibutilide	breast neoplasms	40	-1.43
DB00308	Ibutilide	collagen diseases	25	-1.40
DB00308	Ibutilide	insulin resistance	26	-1.40
DB00308	Ibutilide	kidney diseases	144	-1.30
DB00308	Ibutilide	keratosis	21	-1.24
DB00308	Ibutilide	diabetes mellitus	162	-1.23
DB00308	Ibutilide	arterial occlusive diseases	44	-1.15
DB00308	Ibutilide	multiple sclerosis	69	-1.13
DB00308	Ibutilide	motor neuron disease	31	-1.03
DB00308	Ibutilide	lung diseases	71	-1.03
DB00308	Ibutilide	arthritis rheumatoid	42	-0.98
DB00308	Ibutilide	thyroid diseases	30	-0.97
DB00308	Ibutilide	kidney neoplasms	20	-0.94
DB00308	Ibutilide	endocrine system diseases	291	-0.93
DB00308	Ibutilide	colitis ulcerative	55	-0.92
DB00308	Ibutilide	skin diseases	278	-0.91
DB00308	Ibutilide	bacterial infections	26	-0.89
DB00308	Ibutilide	colitis	55	-0.87
DB00308	Ibutilide	malabsorption syndromes	34	-0.84
DB00308	Ibutilide	eye diseases	231	-0.77
DB00308	Ibutilide	prostatic neoplasms	61	-0.73
DB00308	Ibutilide	bone diseases metabolic	27	-0.72
DB00308	Ibutilide	sarcoma	25	-0.62
DB00308	Ibutilide	rheumatic diseases	59	-0.62
DB00308	Ibutilide	lupus erythematosus systemic	75	-0.59
DB00308	Ibutilide	metabolism inborn errors	289	-0.56
DB00308	Ibutilide	leukemia myeloid acute	43	-0.56
DB00308	Ibutilide	intestinal neoplasms	42	-0.55
DB00308	Ibutilide	diabetes mellitus type 1	82	-0.49
DB00308	Ibutilide	colorectal neoplasms	42	-0.49
DB00308	Ibutilide	autoimmune diseases	243	-0.49
DB00308	Ibutilide	bone diseases	144	-0.41
DB00308	Ibutilide	arthritis	76	-0.35
DB00308	Ibutilide	joint diseases	79	-0.31
DB00308	Ibutilide	adenocarcinoma	32	-0.28
DB00308	Ibutilide	leukemia lymphoid	66	-0.26
DB00308	Ibutilide	anemia hemolytic	29	-0.26
DB00308	Ibutilide	vascular diseases	181	-0.06
DB00308	Ibutilide	gastrointestinal neoplasms	72	-0.01
DB00308	Ibutilide	gastroenteritis	122	0.03
DB00308	Ibutilide	inflammatory bowel diseases	119	0.05
DB00308	Ibutilide	asthma	36	0.06
DB00308	Ibutilide	mycobacterium infections	22	0.15
DB00308	Ibutilide	blood coagulation disorders	40	0.24
DB00308	Ibutilide	hypersensitivity	45	0.26
DB00308	Ibutilide	crohn disease	71	0.28
DB00308	Ibutilide	anemia	58	0.41
DB00308	Ibutilide	leukemia	117	0.44
DB00308	Ibutilide	neoplasms	482	0.63
DB00308	Ibutilide	neuroendocrine tumors	24	0.67
DB00308	Ibutilide	hematologic diseases	188	0.88
DB06655	Liraglutide	epilepsy	25	-0.72
DB06655	Liraglutide	collagen diseases	25	-0.63
DB06655	Liraglutide	arrhythmias cardiac	30	-0.61
DB06655	Liraglutide	mycobacterium infections	22	-0.54
DB06655	Liraglutide	macular degeneration	44	-0.54
DB06655	Liraglutide	kidney neoplasms	20	-0.52
DB06655	Liraglutide	hypopigmentation	22	-0.51
DB06655	Liraglutide	thyroid diseases	30	-0.48
DB06655	Liraglutide	bacterial infections	26	-0.47
DB06655	Liraglutide	malabsorption syndromes	34	-0.47
DB06655	Liraglutide	arteriosclerosis	38	-0.47
DB06655	Liraglutide	pancreatic diseases	24	-0.45
DB06655	Liraglutide	neuroendocrine tumors	24	-0.44
DB06655	Liraglutide	parkinsonian disorders	31	-0.43
DB06655	Liraglutide	parkinson disease	30	-0.43
DB06655	Liraglutide	alzheimer disease	29	-0.42
DB06655	Liraglutide	amyotrophic lateral sclerosis	21	-0.38
DB06655	Liraglutide	liver cirrhosis biliary	23	-0.38
DB06655	Liraglutide	cardiomyopathy dilated	29	-0.37
DB06655	Liraglutide	liver cirrhosis	24	-0.36
DB06655	Liraglutide	arterial occlusive diseases	44	-0.34
DB06655	Liraglutide	sarcoma	25	-0.33
DB06655	Liraglutide	blood coagulation disorders	40	-0.31
DB06655	Liraglutide	lymphoma non hodgkin	22	-0.29
DB06655	Liraglutide	hypersensitivity	45	-0.27
DB06655	Liraglutide	lymphoma	24	-0.27
DB06655	Liraglutide	colitis	55	-0.23
DB06655	Liraglutide	prostatic neoplasms	61	-0.22
DB06655	Liraglutide	motor neuron disease	31	-0.22
DB06655	Liraglutide	colitis ulcerative	55	-0.19
DB06655	Liraglutide	head and neck neoplasms	35	-0.19
DB06655	Liraglutide	arthritis rheumatoid	42	-0.18
DB06655	Liraglutide	adenocarcinoma	32	-0.17
DB06655	Liraglutide	dementia	42	-0.15
DB06655	Liraglutide	diabetes mellitus type 2	72	-0.10
DB06655	Liraglutide	psoriasis	54	-0.09
DB06655	Liraglutide	rheumatic diseases	59	-0.07
DB06655	Liraglutide	lupus erythematosus systemic	75	-0.07
DB06655	Liraglutide	crohn disease	71	-0.06
DB06655	Liraglutide	breast neoplasms	40	-0.06
DB06655	Liraglutide	leukemia myeloid acute	43	-0.02
DB06655	Liraglutide	spinal cord diseases	59	0.00
DB06655	Liraglutide	multiple sclerosis	69	0.00
DB06655	Liraglutide	joint diseases	79	0.02
DB06655	Liraglutide	arthritis	76	0.03
DB06655	Liraglutide	colorectal neoplasms	42	0.03
DB06655	Liraglutide	diabetes mellitus type 1	82	0.03
DB06655	Liraglutide	intestinal neoplasms	42	0.05
DB06655	Liraglutide	lung diseases	71	0.06
DB06655	Liraglutide	anemia	58	0.06
DB06655	Liraglutide	leukemia lymphoid	66	0.09
DB06655	Liraglutide	kidney diseases	144	0.16
DB06655	Liraglutide	gastroenteritis	122	0.17
DB06655	Liraglutide	inflammatory bowel diseases	119	0.19
DB06655	Liraglutide	gastrointestinal neoplasms	72	0.19
DB06655	Liraglutide	diabetes mellitus	162	0.25
DB06655	Liraglutide	heart diseases	167	0.30
DB06655	Liraglutide	bone diseases	144	0.31
DB06655	Liraglutide	vascular diseases	181	0.34
DB06655	Liraglutide	leukemia	117	0.42
DB06655	Liraglutide	eye diseases	231	0.44
DB06655	Liraglutide	metabolism inborn errors	289	0.46
DB06655	Liraglutide	autoimmune diseases	243	0.49
DB06655	Liraglutide	hematologic diseases	188	0.53
DB06655	Liraglutide	endocrine system diseases	291	0.54
DB06655	Liraglutide	skin diseases	278	0.56
DB06655	Liraglutide	cardiovascular diseases	330	0.61
DB06655	Liraglutide	neoplasms	482	0.94
DB06655	Liraglutide	varicose veins	20	1.07
DB06655	Liraglutide	insulin resistance	26	1.20
DB06655	Liraglutide	hyperinsulinism	26	1.22
DB06655	Liraglutide	bone diseases metabolic	27	1.24
DB06655	Liraglutide	coronary artery disease	31	1.37
DB06655	Liraglutide	keratosis	21	1.42
DB06655	Liraglutide	anemia hemolytic	29	1.51
DB06655	Liraglutide	coronary disease	37	1.52
DB06655	Liraglutide	asthma	36	1.63
DB06655	Liraglutide	myocardial ischemia	43	1.71
DB01064	Isoproterenol	varicose veins	20	-3.93
DB01064	Isoproterenol	diabetes mellitus type 2	72	-3.49
DB01064	Isoproterenol	intestinal neoplasms	42	-2.80
DB01064	Isoproterenol	colorectal neoplasms	42	-2.77
DB01064	Isoproterenol	pancreatic diseases	24	-2.35
DB01064	Isoproterenol	diabetes mellitus	162	-2.09
DB01064	Isoproterenol	thyroid diseases	30	-2.07
DB01064	Isoproterenol	arrhythmias cardiac	30	-2.02
DB01064	Isoproterenol	gastrointestinal neoplasms	72	-1.98
DB01064	Isoproterenol	bone diseases	144	-1.92
DB01064	Isoproterenol	endocrine system diseases	291	-1.86
DB01064	Isoproterenol	hypopigmentation	22	-1.67
DB01064	Isoproterenol	lung diseases	71	-1.67
DB01064	Isoproterenol	adenocarcinoma	32	-1.63
DB01064	Isoproterenol	prostatic neoplasms	61	-1.60
DB01064	Isoproterenol	blood coagulation disorders	40	-1.46
DB01064	Isoproterenol	head and neck neoplasms	35	-1.45
DB01064	Isoproterenol	diabetes mellitus type 1	82	-1.39
DB01064	Isoproterenol	breast neoplasms	40	-1.38
DB01064	Isoproterenol	sarcoma	25	-1.26
DB01064	Isoproterenol	keratosis	21	-1.20
DB01064	Isoproterenol	leukemia myeloid acute	43	-1.13
DB01064	Isoproterenol	heart diseases	167	-1.05
DB01064	Isoproterenol	bone diseases metabolic	27	-0.96
DB01064	Isoproterenol	malabsorption syndromes	34	-0.92
DB01064	Isoproterenol	kidney neoplasms	20	-0.91
DB01064	Isoproterenol	leukemia lymphoid	66	-0.87
DB01064	Isoproterenol	amyotrophic lateral sclerosis	21	-0.82
DB01064	Isoproterenol	alzheimer disease	29	-0.77
DB01064	Isoproterenol	neoplasms	482	-0.68
DB01064	Isoproterenol	liver cirrhosis	24	-0.66
DB01064	Isoproterenol	liver cirrhosis biliary	23	-0.63
DB01064	Isoproterenol	neuroendocrine tumors	24	-0.55
DB01064	Isoproterenol	asthma	36	-0.54
DB01064	Isoproterenol	rheumatic diseases	59	-0.50
DB01064	Isoproterenol	anemia hemolytic	29	-0.40
DB01064	Isoproterenol	colitis ulcerative	55	-0.36
DB01064	Isoproterenol	colitis	55	-0.35
DB01064	Isoproterenol	parkinson disease	30	-0.34
DB01064	Isoproterenol	multiple sclerosis	69	-0.34
DB01064	Isoproterenol	parkinsonian disorders	31	-0.34
DB01064	Isoproterenol	hypersensitivity	45	-0.30
DB01064	Isoproterenol	autoimmune diseases	243	-0.28
DB01064	Isoproterenol	lymphoma	24	-0.24
DB01064	Isoproterenol	lymphoma non hodgkin	22	-0.23
DB01064	Isoproterenol	joint diseases	79	-0.13
DB01064	Isoproterenol	arthritis	76	-0.09
DB01064	Isoproterenol	hyperinsulinism	26	-0.07
DB01064	Isoproterenol	insulin resistance	26	-0.07
DB01064	Isoproterenol	dementia	42	-0.06
DB01064	Isoproterenol	motor neuron disease	31	-0.05
DB01064	Isoproterenol	macular degeneration	44	-0.04
DB01064	Isoproterenol	cardiomyopathy dilated	29	0.01
DB01064	Isoproterenol	arthritis rheumatoid	42	0.03
DB01064	Isoproterenol	cardiovascular diseases	330	0.07
DB01064	Isoproterenol	skin diseases	278	0.09
DB01064	Isoproterenol	bacterial infections	26	0.09
DB01064	Isoproterenol	psoriasis	54	0.14
DB01064	Isoproterenol	metabolism inborn errors	289	0.16
DB01064	Isoproterenol	leukemia	117	0.18
DB01064	Isoproterenol	gastroenteritis	122	0.23
DB01064	Isoproterenol	inflammatory bowel diseases	119	0.24
DB01064	Isoproterenol	vascular diseases	181	0.25
DB01064	Isoproterenol	coronary artery disease	31	0.27
DB01064	Isoproterenol	kidney diseases	144	0.30
DB01064	Isoproterenol	lupus erythematosus systemic	75	0.38
DB01064	Isoproterenol	coronary disease	37	0.51
DB01064	Isoproterenol	epilepsy	25	0.55
DB01064	Isoproterenol	mycobacterium infections	22	0.56
DB01064	Isoproterenol	crohn disease	71	0.59
DB01064	Isoproterenol	myocardial ischemia	43	0.64
DB01064	Isoproterenol	hematologic diseases	188	0.64
DB01064	Isoproterenol	spinal cord diseases	59	0.69
DB01064	Isoproterenol	arteriosclerosis	38	0.73
DB01064	Isoproterenol	collagen diseases	25	0.77
DB01064	Isoproterenol	anemia	58	0.86
DB01064	Isoproterenol	arterial occlusive diseases	44	0.96
DB01064	Isoproterenol	eye diseases	231	1.08
DB00619	Imatinib	neoplasms	482	-4.86
DB00619	Imatinib	leukemia	117	-4.49
DB00619	Imatinib	diabetes mellitus type 2	72	-4.17
DB00619	Imatinib	hematologic diseases	188	-4.17
DB00619	Imatinib	vascular diseases	181	-2.98
DB00619	Imatinib	varicose veins	20	-2.94
DB00619	Imatinib	arrhythmias cardiac	30	-2.87
DB00619	Imatinib	leukemia myeloid acute	43	-2.79
DB00619	Imatinib	bacterial infections	26	-2.70
DB00619	Imatinib	autoimmune diseases	243	-2.67
DB00619	Imatinib	diabetes mellitus	162	-2.63
DB00619	Imatinib	heart diseases	167	-2.57
DB00619	Imatinib	bone diseases	144	-2.54
DB00619	Imatinib	blood coagulation disorders	40	-2.52
DB00619	Imatinib	lupus erythematosus systemic	75	-2.49
DB00619	Imatinib	multiple sclerosis	69	-2.35
DB00619	Imatinib	arthritis rheumatoid	42	-2.16
DB00619	Imatinib	cardiovascular diseases	330	-2.11
DB00619	Imatinib	eye diseases	231	-2.10
DB00619	Imatinib	crohn disease	71	-2.09
DB00619	Imatinib	skin diseases	278	-2.08
DB00619	Imatinib	mycobacterium infections	22	-2.01
DB00619	Imatinib	metabolism inborn errors	289	-1.94
DB00619	Imatinib	hypopigmentation	22	-1.92
DB00619	Imatinib	arteriosclerosis	38	-1.88
DB00619	Imatinib	gastrointestinal neoplasms	72	-1.71
DB00619	Imatinib	psoriasis	54	-1.66
DB00619	Imatinib	arterial occlusive diseases	44	-1.64
DB00619	Imatinib	rheumatic diseases	59	-1.53
DB00619	Imatinib	coronary artery disease	31	-1.46
DB00619	Imatinib	inflammatory bowel diseases	119	-1.39
DB00619	Imatinib	gastroenteritis	122	-1.37
DB00619	Imatinib	endocrine system diseases	291	-1.36
DB00619	Imatinib	sarcoma	25	-1.35
DB00619	Imatinib	diabetes mellitus type 1	82	-1.27
DB00619	Imatinib	coronary disease	37	-1.24
DB00619	Imatinib	colitis ulcerative	55	-1.22
DB00619	Imatinib	malabsorption syndromes	34	-1.19
DB00619	Imatinib	joint diseases	79	-1.18
DB00619	Imatinib	myocardial ischemia	43	-1.17
DB00619	Imatinib	colitis	55	-1.15
DB00619	Imatinib	arthritis	76	-1.10
DB00619	Imatinib	epilepsy	25	-1.09
DB00619	Imatinib	collagen diseases	25	-0.93
DB00619	Imatinib	macular degeneration	44	-0.90
DB00619	Imatinib	leukemia lymphoid	66	-0.84
DB00619	Imatinib	liver cirrhosis biliary	23	-0.83
DB00619	Imatinib	prostatic neoplasms	61	-0.82
DB00619	Imatinib	liver cirrhosis	24	-0.82
DB00619	Imatinib	cardiomyopathy dilated	29	-0.82
DB00619	Imatinib	alzheimer disease	29	-0.67
DB00619	Imatinib	kidney diseases	144	-0.56
DB00619	Imatinib	anemia hemolytic	29	-0.48
DB00619	Imatinib	keratosis	21	-0.46
DB00619	Imatinib	parkinsonian disorders	31	-0.22
DB00619	Imatinib	parkinson disease	30	-0.20
DB00619	Imatinib	kidney neoplasms	20	-0.14
DB00619	Imatinib	thyroid diseases	30	-0.14
DB00619	Imatinib	hyperinsulinism	26	-0.12
DB00619	Imatinib	insulin resistance	26	-0.12
DB00619	Imatinib	lung diseases	71	-0.11
DB00619	Imatinib	adenocarcinoma	32	-0.03
DB00619	Imatinib	dementia	42	-0.01
DB00619	Imatinib	pancreatic diseases	24	0.09
DB00619	Imatinib	asthma	36	0.09
DB00619	Imatinib	head and neck neoplasms	35	0.10
DB00619	Imatinib	neuroendocrine tumors	24	0.13
DB00619	Imatinib	hypersensitivity	45	0.27
DB00619	Imatinib	breast neoplasms	40	0.36
DB00619	Imatinib	lymphoma	24	0.53
DB00619	Imatinib	lymphoma non hodgkin	22	0.56
DB00619	Imatinib	colorectal neoplasms	42	0.63
DB00619	Imatinib	intestinal neoplasms	42	0.63
DB00619	Imatinib	bone diseases metabolic	27	0.83
DB00619	Imatinib	amyotrophic lateral sclerosis	21	0.96
DB00619	Imatinib	anemia	58	1.46
DB00619	Imatinib	motor neuron disease	31	1.52
DB00619	Imatinib	spinal cord diseases	59	2.28
DB01119	Diazoxide	metabolism inborn errors	289	-3.96
DB01119	Diazoxide	kidney diseases	144	-3.20
DB01119	Diazoxide	multiple sclerosis	69	-2.18
DB01119	Diazoxide	endocrine system diseases	291	-2.12
DB01119	Diazoxide	adenocarcinoma	32	-1.91
DB01119	Diazoxide	diabetes mellitus	162	-1.66
DB01119	Diazoxide	lupus erythematosus systemic	75	-1.56
DB01119	Diazoxide	epilepsy	25	-1.51
DB01119	Diazoxide	cardiomyopathy dilated	29	-1.45
DB01119	Diazoxide	lymphoma	24	-1.34
DB01119	Diazoxide	anemia	58	-1.31
DB01119	Diazoxide	lymphoma non hodgkin	22	-1.30
DB01119	Diazoxide	keratosis	21	-1.05
DB01119	Diazoxide	head and neck neoplasms	35	-0.98
DB01119	Diazoxide	kidney neoplasms	20	-0.95
DB01119	Diazoxide	prostatic neoplasms	61	-0.93
DB01119	Diazoxide	anemia hemolytic	29	-0.92
DB01119	Diazoxide	hypopigmentation	22	-0.90
DB01119	Diazoxide	diabetes mellitus type 2	72	-0.83
DB01119	Diazoxide	pancreatic diseases	24	-0.81
DB01119	Diazoxide	liver cirrhosis biliary	23	-0.80
DB01119	Diazoxide	liver cirrhosis	24	-0.74
DB01119	Diazoxide	autoimmune diseases	243	-0.73
DB01119	Diazoxide	heart diseases	167	-0.66
DB01119	Diazoxide	colorectal neoplasms	42	-0.64
DB01119	Diazoxide	arrhythmias cardiac	30	-0.64
DB01119	Diazoxide	diabetes mellitus type 1	82	-0.61
DB01119	Diazoxide	intestinal neoplasms	42	-0.59
DB01119	Diazoxide	bone diseases	144	-0.56
DB01119	Diazoxide	bone diseases metabolic	27	-0.53
DB01119	Diazoxide	collagen diseases	25	-0.52
DB01119	Diazoxide	leukemia lymphoid	66	-0.37
DB01119	Diazoxide	coronary artery disease	31	-0.36
DB01119	Diazoxide	lung diseases	71	-0.36
DB01119	Diazoxide	eye diseases	231	-0.27
DB01119	Diazoxide	arthritis rheumatoid	42	-0.23
DB01119	Diazoxide	dementia	42	-0.22
DB01119	Diazoxide	colitis	55	-0.21
DB01119	Diazoxide	colitis ulcerative	55	-0.19
DB01119	Diazoxide	thyroid diseases	30	-0.16
DB01119	Diazoxide	coronary disease	37	-0.14
DB01119	Diazoxide	varicose veins	20	-0.12
DB01119	Diazoxide	gastrointestinal neoplasms	72	-0.11
DB01119	Diazoxide	bacterial infections	26	-0.08
DB01119	Diazoxide	hematologic diseases	188	-0.05
DB01119	Diazoxide	psoriasis	54	-0.03
DB01119	Diazoxide	arteriosclerosis	38	0.01
DB01119	Diazoxide	myocardial ischemia	43	0.04
DB01119	Diazoxide	alzheimer disease	29	0.05
DB01119	Diazoxide	rheumatic diseases	59	0.11
DB01119	Diazoxide	neuroendocrine tumors	24	0.13
DB01119	Diazoxide	asthma	36	0.16
DB01119	Diazoxide	leukemia myeloid acute	43	0.19
DB01119	Diazoxide	crohn disease	71	0.22
DB01119	Diazoxide	arterial occlusive diseases	44	0.27
DB01119	Diazoxide	blood coagulation disorders	40	0.31
DB01119	Diazoxide	cardiovascular diseases	330	0.32
DB01119	Diazoxide	joint diseases	79	0.32
DB01119	Diazoxide	arthritis	76	0.35
DB01119	Diazoxide	hypersensitivity	45	0.36
DB01119	Diazoxide	neoplasms	482	0.40
DB01119	Diazoxide	leukemia	117	0.42
DB01119	Diazoxide	mycobacterium infections	22	0.43
DB01119	Diazoxide	vascular diseases	181	0.44
DB01119	Diazoxide	motor neuron disease	31	0.46
DB01119	Diazoxide	macular degeneration	44	0.53
DB01119	Diazoxide	inflammatory bowel diseases	119	0.68
DB01119	Diazoxide	gastroenteritis	122	0.72
DB01119	Diazoxide	amyotrophic lateral sclerosis	21	0.79
DB01119	Diazoxide	breast neoplasms	40	0.83
DB01119	Diazoxide	insulin resistance	26	0.86
DB01119	Diazoxide	malabsorption syndromes	34	0.86
DB01119	Diazoxide	hyperinsulinism	26	0.91
DB01119	Diazoxide	skin diseases	278	1.02
DB01119	Diazoxide	sarcoma	25	1.07
DB01119	Diazoxide	spinal cord diseases	59	1.13
DB01119	Diazoxide	parkinsonian disorders	31	1.54
DB01119	Diazoxide	parkinson disease	30	1.57
DB00759	Tetracycline	dementia	42	-3.07
DB00759	Tetracycline	arrhythmias cardiac	30	-2.53
DB00759	Tetracycline	arteriosclerosis	38	-2.08
DB00759	Tetracycline	alzheimer disease	29	-1.85
DB00759	Tetracycline	asthma	36	-1.75
DB00759	Tetracycline	arterial occlusive diseases	44	-1.71
DB00759	Tetracycline	hypersensitivity	45	-1.71
DB00759	Tetracycline	amyotrophic lateral sclerosis	21	-1.57
DB00759	Tetracycline	arthritis rheumatoid	42	-1.51
DB00759	Tetracycline	prostatic neoplasms	61	-1.47
DB00759	Tetracycline	motor neuron disease	31	-1.29
DB00759	Tetracycline	head and neck neoplasms	35	-1.23
DB00759	Tetracycline	diabetes mellitus type 1	82	-1.21
DB00759	Tetracycline	psoriasis	54	-1.20
DB00759	Tetracycline	lupus erythematosus systemic	75	-1.16
DB00759	Tetracycline	rheumatic diseases	59	-1.11
DB00759	Tetracycline	multiple sclerosis	69	-1.06
DB00759	Tetracycline	lung diseases	71	-1.03
DB00759	Tetracycline	spinal cord diseases	59	-0.98
DB00759	Tetracycline	joint diseases	79	-0.96
DB00759	Tetracycline	arthritis	76	-0.92
DB00759	Tetracycline	heart diseases	167	-0.77
DB00759	Tetracycline	gastroenteritis	122	-0.66
DB00759	Tetracycline	eye diseases	231	-0.65
DB00759	Tetracycline	diabetes mellitus	162	-0.62
DB00759	Tetracycline	vascular diseases	181	-0.55
DB00759	Tetracycline	metabolism inborn errors	289	-0.46
DB00759	Tetracycline	cardiovascular diseases	330	-0.28
DB00759	Tetracycline	autoimmune diseases	243	-0.27
DB00759	Tetracycline	hematologic diseases	188	-0.26
DB00759	Tetracycline	skin diseases	278	-0.18
DB00759	Tetracycline	endocrine system diseases	291	-0.14
DB00759	Tetracycline	varicose veins	20	0.04
DB00759	Tetracycline	hyperinsulinism	26	0.04
DB00759	Tetracycline	collagen diseases	25	0.08
DB00759	Tetracycline	insulin resistance	26	0.10
DB00759	Tetracycline	macular degeneration	44	0.11
DB00759	Tetracycline	epilepsy	25	0.11
DB00759	Tetracycline	bone diseases metabolic	27	0.19
DB00759	Tetracycline	anemia hemolytic	29	0.20
DB00759	Tetracycline	coronary artery disease	31	0.22
DB00759	Tetracycline	neoplasms	482	0.23
DB00759	Tetracycline	coronary disease	37	0.28
DB00759	Tetracycline	keratosis	21	0.29
DB00759	Tetracycline	mycobacterium infections	22	0.31
DB00759	Tetracycline	parkinson disease	30	0.34
DB00759	Tetracycline	myocardial ischemia	43	0.35
DB00759	Tetracycline	hypopigmentation	22	0.36
DB00759	Tetracycline	malabsorption syndromes	34	0.36
DB00759	Tetracycline	parkinsonian disorders	31	0.38
DB00759	Tetracycline	cardiomyopathy dilated	29	0.41
DB00759	Tetracycline	bacterial infections	26	0.43
DB00759	Tetracycline	thyroid diseases	30	0.45
DB00759	Tetracycline	kidney neoplasms	20	0.46
DB00759	Tetracycline	blood coagulation disorders	40	0.48
DB00759	Tetracycline	liver cirrhosis biliary	23	0.48
DB00759	Tetracycline	neuroendocrine tumors	24	0.51
DB00759	Tetracycline	liver cirrhosis	24	0.52
DB00759	Tetracycline	pancreatic diseases	24	0.54
DB00759	Tetracycline	sarcoma	25	0.59
DB00759	Tetracycline	lymphoma non hodgkin	22	0.64
DB00759	Tetracycline	lymphoma	24	0.65
DB00759	Tetracycline	colitis	55	0.66
DB00759	Tetracycline	colitis ulcerative	55	0.70
DB00759	Tetracycline	adenocarcinoma	32	0.73
DB00759	Tetracycline	diabetes mellitus type 2	72	0.74
DB00759	Tetracycline	crohn disease	71	0.89
DB00759	Tetracycline	breast neoplasms	40	0.89
DB00759	Tetracycline	colorectal neoplasms	42	0.92
DB00759	Tetracycline	intestinal neoplasms	42	0.92
DB00759	Tetracycline	leukemia myeloid acute	43	0.92
DB00759	Tetracycline	anemia	58	1.07
DB00759	Tetracycline	kidney diseases	144	1.07
DB00759	Tetracycline	leukemia lymphoid	66	1.08
DB00759	Tetracycline	inflammatory bowel diseases	119	1.18
DB00759	Tetracycline	gastrointestinal neoplasms	72	1.29
DB00759	Tetracycline	bone diseases	144	1.42
DB00759	Tetracycline	leukemia	117	1.86
DB01222	Budesonide	coronary disease	37	-1.56
DB01222	Budesonide	coronary artery disease	31	-1.47
DB01222	Budesonide	myocardial ischemia	43	-1.47
DB01222	Budesonide	malabsorption syndromes	34	-1.38
DB01222	Budesonide	arteriosclerosis	38	-1.31
DB01222	Budesonide	kidney neoplasms	20	-1.30
DB01222	Budesonide	colitis ulcerative	55	-1.29
DB01222	Budesonide	colitis	55	-1.28
DB01222	Budesonide	alzheimer disease	29	-1.22
DB01222	Budesonide	arterial occlusive diseases	44	-1.15
DB01222	Budesonide	mycobacterium infections	22	-1.11
DB01222	Budesonide	neuroendocrine tumors	24	-1.10
DB01222	Budesonide	asthma	36	-1.09
DB01222	Budesonide	bacterial infections	26	-1.02
DB01222	Budesonide	dementia	42	-0.99
DB01222	Budesonide	hypersensitivity	45	-0.99
DB01222	Budesonide	sarcoma	25	-0.95
DB01222	Budesonide	prostatic neoplasms	61	-0.86
DB01222	Budesonide	head and neck neoplasms	35	-0.83
DB01222	Budesonide	motor neuron disease	31	-0.80
DB01222	Budesonide	liver cirrhosis	24	-0.77
DB01222	Budesonide	arthritis rheumatoid	42	-0.77
DB01222	Budesonide	lymphoma	24	-0.75
DB01222	Budesonide	lupus erythematosus systemic	75	-0.75
DB01222	Budesonide	diabetes mellitus type 1	82	-0.75
DB01222	Budesonide	liver cirrhosis biliary	23	-0.72
DB01222	Budesonide	adenocarcinoma	32	-0.70
DB01222	Budesonide	lymphoma non hodgkin	22	-0.69
DB01222	Budesonide	breast neoplasms	40	-0.62
DB01222	Budesonide	rheumatic diseases	59	-0.60
DB01222	Budesonide	leukemia myeloid acute	43	-0.56
DB01222	Budesonide	crohn disease	71	-0.53
DB01222	Budesonide	leukemia lymphoid	66	-0.50
DB01222	Budesonide	arthritis	76	-0.48
DB01222	Budesonide	diabetes mellitus	162	-0.47
DB01222	Budesonide	joint diseases	79	-0.46
DB01222	Budesonide	colorectal neoplasms	42	-0.46
DB01222	Budesonide	kidney diseases	144	-0.45
DB01222	Budesonide	inflammatory bowel diseases	119	-0.43
DB01222	Budesonide	intestinal neoplasms	42	-0.41
DB01222	Budesonide	multiple sclerosis	69	-0.40
DB01222	Budesonide	gastroenteritis	122	-0.38
DB01222	Budesonide	spinal cord diseases	59	-0.35
DB01222	Budesonide	heart diseases	167	-0.34
DB01222	Budesonide	metabolism inborn errors	289	-0.31
DB01222	Budesonide	lung diseases	71	-0.30
DB01222	Budesonide	gastrointestinal neoplasms	72	-0.25
DB01222	Budesonide	bone diseases	144	-0.24
DB01222	Budesonide	leukemia	117	-0.08
DB01222	Budesonide	eye diseases	231	-0.01
DB01222	Budesonide	vascular diseases	181	0.04
DB01222	Budesonide	skin diseases	278	0.04
DB01222	Budesonide	hematologic diseases	188	0.05
DB01222	Budesonide	autoimmune diseases	243	0.10
DB01222	Budesonide	endocrine system diseases	291	0.14
DB01222	Budesonide	cardiovascular diseases	330	0.15
DB01222	Budesonide	neoplasms	482	0.21
DB01222	Budesonide	arrhythmias cardiac	30	0.31
DB01222	Budesonide	collagen diseases	25	0.37
DB01222	Budesonide	varicose veins	20	0.37
DB01222	Budesonide	epilepsy	25	0.38
DB01222	Budesonide	macular degeneration	44	0.40
DB01222	Budesonide	bone diseases metabolic	27	0.44
DB01222	Budesonide	parkinson disease	30	0.47
DB01222	Budesonide	parkinsonian disorders	31	0.51
DB01222	Budesonide	hyperinsulinism	26	0.55
DB01222	Budesonide	insulin resistance	26	0.59
DB01222	Budesonide	anemia hemolytic	29	0.63
DB01222	Budesonide	cardiomyopathy dilated	29	0.63
DB01222	Budesonide	keratosis	21	0.66
DB01222	Budesonide	blood coagulation disorders	40	0.69
DB01222	Budesonide	hypopigmentation	22	0.72
DB01222	Budesonide	thyroid diseases	30	0.74
DB01222	Budesonide	amyotrophic lateral sclerosis	21	0.80
DB01222	Budesonide	diabetes mellitus type 2	72	0.88
DB01222	Budesonide	pancreatic diseases	24	1.13
DB01222	Budesonide	psoriasis	54	1.19
DB01222	Budesonide	anemia	58	2.37
DB01101	Capecitabine	anemia hemolytic	29	-2.63
DB01101	Capecitabine	myocardial ischemia	43	-2.47
DB01101	Capecitabine	alzheimer disease	29	-2.45
DB01101	Capecitabine	coronary disease	37	-2.42
DB01101	Capecitabine	dementia	42	-2.20
DB01101	Capecitabine	colorectal neoplasms	42	-1.99
DB01101	Capecitabine	intestinal neoplasms	42	-1.98
DB01101	Capecitabine	anemia	58	-1.78
DB01101	Capecitabine	gastrointestinal neoplasms	72	-1.46
DB01101	Capecitabine	heart diseases	167	-1.27
DB01101	Capecitabine	vascular diseases	181	-1.23
DB01101	Capecitabine	hematologic diseases	188	-1.04
DB01101	Capecitabine	metabolism inborn errors	289	-1.00
DB01101	Capecitabine	cardiovascular diseases	330	-0.78
DB01101	Capecitabine	varicose veins	20	-0.37
DB01101	Capecitabine	neoplasms	482	-0.34
DB01101	Capecitabine	bone diseases metabolic	27	-0.33
DB01101	Capecitabine	arrhythmias cardiac	30	-0.32
DB01101	Capecitabine	collagen diseases	25	-0.24
DB01101	Capecitabine	insulin resistance	26	-0.24
DB01101	Capecitabine	hyperinsulinism	26	-0.23
DB01101	Capecitabine	mycobacterium infections	22	-0.23
DB01101	Capecitabine	keratosis	21	-0.21
DB01101	Capecitabine	coronary artery disease	31	-0.18
DB01101	Capecitabine	macular degeneration	44	-0.11
DB01101	Capecitabine	thyroid diseases	30	-0.10
DB01101	Capecitabine	kidney neoplasms	20	-0.08
DB01101	Capecitabine	liver cirrhosis	24	-0.07
DB01101	Capecitabine	hypopigmentation	22	-0.07
DB01101	Capecitabine	bacterial infections	26	-0.06
DB01101	Capecitabine	malabsorption syndromes	34	-0.06
DB01101	Capecitabine	parkinsonian disorders	31	-0.06
DB01101	Capecitabine	amyotrophic lateral sclerosis	21	-0.06
DB01101	Capecitabine	liver cirrhosis biliary	23	-0.05
DB01101	Capecitabine	pancreatic diseases	24	-0.04
DB01101	Capecitabine	sarcoma	25	-0.04
DB01101	Capecitabine	asthma	36	-0.04
DB01101	Capecitabine	neuroendocrine tumors	24	-0.01
DB01101	Capecitabine	parkinson disease	30	0.00
DB01101	Capecitabine	blood coagulation disorders	40	0.01
DB01101	Capecitabine	lymphoma non hodgkin	22	0.04
DB01101	Capecitabine	arteriosclerosis	38	0.04
DB01101	Capecitabine	arterial occlusive diseases	44	0.06
DB01101	Capecitabine	cardiomyopathy dilated	29	0.07
DB01101	Capecitabine	motor neuron disease	31	0.07
DB01101	Capecitabine	lymphoma	24	0.08
DB01101	Capecitabine	hypersensitivity	45	0.08
DB01101	Capecitabine	adenocarcinoma	32	0.13
DB01101	Capecitabine	colitis ulcerative	55	0.14
DB01101	Capecitabine	colitis	55	0.14
DB01101	Capecitabine	arthritis rheumatoid	42	0.20
DB01101	Capecitabine	head and neck neoplasms	35	0.20
DB01101	Capecitabine	breast neoplasms	40	0.23
DB01101	Capecitabine	rheumatic diseases	59	0.24
DB01101	Capecitabine	diabetes mellitus type 2	72	0.24
DB01101	Capecitabine	psoriasis	54	0.24
DB01101	Capecitabine	prostatic neoplasms	61	0.25
DB01101	Capecitabine	lupus erythematosus systemic	75	0.28
DB01101	Capecitabine	spinal cord diseases	59	0.30
DB01101	Capecitabine	lung diseases	71	0.31
DB01101	Capecitabine	multiple sclerosis	69	0.32
DB01101	Capecitabine	diabetes mellitus type 1	82	0.32
DB01101	Capecitabine	crohn disease	71	0.33
DB01101	Capecitabine	arthritis	76	0.34
DB01101	Capecitabine	leukemia myeloid acute	43	0.34
DB01101	Capecitabine	joint diseases	79	0.40
DB01101	Capecitabine	leukemia lymphoid	66	0.42
DB01101	Capecitabine	kidney diseases	144	0.49
DB01101	Capecitabine	inflammatory bowel diseases	119	0.49
DB01101	Capecitabine	gastroenteritis	122	0.51
DB01101	Capecitabine	diabetes mellitus	162	0.57
DB01101	Capecitabine	bone diseases	144	0.63
DB01101	Capecitabine	leukemia	117	0.76
DB01101	Capecitabine	eye diseases	231	0.78
DB01101	Capecitabine	autoimmune diseases	243	0.90
DB01101	Capecitabine	skin diseases	278	0.97
DB01101	Capecitabine	endocrine system diseases	291	1.03
DB01101	Capecitabine	epilepsy	25	1.90
DB00204	Dofetilide	arrhythmias cardiac	30	-4.53
DB00204	Dofetilide	heart diseases	167	-3.90
DB00204	Dofetilide	cardiovascular diseases	330	-2.92
DB00204	Dofetilide	bone diseases metabolic	27	-2.09
DB00204	Dofetilide	thyroid diseases	30	-1.96
DB00204	Dofetilide	lymphoma non hodgkin	22	-1.94
DB00204	Dofetilide	lymphoma	24	-1.94
DB00204	Dofetilide	coronary disease	37	-1.92
DB00204	Dofetilide	cardiomyopathy dilated	29	-1.88
DB00204	Dofetilide	arteriosclerosis	38	-1.87
DB00204	Dofetilide	coronary artery disease	31	-1.86
DB00204	Dofetilide	myocardial ischemia	43	-1.82
DB00204	Dofetilide	head and neck neoplasms	35	-1.79
DB00204	Dofetilide	arterial occlusive diseases	44	-1.65
DB00204	Dofetilide	bone diseases	144	-0.93
DB00204	Dofetilide	epilepsy	25	-0.76
DB00204	Dofetilide	eye diseases	231	-0.75
DB00204	Dofetilide	vascular diseases	181	-0.72
DB00204	Dofetilide	collagen diseases	25	-0.68
DB00204	Dofetilide	hyperinsulinism	26	-0.64
DB00204	Dofetilide	insulin resistance	26	-0.61
DB00204	Dofetilide	autoimmune diseases	243	-0.60
DB00204	Dofetilide	keratosis	21	-0.58
DB00204	Dofetilide	kidney neoplasms	20	-0.50
DB00204	Dofetilide	bacterial infections	26	-0.46
DB00204	Dofetilide	endocrine system diseases	291	-0.44
DB00204	Dofetilide	parkinsonian disorders	31	-0.41
DB00204	Dofetilide	hypopigmentation	22	-0.40
DB00204	Dofetilide	malabsorption syndromes	34	-0.38
DB00204	Dofetilide	anemia hemolytic	29	-0.38
DB00204	Dofetilide	parkinson disease	30	-0.35
DB00204	Dofetilide	asthma	36	-0.33
DB00204	Dofetilide	liver cirrhosis biliary	23	-0.33
DB00204	Dofetilide	neuroendocrine tumors	24	-0.32
DB00204	Dofetilide	pancreatic diseases	24	-0.30
DB00204	Dofetilide	liver cirrhosis	24	-0.28
DB00204	Dofetilide	alzheimer disease	29	-0.25
DB00204	Dofetilide	blood coagulation disorders	40	-0.15
DB00204	Dofetilide	sarcoma	25	-0.11
DB00204	Dofetilide	adenocarcinoma	32	-0.07
DB00204	Dofetilide	motor neuron disease	31	-0.07
DB00204	Dofetilide	hypersensitivity	45	-0.04
DB00204	Dofetilide	arthritis rheumatoid	42	0.02
DB00204	Dofetilide	colitis	55	0.02
DB00204	Dofetilide	colitis ulcerative	55	0.04
DB00204	Dofetilide	breast neoplasms	40	0.04
DB00204	Dofetilide	psoriasis	54	0.08
DB00204	Dofetilide	dementia	42	0.09
DB00204	Dofetilide	prostatic neoplasms	61	0.10
DB00204	Dofetilide	diabetes mellitus type 2	72	0.12
DB00204	Dofetilide	rheumatic diseases	59	0.17
DB00204	Dofetilide	lupus erythematosus systemic	75	0.20
DB00204	Dofetilide	intestinal neoplasms	42	0.20
DB00204	Dofetilide	diabetes mellitus type 1	82	0.24
DB00204	Dofetilide	colorectal neoplasms	42	0.24
DB00204	Dofetilide	leukemia myeloid acute	43	0.24
DB00204	Dofetilide	crohn disease	71	0.25
DB00204	Dofetilide	spinal cord diseases	59	0.26
DB00204	Dofetilide	multiple sclerosis	69	0.27
DB00204	Dofetilide	joint diseases	79	0.29
DB00204	Dofetilide	lung diseases	71	0.34
DB00204	Dofetilide	arthritis	76	0.34
DB00204	Dofetilide	anemia	58	0.36
DB00204	Dofetilide	neoplasms	482	0.38
DB00204	Dofetilide	leukemia lymphoid	66	0.41
DB00204	Dofetilide	varicose veins	20	0.46
DB00204	Dofetilide	inflammatory bowel diseases	119	0.49
DB00204	Dofetilide	kidney diseases	144	0.49
DB00204	Dofetilide	gastroenteritis	122	0.49
DB00204	Dofetilide	gastrointestinal neoplasms	72	0.51
DB00204	Dofetilide	diabetes mellitus	162	0.59
DB00204	Dofetilide	leukemia	117	0.70
DB00204	Dofetilide	metabolism inborn errors	289	0.83
DB00204	Dofetilide	hematologic diseases	188	0.88
DB00204	Dofetilide	macular degeneration	44	0.97
DB00204	Dofetilide	skin diseases	278	1.03
DB00204	Dofetilide	amyotrophic lateral sclerosis	21	1.25
DB00204	Dofetilide	mycobacterium infections	22	2.51
DB01068	Clonazepam	epilepsy	25	-9.35
DB01068	Clonazepam	vascular diseases	181	-3.00
DB01068	Clonazepam	spinal cord diseases	59	-2.94
DB01068	Clonazepam	collagen diseases	25	-2.45
DB01068	Clonazepam	cardiovascular diseases	330	-1.94
DB01068	Clonazepam	varicose veins	20	-1.44
DB01068	Clonazepam	neuroendocrine tumors	24	-0.96
DB01068	Clonazepam	sarcoma	25	-0.83
DB01068	Clonazepam	colorectal neoplasms	42	-0.82
DB01068	Clonazepam	multiple sclerosis	69	-0.81
DB01068	Clonazepam	intestinal neoplasms	42	-0.81
DB01068	Clonazepam	bone diseases	144	-0.78
DB01068	Clonazepam	malabsorption syndromes	34	-0.74
DB01068	Clonazepam	amyotrophic lateral sclerosis	21	-0.68
DB01068	Clonazepam	keratosis	21	-0.65
DB01068	Clonazepam	arrhythmias cardiac	30	-0.64
DB01068	Clonazepam	gastrointestinal neoplasms	72	-0.58
DB01068	Clonazepam	cardiomyopathy dilated	29	-0.48
DB01068	Clonazepam	motor neuron disease	31	-0.48
DB01068	Clonazepam	autoimmune diseases	243	-0.45
DB01068	Clonazepam	kidney neoplasms	20	-0.36
DB01068	Clonazepam	lupus erythematosus systemic	75	-0.35
DB01068	Clonazepam	adenocarcinoma	32	-0.32
DB01068	Clonazepam	pancreatic diseases	24	-0.16
DB01068	Clonazepam	diabetes mellitus type 2	72	-0.05
DB01068	Clonazepam	thyroid diseases	30	0.03
DB01068	Clonazepam	asthma	36	0.03
DB01068	Clonazepam	lung diseases	71	0.05
DB01068	Clonazepam	leukemia lymphoid	66	0.10
DB01068	Clonazepam	hypopigmentation	22	0.15
DB01068	Clonazepam	bacterial infections	26	0.15
DB01068	Clonazepam	lymphoma non hodgkin	22	0.25
DB01068	Clonazepam	leukemia myeloid acute	43	0.27
DB01068	Clonazepam	diabetes mellitus type 1	82	0.29
DB01068	Clonazepam	crohn disease	71	0.29
DB01068	Clonazepam	parkinson disease	30	0.30
DB01068	Clonazepam	insulin resistance	26	0.30
DB01068	Clonazepam	dementia	42	0.30
DB01068	Clonazepam	blood coagulation disorders	40	0.30
DB01068	Clonazepam	parkinsonian disorders	31	0.31
DB01068	Clonazepam	hyperinsulinism	26	0.31
DB01068	Clonazepam	lymphoma	24	0.33
DB01068	Clonazepam	hypersensitivity	45	0.35
DB01068	Clonazepam	prostatic neoplasms	61	0.38
DB01068	Clonazepam	psoriasis	54	0.38
DB01068	Clonazepam	endocrine system diseases	291	0.38
DB01068	Clonazepam	macular degeneration	44	0.39
DB01068	Clonazepam	bone diseases metabolic	27	0.41
DB01068	Clonazepam	breast neoplasms	40	0.44
DB01068	Clonazepam	leukemia	117	0.56
DB01068	Clonazepam	alzheimer disease	29	0.59
DB01068	Clonazepam	mycobacterium infections	22	0.66
DB01068	Clonazepam	arthritis rheumatoid	42	0.67
DB01068	Clonazepam	diabetes mellitus	162	0.72
DB01068	Clonazepam	coronary artery disease	31	0.74
DB01068	Clonazepam	colitis	55	0.79
DB01068	Clonazepam	colitis ulcerative	55	0.79
DB01068	Clonazepam	heart diseases	167	0.88
DB01068	Clonazepam	inflammatory bowel diseases	119	0.97
DB01068	Clonazepam	skin diseases	278	0.99
DB01068	Clonazepam	anemia hemolytic	29	1.05
DB01068	Clonazepam	gastroenteritis	122	1.08
DB01068	Clonazepam	kidney diseases	144	1.08
DB01068	Clonazepam	rheumatic diseases	59	1.16
DB01068	Clonazepam	coronary disease	37	1.19
DB01068	Clonazepam	arterial occlusive diseases	44	1.32
DB01068	Clonazepam	myocardial ischemia	43	1.37
DB01068	Clonazepam	arteriosclerosis	38	1.47
DB01068	Clonazepam	metabolism inborn errors	289	1.48
DB01068	Clonazepam	arthritis	76	1.52
DB01068	Clonazepam	joint diseases	79	1.66
DB01068	Clonazepam	liver cirrhosis biliary	23	1.70
DB01068	Clonazepam	liver cirrhosis	24	1.75
DB01068	Clonazepam	eye diseases	231	1.79
DB01068	Clonazepam	head and neck neoplasms	35	1.86
DB01068	Clonazepam	neoplasms	482	1.92
DB01068	Clonazepam	hematologic diseases	188	2.20
DB01068	Clonazepam	anemia	58	2.26
DB01069	Promethazine	colitis	55	-2.33
DB01069	Promethazine	colitis ulcerative	55	-2.28
DB01069	Promethazine	arthritis	76	-1.58
DB01069	Promethazine	joint diseases	79	-1.53
DB01069	Promethazine	epilepsy	25	-1.53
DB01069	Promethazine	psoriasis	54	-1.42
DB01069	Promethazine	arterial occlusive diseases	44	-1.36
DB01069	Promethazine	bone diseases	144	-1.34
DB01069	Promethazine	arrhythmias cardiac	30	-1.33
DB01069	Promethazine	thyroid diseases	30	-1.30
DB01069	Promethazine	arteriosclerosis	38	-1.06
DB01069	Promethazine	crohn disease	71	-1.01
DB01069	Promethazine	gastroenteritis	122	-1.00
DB01069	Promethazine	pancreatic diseases	24	-0.98
DB01069	Promethazine	inflammatory bowel diseases	119	-0.98
DB01069	Promethazine	dementia	42	-0.97
DB01069	Promethazine	head and neck neoplasms	35	-0.94
DB01069	Promethazine	parkinsonian disorders	31	-0.74
DB01069	Promethazine	hyperinsulinism	26	-0.74
DB01069	Promethazine	parkinson disease	30	-0.71
DB01069	Promethazine	insulin resistance	26	-0.71
DB01069	Promethazine	hypopigmentation	22	-0.68
DB01069	Promethazine	bacterial infections	26	-0.58
DB01069	Promethazine	lupus erythematosus systemic	75	-0.47
DB01069	Promethazine	liver cirrhosis biliary	23	-0.42
DB01069	Promethazine	liver cirrhosis	24	-0.42
DB01069	Promethazine	leukemia myeloid acute	43	-0.39
DB01069	Promethazine	neuroendocrine tumors	24	-0.36
DB01069	Promethazine	adenocarcinoma	32	-0.36
DB01069	Promethazine	multiple sclerosis	69	-0.32
DB01069	Promethazine	mycobacterium infections	22	-0.32
DB01069	Promethazine	kidney diseases	144	-0.25
DB01069	Promethazine	diabetes mellitus type 2	72	-0.23
DB01069	Promethazine	skin diseases	278	-0.21
DB01069	Promethazine	lung diseases	71	-0.09
DB01069	Promethazine	breast neoplasms	40	-0.07
DB01069	Promethazine	autoimmune diseases	243	0.02
DB01069	Promethazine	varicose veins	20	0.02
DB01069	Promethazine	amyotrophic lateral sclerosis	21	0.04
DB01069	Promethazine	hematologic diseases	188	0.05
DB01069	Promethazine	motor neuron disease	31	0.20
DB01069	Promethazine	diabetes mellitus type 1	82	0.23
DB01069	Promethazine	cardiomyopathy dilated	29	0.23
DB01069	Promethazine	leukemia	117	0.24
DB01069	Promethazine	alzheimer disease	29	0.26
DB01069	Promethazine	gastrointestinal neoplasms	72	0.30
DB01069	Promethazine	asthma	36	0.32
DB01069	Promethazine	spinal cord diseases	59	0.40
DB01069	Promethazine	vascular diseases	181	0.42
DB01069	Promethazine	blood coagulation disorders	40	0.44
DB01069	Promethazine	eye diseases	231	0.44
DB01069	Promethazine	anemia hemolytic	29	0.45
DB01069	Promethazine	diabetes mellitus	162	0.45
DB01069	Promethazine	metabolism inborn errors	289	0.47
DB01069	Promethazine	bone diseases metabolic	27	0.50
DB01069	Promethazine	cardiovascular diseases	330	0.53
DB01069	Promethazine	kidney neoplasms	20	0.55
DB01069	Promethazine	hypersensitivity	45	0.59
DB01069	Promethazine	leukemia lymphoid	66	0.60
DB01069	Promethazine	lymphoma	24	0.61
DB01069	Promethazine	heart diseases	167	0.62
DB01069	Promethazine	lymphoma non hodgkin	22	0.67
DB01069	Promethazine	myocardial ischemia	43	0.68
DB01069	Promethazine	malabsorption syndromes	34	0.76
DB01069	Promethazine	keratosis	21	0.81
DB01069	Promethazine	arthritis rheumatoid	42	0.89
DB01069	Promethazine	colorectal neoplasms	42	0.89
DB01069	Promethazine	neoplasms	482	0.90
DB01069	Promethazine	intestinal neoplasms	42	0.90
DB01069	Promethazine	endocrine system diseases	291	0.91
DB01069	Promethazine	collagen diseases	25	1.03
DB01069	Promethazine	sarcoma	25	1.07
DB01069	Promethazine	anemia	58	1.18
DB01069	Promethazine	rheumatic diseases	59	1.39
DB01069	Promethazine	macular degeneration	44	1.44
DB01069	Promethazine	coronary artery disease	31	1.45
DB01069	Promethazine	coronary disease	37	1.72
DB01069	Promethazine	prostatic neoplasms	61	1.76
DB00046	Insulin.Lispro	hyperinsulinism	26	-4.10
DB00046	Insulin.Lispro	pancreatic diseases	24	-4.08
DB00046	Insulin.Lispro	insulin resistance	26	-3.92
DB00046	Insulin.Lispro	varicose veins	20	-3.71
DB00046	Insulin.Lispro	diabetes mellitus type 2	72	-3.34
DB00046	Insulin.Lispro	blood coagulation disorders	40	-2.76
DB00046	Insulin.Lispro	diabetes mellitus	162	-2.48
DB00046	Insulin.Lispro	skin diseases	278	-2.43
DB00046	Insulin.Lispro	endocrine system diseases	291	-2.14
DB00046	Insulin.Lispro	colitis ulcerative	55	-2.04
DB00046	Insulin.Lispro	colitis	55	-1.99
DB00046	Insulin.Lispro	arrhythmias cardiac	30	-1.78
DB00046	Insulin.Lispro	crohn disease	71	-1.67
DB00046	Insulin.Lispro	diabetes mellitus type 1	82	-1.64
DB00046	Insulin.Lispro	multiple sclerosis	69	-1.63
DB00046	Insulin.Lispro	bone diseases metabolic	27	-1.63
DB00046	Insulin.Lispro	collagen diseases	25	-1.51
DB00046	Insulin.Lispro	leukemia myeloid acute	43	-1.41
DB00046	Insulin.Lispro	malabsorption syndromes	34	-1.25
DB00046	Insulin.Lispro	gastroenteritis	122	-1.12
DB00046	Insulin.Lispro	thyroid diseases	30	-1.09
DB00046	Insulin.Lispro	inflammatory bowel diseases	119	-1.07
DB00046	Insulin.Lispro	heart diseases	167	-0.97
DB00046	Insulin.Lispro	vascular diseases	181	-0.67
DB00046	Insulin.Lispro	leukemia	117	-0.59
DB00046	Insulin.Lispro	hematologic diseases	188	-0.53
DB00046	Insulin.Lispro	autoimmune diseases	243	-0.51
DB00046	Insulin.Lispro	head and neck neoplasms	35	-0.35
DB00046	Insulin.Lispro	breast neoplasms	40	-0.27
DB00046	Insulin.Lispro	cardiovascular diseases	330	-0.22
DB00046	Insulin.Lispro	spinal cord diseases	59	-0.07
DB00046	Insulin.Lispro	lung diseases	71	0.03
DB00046	Insulin.Lispro	kidney diseases	144	0.21
DB00046	Insulin.Lispro	neoplasms	482	0.22
DB00046	Insulin.Lispro	epilepsy	25	0.36
DB00046	Insulin.Lispro	macular degeneration	44	0.38
DB00046	Insulin.Lispro	bone diseases	144	0.49
DB00046	Insulin.Lispro	coronary artery disease	31	0.50
DB00046	Insulin.Lispro	anemia hemolytic	29	0.51
DB00046	Insulin.Lispro	mycobacterium infections	22	0.54
DB00046	Insulin.Lispro	keratosis	21	0.55
DB00046	Insulin.Lispro	coronary disease	37	0.56
DB00046	Insulin.Lispro	myocardial ischemia	43	0.59
DB00046	Insulin.Lispro	parkinsonian disorders	31	0.64
DB00046	Insulin.Lispro	hypopigmentation	22	0.66
DB00046	Insulin.Lispro	arteriosclerosis	38	0.66
DB00046	Insulin.Lispro	parkinson disease	30	0.67
DB00046	Insulin.Lispro	bacterial infections	26	0.69
DB00046	Insulin.Lispro	kidney neoplasms	20	0.70
DB00046	Insulin.Lispro	asthma	36	0.72
DB00046	Insulin.Lispro	cardiomyopathy dilated	29	0.72
DB00046	Insulin.Lispro	liver cirrhosis	24	0.72
DB00046	Insulin.Lispro	arterial occlusive diseases	44	0.74
DB00046	Insulin.Lispro	liver cirrhosis biliary	23	0.77
DB00046	Insulin.Lispro	eye diseases	231	0.77
DB00046	Insulin.Lispro	alzheimer disease	29	0.78
DB00046	Insulin.Lispro	amyotrophic lateral sclerosis	21	0.78
DB00046	Insulin.Lispro	metabolism inborn errors	289	0.78
DB00046	Insulin.Lispro	neuroendocrine tumors	24	0.79
DB00046	Insulin.Lispro	hypersensitivity	45	0.81
DB00046	Insulin.Lispro	sarcoma	25	0.84
DB00046	Insulin.Lispro	lymphoma non hodgkin	22	0.90
DB00046	Insulin.Lispro	lymphoma	24	0.92
DB00046	Insulin.Lispro	dementia	42	0.95
DB00046	Insulin.Lispro	motor neuron disease	31	0.97
DB00046	Insulin.Lispro	psoriasis	54	1.00
DB00046	Insulin.Lispro	arthritis rheumatoid	42	1.00
DB00046	Insulin.Lispro	prostatic neoplasms	61	1.02
DB00046	Insulin.Lispro	adenocarcinoma	32	1.03
DB00046	Insulin.Lispro	lupus erythematosus systemic	75	1.09
DB00046	Insulin.Lispro	rheumatic diseases	59	1.14
DB00046	Insulin.Lispro	arthritis	76	1.30
DB00046	Insulin.Lispro	joint diseases	79	1.31
DB00046	Insulin.Lispro	colorectal neoplasms	42	1.33
DB00046	Insulin.Lispro	intestinal neoplasms	42	1.35
DB00046	Insulin.Lispro	anemia	58	1.43
DB00046	Insulin.Lispro	leukemia lymphoid	66	1.48
DB00046	Insulin.Lispro	gastrointestinal neoplasms	72	1.80
DB00286	Conjugated.Estrogens	cardiovascular diseases	330	-7.00
DB00286	Conjugated.Estrogens	skin diseases	278	-4.90
DB00286	Conjugated.Estrogens	heart diseases	167	-4.79
DB00286	Conjugated.Estrogens	breast neoplasms	40	-2.99
DB00286	Conjugated.Estrogens	neoplasms	482	-2.79
DB00286	Conjugated.Estrogens	coronary artery disease	31	-1.43
DB00286	Conjugated.Estrogens	myocardial ischemia	43	-1.21
DB00286	Conjugated.Estrogens	coronary disease	37	-1.21
DB00286	Conjugated.Estrogens	thyroid diseases	30	-1.14
DB00286	Conjugated.Estrogens	arteriosclerosis	38	-1.09
DB00286	Conjugated.Estrogens	cardiomyopathy dilated	29	-1.00
DB00286	Conjugated.Estrogens	alzheimer disease	29	-0.98
DB00286	Conjugated.Estrogens	arterial occlusive diseases	44	-0.96
DB00286	Conjugated.Estrogens	colitis ulcerative	55	-0.88
DB00286	Conjugated.Estrogens	colitis	55	-0.86
DB00286	Conjugated.Estrogens	diabetes mellitus type 2	72	-0.82
DB00286	Conjugated.Estrogens	kidney neoplasms	20	-0.81
DB00286	Conjugated.Estrogens	asthma	36	-0.70
DB00286	Conjugated.Estrogens	liver cirrhosis	24	-0.70
DB00286	Conjugated.Estrogens	neuroendocrine tumors	24	-0.68
DB00286	Conjugated.Estrogens	sarcoma	25	-0.68
DB00286	Conjugated.Estrogens	pancreatic diseases	24	-0.68
DB00286	Conjugated.Estrogens	dementia	42	-0.65
DB00286	Conjugated.Estrogens	liver cirrhosis biliary	23	-0.64
DB00286	Conjugated.Estrogens	hypersensitivity	45	-0.59
DB00286	Conjugated.Estrogens	diabetes mellitus type 1	82	-0.52
DB00286	Conjugated.Estrogens	head and neck neoplasms	35	-0.52
DB00286	Conjugated.Estrogens	lymphoma non hodgkin	22	-0.51
DB00286	Conjugated.Estrogens	lymphoma	24	-0.51
DB00286	Conjugated.Estrogens	motor neuron disease	31	-0.51
DB00286	Conjugated.Estrogens	prostatic neoplasms	61	-0.47
DB00286	Conjugated.Estrogens	adenocarcinoma	32	-0.43
DB00286	Conjugated.Estrogens	lupus erythematosus systemic	75	-0.42
DB00286	Conjugated.Estrogens	diabetes mellitus	162	-0.34
DB00286	Conjugated.Estrogens	crohn disease	71	-0.32
DB00286	Conjugated.Estrogens	multiple sclerosis	69	-0.32
DB00286	Conjugated.Estrogens	leukemia lymphoid	66	-0.25
DB00286	Conjugated.Estrogens	gastroenteritis	122	-0.25
DB00286	Conjugated.Estrogens	metabolism inborn errors	289	-0.24
DB00286	Conjugated.Estrogens	inflammatory bowel diseases	119	-0.23
DB00286	Conjugated.Estrogens	leukemia myeloid acute	43	-0.23
DB00286	Conjugated.Estrogens	kidney diseases	144	-0.22
DB00286	Conjugated.Estrogens	spinal cord diseases	59	-0.22
DB00286	Conjugated.Estrogens	colorectal neoplasms	42	-0.20
DB00286	Conjugated.Estrogens	intestinal neoplasms	42	-0.19
DB00286	Conjugated.Estrogens	lung diseases	71	-0.18
DB00286	Conjugated.Estrogens	anemia	58	-0.17
DB00286	Conjugated.Estrogens	gastrointestinal neoplasms	72	-0.09
DB00286	Conjugated.Estrogens	bone diseases	144	-0.01
DB00286	Conjugated.Estrogens	eye diseases	231	0.05
DB00286	Conjugated.Estrogens	vascular diseases	181	0.07
DB00286	Conjugated.Estrogens	endocrine system diseases	291	0.16
DB00286	Conjugated.Estrogens	autoimmune diseases	243	0.18
DB00286	Conjugated.Estrogens	leukemia	117	0.18
DB00286	Conjugated.Estrogens	hematologic diseases	188	0.19
DB00286	Conjugated.Estrogens	arrhythmias cardiac	30	0.44
DB00286	Conjugated.Estrogens	collagen diseases	25	0.52
DB00286	Conjugated.Estrogens	varicose veins	20	0.53
DB00286	Conjugated.Estrogens	macular degeneration	44	0.54
DB00286	Conjugated.Estrogens	epilepsy	25	0.57
DB00286	Conjugated.Estrogens	bone diseases metabolic	27	0.58
DB00286	Conjugated.Estrogens	parkinsonian disorders	31	0.65
DB00286	Conjugated.Estrogens	parkinson disease	30	0.67
DB00286	Conjugated.Estrogens	insulin resistance	26	0.67
DB00286	Conjugated.Estrogens	hyperinsulinism	26	0.68
DB00286	Conjugated.Estrogens	anemia hemolytic	29	0.76
DB00286	Conjugated.Estrogens	keratosis	21	0.83
DB00286	Conjugated.Estrogens	malabsorption syndromes	34	0.97
DB00286	Conjugated.Estrogens	blood coagulation disorders	40	0.98
DB00286	Conjugated.Estrogens	hypopigmentation	22	1.02
DB00286	Conjugated.Estrogens	amyotrophic lateral sclerosis	21	1.08
DB00286	Conjugated.Estrogens	mycobacterium infections	22	1.10
DB00286	Conjugated.Estrogens	bacterial infections	26	1.26
DB00286	Conjugated.Estrogens	psoriasis	54	1.76
DB00286	Conjugated.Estrogens	arthritis rheumatoid	42	2.00
DB00286	Conjugated.Estrogens	rheumatic diseases	59	2.33
DB00286	Conjugated.Estrogens	arthritis	76	2.87
DB00286	Conjugated.Estrogens	joint diseases	79	3.01
DB00284	Acarbose	diabetes mellitus type 1	82	-3.53
DB00284	Acarbose	metabolism inborn errors	289	-3.33
DB00284	Acarbose	malabsorption syndromes	34	-3.23
DB00284	Acarbose	alzheimer disease	29	-3.15
DB00284	Acarbose	diabetes mellitus	162	-3.15
DB00284	Acarbose	dementia	42	-2.76
DB00284	Acarbose	bone diseases metabolic	27	-2.55
DB00284	Acarbose	autoimmune diseases	243	-2.44
DB00284	Acarbose	parkinson disease	30	-2.41
DB00284	Acarbose	parkinsonian disorders	31	-2.29
DB00284	Acarbose	endocrine system diseases	291	-2.18
DB00284	Acarbose	bone diseases	144	-2.00
DB00284	Acarbose	diabetes mellitus type 2	72	-1.69
DB00284	Acarbose	prostatic neoplasms	61	-1.62
DB00284	Acarbose	hematologic diseases	188	-1.39
DB00284	Acarbose	kidney diseases	144	-1.06
DB00284	Acarbose	lymphoma	24	-1.00
DB00284	Acarbose	lymphoma non hodgkin	22	-0.94
DB00284	Acarbose	arthritis rheumatoid	42	-0.83
DB00284	Acarbose	rheumatic diseases	59	-0.58
DB00284	Acarbose	lupus erythematosus systemic	75	-0.48
DB00284	Acarbose	joint diseases	79	-0.38
DB00284	Acarbose	arthritis	76	-0.37
DB00284	Acarbose	leukemia lymphoid	66	-0.24
DB00284	Acarbose	epilepsy	25	0.01
DB00284	Acarbose	hyperinsulinism	26	0.09
DB00284	Acarbose	insulin resistance	26	0.11
DB00284	Acarbose	arrhythmias cardiac	30	0.12
DB00284	Acarbose	heart diseases	167	0.17
DB00284	Acarbose	collagen diseases	25	0.19
DB00284	Acarbose	leukemia	117	0.34
DB00284	Acarbose	keratosis	21	0.36
DB00284	Acarbose	thyroid diseases	30	0.48
DB00284	Acarbose	kidney neoplasms	20	0.52
DB00284	Acarbose	anemia hemolytic	29	0.53
DB00284	Acarbose	neoplasms	482	0.59
DB00284	Acarbose	liver cirrhosis biliary	23	0.67
DB00284	Acarbose	liver cirrhosis	24	0.68
DB00284	Acarbose	pancreatic diseases	24	0.70
DB00284	Acarbose	varicose veins	20	0.74
DB00284	Acarbose	neuroendocrine tumors	24	0.76
DB00284	Acarbose	asthma	36	0.78
DB00284	Acarbose	cardiomyopathy dilated	29	0.81
DB00284	Acarbose	sarcoma	25	0.85
DB00284	Acarbose	cardiovascular diseases	330	0.90
DB00284	Acarbose	arterial occlusive diseases	44	0.95
DB00284	Acarbose	hypersensitivity	45	0.99
DB00284	Acarbose	blood coagulation disorders	40	1.08
DB00284	Acarbose	motor neuron disease	31	1.10
DB00284	Acarbose	head and neck neoplasms	35	1.19
DB00284	Acarbose	adenocarcinoma	32	1.23
DB00284	Acarbose	colitis	55	1.26
DB00284	Acarbose	coronary artery disease	31	1.28
DB00284	Acarbose	colitis ulcerative	55	1.33
DB00284	Acarbose	macular degeneration	44	1.35
DB00284	Acarbose	breast neoplasms	40	1.39
DB00284	Acarbose	bacterial infections	26	1.52
DB00284	Acarbose	hypopigmentation	22	1.53
DB00284	Acarbose	coronary disease	37	1.53
DB00284	Acarbose	multiple sclerosis	69	1.60
DB00284	Acarbose	amyotrophic lateral sclerosis	21	1.62
DB00284	Acarbose	colorectal neoplasms	42	1.62
DB00284	Acarbose	leukemia myeloid acute	43	1.63
DB00284	Acarbose	myocardial ischemia	43	1.65
DB00284	Acarbose	intestinal neoplasms	42	1.66
DB00284	Acarbose	crohn disease	71	1.67
DB00284	Acarbose	arteriosclerosis	38	1.72
DB00284	Acarbose	spinal cord diseases	59	1.74
DB00284	Acarbose	lung diseases	71	1.76
DB00284	Acarbose	anemia	58	1.81
DB00284	Acarbose	inflammatory bowel diseases	119	2.01
DB00284	Acarbose	gastroenteritis	122	2.03
DB00284	Acarbose	gastrointestinal neoplasms	72	2.10
DB00284	Acarbose	mycobacterium infections	22	2.17
DB00284	Acarbose	eye diseases	231	2.34
DB00284	Acarbose	psoriasis	54	2.41
DB00284	Acarbose	vascular diseases	181	2.43
DB00284	Acarbose	skin diseases	278	2.73
DB00282	Pamidronate	spinal cord diseases	59	-2.34
DB00282	Pamidronate	bone diseases	144	-2.08
DB00282	Pamidronate	endocrine system diseases	291	-1.62
DB00282	Pamidronate	hematologic diseases	188	-1.60
DB00282	Pamidronate	varicose veins	20	-0.84
DB00282	Pamidronate	epilepsy	25	-0.80
DB00282	Pamidronate	keratosis	21	-0.71
DB00282	Pamidronate	mycobacterium infections	22	-0.65
DB00282	Pamidronate	coronary artery disease	31	-0.62
DB00282	Pamidronate	bacterial infections	26	-0.55
DB00282	Pamidronate	macular degeneration	44	-0.55
DB00282	Pamidronate	thyroid diseases	30	-0.55
DB00282	Pamidronate	parkinsonian disorders	31	-0.53
DB00282	Pamidronate	coronary disease	37	-0.52
DB00282	Pamidronate	amyotrophic lateral sclerosis	21	-0.50
DB00282	Pamidronate	liver cirrhosis biliary	23	-0.49
DB00282	Pamidronate	myocardial ischemia	43	-0.49
DB00282	Pamidronate	parkinson disease	30	-0.48
DB00282	Pamidronate	malabsorption syndromes	34	-0.48
DB00282	Pamidronate	liver cirrhosis	24	-0.47
DB00282	Pamidronate	alzheimer disease	29	-0.45
DB00282	Pamidronate	sarcoma	25	-0.41
DB00282	Pamidronate	cardiomyopathy dilated	29	-0.39
DB00282	Pamidronate	arteriosclerosis	38	-0.39
DB00282	Pamidronate	asthma	36	-0.36
DB00282	Pamidronate	lymphoma	24	-0.34
DB00282	Pamidronate	motor neuron disease	31	-0.33
DB00282	Pamidronate	lymphoma non hodgkin	22	-0.32
DB00282	Pamidronate	blood coagulation disorders	40	-0.28
DB00282	Pamidronate	head and neck neoplasms	35	-0.26
DB00282	Pamidronate	hypersensitivity	45	-0.25
DB00282	Pamidronate	arterial occlusive diseases	44	-0.25
DB00282	Pamidronate	colitis ulcerative	55	-0.24
DB00282	Pamidronate	dementia	42	-0.24
DB00282	Pamidronate	adenocarcinoma	32	-0.23
DB00282	Pamidronate	breast neoplasms	40	-0.22
DB00282	Pamidronate	arthritis rheumatoid	42	-0.21
DB00282	Pamidronate	diabetes mellitus type 2	72	-0.20
DB00282	Pamidronate	colitis	55	-0.19
DB00282	Pamidronate	prostatic neoplasms	61	-0.19
DB00282	Pamidronate	psoriasis	54	-0.17
DB00282	Pamidronate	diabetes mellitus type 1	82	-0.12
DB00282	Pamidronate	rheumatic diseases	59	-0.11
DB00282	Pamidronate	intestinal neoplasms	42	-0.11
DB00282	Pamidronate	lupus erythematosus systemic	75	-0.09
DB00282	Pamidronate	colorectal neoplasms	42	-0.08
DB00282	Pamidronate	multiple sclerosis	69	-0.07
DB00282	Pamidronate	leukemia myeloid acute	43	-0.05
DB00282	Pamidronate	joint diseases	79	-0.01
DB00282	Pamidronate	crohn disease	71	0.00
DB00282	Pamidronate	lung diseases	71	0.01
DB00282	Pamidronate	arthritis	76	0.02
DB00282	Pamidronate	anemia	58	0.02
DB00282	Pamidronate	leukemia lymphoid	66	0.07
DB00282	Pamidronate	gastrointestinal neoplasms	72	0.14
DB00282	Pamidronate	gastroenteritis	122	0.16
DB00282	Pamidronate	inflammatory bowel diseases	119	0.17
DB00282	Pamidronate	kidney diseases	144	0.19
DB00282	Pamidronate	diabetes mellitus	162	0.24
DB00282	Pamidronate	heart diseases	167	0.31
DB00282	Pamidronate	leukemia	117	0.32
DB00282	Pamidronate	eye diseases	231	0.36
DB00282	Pamidronate	vascular diseases	181	0.37
DB00282	Pamidronate	autoimmune diseases	243	0.44
DB00282	Pamidronate	metabolism inborn errors	289	0.44
DB00282	Pamidronate	skin diseases	278	0.51
DB00282	Pamidronate	cardiovascular diseases	330	0.57
DB00282	Pamidronate	neoplasms	482	0.83
DB00282	Pamidronate	hyperinsulinism	26	1.14
DB00282	Pamidronate	arrhythmias cardiac	30	1.15
DB00282	Pamidronate	insulin resistance	26	1.17
DB00282	Pamidronate	collagen diseases	25	1.19
DB00282	Pamidronate	bone diseases metabolic	27	1.21
DB00282	Pamidronate	kidney neoplasms	20	1.36
DB00282	Pamidronate	anemia hemolytic	29	1.41
DB00282	Pamidronate	hypopigmentation	22	1.46
DB00282	Pamidronate	pancreatic diseases	24	1.47
DB00282	Pamidronate	neuroendocrine tumors	24	1.61
DB00281	Lidocaine	cardiomyopathy dilated	29	-3.73
DB00281	Lidocaine	arrhythmias cardiac	30	-3.25
DB00281	Lidocaine	heart diseases	167	-2.65
DB00281	Lidocaine	cardiovascular diseases	330	-2.04
DB00281	Lidocaine	parkinson disease	30	-1.78
DB00281	Lidocaine	thyroid diseases	30	-1.74
DB00281	Lidocaine	lung diseases	71	-1.74
DB00281	Lidocaine	parkinsonian disorders	31	-1.73
DB00281	Lidocaine	coronary disease	37	-1.65
DB00281	Lidocaine	mycobacterium infections	22	-1.61
DB00281	Lidocaine	myocardial ischemia	43	-1.57
DB00281	Lidocaine	arteriosclerosis	38	-1.52
DB00281	Lidocaine	kidney neoplasms	20	-1.48
DB00281	Lidocaine	bacterial infections	26	-1.39
DB00281	Lidocaine	alzheimer disease	29	-1.37
DB00281	Lidocaine	arterial occlusive diseases	44	-1.29
DB00281	Lidocaine	neoplasms	482	-1.29
DB00281	Lidocaine	asthma	36	-1.22
DB00281	Lidocaine	leukemia	117	-1.20
DB00281	Lidocaine	colitis ulcerative	55	-1.15
DB00281	Lidocaine	varicose veins	20	-1.12
DB00281	Lidocaine	colitis	55	-1.05
DB00281	Lidocaine	head and neck neoplasms	35	-1.04
DB00281	Lidocaine	hypersensitivity	45	-0.99
DB00281	Lidocaine	dementia	42	-0.99
DB00281	Lidocaine	motor neuron disease	31	-0.99
DB00281	Lidocaine	adenocarcinoma	32	-0.92
DB00281	Lidocaine	endocrine system diseases	291	-0.89
DB00281	Lidocaine	hematologic diseases	188	-0.88
DB00281	Lidocaine	hyperinsulinism	26	-0.75
DB00281	Lidocaine	diabetes mellitus type 1	82	-0.75
DB00281	Lidocaine	prostatic neoplasms	61	-0.75
DB00281	Lidocaine	breast neoplasms	40	-0.75
DB00281	Lidocaine	insulin resistance	26	-0.74
DB00281	Lidocaine	macular degeneration	44	-0.72
DB00281	Lidocaine	lupus erythematosus systemic	75	-0.72
DB00281	Lidocaine	leukemia myeloid acute	43	-0.67
DB00281	Lidocaine	coronary artery disease	31	-0.64
DB00281	Lidocaine	keratosis	21	-0.63
DB00281	Lidocaine	intestinal neoplasms	42	-0.60
DB00281	Lidocaine	crohn disease	71	-0.57
DB00281	Lidocaine	arthritis	76	-0.56
DB00281	Lidocaine	colorectal neoplasms	42	-0.56
DB00281	Lidocaine	joint diseases	79	-0.53
DB00281	Lidocaine	anemia hemolytic	29	-0.50
DB00281	Lidocaine	spinal cord diseases	59	-0.48
DB00281	Lidocaine	leukemia lymphoid	66	-0.47
DB00281	Lidocaine	anemia	58	-0.43
DB00281	Lidocaine	kidney diseases	144	-0.28
DB00281	Lidocaine	malabsorption syndromes	34	-0.26
DB00281	Lidocaine	inflammatory bowel diseases	119	-0.24
DB00281	Lidocaine	amyotrophic lateral sclerosis	21	-0.22
DB00281	Lidocaine	blood coagulation disorders	40	-0.20
DB00281	Lidocaine	gastrointestinal neoplasms	72	-0.20
DB00281	Lidocaine	gastroenteritis	122	-0.17
DB00281	Lidocaine	diabetes mellitus	162	-0.15
DB00281	Lidocaine	neuroendocrine tumors	24	-0.03
DB00281	Lidocaine	bone diseases	144	-0.02
DB00281	Lidocaine	vascular diseases	181	0.12
DB00281	Lidocaine	metabolism inborn errors	289	0.14
DB00281	Lidocaine	eye diseases	231	0.17
DB00281	Lidocaine	lymphoma non hodgkin	22	0.18
DB00281	Lidocaine	epilepsy	25	0.19
DB00281	Lidocaine	diabetes mellitus type 2	72	0.20
DB00281	Lidocaine	lymphoma	24	0.22
DB00281	Lidocaine	autoimmune diseases	243	0.29
DB00281	Lidocaine	bone diseases metabolic	27	0.33
DB00281	Lidocaine	arthritis rheumatoid	42	0.34
DB00281	Lidocaine	psoriasis	54	0.41
DB00281	Lidocaine	skin diseases	278	0.49
DB00281	Lidocaine	rheumatic diseases	59	0.59
DB00281	Lidocaine	multiple sclerosis	69	0.75
DB00281	Lidocaine	hypopigmentation	22	0.79
DB00281	Lidocaine	liver cirrhosis	24	1.00
DB00281	Lidocaine	liver cirrhosis biliary	23	1.08
DB00281	Lidocaine	pancreatic diseases	24	1.08
DB00281	Lidocaine	sarcoma	25	1.17
DB00281	Lidocaine	collagen diseases	25	1.44
DB00280	Disopyramide	thyroid diseases	30	-0.81
DB00280	Disopyramide	cardiomyopathy dilated	29	-0.54
DB00280	Disopyramide	asthma	36	-0.50
DB00280	Disopyramide	lung diseases	71	-0.32
DB00280	Disopyramide	hypersensitivity	45	-0.22
DB00280	Disopyramide	dementia	42	-0.05
DB00280	Disopyramide	epilepsy	25	0.09
DB00280	Disopyramide	liver cirrhosis	24	0.12
DB00280	Disopyramide	liver cirrhosis biliary	23	0.14
DB00280	Disopyramide	pancreatic diseases	24	0.14
DB00280	Disopyramide	hyperinsulinism	26	0.22
DB00280	Disopyramide	insulin resistance	26	0.24
DB00280	Disopyramide	arrhythmias cardiac	30	0.25
DB00280	Disopyramide	heart diseases	167	0.30
DB00280	Disopyramide	bone diseases metabolic	27	0.33
DB00280	Disopyramide	cardiovascular diseases	330	0.38
DB00280	Disopyramide	arterial occlusive diseases	44	0.46
DB00280	Disopyramide	colitis ulcerative	55	0.75
DB00280	Disopyramide	head and neck neoplasms	35	0.77
DB00280	Disopyramide	colitis	55	0.79
DB00280	Disopyramide	bacterial infections	26	0.80
DB00280	Disopyramide	parkinson disease	30	0.90
DB00280	Disopyramide	parkinsonian disorders	31	0.91
DB00280	Disopyramide	psoriasis	54	0.97
DB00280	Disopyramide	neuroendocrine tumors	24	0.98
DB00280	Disopyramide	arteriosclerosis	38	1.04
DB00280	Disopyramide	skin diseases	278	1.07
DB00280	Disopyramide	alzheimer disease	29	1.11
DB00280	Disopyramide	lupus erythematosus systemic	75	1.11
DB00280	Disopyramide	leukemia myeloid acute	43	1.19
DB00280	Disopyramide	diabetes mellitus type 1	82	1.21
DB00280	Disopyramide	crohn disease	71	1.22
DB00280	Disopyramide	lymphoma	24	1.25
DB00280	Disopyramide	mycobacterium infections	22	1.28
DB00280	Disopyramide	leukemia	117	1.29
DB00280	Disopyramide	keratosis	21	1.29
DB00280	Disopyramide	lymphoma non hodgkin	22	1.31
DB00280	Disopyramide	eye diseases	231	1.31
DB00280	Disopyramide	joint diseases	79	1.38
DB00280	Disopyramide	arthritis	76	1.44
DB00280	Disopyramide	varicose veins	20	1.48
DB00280	Disopyramide	leukemia lymphoid	66	1.48
DB00280	Disopyramide	kidney neoplasms	20	1.51
DB00280	Disopyramide	adenocarcinoma	32	1.53
DB00280	Disopyramide	anemia hemolytic	29	1.61
DB00280	Disopyramide	inflammatory bowel diseases	119	1.64
DB00280	Disopyramide	hematologic diseases	188	1.65
DB00280	Disopyramide	gastroenteritis	122	1.71
DB00280	Disopyramide	endocrine system diseases	291	1.72
DB00280	Disopyramide	amyotrophic lateral sclerosis	21	1.74
DB00280	Disopyramide	malabsorption syndromes	34	1.78
DB00280	Disopyramide	kidney diseases	144	1.79
DB00280	Disopyramide	myocardial ischemia	43	1.81
DB00280	Disopyramide	gastrointestinal neoplasms	72	1.82
DB00280	Disopyramide	diabetes mellitus	162	1.85
DB00280	Disopyramide	diabetes mellitus type 2	72	1.88
DB00280	Disopyramide	bone diseases	144	1.89
DB00280	Disopyramide	neoplasms	482	1.89
DB00280	Disopyramide	multiple sclerosis	69	1.98
DB00280	Disopyramide	sarcoma	25	2.02
DB00280	Disopyramide	colorectal neoplasms	42	2.07
DB00280	Disopyramide	intestinal neoplasms	42	2.11
DB00280	Disopyramide	spinal cord diseases	59	2.11
DB00280	Disopyramide	metabolism inborn errors	289	2.17
DB00280	Disopyramide	blood coagulation disorders	40	2.17
DB00280	Disopyramide	vascular diseases	181	2.20
DB00280	Disopyramide	anemia	58	2.28
DB00280	Disopyramide	motor neuron disease	31	2.34
DB00280	Disopyramide	autoimmune diseases	243	2.35
DB00280	Disopyramide	hypopigmentation	22	2.41
DB00280	Disopyramide	collagen diseases	25	2.57
DB00280	Disopyramide	prostatic neoplasms	61	2.66
DB00280	Disopyramide	breast neoplasms	40	2.77
DB00280	Disopyramide	macular degeneration	44	2.87
DB00280	Disopyramide	coronary disease	37	3.09
DB00280	Disopyramide	arthritis rheumatoid	42	3.09
DB00280	Disopyramide	coronary artery disease	31	3.57
DB00280	Disopyramide	rheumatic diseases	59	3.69
DB02300	Calcipotriol	bone diseases metabolic	27	-4.00
DB02300	Calcipotriol	kidney diseases	144	-2.68
DB02300	Calcipotriol	bone diseases	144	-2.60
DB02300	Calcipotriol	metabolism inborn errors	289	-2.57
DB02300	Calcipotriol	coronary artery disease	31	-2.37
DB02300	Calcipotriol	myocardial ischemia	43	-2.31
DB02300	Calcipotriol	coronary disease	37	-2.24
DB02300	Calcipotriol	mycobacterium infections	22	-2.07
DB02300	Calcipotriol	arteriosclerosis	38	-2.00
DB02300	Calcipotriol	bacterial infections	26	-1.90
DB02300	Calcipotriol	arterial occlusive diseases	44	-1.78
DB02300	Calcipotriol	asthma	36	-1.77
DB02300	Calcipotriol	neuroendocrine tumors	24	-1.71
DB02300	Calcipotriol	hypersensitivity	45	-1.65
DB02300	Calcipotriol	sarcoma	25	-1.56
DB02300	Calcipotriol	adenocarcinoma	32	-1.42
DB02300	Calcipotriol	colitis ulcerative	55	-1.33
DB02300	Calcipotriol	colitis	55	-1.25
DB02300	Calcipotriol	diabetes mellitus type 1	82	-1.25
DB02300	Calcipotriol	head and neck neoplasms	35	-1.24
DB02300	Calcipotriol	colorectal neoplasms	42	-1.12
DB02300	Calcipotriol	intestinal neoplasms	42	-1.08
DB02300	Calcipotriol	lung diseases	71	-0.99
DB02300	Calcipotriol	crohn disease	71	-0.97
DB02300	Calcipotriol	leukemia lymphoid	66	-0.89
DB02300	Calcipotriol	leukemia myeloid acute	43	-0.83
DB02300	Calcipotriol	gastrointestinal neoplasms	72	-0.82
DB02300	Calcipotriol	heart diseases	167	-0.78
DB02300	Calcipotriol	gastroenteritis	122	-0.70
DB02300	Calcipotriol	eye diseases	231	-0.67
DB02300	Calcipotriol	inflammatory bowel diseases	119	-0.65
DB02300	Calcipotriol	vascular diseases	181	-0.59
DB02300	Calcipotriol	diabetes mellitus	162	-0.57
DB02300	Calcipotriol	leukemia	117	-0.33
DB02300	Calcipotriol	cardiovascular diseases	330	-0.31
DB02300	Calcipotriol	autoimmune diseases	243	-0.30
DB02300	Calcipotriol	hematologic diseases	188	-0.26
DB02300	Calcipotriol	endocrine system diseases	291	-0.09
DB02300	Calcipotriol	skin diseases	278	-0.08
DB02300	Calcipotriol	arrhythmias cardiac	30	0.02
DB02300	Calcipotriol	varicose veins	20	0.02
DB02300	Calcipotriol	hyperinsulinism	26	0.06
DB02300	Calcipotriol	macular degeneration	44	0.09
DB02300	Calcipotriol	insulin resistance	26	0.10
DB02300	Calcipotriol	collagen diseases	25	0.11
DB02300	Calcipotriol	epilepsy	25	0.14
DB02300	Calcipotriol	neoplasms	482	0.23
DB02300	Calcipotriol	anemia hemolytic	29	0.27
DB02300	Calcipotriol	keratosis	21	0.27
DB02300	Calcipotriol	parkinsonian disorders	31	0.30
DB02300	Calcipotriol	parkinson disease	30	0.31
DB02300	Calcipotriol	hypopigmentation	22	0.34
DB02300	Calcipotriol	malabsorption syndromes	34	0.35
DB02300	Calcipotriol	cardiomyopathy dilated	29	0.42
DB02300	Calcipotriol	alzheimer disease	29	0.44
DB02300	Calcipotriol	thyroid diseases	30	0.44
DB02300	Calcipotriol	kidney neoplasms	20	0.46
DB02300	Calcipotriol	pancreatic diseases	24	0.46
DB02300	Calcipotriol	blood coagulation disorders	40	0.50
DB02300	Calcipotriol	amyotrophic lateral sclerosis	21	0.51
DB02300	Calcipotriol	liver cirrhosis	24	0.52
DB02300	Calcipotriol	liver cirrhosis biliary	23	0.55
DB02300	Calcipotriol	lymphoma non hodgkin	22	0.64
DB02300	Calcipotriol	dementia	42	0.65
DB02300	Calcipotriol	arthritis rheumatoid	42	0.67
DB02300	Calcipotriol	lymphoma	24	0.67
DB02300	Calcipotriol	prostatic neoplasms	61	0.70
DB02300	Calcipotriol	motor neuron disease	31	0.70
DB02300	Calcipotriol	psoriasis	54	0.75
DB02300	Calcipotriol	lupus erythematosus systemic	75	0.77
DB02300	Calcipotriol	diabetes mellitus type 2	72	0.79
DB02300	Calcipotriol	rheumatic diseases	59	0.81
DB02300	Calcipotriol	breast neoplasms	40	0.83
DB02300	Calcipotriol	multiple sclerosis	69	0.89
DB02300	Calcipotriol	joint diseases	79	0.92
DB02300	Calcipotriol	arthritis	76	0.94
DB02300	Calcipotriol	spinal cord diseases	59	0.95
DB02300	Calcipotriol	anemia	58	1.10
DB00564	Carbamazepine	cardiomyopathy dilated	29	-4.63
DB00564	Carbamazepine	arrhythmias cardiac	30	-3.98
DB00564	Carbamazepine	heart diseases	167	-3.82
DB00564	Carbamazepine	cardiovascular diseases	330	-2.77
DB00564	Carbamazepine	thyroid diseases	30	-2.52
DB00564	Carbamazepine	leukemia	117	-1.50
DB00564	Carbamazepine	endocrine system diseases	291	-1.21
DB00564	Carbamazepine	hematologic diseases	188	-1.16
DB00564	Carbamazepine	neoplasms	482	-0.59
DB00564	Carbamazepine	varicose veins	20	-0.55
DB00564	Carbamazepine	epilepsy	25	-0.48
DB00564	Carbamazepine	hyperinsulinism	26	-0.48
DB00564	Carbamazepine	insulin resistance	26	-0.47
DB00564	Carbamazepine	mycobacterium infections	22	-0.37
DB00564	Carbamazepine	keratosis	21	-0.35
DB00564	Carbamazepine	macular degeneration	44	-0.35
DB00564	Carbamazepine	bone diseases metabolic	27	-0.34
DB00564	Carbamazepine	hypopigmentation	22	-0.22
DB00564	Carbamazepine	malabsorption syndromes	34	-0.22
DB00564	Carbamazepine	parkinson disease	30	-0.22
DB00564	Carbamazepine	parkinsonian disorders	31	-0.22
DB00564	Carbamazepine	kidney neoplasms	20	-0.22
DB00564	Carbamazepine	myocardial ischemia	43	-0.21
DB00564	Carbamazepine	bacterial infections	26	-0.21
DB00564	Carbamazepine	amyotrophic lateral sclerosis	21	-0.20
DB00564	Carbamazepine	liver cirrhosis	24	-0.19
DB00564	Carbamazepine	asthma	36	-0.18
DB00564	Carbamazepine	pancreatic diseases	24	-0.18
DB00564	Carbamazepine	anemia hemolytic	29	-0.18
DB00564	Carbamazepine	arteriosclerosis	38	-0.15
DB00564	Carbamazepine	coronary disease	37	-0.15
DB00564	Carbamazepine	neuroendocrine tumors	24	-0.15
DB00564	Carbamazepine	liver cirrhosis biliary	23	-0.12
DB00564	Carbamazepine	lymphoma	24	-0.10
DB00564	Carbamazepine	alzheimer disease	29	-0.10
DB00564	Carbamazepine	lymphoma non hodgkin	22	-0.07
DB00564	Carbamazepine	arterial occlusive diseases	44	-0.07
DB00564	Carbamazepine	blood coagulation disorders	40	-0.05
DB00564	Carbamazepine	arthritis rheumatoid	42	-0.04
DB00564	Carbamazepine	hypersensitivity	45	-0.02
DB00564	Carbamazepine	head and neck neoplasms	35	0.00
DB00564	Carbamazepine	sarcoma	25	0.00
DB00564	Carbamazepine	colitis	55	0.02
DB00564	Carbamazepine	motor neuron disease	31	0.03
DB00564	Carbamazepine	adenocarcinoma	32	0.05
DB00564	Carbamazepine	colitis ulcerative	55	0.06
DB00564	Carbamazepine	prostatic neoplasms	61	0.10
DB00564	Carbamazepine	dementia	42	0.11
DB00564	Carbamazepine	breast neoplasms	40	0.11
DB00564	Carbamazepine	rheumatic diseases	59	0.13
DB00564	Carbamazepine	diabetes mellitus type 2	72	0.14
DB00564	Carbamazepine	lupus erythematosus systemic	75	0.17
DB00564	Carbamazepine	diabetes mellitus type 1	82	0.18
DB00564	Carbamazepine	psoriasis	54	0.18
DB00564	Carbamazepine	leukemia myeloid acute	43	0.21
DB00564	Carbamazepine	intestinal neoplasms	42	0.22
DB00564	Carbamazepine	multiple sclerosis	69	0.23
DB00564	Carbamazepine	colorectal neoplasms	42	0.24
DB00564	Carbamazepine	crohn disease	71	0.25
DB00564	Carbamazepine	joint diseases	79	0.26
DB00564	Carbamazepine	arthritis	76	0.28
DB00564	Carbamazepine	lung diseases	71	0.29
DB00564	Carbamazepine	spinal cord diseases	59	0.30
DB00564	Carbamazepine	anemia	58	0.30
DB00564	Carbamazepine	leukemia lymphoid	66	0.33
DB00564	Carbamazepine	gastroenteritis	122	0.37
DB00564	Carbamazepine	inflammatory bowel diseases	119	0.37
DB00564	Carbamazepine	kidney diseases	144	0.38
DB00564	Carbamazepine	gastrointestinal neoplasms	72	0.42
DB00564	Carbamazepine	bone diseases	144	0.42
DB00564	Carbamazepine	diabetes mellitus	162	0.43
DB00564	Carbamazepine	eye diseases	231	0.54
DB00564	Carbamazepine	vascular diseases	181	0.55
DB00564	Carbamazepine	metabolism inborn errors	289	0.57
DB00564	Carbamazepine	autoimmune diseases	243	0.66
DB00564	Carbamazepine	skin diseases	278	0.76
DB00564	Carbamazepine	collagen diseases	25	1.62
DB00564	Carbamazepine	coronary artery disease	31	1.73
DB00680	Moricizine	cardiomyopathy dilated	29	-4.82
DB00680	Moricizine	arrhythmias cardiac	30	-4.04
DB00680	Moricizine	heart diseases	167	-3.57
DB00680	Moricizine	thyroid diseases	30	-2.76
DB00680	Moricizine	cardiovascular diseases	330	-2.69
DB00680	Moricizine	leukemia	117	-1.27
DB00680	Moricizine	endocrine system diseases	291	-1.24
DB00680	Moricizine	hematologic diseases	188	-1.17
DB00680	Moricizine	varicose veins	20	-0.56
DB00680	Moricizine	neoplasms	482	-0.55
DB00680	Moricizine	epilepsy	25	-0.50
DB00680	Moricizine	insulin resistance	26	-0.45
DB00680	Moricizine	hyperinsulinism	26	-0.41
DB00680	Moricizine	mycobacterium infections	22	-0.36
DB00680	Moricizine	bone diseases metabolic	27	-0.36
DB00680	Moricizine	macular degeneration	44	-0.34
DB00680	Moricizine	keratosis	21	-0.32
DB00680	Moricizine	parkinson disease	30	-0.27
DB00680	Moricizine	bacterial infections	26	-0.25
DB00680	Moricizine	parkinsonian disorders	31	-0.23
DB00680	Moricizine	pancreatic diseases	24	-0.22
DB00680	Moricizine	malabsorption syndromes	34	-0.21
DB00680	Moricizine	kidney neoplasms	20	-0.21
DB00680	Moricizine	coronary disease	37	-0.21
DB00680	Moricizine	hypopigmentation	22	-0.20
DB00680	Moricizine	myocardial ischemia	43	-0.20
DB00680	Moricizine	amyotrophic lateral sclerosis	21	-0.17
DB00680	Moricizine	anemia hemolytic	29	-0.17
DB00680	Moricizine	liver cirrhosis biliary	23	-0.17
DB00680	Moricizine	liver cirrhosis	24	-0.14
DB00680	Moricizine	neuroendocrine tumors	24	-0.12
DB00680	Moricizine	alzheimer disease	29	-0.11
DB00680	Moricizine	asthma	36	-0.10
DB00680	Moricizine	arteriosclerosis	38	-0.09
DB00680	Moricizine	lymphoma non hodgkin	22	-0.08
DB00680	Moricizine	lymphoma	24	-0.07
DB00680	Moricizine	arterial occlusive diseases	44	-0.05
DB00680	Moricizine	blood coagulation disorders	40	-0.02
DB00680	Moricizine	sarcoma	25	-0.02
DB00680	Moricizine	hypersensitivity	45	-0.02
DB00680	Moricizine	arthritis rheumatoid	42	0.01
DB00680	Moricizine	colitis	55	0.03
DB00680	Moricizine	adenocarcinoma	32	0.05
DB00680	Moricizine	colitis ulcerative	55	0.05
DB00680	Moricizine	head and neck neoplasms	35	0.07
DB00680	Moricizine	motor neuron disease	31	0.09
DB00680	Moricizine	dementia	42	0.10
DB00680	Moricizine	rheumatic diseases	59	0.11
DB00680	Moricizine	psoriasis	54	0.13
DB00680	Moricizine	prostatic neoplasms	61	0.13
DB00680	Moricizine	breast neoplasms	40	0.13
DB00680	Moricizine	lupus erythematosus systemic	75	0.17
DB00680	Moricizine	diabetes mellitus type 2	72	0.19
DB00680	Moricizine	crohn disease	71	0.22
DB00680	Moricizine	multiple sclerosis	69	0.22
DB00680	Moricizine	diabetes mellitus type 1	82	0.23
DB00680	Moricizine	leukemia myeloid acute	43	0.24
DB00680	Moricizine	colorectal neoplasms	42	0.27
DB00680	Moricizine	intestinal neoplasms	42	0.28
DB00680	Moricizine	joint diseases	79	0.29
DB00680	Moricizine	spinal cord diseases	59	0.30
DB00680	Moricizine	lung diseases	71	0.31
DB00680	Moricizine	arthritis	76	0.32
DB00680	Moricizine	anemia	58	0.33
DB00680	Moricizine	leukemia lymphoid	66	0.33
DB00680	Moricizine	inflammatory bowel diseases	119	0.35
DB00680	Moricizine	kidney diseases	144	0.39
DB00680	Moricizine	gastroenteritis	122	0.40
DB00680	Moricizine	gastrointestinal neoplasms	72	0.40
DB00680	Moricizine	diabetes mellitus	162	0.43
DB00680	Moricizine	bone diseases	144	0.46
DB00680	Moricizine	vascular diseases	181	0.54
DB00680	Moricizine	eye diseases	231	0.56
DB00680	Moricizine	metabolism inborn errors	289	0.58
DB00680	Moricizine	autoimmune diseases	243	0.68
DB00680	Moricizine	skin diseases	278	0.80
DB00680	Moricizine	collagen diseases	25	1.72
DB00680	Moricizine	coronary artery disease	31	1.85
DB00563	Methotrexate	anemia	58	-4.57
DB00563	Methotrexate	hematologic diseases	188	-3.68
DB00563	Methotrexate	adenocarcinoma	32	-2.68
DB00563	Methotrexate	head and neck neoplasms	35	-2.68
DB00563	Methotrexate	spinal cord diseases	59	-2.37
DB00563	Methotrexate	gastrointestinal neoplasms	72	-2.29
DB00563	Methotrexate	lung diseases	71	-2.02
DB00563	Methotrexate	endocrine system diseases	291	-1.40
DB00563	Methotrexate	neoplasms	482	-0.80
DB00563	Methotrexate	arrhythmias cardiac	30	-0.65
DB00563	Methotrexate	insulin resistance	26	-0.63
DB00563	Methotrexate	epilepsy	25	-0.62
DB00563	Methotrexate	hyperinsulinism	26	-0.60
DB00563	Methotrexate	bone diseases metabolic	27	-0.58
DB00563	Methotrexate	collagen diseases	25	-0.56
DB00563	Methotrexate	mycobacterium infections	22	-0.50
DB00563	Methotrexate	coronary artery disease	31	-0.47
DB00563	Methotrexate	bacterial infections	26	-0.43
DB00563	Methotrexate	keratosis	21	-0.42
DB00563	Methotrexate	macular degeneration	44	-0.42
DB00563	Methotrexate	thyroid diseases	30	-0.41
DB00563	Methotrexate	anemia hemolytic	29	-0.40
DB00563	Methotrexate	coronary disease	37	-0.39
DB00563	Methotrexate	kidney neoplasms	20	-0.38
DB00563	Methotrexate	liver cirrhosis biliary	23	-0.38
DB00563	Methotrexate	hypopigmentation	22	-0.36
DB00563	Methotrexate	liver cirrhosis	24	-0.35
DB00563	Methotrexate	parkinsonian disorders	31	-0.35
DB00563	Methotrexate	amyotrophic lateral sclerosis	21	-0.34
DB00563	Methotrexate	pancreatic diseases	24	-0.33
DB00563	Methotrexate	arteriosclerosis	38	-0.32
DB00563	Methotrexate	sarcoma	25	-0.31
DB00563	Methotrexate	myocardial ischemia	43	-0.31
DB00563	Methotrexate	parkinson disease	30	-0.30
DB00563	Methotrexate	malabsorption syndromes	34	-0.30
DB00563	Methotrexate	alzheimer disease	29	-0.29
DB00563	Methotrexate	asthma	36	-0.26
DB00563	Methotrexate	neuroendocrine tumors	24	-0.24
DB00563	Methotrexate	blood coagulation disorders	40	-0.22
DB00563	Methotrexate	cardiomyopathy dilated	29	-0.20
DB00563	Methotrexate	hypersensitivity	45	-0.19
DB00563	Methotrexate	arterial occlusive diseases	44	-0.16
DB00563	Methotrexate	lymphoma non hodgkin	22	-0.15
DB00563	Methotrexate	motor neuron disease	31	-0.15
DB00563	Methotrexate	lymphoma	24	-0.11
DB00563	Methotrexate	breast neoplasms	40	-0.09
DB00563	Methotrexate	arthritis rheumatoid	42	-0.08
DB00563	Methotrexate	dementia	42	-0.08
DB00563	Methotrexate	colitis	55	-0.08
DB00563	Methotrexate	colitis ulcerative	55	-0.04
DB00563	Methotrexate	prostatic neoplasms	61	-0.03
DB00563	Methotrexate	psoriasis	54	-0.03
DB00563	Methotrexate	diabetes mellitus type 2	72	0.02
DB00563	Methotrexate	multiple sclerosis	69	0.04
DB00563	Methotrexate	rheumatic diseases	59	0.05
DB00563	Methotrexate	lupus erythematosus systemic	75	0.05
DB00563	Methotrexate	colorectal neoplasms	42	0.07
DB00563	Methotrexate	joint diseases	79	0.08
DB00563	Methotrexate	crohn disease	71	0.09
DB00563	Methotrexate	leukemia myeloid acute	43	0.10
DB00563	Methotrexate	diabetes mellitus type 1	82	0.11
DB00563	Methotrexate	intestinal neoplasms	42	0.15
DB00563	Methotrexate	leukemia lymphoid	66	0.16
DB00563	Methotrexate	arthritis	76	0.17
DB00563	Methotrexate	inflammatory bowel diseases	119	0.23
DB00563	Methotrexate	kidney diseases	144	0.24
DB00563	Methotrexate	gastroenteritis	122	0.26
DB00563	Methotrexate	diabetes mellitus	162	0.28
DB00563	Methotrexate	bone diseases	144	0.31
DB00563	Methotrexate	heart diseases	167	0.32
DB00563	Methotrexate	vascular diseases	181	0.40
DB00563	Methotrexate	eye diseases	231	0.43
DB00563	Methotrexate	leukemia	117	0.44
DB00563	Methotrexate	metabolism inborn errors	289	0.45
DB00563	Methotrexate	autoimmune diseases	243	0.55
DB00563	Methotrexate	skin diseases	278	0.56
DB00563	Methotrexate	cardiovascular diseases	330	0.63
DB00563	Methotrexate	varicose veins	20	1.28
DB00445	Epirubicin	kidney neoplasms	20	-1.56
DB00445	Epirubicin	cardiomyopathy dilated	29	-1.56
DB00445	Epirubicin	sarcoma	25	-1.50
DB00445	Epirubicin	pancreatic diseases	24	-1.48
DB00445	Epirubicin	arthritis rheumatoid	42	-1.20
DB00445	Epirubicin	lymphoma	24	-1.18
DB00445	Epirubicin	lymphoma non hodgkin	22	-1.14
DB00445	Epirubicin	head and neck neoplasms	35	-1.13
DB00445	Epirubicin	prostatic neoplasms	61	-1.03
DB00445	Epirubicin	adenocarcinoma	32	-1.01
DB00445	Epirubicin	breast neoplasms	40	-0.98
DB00445	Epirubicin	rheumatic diseases	59	-0.93
DB00445	Epirubicin	intestinal neoplasms	42	-0.88
DB00445	Epirubicin	leukemia myeloid acute	43	-0.86
DB00445	Epirubicin	colorectal neoplasms	42	-0.83
DB00445	Epirubicin	multiple sclerosis	69	-0.83
DB00445	Epirubicin	spinal cord diseases	59	-0.82
DB00445	Epirubicin	joint diseases	79	-0.81
DB00445	Epirubicin	lung diseases	71	-0.71
DB00445	Epirubicin	arthritis	76	-0.68
DB00445	Epirubicin	leukemia lymphoid	66	-0.66
DB00445	Epirubicin	collagen diseases	25	-0.60
DB00445	Epirubicin	arrhythmias cardiac	30	-0.55
DB00445	Epirubicin	kidney diseases	144	-0.52
DB00445	Epirubicin	epilepsy	25	-0.49
DB00445	Epirubicin	bone diseases metabolic	27	-0.49
DB00445	Epirubicin	gastrointestinal neoplasms	72	-0.47
DB00445	Epirubicin	coronary artery disease	31	-0.46
DB00445	Epirubicin	heart diseases	167	-0.43
DB00445	Epirubicin	macular degeneration	44	-0.38
DB00445	Epirubicin	coronary disease	37	-0.33
DB00445	Epirubicin	anemia hemolytic	29	-0.33
DB00445	Epirubicin	mycobacterium infections	22	-0.29
DB00445	Epirubicin	parkinsonian disorders	31	-0.28
DB00445	Epirubicin	myocardial ischemia	43	-0.27
DB00445	Epirubicin	thyroid diseases	30	-0.25
DB00445	Epirubicin	hypopigmentation	22	-0.24
DB00445	Epirubicin	parkinson disease	30	-0.23
DB00445	Epirubicin	malabsorption syndromes	34	-0.20
DB00445	Epirubicin	eye diseases	231	-0.18
DB00445	Epirubicin	bacterial infections	26	-0.16
DB00445	Epirubicin	vascular diseases	181	-0.15
DB00445	Epirubicin	arteriosclerosis	38	-0.14
DB00445	Epirubicin	leukemia	117	-0.13
DB00445	Epirubicin	liver cirrhosis	24	-0.11
DB00445	Epirubicin	amyotrophic lateral sclerosis	21	-0.09
DB00445	Epirubicin	alzheimer disease	29	-0.08
DB00445	Epirubicin	liver cirrhosis biliary	23	-0.08
DB00445	Epirubicin	metabolism inborn errors	289	-0.05
DB00445	Epirubicin	neuroendocrine tumors	24	-0.03
DB00445	Epirubicin	asthma	36	0.00
DB00445	Epirubicin	blood coagulation disorders	40	0.04
DB00445	Epirubicin	arterial occlusive diseases	44	0.04
DB00445	Epirubicin	hematologic diseases	188	0.07
DB00445	Epirubicin	hypersensitivity	45	0.14
DB00445	Epirubicin	autoimmune diseases	243	0.17
DB00445	Epirubicin	skin diseases	278	0.21
DB00445	Epirubicin	motor neuron disease	31	0.21
DB00445	Epirubicin	colitis	55	0.24
DB00445	Epirubicin	cardiovascular diseases	330	0.27
DB00445	Epirubicin	endocrine system diseases	291	0.28
DB00445	Epirubicin	colitis ulcerative	55	0.29
DB00445	Epirubicin	dementia	42	0.30
DB00445	Epirubicin	psoriasis	54	0.38
DB00445	Epirubicin	diabetes mellitus type 2	72	0.41
DB00445	Epirubicin	lupus erythematosus systemic	75	0.51
DB00445	Epirubicin	diabetes mellitus type 1	82	0.53
DB00445	Epirubicin	crohn disease	71	0.55
DB00445	Epirubicin	neoplasms	482	0.71
DB00445	Epirubicin	anemia	58	0.79
DB00445	Epirubicin	varicose veins	20	0.85
DB00445	Epirubicin	gastroenteritis	122	0.92
DB00445	Epirubicin	inflammatory bowel diseases	119	0.93
DB00445	Epirubicin	insulin resistance	26	0.98
DB00445	Epirubicin	hyperinsulinism	26	0.98
DB00445	Epirubicin	diabetes mellitus	162	1.04
DB00445	Epirubicin	keratosis	21	1.14
DB00445	Epirubicin	bone diseases	144	1.27
DB00444	Teniposide	cardiomyopathy dilated	29	-1.69
DB00444	Teniposide	pancreatic diseases	24	-1.59
DB00444	Teniposide	kidney neoplasms	20	-1.54
DB00444	Teniposide	sarcoma	25	-1.44
DB00444	Teniposide	arthritis rheumatoid	42	-1.29
DB00444	Teniposide	head and neck neoplasms	35	-1.27
DB00444	Teniposide	lymphoma	24	-1.25
DB00444	Teniposide	lymphoma non hodgkin	22	-1.20
DB00444	Teniposide	prostatic neoplasms	61	-1.17
DB00444	Teniposide	rheumatic diseases	59	-1.09
DB00444	Teniposide	breast neoplasms	40	-1.07
DB00444	Teniposide	adenocarcinoma	32	-1.05
DB00444	Teniposide	leukemia myeloid acute	43	-1.00
DB00444	Teniposide	spinal cord diseases	59	-0.98
DB00444	Teniposide	arthritis	76	-0.96
DB00444	Teniposide	joint diseases	79	-0.95
DB00444	Teniposide	colorectal neoplasms	42	-0.93
DB00444	Teniposide	intestinal neoplasms	42	-0.91
DB00444	Teniposide	multiple sclerosis	69	-0.89
DB00444	Teniposide	lung diseases	71	-0.79
DB00444	Teniposide	kidney diseases	144	-0.72
DB00444	Teniposide	leukemia lymphoid	66	-0.71
DB00444	Teniposide	gastrointestinal neoplasms	72	-0.65
DB00444	Teniposide	heart diseases	167	-0.62
DB00444	Teniposide	eye diseases	231	-0.49
DB00444	Teniposide	metabolism inborn errors	289	-0.45
DB00444	Teniposide	vascular diseases	181	-0.33
DB00444	Teniposide	hematologic diseases	188	-0.30
DB00444	Teniposide	leukemia	117	-0.28
DB00444	Teniposide	skin diseases	278	-0.22
DB00444	Teniposide	autoimmune diseases	243	-0.20
DB00444	Teniposide	cardiovascular diseases	330	-0.12
DB00444	Teniposide	endocrine system diseases	291	-0.04
DB00444	Teniposide	neoplasms	482	0.23
DB00444	Teniposide	arrhythmias cardiac	30	0.26
DB00444	Teniposide	epilepsy	25	0.31
DB00444	Teniposide	bone diseases metabolic	27	0.31
DB00444	Teniposide	collagen diseases	25	0.31
DB00444	Teniposide	hyperinsulinism	26	0.31
DB00444	Teniposide	varicose veins	20	0.32
DB00444	Teniposide	insulin resistance	26	0.32
DB00444	Teniposide	macular degeneration	44	0.34
DB00444	Teniposide	coronary artery disease	31	0.37
DB00444	Teniposide	coronary disease	37	0.44
DB00444	Teniposide	anemia hemolytic	29	0.44
DB00444	Teniposide	parkinson disease	30	0.45
DB00444	Teniposide	malabsorption syndromes	34	0.45
DB00444	Teniposide	keratosis	21	0.46
DB00444	Teniposide	parkinsonian disorders	31	0.47
DB00444	Teniposide	myocardial ischemia	43	0.47
DB00444	Teniposide	mycobacterium infections	22	0.48
DB00444	Teniposide	arteriosclerosis	38	0.49
DB00444	Teniposide	bacterial infections	26	0.49
DB00444	Teniposide	thyroid diseases	30	0.50
DB00444	Teniposide	hypopigmentation	22	0.54
DB00444	Teniposide	amyotrophic lateral sclerosis	21	0.56
DB00444	Teniposide	arterial occlusive diseases	44	0.57
DB00444	Teniposide	alzheimer disease	29	0.57
DB00444	Teniposide	asthma	36	0.58
DB00444	Teniposide	liver cirrhosis biliary	23	0.58
DB00444	Teniposide	liver cirrhosis	24	0.60
DB00444	Teniposide	neuroendocrine tumors	24	0.61
DB00444	Teniposide	blood coagulation disorders	40	0.62
DB00444	Teniposide	hypersensitivity	45	0.67
DB00444	Teniposide	colitis	55	0.68
DB00444	Teniposide	colitis ulcerative	55	0.70
DB00444	Teniposide	dementia	42	0.75
DB00444	Teniposide	diabetes mellitus type 2	72	0.77
DB00444	Teniposide	motor neuron disease	31	0.79
DB00444	Teniposide	psoriasis	54	0.85
DB00444	Teniposide	diabetes mellitus type 1	82	0.90
DB00444	Teniposide	lupus erythematosus systemic	75	0.95
DB00444	Teniposide	crohn disease	71	0.97
DB00444	Teniposide	anemia	58	1.13
DB00444	Teniposide	inflammatory bowel diseases	119	1.26
DB00444	Teniposide	gastroenteritis	122	1.29
DB00444	Teniposide	diabetes mellitus	162	1.36
DB00444	Teniposide	bone diseases	144	1.67
DB00162	Vitamin.A	eye diseases	231	-4.69
DB00162	Vitamin.A	head and neck neoplasms	35	-0.86
DB00162	Vitamin.A	heart diseases	167	-0.25
DB00162	Vitamin.A	coronary artery disease	31	0.50
DB00162	Vitamin.A	coronary disease	37	0.87
DB00162	Vitamin.A	myocardial ischemia	43	1.04
DB00162	Vitamin.A	keratosis	21	1.07
DB00162	Vitamin.A	gastrointestinal neoplasms	72	1.14
DB00162	Vitamin.A	arteriosclerosis	38	1.14
DB00162	Vitamin.A	cardiovascular diseases	330	1.14
DB00162	Vitamin.A	bacterial infections	26	1.40
DB00162	Vitamin.A	mycobacterium infections	22	1.41
DB00162	Vitamin.A	arterial occlusive diseases	44	1.56
DB00162	Vitamin.A	arrhythmias cardiac	30	1.66
DB00162	Vitamin.A	kidney diseases	144	1.68
DB00162	Vitamin.A	adenocarcinoma	32	1.82
DB00162	Vitamin.A	cardiomyopathy dilated	29	1.84
DB00162	Vitamin.A	arthritis rheumatoid	42	1.87
DB00162	Vitamin.A	colitis ulcerative	55	1.97
DB00162	Vitamin.A	colitis	55	2.00
DB00162	Vitamin.A	metabolism inborn errors	289	2.00
DB00162	Vitamin.A	arthritis	76	2.20
DB00162	Vitamin.A	lung diseases	71	2.22
DB00162	Vitamin.A	joint diseases	79	2.26
DB00162	Vitamin.A	thyroid diseases	30	2.30
DB00162	Vitamin.A	rheumatic diseases	59	2.37
DB00162	Vitamin.A	epilepsy	25	2.43
DB00162	Vitamin.A	colorectal neoplasms	42	2.50
DB00162	Vitamin.A	asthma	36	2.59
DB00162	Vitamin.A	leukemia myeloid acute	43	2.60
DB00162	Vitamin.A	intestinal neoplasms	42	2.61
DB00162	Vitamin.A	crohn disease	71	2.61
DB00162	Vitamin.A	inflammatory bowel diseases	119	2.72
DB00162	Vitamin.A	collagen diseases	25	2.81
DB00162	Vitamin.A	gastroenteritis	122	2.81
DB00162	Vitamin.A	diabetes mellitus type 2	72	2.85
DB00162	Vitamin.A	neoplasms	482	2.89
DB00162	Vitamin.A	diabetes mellitus	162	2.94
DB00162	Vitamin.A	endocrine system diseases	291	2.94
DB00162	Vitamin.A	liver cirrhosis biliary	23	2.98
DB00162	Vitamin.A	alzheimer disease	29	2.98
DB00162	Vitamin.A	liver cirrhosis	24	3.01
DB00162	Vitamin.A	pancreatic diseases	24	3.03
DB00162	Vitamin.A	multiple sclerosis	69	3.15
DB00162	Vitamin.A	bone diseases	144	3.18
DB00162	Vitamin.A	insulin resistance	26	3.18
DB00162	Vitamin.A	hypersensitivity	45	3.21
DB00162	Vitamin.A	hyperinsulinism	26	3.22
DB00162	Vitamin.A	neuroendocrine tumors	24	3.27
DB00162	Vitamin.A	dementia	42	3.30
DB00162	Vitamin.A	breast neoplasms	40	3.34
DB00162	Vitamin.A	psoriasis	54	3.34
DB00162	Vitamin.A	macular degeneration	44	3.34
DB00162	Vitamin.A	varicose veins	20	3.38
DB00162	Vitamin.A	motor neuron disease	31	3.47
DB00162	Vitamin.A	kidney neoplasms	20	3.48
DB00162	Vitamin.A	vascular diseases	181	3.52
DB00162	Vitamin.A	hypopigmentation	22	3.52
DB00162	Vitamin.A	leukemia lymphoid	66	3.56
DB00162	Vitamin.A	sarcoma	25	3.59
DB00162	Vitamin.A	amyotrophic lateral sclerosis	21	3.59
DB00162	Vitamin.A	anemia hemolytic	29	3.61
DB00162	Vitamin.A	parkinsonian disorders	31	3.67
DB00162	Vitamin.A	autoimmune diseases	243	3.67
DB00162	Vitamin.A	parkinson disease	30	3.77
DB00162	Vitamin.A	diabetes mellitus type 1	82	3.81
DB00162	Vitamin.A	malabsorption syndromes	34	3.85
DB00162	Vitamin.A	hematologic diseases	188	3.93
DB00162	Vitamin.A	prostatic neoplasms	61	3.94
DB00162	Vitamin.A	anemia	58	3.96
DB00162	Vitamin.A	leukemia	117	4.08
DB00162	Vitamin.A	lymphoma	24	4.17
DB00162	Vitamin.A	lymphoma non hodgkin	22	4.18
DB00162	Vitamin.A	skin diseases	278	4.21
DB00162	Vitamin.A	spinal cord diseases	59	4.24
DB00162	Vitamin.A	bone diseases metabolic	27	4.47
DB00162	Vitamin.A	blood coagulation disorders	40	5.00
DB00162	Vitamin.A	lupus erythematosus systemic	75	5.58
DB00163	Vitamin.E	bone diseases metabolic	27	-2.42
DB00163	Vitamin.E	sarcoma	25	-2.30
DB00163	Vitamin.E	arteriosclerosis	38	-2.29
DB00163	Vitamin.E	gastroenteritis	122	-2.15
DB00163	Vitamin.E	kidney neoplasms	20	-2.07
DB00163	Vitamin.E	rheumatic diseases	59	-2.01
DB00163	Vitamin.E	vascular diseases	181	-2.01
DB00163	Vitamin.E	blood coagulation disorders	40	-1.99
DB00163	Vitamin.E	cardiovascular diseases	330	-1.96
DB00163	Vitamin.E	arterial occlusive diseases	44	-1.91
DB00163	Vitamin.E	epilepsy	25	-1.90
DB00163	Vitamin.E	arrhythmias cardiac	30	-1.87
DB00163	Vitamin.E	crohn disease	71	-1.84
DB00163	Vitamin.E	arthritis rheumatoid	42	-1.81
DB00163	Vitamin.E	head and neck neoplasms	35	-1.75
DB00163	Vitamin.E	asthma	36	-1.72
DB00163	Vitamin.E	arthritis	76	-1.71
DB00163	Vitamin.E	joint diseases	79	-1.71
DB00163	Vitamin.E	adenocarcinoma	32	-1.67
DB00163	Vitamin.E	lung diseases	71	-1.65
DB00163	Vitamin.E	psoriasis	54	-1.65
DB00163	Vitamin.E	bone diseases	144	-1.64
DB00163	Vitamin.E	colitis ulcerative	55	-1.61
DB00163	Vitamin.E	myocardial ischemia	43	-1.61
DB00163	Vitamin.E	colitis	55	-1.60
DB00163	Vitamin.E	malabsorption syndromes	34	-1.47
DB00163	Vitamin.E	hypopigmentation	22	-1.44
DB00163	Vitamin.E	inflammatory bowel diseases	119	-1.42
DB00163	Vitamin.E	cardiomyopathy dilated	29	-1.39
DB00163	Vitamin.E	hypersensitivity	45	-1.39
DB00163	Vitamin.E	diabetes mellitus type 2	72	-1.34
DB00163	Vitamin.E	bacterial infections	26	-1.33
DB00163	Vitamin.E	multiple sclerosis	69	-1.32
DB00163	Vitamin.E	skin diseases	278	-1.32
DB00163	Vitamin.E	lymphoma	24	-1.27
DB00163	Vitamin.E	lymphoma non hodgkin	22	-1.27
DB00163	Vitamin.E	kidney diseases	144	-1.27
DB00163	Vitamin.E	coronary artery disease	31	-1.27
DB00163	Vitamin.E	prostatic neoplasms	61	-1.17
DB00163	Vitamin.E	pancreatic diseases	24	-1.11
DB00163	Vitamin.E	parkinson disease	30	-1.08
DB00163	Vitamin.E	parkinsonian disorders	31	-1.08
DB00163	Vitamin.E	coronary disease	37	-1.06
DB00163	Vitamin.E	spinal cord diseases	59	-1.05
DB00163	Vitamin.E	anemia hemolytic	29	-1.00
DB00163	Vitamin.E	thyroid diseases	30	-0.96
DB00163	Vitamin.E	leukemia lymphoid	66	-0.94
DB00163	Vitamin.E	autoimmune diseases	243	-0.84
DB00163	Vitamin.E	macular degeneration	44	-0.83
DB00163	Vitamin.E	lupus erythematosus systemic	75	-0.74
DB00163	Vitamin.E	varicose veins	20	-0.58
DB00163	Vitamin.E	dementia	42	-0.58
DB00163	Vitamin.E	amyotrophic lateral sclerosis	21	-0.55
DB00163	Vitamin.E	leukemia	117	-0.55
DB00163	Vitamin.E	leukemia myeloid acute	43	-0.54
DB00163	Vitamin.E	metabolism inborn errors	289	-0.53
DB00163	Vitamin.E	motor neuron disease	31	-0.49
DB00163	Vitamin.E	gastrointestinal neoplasms	72	-0.46
DB00163	Vitamin.E	colorectal neoplasms	42	-0.46
DB00163	Vitamin.E	intestinal neoplasms	42	-0.38
DB00163	Vitamin.E	heart diseases	167	-0.35
DB00163	Vitamin.E	mycobacterium infections	22	-0.28
DB00163	Vitamin.E	collagen diseases	25	-0.24
DB00163	Vitamin.E	neoplasms	482	-0.19
DB00163	Vitamin.E	breast neoplasms	40	-0.06
DB00163	Vitamin.E	diabetes mellitus type 1	82	-0.05
DB00163	Vitamin.E	alzheimer disease	29	0.14
DB00163	Vitamin.E	diabetes mellitus	162	0.19
DB00163	Vitamin.E	eye diseases	231	0.28
DB00163	Vitamin.E	liver cirrhosis	24	0.28
DB00163	Vitamin.E	liver cirrhosis biliary	23	0.29
DB00163	Vitamin.E	neuroendocrine tumors	24	0.35
DB00163	Vitamin.E	anemia	58	0.57
DB00163	Vitamin.E	hematologic diseases	188	0.75
DB00163	Vitamin.E	keratosis	21	0.97
DB00163	Vitamin.E	endocrine system diseases	291	0.98
DB00163	Vitamin.E	hyperinsulinism	26	1.25
DB00163	Vitamin.E	insulin resistance	26	1.25
DB00279	Liothyronine	thyroid diseases	30	-2.78
DB00279	Liothyronine	kidney neoplasms	20	-2.70
DB00279	Liothyronine	sarcoma	25	-2.44
DB00279	Liothyronine	lymphoma non hodgkin	22	-2.25
DB00279	Liothyronine	lymphoma	24	-2.21
DB00279	Liothyronine	colitis ulcerative	55	-2.18
DB00279	Liothyronine	colitis	55	-2.14
DB00279	Liothyronine	endocrine system diseases	291	-2.12
DB00279	Liothyronine	adenocarcinoma	32	-2.00
DB00279	Liothyronine	crohn disease	71	-1.89
DB00279	Liothyronine	leukemia myeloid acute	43	-1.80
DB00279	Liothyronine	head and neck neoplasms	35	-1.79
DB00279	Liothyronine	breast neoplasms	40	-1.73
DB00279	Liothyronine	leukemia lymphoid	66	-1.64
DB00279	Liothyronine	inflammatory bowel diseases	119	-1.48
DB00279	Liothyronine	coronary artery disease	31	-1.41
DB00279	Liothyronine	gastroenteritis	122	-1.40
DB00279	Liothyronine	kidney diseases	144	-1.35
DB00279	Liothyronine	myocardial ischemia	43	-1.29
DB00279	Liothyronine	coronary disease	37	-1.29
DB00279	Liothyronine	arteriosclerosis	38	-1.20
DB00279	Liothyronine	amyotrophic lateral sclerosis	21	-1.15
DB00279	Liothyronine	arterial occlusive diseases	44	-1.09
DB00279	Liothyronine	heart diseases	167	-1.02
DB00279	Liothyronine	leukemia	117	-1.00
DB00279	Liothyronine	vascular diseases	181	-0.82
DB00279	Liothyronine	diabetes mellitus type 2	72	-0.79
DB00279	Liothyronine	motor neuron disease	31	-0.76
DB00279	Liothyronine	hematologic diseases	188	-0.65
DB00279	Liothyronine	multiple sclerosis	69	-0.53
DB00279	Liothyronine	skin diseases	278	-0.37
DB00279	Liothyronine	spinal cord diseases	59	-0.34
DB00279	Liothyronine	cardiovascular diseases	330	-0.31
DB00279	Liothyronine	lung diseases	71	-0.22
DB00279	Liothyronine	varicose veins	20	-0.19
DB00279	Liothyronine	epilepsy	25	-0.11
DB00279	Liothyronine	insulin resistance	26	-0.09
DB00279	Liothyronine	hyperinsulinism	26	-0.08
DB00279	Liothyronine	bone diseases metabolic	27	-0.03
DB00279	Liothyronine	macular degeneration	44	0.01
DB00279	Liothyronine	collagen diseases	25	0.05
DB00279	Liothyronine	diabetes mellitus	162	0.06
DB00279	Liothyronine	arrhythmias cardiac	30	0.10
DB00279	Liothyronine	mycobacterium infections	22	0.15
DB00279	Liothyronine	anemia hemolytic	29	0.19
DB00279	Liothyronine	malabsorption syndromes	34	0.21
DB00279	Liothyronine	keratosis	21	0.21
DB00279	Liothyronine	bone diseases	144	0.23
DB00279	Liothyronine	gastrointestinal neoplasms	72	0.24
DB00279	Liothyronine	neoplasms	482	0.24
DB00279	Liothyronine	liver cirrhosis biliary	23	0.26
DB00279	Liothyronine	bacterial infections	26	0.27
DB00279	Liothyronine	asthma	36	0.29
DB00279	Liothyronine	hypopigmentation	22	0.29
DB00279	Liothyronine	liver cirrhosis	24	0.30
DB00279	Liothyronine	pancreatic diseases	24	0.30
DB00279	Liothyronine	neuroendocrine tumors	24	0.34
DB00279	Liothyronine	hypersensitivity	45	0.42
DB00279	Liothyronine	cardiomyopathy dilated	29	0.46
DB00279	Liothyronine	blood coagulation disorders	40	0.48
DB00279	Liothyronine	parkinson disease	30	0.51
DB00279	Liothyronine	parkinsonian disorders	31	0.55
DB00279	Liothyronine	arthritis rheumatoid	42	0.57
DB00279	Liothyronine	alzheimer disease	29	0.63
DB00279	Liothyronine	metabolism inborn errors	289	0.67
DB00279	Liothyronine	lupus erythematosus systemic	75	0.77
DB00279	Liothyronine	rheumatic diseases	59	0.79
DB00279	Liothyronine	dementia	42	0.81
DB00279	Liothyronine	psoriasis	54	0.81
DB00279	Liothyronine	prostatic neoplasms	61	0.82
DB00279	Liothyronine	diabetes mellitus type 1	82	0.89
DB00279	Liothyronine	autoimmune diseases	243	0.91
DB00279	Liothyronine	joint diseases	79	0.98
DB00279	Liothyronine	arthritis	76	1.00
DB00279	Liothyronine	anemia	58	1.03
DB00279	Liothyronine	colorectal neoplasms	42	1.10
DB00279	Liothyronine	intestinal neoplasms	42	1.17
DB00279	Liothyronine	eye diseases	231	1.94
DB00376	Trihexyphenidyl	colitis	55	-1.48
DB00376	Trihexyphenidyl	colitis ulcerative	55	-1.45
DB00376	Trihexyphenidyl	thyroid diseases	30	-1.38
DB00376	Trihexyphenidyl	pancreatic diseases	24	-1.18
DB00376	Trihexyphenidyl	arteriosclerosis	38	-1.17
DB00376	Trihexyphenidyl	epilepsy	25	-1.09
DB00376	Trihexyphenidyl	hyperinsulinism	26	-0.98
DB00376	Trihexyphenidyl	insulin resistance	26	-0.90
DB00376	Trihexyphenidyl	arterial occlusive diseases	44	-0.90
DB00376	Trihexyphenidyl	inflammatory bowel diseases	119	-0.75
DB00376	Trihexyphenidyl	gastroenteritis	122	-0.74
DB00376	Trihexyphenidyl	dementia	42	-0.68
DB00376	Trihexyphenidyl	head and neck neoplasms	35	-0.67
DB00376	Trihexyphenidyl	kidney diseases	144	-0.53
DB00376	Trihexyphenidyl	hypopigmentation	22	-0.53
DB00376	Trihexyphenidyl	psoriasis	54	-0.53
DB00376	Trihexyphenidyl	liver cirrhosis biliary	23	-0.47
DB00376	Trihexyphenidyl	liver cirrhosis	24	-0.43
DB00376	Trihexyphenidyl	lupus erythematosus systemic	75	-0.39
DB00376	Trihexyphenidyl	leukemia myeloid acute	43	-0.35
DB00376	Trihexyphenidyl	diabetes mellitus type 1	82	-0.35
DB00376	Trihexyphenidyl	bone diseases	144	-0.35
DB00376	Trihexyphenidyl	crohn disease	71	-0.33
DB00376	Trihexyphenidyl	asthma	36	-0.25
DB00376	Trihexyphenidyl	joint diseases	79	-0.18
DB00376	Trihexyphenidyl	arthritis	76	-0.17
DB00376	Trihexyphenidyl	eye diseases	231	-0.12
DB00376	Trihexyphenidyl	lung diseases	71	-0.11
DB00376	Trihexyphenidyl	bone diseases metabolic	27	-0.04
DB00376	Trihexyphenidyl	leukemia lymphoid	66	-0.04
DB00376	Trihexyphenidyl	hypersensitivity	45	-0.01
DB00376	Trihexyphenidyl	metabolism inborn errors	289	0.02
DB00376	Trihexyphenidyl	mycobacterium infections	22	0.02
DB00376	Trihexyphenidyl	adenocarcinoma	32	0.05
DB00376	Trihexyphenidyl	keratosis	21	0.09
DB00376	Trihexyphenidyl	gastrointestinal neoplasms	72	0.12
DB00376	Trihexyphenidyl	coronary artery disease	31	0.13
DB00376	Trihexyphenidyl	neoplasms	482	0.13
DB00376	Trihexyphenidyl	bacterial infections	26	0.25
DB00376	Trihexyphenidyl	kidney neoplasms	20	0.26
DB00376	Trihexyphenidyl	coronary disease	37	0.31
DB00376	Trihexyphenidyl	skin diseases	278	0.32
DB00376	Trihexyphenidyl	diabetes mellitus type 2	72	0.32
DB00376	Trihexyphenidyl	diabetes mellitus	162	0.34
DB00376	Trihexyphenidyl	amyotrophic lateral sclerosis	21	0.39
DB00376	Trihexyphenidyl	myocardial ischemia	43	0.40
DB00376	Trihexyphenidyl	neuroendocrine tumors	24	0.44
DB00376	Trihexyphenidyl	intestinal neoplasms	42	0.46
DB00376	Trihexyphenidyl	colorectal neoplasms	42	0.47
DB00376	Trihexyphenidyl	alzheimer disease	29	0.53
DB00376	Trihexyphenidyl	multiple sclerosis	69	0.55
DB00376	Trihexyphenidyl	leukemia	117	0.56
DB00376	Trihexyphenidyl	spinal cord diseases	59	0.58
DB00376	Trihexyphenidyl	sarcoma	25	0.60
DB00376	Trihexyphenidyl	vascular diseases	181	0.64
DB00376	Trihexyphenidyl	anemia	58	0.65
DB00376	Trihexyphenidyl	lymphoma non hodgkin	22	0.67
DB00376	Trihexyphenidyl	lymphoma	24	0.69
DB00376	Trihexyphenidyl	arrhythmias cardiac	30	0.70
DB00376	Trihexyphenidyl	blood coagulation disorders	40	0.70
DB00376	Trihexyphenidyl	motor neuron disease	31	0.81
DB00376	Trihexyphenidyl	autoimmune diseases	243	0.85
DB00376	Trihexyphenidyl	hematologic diseases	188	0.89
DB00376	Trihexyphenidyl	macular degeneration	44	0.97
DB00376	Trihexyphenidyl	anemia hemolytic	29	1.05
DB00376	Trihexyphenidyl	endocrine system diseases	291	1.06
DB00376	Trihexyphenidyl	breast neoplasms	40	1.10
DB00376	Trihexyphenidyl	malabsorption syndromes	34	1.14
DB00376	Trihexyphenidyl	cardiovascular diseases	330	1.19
DB00376	Trihexyphenidyl	parkinsonian disorders	31	1.19
DB00376	Trihexyphenidyl	varicose veins	20	1.19
DB00376	Trihexyphenidyl	heart diseases	167	1.23
DB00376	Trihexyphenidyl	parkinson disease	30	1.27
DB00376	Trihexyphenidyl	cardiomyopathy dilated	29	1.42
DB00376	Trihexyphenidyl	collagen diseases	25	1.47
DB00376	Trihexyphenidyl	arthritis rheumatoid	42	1.71
DB00376	Trihexyphenidyl	prostatic neoplasms	61	1.92
DB00376	Trihexyphenidyl	rheumatic diseases	59	2.13
DB00165	Pyridoxine	varicose veins	20	-0.85
DB00165	Pyridoxine	hyperinsulinism	26	-0.78
DB00165	Pyridoxine	insulin resistance	26	-0.72
DB00165	Pyridoxine	arrhythmias cardiac	30	-0.72
DB00165	Pyridoxine	bone diseases metabolic	27	-0.71
DB00165	Pyridoxine	collagen diseases	25	-0.69
DB00165	Pyridoxine	mycobacterium infections	22	-0.66
DB00165	Pyridoxine	coronary artery disease	31	-0.65
DB00165	Pyridoxine	thyroid diseases	30	-0.63
DB00165	Pyridoxine	keratosis	21	-0.62
DB00165	Pyridoxine	bacterial infections	26	-0.60
DB00165	Pyridoxine	parkinson disease	30	-0.57
DB00165	Pyridoxine	anemia hemolytic	29	-0.56
DB00165	Pyridoxine	amyotrophic lateral sclerosis	21	-0.56
DB00165	Pyridoxine	parkinsonian disorders	31	-0.55
DB00165	Pyridoxine	pancreatic diseases	24	-0.55
DB00165	Pyridoxine	kidney neoplasms	20	-0.55
DB00165	Pyridoxine	coronary disease	37	-0.55
DB00165	Pyridoxine	malabsorption syndromes	34	-0.51
DB00165	Pyridoxine	liver cirrhosis	24	-0.50
DB00165	Pyridoxine	alzheimer disease	29	-0.49
DB00165	Pyridoxine	liver cirrhosis biliary	23	-0.47
DB00165	Pyridoxine	myocardial ischemia	43	-0.47
DB00165	Pyridoxine	neuroendocrine tumors	24	-0.45
DB00165	Pyridoxine	asthma	36	-0.45
DB00165	Pyridoxine	cardiomyopathy dilated	29	-0.44
DB00165	Pyridoxine	sarcoma	25	-0.42
DB00165	Pyridoxine	arteriosclerosis	38	-0.40
DB00165	Pyridoxine	lymphoma non hodgkin	22	-0.39
DB00165	Pyridoxine	lymphoma	24	-0.36
DB00165	Pyridoxine	arterial occlusive diseases	44	-0.36
DB00165	Pyridoxine	motor neuron disease	31	-0.34
DB00165	Pyridoxine	hypersensitivity	45	-0.32
DB00165	Pyridoxine	head and neck neoplasms	35	-0.31
DB00165	Pyridoxine	adenocarcinoma	32	-0.31
DB00165	Pyridoxine	arthritis rheumatoid	42	-0.30
DB00165	Pyridoxine	blood coagulation disorders	40	-0.28
DB00165	Pyridoxine	dementia	42	-0.28
DB00165	Pyridoxine	colitis	55	-0.25
DB00165	Pyridoxine	prostatic neoplasms	61	-0.25
DB00165	Pyridoxine	breast neoplasms	40	-0.20
DB00165	Pyridoxine	diabetes mellitus type 2	72	-0.20
DB00165	Pyridoxine	psoriasis	54	-0.20
DB00165	Pyridoxine	colitis ulcerative	55	-0.16
DB00165	Pyridoxine	rheumatic diseases	59	-0.14
DB00165	Pyridoxine	colorectal neoplasms	42	-0.14
DB00165	Pyridoxine	lupus erythematosus systemic	75	-0.11
DB00165	Pyridoxine	diabetes mellitus type 1	82	-0.09
DB00165	Pyridoxine	intestinal neoplasms	42	-0.09
DB00165	Pyridoxine	spinal cord diseases	59	-0.07
DB00165	Pyridoxine	crohn disease	71	-0.06
DB00165	Pyridoxine	arthritis	76	-0.06
DB00165	Pyridoxine	leukemia myeloid acute	43	-0.03
DB00165	Pyridoxine	joint diseases	79	-0.02
DB00165	Pyridoxine	anemia	58	0.04
DB00165	Pyridoxine	lung diseases	71	0.05
DB00165	Pyridoxine	leukemia lymphoid	66	0.09
DB00165	Pyridoxine	inflammatory bowel diseases	119	0.11
DB00165	Pyridoxine	diabetes mellitus	162	0.12
DB00165	Pyridoxine	gastrointestinal neoplasms	72	0.13
DB00165	Pyridoxine	gastroenteritis	122	0.18
DB00165	Pyridoxine	kidney diseases	144	0.18
DB00165	Pyridoxine	bone diseases	144	0.27
DB00165	Pyridoxine	heart diseases	167	0.29
DB00165	Pyridoxine	leukemia	117	0.33
DB00165	Pyridoxine	vascular diseases	181	0.35
DB00165	Pyridoxine	eye diseases	231	0.35
DB00165	Pyridoxine	autoimmune diseases	243	0.43
DB00165	Pyridoxine	metabolism inborn errors	289	0.43
DB00165	Pyridoxine	endocrine system diseases	291	0.46
DB00165	Pyridoxine	hematologic diseases	188	0.47
DB00165	Pyridoxine	skin diseases	278	0.52
DB00165	Pyridoxine	cardiovascular diseases	330	0.61
DB00165	Pyridoxine	neoplasms	482	0.86
DB00165	Pyridoxine	epilepsy	25	1.08
DB00165	Pyridoxine	macular degeneration	44	1.31
DB00165	Pyridoxine	hypopigmentation	22	1.40
DB00165	Pyridoxine	multiple sclerosis	69	2.23
DB00302	Tranexamic.Acid	hematologic diseases	188	-2.66
DB00302	Tranexamic.Acid	eye diseases	231	-2.55
DB00302	Tranexamic.Acid	vascular diseases	181	-2.35
DB00302	Tranexamic.Acid	cardiovascular diseases	330	-2.31
DB00302	Tranexamic.Acid	hypersensitivity	45	-2.27
DB00302	Tranexamic.Acid	blood coagulation disorders	40	-1.92
DB00302	Tranexamic.Acid	diabetes mellitus type 1	82	-1.42
DB00302	Tranexamic.Acid	prostatic neoplasms	61	-1.35
DB00302	Tranexamic.Acid	dementia	42	-1.32
DB00302	Tranexamic.Acid	diabetes mellitus	162	-1.02
DB00302	Tranexamic.Acid	intestinal neoplasms	42	-0.96
DB00302	Tranexamic.Acid	colorectal neoplasms	42	-0.89
DB00302	Tranexamic.Acid	bone diseases	144	-0.84
DB00302	Tranexamic.Acid	heart diseases	167	-0.72
DB00302	Tranexamic.Acid	gastrointestinal neoplasms	72	-0.64
DB00302	Tranexamic.Acid	autoimmune diseases	243	-0.59
DB00302	Tranexamic.Acid	endocrine system diseases	291	-0.41
DB00302	Tranexamic.Acid	skin diseases	278	-0.32
DB00302	Tranexamic.Acid	varicose veins	20	-0.28
DB00302	Tranexamic.Acid	epilepsy	25	-0.25
DB00302	Tranexamic.Acid	hyperinsulinism	26	-0.24
DB00302	Tranexamic.Acid	insulin resistance	26	-0.22
DB00302	Tranexamic.Acid	bone diseases metabolic	27	-0.18
DB00302	Tranexamic.Acid	macular degeneration	44	-0.15
DB00302	Tranexamic.Acid	mycobacterium infections	22	-0.11
DB00302	Tranexamic.Acid	collagen diseases	25	-0.07
DB00302	Tranexamic.Acid	arrhythmias cardiac	30	-0.05
DB00302	Tranexamic.Acid	anemia hemolytic	29	-0.04
DB00302	Tranexamic.Acid	coronary artery disease	31	-0.02
DB00302	Tranexamic.Acid	liver cirrhosis biliary	23	-0.01
DB00302	Tranexamic.Acid	neuroendocrine tumors	24	0.00
DB00302	Tranexamic.Acid	malabsorption syndromes	34	0.01
DB00302	Tranexamic.Acid	liver cirrhosis	24	0.02
DB00302	Tranexamic.Acid	bacterial infections	26	0.02
DB00302	Tranexamic.Acid	asthma	36	0.06
DB00302	Tranexamic.Acid	kidney neoplasms	20	0.07
DB00302	Tranexamic.Acid	keratosis	21	0.09
DB00302	Tranexamic.Acid	coronary disease	37	0.12
DB00302	Tranexamic.Acid	hypopigmentation	22	0.12
DB00302	Tranexamic.Acid	myocardial ischemia	43	0.14
DB00302	Tranexamic.Acid	neoplasms	482	0.14
DB00302	Tranexamic.Acid	pancreatic diseases	24	0.16
DB00302	Tranexamic.Acid	arteriosclerosis	38	0.17
DB00302	Tranexamic.Acid	amyotrophic lateral sclerosis	21	0.18
DB00302	Tranexamic.Acid	arthritis rheumatoid	42	0.21
DB00302	Tranexamic.Acid	thyroid diseases	30	0.21
DB00302	Tranexamic.Acid	cardiomyopathy dilated	29	0.21
DB00302	Tranexamic.Acid	sarcoma	25	0.26
DB00302	Tranexamic.Acid	arterial occlusive diseases	44	0.27
DB00302	Tranexamic.Acid	alzheimer disease	29	0.32
DB00302	Tranexamic.Acid	parkinsonian disorders	31	0.32
DB00302	Tranexamic.Acid	lymphoma non hodgkin	22	0.33
DB00302	Tranexamic.Acid	lymphoma	24	0.34
DB00302	Tranexamic.Acid	parkinson disease	30	0.39
DB00302	Tranexamic.Acid	lupus erythematosus systemic	75	0.39
DB00302	Tranexamic.Acid	rheumatic diseases	59	0.39
DB00302	Tranexamic.Acid	colitis ulcerative	55	0.40
DB00302	Tranexamic.Acid	diabetes mellitus type 2	72	0.43
DB00302	Tranexamic.Acid	motor neuron disease	31	0.44
DB00302	Tranexamic.Acid	multiple sclerosis	69	0.44
DB00302	Tranexamic.Acid	colitis	55	0.45
DB00302	Tranexamic.Acid	adenocarcinoma	32	0.47
DB00302	Tranexamic.Acid	joint diseases	79	0.52
DB00302	Tranexamic.Acid	psoriasis	54	0.52
DB00302	Tranexamic.Acid	arthritis	76	0.55
DB00302	Tranexamic.Acid	leukemia myeloid acute	43	0.55
DB00302	Tranexamic.Acid	anemia	58	0.56
DB00302	Tranexamic.Acid	crohn disease	71	0.57
DB00302	Tranexamic.Acid	head and neck neoplasms	35	0.62
DB00302	Tranexamic.Acid	breast neoplasms	40	0.63
DB00302	Tranexamic.Acid	spinal cord diseases	59	0.63
DB00302	Tranexamic.Acid	lung diseases	71	0.69
DB00302	Tranexamic.Acid	leukemia lymphoid	66	0.72
DB00302	Tranexamic.Acid	gastroenteritis	122	0.79
DB00302	Tranexamic.Acid	inflammatory bowel diseases	119	0.83
DB00302	Tranexamic.Acid	kidney diseases	144	0.84
DB00302	Tranexamic.Acid	leukemia	117	1.18
DB00302	Tranexamic.Acid	metabolism inborn errors	289	1.41
DB00379	Mexiletine	thyroid diseases	30	-3.79
DB00379	Mexiletine	cardiomyopathy dilated	29	-3.52
DB00379	Mexiletine	arrhythmias cardiac	30	-3.26
DB00379	Mexiletine	heart diseases	167	-3.16
DB00379	Mexiletine	cardiovascular diseases	330	-2.52
DB00379	Mexiletine	coronary disease	37	-2.09
DB00379	Mexiletine	myocardial ischemia	43	-1.79
DB00379	Mexiletine	arteriosclerosis	38	-1.76
DB00379	Mexiletine	leukemia	117	-1.74
DB00379	Mexiletine	sarcoma	25	-1.55
DB00379	Mexiletine	colitis ulcerative	55	-1.46
DB00379	Mexiletine	arterial occlusive diseases	44	-1.46
DB00379	Mexiletine	hematologic diseases	188	-1.31
DB00379	Mexiletine	breast neoplasms	40	-1.28
DB00379	Mexiletine	colitis	55	-1.26
DB00379	Mexiletine	endocrine system diseases	291	-1.24
DB00379	Mexiletine	leukemia myeloid acute	43	-1.19
DB00379	Mexiletine	spinal cord diseases	59	-1.16
DB00379	Mexiletine	intestinal neoplasms	42	-1.10
DB00379	Mexiletine	colorectal neoplasms	42	-1.04
DB00379	Mexiletine	crohn disease	71	-0.86
DB00379	Mexiletine	gastrointestinal neoplasms	72	-0.66
DB00379	Mexiletine	inflammatory bowel diseases	119	-0.65
DB00379	Mexiletine	gastroenteritis	122	-0.61
DB00379	Mexiletine	neoplasms	482	-0.54
DB00379	Mexiletine	varicose veins	20	-0.54
DB00379	Mexiletine	epilepsy	25	-0.47
DB00379	Mexiletine	bone diseases	144	-0.45
DB00379	Mexiletine	hyperinsulinism	26	-0.40
DB00379	Mexiletine	insulin resistance	26	-0.37
DB00379	Mexiletine	vascular diseases	181	-0.34
DB00379	Mexiletine	eye diseases	231	-0.29
DB00379	Mexiletine	macular degeneration	44	-0.24
DB00379	Mexiletine	bone diseases metabolic	27	-0.24
DB00379	Mexiletine	mycobacterium infections	22	-0.23
DB00379	Mexiletine	keratosis	21	-0.22
DB00379	Mexiletine	coronary artery disease	31	-0.15
DB00379	Mexiletine	anemia hemolytic	29	-0.11
DB00379	Mexiletine	bacterial infections	26	-0.08
DB00379	Mexiletine	hypopigmentation	22	-0.05
DB00379	Mexiletine	parkinsonian disorders	31	-0.03
DB00379	Mexiletine	kidney neoplasms	20	-0.03
DB00379	Mexiletine	malabsorption syndromes	34	0.00
DB00379	Mexiletine	parkinson disease	30	0.02
DB00379	Mexiletine	pancreatic diseases	24	0.02
DB00379	Mexiletine	amyotrophic lateral sclerosis	21	0.02
DB00379	Mexiletine	neuroendocrine tumors	24	0.03
DB00379	Mexiletine	asthma	36	0.04
DB00379	Mexiletine	liver cirrhosis	24	0.04
DB00379	Mexiletine	liver cirrhosis biliary	23	0.05
DB00379	Mexiletine	skin diseases	278	0.10
DB00379	Mexiletine	alzheimer disease	29	0.11
DB00379	Mexiletine	lymphoma	24	0.19
DB00379	Mexiletine	blood coagulation disorders	40	0.20
DB00379	Mexiletine	lymphoma non hodgkin	22	0.20
DB00379	Mexiletine	hypersensitivity	45	0.20
DB00379	Mexiletine	motor neuron disease	31	0.29
DB00379	Mexiletine	arthritis rheumatoid	42	0.31
DB00379	Mexiletine	adenocarcinoma	32	0.36
DB00379	Mexiletine	dementia	42	0.39
DB00379	Mexiletine	diabetes mellitus type 2	72	0.43
DB00379	Mexiletine	prostatic neoplasms	61	0.44
DB00379	Mexiletine	psoriasis	54	0.46
DB00379	Mexiletine	head and neck neoplasms	35	0.48
DB00379	Mexiletine	lupus erythematosus systemic	75	0.49
DB00379	Mexiletine	rheumatic diseases	59	0.51
DB00379	Mexiletine	multiple sclerosis	69	0.52
DB00379	Mexiletine	diabetes mellitus type 1	82	0.55
DB00379	Mexiletine	joint diseases	79	0.63
DB00379	Mexiletine	arthritis	76	0.64
DB00379	Mexiletine	lung diseases	71	0.64
DB00379	Mexiletine	anemia	58	0.67
DB00379	Mexiletine	leukemia lymphoid	66	0.70
DB00379	Mexiletine	kidney diseases	144	0.81
DB00379	Mexiletine	diabetes mellitus	162	0.88
DB00379	Mexiletine	metabolism inborn errors	289	1.16
DB00379	Mexiletine	collagen diseases	25	1.28
DB00379	Mexiletine	autoimmune diseases	243	1.31
DB00169	Cholecalciferol	bone diseases metabolic	27	-4.15
DB00169	Cholecalciferol	kidney diseases	144	-2.72
DB00169	Cholecalciferol	metabolism inborn errors	289	-2.64
DB00169	Cholecalciferol	bone diseases	144	-2.49
DB00169	Cholecalciferol	coronary artery disease	31	-2.39
DB00169	Cholecalciferol	myocardial ischemia	43	-2.23
DB00169	Cholecalciferol	arteriosclerosis	38	-2.17
DB00169	Cholecalciferol	coronary disease	37	-2.08
DB00169	Cholecalciferol	mycobacterium infections	22	-2.08
DB00169	Cholecalciferol	bacterial infections	26	-1.96
DB00169	Cholecalciferol	asthma	36	-1.93
DB00169	Cholecalciferol	arterial occlusive diseases	44	-1.85
DB00169	Cholecalciferol	hypersensitivity	45	-1.75
DB00169	Cholecalciferol	neuroendocrine tumors	24	-1.72
DB00169	Cholecalciferol	sarcoma	25	-1.49
DB00169	Cholecalciferol	adenocarcinoma	32	-1.41
DB00169	Cholecalciferol	colitis ulcerative	55	-1.35
DB00169	Cholecalciferol	colitis	55	-1.28
DB00169	Cholecalciferol	diabetes mellitus type 1	82	-1.17
DB00169	Cholecalciferol	head and neck neoplasms	35	-1.13
DB00169	Cholecalciferol	intestinal neoplasms	42	-1.11
DB00169	Cholecalciferol	crohn disease	71	-1.08
DB00169	Cholecalciferol	colorectal neoplasms	42	-1.07
DB00169	Cholecalciferol	lung diseases	71	-1.00
DB00169	Cholecalciferol	leukemia myeloid acute	43	-0.83
DB00169	Cholecalciferol	leukemia lymphoid	66	-0.82
DB00169	Cholecalciferol	gastrointestinal neoplasms	72	-0.80
DB00169	Cholecalciferol	heart diseases	167	-0.79
DB00169	Cholecalciferol	gastroenteritis	122	-0.71
DB00169	Cholecalciferol	eye diseases	231	-0.69
DB00169	Cholecalciferol	inflammatory bowel diseases	119	-0.66
DB00169	Cholecalciferol	diabetes mellitus	162	-0.61
DB00169	Cholecalciferol	vascular diseases	181	-0.55
DB00169	Cholecalciferol	leukemia	117	-0.38
DB00169	Cholecalciferol	hematologic diseases	188	-0.32
DB00169	Cholecalciferol	cardiovascular diseases	330	-0.32
DB00169	Cholecalciferol	autoimmune diseases	243	-0.28
DB00169	Cholecalciferol	skin diseases	278	-0.14
DB00169	Cholecalciferol	endocrine system diseases	291	-0.13
DB00169	Cholecalciferol	varicose veins	20	-0.04
DB00169	Cholecalciferol	arrhythmias cardiac	30	-0.03
DB00169	Cholecalciferol	collagen diseases	25	0.04
DB00169	Cholecalciferol	insulin resistance	26	0.08
DB00169	Cholecalciferol	epilepsy	25	0.08
DB00169	Cholecalciferol	hyperinsulinism	26	0.08
DB00169	Cholecalciferol	macular degeneration	44	0.11
DB00169	Cholecalciferol	neoplasms	482	0.22
DB00169	Cholecalciferol	anemia hemolytic	29	0.23
DB00169	Cholecalciferol	parkinsonian disorders	31	0.27
DB00169	Cholecalciferol	keratosis	21	0.28
DB00169	Cholecalciferol	parkinson disease	30	0.30
DB00169	Cholecalciferol	malabsorption syndromes	34	0.31
DB00169	Cholecalciferol	hypopigmentation	22	0.37
DB00169	Cholecalciferol	cardiomyopathy dilated	29	0.41
DB00169	Cholecalciferol	kidney neoplasms	20	0.41
DB00169	Cholecalciferol	alzheimer disease	29	0.44
DB00169	Cholecalciferol	amyotrophic lateral sclerosis	21	0.48
DB00169	Cholecalciferol	liver cirrhosis biliary	23	0.48
DB00169	Cholecalciferol	thyroid diseases	30	0.49
DB00169	Cholecalciferol	blood coagulation disorders	40	0.51
DB00169	Cholecalciferol	liver cirrhosis	24	0.53
DB00169	Cholecalciferol	pancreatic diseases	24	0.54
DB00169	Cholecalciferol	lymphoma non hodgkin	22	0.61
DB00169	Cholecalciferol	arthritis rheumatoid	42	0.65
DB00169	Cholecalciferol	lymphoma	24	0.65
DB00169	Cholecalciferol	prostatic neoplasms	61	0.67
DB00169	Cholecalciferol	motor neuron disease	31	0.67
DB00169	Cholecalciferol	dementia	42	0.68
DB00169	Cholecalciferol	lupus erythematosus systemic	75	0.74
DB00169	Cholecalciferol	psoriasis	54	0.78
DB00169	Cholecalciferol	diabetes mellitus type 2	72	0.78
DB00169	Cholecalciferol	rheumatic diseases	59	0.80
DB00169	Cholecalciferol	multiple sclerosis	69	0.86
DB00169	Cholecalciferol	breast neoplasms	40	0.92
DB00169	Cholecalciferol	arthritis	76	0.96
DB00169	Cholecalciferol	joint diseases	79	0.98
DB00169	Cholecalciferol	spinal cord diseases	59	0.99
DB00169	Cholecalciferol	anemia	58	1.16
DB01274	Arformoterol	arrhythmias cardiac	30	-2.71
DB01274	Arformoterol	pancreatic diseases	24	-2.65
DB01274	Arformoterol	diabetes mellitus type 2	72	-1.80
DB01274	Arformoterol	breast neoplasms	40	-1.72
DB01274	Arformoterol	intestinal neoplasms	42	-1.59
DB01274	Arformoterol	colorectal neoplasms	42	-1.49
DB01274	Arformoterol	lung diseases	71	-1.37
DB01274	Arformoterol	diabetes mellitus	162	-1.11
DB01274	Arformoterol	gastrointestinal neoplasms	72	-1.01
DB01274	Arformoterol	heart diseases	167	-0.91
DB01274	Arformoterol	bone diseases	144	-0.83
DB01274	Arformoterol	skin diseases	278	-0.53
DB01274	Arformoterol	endocrine system diseases	291	-0.45
DB01274	Arformoterol	cardiovascular diseases	330	-0.45
DB01274	Arformoterol	varicose veins	20	-0.08
DB01274	Arformoterol	neoplasms	482	-0.01
DB01274	Arformoterol	hyperinsulinism	26	0.05
DB01274	Arformoterol	collagen diseases	25	0.06
DB01274	Arformoterol	insulin resistance	26	0.07
DB01274	Arformoterol	epilepsy	25	0.11
DB01274	Arformoterol	macular degeneration	44	0.17
DB01274	Arformoterol	bone diseases metabolic	27	0.17
DB01274	Arformoterol	mycobacterium infections	22	0.19
DB01274	Arformoterol	coronary artery disease	31	0.21
DB01274	Arformoterol	keratosis	21	0.26
DB01274	Arformoterol	anemia hemolytic	29	0.26
DB01274	Arformoterol	coronary disease	37	0.27
DB01274	Arformoterol	bacterial infections	26	0.29
DB01274	Arformoterol	thyroid diseases	30	0.30
DB01274	Arformoterol	malabsorption syndromes	34	0.30
DB01274	Arformoterol	parkinson disease	30	0.31
DB01274	Arformoterol	liver cirrhosis biliary	23	0.32
DB01274	Arformoterol	myocardial ischemia	43	0.32
DB01274	Arformoterol	arteriosclerosis	38	0.33
DB01274	Arformoterol	hypopigmentation	22	0.33
DB01274	Arformoterol	liver cirrhosis	24	0.33
DB01274	Arformoterol	neuroendocrine tumors	24	0.34
DB01274	Arformoterol	kidney neoplasms	20	0.34
DB01274	Arformoterol	parkinsonian disorders	31	0.35
DB01274	Arformoterol	amyotrophic lateral sclerosis	21	0.36
DB01274	Arformoterol	asthma	36	0.36
DB01274	Arformoterol	alzheimer disease	29	0.38
DB01274	Arformoterol	cardiomyopathy dilated	29	0.40
DB01274	Arformoterol	lymphoma non hodgkin	22	0.42
DB01274	Arformoterol	hypersensitivity	45	0.43
DB01274	Arformoterol	arterial occlusive diseases	44	0.43
DB01274	Arformoterol	sarcoma	25	0.44
DB01274	Arformoterol	blood coagulation disorders	40	0.44
DB01274	Arformoterol	arthritis rheumatoid	42	0.45
DB01274	Arformoterol	lymphoma	24	0.46
DB01274	Arformoterol	motor neuron disease	31	0.46
DB01274	Arformoterol	prostatic neoplasms	61	0.50
DB01274	Arformoterol	colitis ulcerative	55	0.50
DB01274	Arformoterol	adenocarcinoma	32	0.51
DB01274	Arformoterol	head and neck neoplasms	35	0.53
DB01274	Arformoterol	dementia	42	0.53
DB01274	Arformoterol	colitis	55	0.55
DB01274	Arformoterol	psoriasis	54	0.55
DB01274	Arformoterol	lupus erythematosus systemic	75	0.56
DB01274	Arformoterol	rheumatic diseases	59	0.58
DB01274	Arformoterol	multiple sclerosis	69	0.60
DB01274	Arformoterol	crohn disease	71	0.64
DB01274	Arformoterol	diabetes mellitus type 1	82	0.65
DB01274	Arformoterol	leukemia myeloid acute	43	0.65
DB01274	Arformoterol	arthritis	76	0.65
DB01274	Arformoterol	leukemia lymphoid	66	0.66
DB01274	Arformoterol	joint diseases	79	0.68
DB01274	Arformoterol	spinal cord diseases	59	0.68
DB01274	Arformoterol	anemia	58	0.69
DB01274	Arformoterol	gastroenteritis	122	0.81
DB01274	Arformoterol	inflammatory bowel diseases	119	0.82
DB01274	Arformoterol	kidney diseases	144	0.84
DB01274	Arformoterol	leukemia	117	1.12
DB01274	Arformoterol	vascular diseases	181	1.13
DB01274	Arformoterol	eye diseases	231	1.15
DB01274	Arformoterol	metabolism inborn errors	289	1.31
DB01274	Arformoterol	autoimmune diseases	243	1.34
DB01274	Arformoterol	hematologic diseases	188	1.43
DB01409	Tiotropium	thyroid diseases	30	-1.17
DB01409	Tiotropium	liver cirrhosis	24	-1.10
DB01409	Tiotropium	liver cirrhosis biliary	23	-1.09
DB01409	Tiotropium	pancreatic diseases	24	-1.07
DB01409	Tiotropium	arteriosclerosis	38	-0.94
DB01409	Tiotropium	arterial occlusive diseases	44	-0.86
DB01409	Tiotropium	eye diseases	231	-0.79
DB01409	Tiotropium	head and neck neoplasms	35	-0.73
DB01409	Tiotropium	dementia	42	-0.69
DB01409	Tiotropium	colitis	55	-0.69
DB01409	Tiotropium	colitis ulcerative	55	-0.66
DB01409	Tiotropium	epilepsy	25	-0.60
DB01409	Tiotropium	psoriasis	54	-0.52
DB01409	Tiotropium	hyperinsulinism	26	-0.50
DB01409	Tiotropium	leukemia myeloid acute	43	-0.46
DB01409	Tiotropium	lupus erythematosus systemic	75	-0.44
DB01409	Tiotropium	diabetes mellitus type 1	82	-0.44
DB01409	Tiotropium	crohn disease	71	-0.42
DB01409	Tiotropium	insulin resistance	26	-0.41
DB01409	Tiotropium	bone diseases metabolic	27	-0.37
DB01409	Tiotropium	skin diseases	278	-0.37
DB01409	Tiotropium	arthritis	76	-0.29
DB01409	Tiotropium	joint diseases	79	-0.28
DB01409	Tiotropium	leukemia lymphoid	66	-0.28
DB01409	Tiotropium	lung diseases	71	-0.22
DB01409	Tiotropium	inflammatory bowel diseases	119	-0.13
DB01409	Tiotropium	gastrointestinal neoplasms	72	-0.10
DB01409	Tiotropium	gastroenteritis	122	-0.10
DB01409	Tiotropium	parkinson disease	30	-0.07
DB01409	Tiotropium	hypopigmentation	22	-0.02
DB01409	Tiotropium	parkinsonian disorders	31	-0.02
DB01409	Tiotropium	diabetes mellitus	162	0.02
DB01409	Tiotropium	kidney diseases	144	0.06
DB01409	Tiotropium	neuroendocrine tumors	24	0.09
DB01409	Tiotropium	bone diseases	144	0.12
DB01409	Tiotropium	asthma	36	0.14
DB01409	Tiotropium	neoplasms	482	0.17
DB01409	Tiotropium	leukemia	117	0.21
DB01409	Tiotropium	lymphoma	24	0.21
DB01409	Tiotropium	lymphoma non hodgkin	22	0.22
DB01409	Tiotropium	hypersensitivity	45	0.33
DB01409	Tiotropium	adenocarcinoma	32	0.37
DB01409	Tiotropium	vascular diseases	181	0.37
DB01409	Tiotropium	metabolism inborn errors	289	0.45
DB01409	Tiotropium	autoimmune diseases	243	0.48
DB01409	Tiotropium	hematologic diseases	188	0.48
DB01409	Tiotropium	endocrine system diseases	291	0.59
DB01409	Tiotropium	diabetes mellitus type 2	72	0.63
DB01409	Tiotropium	cardiovascular diseases	330	0.73
DB01409	Tiotropium	multiple sclerosis	69	0.77
DB01409	Tiotropium	spinal cord diseases	59	0.77
DB01409	Tiotropium	colorectal neoplasms	42	0.77
DB01409	Tiotropium	intestinal neoplasms	42	0.81
DB01409	Tiotropium	keratosis	21	0.82
DB01409	Tiotropium	mycobacterium infections	22	0.85
DB01409	Tiotropium	coronary artery disease	31	0.86
DB01409	Tiotropium	bacterial infections	26	0.92
DB01409	Tiotropium	anemia	58	0.94
DB01409	Tiotropium	kidney neoplasms	20	0.96
DB01409	Tiotropium	anemia hemolytic	29	0.96
DB01409	Tiotropium	coronary disease	37	1.05
DB01409	Tiotropium	amyotrophic lateral sclerosis	21	1.07
DB01409	Tiotropium	myocardial ischemia	43	1.10
DB01409	Tiotropium	malabsorption syndromes	34	1.11
DB01409	Tiotropium	alzheimer disease	29	1.22
DB01409	Tiotropium	sarcoma	25	1.28
DB01409	Tiotropium	cardiomyopathy dilated	29	1.30
DB01409	Tiotropium	heart diseases	167	1.33
DB01409	Tiotropium	varicose veins	20	1.39
DB01409	Tiotropium	blood coagulation disorders	40	1.43
DB01409	Tiotropium	motor neuron disease	31	1.48
DB01409	Tiotropium	prostatic neoplasms	61	1.65
DB01409	Tiotropium	arrhythmias cardiac	30	1.69
DB01409	Tiotropium	breast neoplasms	40	1.70
DB01409	Tiotropium	collagen diseases	25	1.71
DB01409	Tiotropium	macular degeneration	44	1.92
DB01409	Tiotropium	arthritis rheumatoid	42	2.71
DB01409	Tiotropium	rheumatic diseases	59	3.03
DB00588	Fluticasone.Propionate	asthma	36	-2.77
DB00588	Fluticasone.Propionate	hypersensitivity	45	-2.65
DB00588	Fluticasone.Propionate	sarcoma	25	-2.55
DB00588	Fluticasone.Propionate	metabolism inborn errors	289	-2.55
DB00588	Fluticasone.Propionate	multiple sclerosis	69	-1.91
DB00588	Fluticasone.Propionate	varicose veins	20	-1.64
DB00588	Fluticasone.Propionate	lung diseases	71	-1.61
DB00588	Fluticasone.Propionate	prostatic neoplasms	61	-1.30
DB00588	Fluticasone.Propionate	diabetes mellitus	162	-1.25
DB00588	Fluticasone.Propionate	kidney diseases	144	-1.22
DB00588	Fluticasone.Propionate	cardiovascular diseases	330	-1.10
DB00588	Fluticasone.Propionate	breast neoplasms	40	-1.03
DB00588	Fluticasone.Propionate	coronary artery disease	31	-1.01
DB00588	Fluticasone.Propionate	bone diseases	144	-0.98
DB00588	Fluticasone.Propionate	diabetes mellitus type 1	82	-0.93
DB00588	Fluticasone.Propionate	kidney neoplasms	20	-0.82
DB00588	Fluticasone.Propionate	coronary disease	37	-0.82
DB00588	Fluticasone.Propionate	mycobacterium infections	22	-0.81
DB00588	Fluticasone.Propionate	myocardial ischemia	43	-0.76
DB00588	Fluticasone.Propionate	cardiomyopathy dilated	29	-0.73
DB00588	Fluticasone.Propionate	vascular diseases	181	-0.72
DB00588	Fluticasone.Propionate	arteriosclerosis	38	-0.72
DB00588	Fluticasone.Propionate	malabsorption syndromes	34	-0.68
DB00588	Fluticasone.Propionate	bacterial infections	26	-0.59
DB00588	Fluticasone.Propionate	neuroendocrine tumors	24	-0.58
DB00588	Fluticasone.Propionate	alzheimer disease	29	-0.46
DB00588	Fluticasone.Propionate	liver cirrhosis	24	-0.42
DB00588	Fluticasone.Propionate	arterial occlusive diseases	44	-0.41
DB00588	Fluticasone.Propionate	autoimmune diseases	243	-0.40
DB00588	Fluticasone.Propionate	liver cirrhosis biliary	23	-0.40
DB00588	Fluticasone.Propionate	colitis ulcerative	55	-0.34
DB00588	Fluticasone.Propionate	colitis	55	-0.34
DB00588	Fluticasone.Propionate	epilepsy	25	-0.27
DB00588	Fluticasone.Propionate	skin diseases	278	-0.21
DB00588	Fluticasone.Propionate	endocrine system diseases	291	-0.20
DB00588	Fluticasone.Propionate	arrhythmias cardiac	30	-0.17
DB00588	Fluticasone.Propionate	lymphoma	24	-0.15
DB00588	Fluticasone.Propionate	diabetes mellitus type 2	72	-0.14
DB00588	Fluticasone.Propionate	motor neuron disease	31	-0.13
DB00588	Fluticasone.Propionate	arthritis rheumatoid	42	-0.13
DB00588	Fluticasone.Propionate	lymphoma non hodgkin	22	-0.10
DB00588	Fluticasone.Propionate	adenocarcinoma	32	-0.09
DB00588	Fluticasone.Propionate	collagen diseases	25	-0.09
DB00588	Fluticasone.Propionate	dementia	42	-0.08
DB00588	Fluticasone.Propionate	bone diseases metabolic	27	-0.06
DB00588	Fluticasone.Propionate	head and neck neoplasms	35	-0.04
DB00588	Fluticasone.Propionate	heart diseases	167	-0.03
DB00588	Fluticasone.Propionate	lupus erythematosus systemic	75	0.16
DB00588	Fluticasone.Propionate	rheumatic diseases	59	0.24
DB00588	Fluticasone.Propionate	parkinson disease	30	0.25
DB00588	Fluticasone.Propionate	anemia hemolytic	29	0.27
DB00588	Fluticasone.Propionate	keratosis	21	0.28
DB00588	Fluticasone.Propionate	crohn disease	71	0.30
DB00588	Fluticasone.Propionate	parkinsonian disorders	31	0.31
DB00588	Fluticasone.Propionate	leukemia myeloid acute	43	0.37
DB00588	Fluticasone.Propionate	hypopigmentation	22	0.42
DB00588	Fluticasone.Propionate	thyroid diseases	30	0.43
DB00588	Fluticasone.Propionate	intestinal neoplasms	42	0.48
DB00588	Fluticasone.Propionate	joint diseases	79	0.51
DB00588	Fluticasone.Propionate	colorectal neoplasms	42	0.52
DB00588	Fluticasone.Propionate	spinal cord diseases	59	0.54
DB00588	Fluticasone.Propionate	amyotrophic lateral sclerosis	21	0.55
DB00588	Fluticasone.Propionate	arthritis	76	0.56
DB00588	Fluticasone.Propionate	leukemia lymphoid	66	0.59
DB00588	Fluticasone.Propionate	hematologic diseases	188	0.73
DB00588	Fluticasone.Propionate	pancreatic diseases	24	0.73
DB00588	Fluticasone.Propionate	inflammatory bowel diseases	119	0.76
DB00588	Fluticasone.Propionate	neoplasms	482	0.77
DB00588	Fluticasone.Propionate	gastroenteritis	122	0.78
DB00588	Fluticasone.Propionate	gastrointestinal neoplasms	72	0.99
DB00588	Fluticasone.Propionate	insulin resistance	26	1.09
DB00588	Fluticasone.Propionate	psoriasis	54	1.12
DB00588	Fluticasone.Propionate	hyperinsulinism	26	1.13
DB00588	Fluticasone.Propionate	macular degeneration	44	1.26
DB00588	Fluticasone.Propionate	leukemia	117	1.29
DB00588	Fluticasone.Propionate	eye diseases	231	1.45
DB00588	Fluticasone.Propionate	anemia	58	1.73
DB00588	Fluticasone.Propionate	blood coagulation disorders	40	1.79
DB01050	Ibuprofen	skin diseases	278	-2.10
DB01050	Ibuprofen	gastrointestinal neoplasms	72	-1.97
DB01050	Ibuprofen	bone diseases metabolic	27	-1.32
DB01050	Ibuprofen	eye diseases	231	-1.26
DB01050	Ibuprofen	neoplasms	482	-1.07
DB01050	Ibuprofen	bone diseases	144	-0.98
DB01050	Ibuprofen	lung diseases	71	-0.96
DB01050	Ibuprofen	varicose veins	20	-0.92
DB01050	Ibuprofen	keratosis	21	-0.90
DB01050	Ibuprofen	hyperinsulinism	26	-0.59
DB01050	Ibuprofen	insulin resistance	26	-0.58
DB01050	Ibuprofen	vascular diseases	181	-0.58
DB01050	Ibuprofen	colorectal neoplasms	42	-0.55
DB01050	Ibuprofen	dementia	42	-0.55
DB01050	Ibuprofen	amyotrophic lateral sclerosis	21	-0.55
DB01050	Ibuprofen	intestinal neoplasms	42	-0.53
DB01050	Ibuprofen	alzheimer disease	29	-0.42
DB01050	Ibuprofen	pancreatic diseases	24	-0.35
DB01050	Ibuprofen	heart diseases	167	-0.32
DB01050	Ibuprofen	prostatic neoplasms	61	-0.29
DB01050	Ibuprofen	coronary artery disease	31	-0.23
DB01050	Ibuprofen	hematologic diseases	188	-0.19
DB01050	Ibuprofen	hypersensitivity	45	0.00
DB01050	Ibuprofen	coronary disease	37	0.05
DB01050	Ibuprofen	arteriosclerosis	38	0.10
DB01050	Ibuprofen	metabolism inborn errors	289	0.14
DB01050	Ibuprofen	diabetes mellitus type 2	72	0.16
DB01050	Ibuprofen	myocardial ischemia	43	0.16
DB01050	Ibuprofen	multiple sclerosis	69	0.21
DB01050	Ibuprofen	motor neuron disease	31	0.25
DB01050	Ibuprofen	arthritis rheumatoid	42	0.30
DB01050	Ibuprofen	spinal cord diseases	59	0.31
DB01050	Ibuprofen	cardiovascular diseases	330	0.32
DB01050	Ibuprofen	adenocarcinoma	32	0.34
DB01050	Ibuprofen	asthma	36	0.41
DB01050	Ibuprofen	psoriasis	54	0.41
DB01050	Ibuprofen	macular degeneration	44	0.42
DB01050	Ibuprofen	arterial occlusive diseases	44	0.43
DB01050	Ibuprofen	anemia	58	0.49
DB01050	Ibuprofen	autoimmune diseases	243	0.60
DB01050	Ibuprofen	sarcoma	25	0.61
DB01050	Ibuprofen	gastroenteritis	122	0.66
DB01050	Ibuprofen	rheumatic diseases	59	0.70
DB01050	Ibuprofen	anemia hemolytic	29	0.70
DB01050	Ibuprofen	inflammatory bowel diseases	119	0.70
DB01050	Ibuprofen	lupus erythematosus systemic	75	0.71
DB01050	Ibuprofen	kidney diseases	144	0.71
DB01050	Ibuprofen	lymphoma	24	0.77
DB01050	Ibuprofen	colitis	55	0.78
DB01050	Ibuprofen	colitis ulcerative	55	0.79
DB01050	Ibuprofen	thyroid diseases	30	0.83
DB01050	Ibuprofen	arrhythmias cardiac	30	0.84
DB01050	Ibuprofen	leukemia	117	0.84
DB01050	Ibuprofen	endocrine system diseases	291	0.84
DB01050	Ibuprofen	kidney neoplasms	20	0.89
DB01050	Ibuprofen	crohn disease	71	0.89
DB01050	Ibuprofen	lymphoma non hodgkin	22	0.91
DB01050	Ibuprofen	collagen diseases	25	0.94
DB01050	Ibuprofen	cardiomyopathy dilated	29	1.06
DB01050	Ibuprofen	head and neck neoplasms	35	1.07
DB01050	Ibuprofen	joint diseases	79	1.11
DB01050	Ibuprofen	arthritis	76	1.11
DB01050	Ibuprofen	leukemia lymphoid	66	1.14
DB01050	Ibuprofen	blood coagulation disorders	40	1.20
DB01050	Ibuprofen	breast neoplasms	40	1.36
DB01050	Ibuprofen	diabetes mellitus type 1	82	1.45
DB01050	Ibuprofen	parkinsonian disorders	31	1.47
DB01050	Ibuprofen	diabetes mellitus	162	1.50
DB01050	Ibuprofen	epilepsy	25	1.56
DB01050	Ibuprofen	parkinson disease	30	1.66
DB01050	Ibuprofen	leukemia myeloid acute	43	1.69
DB01050	Ibuprofen	malabsorption syndromes	34	1.70
DB01050	Ibuprofen	bacterial infections	26	1.75
DB01050	Ibuprofen	neuroendocrine tumors	24	1.94
DB01050	Ibuprofen	hypopigmentation	22	2.27
DB01050	Ibuprofen	mycobacterium infections	22	2.97
DB01050	Ibuprofen	liver cirrhosis	24	3.33
DB01050	Ibuprofen	liver cirrhosis biliary	23	3.43
DB01611	Hydroxychloroquine	hematologic diseases	188	-1.41
DB01611	Hydroxychloroquine	thyroid diseases	30	-1.38
DB01611	Hydroxychloroquine	macular degeneration	44	-1.38
DB01611	Hydroxychloroquine	pancreatic diseases	24	-1.33
DB01611	Hydroxychloroquine	liver cirrhosis biliary	23	-1.31
DB01611	Hydroxychloroquine	cardiomyopathy dilated	29	-1.29
DB01611	Hydroxychloroquine	liver cirrhosis	24	-1.25
DB01611	Hydroxychloroquine	malabsorption syndromes	34	-1.23
DB01611	Hydroxychloroquine	asthma	36	-1.21
DB01611	Hydroxychloroquine	arthritis rheumatoid	42	-1.06
DB01611	Hydroxychloroquine	colitis ulcerative	55	-1.02
DB01611	Hydroxychloroquine	head and neck neoplasms	35	-1.01
DB01611	Hydroxychloroquine	colitis	55	-0.99
DB01611	Hydroxychloroquine	hypersensitivity	45	-0.99
DB01611	Hydroxychloroquine	breast neoplasms	40	-0.90
DB01611	Hydroxychloroquine	prostatic neoplasms	61	-0.80
DB01611	Hydroxychloroquine	lupus erythematosus systemic	75	-0.75
DB01611	Hydroxychloroquine	rheumatic diseases	59	-0.72
DB01611	Hydroxychloroquine	spinal cord diseases	59	-0.69
DB01611	Hydroxychloroquine	neoplasms	482	-0.69
DB01611	Hydroxychloroquine	joint diseases	79	-0.68
DB01611	Hydroxychloroquine	arthritis	76	-0.63
DB01611	Hydroxychloroquine	leukemia lymphoid	66	-0.59
DB01611	Hydroxychloroquine	lung diseases	71	-0.55
DB01611	Hydroxychloroquine	gastroenteritis	122	-0.46
DB01611	Hydroxychloroquine	insulin resistance	26	-0.42
DB01611	Hydroxychloroquine	inflammatory bowel diseases	119	-0.41
DB01611	Hydroxychloroquine	kidney diseases	144	-0.40
DB01611	Hydroxychloroquine	hyperinsulinism	26	-0.38
DB01611	Hydroxychloroquine	arrhythmias cardiac	30	-0.31
DB01611	Hydroxychloroquine	heart diseases	167	-0.28
DB01611	Hydroxychloroquine	keratosis	21	-0.22
DB01611	Hydroxychloroquine	mycobacterium infections	22	-0.21
DB01611	Hydroxychloroquine	coronary artery disease	31	-0.19
DB01611	Hydroxychloroquine	leukemia	117	-0.17
DB01611	Hydroxychloroquine	vascular diseases	181	-0.14
DB01611	Hydroxychloroquine	eye diseases	231	-0.10
DB01611	Hydroxychloroquine	hypopigmentation	22	-0.08
DB01611	Hydroxychloroquine	bacterial infections	26	-0.04
DB01611	Hydroxychloroquine	amyotrophic lateral sclerosis	21	-0.02
DB01611	Hydroxychloroquine	arteriosclerosis	38	-0.02
DB01611	Hydroxychloroquine	myocardial ischemia	43	-0.01
DB01611	Hydroxychloroquine	metabolism inborn errors	289	0.01
DB01611	Hydroxychloroquine	coronary disease	37	0.01
DB01611	Hydroxychloroquine	autoimmune diseases	243	0.05
DB01611	Hydroxychloroquine	sarcoma	25	0.08
DB01611	Hydroxychloroquine	alzheimer disease	29	0.09
DB01611	Hydroxychloroquine	lymphoma non hodgkin	22	0.16
DB01611	Hydroxychloroquine	endocrine system diseases	291	0.17
DB01611	Hydroxychloroquine	arterial occlusive diseases	44	0.18
DB01611	Hydroxychloroquine	cardiovascular diseases	330	0.18
DB01611	Hydroxychloroquine	skin diseases	278	0.21
DB01611	Hydroxychloroquine	blood coagulation disorders	40	0.22
DB01611	Hydroxychloroquine	lymphoma	24	0.24
DB01611	Hydroxychloroquine	motor neuron disease	31	0.25
DB01611	Hydroxychloroquine	adenocarcinoma	32	0.30
DB01611	Hydroxychloroquine	dementia	42	0.39
DB01611	Hydroxychloroquine	psoriasis	54	0.44
DB01611	Hydroxychloroquine	diabetes mellitus type 2	72	0.48
DB01611	Hydroxychloroquine	colorectal neoplasms	42	0.53
DB01611	Hydroxychloroquine	intestinal neoplasms	42	0.56
DB01611	Hydroxychloroquine	leukemia myeloid acute	43	0.56
DB01611	Hydroxychloroquine	multiple sclerosis	69	0.60
DB01611	Hydroxychloroquine	crohn disease	71	0.64
DB01611	Hydroxychloroquine	diabetes mellitus type 1	82	0.66
DB01611	Hydroxychloroquine	anemia	58	0.72
DB01611	Hydroxychloroquine	varicose veins	20	0.75
DB01611	Hydroxychloroquine	epilepsy	25	0.82
DB01611	Hydroxychloroquine	gastrointestinal neoplasms	72	0.90
DB01611	Hydroxychloroquine	bone diseases metabolic	27	0.97
DB01611	Hydroxychloroquine	collagen diseases	25	0.98
DB01611	Hydroxychloroquine	diabetes mellitus	162	1.03
DB01611	Hydroxychloroquine	bone diseases	144	1.14
DB01611	Hydroxychloroquine	anemia hemolytic	29	1.17
DB01611	Hydroxychloroquine	parkinsonian disorders	31	1.19
DB01611	Hydroxychloroquine	kidney neoplasms	20	1.19
DB01611	Hydroxychloroquine	neuroendocrine tumors	24	1.26
DB01611	Hydroxychloroquine	parkinson disease	30	1.27
DB00749	Etodolac	eye diseases	231	-1.93
DB00749	Etodolac	bone diseases metabolic	27	-1.69
DB00749	Etodolac	skin diseases	278	-1.25
DB00749	Etodolac	lung diseases	71	-1.22
DB00749	Etodolac	gastrointestinal neoplasms	72	-1.00
DB00749	Etodolac	dementia	42	-0.67
DB00749	Etodolac	metabolism inborn errors	289	-0.59
DB00749	Etodolac	psoriasis	54	-0.55
DB00749	Etodolac	diabetes mellitus type 1	82	-0.43
DB00749	Etodolac	lupus erythematosus systemic	75	-0.39
DB00749	Etodolac	breast neoplasms	40	-0.39
DB00749	Etodolac	multiple sclerosis	69	-0.14
DB00749	Etodolac	endocrine system diseases	291	-0.13
DB00749	Etodolac	colorectal neoplasms	42	-0.11
DB00749	Etodolac	intestinal neoplasms	42	-0.08
DB00749	Etodolac	leukemia lymphoid	66	-0.07
DB00749	Etodolac	spinal cord diseases	59	-0.02
DB00749	Etodolac	thyroid diseases	30	0.11
DB00749	Etodolac	keratosis	21	0.11
DB00749	Etodolac	diabetes mellitus	162	0.13
DB00749	Etodolac	amyotrophic lateral sclerosis	21	0.24
DB00749	Etodolac	malabsorption syndromes	34	0.27
DB00749	Etodolac	alzheimer disease	29	0.31
DB00749	Etodolac	heart diseases	167	0.39
DB00749	Etodolac	bone diseases	144	0.48
DB00749	Etodolac	colitis ulcerative	55	0.48
DB00749	Etodolac	colitis	55	0.48
DB00749	Etodolac	diabetes mellitus type 2	72	0.55
DB00749	Etodolac	sarcoma	25	0.56
DB00749	Etodolac	leukemia	117	0.64
DB00749	Etodolac	neoplasms	482	0.65
DB00749	Etodolac	lymphoma non hodgkin	22	0.70
DB00749	Etodolac	varicose veins	20	0.72
DB00749	Etodolac	head and neck neoplasms	35	0.73
DB00749	Etodolac	lymphoma	24	0.74
DB00749	Etodolac	adenocarcinoma	32	0.78
DB00749	Etodolac	arthritis rheumatoid	42	0.79
DB00749	Etodolac	prostatic neoplasms	61	0.81
DB00749	Etodolac	motor neuron disease	31	0.83
DB00749	Etodolac	arrhythmias cardiac	30	0.91
DB00749	Etodolac	hematologic diseases	188	0.93
DB00749	Etodolac	collagen diseases	25	0.93
DB00749	Etodolac	hyperinsulinism	26	0.96
DB00749	Etodolac	autoimmune diseases	243	0.99
DB00749	Etodolac	insulin resistance	26	1.00
DB00749	Etodolac	crohn disease	71	1.12
DB00749	Etodolac	rheumatic diseases	59	1.13
DB00749	Etodolac	macular degeneration	44	1.14
DB00749	Etodolac	leukemia myeloid acute	43	1.18
DB00749	Etodolac	cardiovascular diseases	330	1.21
DB00749	Etodolac	coronary artery disease	31	1.28
DB00749	Etodolac	arthritis	76	1.33
DB00749	Etodolac	joint diseases	79	1.35
DB00749	Etodolac	kidney diseases	144	1.39
DB00749	Etodolac	gastroenteritis	122	1.41
DB00749	Etodolac	inflammatory bowel diseases	119	1.42
DB00749	Etodolac	parkinsonian disorders	31	1.44
DB00749	Etodolac	parkinson disease	30	1.47
DB00749	Etodolac	coronary disease	37	1.48
DB00749	Etodolac	kidney neoplasms	20	1.49
DB00749	Etodolac	anemia	58	1.54
DB00749	Etodolac	arteriosclerosis	38	1.61
DB00749	Etodolac	myocardial ischemia	43	1.65
DB00749	Etodolac	neuroendocrine tumors	24	1.71
DB00749	Etodolac	arterial occlusive diseases	44	1.74
DB00749	Etodolac	asthma	36	1.74
DB00749	Etodolac	liver cirrhosis biliary	23	1.78
DB00749	Etodolac	liver cirrhosis	24	1.80
DB00749	Etodolac	pancreatic diseases	24	1.83
DB00749	Etodolac	hypersensitivity	45	1.96
DB00749	Etodolac	vascular diseases	181	1.97
DB00749	Etodolac	epilepsy	25	2.09
DB00749	Etodolac	mycobacterium infections	22	2.53
DB00749	Etodolac	anemia hemolytic	29	2.67
DB00749	Etodolac	hypopigmentation	22	2.75
DB00749	Etodolac	bacterial infections	26	2.79
DB00749	Etodolac	cardiomyopathy dilated	29	3.09
DB00749	Etodolac	blood coagulation disorders	40	3.28
DB00214	Torasemide	kidney diseases	144	-3.63
DB00214	Torasemide	endocrine system diseases	291	-3.38
DB00214	Torasemide	gastrointestinal neoplasms	72	-2.28
DB00214	Torasemide	neoplasms	482	-1.51
DB00214	Torasemide	varicose veins	20	-1.39
DB00214	Torasemide	arrhythmias cardiac	30	-1.26
DB00214	Torasemide	anemia hemolytic	29	-1.11
DB00214	Torasemide	liver cirrhosis	24	-1.01
DB00214	Torasemide	liver cirrhosis biliary	23	-1.01
DB00214	Torasemide	pancreatic diseases	24	-0.96
DB00214	Torasemide	colitis ulcerative	55	-0.80
DB00214	Torasemide	colitis	55	-0.76
DB00214	Torasemide	arthritis rheumatoid	42	-0.74
DB00214	Torasemide	head and neck neoplasms	35	-0.73
DB00214	Torasemide	adenocarcinoma	32	-0.73
DB00214	Torasemide	prostatic neoplasms	61	-0.70
DB00214	Torasemide	rheumatic diseases	59	-0.69
DB00214	Torasemide	diabetes mellitus type 2	72	-0.66
DB00214	Torasemide	intestinal neoplasms	42	-0.66
DB00214	Torasemide	leukemia myeloid acute	43	-0.63
DB00214	Torasemide	colorectal neoplasms	42	-0.61
DB00214	Torasemide	anemia	58	-0.55
DB00214	Torasemide	leukemia lymphoid	66	-0.54
DB00214	Torasemide	arthritis	76	-0.53
DB00214	Torasemide	diabetes mellitus type 1	82	-0.53
DB00214	Torasemide	joint diseases	79	-0.52
DB00214	Torasemide	inflammatory bowel diseases	119	-0.43
DB00214	Torasemide	gastroenteritis	122	-0.43
DB00214	Torasemide	lung diseases	71	-0.43
DB00214	Torasemide	bone diseases	144	-0.31
DB00214	Torasemide	heart diseases	167	-0.29
DB00214	Torasemide	leukemia	117	-0.27
DB00214	Torasemide	diabetes mellitus	162	-0.26
DB00214	Torasemide	vascular diseases	181	-0.17
DB00214	Torasemide	hematologic diseases	188	-0.16
DB00214	Torasemide	autoimmune diseases	243	-0.12
DB00214	Torasemide	metabolism inborn errors	289	-0.10
DB00214	Torasemide	cardiovascular diseases	330	-0.03
DB00214	Torasemide	skin diseases	278	-0.01
DB00214	Torasemide	epilepsy	25	0.39
DB00214	Torasemide	hyperinsulinism	26	0.41
DB00214	Torasemide	collagen diseases	25	0.45
DB00214	Torasemide	insulin resistance	26	0.46
DB00214	Torasemide	bone diseases metabolic	27	0.49
DB00214	Torasemide	mycobacterium infections	22	0.52
DB00214	Torasemide	keratosis	21	0.54
DB00214	Torasemide	macular degeneration	44	0.54
DB00214	Torasemide	coronary artery disease	31	0.56
DB00214	Torasemide	kidney neoplasms	20	0.59
DB00214	Torasemide	hypopigmentation	22	0.62
DB00214	Torasemide	bacterial infections	26	0.62
DB00214	Torasemide	amyotrophic lateral sclerosis	21	0.62
DB00214	Torasemide	thyroid diseases	30	0.63
DB00214	Torasemide	coronary disease	37	0.63
DB00214	Torasemide	myocardial ischemia	43	0.64
DB00214	Torasemide	parkinsonian disorders	31	0.64
DB00214	Torasemide	malabsorption syndromes	34	0.64
DB00214	Torasemide	parkinson disease	30	0.66
DB00214	Torasemide	cardiomyopathy dilated	29	0.67
DB00214	Torasemide	arteriosclerosis	38	0.67
DB00214	Torasemide	neuroendocrine tumors	24	0.68
DB00214	Torasemide	sarcoma	25	0.72
DB00214	Torasemide	asthma	36	0.73
DB00214	Torasemide	alzheimer disease	29	0.74
DB00214	Torasemide	arterial occlusive diseases	44	0.78
DB00214	Torasemide	lymphoma	24	0.78
DB00214	Torasemide	lymphoma non hodgkin	22	0.80
DB00214	Torasemide	hypersensitivity	45	0.80
DB00214	Torasemide	blood coagulation disorders	40	0.81
DB00214	Torasemide	motor neuron disease	31	0.89
DB00214	Torasemide	dementia	42	0.93
DB00214	Torasemide	psoriasis	54	0.94
DB00214	Torasemide	breast neoplasms	40	0.95
DB00214	Torasemide	lupus erythematosus systemic	75	1.06
DB00214	Torasemide	multiple sclerosis	69	1.09
DB00214	Torasemide	spinal cord diseases	59	1.09
DB00214	Torasemide	crohn disease	71	1.11
DB00214	Torasemide	eye diseases	231	1.60
DB00215	Citalopram	arthritis	76	-2.65
DB00215	Citalopram	joint diseases	79	-2.57
DB00215	Citalopram	psoriasis	54	-1.93
DB00215	Citalopram	crohn disease	71	-1.73
DB00215	Citalopram	autoimmune diseases	243	-1.59
DB00215	Citalopram	inflammatory bowel diseases	119	-1.40
DB00215	Citalopram	gastroenteritis	122	-1.32
DB00215	Citalopram	arterial occlusive diseases	44	-1.21
DB00215	Citalopram	hyperinsulinism	26	-1.14
DB00215	Citalopram	arrhythmias cardiac	30	-1.08
DB00215	Citalopram	bone diseases	144	-1.08
DB00215	Citalopram	insulin resistance	26	-1.07
DB00215	Citalopram	colitis	55	-1.05
DB00215	Citalopram	colitis ulcerative	55	-1.01
DB00215	Citalopram	dementia	42	-0.96
DB00215	Citalopram	diabetes mellitus type 2	72	-0.88
DB00215	Citalopram	thyroid diseases	30	-0.72
DB00215	Citalopram	lupus erythematosus systemic	75	-0.71
DB00215	Citalopram	multiple sclerosis	69	-0.67
DB00215	Citalopram	parkinsonian disorders	31	-0.65
DB00215	Citalopram	parkinson disease	30	-0.64
DB00215	Citalopram	liver cirrhosis biliary	23	-0.62
DB00215	Citalopram	liver cirrhosis	24	-0.61
DB00215	Citalopram	bacterial infections	26	-0.59
DB00215	Citalopram	amyotrophic lateral sclerosis	21	-0.58
DB00215	Citalopram	pancreatic diseases	24	-0.58
DB00215	Citalopram	arteriosclerosis	38	-0.55
DB00215	Citalopram	lung diseases	71	-0.51
DB00215	Citalopram	neuroendocrine tumors	24	-0.48
DB00215	Citalopram	cardiomyopathy dilated	29	-0.45
DB00215	Citalopram	alzheimer disease	29	-0.42
DB00215	Citalopram	skin diseases	278	-0.42
DB00215	Citalopram	sarcoma	25	-0.36
DB00215	Citalopram	lymphoma non hodgkin	22	-0.30
DB00215	Citalopram	lymphoma	24	-0.30
DB00215	Citalopram	kidney diseases	144	-0.28
DB00215	Citalopram	motor neuron disease	31	-0.16
DB00215	Citalopram	collagen diseases	25	-0.15
DB00215	Citalopram	diabetes mellitus	162	-0.14
DB00215	Citalopram	arthritis rheumatoid	42	-0.12
DB00215	Citalopram	adenocarcinoma	32	-0.11
DB00215	Citalopram	bone diseases metabolic	27	-0.11
DB00215	Citalopram	head and neck neoplasms	35	-0.08
DB00215	Citalopram	coronary artery disease	31	0.04
DB00215	Citalopram	keratosis	21	0.05
DB00215	Citalopram	mycobacterium infections	22	0.07
DB00215	Citalopram	leukemia	117	0.07
DB00215	Citalopram	breast neoplasms	40	0.09
DB00215	Citalopram	vascular diseases	181	0.12
DB00215	Citalopram	eye diseases	231	0.18
DB00215	Citalopram	rheumatic diseases	59	0.21
DB00215	Citalopram	anemia hemolytic	29	0.21
DB00215	Citalopram	hypopigmentation	22	0.23
DB00215	Citalopram	metabolism inborn errors	289	0.26
DB00215	Citalopram	intestinal neoplasms	42	0.26
DB00215	Citalopram	colorectal neoplasms	42	0.26
DB00215	Citalopram	leukemia myeloid acute	43	0.26
DB00215	Citalopram	coronary disease	37	0.28
DB00215	Citalopram	hematologic diseases	188	0.32
DB00215	Citalopram	diabetes mellitus type 1	82	0.32
DB00215	Citalopram	myocardial ischemia	43	0.36
DB00215	Citalopram	spinal cord diseases	59	0.36
DB00215	Citalopram	anemia	58	0.41
DB00215	Citalopram	asthma	36	0.42
DB00215	Citalopram	endocrine system diseases	291	0.50
DB00215	Citalopram	leukemia lymphoid	66	0.51
DB00215	Citalopram	varicose veins	20	0.53
DB00215	Citalopram	epilepsy	25	0.57
DB00215	Citalopram	cardiovascular diseases	330	0.61
DB00215	Citalopram	blood coagulation disorders	40	0.65
DB00215	Citalopram	hypersensitivity	45	0.68
DB00215	Citalopram	gastrointestinal neoplasms	72	0.68
DB00215	Citalopram	heart diseases	167	0.92
DB00215	Citalopram	macular degeneration	44	1.01
DB00215	Citalopram	prostatic neoplasms	61	1.09
DB00215	Citalopram	neoplasms	482	1.10
DB00215	Citalopram	kidney neoplasms	20	1.10
DB00215	Citalopram	malabsorption syndromes	34	1.22
DB00744	Zileuton	psoriasis	54	-2.64
DB00744	Zileuton	multiple sclerosis	69	-2.40
DB00744	Zileuton	myocardial ischemia	43	-2.37
DB00744	Zileuton	arthritis rheumatoid	42	-2.32
DB00744	Zileuton	arthritis	76	-2.26
DB00744	Zileuton	rheumatic diseases	59	-2.25
DB00744	Zileuton	joint diseases	79	-2.16
DB00744	Zileuton	gastroenteritis	122	-1.84
DB00744	Zileuton	heart diseases	167	-1.57
DB00744	Zileuton	bone diseases	144	-1.50
DB00744	Zileuton	vascular diseases	181	-1.32
DB00744	Zileuton	autoimmune diseases	243	-1.07
DB00744	Zileuton	cardiovascular diseases	330	-1.03
DB00744	Zileuton	skin diseases	278	-0.94
DB00744	Zileuton	neoplasms	482	-0.54
DB00744	Zileuton	varicose veins	20	-0.51
DB00744	Zileuton	epilepsy	25	-0.51
DB00744	Zileuton	arrhythmias cardiac	30	-0.44
DB00744	Zileuton	hyperinsulinism	26	-0.40
DB00744	Zileuton	insulin resistance	26	-0.40
DB00744	Zileuton	bone diseases metabolic	27	-0.32
DB00744	Zileuton	mycobacterium infections	22	-0.32
DB00744	Zileuton	collagen diseases	25	-0.32
DB00744	Zileuton	keratosis	21	-0.31
DB00744	Zileuton	coronary artery disease	31	-0.31
DB00744	Zileuton	macular degeneration	44	-0.29
DB00744	Zileuton	coronary disease	37	-0.22
DB00744	Zileuton	malabsorption syndromes	34	-0.21
DB00744	Zileuton	parkinson disease	30	-0.20
DB00744	Zileuton	bacterial infections	26	-0.20
DB00744	Zileuton	liver cirrhosis	24	-0.19
DB00744	Zileuton	anemia hemolytic	29	-0.19
DB00744	Zileuton	pancreatic diseases	24	-0.19
DB00744	Zileuton	liver cirrhosis biliary	23	-0.18
DB00744	Zileuton	parkinsonian disorders	31	-0.17
DB00744	Zileuton	hypopigmentation	22	-0.16
DB00744	Zileuton	thyroid diseases	30	-0.15
DB00744	Zileuton	arteriosclerosis	38	-0.15
DB00744	Zileuton	alzheimer disease	29	-0.14
DB00744	Zileuton	amyotrophic lateral sclerosis	21	-0.13
DB00744	Zileuton	neuroendocrine tumors	24	-0.12
DB00744	Zileuton	kidney neoplasms	20	-0.12
DB00744	Zileuton	asthma	36	-0.11
DB00744	Zileuton	cardiomyopathy dilated	29	-0.08
DB00744	Zileuton	sarcoma	25	-0.07
DB00744	Zileuton	arterial occlusive diseases	44	-0.06
DB00744	Zileuton	lymphoma non hodgkin	22	-0.06
DB00744	Zileuton	lymphoma	24	-0.03
DB00744	Zileuton	hypersensitivity	45	-0.03
DB00744	Zileuton	colitis	55	0.00
DB00744	Zileuton	blood coagulation disorders	40	0.03
DB00744	Zileuton	colitis ulcerative	55	0.05
DB00744	Zileuton	adenocarcinoma	32	0.10
DB00744	Zileuton	head and neck neoplasms	35	0.11
DB00744	Zileuton	motor neuron disease	31	0.12
DB00744	Zileuton	dementia	42	0.15
DB00744	Zileuton	breast neoplasms	40	0.16
DB00744	Zileuton	prostatic neoplasms	61	0.17
DB00744	Zileuton	lupus erythematosus systemic	75	0.17
DB00744	Zileuton	intestinal neoplasms	42	0.22
DB00744	Zileuton	diabetes mellitus type 2	72	0.23
DB00744	Zileuton	diabetes mellitus type 1	82	0.23
DB00744	Zileuton	crohn disease	71	0.26
DB00744	Zileuton	leukemia myeloid acute	43	0.26
DB00744	Zileuton	colorectal neoplasms	42	0.28
DB00744	Zileuton	spinal cord diseases	59	0.29
DB00744	Zileuton	lung diseases	71	0.29
DB00744	Zileuton	anemia	58	0.30
DB00744	Zileuton	leukemia lymphoid	66	0.31
DB00744	Zileuton	inflammatory bowel diseases	119	0.39
DB00744	Zileuton	kidney diseases	144	0.45
DB00744	Zileuton	gastrointestinal neoplasms	72	0.45
DB00744	Zileuton	diabetes mellitus	162	0.51
DB00744	Zileuton	leukemia	117	0.60
DB00744	Zileuton	eye diseases	231	0.61
DB00744	Zileuton	metabolism inborn errors	289	0.65
DB00744	Zileuton	hematologic diseases	188	0.71
DB00744	Zileuton	endocrine system diseases	291	0.83
DB01113	Papaverine	eye diseases	231	-1.53
DB01113	Papaverine	varicose veins	20	-0.62
DB01113	Papaverine	epilepsy	25	-0.58
DB01113	Papaverine	arrhythmias cardiac	30	-0.52
DB01113	Papaverine	bone diseases metabolic	27	-0.46
DB01113	Papaverine	collagen diseases	25	-0.45
DB01113	Papaverine	coronary artery disease	31	-0.31
DB01113	Papaverine	metabolism inborn errors	289	-0.27
DB01113	Papaverine	coronary disease	37	-0.22
DB01113	Papaverine	autoimmune diseases	243	-0.21
DB01113	Papaverine	bacterial infections	26	-0.21
DB01113	Papaverine	thyroid diseases	30	-0.20
DB01113	Papaverine	kidney neoplasms	20	-0.20
DB01113	Papaverine	amyotrophic lateral sclerosis	21	-0.18
DB01113	Papaverine	pancreatic diseases	24	-0.18
DB01113	Papaverine	parkinsonian disorders	31	-0.15
DB01113	Papaverine	myocardial ischemia	43	-0.15
DB01113	Papaverine	hypopigmentation	22	-0.14
DB01113	Papaverine	parkinson disease	30	-0.13
DB01113	Papaverine	arteriosclerosis	38	-0.13
DB01113	Papaverine	asthma	36	-0.10
DB01113	Papaverine	cardiomyopathy dilated	29	-0.10
DB01113	Papaverine	alzheimer disease	29	-0.10
DB01113	Papaverine	sarcoma	25	-0.03
DB01113	Papaverine	endocrine system diseases	291	-0.01
DB01113	Papaverine	hypersensitivity	45	0.00
DB01113	Papaverine	lymphoma non hodgkin	22	0.04
DB01113	Papaverine	arterial occlusive diseases	44	0.04
DB01113	Papaverine	lymphoma	24	0.05
DB01113	Papaverine	motor neuron disease	31	0.15
DB01113	Papaverine	arthritis rheumatoid	42	0.16
DB01113	Papaverine	head and neck neoplasms	35	0.18
DB01113	Papaverine	dementia	42	0.18
DB01113	Papaverine	adenocarcinoma	32	0.20
DB01113	Papaverine	breast neoplasms	40	0.23
DB01113	Papaverine	diabetes mellitus type 2	72	0.24
DB01113	Papaverine	psoriasis	54	0.26
DB01113	Papaverine	prostatic neoplasms	61	0.31
DB01113	Papaverine	rheumatic diseases	59	0.31
DB01113	Papaverine	multiple sclerosis	69	0.35
DB01113	Papaverine	spinal cord diseases	59	0.38
DB01113	Papaverine	colorectal neoplasms	42	0.40
DB01113	Papaverine	joint diseases	79	0.40
DB01113	Papaverine	intestinal neoplasms	42	0.42
DB01113	Papaverine	arthritis	76	0.45
DB01113	Papaverine	lung diseases	71	0.46
DB01113	Papaverine	leukemia lymphoid	66	0.50
DB01113	Papaverine	kidney diseases	144	0.68
DB01113	Papaverine	gastrointestinal neoplasms	72	0.68
DB01113	Papaverine	diabetes mellitus	162	0.70
DB01113	Papaverine	heart diseases	167	0.82
DB01113	Papaverine	bone diseases	144	0.84
DB01113	Papaverine	vascular diseases	181	0.93
DB01113	Papaverine	leukemia	117	0.93
DB01113	Papaverine	hyperinsulinism	26	0.99
DB01113	Papaverine	insulin resistance	26	1.09
DB01113	Papaverine	macular degeneration	44	1.16
DB01113	Papaverine	hematologic diseases	188	1.21
DB01113	Papaverine	keratosis	21	1.25
DB01113	Papaverine	skin diseases	278	1.33
DB01113	Papaverine	anemia hemolytic	29	1.39
DB01113	Papaverine	cardiovascular diseases	330	1.43
DB01113	Papaverine	liver cirrhosis	24	1.53
DB01113	Papaverine	liver cirrhosis biliary	23	1.54
DB01113	Papaverine	malabsorption syndromes	34	1.55
DB01113	Papaverine	neuroendocrine tumors	24	1.60
DB01113	Papaverine	blood coagulation disorders	40	1.74
DB01113	Papaverine	colitis ulcerative	55	1.81
DB01113	Papaverine	colitis	55	1.81
DB01113	Papaverine	leukemia myeloid acute	43	1.88
DB01113	Papaverine	diabetes mellitus type 1	82	1.92
DB01113	Papaverine	lupus erythematosus systemic	75	1.95
DB01113	Papaverine	crohn disease	71	1.99
DB01113	Papaverine	inflammatory bowel diseases	119	2.02
DB01113	Papaverine	anemia	58	2.08
DB01113	Papaverine	gastroenteritis	122	2.11
DB01113	Papaverine	neoplasms	482	2.29
DB01113	Papaverine	mycobacterium infections	22	2.79
DB00584	Enalapril	diabetes mellitus	162	-4.41
DB00584	Enalapril	vascular diseases	181	-4.33
DB00584	Enalapril	kidney diseases	144	-4.32
DB00584	Enalapril	endocrine system diseases	291	-3.88
DB00584	Enalapril	metabolism inborn errors	289	-3.82
DB00584	Enalapril	cardiovascular diseases	330	-3.56
DB00584	Enalapril	varicose veins	20	-1.21
DB00584	Enalapril	collagen diseases	25	-1.10
DB00584	Enalapril	coronary artery disease	31	-0.98
DB00584	Enalapril	mycobacterium infections	22	-0.95
DB00584	Enalapril	thyroid diseases	30	-0.95
DB00584	Enalapril	keratosis	21	-0.94
DB00584	Enalapril	bone diseases metabolic	27	-0.90
DB00584	Enalapril	amyotrophic lateral sclerosis	21	-0.89
DB00584	Enalapril	macular degeneration	44	-0.86
DB00584	Enalapril	anemia hemolytic	29	-0.85
DB00584	Enalapril	liver cirrhosis	24	-0.85
DB00584	Enalapril	parkinson disease	30	-0.84
DB00584	Enalapril	malabsorption syndromes	34	-0.84
DB00584	Enalapril	myocardial ischemia	43	-0.82
DB00584	Enalapril	neuroendocrine tumors	24	-0.81
DB00584	Enalapril	liver cirrhosis biliary	23	-0.80
DB00584	Enalapril	bacterial infections	26	-0.80
DB00584	Enalapril	coronary disease	37	-0.80
DB00584	Enalapril	pancreatic diseases	24	-0.80
DB00584	Enalapril	parkinsonian disorders	31	-0.79
DB00584	Enalapril	arteriosclerosis	38	-0.78
DB00584	Enalapril	alzheimer disease	29	-0.78
DB00584	Enalapril	cardiomyopathy dilated	29	-0.78
DB00584	Enalapril	asthma	36	-0.73
DB00584	Enalapril	arterial occlusive diseases	44	-0.72
DB00584	Enalapril	sarcoma	25	-0.72
DB00584	Enalapril	lymphoma	24	-0.71
DB00584	Enalapril	lymphoma non hodgkin	22	-0.69
DB00584	Enalapril	hypersensitivity	45	-0.65
DB00584	Enalapril	blood coagulation disorders	40	-0.63
DB00584	Enalapril	motor neuron disease	31	-0.60
DB00584	Enalapril	colitis ulcerative	55	-0.59
DB00584	Enalapril	adenocarcinoma	32	-0.58
DB00584	Enalapril	dementia	42	-0.57
DB00584	Enalapril	breast neoplasms	40	-0.53
DB00584	Enalapril	prostatic neoplasms	61	-0.53
DB00584	Enalapril	head and neck neoplasms	35	-0.52
DB00584	Enalapril	colitis	55	-0.50
DB00584	Enalapril	psoriasis	54	-0.49
DB00584	Enalapril	intestinal neoplasms	42	-0.43
DB00584	Enalapril	diabetes mellitus type 2	72	-0.43
DB00584	Enalapril	crohn disease	71	-0.42
DB00584	Enalapril	colorectal neoplasms	42	-0.41
DB00584	Enalapril	leukemia myeloid acute	43	-0.39
DB00584	Enalapril	multiple sclerosis	69	-0.39
DB00584	Enalapril	lupus erythematosus systemic	75	-0.38
DB00584	Enalapril	diabetes mellitus type 1	82	-0.37
DB00584	Enalapril	spinal cord diseases	59	-0.35
DB00584	Enalapril	anemia	58	-0.35
DB00584	Enalapril	joint diseases	79	-0.31
DB00584	Enalapril	lung diseases	71	-0.29
DB00584	Enalapril	arthritis	76	-0.28
DB00584	Enalapril	gastrointestinal neoplasms	72	-0.25
DB00584	Enalapril	leukemia lymphoid	66	-0.21
DB00584	Enalapril	gastroenteritis	122	-0.19
DB00584	Enalapril	inflammatory bowel diseases	119	-0.18
DB00584	Enalapril	bone diseases	144	-0.05
DB00584	Enalapril	heart diseases	167	-0.04
DB00584	Enalapril	eye diseases	231	0.05
DB00584	Enalapril	leukemia	117	0.07
DB00584	Enalapril	hematologic diseases	188	0.08
DB00584	Enalapril	autoimmune diseases	243	0.11
DB00584	Enalapril	skin diseases	278	0.16
DB00584	Enalapril	neoplasms	482	0.50
DB00584	Enalapril	epilepsy	25	0.72
DB00584	Enalapril	arrhythmias cardiac	30	0.73
DB00584	Enalapril	insulin resistance	26	0.77
DB00584	Enalapril	hyperinsulinism	26	0.80
DB00584	Enalapril	kidney neoplasms	20	0.96
DB00584	Enalapril	hypopigmentation	22	0.97
DB00584	Enalapril	arthritis rheumatoid	42	1.29
DB00584	Enalapril	rheumatic diseases	59	1.53
DB00740	Riluzole	bone diseases metabolic	27	-3.74
DB00740	Riluzole	bone diseases	144	-2.73
DB00740	Riluzole	arrhythmias cardiac	30	-2.39
DB00740	Riluzole	cardiomyopathy dilated	29	-2.19
DB00740	Riluzole	cardiovascular diseases	330	-1.86
DB00740	Riluzole	heart diseases	167	-1.31
DB00740	Riluzole	leukemia	117	-1.19
DB00740	Riluzole	hematologic diseases	188	-0.99
DB00740	Riluzole	anemia hemolytic	29	-0.99
DB00740	Riluzole	thyroid diseases	30	-0.96
DB00740	Riluzole	amyotrophic lateral sclerosis	21	-0.94
DB00740	Riluzole	neuroendocrine tumors	24	-0.93
DB00740	Riluzole	blood coagulation disorders	40	-0.82
DB00740	Riluzole	endocrine system diseases	291	-0.79
DB00740	Riluzole	sarcoma	25	-0.79
DB00740	Riluzole	motor neuron disease	31	-0.65
DB00740	Riluzole	head and neck neoplasms	35	-0.62
DB00740	Riluzole	intestinal neoplasms	42	-0.44
DB00740	Riluzole	colorectal neoplasms	42	-0.41
DB00740	Riluzole	multiple sclerosis	69	-0.39
DB00740	Riluzole	crohn disease	71	-0.33
DB00740	Riluzole	spinal cord diseases	59	-0.33
DB00740	Riluzole	lung diseases	71	-0.30
DB00740	Riluzole	anemia	58	-0.26
DB00740	Riluzole	neoplasms	482	-0.24
DB00740	Riluzole	gastrointestinal neoplasms	72	-0.16
DB00740	Riluzole	varicose veins	20	-0.10
DB00740	Riluzole	inflammatory bowel diseases	119	-0.09
DB00740	Riluzole	kidney diseases	144	-0.08
DB00740	Riluzole	gastroenteritis	122	-0.08
DB00740	Riluzole	epilepsy	25	-0.02
DB00740	Riluzole	collagen diseases	25	0.03
DB00740	Riluzole	hyperinsulinism	26	0.07
DB00740	Riluzole	insulin resistance	26	0.09
DB00740	Riluzole	keratosis	21	0.18
DB00740	Riluzole	vascular diseases	181	0.18
DB00740	Riluzole	mycobacterium infections	22	0.22
DB00740	Riluzole	macular degeneration	44	0.27
DB00740	Riluzole	metabolism inborn errors	289	0.29
DB00740	Riluzole	hypopigmentation	22	0.32
DB00740	Riluzole	kidney neoplasms	20	0.33
DB00740	Riluzole	autoimmune diseases	243	0.33
DB00740	Riluzole	bacterial infections	26	0.34
DB00740	Riluzole	liver cirrhosis biliary	23	0.37
DB00740	Riluzole	parkinson disease	30	0.37
DB00740	Riluzole	pancreatic diseases	24	0.38
DB00740	Riluzole	coronary disease	37	0.39
DB00740	Riluzole	myocardial ischemia	43	0.40
DB00740	Riluzole	malabsorption syndromes	34	0.40
DB00740	Riluzole	parkinsonian disorders	31	0.42
DB00740	Riluzole	liver cirrhosis	24	0.44
DB00740	Riluzole	skin diseases	278	0.48
DB00740	Riluzole	asthma	36	0.49
DB00740	Riluzole	arteriosclerosis	38	0.50
DB00740	Riluzole	alzheimer disease	29	0.53
DB00740	Riluzole	lymphoma non hodgkin	22	0.57
DB00740	Riluzole	lymphoma	24	0.60
DB00740	Riluzole	arterial occlusive diseases	44	0.63
DB00740	Riluzole	hypersensitivity	45	0.65
DB00740	Riluzole	arthritis rheumatoid	42	0.73
DB00740	Riluzole	adenocarcinoma	32	0.76
DB00740	Riluzole	colitis ulcerative	55	0.76
DB00740	Riluzole	colitis	55	0.79
DB00740	Riluzole	dementia	42	0.80
DB00740	Riluzole	prostatic neoplasms	61	0.82
DB00740	Riluzole	breast neoplasms	40	0.87
DB00740	Riluzole	psoriasis	54	0.87
DB00740	Riluzole	diabetes mellitus type 2	72	0.92
DB00740	Riluzole	rheumatic diseases	59	0.94
DB00740	Riluzole	diabetes mellitus type 1	82	1.00
DB00740	Riluzole	leukemia myeloid acute	43	1.04
DB00740	Riluzole	lupus erythematosus systemic	75	1.05
DB00740	Riluzole	joint diseases	79	1.10
DB00740	Riluzole	arthritis	76	1.12
DB00740	Riluzole	leukemia lymphoid	66	1.17
DB00740	Riluzole	diabetes mellitus	162	1.33
DB00740	Riluzole	coronary artery disease	31	1.50
DB00740	Riluzole	eye diseases	231	1.53
DB00741	Hydrocortisone	arterial occlusive diseases	44	-1.98
DB00741	Hydrocortisone	varicose veins	20	-1.63
DB00741	Hydrocortisone	motor neuron disease	31	-1.27
DB00741	Hydrocortisone	lymphoma	24	-1.27
DB00741	Hydrocortisone	lymphoma non hodgkin	22	-1.25
DB00741	Hydrocortisone	coronary artery disease	31	-0.87
DB00741	Hydrocortisone	leukemia myeloid acute	43	-0.86
DB00741	Hydrocortisone	arthritis	76	-0.85
DB00741	Hydrocortisone	leukemia lymphoid	66	-0.83
DB00741	Hydrocortisone	joint diseases	79	-0.83
DB00741	Hydrocortisone	myocardial ischemia	43	-0.82
DB00741	Hydrocortisone	spinal cord diseases	59	-0.79
DB00741	Hydrocortisone	coronary disease	37	-0.76
DB00741	Hydrocortisone	arteriosclerosis	38	-0.73
DB00741	Hydrocortisone	lung diseases	71	-0.71
DB00741	Hydrocortisone	malabsorption syndromes	34	-0.68
DB00741	Hydrocortisone	metabolism inborn errors	289	-0.63
DB00741	Hydrocortisone	bone diseases	144	-0.54
DB00741	Hydrocortisone	kidney neoplasms	20	-0.50
DB00741	Hydrocortisone	alzheimer disease	29	-0.48
DB00741	Hydrocortisone	amyotrophic lateral sclerosis	21	-0.46
DB00741	Hydrocortisone	mycobacterium infections	22	-0.44
DB00741	Hydrocortisone	colitis ulcerative	55	-0.43
DB00741	Hydrocortisone	colitis	55	-0.36
DB00741	Hydrocortisone	bacterial infections	26	-0.34
DB00741	Hydrocortisone	eye diseases	231	-0.30
DB00741	Hydrocortisone	leukemia	117	-0.26
DB00741	Hydrocortisone	vascular diseases	181	-0.18
DB00741	Hydrocortisone	dementia	42	-0.18
DB00741	Hydrocortisone	sarcoma	25	-0.17
DB00741	Hydrocortisone	asthma	36	-0.15
DB00741	Hydrocortisone	liver cirrhosis	24	-0.14
DB00741	Hydrocortisone	liver cirrhosis biliary	23	-0.10
DB00741	Hydrocortisone	neuroendocrine tumors	24	-0.09
DB00741	Hydrocortisone	hypersensitivity	45	-0.08
DB00741	Hydrocortisone	hematologic diseases	188	-0.05
DB00741	Hydrocortisone	prostatic neoplasms	61	0.03
DB00741	Hydrocortisone	head and neck neoplasms	35	0.05
DB00741	Hydrocortisone	skin diseases	278	0.09
DB00741	Hydrocortisone	cardiovascular diseases	330	0.13
DB00741	Hydrocortisone	diabetes mellitus type 1	82	0.15
DB00741	Hydrocortisone	arthritis rheumatoid	42	0.16
DB00741	Hydrocortisone	psoriasis	54	0.18
DB00741	Hydrocortisone	adenocarcinoma	32	0.19
DB00741	Hydrocortisone	lupus erythematosus systemic	75	0.21
DB00741	Hydrocortisone	breast neoplasms	40	0.38
DB00741	Hydrocortisone	arrhythmias cardiac	30	0.39
DB00741	Hydrocortisone	neoplasms	482	0.39
DB00741	Hydrocortisone	crohn disease	71	0.43
DB00741	Hydrocortisone	rheumatic diseases	59	0.46
DB00741	Hydrocortisone	epilepsy	25	0.47
DB00741	Hydrocortisone	bone diseases metabolic	27	0.48
DB00741	Hydrocortisone	macular degeneration	44	0.49
DB00741	Hydrocortisone	collagen diseases	25	0.51
DB00741	Hydrocortisone	parkinsonian disorders	31	0.66
DB00741	Hydrocortisone	insulin resistance	26	0.66
DB00741	Hydrocortisone	hyperinsulinism	26	0.67
DB00741	Hydrocortisone	parkinson disease	30	0.67
DB00741	Hydrocortisone	diabetes mellitus	162	0.69
DB00741	Hydrocortisone	multiple sclerosis	69	0.71
DB00741	Hydrocortisone	colorectal neoplasms	42	0.76
DB00741	Hydrocortisone	kidney diseases	144	0.78
DB00741	Hydrocortisone	intestinal neoplasms	42	0.80
DB00741	Hydrocortisone	keratosis	21	0.81
DB00741	Hydrocortisone	gastroenteritis	122	0.82
DB00741	Hydrocortisone	anemia hemolytic	29	0.83
DB00741	Hydrocortisone	cardiomyopathy dilated	29	0.84
DB00741	Hydrocortisone	inflammatory bowel diseases	119	0.86
DB00741	Hydrocortisone	thyroid diseases	30	0.89
DB00741	Hydrocortisone	blood coagulation disorders	40	0.90
DB00741	Hydrocortisone	anemia	58	0.93
DB00741	Hydrocortisone	hypopigmentation	22	0.95
DB00741	Hydrocortisone	heart diseases	167	1.08
DB00741	Hydrocortisone	diabetes mellitus type 2	72	1.10
DB00741	Hydrocortisone	pancreatic diseases	24	1.32
DB00741	Hydrocortisone	gastrointestinal neoplasms	72	1.36
DB00741	Hydrocortisone	autoimmune diseases	243	2.74
DB00741	Hydrocortisone	endocrine system diseases	291	3.28
DB00290	Bleomycin	asthma	36	-3.63
DB00290	Bleomycin	hypersensitivity	45	-3.46
DB00290	Bleomycin	lung diseases	71	-2.42
DB00290	Bleomycin	neuroendocrine tumors	24	-1.65
DB00290	Bleomycin	hematologic diseases	188	-1.31
DB00290	Bleomycin	spinal cord diseases	59	-1.17
DB00290	Bleomycin	varicose veins	20	-0.58
DB00290	Bleomycin	epilepsy	25	-0.47
DB00290	Bleomycin	neoplasms	482	-0.44
DB00290	Bleomycin	hyperinsulinism	26	-0.42
DB00290	Bleomycin	arrhythmias cardiac	30	-0.42
DB00290	Bleomycin	insulin resistance	26	-0.39
DB00290	Bleomycin	bone diseases metabolic	27	-0.37
DB00290	Bleomycin	leukemia	117	-0.31
DB00290	Bleomycin	mycobacterium infections	22	-0.25
DB00290	Bleomycin	keratosis	21	-0.22
DB00290	Bleomycin	coronary artery disease	31	-0.21
DB00290	Bleomycin	macular degeneration	44	-0.19
DB00290	Bleomycin	thyroid diseases	30	-0.14
DB00290	Bleomycin	kidney neoplasms	20	-0.11
DB00290	Bleomycin	bacterial infections	26	-0.11
DB00290	Bleomycin	hypopigmentation	22	-0.11
DB00290	Bleomycin	coronary disease	37	-0.09
DB00290	Bleomycin	liver cirrhosis biliary	23	-0.09
DB00290	Bleomycin	malabsorption syndromes	34	-0.07
DB00290	Bleomycin	pancreatic diseases	24	-0.06
DB00290	Bleomycin	anemia hemolytic	29	-0.05
DB00290	Bleomycin	liver cirrhosis	24	-0.04
DB00290	Bleomycin	parkinson disease	30	-0.04
DB00290	Bleomycin	arteriosclerosis	38	-0.03
DB00290	Bleomycin	amyotrophic lateral sclerosis	21	-0.01
DB00290	Bleomycin	alzheimer disease	29	0.00
DB00290	Bleomycin	myocardial ischemia	43	0.01
DB00290	Bleomycin	parkinsonian disorders	31	0.02
DB00290	Bleomycin	sarcoma	25	0.07
DB00290	Bleomycin	cardiomyopathy dilated	29	0.08
DB00290	Bleomycin	skin diseases	278	0.12
DB00290	Bleomycin	arterial occlusive diseases	44	0.16
DB00290	Bleomycin	lymphoma	24	0.16
DB00290	Bleomycin	lymphoma non hodgkin	22	0.16
DB00290	Bleomycin	blood coagulation disorders	40	0.19
DB00290	Bleomycin	motor neuron disease	31	0.23
DB00290	Bleomycin	dementia	42	0.25
DB00290	Bleomycin	colitis ulcerative	55	0.29
DB00290	Bleomycin	adenocarcinoma	32	0.29
DB00290	Bleomycin	arthritis rheumatoid	42	0.29
DB00290	Bleomycin	colitis	55	0.32
DB00290	Bleomycin	breast neoplasms	40	0.34
DB00290	Bleomycin	prostatic neoplasms	61	0.35
DB00290	Bleomycin	head and neck neoplasms	35	0.36
DB00290	Bleomycin	psoriasis	54	0.36
DB00290	Bleomycin	diabetes mellitus type 2	72	0.37
DB00290	Bleomycin	rheumatic diseases	59	0.38
DB00290	Bleomycin	crohn disease	71	0.43
DB00290	Bleomycin	lupus erythematosus systemic	75	0.46
DB00290	Bleomycin	multiple sclerosis	69	0.48
DB00290	Bleomycin	leukemia myeloid acute	43	0.50
DB00290	Bleomycin	intestinal neoplasms	42	0.50
DB00290	Bleomycin	arthritis	76	0.51
DB00290	Bleomycin	diabetes mellitus type 1	82	0.53
DB00290	Bleomycin	colorectal neoplasms	42	0.53
DB00290	Bleomycin	anemia	58	0.55
DB00290	Bleomycin	joint diseases	79	0.57
DB00290	Bleomycin	leukemia lymphoid	66	0.64
DB00290	Bleomycin	inflammatory bowel diseases	119	0.72
DB00290	Bleomycin	gastroenteritis	122	0.75
DB00290	Bleomycin	kidney diseases	144	0.76
DB00290	Bleomycin	gastrointestinal neoplasms	72	0.76
DB00290	Bleomycin	diabetes mellitus	162	0.86
DB00290	Bleomycin	bone diseases	144	0.86
DB00290	Bleomycin	heart diseases	167	0.90
DB00290	Bleomycin	eye diseases	231	1.04
DB00290	Bleomycin	vascular diseases	181	1.08
DB00290	Bleomycin	metabolism inborn errors	289	1.16
DB00290	Bleomycin	collagen diseases	25	1.24
DB00290	Bleomycin	autoimmune diseases	243	1.25
DB00290	Bleomycin	endocrine system diseases	291	1.39
DB00290	Bleomycin	cardiovascular diseases	330	1.55
DB00586	Diclofenac	epilepsy	25	-3.23
DB00586	Diclofenac	metabolism inborn errors	289	-2.11
DB00586	Diclofenac	rheumatic diseases	59	-1.84
DB00586	Diclofenac	arrhythmias cardiac	30	-1.81
DB00586	Diclofenac	joint diseases	79	-1.57
DB00586	Diclofenac	arthritis	76	-1.48
DB00586	Diclofenac	lung diseases	71	-1.41
DB00586	Diclofenac	heart diseases	167	-1.36
DB00586	Diclofenac	arthritis rheumatoid	42	-1.35
DB00586	Diclofenac	psoriasis	54	-1.24
DB00586	Diclofenac	eye diseases	231	-1.09
DB00586	Diclofenac	multiple sclerosis	69	-0.95
DB00586	Diclofenac	cardiovascular diseases	330	-0.90
DB00586	Diclofenac	diabetes mellitus	162	-0.71
DB00586	Diclofenac	parkinsonian disorders	31	-0.57
DB00586	Diclofenac	adenocarcinoma	32	-0.54
DB00586	Diclofenac	parkinson disease	30	-0.51
DB00586	Diclofenac	malabsorption syndromes	34	-0.48
DB00586	Diclofenac	bone diseases metabolic	27	-0.48
DB00586	Diclofenac	dementia	42	-0.48
DB00586	Diclofenac	endocrine system diseases	291	-0.40
DB00586	Diclofenac	breast neoplasms	40	-0.35
DB00586	Diclofenac	vascular diseases	181	-0.35
DB00586	Diclofenac	neuroendocrine tumors	24	-0.34
DB00586	Diclofenac	skin diseases	278	-0.33
DB00586	Diclofenac	diabetes mellitus type 2	72	-0.29
DB00586	Diclofenac	gastrointestinal neoplasms	72	-0.28
DB00586	Diclofenac	lupus erythematosus systemic	75	-0.15
DB00586	Diclofenac	lymphoma non hodgkin	22	-0.09
DB00586	Diclofenac	lymphoma	24	-0.07
DB00586	Diclofenac	arterial occlusive diseases	44	-0.07
DB00586	Diclofenac	bone diseases	144	-0.06
DB00586	Diclofenac	thyroid diseases	30	-0.05
DB00586	Diclofenac	autoimmune diseases	243	-0.02
DB00586	Diclofenac	spinal cord diseases	59	0.01
DB00586	Diclofenac	diabetes mellitus type 1	82	0.02
DB00586	Diclofenac	collagen diseases	25	0.16
DB00586	Diclofenac	pancreatic diseases	24	0.21
DB00586	Diclofenac	leukemia lymphoid	66	0.23
DB00586	Diclofenac	head and neck neoplasms	35	0.27
DB00586	Diclofenac	prostatic neoplasms	61	0.38
DB00586	Diclofenac	cardiomyopathy dilated	29	0.41
DB00586	Diclofenac	alzheimer disease	29	0.42
DB00586	Diclofenac	varicose veins	20	0.42
DB00586	Diclofenac	macular degeneration	44	0.50
DB00586	Diclofenac	keratosis	21	0.52
DB00586	Diclofenac	sarcoma	25	0.53
DB00586	Diclofenac	kidney diseases	144	0.56
DB00586	Diclofenac	leukemia myeloid acute	43	0.72
DB00586	Diclofenac	insulin resistance	26	0.74
DB00586	Diclofenac	intestinal neoplasms	42	0.75
DB00586	Diclofenac	colorectal neoplasms	42	0.76
DB00586	Diclofenac	hyperinsulinism	26	0.77
DB00586	Diclofenac	kidney neoplasms	20	0.78
DB00586	Diclofenac	motor neuron disease	31	0.81
DB00586	Diclofenac	neoplasms	482	0.86
DB00586	Diclofenac	liver cirrhosis	24	0.91
DB00586	Diclofenac	liver cirrhosis biliary	23	0.91
DB00586	Diclofenac	myocardial ischemia	43	0.96
DB00586	Diclofenac	colitis ulcerative	55	1.02
DB00586	Diclofenac	leukemia	117	1.05
DB00586	Diclofenac	colitis	55	1.06
DB00586	Diclofenac	arteriosclerosis	38	1.06
DB00586	Diclofenac	asthma	36	1.07
DB00586	Diclofenac	coronary artery disease	31	1.14
DB00586	Diclofenac	gastroenteritis	122	1.25
DB00586	Diclofenac	hematologic diseases	188	1.33
DB00586	Diclofenac	bacterial infections	26	1.43
DB00586	Diclofenac	hypersensitivity	45	1.45
DB00586	Diclofenac	coronary disease	37	1.51
DB00586	Diclofenac	crohn disease	71	1.55
DB00586	Diclofenac	amyotrophic lateral sclerosis	21	1.67
DB00586	Diclofenac	mycobacterium infections	22	1.70
DB00586	Diclofenac	anemia	58	1.75
DB00586	Diclofenac	inflammatory bowel diseases	119	2.07
DB00586	Diclofenac	anemia hemolytic	29	2.07
DB00586	Diclofenac	blood coagulation disorders	40	2.11
DB00586	Diclofenac	hypopigmentation	22	2.20
DB04855	Dronedarone	arrhythmias cardiac	30	-6.51
DB04855	Dronedarone	heart diseases	167	-4.86
DB04855	Dronedarone	cardiovascular diseases	330	-3.73
DB04855	Dronedarone	epilepsy	25	-3.65
DB04855	Dronedarone	crohn disease	71	-2.94
DB04855	Dronedarone	gastroenteritis	122	-2.46
DB04855	Dronedarone	inflammatory bowel diseases	119	-2.45
DB04855	Dronedarone	eye diseases	231	-2.37
DB04855	Dronedarone	cardiomyopathy dilated	29	-2.27
DB04855	Dronedarone	colitis ulcerative	55	-2.03
DB04855	Dronedarone	colitis	55	-2.01
DB04855	Dronedarone	alzheimer disease	29	-1.85
DB04855	Dronedarone	thyroid diseases	30	-1.85
DB04855	Dronedarone	bacterial infections	26	-1.65
DB04855	Dronedarone	spinal cord diseases	59	-1.63
DB04855	Dronedarone	bone diseases	144	-1.54
DB04855	Dronedarone	autoimmune diseases	243	-1.43
DB04855	Dronedarone	hyperinsulinism	26	-1.37
DB04855	Dronedarone	multiple sclerosis	69	-1.35
DB04855	Dronedarone	insulin resistance	26	-1.33
DB04855	Dronedarone	psoriasis	54	-1.31
DB04855	Dronedarone	mycobacterium infections	22	-1.25
DB04855	Dronedarone	parkinson disease	30	-1.23
DB04855	Dronedarone	parkinsonian disorders	31	-1.20
DB04855	Dronedarone	joint diseases	79	-1.14
DB04855	Dronedarone	dementia	42	-1.12
DB04855	Dronedarone	arthritis	76	-1.11
DB04855	Dronedarone	varicose veins	20	-0.83
DB04855	Dronedarone	metabolism inborn errors	289	-0.72
DB04855	Dronedarone	arterial occlusive diseases	44	-0.72
DB04855	Dronedarone	lymphoma	24	-0.59
DB04855	Dronedarone	lymphoma non hodgkin	22	-0.54
DB04855	Dronedarone	kidney diseases	144	-0.42
DB04855	Dronedarone	coronary artery disease	31	-0.41
DB04855	Dronedarone	coronary disease	37	-0.40
DB04855	Dronedarone	breast neoplasms	40	-0.39
DB04855	Dronedarone	collagen diseases	25	-0.34
DB04855	Dronedarone	bone diseases metabolic	27	-0.34
DB04855	Dronedarone	diabetes mellitus type 2	72	-0.33
DB04855	Dronedarone	liver cirrhosis	24	-0.30
DB04855	Dronedarone	liver cirrhosis biliary	23	-0.28
DB04855	Dronedarone	pancreatic diseases	24	-0.24
DB04855	Dronedarone	myocardial ischemia	43	-0.23
DB04855	Dronedarone	skin diseases	278	-0.18
DB04855	Dronedarone	neuroendocrine tumors	24	-0.14
DB04855	Dronedarone	motor neuron disease	31	0.11
DB04855	Dronedarone	sarcoma	25	0.13
DB04855	Dronedarone	arteriosclerosis	38	0.28
DB04855	Dronedarone	head and neck neoplasms	35	0.29
DB04855	Dronedarone	anemia hemolytic	29	0.38
DB04855	Dronedarone	vascular diseases	181	0.40
DB04855	Dronedarone	kidney neoplasms	20	0.40
DB04855	Dronedarone	keratosis	21	0.49
DB04855	Dronedarone	lupus erythematosus systemic	75	0.50
DB04855	Dronedarone	intestinal neoplasms	42	0.54
DB04855	Dronedarone	prostatic neoplasms	61	0.57
DB04855	Dronedarone	colorectal neoplasms	42	0.58
DB04855	Dronedarone	amyotrophic lateral sclerosis	21	0.59
DB04855	Dronedarone	arthritis rheumatoid	42	0.61
DB04855	Dronedarone	malabsorption syndromes	34	0.63
DB04855	Dronedarone	diabetes mellitus	162	0.67
DB04855	Dronedarone	leukemia	117	0.71
DB04855	Dronedarone	endocrine system diseases	291	0.74
DB04855	Dronedarone	adenocarcinoma	32	0.75
DB04855	Dronedarone	hematologic diseases	188	0.85
DB04855	Dronedarone	lung diseases	71	0.89
DB04855	Dronedarone	anemia	58	0.91
DB04855	Dronedarone	gastrointestinal neoplasms	72	0.99
DB04855	Dronedarone	macular degeneration	44	1.03
DB04855	Dronedarone	leukemia myeloid acute	43	1.04
DB04855	Dronedarone	diabetes mellitus type 1	82	1.07
DB04855	Dronedarone	neoplasms	482	1.25
DB04855	Dronedarone	hypopigmentation	22	1.29
DB04855	Dronedarone	rheumatic diseases	59	1.32
DB04855	Dronedarone	leukemia lymphoid	66	1.49
DB04855	Dronedarone	asthma	36	1.61
DB04855	Dronedarone	blood coagulation disorders	40	1.68
DB04855	Dronedarone	hypersensitivity	45	2.16
DB00006	Bivalirudin	blood coagulation disorders	40	-4.18
DB00006	Bivalirudin	hyperinsulinism	26	-2.91
DB00006	Bivalirudin	vascular diseases	181	-2.79
DB00006	Bivalirudin	insulin resistance	26	-2.71
DB00006	Bivalirudin	cardiovascular diseases	330	-2.64
DB00006	Bivalirudin	anemia hemolytic	29	-2.59
DB00006	Bivalirudin	thyroid diseases	30	-2.57
DB00006	Bivalirudin	bone diseases metabolic	27	-2.56
DB00006	Bivalirudin	hypersensitivity	45	-2.40
DB00006	Bivalirudin	hematologic diseases	188	-2.39
DB00006	Bivalirudin	prostatic neoplasms	61	-2.07
DB00006	Bivalirudin	kidney diseases	144	-1.29
DB00006	Bivalirudin	anemia	58	-1.28
DB00006	Bivalirudin	bone diseases	144	-1.04
DB00006	Bivalirudin	heart diseases	167	-0.95
DB00006	Bivalirudin	metabolism inborn errors	289	-0.76
DB00006	Bivalirudin	skin diseases	278	-0.53
DB00006	Bivalirudin	endocrine system diseases	291	-0.47
DB00006	Bivalirudin	epilepsy	25	-0.04
DB00006	Bivalirudin	neoplasms	482	-0.04
DB00006	Bivalirudin	arrhythmias cardiac	30	0.02
DB00006	Bivalirudin	collagen diseases	25	0.07
DB00006	Bivalirudin	macular degeneration	44	0.09
DB00006	Bivalirudin	coronary artery disease	31	0.13
DB00006	Bivalirudin	keratosis	21	0.14
DB00006	Bivalirudin	coronary disease	37	0.18
DB00006	Bivalirudin	myocardial ischemia	43	0.22
DB00006	Bivalirudin	bacterial infections	26	0.23
DB00006	Bivalirudin	kidney neoplasms	20	0.24
DB00006	Bivalirudin	liver cirrhosis biliary	23	0.25
DB00006	Bivalirudin	pancreatic diseases	24	0.28
DB00006	Bivalirudin	hypopigmentation	22	0.28
DB00006	Bivalirudin	arteriosclerosis	38	0.28
DB00006	Bivalirudin	neuroendocrine tumors	24	0.29
DB00006	Bivalirudin	liver cirrhosis	24	0.29
DB00006	Bivalirudin	malabsorption syndromes	34	0.30
DB00006	Bivalirudin	asthma	36	0.31
DB00006	Bivalirudin	amyotrophic lateral sclerosis	21	0.31
DB00006	Bivalirudin	cardiomyopathy dilated	29	0.33
DB00006	Bivalirudin	alzheimer disease	29	0.36
DB00006	Bivalirudin	lymphoma	24	0.37
DB00006	Bivalirudin	sarcoma	25	0.37
DB00006	Bivalirudin	lymphoma non hodgkin	22	0.38
DB00006	Bivalirudin	motor neuron disease	31	0.39
DB00006	Bivalirudin	arterial occlusive diseases	44	0.40
DB00006	Bivalirudin	arthritis rheumatoid	42	0.42
DB00006	Bivalirudin	dementia	42	0.47
DB00006	Bivalirudin	colitis	55	0.47
DB00006	Bivalirudin	rheumatic diseases	59	0.48
DB00006	Bivalirudin	head and neck neoplasms	35	0.49
DB00006	Bivalirudin	adenocarcinoma	32	0.49
DB00006	Bivalirudin	colitis ulcerative	55	0.49
DB00006	Bivalirudin	multiple sclerosis	69	0.50
DB00006	Bivalirudin	breast neoplasms	40	0.51
DB00006	Bivalirudin	lupus erythematosus systemic	75	0.51
DB00006	Bivalirudin	psoriasis	54	0.52
DB00006	Bivalirudin	diabetes mellitus type 2	72	0.53
DB00006	Bivalirudin	arthritis	76	0.59
DB00006	Bivalirudin	crohn disease	71	0.60
DB00006	Bivalirudin	spinal cord diseases	59	0.60
DB00006	Bivalirudin	diabetes mellitus type 1	82	0.60
DB00006	Bivalirudin	colorectal neoplasms	42	0.61
DB00006	Bivalirudin	joint diseases	79	0.62
DB00006	Bivalirudin	lung diseases	71	0.64
DB00006	Bivalirudin	intestinal neoplasms	42	0.64
DB00006	Bivalirudin	leukemia lymphoid	66	0.68
DB00006	Bivalirudin	gastroenteritis	122	0.76
DB00006	Bivalirudin	inflammatory bowel diseases	119	0.80
DB00006	Bivalirudin	gastrointestinal neoplasms	72	0.82
DB00006	Bivalirudin	diabetes mellitus	162	0.85
DB00006	Bivalirudin	eye diseases	231	1.08
DB00006	Bivalirudin	leukemia	117	1.11
DB00006	Bivalirudin	autoimmune diseases	243	1.33
DB00006	Bivalirudin	varicose veins	20	2.55
DB00006	Bivalirudin	leukemia myeloid acute	43	2.79
DB00006	Bivalirudin	parkinsonian disorders	31	2.85
DB00006	Bivalirudin	parkinson disease	30	2.89
DB00006	Bivalirudin	mycobacterium infections	22	3.01
DB00063	Eptifibatide	blood coagulation disorders	40	-3.64
DB00063	Eptifibatide	hematologic diseases	188	-2.78
DB00063	Eptifibatide	collagen diseases	25	-2.52
DB00063	Eptifibatide	coronary artery disease	31	-2.25
DB00063	Eptifibatide	coronary disease	37	-2.21
DB00063	Eptifibatide	myocardial ischemia	43	-2.12
DB00063	Eptifibatide	arteriosclerosis	38	-2.08
DB00063	Eptifibatide	pancreatic diseases	24	-1.92
DB00063	Eptifibatide	arterial occlusive diseases	44	-1.86
DB00063	Eptifibatide	colitis ulcerative	55	-1.71
DB00063	Eptifibatide	colitis	55	-1.59
DB00063	Eptifibatide	diabetes mellitus type 2	72	-1.43
DB00063	Eptifibatide	breast neoplasms	40	-1.33
DB00063	Eptifibatide	multiple sclerosis	69	-1.28
DB00063	Eptifibatide	crohn disease	71	-1.27
DB00063	Eptifibatide	prostatic neoplasms	61	-1.26
DB00063	Eptifibatide	leukemia myeloid acute	43	-1.17
DB00063	Eptifibatide	colorectal neoplasms	42	-1.17
DB00063	Eptifibatide	intestinal neoplasms	42	-1.14
DB00063	Eptifibatide	lung diseases	71	-1.12
DB00063	Eptifibatide	leukemia lymphoid	66	-1.06
DB00063	Eptifibatide	inflammatory bowel diseases	119	-0.96
DB00063	Eptifibatide	gastroenteritis	122	-0.92
DB00063	Eptifibatide	kidney diseases	144	-0.88
DB00063	Eptifibatide	diabetes mellitus	162	-0.80
DB00063	Eptifibatide	bone diseases	144	-0.79
DB00063	Eptifibatide	heart diseases	167	-0.68
DB00063	Eptifibatide	gastrointestinal neoplasms	72	-0.67
DB00063	Eptifibatide	vascular diseases	181	-0.60
DB00063	Eptifibatide	leukemia	117	-0.59
DB00063	Eptifibatide	eye diseases	231	-0.55
DB00063	Eptifibatide	metabolism inborn errors	289	-0.49
DB00063	Eptifibatide	autoimmune diseases	243	-0.35
DB00063	Eptifibatide	cardiovascular diseases	330	-0.25
DB00063	Eptifibatide	endocrine system diseases	291	-0.25
DB00063	Eptifibatide	skin diseases	278	-0.15
DB00063	Eptifibatide	varicose veins	20	0.04
DB00063	Eptifibatide	hyperinsulinism	26	0.12
DB00063	Eptifibatide	epilepsy	25	0.12
DB00063	Eptifibatide	insulin resistance	26	0.16
DB00063	Eptifibatide	bone diseases metabolic	27	0.17
DB00063	Eptifibatide	neoplasms	482	0.18
DB00063	Eptifibatide	macular degeneration	44	0.18
DB00063	Eptifibatide	arrhythmias cardiac	30	0.19
DB00063	Eptifibatide	mycobacterium infections	22	0.24
DB00063	Eptifibatide	keratosis	21	0.26
DB00063	Eptifibatide	anemia hemolytic	29	0.29
DB00063	Eptifibatide	malabsorption syndromes	34	0.31
DB00063	Eptifibatide	bacterial infections	26	0.32
DB00063	Eptifibatide	kidney neoplasms	20	0.33
DB00063	Eptifibatide	hypopigmentation	22	0.35
DB00063	Eptifibatide	asthma	36	0.35
DB00063	Eptifibatide	liver cirrhosis	24	0.37
DB00063	Eptifibatide	thyroid diseases	30	0.37
DB00063	Eptifibatide	neuroendocrine tumors	24	0.40
DB00063	Eptifibatide	hypersensitivity	45	0.40
DB00063	Eptifibatide	parkinsonian disorders	31	0.42
DB00063	Eptifibatide	liver cirrhosis biliary	23	0.42
DB00063	Eptifibatide	amyotrophic lateral sclerosis	21	0.43
DB00063	Eptifibatide	cardiomyopathy dilated	29	0.43
DB00063	Eptifibatide	parkinson disease	30	0.47
DB00063	Eptifibatide	alzheimer disease	29	0.47
DB00063	Eptifibatide	sarcoma	25	0.51
DB00063	Eptifibatide	lymphoma	24	0.52
DB00063	Eptifibatide	arthritis rheumatoid	42	0.58
DB00063	Eptifibatide	lymphoma non hodgkin	22	0.58
DB00063	Eptifibatide	motor neuron disease	31	0.58
DB00063	Eptifibatide	adenocarcinoma	32	0.66
DB00063	Eptifibatide	psoriasis	54	0.67
DB00063	Eptifibatide	rheumatic diseases	59	0.68
DB00063	Eptifibatide	dementia	42	0.68
DB00063	Eptifibatide	lupus erythematosus systemic	75	0.68
DB00063	Eptifibatide	head and neck neoplasms	35	0.69
DB00063	Eptifibatide	diabetes mellitus type 1	82	0.73
DB00063	Eptifibatide	anemia	58	0.80
DB00063	Eptifibatide	spinal cord diseases	59	0.80
DB00063	Eptifibatide	joint diseases	79	0.81
DB00063	Eptifibatide	arthritis	76	0.87
DB01216	Finasteride	endocrine system diseases	291	-2.63
DB01216	Finasteride	eye diseases	231	-1.91
DB01216	Finasteride	metabolism inborn errors	289	-1.66
DB01216	Finasteride	skin diseases	278	-1.34
DB01216	Finasteride	keratosis	21	-0.35
DB01216	Finasteride	malabsorption syndromes	34	-0.16
DB01216	Finasteride	diabetes mellitus type 2	72	0.19
DB01216	Finasteride	breast neoplasms	40	0.29
DB01216	Finasteride	lupus erythematosus systemic	75	0.36
DB01216	Finasteride	colorectal neoplasms	42	0.37
DB01216	Finasteride	anemia	58	0.39
DB01216	Finasteride	diabetes mellitus type 1	82	0.40
DB01216	Finasteride	intestinal neoplasms	42	0.40
DB01216	Finasteride	gastrointestinal neoplasms	72	0.60
DB01216	Finasteride	diabetes mellitus	162	0.67
DB01216	Finasteride	bone diseases	144	0.74
DB01216	Finasteride	heart diseases	167	0.75
DB01216	Finasteride	autoimmune diseases	243	1.00
DB01216	Finasteride	hematologic diseases	188	1.08
DB01216	Finasteride	cardiovascular diseases	330	1.27
DB01216	Finasteride	kidney neoplasms	20	1.41
DB01216	Finasteride	lymphoma	24	1.75
DB01216	Finasteride	lymphoma non hodgkin	22	1.76
DB01216	Finasteride	adenocarcinoma	32	1.81
DB01216	Finasteride	head and neck neoplasms	35	1.89
DB01216	Finasteride	joint diseases	79	1.99
DB01216	Finasteride	kidney diseases	144	2.00
DB01216	Finasteride	neoplasms	482	2.03
DB01216	Finasteride	crohn disease	71	2.06
DB01216	Finasteride	leukemia myeloid acute	43	2.07
DB01216	Finasteride	arthritis	76	2.08
DB01216	Finasteride	leukemia lymphoid	66	2.12
DB01216	Finasteride	gastroenteritis	122	2.13
DB01216	Finasteride	varicose veins	20	2.14
DB01216	Finasteride	inflammatory bowel diseases	119	2.17
DB01216	Finasteride	leukemia	117	2.31
DB01216	Finasteride	epilepsy	25	2.32
DB01216	Finasteride	collagen diseases	25	2.33
DB01216	Finasteride	vascular diseases	181	2.36
DB01216	Finasteride	arrhythmias cardiac	30	2.41
DB01216	Finasteride	hyperinsulinism	26	2.43
DB01216	Finasteride	bone diseases metabolic	27	2.46
DB01216	Finasteride	insulin resistance	26	2.54
DB01216	Finasteride	macular degeneration	44	2.62
DB01216	Finasteride	coronary artery disease	31	2.73
DB01216	Finasteride	thyroid diseases	30	2.84
DB01216	Finasteride	anemia hemolytic	29	2.85
DB01216	Finasteride	mycobacterium infections	22	2.88
DB01216	Finasteride	parkinsonian disorders	31	2.94
DB01216	Finasteride	amyotrophic lateral sclerosis	21	3.06
DB01216	Finasteride	parkinson disease	30	3.09
DB01216	Finasteride	liver cirrhosis biliary	23	3.15
DB01216	Finasteride	bacterial infections	26	3.16
DB01216	Finasteride	neuroendocrine tumors	24	3.21
DB01216	Finasteride	arteriosclerosis	38	3.24
DB01216	Finasteride	pancreatic diseases	24	3.24
DB01216	Finasteride	liver cirrhosis	24	3.26
DB01216	Finasteride	asthma	36	3.30
DB01216	Finasteride	hypopigmentation	22	3.30
DB01216	Finasteride	coronary disease	37	3.35
DB01216	Finasteride	myocardial ischemia	43	3.36
DB01216	Finasteride	blood coagulation disorders	40	3.40
DB01216	Finasteride	alzheimer disease	29	3.45
DB01216	Finasteride	psoriasis	54	3.50
DB01216	Finasteride	sarcoma	25	3.51
DB01216	Finasteride	colitis	55	3.53
DB01216	Finasteride	motor neuron disease	31	3.56
DB01216	Finasteride	prostatic neoplasms	61	3.59
DB01216	Finasteride	arterial occlusive diseases	44	3.61
DB01216	Finasteride	colitis ulcerative	55	3.63
DB01216	Finasteride	hypersensitivity	45	3.65
DB01216	Finasteride	multiple sclerosis	69	3.66
DB01216	Finasteride	cardiomyopathy dilated	29	3.69
DB01216	Finasteride	lung diseases	71	3.70
DB01216	Finasteride	arthritis rheumatoid	42	3.72
DB01216	Finasteride	spinal cord diseases	59	3.75
DB01216	Finasteride	rheumatic diseases	59	3.79
DB01216	Finasteride	dementia	42	3.96
DB01182	Propafenone	arrhythmias cardiac	30	-5.76
DB01182	Propafenone	heart diseases	167	-5.27
DB01182	Propafenone	cardiovascular diseases	330	-3.98
DB01182	Propafenone	thyroid diseases	30	-3.58
DB01182	Propafenone	cardiomyopathy dilated	29	-3.54
DB01182	Propafenone	coronary disease	37	-2.13
DB01182	Propafenone	bone diseases metabolic	27	-2.06
DB01182	Propafenone	lymphoma	24	-1.92
DB01182	Propafenone	lymphoma non hodgkin	22	-1.89
DB01182	Propafenone	myocardial ischemia	43	-1.88
DB01182	Propafenone	head and neck neoplasms	35	-1.76
DB01182	Propafenone	arteriosclerosis	38	-1.74
DB01182	Propafenone	endocrine system diseases	291	-1.67
DB01182	Propafenone	arterial occlusive diseases	44	-1.63
DB01182	Propafenone	bone diseases	144	-0.99
DB01182	Propafenone	neoplasms	482	-0.93
DB01182	Propafenone	varicose veins	20	-0.87
DB01182	Propafenone	epilepsy	25	-0.81
DB01182	Propafenone	leukemia	117	-0.80
DB01182	Propafenone	vascular diseases	181	-0.74
DB01182	Propafenone	insulin resistance	26	-0.61
DB01182	Propafenone	hyperinsulinism	26	-0.60
DB01182	Propafenone	eye diseases	231	-0.59
DB01182	Propafenone	keratosis	21	-0.59
DB01182	Propafenone	autoimmune diseases	243	-0.58
DB01182	Propafenone	coronary artery disease	31	-0.53
DB01182	Propafenone	macular degeneration	44	-0.49
DB01182	Propafenone	kidney neoplasms	20	-0.48
DB01182	Propafenone	bacterial infections	26	-0.45
DB01182	Propafenone	parkinson disease	30	-0.45
DB01182	Propafenone	hematologic diseases	188	-0.44
DB01182	Propafenone	malabsorption syndromes	34	-0.43
DB01182	Propafenone	anemia hemolytic	29	-0.43
DB01182	Propafenone	parkinsonian disorders	31	-0.42
DB01182	Propafenone	amyotrophic lateral sclerosis	21	-0.39
DB01182	Propafenone	hypopigmentation	22	-0.39
DB01182	Propafenone	neuroendocrine tumors	24	-0.34
DB01182	Propafenone	liver cirrhosis	24	-0.34
DB01182	Propafenone	liver cirrhosis biliary	23	-0.32
DB01182	Propafenone	asthma	36	-0.32
DB01182	Propafenone	pancreatic diseases	24	-0.31
DB01182	Propafenone	alzheimer disease	29	-0.29
DB01182	Propafenone	sarcoma	25	-0.25
DB01182	Propafenone	blood coagulation disorders	40	-0.18
DB01182	Propafenone	motor neuron disease	31	-0.15
DB01182	Propafenone	hypersensitivity	45	-0.14
DB01182	Propafenone	adenocarcinoma	32	-0.06
DB01182	Propafenone	colitis ulcerative	55	-0.02
DB01182	Propafenone	arthritis rheumatoid	42	-0.02
DB01182	Propafenone	dementia	42	-0.02
DB01182	Propafenone	prostatic neoplasms	61	0.03
DB01182	Propafenone	colitis	55	0.03
DB01182	Propafenone	psoriasis	54	0.03
DB01182	Propafenone	breast neoplasms	40	0.04
DB01182	Propafenone	diabetes mellitus type 2	72	0.08
DB01182	Propafenone	diabetes mellitus type 1	82	0.15
DB01182	Propafenone	rheumatic diseases	59	0.17
DB01182	Propafenone	lupus erythematosus systemic	75	0.18
DB01182	Propafenone	crohn disease	71	0.20
DB01182	Propafenone	spinal cord diseases	59	0.21
DB01182	Propafenone	intestinal neoplasms	42	0.21
DB01182	Propafenone	leukemia myeloid acute	43	0.21
DB01182	Propafenone	multiple sclerosis	69	0.22
DB01182	Propafenone	colorectal neoplasms	42	0.22
DB01182	Propafenone	arthritis	76	0.25
DB01182	Propafenone	joint diseases	79	0.28
DB01182	Propafenone	lung diseases	71	0.30
DB01182	Propafenone	anemia	58	0.33
DB01182	Propafenone	leukemia lymphoid	66	0.37
DB01182	Propafenone	inflammatory bowel diseases	119	0.42
DB01182	Propafenone	gastrointestinal neoplasms	72	0.44
DB01182	Propafenone	gastroenteritis	122	0.45
DB01182	Propafenone	kidney diseases	144	0.49
DB01182	Propafenone	diabetes mellitus	162	0.49
DB01182	Propafenone	collagen diseases	25	0.69
DB01182	Propafenone	metabolism inborn errors	289	0.80
DB01182	Propafenone	mycobacterium infections	22	0.90
DB01182	Propafenone	skin diseases	278	0.95
DB00843	Donepezil	arteriosclerosis	38	-2.07
DB00843	Donepezil	myocardial ischemia	43	-2.05
DB00843	Donepezil	vascular diseases	181	-1.96
DB00843	Donepezil	alzheimer disease	29	-1.93
DB00843	Donepezil	breast neoplasms	40	-1.90
DB00843	Donepezil	asthma	36	-1.86
DB00843	Donepezil	arterial occlusive diseases	44	-1.86
DB00843	Donepezil	dementia	42	-1.83
DB00843	Donepezil	blood coagulation disorders	40	-1.82
DB00843	Donepezil	colitis	55	-1.81
DB00843	Donepezil	hypersensitivity	45	-1.81
DB00843	Donepezil	colitis ulcerative	55	-1.74
DB00843	Donepezil	leukemia myeloid acute	43	-1.61
DB00843	Donepezil	cardiovascular diseases	330	-1.37
DB00843	Donepezil	lung diseases	71	-1.35
DB00843	Donepezil	crohn disease	71	-1.29
DB00843	Donepezil	inflammatory bowel diseases	119	-1.22
DB00843	Donepezil	gastroenteritis	122	-0.96
DB00843	Donepezil	heart diseases	167	-0.76
DB00843	Donepezil	varicose veins	20	-0.75
DB00843	Donepezil	epilepsy	25	-0.71
DB00843	Donepezil	leukemia	117	-0.68
DB00843	Donepezil	insulin resistance	26	-0.65
DB00843	Donepezil	hyperinsulinism	26	-0.63
DB00843	Donepezil	mycobacterium infections	22	-0.51
DB00843	Donepezil	coronary artery disease	31	-0.47
DB00843	Donepezil	macular degeneration	44	-0.45
DB00843	Donepezil	coronary disease	37	-0.38
DB00843	Donepezil	bacterial infections	26	-0.34
DB00843	Donepezil	hematologic diseases	188	-0.33
DB00843	Donepezil	parkinson disease	30	-0.32
DB00843	Donepezil	anemia hemolytic	29	-0.28
DB00843	Donepezil	amyotrophic lateral sclerosis	21	-0.27
DB00843	Donepezil	parkinsonian disorders	31	-0.26
DB00843	Donepezil	skin diseases	278	-0.24
DB00843	Donepezil	pancreatic diseases	24	-0.24
DB00843	Donepezil	liver cirrhosis biliary	23	-0.22
DB00843	Donepezil	liver cirrhosis	24	-0.20
DB00843	Donepezil	neuroendocrine tumors	24	-0.18
DB00843	Donepezil	lymphoma non hodgkin	22	-0.10
DB00843	Donepezil	cardiomyopathy dilated	29	-0.09
DB00843	Donepezil	lymphoma	24	-0.05
DB00843	Donepezil	motor neuron disease	31	0.02
DB00843	Donepezil	adenocarcinoma	32	0.03
DB00843	Donepezil	head and neck neoplasms	35	0.04
DB00843	Donepezil	prostatic neoplasms	61	0.10
DB00843	Donepezil	psoriasis	54	0.12
DB00843	Donepezil	diabetes mellitus type 2	72	0.17
DB00843	Donepezil	diabetes mellitus type 1	82	0.24
DB00843	Donepezil	intestinal neoplasms	42	0.26
DB00843	Donepezil	multiple sclerosis	69	0.30
DB00843	Donepezil	colorectal neoplasms	42	0.32
DB00843	Donepezil	spinal cord diseases	59	0.33
DB00843	Donepezil	joint diseases	79	0.33
DB00843	Donepezil	arthritis	76	0.39
DB00843	Donepezil	anemia	58	0.44
DB00843	Donepezil	neoplasms	482	0.46
DB00843	Donepezil	leukemia lymphoid	66	0.47
DB00843	Donepezil	kidney diseases	144	0.49
DB00843	Donepezil	diabetes mellitus	162	0.55
DB00843	Donepezil	gastrointestinal neoplasms	72	0.61
DB00843	Donepezil	bone diseases	144	0.64
DB00843	Donepezil	eye diseases	231	0.77
DB00843	Donepezil	arrhythmias cardiac	30	0.80
DB00843	Donepezil	bone diseases metabolic	27	0.83
DB00843	Donepezil	metabolism inborn errors	289	0.84
DB00843	Donepezil	collagen diseases	25	0.88
DB00843	Donepezil	autoimmune diseases	243	0.95
DB00843	Donepezil	endocrine system diseases	291	1.06
DB00843	Donepezil	keratosis	21	1.11
DB00843	Donepezil	thyroid diseases	30	1.20
DB00843	Donepezil	kidney neoplasms	20	1.32
DB00843	Donepezil	hypopigmentation	22	1.33
DB00843	Donepezil	malabsorption syndromes	34	1.40
DB00843	Donepezil	sarcoma	25	1.43
DB00843	Donepezil	arthritis rheumatoid	42	1.81
DB00843	Donepezil	rheumatic diseases	59	2.00
DB00843	Donepezil	lupus erythematosus systemic	75	2.10
DB01009	Ketoprofen	colitis ulcerative	55	-1.41
DB01009	Ketoprofen	colitis	55	-1.41
DB01009	Ketoprofen	psoriasis	54	-1.30
DB01009	Ketoprofen	eye diseases	231	-1.25
DB01009	Ketoprofen	lung diseases	71	-0.89
DB01009	Ketoprofen	inflammatory bowel diseases	119	-0.73
DB01009	Ketoprofen	skin diseases	278	-0.69
DB01009	Ketoprofen	gastroenteritis	122	-0.68
DB01009	Ketoprofen	gastrointestinal neoplasms	72	-0.64
DB01009	Ketoprofen	keratosis	21	-0.48
DB01009	Ketoprofen	malabsorption syndromes	34	-0.31
DB01009	Ketoprofen	vascular diseases	181	-0.15
DB01009	Ketoprofen	arterial occlusive diseases	44	-0.13
DB01009	Ketoprofen	lymphoma	24	-0.10
DB01009	Ketoprofen	lymphoma non hodgkin	22	-0.06
DB01009	Ketoprofen	metabolism inborn errors	289	0.02
DB01009	Ketoprofen	prostatic neoplasms	61	0.17
DB01009	Ketoprofen	dementia	42	0.17
DB01009	Ketoprofen	diabetes mellitus type 2	72	0.22
DB01009	Ketoprofen	endocrine system diseases	291	0.32
DB01009	Ketoprofen	multiple sclerosis	69	0.32
DB01009	Ketoprofen	lupus erythematosus systemic	75	0.35
DB01009	Ketoprofen	diabetes mellitus type 1	82	0.37
DB01009	Ketoprofen	spinal cord diseases	59	0.39
DB01009	Ketoprofen	joint diseases	79	0.40
DB01009	Ketoprofen	arthritis	76	0.40
DB01009	Ketoprofen	cardiovascular diseases	330	0.41
DB01009	Ketoprofen	insulin resistance	26	0.42
DB01009	Ketoprofen	hyperinsulinism	26	0.46
DB01009	Ketoprofen	anemia	58	0.49
DB01009	Ketoprofen	leukemia lymphoid	66	0.49
DB01009	Ketoprofen	bone diseases metabolic	27	0.55
DB01009	Ketoprofen	coronary artery disease	31	0.72
DB01009	Ketoprofen	diabetes mellitus	162	0.74
DB01009	Ketoprofen	bone diseases	144	0.79
DB01009	Ketoprofen	thyroid diseases	30	0.80
DB01009	Ketoprofen	heart diseases	167	0.88
DB01009	Ketoprofen	leukemia	117	0.94
DB01009	Ketoprofen	coronary disease	37	0.94
DB01009	Ketoprofen	parkinson disease	30	0.96
DB01009	Ketoprofen	parkinsonian disorders	31	0.98
DB01009	Ketoprofen	myocardial ischemia	43	1.01
DB01009	Ketoprofen	pancreatic diseases	24	1.03
DB01009	Ketoprofen	arteriosclerosis	38	1.03
DB01009	Ketoprofen	neoplasms	482	1.10
DB01009	Ketoprofen	asthma	36	1.11
DB01009	Ketoprofen	alzheimer disease	29	1.14
DB01009	Ketoprofen	hematologic diseases	188	1.19
DB01009	Ketoprofen	sarcoma	25	1.20
DB01009	Ketoprofen	autoimmune diseases	243	1.22
DB01009	Ketoprofen	varicose veins	20	1.29
DB01009	Ketoprofen	hypersensitivity	45	1.31
DB01009	Ketoprofen	arrhythmias cardiac	30	1.48
DB01009	Ketoprofen	arthritis rheumatoid	42	1.51
DB01009	Ketoprofen	adenocarcinoma	32	1.56
DB01009	Ketoprofen	breast neoplasms	40	1.63
DB01009	Ketoprofen	head and neck neoplasms	35	1.66
DB01009	Ketoprofen	collagen diseases	25	1.67
DB01009	Ketoprofen	rheumatic diseases	59	1.74
DB01009	Ketoprofen	intestinal neoplasms	42	1.79
DB01009	Ketoprofen	macular degeneration	44	1.85
DB01009	Ketoprofen	leukemia myeloid acute	43	1.85
DB01009	Ketoprofen	crohn disease	71	1.88
DB01009	Ketoprofen	colorectal neoplasms	42	1.89
DB01009	Ketoprofen	mycobacterium infections	22	1.89
DB01009	Ketoprofen	kidney diseases	144	2.03
DB01009	Ketoprofen	kidney neoplasms	20	2.22
DB01009	Ketoprofen	liver cirrhosis	24	2.24
DB01009	Ketoprofen	bacterial infections	26	2.24
DB01009	Ketoprofen	amyotrophic lateral sclerosis	21	2.35
DB01009	Ketoprofen	neuroendocrine tumors	24	2.40
DB01009	Ketoprofen	liver cirrhosis biliary	23	2.43
DB01009	Ketoprofen	epilepsy	25	2.62
DB01009	Ketoprofen	motor neuron disease	31	2.87
DB01009	Ketoprofen	hypopigmentation	22	3.42
DB01009	Ketoprofen	anemia hemolytic	29	3.49
DB01009	Ketoprofen	cardiomyopathy dilated	29	3.90
DB01009	Ketoprofen	blood coagulation disorders	40	4.24
DB00694	Daunorubicin	kidney neoplasms	20	-2.57
DB00694	Daunorubicin	lymphoma non hodgkin	22	-2.11
DB00694	Daunorubicin	lymphoma	24	-2.06
DB00694	Daunorubicin	adenocarcinoma	32	-2.01
DB00694	Daunorubicin	head and neck neoplasms	35	-1.79
DB00694	Daunorubicin	breast neoplasms	40	-1.64
DB00694	Daunorubicin	leukemia myeloid acute	43	-1.61
DB00694	Daunorubicin	bone diseases metabolic	27	-1.57
DB00694	Daunorubicin	lung diseases	71	-1.47
DB00694	Daunorubicin	coronary artery disease	31	-1.47
DB00694	Daunorubicin	coronary disease	37	-1.37
DB00694	Daunorubicin	myocardial ischemia	43	-1.34
DB00694	Daunorubicin	kidney diseases	144	-1.32
DB00694	Daunorubicin	gastrointestinal neoplasms	72	-1.06
DB00694	Daunorubicin	heart diseases	167	-1.05
DB00694	Daunorubicin	arteriosclerosis	38	-1.05
DB00694	Daunorubicin	neuroendocrine tumors	24	-0.99
DB00694	Daunorubicin	cardiomyopathy dilated	29	-0.97
DB00694	Daunorubicin	pancreatic diseases	24	-0.88
DB00694	Daunorubicin	arterial occlusive diseases	44	-0.85
DB00694	Daunorubicin	metabolism inborn errors	289	-0.84
DB00694	Daunorubicin	sarcoma	25	-0.77
DB00694	Daunorubicin	leukemia	117	-0.74
DB00694	Daunorubicin	arthritis rheumatoid	42	-0.69
DB00694	Daunorubicin	vascular diseases	181	-0.69
DB00694	Daunorubicin	hematologic diseases	188	-0.55
DB00694	Daunorubicin	autoimmune diseases	243	-0.53
DB00694	Daunorubicin	rheumatic diseases	59	-0.47
DB00694	Daunorubicin	prostatic neoplasms	61	-0.45
DB00694	Daunorubicin	lupus erythematosus systemic	75	-0.40
DB00694	Daunorubicin	cardiovascular diseases	330	-0.33
DB00694	Daunorubicin	skin diseases	278	-0.32
DB00694	Daunorubicin	endocrine system diseases	291	-0.31
DB00694	Daunorubicin	multiple sclerosis	69	-0.29
DB00694	Daunorubicin	diabetes mellitus type 1	82	-0.25
DB00694	Daunorubicin	joint diseases	79	-0.24
DB00694	Daunorubicin	spinal cord diseases	59	-0.20
DB00694	Daunorubicin	arthritis	76	-0.14
DB00694	Daunorubicin	intestinal neoplasms	42	-0.10
DB00694	Daunorubicin	colorectal neoplasms	42	-0.08
DB00694	Daunorubicin	leukemia lymphoid	66	0.08
DB00694	Daunorubicin	hyperinsulinism	26	0.14
DB00694	Daunorubicin	varicose veins	20	0.16
DB00694	Daunorubicin	insulin resistance	26	0.16
DB00694	Daunorubicin	epilepsy	25	0.23
DB00694	Daunorubicin	arrhythmias cardiac	30	0.23
DB00694	Daunorubicin	macular degeneration	44	0.30
DB00694	Daunorubicin	neoplasms	482	0.30
DB00694	Daunorubicin	collagen diseases	25	0.30
DB00694	Daunorubicin	diabetes mellitus	162	0.32
DB00694	Daunorubicin	anemia hemolytic	29	0.43
DB00694	Daunorubicin	mycobacterium infections	22	0.43
DB00694	Daunorubicin	keratosis	21	0.48
DB00694	Daunorubicin	bone diseases	144	0.50
DB00694	Daunorubicin	malabsorption syndromes	34	0.52
DB00694	Daunorubicin	bacterial infections	26	0.54
DB00694	Daunorubicin	hypopigmentation	22	0.56
DB00694	Daunorubicin	liver cirrhosis biliary	23	0.59
DB00694	Daunorubicin	thyroid diseases	30	0.61
DB00694	Daunorubicin	parkinson disease	30	0.63
DB00694	Daunorubicin	liver cirrhosis	24	0.63
DB00694	Daunorubicin	parkinsonian disorders	31	0.64
DB00694	Daunorubicin	asthma	36	0.65
DB00694	Daunorubicin	blood coagulation disorders	40	0.69
DB00694	Daunorubicin	amyotrophic lateral sclerosis	21	0.70
DB00694	Daunorubicin	eye diseases	231	0.74
DB00694	Daunorubicin	hypersensitivity	45	0.75
DB00694	Daunorubicin	alzheimer disease	29	0.76
DB00694	Daunorubicin	colitis	55	0.84
DB00694	Daunorubicin	motor neuron disease	31	0.88
DB00694	Daunorubicin	colitis ulcerative	55	0.93
DB00694	Daunorubicin	dementia	42	0.95
DB00694	Daunorubicin	diabetes mellitus type 2	72	0.96
DB00694	Daunorubicin	psoriasis	54	1.01
DB00694	Daunorubicin	crohn disease	71	1.16
DB00694	Daunorubicin	anemia	58	1.29
DB00694	Daunorubicin	inflammatory bowel diseases	119	1.48
DB00694	Daunorubicin	gastroenteritis	122	1.54
DB00695	Furosemide	kidney diseases	144	-5.90
DB00695	Furosemide	bone diseases	144	-2.94
DB00695	Furosemide	metabolism inborn errors	289	-2.63
DB00695	Furosemide	anemia hemolytic	29	-2.44
DB00695	Furosemide	endocrine system diseases	291	-2.26
DB00695	Furosemide	adenocarcinoma	32	-2.08
DB00695	Furosemide	anemia	58	-1.74
DB00695	Furosemide	gastrointestinal neoplasms	72	-1.63
DB00695	Furosemide	neoplasms	482	-1.60
DB00695	Furosemide	kidney neoplasms	20	-1.16
DB00695	Furosemide	hematologic diseases	188	-1.14
DB00695	Furosemide	pancreatic diseases	24	-1.05
DB00695	Furosemide	liver cirrhosis biliary	23	-1.03
DB00695	Furosemide	liver cirrhosis	24	-1.01
DB00695	Furosemide	colitis ulcerative	55	-0.70
DB00695	Furosemide	prostatic neoplasms	61	-0.70
DB00695	Furosemide	head and neck neoplasms	35	-0.69
DB00695	Furosemide	arthritis rheumatoid	42	-0.66
DB00695	Furosemide	colitis	55	-0.64
DB00695	Furosemide	leukemia myeloid acute	43	-0.49
DB00695	Furosemide	intestinal neoplasms	42	-0.48
DB00695	Furosemide	rheumatic diseases	59	-0.47
DB00695	Furosemide	diabetes mellitus type 1	82	-0.45
DB00695	Furosemide	colorectal neoplasms	42	-0.45
DB00695	Furosemide	leukemia lymphoid	66	-0.34
DB00695	Furosemide	arthritis	76	-0.32
DB00695	Furosemide	joint diseases	79	-0.31
DB00695	Furosemide	lung diseases	71	-0.24
DB00695	Furosemide	varicose veins	20	-0.22
DB00695	Furosemide	gastroenteritis	122	-0.19
DB00695	Furosemide	inflammatory bowel diseases	119	-0.19
DB00695	Furosemide	epilepsy	25	-0.15
DB00695	Furosemide	diabetes mellitus	162	-0.07
DB00695	Furosemide	arrhythmias cardiac	30	-0.07
DB00695	Furosemide	heart diseases	167	0.02
DB00695	Furosemide	leukemia	117	0.06
DB00695	Furosemide	mycobacterium infections	22	0.10
DB00695	Furosemide	vascular diseases	181	0.10
DB00695	Furosemide	keratosis	21	0.11
DB00695	Furosemide	coronary artery disease	31	0.12
DB00695	Furosemide	hypopigmentation	22	0.21
DB00695	Furosemide	coronary disease	37	0.23
DB00695	Furosemide	autoimmune diseases	243	0.30
DB00695	Furosemide	bacterial infections	26	0.30
DB00695	Furosemide	neuroendocrine tumors	24	0.38
DB00695	Furosemide	arteriosclerosis	38	0.38
DB00695	Furosemide	myocardial ischemia	43	0.40
DB00695	Furosemide	skin diseases	278	0.40
DB00695	Furosemide	asthma	36	0.43
DB00695	Furosemide	cardiomyopathy dilated	29	0.44
DB00695	Furosemide	cardiovascular diseases	330	0.47
DB00695	Furosemide	lymphoma non hodgkin	22	0.50
DB00695	Furosemide	blood coagulation disorders	40	0.52
DB00695	Furosemide	lymphoma	24	0.53
DB00695	Furosemide	arterial occlusive diseases	44	0.54
DB00695	Furosemide	hypersensitivity	45	0.56
DB00695	Furosemide	motor neuron disease	31	0.59
DB00695	Furosemide	dementia	42	0.75
DB00695	Furosemide	breast neoplasms	40	0.79
DB00695	Furosemide	psoriasis	54	0.82
DB00695	Furosemide	diabetes mellitus type 2	72	0.84
DB00695	Furosemide	multiple sclerosis	69	0.93
DB00695	Furosemide	spinal cord diseases	59	0.96
DB00695	Furosemide	lupus erythematosus systemic	75	0.96
DB00695	Furosemide	crohn disease	71	1.00
DB00695	Furosemide	insulin resistance	26	1.20
DB00695	Furosemide	collagen diseases	25	1.21
DB00695	Furosemide	hyperinsulinism	26	1.25
DB00695	Furosemide	bone diseases metabolic	27	1.29
DB00695	Furosemide	macular degeneration	44	1.37
DB00695	Furosemide	eye diseases	231	1.51
DB00695	Furosemide	thyroid diseases	30	1.60
DB00695	Furosemide	parkinsonian disorders	31	1.65
DB00695	Furosemide	malabsorption syndromes	34	1.66
DB00695	Furosemide	amyotrophic lateral sclerosis	21	1.69
DB00695	Furosemide	parkinson disease	30	1.70
DB00695	Furosemide	sarcoma	25	1.70
DB00695	Furosemide	alzheimer disease	29	1.73
DB01185	Fluoxymesterone	skin diseases	278	-3.82
DB01185	Fluoxymesterone	heart diseases	167	-2.83
DB01185	Fluoxymesterone	neoplasms	482	-2.71
DB01185	Fluoxymesterone	cardiovascular diseases	330	-2.55
DB01185	Fluoxymesterone	colitis ulcerative	55	-2.45
DB01185	Fluoxymesterone	colitis	55	-2.39
DB01185	Fluoxymesterone	endocrine system diseases	291	-2.35
DB01185	Fluoxymesterone	coronary artery disease	31	-2.29
DB01185	Fluoxymesterone	coronary disease	37	-2.11
DB01185	Fluoxymesterone	motor neuron disease	31	-1.96
DB01185	Fluoxymesterone	arteriosclerosis	38	-1.93
DB01185	Fluoxymesterone	myocardial ischemia	43	-1.91
DB01185	Fluoxymesterone	prostatic neoplasms	61	-1.89
DB01185	Fluoxymesterone	breast neoplasms	40	-1.78
DB01185	Fluoxymesterone	crohn disease	71	-1.75
DB01185	Fluoxymesterone	arterial occlusive diseases	44	-1.66
DB01185	Fluoxymesterone	leukemia myeloid acute	43	-1.64
DB01185	Fluoxymesterone	spinal cord diseases	59	-1.58
DB01185	Fluoxymesterone	kidney neoplasms	20	-1.56
DB01185	Fluoxymesterone	inflammatory bowel diseases	119	-1.53
DB01185	Fluoxymesterone	gastroenteritis	122	-1.51
DB01185	Fluoxymesterone	bone diseases	144	-1.32
DB01185	Fluoxymesterone	asthma	36	-1.28
DB01185	Fluoxymesterone	sarcoma	25	-1.22
DB01185	Fluoxymesterone	vascular diseases	181	-1.21
DB01185	Fluoxymesterone	liver cirrhosis	24	-1.13
DB01185	Fluoxymesterone	liver cirrhosis biliary	23	-1.12
DB01185	Fluoxymesterone	hypersensitivity	45	-1.03
DB01185	Fluoxymesterone	leukemia	117	-0.91
DB01185	Fluoxymesterone	lymphoma non hodgkin	22	-0.90
DB01185	Fluoxymesterone	head and neck neoplasms	35	-0.86
DB01185	Fluoxymesterone	lymphoma	24	-0.86
DB01185	Fluoxymesterone	adenocarcinoma	32	-0.78
DB01185	Fluoxymesterone	hematologic diseases	188	-0.76
DB01185	Fluoxymesterone	diabetes mellitus type 1	82	-0.73
DB01185	Fluoxymesterone	malabsorption syndromes	34	-0.72
DB01185	Fluoxymesterone	lupus erythematosus systemic	75	-0.63
DB01185	Fluoxymesterone	alzheimer disease	29	-0.55
DB01185	Fluoxymesterone	diabetes mellitus type 2	72	-0.40
DB01185	Fluoxymesterone	colorectal neoplasms	42	-0.34
DB01185	Fluoxymesterone	parkinson disease	30	-0.29
DB01185	Fluoxymesterone	multiple sclerosis	69	-0.28
DB01185	Fluoxymesterone	parkinsonian disorders	31	-0.27
DB01185	Fluoxymesterone	leukemia lymphoid	66	-0.26
DB01185	Fluoxymesterone	intestinal neoplasms	42	-0.24
DB01185	Fluoxymesterone	neuroendocrine tumors	24	-0.23
DB01185	Fluoxymesterone	diabetes mellitus	162	-0.22
DB01185	Fluoxymesterone	kidney diseases	144	-0.17
DB01185	Fluoxymesterone	dementia	42	-0.14
DB01185	Fluoxymesterone	pancreatic diseases	24	-0.12
DB01185	Fluoxymesterone	lung diseases	71	-0.09
DB01185	Fluoxymesterone	keratosis	21	-0.02
DB01185	Fluoxymesterone	thyroid diseases	30	0.14
DB01185	Fluoxymesterone	gastrointestinal neoplasms	72	0.16
DB01185	Fluoxymesterone	metabolism inborn errors	289	0.18
DB01185	Fluoxymesterone	blood coagulation disorders	40	0.26
DB01185	Fluoxymesterone	cardiomyopathy dilated	29	0.29
DB01185	Fluoxymesterone	arrhythmias cardiac	30	0.29
DB01185	Fluoxymesterone	mycobacterium infections	22	0.33
DB01185	Fluoxymesterone	varicose veins	20	0.36
DB01185	Fluoxymesterone	collagen diseases	25	0.38
DB01185	Fluoxymesterone	epilepsy	25	0.42
DB01185	Fluoxymesterone	amyotrophic lateral sclerosis	21	0.43
DB01185	Fluoxymesterone	eye diseases	231	0.53
DB01185	Fluoxymesterone	macular degeneration	44	0.56
DB01185	Fluoxymesterone	bacterial infections	26	0.58
DB01185	Fluoxymesterone	autoimmune diseases	243	0.70
DB01185	Fluoxymesterone	anemia hemolytic	29	1.00
DB01185	Fluoxymesterone	hypopigmentation	22	1.26
DB01185	Fluoxymesterone	arthritis rheumatoid	42	1.37
DB01185	Fluoxymesterone	bone diseases metabolic	27	1.66
DB01185	Fluoxymesterone	insulin resistance	26	1.73
DB01185	Fluoxymesterone	hyperinsulinism	26	1.74
DB01185	Fluoxymesterone	rheumatic diseases	59	1.87
DB01185	Fluoxymesterone	psoriasis	54	2.32
DB01185	Fluoxymesterone	arthritis	76	2.34
DB01185	Fluoxymesterone	joint diseases	79	2.57
DB01185	Fluoxymesterone	anemia	58	2.67
DB00697	Tizanidine	varicose veins	20	-3.00
DB00697	Tizanidine	spinal cord diseases	59	-2.61
DB00697	Tizanidine	motor neuron disease	31	-1.89
DB00697	Tizanidine	vascular diseases	181	-1.89
DB00697	Tizanidine	collagen diseases	25	-1.83
DB00697	Tizanidine	diabetes mellitus type 2	72	-1.80
DB00697	Tizanidine	prostatic neoplasms	61	-1.76
DB00697	Tizanidine	keratosis	21	-1.69
DB00697	Tizanidine	coronary artery disease	31	-1.61
DB00697	Tizanidine	coronary disease	37	-1.53
DB00697	Tizanidine	parkinson disease	30	-1.45
DB00697	Tizanidine	parkinsonian disorders	31	-1.45
DB00697	Tizanidine	kidney neoplasms	20	-1.44
DB00697	Tizanidine	arteriosclerosis	38	-1.40
DB00697	Tizanidine	liver cirrhosis biliary	23	-1.37
DB00697	Tizanidine	amyotrophic lateral sclerosis	21	-1.36
DB00697	Tizanidine	malabsorption syndromes	34	-1.35
DB00697	Tizanidine	myocardial ischemia	43	-1.34
DB00697	Tizanidine	liver cirrhosis	24	-1.29
DB00697	Tizanidine	neuroendocrine tumors	24	-1.29
DB00697	Tizanidine	cardiovascular diseases	330	-1.24
DB00697	Tizanidine	sarcoma	25	-1.18
DB00697	Tizanidine	diabetes mellitus	162	-1.16
DB00697	Tizanidine	lymphoma non hodgkin	22	-1.15
DB00697	Tizanidine	blood coagulation disorders	40	-1.13
DB00697	Tizanidine	lymphoma	24	-1.11
DB00697	Tizanidine	arterial occlusive diseases	44	-1.10
DB00697	Tizanidine	insulin resistance	26	-0.98
DB00697	Tizanidine	hyperinsulinism	26	-0.96
DB00697	Tizanidine	head and neck neoplasms	35	-0.94
DB00697	Tizanidine	adenocarcinoma	32	-0.93
DB00697	Tizanidine	colitis ulcerative	55	-0.92
DB00697	Tizanidine	colitis	55	-0.81
DB00697	Tizanidine	breast neoplasms	40	-0.80
DB00697	Tizanidine	psoriasis	54	-0.80
DB00697	Tizanidine	mycobacterium infections	22	-0.74
DB00697	Tizanidine	lupus erythematosus systemic	75	-0.65
DB00697	Tizanidine	leukemia myeloid acute	43	-0.60
DB00697	Tizanidine	thyroid diseases	30	-0.60
DB00697	Tizanidine	diabetes mellitus type 1	82	-0.58
DB00697	Tizanidine	intestinal neoplasms	42	-0.58
DB00697	Tizanidine	colorectal neoplasms	42	-0.55
DB00697	Tizanidine	crohn disease	71	-0.51
DB00697	Tizanidine	bacterial infections	26	-0.49
DB00697	Tizanidine	multiple sclerosis	69	-0.49
DB00697	Tizanidine	pancreatic diseases	24	-0.40
DB00697	Tizanidine	lung diseases	71	-0.37
DB00697	Tizanidine	endocrine system diseases	291	-0.37
DB00697	Tizanidine	alzheimer disease	29	-0.37
DB00697	Tizanidine	leukemia lymphoid	66	-0.36
DB00697	Tizanidine	skin diseases	278	-0.36
DB00697	Tizanidine	cardiomyopathy dilated	29	-0.32
DB00697	Tizanidine	gastrointestinal neoplasms	72	-0.21
DB00697	Tizanidine	inflammatory bowel diseases	119	-0.20
DB00697	Tizanidine	kidney diseases	144	-0.16
DB00697	Tizanidine	gastroenteritis	122	-0.07
DB00697	Tizanidine	heart diseases	167	0.01
DB00697	Tizanidine	bone diseases	144	0.03
DB00697	Tizanidine	arthritis rheumatoid	42	0.04
DB00697	Tizanidine	bone diseases metabolic	27	0.05
DB00697	Tizanidine	dementia	42	0.14
DB00697	Tizanidine	leukemia	117	0.16
DB00697	Tizanidine	eye diseases	231	0.32
DB00697	Tizanidine	neoplasms	482	0.32
DB00697	Tizanidine	rheumatic diseases	59	0.36
DB00697	Tizanidine	metabolism inborn errors	289	0.40
DB00697	Tizanidine	autoimmune diseases	243	0.43
DB00697	Tizanidine	hematologic diseases	188	0.45
DB00697	Tizanidine	arthritis	76	0.54
DB00697	Tizanidine	joint diseases	79	0.55
DB00697	Tizanidine	asthma	36	0.59
DB00697	Tizanidine	anemia	58	0.60
DB00697	Tizanidine	epilepsy	25	0.78
DB00697	Tizanidine	hypersensitivity	45	0.79
DB00697	Tizanidine	arrhythmias cardiac	30	0.89
DB00697	Tizanidine	macular degeneration	44	1.20
DB00697	Tizanidine	anemia hemolytic	29	1.29
DB00697	Tizanidine	hypopigmentation	22	1.36
DB01268	Sunitinib	bacterial infections	26	-5.87
DB01268	Sunitinib	mycobacterium infections	22	-5.85
DB01268	Sunitinib	neoplasms	482	-5.49
DB01268	Sunitinib	leukemia	117	-5.17
DB01268	Sunitinib	leukemia myeloid acute	43	-4.03
DB01268	Sunitinib	multiple sclerosis	69	-3.39
DB01268	Sunitinib	hematologic diseases	188	-3.02
DB01268	Sunitinib	blood coagulation disorders	40	-2.92
DB01268	Sunitinib	gastrointestinal neoplasms	72	-2.90
DB01268	Sunitinib	heart diseases	167	-2.82
DB01268	Sunitinib	colitis	55	-2.38
DB01268	Sunitinib	colitis ulcerative	55	-2.36
DB01268	Sunitinib	eye diseases	231	-2.31
DB01268	Sunitinib	arrhythmias cardiac	30	-2.18
DB01268	Sunitinib	macular degeneration	44	-2.13
DB01268	Sunitinib	diabetes mellitus type 2	72	-2.04
DB01268	Sunitinib	diabetes mellitus	162	-2.03
DB01268	Sunitinib	skin diseases	278	-2.02
DB01268	Sunitinib	crohn disease	71	-1.90
DB01268	Sunitinib	gastroenteritis	122	-1.84
DB01268	Sunitinib	inflammatory bowel diseases	119	-1.78
DB01268	Sunitinib	varicose veins	20	-1.65
DB01268	Sunitinib	malabsorption syndromes	34	-1.57
DB01268	Sunitinib	arteriosclerosis	38	-1.53
DB01268	Sunitinib	liver cirrhosis biliary	23	-1.45
DB01268	Sunitinib	hypopigmentation	22	-1.44
DB01268	Sunitinib	liver cirrhosis	24	-1.43
DB01268	Sunitinib	cardiovascular diseases	330	-1.33
DB01268	Sunitinib	endocrine system diseases	291	-1.27
DB01268	Sunitinib	metabolism inborn errors	289	-1.25
DB01268	Sunitinib	bone diseases	144	-1.24
DB01268	Sunitinib	arterial occlusive diseases	44	-1.15
DB01268	Sunitinib	sarcoma	25	-1.09
DB01268	Sunitinib	coronary artery disease	31	-1.05
DB01268	Sunitinib	autoimmune diseases	243	-1.01
DB01268	Sunitinib	kidney diseases	144	-0.97
DB01268	Sunitinib	colorectal neoplasms	42	-0.91
DB01268	Sunitinib	keratosis	21	-0.91
DB01268	Sunitinib	coronary disease	37	-0.87
DB01268	Sunitinib	intestinal neoplasms	42	-0.85
DB01268	Sunitinib	arthritis rheumatoid	42	-0.81
DB01268	Sunitinib	vascular diseases	181	-0.81
DB01268	Sunitinib	epilepsy	25	-0.77
DB01268	Sunitinib	myocardial ischemia	43	-0.74
DB01268	Sunitinib	hyperinsulinism	26	-0.65
DB01268	Sunitinib	leukemia lymphoid	66	-0.59
DB01268	Sunitinib	insulin resistance	26	-0.54
DB01268	Sunitinib	lupus erythematosus systemic	75	-0.45
DB01268	Sunitinib	collagen diseases	25	-0.44
DB01268	Sunitinib	rheumatic diseases	59	-0.38
DB01268	Sunitinib	diabetes mellitus type 1	82	-0.31
DB01268	Sunitinib	arthritis	76	-0.07
DB01268	Sunitinib	anemia hemolytic	29	-0.04
DB01268	Sunitinib	joint diseases	79	0.01
DB01268	Sunitinib	lung diseases	71	0.05
DB01268	Sunitinib	thyroid diseases	30	0.07
DB01268	Sunitinib	adenocarcinoma	32	0.09
DB01268	Sunitinib	kidney neoplasms	20	0.12
DB01268	Sunitinib	prostatic neoplasms	61	0.19
DB01268	Sunitinib	parkinsonian disorders	31	0.20
DB01268	Sunitinib	parkinson disease	30	0.20
DB01268	Sunitinib	psoriasis	54	0.26
DB01268	Sunitinib	pancreatic diseases	24	0.29
DB01268	Sunitinib	head and neck neoplasms	35	0.29
DB01268	Sunitinib	neuroendocrine tumors	24	0.30
DB01268	Sunitinib	asthma	36	0.32
DB01268	Sunitinib	amyotrophic lateral sclerosis	21	0.32
DB01268	Sunitinib	bone diseases metabolic	27	0.38
DB01268	Sunitinib	breast neoplasms	40	0.42
DB01268	Sunitinib	cardiomyopathy dilated	29	0.42
DB01268	Sunitinib	alzheimer disease	29	0.47
DB01268	Sunitinib	hypersensitivity	45	0.56
DB01268	Sunitinib	lymphoma	24	0.68
DB01268	Sunitinib	lymphoma non hodgkin	22	0.68
DB01268	Sunitinib	motor neuron disease	31	0.78
DB01268	Sunitinib	dementia	42	1.05
DB01268	Sunitinib	spinal cord diseases	59	1.52
DB01268	Sunitinib	anemia	58	1.64
DB00361	Vinorelbine	parkinson disease	30	-2.13
DB00361	Vinorelbine	parkinsonian disorders	31	-2.11
DB00361	Vinorelbine	amyotrophic lateral sclerosis	21	-1.30
DB00361	Vinorelbine	alzheimer disease	29	-1.25
DB00361	Vinorelbine	arterial occlusive diseases	44	-1.25
DB00361	Vinorelbine	mycobacterium infections	22	-1.18
DB00361	Vinorelbine	neuroendocrine tumors	24	-1.14
DB00361	Vinorelbine	bacterial infections	26	-1.07
DB00361	Vinorelbine	dementia	42	-1.00
DB00361	Vinorelbine	prostatic neoplasms	61	-0.90
DB00361	Vinorelbine	psoriasis	54	-0.87
DB00361	Vinorelbine	pancreatic diseases	24	-0.83
DB00361	Vinorelbine	arthritis rheumatoid	42	-0.78
DB00361	Vinorelbine	motor neuron disease	31	-0.76
DB00361	Vinorelbine	liver cirrhosis biliary	23	-0.76
DB00361	Vinorelbine	liver cirrhosis	24	-0.74
DB00361	Vinorelbine	lymphoma	24	-0.73
DB00361	Vinorelbine	diabetes mellitus type 1	82	-0.71
DB00361	Vinorelbine	lymphoma non hodgkin	22	-0.71
DB00361	Vinorelbine	breast neoplasms	40	-0.61
DB00361	Vinorelbine	rheumatic diseases	59	-0.59
DB00361	Vinorelbine	leukemia myeloid acute	43	-0.55
DB00361	Vinorelbine	leukemia lymphoid	66	-0.50
DB00361	Vinorelbine	diabetes mellitus	162	-0.47
DB00361	Vinorelbine	arthritis	76	-0.45
DB00361	Vinorelbine	joint diseases	79	-0.42
DB00361	Vinorelbine	heart diseases	167	-0.37
DB00361	Vinorelbine	spinal cord diseases	59	-0.36
DB00361	Vinorelbine	metabolism inborn errors	289	-0.34
DB00361	Vinorelbine	multiple sclerosis	69	-0.33
DB00361	Vinorelbine	lung diseases	71	-0.31
DB00361	Vinorelbine	anemia	58	-0.29
DB00361	Vinorelbine	bone diseases	144	-0.24
DB00361	Vinorelbine	leukemia	117	-0.10
DB00361	Vinorelbine	vascular diseases	181	-0.05
DB00361	Vinorelbine	skin diseases	278	-0.04
DB00361	Vinorelbine	eye diseases	231	-0.01
DB00361	Vinorelbine	hematologic diseases	188	0.09
DB00361	Vinorelbine	autoimmune diseases	243	0.09
DB00361	Vinorelbine	endocrine system diseases	291	0.15
DB00361	Vinorelbine	cardiovascular diseases	330	0.15
DB00361	Vinorelbine	neoplasms	482	0.20
DB00361	Vinorelbine	arrhythmias cardiac	30	0.32
DB00361	Vinorelbine	varicose veins	20	0.36
DB00361	Vinorelbine	macular degeneration	44	0.37
DB00361	Vinorelbine	collagen diseases	25	0.37
DB00361	Vinorelbine	epilepsy	25	0.39
DB00361	Vinorelbine	bone diseases metabolic	27	0.39
DB00361	Vinorelbine	insulin resistance	26	0.54
DB00361	Vinorelbine	hyperinsulinism	26	0.58
DB00361	Vinorelbine	coronary artery disease	31	0.63
DB00361	Vinorelbine	cardiomyopathy dilated	29	0.63
DB00361	Vinorelbine	anemia hemolytic	29	0.64
DB00361	Vinorelbine	blood coagulation disorders	40	0.64
DB00361	Vinorelbine	keratosis	21	0.66
DB00361	Vinorelbine	coronary disease	37	0.67
DB00361	Vinorelbine	myocardial ischemia	43	0.69
DB00361	Vinorelbine	thyroid diseases	30	0.69
DB00361	Vinorelbine	malabsorption syndromes	34	0.71
DB00361	Vinorelbine	hypopigmentation	22	0.71
DB00361	Vinorelbine	kidney neoplasms	20	0.71
DB00361	Vinorelbine	arteriosclerosis	38	0.72
DB00361	Vinorelbine	colitis ulcerative	55	0.79
DB00361	Vinorelbine	diabetes mellitus type 2	72	0.81
DB00361	Vinorelbine	colitis	55	0.83
DB00361	Vinorelbine	asthma	36	0.96
DB00361	Vinorelbine	hypersensitivity	45	0.98
DB00361	Vinorelbine	sarcoma	25	1.02
DB00361	Vinorelbine	head and neck neoplasms	35	1.09
DB00361	Vinorelbine	adenocarcinoma	32	1.32
DB00361	Vinorelbine	lupus erythematosus systemic	75	1.51
DB00361	Vinorelbine	crohn disease	71	1.61
DB00361	Vinorelbine	kidney diseases	144	1.93
DB00361	Vinorelbine	colorectal neoplasms	42	2.02
DB00361	Vinorelbine	inflammatory bowel diseases	119	2.05
DB00361	Vinorelbine	intestinal neoplasms	42	2.06
DB00361	Vinorelbine	gastroenteritis	122	2.17
DB00361	Vinorelbine	gastrointestinal neoplasms	72	3.49
DB00262	Carmustine	sarcoma	25	-2.64
DB00262	Carmustine	eye diseases	231	-1.58
DB00262	Carmustine	neoplasms	482	-0.71
DB00262	Carmustine	insulin resistance	26	-0.56
DB00262	Carmustine	hyperinsulinism	26	-0.49
DB00262	Carmustine	bone diseases metabolic	27	-0.49
DB00262	Carmustine	mycobacterium infections	22	-0.45
DB00262	Carmustine	coronary artery disease	31	-0.39
DB00262	Carmustine	bacterial infections	26	-0.37
DB00262	Carmustine	anemia hemolytic	29	-0.36
DB00262	Carmustine	liver cirrhosis biliary	23	-0.32
DB00262	Carmustine	pancreatic diseases	24	-0.32
DB00262	Carmustine	keratosis	21	-0.32
DB00262	Carmustine	kidney neoplasms	20	-0.32
DB00262	Carmustine	amyotrophic lateral sclerosis	21	-0.32
DB00262	Carmustine	liver cirrhosis	24	-0.31
DB00262	Carmustine	coronary disease	37	-0.28
DB00262	Carmustine	cardiomyopathy dilated	29	-0.26
DB00262	Carmustine	myocardial ischemia	43	-0.25
DB00262	Carmustine	asthma	36	-0.25
DB00262	Carmustine	neuroendocrine tumors	24	-0.21
DB00262	Carmustine	arteriosclerosis	38	-0.18
DB00262	Carmustine	arterial occlusive diseases	44	-0.18
DB00262	Carmustine	lymphoma	24	-0.14
DB00262	Carmustine	lymphoma non hodgkin	22	-0.14
DB00262	Carmustine	hypersensitivity	45	-0.13
DB00262	Carmustine	motor neuron disease	31	-0.10
DB00262	Carmustine	adenocarcinoma	32	-0.09
DB00262	Carmustine	head and neck neoplasms	35	-0.03
DB00262	Carmustine	prostatic neoplasms	61	0.05
DB00262	Carmustine	breast neoplasms	40	0.08
DB00262	Carmustine	crohn disease	71	0.08
DB00262	Carmustine	diabetes mellitus type 2	72	0.08
DB00262	Carmustine	lupus erythematosus systemic	75	0.09
DB00262	Carmustine	diabetes mellitus type 1	82	0.10
DB00262	Carmustine	leukemia myeloid acute	43	0.14
DB00262	Carmustine	spinal cord diseases	59	0.15
DB00262	Carmustine	multiple sclerosis	69	0.16
DB00262	Carmustine	anemia	58	0.17
DB00262	Carmustine	lung diseases	71	0.19
DB00262	Carmustine	leukemia lymphoid	66	0.23
DB00262	Carmustine	inflammatory bowel diseases	119	0.28
DB00262	Carmustine	gastrointestinal neoplasms	72	0.29
DB00262	Carmustine	gastroenteritis	122	0.30
DB00262	Carmustine	kidney diseases	144	0.34
DB00262	Carmustine	heart diseases	167	0.39
DB00262	Carmustine	bone diseases	144	0.40
DB00262	Carmustine	diabetes mellitus	162	0.40
DB00262	Carmustine	vascular diseases	181	0.48
DB00262	Carmustine	leukemia	117	0.50
DB00262	Carmustine	metabolism inborn errors	289	0.56
DB00262	Carmustine	hematologic diseases	188	0.59
DB00262	Carmustine	autoimmune diseases	243	0.61
DB00262	Carmustine	endocrine system diseases	291	0.70
DB00262	Carmustine	skin diseases	278	0.71
DB00262	Carmustine	cardiovascular diseases	330	0.71
DB00262	Carmustine	varicose veins	20	1.25
DB00262	Carmustine	epilepsy	25	1.30
DB00262	Carmustine	arrhythmias cardiac	30	1.41
DB00262	Carmustine	collagen diseases	25	1.59
DB00262	Carmustine	macular degeneration	44	1.66
DB00262	Carmustine	thyroid diseases	30	1.74
DB00262	Carmustine	hypopigmentation	22	1.79
DB00262	Carmustine	alzheimer disease	29	1.86
DB00262	Carmustine	malabsorption syndromes	34	1.91
DB00262	Carmustine	parkinson disease	30	1.94
DB00262	Carmustine	parkinsonian disorders	31	1.96
DB00262	Carmustine	blood coagulation disorders	40	2.25
DB00262	Carmustine	colitis	55	2.34
DB00262	Carmustine	colitis ulcerative	55	2.38
DB00262	Carmustine	dementia	42	2.40
DB00262	Carmustine	arthritis rheumatoid	42	2.50
DB00262	Carmustine	rheumatic diseases	59	2.54
DB00262	Carmustine	psoriasis	54	2.62
DB00262	Carmustine	colorectal neoplasms	42	2.71
DB00262	Carmustine	arthritis	76	2.79
DB00262	Carmustine	joint diseases	79	2.81
DB00262	Carmustine	intestinal neoplasms	42	2.85
DB06809	Plerixafor	myocardial ischemia	43	-2.78
DB06809	Plerixafor	coronary artery disease	31	-2.73
DB06809	Plerixafor	collagen diseases	25	-2.62
DB06809	Plerixafor	coronary disease	37	-2.59
DB06809	Plerixafor	mycobacterium infections	22	-2.50
DB06809	Plerixafor	arterial occlusive diseases	44	-2.44
DB06809	Plerixafor	blood coagulation disorders	40	-2.40
DB06809	Plerixafor	bacterial infections	26	-2.39
DB06809	Plerixafor	arteriosclerosis	38	-2.37
DB06809	Plerixafor	lymphoma	24	-2.30
DB06809	Plerixafor	lymphoma non hodgkin	22	-2.18
DB06809	Plerixafor	colitis ulcerative	55	-2.05
DB06809	Plerixafor	colitis	55	-2.02
DB06809	Plerixafor	prostatic neoplasms	61	-1.98
DB06809	Plerixafor	multiple sclerosis	69	-1.89
DB06809	Plerixafor	psoriasis	54	-1.85
DB06809	Plerixafor	crohn disease	71	-1.68
DB06809	Plerixafor	diabetes mellitus type 1	82	-1.65
DB06809	Plerixafor	leukemia myeloid acute	43	-1.63
DB06809	Plerixafor	lung diseases	71	-1.61
DB06809	Plerixafor	leukemia lymphoid	66	-1.46
DB06809	Plerixafor	kidney diseases	144	-1.37
DB06809	Plerixafor	inflammatory bowel diseases	119	-1.33
DB06809	Plerixafor	gastroenteritis	122	-1.30
DB06809	Plerixafor	heart diseases	167	-1.19
DB06809	Plerixafor	bone diseases	144	-1.13
DB06809	Plerixafor	diabetes mellitus	162	-1.05
DB06809	Plerixafor	leukemia	117	-0.94
DB06809	Plerixafor	vascular diseases	181	-0.76
DB06809	Plerixafor	autoimmune diseases	243	-0.69
DB06809	Plerixafor	hematologic diseases	188	-0.64
DB06809	Plerixafor	skin diseases	278	-0.59
DB06809	Plerixafor	cardiovascular diseases	330	-0.50
DB06809	Plerixafor	endocrine system diseases	291	-0.49
DB06809	Plerixafor	varicose veins	20	-0.22
DB06809	Plerixafor	epilepsy	25	-0.20
DB06809	Plerixafor	hyperinsulinism	26	-0.11
DB06809	Plerixafor	insulin resistance	26	-0.10
DB06809	Plerixafor	neoplasms	482	-0.02
DB06809	Plerixafor	keratosis	21	0.06
DB06809	Plerixafor	macular degeneration	44	0.07
DB06809	Plerixafor	kidney neoplasms	20	0.08
DB06809	Plerixafor	hypopigmentation	22	0.11
DB06809	Plerixafor	thyroid diseases	30	0.11
DB06809	Plerixafor	anemia hemolytic	29	0.11
DB06809	Plerixafor	bone diseases metabolic	27	0.12
DB06809	Plerixafor	parkinson disease	30	0.13
DB06809	Plerixafor	pancreatic diseases	24	0.16
DB06809	Plerixafor	liver cirrhosis	24	0.17
DB06809	Plerixafor	parkinsonian disorders	31	0.18
DB06809	Plerixafor	asthma	36	0.18
DB06809	Plerixafor	malabsorption syndromes	34	0.20
DB06809	Plerixafor	amyotrophic lateral sclerosis	21	0.20
DB06809	Plerixafor	liver cirrhosis biliary	23	0.23
DB06809	Plerixafor	cardiomyopathy dilated	29	0.23
DB06809	Plerixafor	neuroendocrine tumors	24	0.25
DB06809	Plerixafor	hypersensitivity	45	0.29
DB06809	Plerixafor	sarcoma	25	0.30
DB06809	Plerixafor	alzheimer disease	29	0.32
DB06809	Plerixafor	arthritis rheumatoid	42	0.41
DB06809	Plerixafor	motor neuron disease	31	0.42
DB06809	Plerixafor	adenocarcinoma	32	0.42
DB06809	Plerixafor	head and neck neoplasms	35	0.43
DB06809	Plerixafor	rheumatic diseases	59	0.43
DB06809	Plerixafor	lupus erythematosus systemic	75	0.44
DB06809	Plerixafor	dementia	42	0.45
DB06809	Plerixafor	diabetes mellitus type 2	72	0.46
DB06809	Plerixafor	breast neoplasms	40	0.47
DB06809	Plerixafor	joint diseases	79	0.50
DB06809	Plerixafor	spinal cord diseases	59	0.51
DB06809	Plerixafor	arthritis	76	0.53
DB06809	Plerixafor	intestinal neoplasms	42	0.54
DB06809	Plerixafor	anemia	58	0.57
DB06809	Plerixafor	colorectal neoplasms	42	0.58
DB06809	Plerixafor	gastrointestinal neoplasms	72	0.74
DB06809	Plerixafor	eye diseases	231	0.94
DB06809	Plerixafor	metabolism inborn errors	289	1.02
DB06809	Plerixafor	arrhythmias cardiac	30	2.54
DB00190	Carbidopa	hypopigmentation	22	-2.57
DB00190	Carbidopa	motor neuron disease	31	-2.52
DB00190	Carbidopa	colitis	55	-2.47
DB00190	Carbidopa	parkinson disease	30	-2.47
DB00190	Carbidopa	neuroendocrine tumors	24	-2.45
DB00190	Carbidopa	colitis ulcerative	55	-2.44
DB00190	Carbidopa	parkinsonian disorders	31	-2.44
DB00190	Carbidopa	crohn disease	71	-2.09
DB00190	Carbidopa	prostatic neoplasms	61	-2.07
DB00190	Carbidopa	diabetes mellitus type 1	82	-2.05
DB00190	Carbidopa	spinal cord diseases	59	-2.04
DB00190	Carbidopa	inflammatory bowel diseases	119	-1.60
DB00190	Carbidopa	gastroenteritis	122	-1.50
DB00190	Carbidopa	diabetes mellitus	162	-1.45
DB00190	Carbidopa	eye diseases	231	-1.07
DB00190	Carbidopa	metabolism inborn errors	289	-1.05
DB00190	Carbidopa	autoimmune diseases	243	-0.98
DB00190	Carbidopa	endocrine system diseases	291	-0.92
DB00190	Carbidopa	skin diseases	278	-0.84
DB00190	Carbidopa	neoplasms	482	-0.34
DB00190	Carbidopa	bone diseases metabolic	27	-0.20
DB00190	Carbidopa	mycobacterium infections	22	-0.19
DB00190	Carbidopa	coronary artery disease	31	-0.19
DB00190	Carbidopa	macular degeneration	44	-0.12
DB00190	Carbidopa	keratosis	21	-0.10
DB00190	Carbidopa	amyotrophic lateral sclerosis	21	-0.09
DB00190	Carbidopa	myocardial ischemia	43	-0.06
DB00190	Carbidopa	pancreatic diseases	24	-0.06
DB00190	Carbidopa	liver cirrhosis biliary	23	-0.05
DB00190	Carbidopa	arteriosclerosis	38	-0.05
DB00190	Carbidopa	liver cirrhosis	24	-0.05
DB00190	Carbidopa	kidney neoplasms	20	-0.05
DB00190	Carbidopa	coronary disease	37	-0.04
DB00190	Carbidopa	bacterial infections	26	0.00
DB00190	Carbidopa	malabsorption syndromes	34	0.01
DB00190	Carbidopa	alzheimer disease	29	0.01
DB00190	Carbidopa	asthma	36	0.02
DB00190	Carbidopa	sarcoma	25	0.02
DB00190	Carbidopa	arterial occlusive diseases	44	0.06
DB00190	Carbidopa	lymphoma	24	0.08
DB00190	Carbidopa	lymphoma non hodgkin	22	0.09
DB00190	Carbidopa	arthritis rheumatoid	42	0.16
DB00190	Carbidopa	hypersensitivity	45	0.16
DB00190	Carbidopa	adenocarcinoma	32	0.17
DB00190	Carbidopa	head and neck neoplasms	35	0.19
DB00190	Carbidopa	dementia	42	0.21
DB00190	Carbidopa	diabetes mellitus type 2	72	0.23
DB00190	Carbidopa	psoriasis	54	0.24
DB00190	Carbidopa	breast neoplasms	40	0.26
DB00190	Carbidopa	lupus erythematosus systemic	75	0.28
DB00190	Carbidopa	multiple sclerosis	69	0.32
DB00190	Carbidopa	intestinal neoplasms	42	0.33
DB00190	Carbidopa	rheumatic diseases	59	0.34
DB00190	Carbidopa	joint diseases	79	0.36
DB00190	Carbidopa	arthritis	76	0.36
DB00190	Carbidopa	leukemia myeloid acute	43	0.37
DB00190	Carbidopa	colorectal neoplasms	42	0.37
DB00190	Carbidopa	lung diseases	71	0.42
DB00190	Carbidopa	leukemia lymphoid	66	0.45
DB00190	Carbidopa	gastrointestinal neoplasms	72	0.54
DB00190	Carbidopa	kidney diseases	144	0.56
DB00190	Carbidopa	heart diseases	167	0.61
DB00190	Carbidopa	bone diseases	144	0.63
DB00190	Carbidopa	leukemia	117	0.75
DB00190	Carbidopa	vascular diseases	181	0.79
DB00190	Carbidopa	hematologic diseases	188	0.97
DB00190	Carbidopa	cardiovascular diseases	330	1.14
DB00190	Carbidopa	varicose veins	20	1.73
DB00190	Carbidopa	epilepsy	25	1.84
DB00190	Carbidopa	arrhythmias cardiac	30	1.84
DB00190	Carbidopa	hyperinsulinism	26	1.89
DB00190	Carbidopa	insulin resistance	26	1.90
DB00190	Carbidopa	collagen diseases	25	2.12
DB00190	Carbidopa	anemia hemolytic	29	2.28
DB00190	Carbidopa	thyroid diseases	30	2.46
DB00190	Carbidopa	cardiomyopathy dilated	29	2.63
DB00190	Carbidopa	anemia	58	2.67
DB00190	Carbidopa	blood coagulation disorders	40	2.69
DB00136	Calcitriol	bone diseases metabolic	27	-4.01
DB00136	Calcitriol	kidney diseases	144	-2.69
DB00136	Calcitriol	metabolism inborn errors	289	-2.63
DB00136	Calcitriol	bone diseases	144	-2.60
DB00136	Calcitriol	coronary disease	37	-2.41
DB00136	Calcitriol	coronary artery disease	31	-2.30
DB00136	Calcitriol	myocardial ischemia	43	-2.27
DB00136	Calcitriol	mycobacterium infections	22	-2.06
DB00136	Calcitriol	bacterial infections	26	-2.00
DB00136	Calcitriol	arteriosclerosis	38	-1.97
DB00136	Calcitriol	arterial occlusive diseases	44	-1.85
DB00136	Calcitriol	asthma	36	-1.81
DB00136	Calcitriol	neuroendocrine tumors	24	-1.79
DB00136	Calcitriol	hypersensitivity	45	-1.75
DB00136	Calcitriol	sarcoma	25	-1.44
DB00136	Calcitriol	adenocarcinoma	32	-1.41
DB00136	Calcitriol	colitis ulcerative	55	-1.27
DB00136	Calcitriol	colitis	55	-1.26
DB00136	Calcitriol	head and neck neoplasms	35	-1.19
DB00136	Calcitriol	diabetes mellitus type 1	82	-1.16
DB00136	Calcitriol	colorectal neoplasms	42	-1.11
DB00136	Calcitriol	intestinal neoplasms	42	-1.07
DB00136	Calcitriol	lung diseases	71	-1.05
DB00136	Calcitriol	crohn disease	71	-1.01
DB00136	Calcitriol	leukemia lymphoid	66	-0.91
DB00136	Calcitriol	leukemia myeloid acute	43	-0.90
DB00136	Calcitriol	gastrointestinal neoplasms	72	-0.81
DB00136	Calcitriol	heart diseases	167	-0.76
DB00136	Calcitriol	inflammatory bowel diseases	119	-0.73
DB00136	Calcitriol	gastroenteritis	122	-0.67
DB00136	Calcitriol	eye diseases	231	-0.64
DB00136	Calcitriol	diabetes mellitus	162	-0.63
DB00136	Calcitriol	vascular diseases	181	-0.54
DB00136	Calcitriol	leukemia	117	-0.39
DB00136	Calcitriol	hematologic diseases	188	-0.32
DB00136	Calcitriol	cardiovascular diseases	330	-0.29
DB00136	Calcitriol	autoimmune diseases	243	-0.28
DB00136	Calcitriol	skin diseases	278	-0.15
DB00136	Calcitriol	endocrine system diseases	291	-0.12
DB00136	Calcitriol	varicose veins	20	0.02
DB00136	Calcitriol	arrhythmias cardiac	30	0.04
DB00136	Calcitriol	insulin resistance	26	0.07
DB00136	Calcitriol	collagen diseases	25	0.08
DB00136	Calcitriol	epilepsy	25	0.08
DB00136	Calcitriol	hyperinsulinism	26	0.09
DB00136	Calcitriol	macular degeneration	44	0.15
DB00136	Calcitriol	neoplasms	482	0.21
DB00136	Calcitriol	anemia hemolytic	29	0.26
DB00136	Calcitriol	keratosis	21	0.28
DB00136	Calcitriol	malabsorption syndromes	34	0.32
DB00136	Calcitriol	parkinsonian disorders	31	0.36
DB00136	Calcitriol	parkinson disease	30	0.36
DB00136	Calcitriol	kidney neoplasms	20	0.39
DB00136	Calcitriol	hypopigmentation	22	0.39
DB00136	Calcitriol	blood coagulation disorders	40	0.42
DB00136	Calcitriol	cardiomyopathy dilated	29	0.42
DB00136	Calcitriol	alzheimer disease	29	0.47
DB00136	Calcitriol	pancreatic diseases	24	0.47
DB00136	Calcitriol	thyroid diseases	30	0.47
DB00136	Calcitriol	amyotrophic lateral sclerosis	21	0.48
DB00136	Calcitriol	liver cirrhosis	24	0.49
DB00136	Calcitriol	liver cirrhosis biliary	23	0.51
DB00136	Calcitriol	lymphoma	24	0.62
DB00136	Calcitriol	lymphoma non hodgkin	22	0.63
DB00136	Calcitriol	arthritis rheumatoid	42	0.64
DB00136	Calcitriol	motor neuron disease	31	0.65
DB00136	Calcitriol	prostatic neoplasms	61	0.69
DB00136	Calcitriol	dementia	42	0.71
DB00136	Calcitriol	psoriasis	54	0.77
DB00136	Calcitriol	lupus erythematosus systemic	75	0.79
DB00136	Calcitriol	rheumatic diseases	59	0.80
DB00136	Calcitriol	diabetes mellitus type 2	72	0.81
DB00136	Calcitriol	breast neoplasms	40	0.84
DB00136	Calcitriol	arthritis	76	0.89
DB00136	Calcitriol	joint diseases	79	0.90
DB00136	Calcitriol	multiple sclerosis	69	0.94
DB00136	Calcitriol	spinal cord diseases	59	0.96
DB00136	Calcitriol	anemia	58	1.06
DB00221	Isoetharine	diabetes mellitus type 2	72	-2.72
DB00221	Isoetharine	diabetes mellitus	162	-1.84
DB00221	Isoetharine	endocrine system diseases	291	-1.07
DB00221	Isoetharine	neoplasms	482	-0.66
DB00221	Isoetharine	epilepsy	25	-0.55
DB00221	Isoetharine	insulin resistance	26	-0.51
DB00221	Isoetharine	hyperinsulinism	26	-0.49
DB00221	Isoetharine	bone diseases metabolic	27	-0.48
DB00221	Isoetharine	varicose veins	20	-0.47
DB00221	Isoetharine	collagen diseases	25	-0.46
DB00221	Isoetharine	mycobacterium infections	22	-0.43
DB00221	Isoetharine	arrhythmias cardiac	30	-0.42
DB00221	Isoetharine	coronary artery disease	31	-0.36
DB00221	Isoetharine	keratosis	21	-0.34
DB00221	Isoetharine	macular degeneration	44	-0.33
DB00221	Isoetharine	thyroid diseases	30	-0.31
DB00221	Isoetharine	kidney neoplasms	20	-0.31
DB00221	Isoetharine	coronary disease	37	-0.31
DB00221	Isoetharine	bacterial infections	26	-0.30
DB00221	Isoetharine	anemia hemolytic	29	-0.29
DB00221	Isoetharine	malabsorption syndromes	34	-0.25
DB00221	Isoetharine	myocardial ischemia	43	-0.25
DB00221	Isoetharine	hypopigmentation	22	-0.24
DB00221	Isoetharine	liver cirrhosis	24	-0.24
DB00221	Isoetharine	arteriosclerosis	38	-0.23
DB00221	Isoetharine	alzheimer disease	29	-0.20
DB00221	Isoetharine	pancreatic diseases	24	-0.20
DB00221	Isoetharine	neuroendocrine tumors	24	-0.18
DB00221	Isoetharine	amyotrophic lateral sclerosis	21	-0.18
DB00221	Isoetharine	cardiomyopathy dilated	29	-0.17
DB00221	Isoetharine	liver cirrhosis biliary	23	-0.15
DB00221	Isoetharine	parkinson disease	30	-0.14
DB00221	Isoetharine	parkinsonian disorders	31	-0.13
DB00221	Isoetharine	lymphoma	24	-0.12
DB00221	Isoetharine	sarcoma	25	-0.12
DB00221	Isoetharine	asthma	36	-0.11
DB00221	Isoetharine	blood coagulation disorders	40	-0.09
DB00221	Isoetharine	lymphoma non hodgkin	22	-0.07
DB00221	Isoetharine	arterial occlusive diseases	44	-0.05
DB00221	Isoetharine	hypersensitivity	45	-0.04
DB00221	Isoetharine	adenocarcinoma	32	0.00
DB00221	Isoetharine	arthritis rheumatoid	42	0.00
DB00221	Isoetharine	colitis	55	0.01
DB00221	Isoetharine	head and neck neoplasms	35	0.02
DB00221	Isoetharine	motor neuron disease	31	0.02
DB00221	Isoetharine	colitis ulcerative	55	0.03
DB00221	Isoetharine	dementia	42	0.05
DB00221	Isoetharine	breast neoplasms	40	0.06
DB00221	Isoetharine	psoriasis	54	0.06
DB00221	Isoetharine	prostatic neoplasms	61	0.07
DB00221	Isoetharine	leukemia myeloid acute	43	0.13
DB00221	Isoetharine	multiple sclerosis	69	0.15
DB00221	Isoetharine	intestinal neoplasms	42	0.16
DB00221	Isoetharine	lupus erythematosus systemic	75	0.20
DB00221	Isoetharine	diabetes mellitus type 1	82	0.21
DB00221	Isoetharine	crohn disease	71	0.21
DB00221	Isoetharine	colorectal neoplasms	42	0.22
DB00221	Isoetharine	rheumatic diseases	59	0.22
DB00221	Isoetharine	spinal cord diseases	59	0.22
DB00221	Isoetharine	arthritis	76	0.25
DB00221	Isoetharine	joint diseases	79	0.27
DB00221	Isoetharine	leukemia lymphoid	66	0.28
DB00221	Isoetharine	lung diseases	71	0.29
DB00221	Isoetharine	inflammatory bowel diseases	119	0.31
DB00221	Isoetharine	anemia	58	0.33
DB00221	Isoetharine	gastroenteritis	122	0.36
DB00221	Isoetharine	gastrointestinal neoplasms	72	0.38
DB00221	Isoetharine	kidney diseases	144	0.39
DB00221	Isoetharine	bone diseases	144	0.44
DB00221	Isoetharine	heart diseases	167	0.45
DB00221	Isoetharine	leukemia	117	0.56
DB00221	Isoetharine	metabolism inborn errors	289	0.60
DB00221	Isoetharine	vascular diseases	181	0.62
DB00221	Isoetharine	eye diseases	231	0.62
DB00221	Isoetharine	autoimmune diseases	243	0.67
DB00221	Isoetharine	hematologic diseases	188	0.69
DB00221	Isoetharine	cardiovascular diseases	330	0.77
DB00221	Isoetharine	skin diseases	278	0.78
DB01047	Fluocinonide	lymphoma	24	-2.47
DB01047	Fluocinonide	lymphoma non hodgkin	22	-2.36
DB01047	Fluocinonide	leukemia lymphoid	66	-2.05
DB01047	Fluocinonide	leukemia	117	-2.00
DB01047	Fluocinonide	bone diseases	144	-1.92
DB01047	Fluocinonide	coronary artery disease	31	-1.77
DB01047	Fluocinonide	coronary disease	37	-1.72
DB01047	Fluocinonide	myocardial ischemia	43	-1.69
DB01047	Fluocinonide	arteriosclerosis	38	-1.68
DB01047	Fluocinonide	arterial occlusive diseases	44	-1.40
DB01047	Fluocinonide	neoplasms	482	-1.38
DB01047	Fluocinonide	liver cirrhosis biliary	23	-1.30
DB01047	Fluocinonide	liver cirrhosis	24	-1.27
DB01047	Fluocinonide	arthritis rheumatoid	42	-1.15
DB01047	Fluocinonide	varicose veins	20	-1.10
DB01047	Fluocinonide	lupus erythematosus systemic	75	-0.97
DB01047	Fluocinonide	rheumatic diseases	59	-0.95
DB01047	Fluocinonide	breast neoplasms	40	-0.95
DB01047	Fluocinonide	diabetes mellitus type 1	82	-0.93
DB01047	Fluocinonide	leukemia myeloid acute	43	-0.89
DB01047	Fluocinonide	colorectal neoplasms	42	-0.82
DB01047	Fluocinonide	intestinal neoplasms	42	-0.76
DB01047	Fluocinonide	arthritis	76	-0.74
DB01047	Fluocinonide	spinal cord diseases	59	-0.71
DB01047	Fluocinonide	multiple sclerosis	69	-0.69
DB01047	Fluocinonide	joint diseases	79	-0.69
DB01047	Fluocinonide	kidney diseases	144	-0.56
DB01047	Fluocinonide	diabetes mellitus	162	-0.55
DB01047	Fluocinonide	gastrointestinal neoplasms	72	-0.53
DB01047	Fluocinonide	heart diseases	167	-0.45
DB01047	Fluocinonide	malabsorption syndromes	34	-0.37
DB01047	Fluocinonide	mycobacterium infections	22	-0.36
DB01047	Fluocinonide	kidney neoplasms	20	-0.34
DB01047	Fluocinonide	metabolism inborn errors	289	-0.30
DB01047	Fluocinonide	alzheimer disease	29	-0.24
DB01047	Fluocinonide	bacterial infections	26	-0.24
DB01047	Fluocinonide	neuroendocrine tumors	24	-0.20
DB01047	Fluocinonide	vascular diseases	181	-0.20
DB01047	Fluocinonide	asthma	36	-0.15
DB01047	Fluocinonide	colitis	55	-0.14
DB01047	Fluocinonide	hematologic diseases	188	-0.13
DB01047	Fluocinonide	eye diseases	231	-0.12
DB01047	Fluocinonide	colitis ulcerative	55	-0.11
DB01047	Fluocinonide	autoimmune diseases	243	-0.11
DB01047	Fluocinonide	endocrine system diseases	291	-0.06
DB01047	Fluocinonide	sarcoma	25	-0.04
DB01047	Fluocinonide	skin diseases	278	-0.04
DB01047	Fluocinonide	hypersensitivity	45	-0.03
DB01047	Fluocinonide	diabetes mellitus type 2	72	-0.02
DB01047	Fluocinonide	cardiovascular diseases	330	0.03
DB01047	Fluocinonide	head and neck neoplasms	35	0.07
DB01047	Fluocinonide	dementia	42	0.11
DB01047	Fluocinonide	prostatic neoplasms	61	0.12
DB01047	Fluocinonide	motor neuron disease	31	0.17
DB01047	Fluocinonide	adenocarcinoma	32	0.19
DB01047	Fluocinonide	epilepsy	25	0.49
DB01047	Fluocinonide	arrhythmias cardiac	30	0.51
DB01047	Fluocinonide	crohn disease	71	0.54
DB01047	Fluocinonide	collagen diseases	25	0.54
DB01047	Fluocinonide	bone diseases metabolic	27	0.63
DB01047	Fluocinonide	macular degeneration	44	0.69
DB01047	Fluocinonide	hyperinsulinism	26	0.69
DB01047	Fluocinonide	insulin resistance	26	0.69
DB01047	Fluocinonide	parkinson disease	30	0.74
DB01047	Fluocinonide	parkinsonian disorders	31	0.79
DB01047	Fluocinonide	gastroenteritis	122	0.79
DB01047	Fluocinonide	lung diseases	71	0.81
DB01047	Fluocinonide	inflammatory bowel diseases	119	0.82
DB01047	Fluocinonide	anemia hemolytic	29	0.83
DB01047	Fluocinonide	keratosis	21	0.89
DB01047	Fluocinonide	thyroid diseases	30	0.90
DB01047	Fluocinonide	cardiomyopathy dilated	29	0.94
DB01047	Fluocinonide	hypopigmentation	22	0.94
DB01047	Fluocinonide	blood coagulation disorders	40	0.99
DB01047	Fluocinonide	amyotrophic lateral sclerosis	21	0.99
DB01047	Fluocinonide	pancreatic diseases	24	1.18
DB01047	Fluocinonide	psoriasis	54	1.41
DB01047	Fluocinonide	anemia	58	2.37
DB00731	Nateglinide	pancreatic diseases	24	-3.16
DB00731	Nateglinide	endocrine system diseases	291	-3.03
DB00731	Nateglinide	diabetes mellitus type 2	72	-2.73
DB00731	Nateglinide	diabetes mellitus	162	-2.16
DB00731	Nateglinide	alzheimer disease	29	-1.73
DB00731	Nateglinide	skin diseases	278	-1.61
DB00731	Nateglinide	dementia	42	-1.29
DB00731	Nateglinide	neoplasms	482	-1.11
DB00731	Nateglinide	spinal cord diseases	59	-1.06
DB00731	Nateglinide	arrhythmias cardiac	30	-0.85
DB00731	Nateglinide	heart diseases	167	-0.59
DB00731	Nateglinide	coronary artery disease	31	-0.57
DB00731	Nateglinide	bacterial infections	26	-0.55
DB00731	Nateglinide	coronary disease	37	-0.45
DB00731	Nateglinide	myocardial ischemia	43	-0.41
DB00731	Nateglinide	amyotrophic lateral sclerosis	21	-0.40
DB00731	Nateglinide	arteriosclerosis	38	-0.36
DB00731	Nateglinide	cardiomyopathy dilated	29	-0.33
DB00731	Nateglinide	arterial occlusive diseases	44	-0.25
DB00731	Nateglinide	sarcoma	25	-0.22
DB00731	Nateglinide	autoimmune diseases	243	-0.17
DB00731	Nateglinide	motor neuron disease	31	-0.12
DB00731	Nateglinide	colitis	55	-0.03
DB00731	Nateglinide	arthritis rheumatoid	42	-0.02
DB00731	Nateglinide	colitis ulcerative	55	-0.01
DB00731	Nateglinide	cardiovascular diseases	330	0.03
DB00731	Nateglinide	rheumatic diseases	59	0.18
DB00731	Nateglinide	multiple sclerosis	69	0.25
DB00731	Nateglinide	crohn disease	71	0.27
DB00731	Nateglinide	leukemia myeloid acute	43	0.33
DB00731	Nateglinide	joint diseases	79	0.38
DB00731	Nateglinide	arthritis	76	0.38
DB00731	Nateglinide	inflammatory bowel diseases	119	0.53
DB00731	Nateglinide	varicose veins	20	0.60
DB00731	Nateglinide	hyperinsulinism	26	0.61
DB00731	Nateglinide	epilepsy	25	0.62
DB00731	Nateglinide	gastroenteritis	122	0.63
DB00731	Nateglinide	kidney diseases	144	0.63
DB00731	Nateglinide	insulin resistance	26	0.67
DB00731	Nateglinide	gastrointestinal neoplasms	72	0.69
DB00731	Nateglinide	bone diseases metabolic	27	0.72
DB00731	Nateglinide	collagen diseases	25	0.78
DB00731	Nateglinide	macular degeneration	44	0.86
DB00731	Nateglinide	mycobacterium infections	22	0.88
DB00731	Nateglinide	hypopigmentation	22	0.90
DB00731	Nateglinide	bone diseases	144	0.91
DB00731	Nateglinide	keratosis	21	0.94
DB00731	Nateglinide	thyroid diseases	30	0.94
DB00731	Nateglinide	anemia hemolytic	29	0.95
DB00731	Nateglinide	parkinson disease	30	0.95
DB00731	Nateglinide	kidney neoplasms	20	0.96
DB00731	Nateglinide	malabsorption syndromes	34	0.98
DB00731	Nateglinide	liver cirrhosis	24	0.99
DB00731	Nateglinide	leukemia	117	1.00
DB00731	Nateglinide	liver cirrhosis biliary	23	1.01
DB00731	Nateglinide	parkinsonian disorders	31	1.03
DB00731	Nateglinide	asthma	36	1.06
DB00731	Nateglinide	neuroendocrine tumors	24	1.09
DB00731	Nateglinide	eye diseases	231	1.12
DB00731	Nateglinide	blood coagulation disorders	40	1.16
DB00731	Nateglinide	hypersensitivity	45	1.19
DB00731	Nateglinide	vascular diseases	181	1.19
DB00731	Nateglinide	lymphoma	24	1.20
DB00731	Nateglinide	lymphoma non hodgkin	22	1.20
DB00731	Nateglinide	metabolism inborn errors	289	1.22
DB00731	Nateglinide	head and neck neoplasms	35	1.43
DB00731	Nateglinide	adenocarcinoma	32	1.45
DB00731	Nateglinide	prostatic neoplasms	61	1.45
DB00731	Nateglinide	psoriasis	54	1.50
DB00731	Nateglinide	breast neoplasms	40	1.55
DB00731	Nateglinide	lupus erythematosus systemic	75	1.58
DB00731	Nateglinide	diabetes mellitus type 1	82	1.59
DB00731	Nateglinide	colorectal neoplasms	42	1.73
DB00731	Nateglinide	intestinal neoplasms	42	1.75
DB00731	Nateglinide	anemia	58	1.82
DB00731	Nateglinide	lung diseases	71	1.84
DB00731	Nateglinide	leukemia lymphoid	66	1.88
DB00731	Nateglinide	hematologic diseases	188	3.01
DB00222	Glimepiride	endocrine system diseases	291	-6.05
DB00222	Glimepiride	pancreatic diseases	24	-5.35
DB00222	Glimepiride	diabetes mellitus	162	-5.10
DB00222	Glimepiride	diabetes mellitus type 2	72	-5.09
DB00222	Glimepiride	kidney diseases	144	-4.02
DB00222	Glimepiride	arrhythmias cardiac	30	-3.64
DB00222	Glimepiride	heart diseases	167	-2.11
DB00222	Glimepiride	cardiomyopathy dilated	29	-1.96
DB00222	Glimepiride	metabolism inborn errors	289	-1.73
DB00222	Glimepiride	rheumatic diseases	59	-1.65
DB00222	Glimepiride	joint diseases	79	-1.56
DB00222	Glimepiride	arthritis	76	-1.47
DB00222	Glimepiride	cardiovascular diseases	330	-1.37
DB00222	Glimepiride	bacterial infections	26	-1.18
DB00222	Glimepiride	alzheimer disease	29	-1.03
DB00222	Glimepiride	dementia	42	-0.69
DB00222	Glimepiride	arthritis rheumatoid	42	-0.69
DB00222	Glimepiride	varicose veins	20	-0.67
DB00222	Glimepiride	epilepsy	25	-0.55
DB00222	Glimepiride	bone diseases metabolic	27	-0.43
DB00222	Glimepiride	spinal cord diseases	59	-0.38
DB00222	Glimepiride	collagen diseases	25	-0.37
DB00222	Glimepiride	macular degeneration	44	-0.30
DB00222	Glimepiride	keratosis	21	-0.29
DB00222	Glimepiride	coronary artery disease	31	-0.27
DB00222	Glimepiride	lung diseases	71	-0.24
DB00222	Glimepiride	thyroid diseases	30	-0.17
DB00222	Glimepiride	kidney neoplasms	20	-0.13
DB00222	Glimepiride	coronary disease	37	-0.09
DB00222	Glimepiride	hypopigmentation	22	-0.07
DB00222	Glimepiride	parkinson disease	30	-0.05
DB00222	Glimepiride	liver cirrhosis biliary	23	-0.03
DB00222	Glimepiride	parkinsonian disorders	31	-0.01
DB00222	Glimepiride	malabsorption syndromes	34	0.00
DB00222	Glimepiride	liver cirrhosis	24	0.02
DB00222	Glimepiride	myocardial ischemia	43	0.02
DB00222	Glimepiride	amyotrophic lateral sclerosis	21	0.03
DB00222	Glimepiride	arteriosclerosis	38	0.07
DB00222	Glimepiride	sarcoma	25	0.18
DB00222	Glimepiride	arterial occlusive diseases	44	0.21
DB00222	Glimepiride	lymphoma non hodgkin	22	0.23
DB00222	Glimepiride	blood coagulation disorders	40	0.25
DB00222	Glimepiride	lymphoma	24	0.26
DB00222	Glimepiride	motor neuron disease	31	0.36
DB00222	Glimepiride	colitis ulcerative	55	0.42
DB00222	Glimepiride	adenocarcinoma	32	0.43
DB00222	Glimepiride	colitis	55	0.46
DB00222	Glimepiride	autoimmune diseases	243	0.50
DB00222	Glimepiride	insulin resistance	26	0.51
DB00222	Glimepiride	head and neck neoplasms	35	0.51
DB00222	Glimepiride	hyperinsulinism	26	0.53
DB00222	Glimepiride	breast neoplasms	40	0.59
DB00222	Glimepiride	psoriasis	54	0.62
DB00222	Glimepiride	prostatic neoplasms	61	0.62
DB00222	Glimepiride	skin diseases	278	0.65
DB00222	Glimepiride	mycobacterium infections	22	0.73
DB00222	Glimepiride	lupus erythematosus systemic	75	0.74
DB00222	Glimepiride	multiple sclerosis	69	0.79
DB00222	Glimepiride	crohn disease	71	0.81
DB00222	Glimepiride	leukemia myeloid acute	43	0.81
DB00222	Glimepiride	colorectal neoplasms	42	0.82
DB00222	Glimepiride	intestinal neoplasms	42	0.83
DB00222	Glimepiride	diabetes mellitus type 1	82	0.84
DB00222	Glimepiride	anemia hemolytic	29	0.90
DB00222	Glimepiride	leukemia lymphoid	66	1.00
DB00222	Glimepiride	anemia	58	1.00
DB00222	Glimepiride	neoplasms	482	1.11
DB00222	Glimepiride	neuroendocrine tumors	24	1.11
DB00222	Glimepiride	gastroenteritis	122	1.17
DB00222	Glimepiride	inflammatory bowel diseases	119	1.20
DB00222	Glimepiride	asthma	36	1.21
DB00222	Glimepiride	gastrointestinal neoplasms	72	1.23
DB00222	Glimepiride	bone diseases	144	1.42
DB00222	Glimepiride	hypersensitivity	45	1.45
DB00222	Glimepiride	vascular diseases	181	1.49
DB00222	Glimepiride	leukemia	117	1.55
DB00222	Glimepiride	eye diseases	231	1.57
DB00222	Glimepiride	hematologic diseases	188	1.60
DB06201	Rufinamide	spinal cord diseases	59	-2.00
DB06201	Rufinamide	bone diseases	144	-1.43
DB06201	Rufinamide	heart diseases	167	-1.29
DB06201	Rufinamide	cardiovascular diseases	330	-0.82
DB06201	Rufinamide	epilepsy	25	-0.46
DB06201	Rufinamide	varicose veins	20	-0.45
DB06201	Rufinamide	arrhythmias cardiac	30	-0.42
DB06201	Rufinamide	bone diseases metabolic	27	-0.37
DB06201	Rufinamide	mycobacterium infections	22	-0.36
DB06201	Rufinamide	macular degeneration	44	-0.35
DB06201	Rufinamide	coronary artery disease	31	-0.35
DB06201	Rufinamide	collagen diseases	25	-0.33
DB06201	Rufinamide	keratosis	21	-0.33
DB06201	Rufinamide	thyroid diseases	30	-0.32
DB06201	Rufinamide	hyperinsulinism	26	-0.30
DB06201	Rufinamide	insulin resistance	26	-0.26
DB06201	Rufinamide	bacterial infections	26	-0.26
DB06201	Rufinamide	amyotrophic lateral sclerosis	21	-0.25
DB06201	Rufinamide	kidney neoplasms	20	-0.25
DB06201	Rufinamide	coronary disease	37	-0.24
DB06201	Rufinamide	pancreatic diseases	24	-0.23
DB06201	Rufinamide	anemia hemolytic	29	-0.23
DB06201	Rufinamide	malabsorption syndromes	34	-0.23
DB06201	Rufinamide	parkinson disease	30	-0.20
DB06201	Rufinamide	parkinsonian disorders	31	-0.20
DB06201	Rufinamide	asthma	36	-0.20
DB06201	Rufinamide	liver cirrhosis	24	-0.20
DB06201	Rufinamide	neuroendocrine tumors	24	-0.18
DB06201	Rufinamide	hypopigmentation	22	-0.18
DB06201	Rufinamide	alzheimer disease	29	-0.17
DB06201	Rufinamide	liver cirrhosis biliary	23	-0.16
DB06201	Rufinamide	myocardial ischemia	43	-0.15
DB06201	Rufinamide	arteriosclerosis	38	-0.14
DB06201	Rufinamide	cardiomyopathy dilated	29	-0.14
DB06201	Rufinamide	sarcoma	25	-0.11
DB06201	Rufinamide	hypersensitivity	45	-0.09
DB06201	Rufinamide	blood coagulation disorders	40	-0.07
DB06201	Rufinamide	lymphoma	24	-0.06
DB06201	Rufinamide	motor neuron disease	31	-0.05
DB06201	Rufinamide	lymphoma non hodgkin	22	-0.03
DB06201	Rufinamide	arterial occlusive diseases	44	-0.01
DB06201	Rufinamide	adenocarcinoma	32	-0.01
DB06201	Rufinamide	colitis	55	0.00
DB06201	Rufinamide	colitis ulcerative	55	0.05
DB06201	Rufinamide	dementia	42	0.06
DB06201	Rufinamide	breast neoplasms	40	0.07
DB06201	Rufinamide	arthritis rheumatoid	42	0.07
DB06201	Rufinamide	psoriasis	54	0.08
DB06201	Rufinamide	prostatic neoplasms	61	0.09
DB06201	Rufinamide	head and neck neoplasms	35	0.10
DB06201	Rufinamide	diabetes mellitus type 2	72	0.11
DB06201	Rufinamide	multiple sclerosis	69	0.12
DB06201	Rufinamide	lupus erythematosus systemic	75	0.16
DB06201	Rufinamide	rheumatic diseases	59	0.18
DB06201	Rufinamide	leukemia myeloid acute	43	0.19
DB06201	Rufinamide	diabetes mellitus type 1	82	0.22
DB06201	Rufinamide	joint diseases	79	0.22
DB06201	Rufinamide	intestinal neoplasms	42	0.23
DB06201	Rufinamide	arthritis	76	0.23
DB06201	Rufinamide	leukemia lymphoid	66	0.25
DB06201	Rufinamide	crohn disease	71	0.27
DB06201	Rufinamide	lung diseases	71	0.28
DB06201	Rufinamide	anemia	58	0.28
DB06201	Rufinamide	colorectal neoplasms	42	0.28
DB06201	Rufinamide	inflammatory bowel diseases	119	0.32
DB06201	Rufinamide	gastroenteritis	122	0.37
DB06201	Rufinamide	kidney diseases	144	0.38
DB06201	Rufinamide	gastrointestinal neoplasms	72	0.46
DB06201	Rufinamide	diabetes mellitus	162	0.49
DB06201	Rufinamide	leukemia	117	0.53
DB06201	Rufinamide	vascular diseases	181	0.57
DB06201	Rufinamide	eye diseases	231	0.59
DB06201	Rufinamide	metabolism inborn errors	289	0.63
DB06201	Rufinamide	autoimmune diseases	243	0.64
DB06201	Rufinamide	hematologic diseases	188	0.70
DB06201	Rufinamide	endocrine system diseases	291	0.79
DB06201	Rufinamide	skin diseases	278	0.80
DB06201	Rufinamide	neoplasms	482	1.36
DB01043	Memantine	spinal cord diseases	59	-1.87
DB01043	Memantine	arthritis rheumatoid	42	-1.49
DB01043	Memantine	adenocarcinoma	32	-1.31
DB01043	Memantine	rheumatic diseases	59	-1.22
DB01043	Memantine	prostatic neoplasms	61	-1.20
DB01043	Memantine	dementia	42	-1.20
DB01043	Memantine	multiple sclerosis	69	-1.15
DB01043	Memantine	breast neoplasms	40	-1.14
DB01043	Memantine	keratosis	21	-1.07
DB01043	Memantine	anemia hemolytic	29	-1.06
DB01043	Memantine	liver cirrhosis biliary	23	-1.04
DB01043	Memantine	arthritis	76	-1.02
DB01043	Memantine	liver cirrhosis	24	-0.96
DB01043	Memantine	pancreatic diseases	24	-0.92
DB01043	Memantine	joint diseases	79	-0.89
DB01043	Memantine	thyroid diseases	30	-0.88
DB01043	Memantine	amyotrophic lateral sclerosis	21	-0.87
DB01043	Memantine	neuroendocrine tumors	24	-0.83
DB01043	Memantine	asthma	36	-0.79
DB01043	Memantine	colorectal neoplasms	42	-0.78
DB01043	Memantine	intestinal neoplasms	42	-0.78
DB01043	Memantine	parkinsonian disorders	31	-0.77
DB01043	Memantine	myocardial ischemia	43	-0.76
DB01043	Memantine	cardiomyopathy dilated	29	-0.74
DB01043	Memantine	lung diseases	71	-0.74
DB01043	Memantine	parkinson disease	30	-0.72
DB01043	Memantine	alzheimer disease	29	-0.69
DB01043	Memantine	hypersensitivity	45	-0.65
DB01043	Memantine	sarcoma	25	-0.63
DB01043	Memantine	autoimmune diseases	243	-0.62
DB01043	Memantine	lymphoma	24	-0.61
DB01043	Memantine	lymphoma non hodgkin	22	-0.58
DB01043	Memantine	epilepsy	25	-0.53
DB01043	Memantine	insulin resistance	26	-0.45
DB01043	Memantine	hyperinsulinism	26	-0.44
DB01043	Memantine	motor neuron disease	31	-0.38
DB01043	Memantine	arrhythmias cardiac	30	-0.38
DB01043	Memantine	collagen diseases	25	-0.34
DB01043	Memantine	gastrointestinal neoplasms	72	-0.32
DB01043	Memantine	head and neck neoplasms	35	-0.26
DB01043	Memantine	psoriasis	54	-0.26
DB01043	Memantine	heart diseases	167	-0.20
DB01043	Memantine	mycobacterium infections	22	-0.20
DB01043	Memantine	leukemia	117	-0.13
DB01043	Memantine	coronary artery disease	31	-0.10
DB01043	Memantine	diabetes mellitus type 1	82	-0.07
DB01043	Memantine	leukemia myeloid acute	43	-0.04
DB01043	Memantine	bacterial infections	26	-0.03
DB01043	Memantine	kidney neoplasms	20	-0.02
DB01043	Memantine	hypopigmentation	22	0.01
DB01043	Memantine	coronary disease	37	0.06
DB01043	Memantine	anemia	58	0.09
DB01043	Memantine	vascular diseases	181	0.13
DB01043	Memantine	arteriosclerosis	38	0.14
DB01043	Memantine	leukemia lymphoid	66	0.17
DB01043	Memantine	hematologic diseases	188	0.25
DB01043	Memantine	varicose veins	20	0.36
DB01043	Memantine	arterial occlusive diseases	44	0.36
DB01043	Memantine	blood coagulation disorders	40	0.40
DB01043	Memantine	kidney diseases	144	0.44
DB01043	Memantine	neoplasms	482	0.47
DB01043	Memantine	endocrine system diseases	291	0.52
DB01043	Memantine	diabetes mellitus	162	0.57
DB01043	Memantine	skin diseases	278	0.65
DB01043	Memantine	bone diseases metabolic	27	0.65
DB01043	Memantine	colitis ulcerative	55	0.66
DB01043	Memantine	cardiovascular diseases	330	0.69
DB01043	Memantine	bone diseases	144	0.70
DB01043	Memantine	colitis	55	0.71
DB01043	Memantine	diabetes mellitus type 2	72	0.76
DB01043	Memantine	macular degeneration	44	0.77
DB01043	Memantine	lupus erythematosus systemic	75	0.82
DB01043	Memantine	crohn disease	71	0.94
DB01043	Memantine	malabsorption syndromes	34	1.03
DB01043	Memantine	eye diseases	231	1.06
DB01043	Memantine	metabolism inborn errors	289	1.22
DB01043	Memantine	gastroenteritis	122	1.33
DB01043	Memantine	inflammatory bowel diseases	119	1.39
DB00227	Lovastatin	vascular diseases	181	-2.68
DB00227	Lovastatin	kidney neoplasms	20	-2.21
DB00227	Lovastatin	hematologic diseases	188	-1.99
DB00227	Lovastatin	cardiovascular diseases	330	-1.97
DB00227	Lovastatin	neuroendocrine tumors	24	-1.92
DB00227	Lovastatin	adenocarcinoma	32	-1.73
DB00227	Lovastatin	bone diseases metabolic	27	-1.64
DB00227	Lovastatin	multiple sclerosis	69	-1.48
DB00227	Lovastatin	coronary artery disease	31	-1.30
DB00227	Lovastatin	kidney diseases	144	-1.29
DB00227	Lovastatin	parkinsonian disorders	31	-1.28
DB00227	Lovastatin	parkinson disease	30	-1.25
DB00227	Lovastatin	coronary disease	37	-1.17
DB00227	Lovastatin	anemia hemolytic	29	-1.14
DB00227	Lovastatin	myocardial ischemia	43	-1.12
DB00227	Lovastatin	mycobacterium infections	22	-1.09
DB00227	Lovastatin	arteriosclerosis	38	-1.03
DB00227	Lovastatin	malabsorption syndromes	34	-1.00
DB00227	Lovastatin	neoplasms	482	-0.94
DB00227	Lovastatin	bacterial infections	26	-0.88
DB00227	Lovastatin	arterial occlusive diseases	44	-0.84
DB00227	Lovastatin	pancreatic diseases	24	-0.78
DB00227	Lovastatin	asthma	36	-0.71
DB00227	Lovastatin	colitis	55	-0.66
DB00227	Lovastatin	colitis ulcerative	55	-0.64
DB00227	Lovastatin	autoimmune diseases	243	-0.57
DB00227	Lovastatin	hypersensitivity	45	-0.53
DB00227	Lovastatin	epilepsy	25	-0.47
DB00227	Lovastatin	lymphoma non hodgkin	22	-0.46
DB00227	Lovastatin	collagen diseases	25	-0.45
DB00227	Lovastatin	lymphoma	24	-0.45
DB00227	Lovastatin	prostatic neoplasms	61	-0.43
DB00227	Lovastatin	skin diseases	278	-0.41
DB00227	Lovastatin	hyperinsulinism	26	-0.39
DB00227	Lovastatin	arthritis rheumatoid	42	-0.37
DB00227	Lovastatin	head and neck neoplasms	35	-0.37
DB00227	Lovastatin	insulin resistance	26	-0.34
DB00227	Lovastatin	breast neoplasms	40	-0.30
DB00227	Lovastatin	diabetes mellitus type 1	82	-0.24
DB00227	Lovastatin	lupus erythematosus systemic	75	-0.15
DB00227	Lovastatin	crohn disease	71	-0.10
DB00227	Lovastatin	rheumatic diseases	59	-0.08
DB00227	Lovastatin	colorectal neoplasms	42	-0.05
DB00227	Lovastatin	leukemia myeloid acute	43	-0.04
DB00227	Lovastatin	intestinal neoplasms	42	-0.02
DB00227	Lovastatin	spinal cord diseases	59	0.00
DB00227	Lovastatin	keratosis	21	0.01
DB00227	Lovastatin	arthritis	76	0.06
DB00227	Lovastatin	leukemia lymphoid	66	0.07
DB00227	Lovastatin	joint diseases	79	0.11
DB00227	Lovastatin	lung diseases	71	0.16
DB00227	Lovastatin	anemia	58	0.17
DB00227	Lovastatin	inflammatory bowel diseases	119	0.19
DB00227	Lovastatin	hypopigmentation	22	0.20
DB00227	Lovastatin	gastroenteritis	122	0.21
DB00227	Lovastatin	diabetes mellitus	162	0.22
DB00227	Lovastatin	amyotrophic lateral sclerosis	21	0.30
DB00227	Lovastatin	cardiomyopathy dilated	29	0.35
DB00227	Lovastatin	gastrointestinal neoplasms	72	0.37
DB00227	Lovastatin	alzheimer disease	29	0.38
DB00227	Lovastatin	heart diseases	167	0.40
DB00227	Lovastatin	blood coagulation disorders	40	0.42
DB00227	Lovastatin	liver cirrhosis	24	0.43
DB00227	Lovastatin	liver cirrhosis biliary	23	0.44
DB00227	Lovastatin	bone diseases	144	0.49
DB00227	Lovastatin	metabolism inborn errors	289	0.51
DB00227	Lovastatin	sarcoma	25	0.58
DB00227	Lovastatin	varicose veins	20	0.60
DB00227	Lovastatin	eye diseases	231	0.60
DB00227	Lovastatin	leukemia	117	0.63
DB00227	Lovastatin	arrhythmias cardiac	30	0.71
DB00227	Lovastatin	diabetes mellitus type 2	72	0.80
DB00227	Lovastatin	dementia	42	0.83
DB00227	Lovastatin	endocrine system diseases	291	0.85
DB00227	Lovastatin	macular degeneration	44	0.96
DB00227	Lovastatin	motor neuron disease	31	1.00
DB00227	Lovastatin	thyroid diseases	30	1.23
DB00227	Lovastatin	psoriasis	54	2.61
DB00734	Risperidone	varicose veins	20	-3.12
DB00734	Risperidone	bone diseases	144	-2.78
DB00734	Risperidone	crohn disease	71	-2.24
DB00734	Risperidone	colitis ulcerative	55	-2.11
DB00734	Risperidone	colitis	55	-2.08
DB00734	Risperidone	psoriasis	54	-2.02
DB00734	Risperidone	multiple sclerosis	69	-1.65
DB00734	Risperidone	arrhythmias cardiac	30	-1.64
DB00734	Risperidone	thyroid diseases	30	-1.64
DB00734	Risperidone	cardiovascular diseases	330	-1.60
DB00734	Risperidone	epilepsy	25	-1.54
DB00734	Risperidone	heart diseases	167	-1.50
DB00734	Risperidone	breast neoplasms	40	-1.46
DB00734	Risperidone	joint diseases	79	-1.43
DB00734	Risperidone	inflammatory bowel diseases	119	-1.39
DB00734	Risperidone	arthritis	76	-1.38
DB00734	Risperidone	gastroenteritis	122	-1.34
DB00734	Risperidone	bacterial infections	26	-0.92
DB00734	Risperidone	insulin resistance	26	-0.90
DB00734	Risperidone	hyperinsulinism	26	-0.90
DB00734	Risperidone	collagen diseases	25	-0.72
DB00734	Risperidone	cardiomyopathy dilated	29	-0.66
DB00734	Risperidone	neuroendocrine tumors	24	-0.66
DB00734	Risperidone	alzheimer disease	29	-0.64
DB00734	Risperidone	anemia hemolytic	29	-0.61
DB00734	Risperidone	vascular diseases	181	-0.61
DB00734	Risperidone	leukemia myeloid acute	43	-0.49
DB00734	Risperidone	parkinsonian disorders	31	-0.48
DB00734	Risperidone	intestinal neoplasms	42	-0.43
DB00734	Risperidone	parkinson disease	30	-0.43
DB00734	Risperidone	colorectal neoplasms	42	-0.43
DB00734	Risperidone	mycobacterium infections	22	-0.40
DB00734	Risperidone	amyotrophic lateral sclerosis	21	-0.38
DB00734	Risperidone	spinal cord diseases	59	-0.38
DB00734	Risperidone	myocardial ischemia	43	-0.37
DB00734	Risperidone	skin diseases	278	-0.22
DB00734	Risperidone	autoimmune diseases	243	-0.18
DB00734	Risperidone	lung diseases	71	-0.12
DB00734	Risperidone	hematologic diseases	188	-0.09
DB00734	Risperidone	adenocarcinoma	32	-0.02
DB00734	Risperidone	eye diseases	231	0.00
DB00734	Risperidone	liver cirrhosis biliary	23	0.12
DB00734	Risperidone	keratosis	21	0.12
DB00734	Risperidone	pancreatic diseases	24	0.12
DB00734	Risperidone	dementia	42	0.13
DB00734	Risperidone	endocrine system diseases	291	0.13
DB00734	Risperidone	liver cirrhosis	24	0.16
DB00734	Risperidone	malabsorption syndromes	34	0.20
DB00734	Risperidone	blood coagulation disorders	40	0.20
DB00734	Risperidone	diabetes mellitus type 2	72	0.31
DB00734	Risperidone	gastrointestinal neoplasms	72	0.33
DB00734	Risperidone	kidney neoplasms	20	0.37
DB00734	Risperidone	motor neuron disease	31	0.40
DB00734	Risperidone	leukemia	117	0.43
DB00734	Risperidone	anemia	58	0.43
DB00734	Risperidone	hypopigmentation	22	0.47
DB00734	Risperidone	arthritis rheumatoid	42	0.50
DB00734	Risperidone	lupus erythematosus systemic	75	0.61
DB00734	Risperidone	lymphoma non hodgkin	22	0.62
DB00734	Risperidone	head and neck neoplasms	35	0.64
DB00734	Risperidone	lymphoma	24	0.67
DB00734	Risperidone	arterial occlusive diseases	44	0.67
DB00734	Risperidone	diabetes mellitus type 1	82	0.72
DB00734	Risperidone	arteriosclerosis	38	0.75
DB00734	Risperidone	coronary artery disease	31	1.04
DB00734	Risperidone	rheumatic diseases	59	1.06
DB00734	Risperidone	diabetes mellitus	162	1.10
DB00734	Risperidone	sarcoma	25	1.12
DB00734	Risperidone	leukemia lymphoid	66	1.16
DB00734	Risperidone	macular degeneration	44	1.22
DB00734	Risperidone	metabolism inborn errors	289	1.28
DB00734	Risperidone	asthma	36	1.31
DB00734	Risperidone	prostatic neoplasms	61	1.35
DB00734	Risperidone	coronary disease	37	1.47
DB00734	Risperidone	kidney diseases	144	1.53
DB00734	Risperidone	hypersensitivity	45	1.79
DB00734	Risperidone	bone diseases metabolic	27	2.15
DB00734	Risperidone	neoplasms	482	2.60
DB00277	Theophylline	eye diseases	231	-1.58
DB00277	Theophylline	thyroid diseases	30	-1.41
DB00277	Theophylline	anemia hemolytic	29	-1.27
DB00277	Theophylline	hyperinsulinism	26	-1.13
DB00277	Theophylline	arteriosclerosis	38	-1.07
DB00277	Theophylline	bone diseases metabolic	27	-1.03
DB00277	Theophylline	liver cirrhosis	24	-1.01
DB00277	Theophylline	liver cirrhosis biliary	23	-0.97
DB00277	Theophylline	insulin resistance	26	-0.96
DB00277	Theophylline	pancreatic diseases	24	-0.96
DB00277	Theophylline	endocrine system diseases	291	-0.85
DB00277	Theophylline	arterial occlusive diseases	44	-0.76
DB00277	Theophylline	multiple sclerosis	69	-0.65
DB00277	Theophylline	intestinal neoplasms	42	-0.61
DB00277	Theophylline	colorectal neoplasms	42	-0.59
DB00277	Theophylline	lymphoma non hodgkin	22	-0.56
DB00277	Theophylline	spinal cord diseases	59	-0.54
DB00277	Theophylline	lymphoma	24	-0.52
DB00277	Theophylline	colitis ulcerative	55	-0.52
DB00277	Theophylline	parkinson disease	30	-0.51
DB00277	Theophylline	arrhythmias cardiac	30	-0.47
DB00277	Theophylline	colitis	55	-0.45
DB00277	Theophylline	parkinsonian disorders	31	-0.44
DB00277	Theophylline	heart diseases	167	-0.38
DB00277	Theophylline	kidney neoplasms	20	-0.36
DB00277	Theophylline	myocardial ischemia	43	-0.34
DB00277	Theophylline	bacterial infections	26	-0.30
DB00277	Theophylline	malabsorption syndromes	34	-0.24
DB00277	Theophylline	cardiomyopathy dilated	29	-0.14
DB00277	Theophylline	lupus erythematosus systemic	75	0.02
DB00277	Theophylline	varicose veins	20	0.02
DB00277	Theophylline	neuroendocrine tumors	24	0.04
DB00277	Theophylline	keratosis	21	0.05
DB00277	Theophylline	kidney diseases	144	0.05
DB00277	Theophylline	cardiovascular diseases	330	0.06
DB00277	Theophylline	gastrointestinal neoplasms	72	0.08
DB00277	Theophylline	sarcoma	25	0.12
DB00277	Theophylline	epilepsy	25	0.16
DB00277	Theophylline	crohn disease	71	0.21
DB00277	Theophylline	coronary disease	37	0.31
DB00277	Theophylline	leukemia myeloid acute	43	0.31
DB00277	Theophylline	autoimmune diseases	243	0.33
DB00277	Theophylline	hypopigmentation	22	0.36
DB00277	Theophylline	joint diseases	79	0.39
DB00277	Theophylline	bone diseases	144	0.39
DB00277	Theophylline	motor neuron disease	31	0.40
DB00277	Theophylline	anemia	58	0.42
DB00277	Theophylline	leukemia lymphoid	66	0.46
DB00277	Theophylline	arthritis	76	0.46
DB00277	Theophylline	lung diseases	71	0.47
DB00277	Theophylline	adenocarcinoma	32	0.48
DB00277	Theophylline	arthritis rheumatoid	42	0.49
DB00277	Theophylline	prostatic neoplasms	61	0.59
DB00277	Theophylline	head and neck neoplasms	35	0.61
DB00277	Theophylline	vascular diseases	181	0.63
DB00277	Theophylline	psoriasis	54	0.68
DB00277	Theophylline	breast neoplasms	40	0.69
DB00277	Theophylline	inflammatory bowel diseases	119	0.73
DB00277	Theophylline	metabolism inborn errors	289	0.74
DB00277	Theophylline	asthma	36	0.74
DB00277	Theophylline	gastroenteritis	122	0.76
DB00277	Theophylline	coronary artery disease	31	0.79
DB00277	Theophylline	rheumatic diseases	59	0.87
DB00277	Theophylline	mycobacterium infections	22	0.87
DB00277	Theophylline	diabetes mellitus type 1	82	0.95
DB00277	Theophylline	hypersensitivity	45	1.01
DB00277	Theophylline	collagen diseases	25	1.18
DB00277	Theophylline	neoplasms	482	1.25
DB00277	Theophylline	amyotrophic lateral sclerosis	21	1.27
DB00277	Theophylline	leukemia	117	1.31
DB00277	Theophylline	diabetes mellitus type 2	72	1.32
DB00277	Theophylline	alzheimer disease	29	1.39
DB00277	Theophylline	blood coagulation disorders	40	1.62
DB00277	Theophylline	diabetes mellitus	162	1.66
DB00277	Theophylline	hematologic diseases	188	1.85
DB00277	Theophylline	skin diseases	278	2.01
DB00277	Theophylline	dementia	42	2.08
DB00277	Theophylline	macular degeneration	44	2.15
DB00959	Methylprednisolone	coronary artery disease	31	-1.56
DB00959	Methylprednisolone	coronary disease	37	-1.49
DB00959	Methylprednisolone	myocardial ischemia	43	-1.37
DB00959	Methylprednisolone	kidney neoplasms	20	-1.32
DB00959	Methylprednisolone	arteriosclerosis	38	-1.32
DB00959	Methylprednisolone	malabsorption syndromes	34	-1.30
DB00959	Methylprednisolone	colitis	55	-1.29
DB00959	Methylprednisolone	colitis ulcerative	55	-1.22
DB00959	Methylprednisolone	mycobacterium infections	22	-1.21
DB00959	Methylprednisolone	alzheimer disease	29	-1.20
DB00959	Methylprednisolone	arterial occlusive diseases	44	-1.16
DB00959	Methylprednisolone	bacterial infections	26	-1.12
DB00959	Methylprednisolone	neuroendocrine tumors	24	-1.10
DB00959	Methylprednisolone	asthma	36	-1.08
DB00959	Methylprednisolone	dementia	42	-0.99
DB00959	Methylprednisolone	hypersensitivity	45	-0.96
DB00959	Methylprednisolone	head and neck neoplasms	35	-0.88
DB00959	Methylprednisolone	sarcoma	25	-0.88
DB00959	Methylprednisolone	prostatic neoplasms	61	-0.86
DB00959	Methylprednisolone	arthritis rheumatoid	42	-0.81
DB00959	Methylprednisolone	motor neuron disease	31	-0.79
DB00959	Methylprednisolone	liver cirrhosis	24	-0.79
DB00959	Methylprednisolone	adenocarcinoma	32	-0.76
DB00959	Methylprednisolone	liver cirrhosis biliary	23	-0.75
DB00959	Methylprednisolone	lupus erythematosus systemic	75	-0.71
DB00959	Methylprednisolone	lymphoma non hodgkin	22	-0.70
DB00959	Methylprednisolone	lymphoma	24	-0.70
DB00959	Methylprednisolone	diabetes mellitus type 1	82	-0.68
DB00959	Methylprednisolone	breast neoplasms	40	-0.61
DB00959	Methylprednisolone	rheumatic diseases	59	-0.61
DB00959	Methylprednisolone	crohn disease	71	-0.58
DB00959	Methylprednisolone	leukemia myeloid acute	43	-0.54
DB00959	Methylprednisolone	leukemia lymphoid	66	-0.51
DB00959	Methylprednisolone	diabetes mellitus	162	-0.48
DB00959	Methylprednisolone	colorectal neoplasms	42	-0.47
DB00959	Methylprednisolone	joint diseases	79	-0.46
DB00959	Methylprednisolone	arthritis	76	-0.45
DB00959	Methylprednisolone	kidney diseases	144	-0.45
DB00959	Methylprednisolone	intestinal neoplasms	42	-0.43
DB00959	Methylprednisolone	inflammatory bowel diseases	119	-0.41
DB00959	Methylprednisolone	gastroenteritis	122	-0.39
DB00959	Methylprednisolone	metabolism inborn errors	289	-0.37
DB00959	Methylprednisolone	heart diseases	167	-0.37
DB00959	Methylprednisolone	multiple sclerosis	69	-0.36
DB00959	Methylprednisolone	spinal cord diseases	59	-0.33
DB00959	Methylprednisolone	lung diseases	71	-0.32
DB00959	Methylprednisolone	gastrointestinal neoplasms	72	-0.27
DB00959	Methylprednisolone	bone diseases	144	-0.27
DB00959	Methylprednisolone	leukemia	117	-0.16
DB00959	Methylprednisolone	skin diseases	278	-0.04
DB00959	Methylprednisolone	eye diseases	231	-0.02
DB00959	Methylprednisolone	vascular diseases	181	-0.01
DB00959	Methylprednisolone	autoimmune diseases	243	0.08
DB00959	Methylprednisolone	hematologic diseases	188	0.08
DB00959	Methylprednisolone	cardiovascular diseases	330	0.10
DB00959	Methylprednisolone	endocrine system diseases	291	0.12
DB00959	Methylprednisolone	neoplasms	482	0.18
DB00959	Methylprednisolone	arrhythmias cardiac	30	0.33
DB00959	Methylprednisolone	collagen diseases	25	0.39
DB00959	Methylprednisolone	varicose veins	20	0.41
DB00959	Methylprednisolone	epilepsy	25	0.42
DB00959	Methylprednisolone	bone diseases metabolic	27	0.42
DB00959	Methylprednisolone	macular degeneration	44	0.42
DB00959	Methylprednisolone	parkinson disease	30	0.48
DB00959	Methylprednisolone	parkinsonian disorders	31	0.48
DB00959	Methylprednisolone	hyperinsulinism	26	0.57
DB00959	Methylprednisolone	insulin resistance	26	0.60
DB00959	Methylprednisolone	anemia hemolytic	29	0.65
DB00959	Methylprednisolone	cardiomyopathy dilated	29	0.65
DB00959	Methylprednisolone	blood coagulation disorders	40	0.65
DB00959	Methylprednisolone	keratosis	21	0.68
DB00959	Methylprednisolone	thyroid diseases	30	0.72
DB00959	Methylprednisolone	amyotrophic lateral sclerosis	21	0.77
DB00959	Methylprednisolone	hypopigmentation	22	0.78
DB00959	Methylprednisolone	diabetes mellitus type 2	72	0.85
DB00959	Methylprednisolone	pancreatic diseases	24	1.12
DB00959	Methylprednisolone	psoriasis	54	1.17
DB00959	Methylprednisolone	anemia	58	2.52
DB01597	Cilastatin	amyotrophic lateral sclerosis	21	-0.93
DB01597	Cilastatin	alzheimer disease	29	-0.90
DB01597	Cilastatin	malabsorption syndromes	34	-0.88
DB01597	Cilastatin	blood coagulation disorders	40	-0.81
DB01597	Cilastatin	motor neuron disease	31	-0.73
DB01597	Cilastatin	head and neck neoplasms	35	-0.67
DB01597	Cilastatin	diabetes mellitus type 2	72	-0.64
DB01597	Cilastatin	dementia	42	-0.63
DB01597	Cilastatin	prostatic neoplasms	61	-0.58
DB01597	Cilastatin	leukemia lymphoid	66	-0.43
DB01597	Cilastatin	spinal cord diseases	59	-0.42
DB01597	Cilastatin	gastrointestinal neoplasms	72	-0.35
DB01597	Cilastatin	diabetes mellitus	162	-0.31
DB01597	Cilastatin	leukemia	117	-0.17
DB01597	Cilastatin	vascular diseases	181	-0.16
DB01597	Cilastatin	eye diseases	231	-0.10
DB01597	Cilastatin	hematologic diseases	188	-0.08
DB01597	Cilastatin	autoimmune diseases	243	0.02
DB01597	Cilastatin	skin diseases	278	0.04
DB01597	Cilastatin	endocrine system diseases	291	0.05
DB01597	Cilastatin	cardiovascular diseases	330	0.09
DB01597	Cilastatin	neoplasms	482	0.33
DB01597	Cilastatin	varicose veins	20	0.53
DB01597	Cilastatin	insulin resistance	26	0.59
DB01597	Cilastatin	epilepsy	25	0.59
DB01597	Cilastatin	hyperinsulinism	26	0.61
DB01597	Cilastatin	arrhythmias cardiac	30	0.62
DB01597	Cilastatin	bone diseases metabolic	27	0.63
DB01597	Cilastatin	collagen diseases	25	0.64
DB01597	Cilastatin	mycobacterium infections	22	0.66
DB01597	Cilastatin	coronary artery disease	31	0.68
DB01597	Cilastatin	keratosis	21	0.74
DB01597	Cilastatin	bacterial infections	26	0.78
DB01597	Cilastatin	kidney neoplasms	20	0.78
DB01597	Cilastatin	coronary disease	37	0.79
DB01597	Cilastatin	anemia hemolytic	29	0.80
DB01597	Cilastatin	thyroid diseases	30	0.80
DB01597	Cilastatin	hypopigmentation	22	0.81
DB01597	Cilastatin	parkinson disease	30	0.81
DB01597	Cilastatin	liver cirrhosis biliary	23	0.81
DB01597	Cilastatin	parkinsonian disorders	31	0.84
DB01597	Cilastatin	neuroendocrine tumors	24	0.85
DB01597	Cilastatin	myocardial ischemia	43	0.85
DB01597	Cilastatin	pancreatic diseases	24	0.85
DB01597	Cilastatin	liver cirrhosis	24	0.88
DB01597	Cilastatin	arteriosclerosis	38	0.92
DB01597	Cilastatin	lymphoma non hodgkin	22	0.94
DB01597	Cilastatin	sarcoma	25	0.94
DB01597	Cilastatin	asthma	36	0.94
DB01597	Cilastatin	cardiomyopathy dilated	29	0.96
DB01597	Cilastatin	lymphoma	24	0.99
DB01597	Cilastatin	arterial occlusive diseases	44	1.01
DB01597	Cilastatin	hypersensitivity	45	1.05
DB01597	Cilastatin	adenocarcinoma	32	1.09
DB01597	Cilastatin	arthritis rheumatoid	42	1.11
DB01597	Cilastatin	colitis	55	1.13
DB01597	Cilastatin	colitis ulcerative	55	1.17
DB01597	Cilastatin	breast neoplasms	40	1.27
DB01597	Cilastatin	rheumatic diseases	59	1.28
DB01597	Cilastatin	psoriasis	54	1.30
DB01597	Cilastatin	crohn disease	71	1.31
DB01597	Cilastatin	intestinal neoplasms	42	1.33
DB01597	Cilastatin	multiple sclerosis	69	1.34
DB01597	Cilastatin	lung diseases	71	1.35
DB01597	Cilastatin	lupus erythematosus systemic	75	1.35
DB01597	Cilastatin	colorectal neoplasms	42	1.38
DB01597	Cilastatin	arthritis	76	1.38
DB01597	Cilastatin	leukemia myeloid acute	43	1.42
DB01597	Cilastatin	diabetes mellitus type 1	82	1.43
DB01597	Cilastatin	joint diseases	79	1.48
DB01597	Cilastatin	anemia	58	1.52
DB01597	Cilastatin	kidney diseases	144	1.59
DB01597	Cilastatin	inflammatory bowel diseases	119	1.62
DB01597	Cilastatin	gastroenteritis	122	1.63
DB01597	Cilastatin	bone diseases	144	1.71
DB01597	Cilastatin	heart diseases	167	1.85
DB01597	Cilastatin	metabolism inborn errors	289	1.93
DB01597	Cilastatin	macular degeneration	44	2.47
DB01114	Chlorpheniramine	parkinsonian disorders	31	-2.37
DB01114	Chlorpheniramine	parkinson disease	30	-2.33
DB01114	Chlorpheniramine	dementia	42	-1.91
DB01114	Chlorpheniramine	arrhythmias cardiac	30	-1.81
DB01114	Chlorpheniramine	rheumatic diseases	59	-1.73
DB01114	Chlorpheniramine	joint diseases	79	-1.50
DB01114	Chlorpheniramine	arthritis	76	-1.45
DB01114	Chlorpheniramine	cardiomyopathy dilated	29	-1.32
DB01114	Chlorpheniramine	amyotrophic lateral sclerosis	21	-1.32
DB01114	Chlorpheniramine	pancreatic diseases	24	-1.27
DB01114	Chlorpheniramine	sarcoma	25	-1.22
DB01114	Chlorpheniramine	neuroendocrine tumors	24	-1.20
DB01114	Chlorpheniramine	asthma	36	-1.16
DB01114	Chlorpheniramine	lymphoma non hodgkin	22	-1.14
DB01114	Chlorpheniramine	lymphoma	24	-1.05
DB01114	Chlorpheniramine	epilepsy	25	-1.02
DB01114	Chlorpheniramine	hypersensitivity	45	-0.99
DB01114	Chlorpheniramine	motor neuron disease	31	-0.96
DB01114	Chlorpheniramine	arthritis rheumatoid	42	-0.95
DB01114	Chlorpheniramine	adenocarcinoma	32	-0.90
DB01114	Chlorpheniramine	head and neck neoplasms	35	-0.87
DB01114	Chlorpheniramine	prostatic neoplasms	61	-0.74
DB01114	Chlorpheniramine	keratosis	21	-0.72
DB01114	Chlorpheniramine	diabetes mellitus type 2	72	-0.71
DB01114	Chlorpheniramine	autoimmune diseases	243	-0.62
DB01114	Chlorpheniramine	hypopigmentation	22	-0.56
DB01114	Chlorpheniramine	anemia hemolytic	29	-0.54
DB01114	Chlorpheniramine	multiple sclerosis	69	-0.53
DB01114	Chlorpheniramine	crohn disease	71	-0.53
DB01114	Chlorpheniramine	diabetes mellitus type 1	82	-0.52
DB01114	Chlorpheniramine	intestinal neoplasms	42	-0.51
DB01114	Chlorpheniramine	leukemia myeloid acute	43	-0.50
DB01114	Chlorpheniramine	kidney neoplasms	20	-0.50
DB01114	Chlorpheniramine	colorectal neoplasms	42	-0.48
DB01114	Chlorpheniramine	liver cirrhosis biliary	23	-0.47
DB01114	Chlorpheniramine	liver cirrhosis	24	-0.45
DB01114	Chlorpheniramine	malabsorption syndromes	34	-0.45
DB01114	Chlorpheniramine	bacterial infections	26	-0.44
DB01114	Chlorpheniramine	spinal cord diseases	59	-0.43
DB01114	Chlorpheniramine	lung diseases	71	-0.38
DB01114	Chlorpheniramine	leukemia lymphoid	66	-0.36
DB01114	Chlorpheniramine	varicose veins	20	-0.29
DB01114	Chlorpheniramine	alzheimer disease	29	-0.29
DB01114	Chlorpheniramine	gastrointestinal neoplasms	72	-0.17
DB01114	Chlorpheniramine	gastroenteritis	122	-0.13
DB01114	Chlorpheniramine	inflammatory bowel diseases	119	-0.12
DB01114	Chlorpheniramine	arterial occlusive diseases	44	-0.10
DB01114	Chlorpheniramine	blood coagulation disorders	40	-0.10
DB01114	Chlorpheniramine	hyperinsulinism	26	-0.07
DB01114	Chlorpheniramine	insulin resistance	26	-0.06
DB01114	Chlorpheniramine	kidney diseases	144	-0.05
DB01114	Chlorpheniramine	collagen diseases	25	0.00
DB01114	Chlorpheniramine	diabetes mellitus	162	0.01
DB01114	Chlorpheniramine	bone diseases	144	0.02
DB01114	Chlorpheniramine	heart diseases	167	0.15
DB01114	Chlorpheniramine	mycobacterium infections	22	0.19
DB01114	Chlorpheniramine	leukemia	117	0.23
DB01114	Chlorpheniramine	coronary artery disease	31	0.24
DB01114	Chlorpheniramine	eye diseases	231	0.25
DB01114	Chlorpheniramine	psoriasis	54	0.29
DB01114	Chlorpheniramine	vascular diseases	181	0.31
DB01114	Chlorpheniramine	breast neoplasms	40	0.33
DB01114	Chlorpheniramine	metabolism inborn errors	289	0.42
DB01114	Chlorpheniramine	coronary disease	37	0.43
DB01114	Chlorpheniramine	hematologic diseases	188	0.46
DB01114	Chlorpheniramine	lupus erythematosus systemic	75	0.50
DB01114	Chlorpheniramine	myocardial ischemia	43	0.56
DB01114	Chlorpheniramine	arteriosclerosis	38	0.60
DB01114	Chlorpheniramine	endocrine system diseases	291	0.64
DB01114	Chlorpheniramine	anemia	58	0.65
DB01114	Chlorpheniramine	skin diseases	278	0.65
DB01114	Chlorpheniramine	cardiovascular diseases	330	0.69
DB01114	Chlorpheniramine	bone diseases metabolic	27	1.01
DB01114	Chlorpheniramine	colitis	55	1.14
DB01114	Chlorpheniramine	colitis ulcerative	55	1.15
DB01114	Chlorpheniramine	macular degeneration	44	1.18
DB01114	Chlorpheniramine	neoplasms	482	1.28
DB01114	Chlorpheniramine	thyroid diseases	30	1.28
DB08868	Fingolimod	colitis	55	-2.42
DB08868	Fingolimod	colitis ulcerative	55	-2.40
DB08868	Fingolimod	gastroenteritis	122	-2.23
DB08868	Fingolimod	inflammatory bowel diseases	119	-2.21
DB08868	Fingolimod	insulin resistance	26	-1.13
DB08868	Fingolimod	hyperinsulinism	26	-1.07
DB08868	Fingolimod	hypopigmentation	22	-0.96
DB08868	Fingolimod	liver cirrhosis	24	-0.91
DB08868	Fingolimod	thyroid diseases	30	-0.85
DB08868	Fingolimod	liver cirrhosis biliary	23	-0.84
DB08868	Fingolimod	malabsorption syndromes	34	-0.79
DB08868	Fingolimod	breast neoplasms	40	-0.60
DB08868	Fingolimod	diabetes mellitus type 2	72	-0.59
DB08868	Fingolimod	psoriasis	54	-0.55
DB08868	Fingolimod	intestinal neoplasms	42	-0.51
DB08868	Fingolimod	diabetes mellitus type 1	82	-0.51
DB08868	Fingolimod	colorectal neoplasms	42	-0.48
DB08868	Fingolimod	crohn disease	71	-0.47
DB08868	Fingolimod	lupus erythematosus systemic	75	-0.46
DB08868	Fingolimod	gastrointestinal neoplasms	72	-0.30
DB08868	Fingolimod	diabetes mellitus	162	-0.25
DB08868	Fingolimod	heart diseases	167	-0.20
DB08868	Fingolimod	bone diseases	144	-0.18
DB08868	Fingolimod	hematologic diseases	188	-0.08
DB08868	Fingolimod	eye diseases	231	-0.05
DB08868	Fingolimod	metabolism inborn errors	289	-0.01
DB08868	Fingolimod	autoimmune diseases	243	0.03
DB08868	Fingolimod	endocrine system diseases	291	0.04
DB08868	Fingolimod	skin diseases	278	0.06
DB08868	Fingolimod	cardiovascular diseases	330	0.08
DB08868	Fingolimod	neoplasms	482	0.39
DB08868	Fingolimod	varicose veins	20	0.50
DB08868	Fingolimod	epilepsy	25	0.55
DB08868	Fingolimod	arrhythmias cardiac	30	0.60
DB08868	Fingolimod	bone diseases metabolic	27	0.63
DB08868	Fingolimod	collagen diseases	25	0.64
DB08868	Fingolimod	mycobacterium infections	22	0.68
DB08868	Fingolimod	keratosis	21	0.73
DB08868	Fingolimod	coronary artery disease	31	0.73
DB08868	Fingolimod	macular degeneration	44	0.78
DB08868	Fingolimod	kidney neoplasms	20	0.82
DB08868	Fingolimod	neuroendocrine tumors	24	0.82
DB08868	Fingolimod	anemia hemolytic	29	0.83
DB08868	Fingolimod	parkinsonian disorders	31	0.83
DB08868	Fingolimod	parkinson disease	30	0.83
DB08868	Fingolimod	amyotrophic lateral sclerosis	21	0.84
DB08868	Fingolimod	pancreatic diseases	24	0.85
DB08868	Fingolimod	bacterial infections	26	0.86
DB08868	Fingolimod	myocardial ischemia	43	0.86
DB08868	Fingolimod	coronary disease	37	0.87
DB08868	Fingolimod	alzheimer disease	29	0.89
DB08868	Fingolimod	arteriosclerosis	38	0.89
DB08868	Fingolimod	sarcoma	25	0.91
DB08868	Fingolimod	cardiomyopathy dilated	29	0.93
DB08868	Fingolimod	asthma	36	0.94
DB08868	Fingolimod	lymphoma	24	0.97
DB08868	Fingolimod	lymphoma non hodgkin	22	0.99
DB08868	Fingolimod	arterial occlusive diseases	44	0.99
DB08868	Fingolimod	blood coagulation disorders	40	1.00
DB08868	Fingolimod	arthritis rheumatoid	42	1.05
DB08868	Fingolimod	hypersensitivity	45	1.09
DB08868	Fingolimod	motor neuron disease	31	1.09
DB08868	Fingolimod	adenocarcinoma	32	1.10
DB08868	Fingolimod	dementia	42	1.16
DB08868	Fingolimod	head and neck neoplasms	35	1.16
DB08868	Fingolimod	prostatic neoplasms	61	1.23
DB08868	Fingolimod	rheumatic diseases	59	1.31
DB08868	Fingolimod	leukemia myeloid acute	43	1.32
DB08868	Fingolimod	multiple sclerosis	69	1.35
DB08868	Fingolimod	lung diseases	71	1.42
DB08868	Fingolimod	joint diseases	79	1.43
DB08868	Fingolimod	anemia	58	1.45
DB08868	Fingolimod	spinal cord diseases	59	1.46
DB08868	Fingolimod	leukemia lymphoid	66	1.53
DB08868	Fingolimod	arthritis	76	1.55
DB08868	Fingolimod	kidney diseases	144	1.66
DB08868	Fingolimod	vascular diseases	181	1.90
DB08868	Fingolimod	leukemia	117	1.94
DB00915	Amantadine	arrhythmias cardiac	30	-2.24
DB00915	Amantadine	parkinsonian disorders	31	-2.13
DB00915	Amantadine	parkinson disease	30	-2.00
DB00915	Amantadine	anemia hemolytic	29	-1.90
DB00915	Amantadine	spinal cord diseases	59	-1.64
DB00915	Amantadine	anemia	58	-1.33
DB00915	Amantadine	heart diseases	167	-1.04
DB00915	Amantadine	epilepsy	25	-0.92
DB00915	Amantadine	bone diseases	144	-0.88
DB00915	Amantadine	collagen diseases	25	-0.76
DB00915	Amantadine	kidney neoplasms	20	-0.54
DB00915	Amantadine	liver cirrhosis	24	-0.51
DB00915	Amantadine	thyroid diseases	30	-0.49
DB00915	Amantadine	hypopigmentation	22	-0.49
DB00915	Amantadine	liver cirrhosis biliary	23	-0.49
DB00915	Amantadine	amyotrophic lateral sclerosis	21	-0.49
DB00915	Amantadine	myocardial ischemia	43	-0.49
DB00915	Amantadine	hematologic diseases	188	-0.49
DB00915	Amantadine	pancreatic diseases	24	-0.48
DB00915	Amantadine	endocrine system diseases	291	-0.45
DB00915	Amantadine	alzheimer disease	29	-0.43
DB00915	Amantadine	cardiomyopathy dilated	29	-0.43
DB00915	Amantadine	asthma	36	-0.41
DB00915	Amantadine	neuroendocrine tumors	24	-0.39
DB00915	Amantadine	cardiovascular diseases	330	-0.34
DB00915	Amantadine	hypersensitivity	45	-0.29
DB00915	Amantadine	lymphoma non hodgkin	22	-0.28
DB00915	Amantadine	lymphoma	24	-0.27
DB00915	Amantadine	motor neuron disease	31	-0.18
DB00915	Amantadine	adenocarcinoma	32	-0.17
DB00915	Amantadine	colitis	55	-0.10
DB00915	Amantadine	dementia	42	-0.06
DB00915	Amantadine	head and neck neoplasms	35	-0.06
DB00915	Amantadine	colitis ulcerative	55	-0.05
DB00915	Amantadine	arthritis rheumatoid	42	-0.04
DB00915	Amantadine	psoriasis	54	-0.03
DB00915	Amantadine	prostatic neoplasms	61	-0.02
DB00915	Amantadine	breast neoplasms	40	0.03
DB00915	Amantadine	rheumatic diseases	59	0.07
DB00915	Amantadine	crohn disease	71	0.12
DB00915	Amantadine	multiple sclerosis	69	0.12
DB00915	Amantadine	diabetes mellitus type 1	82	0.13
DB00915	Amantadine	intestinal neoplasms	42	0.14
DB00915	Amantadine	colorectal neoplasms	42	0.15
DB00915	Amantadine	lupus erythematosus systemic	75	0.16
DB00915	Amantadine	arthritis	76	0.20
DB00915	Amantadine	leukemia myeloid acute	43	0.20
DB00915	Amantadine	joint diseases	79	0.21
DB00915	Amantadine	lung diseases	71	0.23
DB00915	Amantadine	leukemia lymphoid	66	0.27
DB00915	Amantadine	gastroenteritis	122	0.39
DB00915	Amantadine	varicose veins	20	0.40
DB00915	Amantadine	kidney diseases	144	0.41
DB00915	Amantadine	inflammatory bowel diseases	119	0.42
DB00915	Amantadine	gastrointestinal neoplasms	72	0.42
DB00915	Amantadine	diabetes mellitus	162	0.53
DB00915	Amantadine	hyperinsulinism	26	0.55
DB00915	Amantadine	insulin resistance	26	0.58
DB00915	Amantadine	eye diseases	231	0.63
DB00915	Amantadine	vascular diseases	181	0.69
DB00915	Amantadine	leukemia	117	0.69
DB00915	Amantadine	metabolism inborn errors	289	0.78
DB00915	Amantadine	mycobacterium infections	22	0.81
DB00915	Amantadine	autoimmune diseases	243	0.86
DB00915	Amantadine	keratosis	21	0.89
DB00915	Amantadine	skin diseases	278	1.00
DB00915	Amantadine	bacterial infections	26	1.06
DB00915	Amantadine	malabsorption syndromes	34	1.11
DB00915	Amantadine	arteriosclerosis	38	1.13
DB00915	Amantadine	blood coagulation disorders	40	1.30
DB00915	Amantadine	sarcoma	25	1.31
DB00915	Amantadine	arterial occlusive diseases	44	1.35
DB00915	Amantadine	neoplasms	482	1.64
DB00915	Amantadine	diabetes mellitus type 2	72	1.71
DB00915	Amantadine	bone diseases metabolic	27	2.04
DB00915	Amantadine	macular degeneration	44	2.23
DB00915	Amantadine	coronary artery disease	31	2.34
DB00915	Amantadine	coronary disease	37	2.69
DB01599	Probucol	metabolism inborn errors	289	-3.11
DB01599	Probucol	varicose veins	20	-2.46
DB01599	Probucol	vascular diseases	181	-1.99
DB01599	Probucol	cardiovascular diseases	330	-1.64
DB01599	Probucol	diabetes mellitus type 1	82	-1.45
DB01599	Probucol	lung diseases	71	-1.30
DB01599	Probucol	spinal cord diseases	59	-1.27
DB01599	Probucol	gastrointestinal neoplasms	72	-0.94
DB01599	Probucol	heart diseases	167	-0.90
DB01599	Probucol	bone diseases	144	-0.90
DB01599	Probucol	arrhythmias cardiac	30	-0.87
DB01599	Probucol	diabetes mellitus	162	-0.86
DB01599	Probucol	bone diseases metabolic	27	-0.79
DB01599	Probucol	mycobacterium infections	22	-0.78
DB01599	Probucol	keratosis	21	-0.76
DB01599	Probucol	coronary artery disease	31	-0.73
DB01599	Probucol	coronary disease	37	-0.66
DB01599	Probucol	parkinson disease	30	-0.60
DB01599	Probucol	bacterial infections	26	-0.60
DB01599	Probucol	eye diseases	231	-0.59
DB01599	Probucol	malabsorption syndromes	34	-0.58
DB01599	Probucol	amyotrophic lateral sclerosis	21	-0.56
DB01599	Probucol	parkinsonian disorders	31	-0.54
DB01599	Probucol	myocardial ischemia	43	-0.53
DB01599	Probucol	arteriosclerosis	38	-0.52
DB01599	Probucol	autoimmune diseases	243	-0.50
DB01599	Probucol	asthma	36	-0.50
DB01599	Probucol	hematologic diseases	188	-0.45
DB01599	Probucol	hypersensitivity	45	-0.42
DB01599	Probucol	sarcoma	25	-0.41
DB01599	Probucol	arterial occlusive diseases	44	-0.41
DB01599	Probucol	neuroendocrine tumors	24	-0.39
DB01599	Probucol	skin diseases	278	-0.33
DB01599	Probucol	endocrine system diseases	291	-0.27
DB01599	Probucol	colitis ulcerative	55	-0.22
DB01599	Probucol	colitis	55	-0.21
DB01599	Probucol	motor neuron disease	31	-0.17
DB01599	Probucol	psoriasis	54	-0.17
DB01599	Probucol	prostatic neoplasms	61	-0.12
DB01599	Probucol	breast neoplasms	40	-0.11
DB01599	Probucol	dementia	42	-0.10
DB01599	Probucol	diabetes mellitus type 2	72	-0.09
DB01599	Probucol	rheumatic diseases	59	-0.09
DB01599	Probucol	lupus erythematosus systemic	75	-0.05
DB01599	Probucol	leukemia myeloid acute	43	-0.02
DB01599	Probucol	multiple sclerosis	69	-0.01
DB01599	Probucol	intestinal neoplasms	42	0.01
DB01599	Probucol	crohn disease	71	0.08
DB01599	Probucol	arthritis	76	0.11
DB01599	Probucol	joint diseases	79	0.11
DB01599	Probucol	colorectal neoplasms	42	0.15
DB01599	Probucol	inflammatory bowel diseases	119	0.36
DB01599	Probucol	gastroenteritis	122	0.38
DB01599	Probucol	kidney diseases	144	0.38
DB01599	Probucol	neoplasms	482	0.43
DB01599	Probucol	epilepsy	25	0.50
DB01599	Probucol	insulin resistance	26	0.57
DB01599	Probucol	hyperinsulinism	26	0.59
DB01599	Probucol	collagen diseases	25	0.62
DB01599	Probucol	leukemia	117	0.70
DB01599	Probucol	macular degeneration	44	0.76
DB01599	Probucol	kidney neoplasms	20	0.85
DB01599	Probucol	anemia hemolytic	29	0.87
DB01599	Probucol	hypopigmentation	22	0.89
DB01599	Probucol	thyroid diseases	30	0.90
DB01599	Probucol	liver cirrhosis	24	0.91
DB01599	Probucol	pancreatic diseases	24	0.93
DB01599	Probucol	liver cirrhosis biliary	23	0.95
DB01599	Probucol	alzheimer disease	29	1.03
DB01599	Probucol	cardiomyopathy dilated	29	1.06
DB01599	Probucol	lymphoma	24	1.10
DB01599	Probucol	lymphoma non hodgkin	22	1.16
DB01599	Probucol	blood coagulation disorders	40	1.21
DB01599	Probucol	adenocarcinoma	32	1.25
DB01599	Probucol	arthritis rheumatoid	42	1.29
DB01599	Probucol	head and neck neoplasms	35	1.33
DB01599	Probucol	anemia	58	1.62
DB01599	Probucol	leukemia lymphoid	66	1.67
DB01223	Aminophylline	bone diseases metabolic	27	-2.73
DB01223	Aminophylline	endocrine system diseases	291	-1.58
DB01223	Aminophylline	insulin resistance	26	-1.50
DB01223	Aminophylline	hyperinsulinism	26	-1.49
DB01223	Aminophylline	colorectal neoplasms	42	-1.44
DB01223	Aminophylline	intestinal neoplasms	42	-1.38
DB01223	Aminophylline	anemia hemolytic	29	-1.15
DB01223	Aminophylline	gastrointestinal neoplasms	72	-1.08
DB01223	Aminophylline	arteriosclerosis	38	-0.94
DB01223	Aminophylline	bone diseases	144	-0.90
DB01223	Aminophylline	heart diseases	167	-0.89
DB01223	Aminophylline	malabsorption syndromes	34	-0.81
DB01223	Aminophylline	arterial occlusive diseases	44	-0.78
DB01223	Aminophylline	liver cirrhosis	24	-0.76
DB01223	Aminophylline	pancreatic diseases	24	-0.74
DB01223	Aminophylline	liver cirrhosis biliary	23	-0.74
DB01223	Aminophylline	neoplasms	482	-0.71
DB01223	Aminophylline	eye diseases	231	-0.70
DB01223	Aminophylline	sarcoma	25	-0.69
DB01223	Aminophylline	colitis	55	-0.68
DB01223	Aminophylline	lymphoma non hodgkin	22	-0.56
DB01223	Aminophylline	lymphoma	24	-0.55
DB01223	Aminophylline	colitis ulcerative	55	-0.55
DB01223	Aminophylline	autoimmune diseases	243	-0.52
DB01223	Aminophylline	arrhythmias cardiac	30	-0.49
DB01223	Aminophylline	lupus erythematosus systemic	75	-0.21
DB01223	Aminophylline	diabetes mellitus type 1	82	-0.16
DB01223	Aminophylline	cardiovascular diseases	330	-0.09
DB01223	Aminophylline	coronary artery disease	31	-0.06
DB01223	Aminophylline	crohn disease	71	0.00
DB01223	Aminophylline	leukemia myeloid acute	43	0.00
DB01223	Aminophylline	multiple sclerosis	69	0.01
DB01223	Aminophylline	parkinson disease	30	0.03
DB01223	Aminophylline	spinal cord diseases	59	0.04
DB01223	Aminophylline	parkinsonian disorders	31	0.06
DB01223	Aminophylline	thyroid diseases	30	0.07
DB01223	Aminophylline	joint diseases	79	0.08
DB01223	Aminophylline	coronary disease	37	0.09
DB01223	Aminophylline	arthritis	76	0.12
DB01223	Aminophylline	mycobacterium infections	22	0.15
DB01223	Aminophylline	leukemia lymphoid	66	0.15
DB01223	Aminophylline	anemia	58	0.15
DB01223	Aminophylline	myocardial ischemia	43	0.16
DB01223	Aminophylline	lung diseases	71	0.24
DB01223	Aminophylline	kidney neoplasms	20	0.25
DB01223	Aminophylline	diabetes mellitus	162	0.30
DB01223	Aminophylline	inflammatory bowel diseases	119	0.31
DB01223	Aminophylline	gastroenteritis	122	0.31
DB01223	Aminophylline	bacterial infections	26	0.32
DB01223	Aminophylline	amyotrophic lateral sclerosis	21	0.35
DB01223	Aminophylline	kidney diseases	144	0.39
DB01223	Aminophylline	asthma	36	0.55
DB01223	Aminophylline	neuroendocrine tumors	24	0.57
DB01223	Aminophylline	metabolism inborn errors	289	0.65
DB01223	Aminophylline	varicose veins	20	0.68
DB01223	Aminophylline	hypersensitivity	45	0.70
DB01223	Aminophylline	vascular diseases	181	0.71
DB01223	Aminophylline	epilepsy	25	0.76
DB01223	Aminophylline	leukemia	117	0.78
DB01223	Aminophylline	diabetes mellitus type 2	72	0.80
DB01223	Aminophylline	motor neuron disease	31	0.81
DB01223	Aminophylline	collagen diseases	25	0.87
DB01223	Aminophylline	prostatic neoplasms	61	0.92
DB01223	Aminophylline	head and neck neoplasms	35	0.96
DB01223	Aminophylline	hematologic diseases	188	0.97
DB01223	Aminophylline	arthritis rheumatoid	42	1.00
DB01223	Aminophylline	adenocarcinoma	32	1.05
DB01223	Aminophylline	macular degeneration	44	1.06
DB01223	Aminophylline	psoriasis	54	1.07
DB01223	Aminophylline	skin diseases	278	1.12
DB01223	Aminophylline	breast neoplasms	40	1.19
DB01223	Aminophylline	keratosis	21	1.20
DB01223	Aminophylline	rheumatic diseases	59	1.36
DB01223	Aminophylline	hypopigmentation	22	1.44
DB01223	Aminophylline	cardiomyopathy dilated	29	1.58
DB01223	Aminophylline	alzheimer disease	29	1.62
DB01223	Aminophylline	blood coagulation disorders	40	1.66
DB01223	Aminophylline	dementia	42	2.26
DB00997	Doxorubicin	cardiomyopathy dilated	29	-1.72
DB00997	Doxorubicin	pancreatic diseases	24	-1.68
DB00997	Doxorubicin	kidney neoplasms	20	-1.60
DB00997	Doxorubicin	sarcoma	25	-1.50
DB00997	Doxorubicin	lymphoma	24	-1.28
DB00997	Doxorubicin	lymphoma non hodgkin	22	-1.28
DB00997	Doxorubicin	arthritis rheumatoid	42	-1.27
DB00997	Doxorubicin	head and neck neoplasms	35	-1.22
DB00997	Doxorubicin	adenocarcinoma	32	-1.19
DB00997	Doxorubicin	breast neoplasms	40	-1.12
DB00997	Doxorubicin	prostatic neoplasms	61	-1.11
DB00997	Doxorubicin	rheumatic diseases	59	-1.09
DB00997	Doxorubicin	leukemia myeloid acute	43	-1.00
DB00997	Doxorubicin	multiple sclerosis	69	-0.98
DB00997	Doxorubicin	spinal cord diseases	59	-0.98
DB00997	Doxorubicin	colorectal neoplasms	42	-0.96
DB00997	Doxorubicin	intestinal neoplasms	42	-0.91
DB00997	Doxorubicin	arthritis	76	-0.90
DB00997	Doxorubicin	joint diseases	79	-0.89
DB00997	Doxorubicin	lung diseases	71	-0.85
DB00997	Doxorubicin	leukemia lymphoid	66	-0.72
DB00997	Doxorubicin	kidney diseases	144	-0.69
DB00997	Doxorubicin	gastrointestinal neoplasms	72	-0.65
DB00997	Doxorubicin	heart diseases	167	-0.63
DB00997	Doxorubicin	metabolism inborn errors	289	-0.48
DB00997	Doxorubicin	eye diseases	231	-0.48
DB00997	Doxorubicin	leukemia	117	-0.36
DB00997	Doxorubicin	vascular diseases	181	-0.34
DB00997	Doxorubicin	hematologic diseases	188	-0.27
DB00997	Doxorubicin	autoimmune diseases	243	-0.25
DB00997	Doxorubicin	skin diseases	278	-0.24
DB00997	Doxorubicin	cardiovascular diseases	330	-0.10
DB00997	Doxorubicin	endocrine system diseases	291	-0.08
DB00997	Doxorubicin	neoplasms	482	0.21
DB00997	Doxorubicin	arrhythmias cardiac	30	0.25
DB00997	Doxorubicin	hyperinsulinism	26	0.26
DB00997	Doxorubicin	varicose veins	20	0.29
DB00997	Doxorubicin	insulin resistance	26	0.31
DB00997	Doxorubicin	macular degeneration	44	0.32
DB00997	Doxorubicin	collagen diseases	25	0.33
DB00997	Doxorubicin	epilepsy	25	0.33
DB00997	Doxorubicin	bone diseases metabolic	27	0.34
DB00997	Doxorubicin	coronary artery disease	31	0.39
DB00997	Doxorubicin	keratosis	21	0.40
DB00997	Doxorubicin	coronary disease	37	0.44
DB00997	Doxorubicin	myocardial ischemia	43	0.45
DB00997	Doxorubicin	parkinsonian disorders	31	0.46
DB00997	Doxorubicin	anemia hemolytic	29	0.46
DB00997	Doxorubicin	mycobacterium infections	22	0.47
DB00997	Doxorubicin	parkinson disease	30	0.48
DB00997	Doxorubicin	malabsorption syndromes	34	0.50
DB00997	Doxorubicin	arteriosclerosis	38	0.50
DB00997	Doxorubicin	thyroid diseases	30	0.51
DB00997	Doxorubicin	hypopigmentation	22	0.52
DB00997	Doxorubicin	bacterial infections	26	0.53
DB00997	Doxorubicin	blood coagulation disorders	40	0.54
DB00997	Doxorubicin	alzheimer disease	29	0.55
DB00997	Doxorubicin	arterial occlusive diseases	44	0.56
DB00997	Doxorubicin	amyotrophic lateral sclerosis	21	0.57
DB00997	Doxorubicin	liver cirrhosis biliary	23	0.58
DB00997	Doxorubicin	asthma	36	0.60
DB00997	Doxorubicin	liver cirrhosis	24	0.61
DB00997	Doxorubicin	neuroendocrine tumors	24	0.61
DB00997	Doxorubicin	hypersensitivity	45	0.63
DB00997	Doxorubicin	colitis ulcerative	55	0.70
DB00997	Doxorubicin	colitis	55	0.71
DB00997	Doxorubicin	diabetes mellitus type 2	72	0.75
DB00997	Doxorubicin	dementia	42	0.75
DB00997	Doxorubicin	motor neuron disease	31	0.76
DB00997	Doxorubicin	psoriasis	54	0.85
DB00997	Doxorubicin	diabetes mellitus type 1	82	0.87
DB00997	Doxorubicin	lupus erythematosus systemic	75	0.89
DB00997	Doxorubicin	crohn disease	71	0.99
DB00997	Doxorubicin	anemia	58	1.14
DB00997	Doxorubicin	inflammatory bowel diseases	119	1.27
DB00997	Doxorubicin	gastroenteritis	122	1.31
DB00997	Doxorubicin	diabetes mellitus	162	1.32
DB00997	Doxorubicin	bone diseases	144	1.66
DB00996	Gabapentin	intestinal neoplasms	42	-2.11
DB00996	Gabapentin	colorectal neoplasms	42	-2.03
DB00996	Gabapentin	bone diseases metabolic	27	-1.68
DB00996	Gabapentin	gastrointestinal neoplasms	72	-1.64
DB00996	Gabapentin	thyroid diseases	30	-1.51
DB00996	Gabapentin	amyotrophic lateral sclerosis	21	-1.40
DB00996	Gabapentin	motor neuron disease	31	-1.17
DB00996	Gabapentin	colitis ulcerative	55	-1.09
DB00996	Gabapentin	colitis	55	-1.08
DB00996	Gabapentin	neoplasms	482	-1.07
DB00996	Gabapentin	eye diseases	231	-1.06
DB00996	Gabapentin	metabolism inborn errors	289	-0.94
DB00996	Gabapentin	spinal cord diseases	59	-0.84
DB00996	Gabapentin	endocrine system diseases	291	-0.81
DB00996	Gabapentin	arthritis	76	-0.72
DB00996	Gabapentin	arrhythmias cardiac	30	-0.71
DB00996	Gabapentin	joint diseases	79	-0.64
DB00996	Gabapentin	keratosis	21	-0.62
DB00996	Gabapentin	inflammatory bowel diseases	119	-0.44
DB00996	Gabapentin	gastroenteritis	122	-0.41
DB00996	Gabapentin	kidney diseases	144	-0.40
DB00996	Gabapentin	malabsorption syndromes	34	-0.39
DB00996	Gabapentin	pancreatic diseases	24	-0.38
DB00996	Gabapentin	liver cirrhosis	24	-0.35
DB00996	Gabapentin	liver cirrhosis biliary	23	-0.34
DB00996	Gabapentin	alzheimer disease	29	-0.30
DB00996	Gabapentin	arteriosclerosis	38	-0.29
DB00996	Gabapentin	sarcoma	25	-0.27
DB00996	Gabapentin	bone diseases	144	-0.24
DB00996	Gabapentin	lymphoma non hodgkin	22	-0.18
DB00996	Gabapentin	arterial occlusive diseases	44	-0.18
DB00996	Gabapentin	lymphoma	24	-0.17
DB00996	Gabapentin	blood coagulation disorders	40	-0.13
DB00996	Gabapentin	vascular diseases	181	-0.03
DB00996	Gabapentin	adenocarcinoma	32	0.04
DB00996	Gabapentin	varicose veins	20	0.05
DB00996	Gabapentin	dementia	42	0.06
DB00996	Gabapentin	psoriasis	54	0.13
DB00996	Gabapentin	hematologic diseases	188	0.13
DB00996	Gabapentin	epilepsy	25	0.15
DB00996	Gabapentin	prostatic neoplasms	61	0.16
DB00996	Gabapentin	diabetes mellitus type 2	72	0.22
DB00996	Gabapentin	rheumatic diseases	59	0.24
DB00996	Gabapentin	hyperinsulinism	26	0.25
DB00996	Gabapentin	insulin resistance	26	0.26
DB00996	Gabapentin	lupus erythematosus systemic	75	0.29
DB00996	Gabapentin	leukemia myeloid acute	43	0.30
DB00996	Gabapentin	collagen diseases	25	0.31
DB00996	Gabapentin	skin diseases	278	0.32
DB00996	Gabapentin	diabetes mellitus type 1	82	0.34
DB00996	Gabapentin	crohn disease	71	0.35
DB00996	Gabapentin	multiple sclerosis	69	0.35
DB00996	Gabapentin	cardiovascular diseases	330	0.40
DB00996	Gabapentin	lung diseases	71	0.45
DB00996	Gabapentin	leukemia lymphoid	66	0.51
DB00996	Gabapentin	anemia hemolytic	29	0.58
DB00996	Gabapentin	bacterial infections	26	0.64
DB00996	Gabapentin	kidney neoplasms	20	0.65
DB00996	Gabapentin	parkinsonian disorders	31	0.68
DB00996	Gabapentin	hypopigmentation	22	0.68
DB00996	Gabapentin	parkinson disease	30	0.69
DB00996	Gabapentin	diabetes mellitus	162	0.80
DB00996	Gabapentin	cardiomyopathy dilated	29	0.83
DB00996	Gabapentin	heart diseases	167	0.84
DB00996	Gabapentin	leukemia	117	0.93
DB00996	Gabapentin	arthritis rheumatoid	42	1.14
DB00996	Gabapentin	autoimmune diseases	243	1.17
DB00996	Gabapentin	breast neoplasms	40	1.28
DB00996	Gabapentin	coronary artery disease	31	1.51
DB00996	Gabapentin	mycobacterium infections	22	1.53
DB00996	Gabapentin	macular degeneration	44	1.55
DB00996	Gabapentin	anemia	58	1.58
DB00996	Gabapentin	coronary disease	37	1.74
DB00996	Gabapentin	myocardial ischemia	43	1.81
DB00996	Gabapentin	neuroendocrine tumors	24	1.86
DB00996	Gabapentin	asthma	36	1.87
DB00996	Gabapentin	hypersensitivity	45	2.15
DB00996	Gabapentin	head and neck neoplasms	35	2.28
DB00995	Auranofin	inflammatory bowel diseases	119	-3.60
DB00995	Auranofin	gastroenteritis	122	-3.52
DB00995	Auranofin	arterial occlusive diseases	44	-2.72
DB00995	Auranofin	varicose veins	20	-2.33
DB00995	Auranofin	crohn disease	71	-2.21
DB00995	Auranofin	breast neoplasms	40	-2.19
DB00995	Auranofin	vascular diseases	181	-2.15
DB00995	Auranofin	skin diseases	278	-1.69
DB00995	Auranofin	mycobacterium infections	22	-1.57
DB00995	Auranofin	cardiovascular diseases	330	-1.57
DB00995	Auranofin	arteriosclerosis	38	-1.54
DB00995	Auranofin	neuroendocrine tumors	24	-1.51
DB00995	Auranofin	bacterial infections	26	-1.46
DB00995	Auranofin	neoplasms	482	-1.35
DB00995	Auranofin	colitis	55	-1.34
DB00995	Auranofin	colitis ulcerative	55	-1.30
DB00995	Auranofin	liver cirrhosis	24	-1.24
DB00995	Auranofin	diabetes mellitus type 2	72	-1.22
DB00995	Auranofin	liver cirrhosis biliary	23	-1.21
DB00995	Auranofin	lymphoma non hodgkin	22	-1.13
DB00995	Auranofin	lymphoma	24	-1.12
DB00995	Auranofin	adenocarcinoma	32	-1.03
DB00995	Auranofin	psoriasis	54	-1.01
DB00995	Auranofin	arthritis rheumatoid	42	-0.99
DB00995	Auranofin	lupus erythematosus systemic	75	-0.88
DB00995	Auranofin	epilepsy	25	-0.81
DB00995	Auranofin	leukemia myeloid acute	43	-0.79
DB00995	Auranofin	diabetes mellitus type 1	82	-0.77
DB00995	Auranofin	rheumatic diseases	59	-0.72
DB00995	Auranofin	collagen diseases	25	-0.71
DB00995	Auranofin	leukemia lymphoid	66	-0.67
DB00995	Auranofin	insulin resistance	26	-0.53
DB00995	Auranofin	hyperinsulinism	26	-0.52
DB00995	Auranofin	lung diseases	71	-0.50
DB00995	Auranofin	diabetes mellitus	162	-0.45
DB00995	Auranofin	anemia	58	-0.44
DB00995	Auranofin	arthritis	76	-0.44
DB00995	Auranofin	joint diseases	79	-0.44
DB00995	Auranofin	parkinsonian disorders	31	-0.42
DB00995	Auranofin	coronary artery disease	31	-0.41
DB00995	Auranofin	parkinson disease	30	-0.40
DB00995	Auranofin	keratosis	21	-0.40
DB00995	Auranofin	gastrointestinal neoplasms	72	-0.37
DB00995	Auranofin	heart diseases	167	-0.29
DB00995	Auranofin	anemia hemolytic	29	-0.28
DB00995	Auranofin	cardiomyopathy dilated	29	-0.26
DB00995	Auranofin	kidney neoplasms	20	-0.24
DB00995	Auranofin	coronary disease	37	-0.24
DB00995	Auranofin	thyroid diseases	30	-0.23
DB00995	Auranofin	myocardial ischemia	43	-0.21
DB00995	Auranofin	amyotrophic lateral sclerosis	21	-0.21
DB00995	Auranofin	bone diseases	144	-0.19
DB00995	Auranofin	metabolism inborn errors	289	-0.13
DB00995	Auranofin	malabsorption syndromes	34	-0.11
DB00995	Auranofin	leukemia	117	-0.10
DB00995	Auranofin	eye diseases	231	-0.03
DB00995	Auranofin	hematologic diseases	188	0.11
DB00995	Auranofin	autoimmune diseases	243	0.16
DB00995	Auranofin	pancreatic diseases	24	0.17
DB00995	Auranofin	endocrine system diseases	291	0.17
DB00995	Auranofin	head and neck neoplasms	35	0.29
DB00995	Auranofin	prostatic neoplasms	61	0.30
DB00995	Auranofin	motor neuron disease	31	0.36
DB00995	Auranofin	arrhythmias cardiac	30	0.73
DB00995	Auranofin	bone diseases metabolic	27	0.79
DB00995	Auranofin	colorectal neoplasms	42	0.85
DB00995	Auranofin	intestinal neoplasms	42	0.88
DB00995	Auranofin	multiple sclerosis	69	0.89
DB00995	Auranofin	kidney diseases	144	0.92
DB00995	Auranofin	macular degeneration	44	0.94
DB00995	Auranofin	spinal cord diseases	59	0.99
DB00995	Auranofin	hypopigmentation	22	1.10
DB00995	Auranofin	blood coagulation disorders	40	1.22
DB00995	Auranofin	alzheimer disease	29	1.31
DB00995	Auranofin	asthma	36	1.33
DB00995	Auranofin	sarcoma	25	1.43
DB00995	Auranofin	hypersensitivity	45	1.44
DB00995	Auranofin	dementia	42	1.59
DB01193	Acebutolol	diabetes mellitus type 2	72	-3.20
DB01193	Acebutolol	diabetes mellitus	162	-2.12
DB01193	Acebutolol	arrhythmias cardiac	30	-1.92
DB01193	Acebutolol	pancreatic diseases	24	-1.61
DB01193	Acebutolol	breast neoplasms	40	-1.25
DB01193	Acebutolol	intestinal neoplasms	42	-1.11
DB01193	Acebutolol	endocrine system diseases	291	-1.07
DB01193	Acebutolol	colorectal neoplasms	42	-1.02
DB01193	Acebutolol	lung diseases	71	-0.81
DB01193	Acebutolol	gastrointestinal neoplasms	72	-0.67
DB01193	Acebutolol	varicose veins	20	-0.47
DB01193	Acebutolol	neoplasms	482	-0.46
DB01193	Acebutolol	epilepsy	25	-0.39
DB01193	Acebutolol	heart diseases	167	-0.39
DB01193	Acebutolol	hyperinsulinism	26	-0.38
DB01193	Acebutolol	bone diseases	144	-0.38
DB01193	Acebutolol	collagen diseases	25	-0.33
DB01193	Acebutolol	insulin resistance	26	-0.27
DB01193	Acebutolol	bone diseases metabolic	27	-0.22
DB01193	Acebutolol	macular degeneration	44	-0.22
DB01193	Acebutolol	coronary artery disease	31	-0.17
DB01193	Acebutolol	mycobacterium infections	22	-0.16
DB01193	Acebutolol	keratosis	21	-0.05
DB01193	Acebutolol	anemia hemolytic	29	-0.05
DB01193	Acebutolol	bacterial infections	26	-0.03
DB01193	Acebutolol	hypopigmentation	22	-0.01
DB01193	Acebutolol	coronary disease	37	0.02
DB01193	Acebutolol	myocardial ischemia	43	0.04
DB01193	Acebutolol	thyroid diseases	30	0.05
DB01193	Acebutolol	kidney neoplasms	20	0.06
DB01193	Acebutolol	liver cirrhosis biliary	23	0.06
DB01193	Acebutolol	malabsorption syndromes	34	0.07
DB01193	Acebutolol	parkinson disease	30	0.08
DB01193	Acebutolol	liver cirrhosis	24	0.08
DB01193	Acebutolol	amyotrophic lateral sclerosis	21	0.08
DB01193	Acebutolol	cardiomyopathy dilated	29	0.11
DB01193	Acebutolol	parkinsonian disorders	31	0.11
DB01193	Acebutolol	neuroendocrine tumors	24	0.11
DB01193	Acebutolol	alzheimer disease	29	0.13
DB01193	Acebutolol	arteriosclerosis	38	0.13
DB01193	Acebutolol	asthma	36	0.14
DB01193	Acebutolol	sarcoma	25	0.20
DB01193	Acebutolol	arterial occlusive diseases	44	0.22
DB01193	Acebutolol	lymphoma non hodgkin	22	0.23
DB01193	Acebutolol	blood coagulation disorders	40	0.26
DB01193	Acebutolol	lymphoma	24	0.26
DB01193	Acebutolol	hypersensitivity	45	0.28
DB01193	Acebutolol	skin diseases	278	0.28
DB01193	Acebutolol	cardiovascular diseases	330	0.31
DB01193	Acebutolol	motor neuron disease	31	0.33
DB01193	Acebutolol	adenocarcinoma	32	0.37
DB01193	Acebutolol	arthritis rheumatoid	42	0.38
DB01193	Acebutolol	colitis	55	0.39
DB01193	Acebutolol	colitis ulcerative	55	0.40
DB01193	Acebutolol	prostatic neoplasms	61	0.41
DB01193	Acebutolol	dementia	42	0.43
DB01193	Acebutolol	psoriasis	54	0.47
DB01193	Acebutolol	rheumatic diseases	59	0.49
DB01193	Acebutolol	head and neck neoplasms	35	0.50
DB01193	Acebutolol	multiple sclerosis	69	0.57
DB01193	Acebutolol	lupus erythematosus systemic	75	0.57
DB01193	Acebutolol	diabetes mellitus type 1	82	0.58
DB01193	Acebutolol	spinal cord diseases	59	0.60
DB01193	Acebutolol	leukemia myeloid acute	43	0.61
DB01193	Acebutolol	crohn disease	71	0.63
DB01193	Acebutolol	arthritis	76	0.66
DB01193	Acebutolol	anemia	58	0.72
DB01193	Acebutolol	joint diseases	79	0.73
DB01193	Acebutolol	leukemia lymphoid	66	0.75
DB01193	Acebutolol	kidney diseases	144	0.89
DB01193	Acebutolol	inflammatory bowel diseases	119	0.89
DB01193	Acebutolol	gastroenteritis	122	0.93
DB01193	Acebutolol	eye diseases	231	1.23
DB01193	Acebutolol	vascular diseases	181	1.24
DB01193	Acebutolol	leukemia	117	1.26
DB01193	Acebutolol	metabolism inborn errors	289	1.30
DB01193	Acebutolol	hematologic diseases	188	1.44
DB01193	Acebutolol	autoimmune diseases	243	1.47
DB00993	Azathioprine	metabolism inborn errors	289	-2.86
DB00993	Azathioprine	neuroendocrine tumors	24	-2.62
DB00993	Azathioprine	kidney neoplasms	20	-2.58
DB00993	Azathioprine	anemia hemolytic	29	-2.46
DB00993	Azathioprine	adenocarcinoma	32	-2.42
DB00993	Azathioprine	lupus erythematosus systemic	75	-2.35
DB00993	Azathioprine	hypopigmentation	22	-2.34
DB00993	Azathioprine	colitis	55	-2.17
DB00993	Azathioprine	head and neck neoplasms	35	-2.10
DB00993	Azathioprine	colitis ulcerative	55	-2.01
DB00993	Azathioprine	psoriasis	54	-1.95
DB00993	Azathioprine	multiple sclerosis	69	-1.88
DB00993	Azathioprine	anemia	58	-1.76
DB00993	Azathioprine	kidney diseases	144	-1.67
DB00993	Azathioprine	gastroenteritis	122	-1.59
DB00993	Azathioprine	inflammatory bowel diseases	119	-1.50
DB00993	Azathioprine	vascular diseases	181	-1.21
DB00993	Azathioprine	eye diseases	231	-1.15
DB00993	Azathioprine	autoimmune diseases	243	-0.91
DB00993	Azathioprine	hematologic diseases	188	-0.88
DB00993	Azathioprine	skin diseases	278	-0.85
DB00993	Azathioprine	cardiovascular diseases	330	-0.81
DB00993	Azathioprine	varicose veins	20	-0.45
DB00993	Azathioprine	epilepsy	25	-0.39
DB00993	Azathioprine	neoplasms	482	-0.32
DB00993	Azathioprine	arrhythmias cardiac	30	-0.29
DB00993	Azathioprine	collagen diseases	25	-0.27
DB00993	Azathioprine	bone diseases metabolic	27	-0.24
DB00993	Azathioprine	mycobacterium infections	22	-0.16
DB00993	Azathioprine	hyperinsulinism	26	-0.16
DB00993	Azathioprine	macular degeneration	44	-0.16
DB00993	Azathioprine	coronary artery disease	31	-0.15
DB00993	Azathioprine	insulin resistance	26	-0.14
DB00993	Azathioprine	keratosis	21	-0.13
DB00993	Azathioprine	thyroid diseases	30	-0.13
DB00993	Azathioprine	bacterial infections	26	-0.07
DB00993	Azathioprine	pancreatic diseases	24	-0.05
DB00993	Azathioprine	liver cirrhosis	24	-0.04
DB00993	Azathioprine	parkinson disease	30	-0.04
DB00993	Azathioprine	parkinsonian disorders	31	-0.01
DB00993	Azathioprine	liver cirrhosis biliary	23	0.01
DB00993	Azathioprine	asthma	36	0.02
DB00993	Azathioprine	amyotrophic lateral sclerosis	21	0.02
DB00993	Azathioprine	coronary disease	37	0.02
DB00993	Azathioprine	malabsorption syndromes	34	0.02
DB00993	Azathioprine	alzheimer disease	29	0.04
DB00993	Azathioprine	lymphoma non hodgkin	22	0.04
DB00993	Azathioprine	blood coagulation disorders	40	0.04
DB00993	Azathioprine	cardiomyopathy dilated	29	0.05
DB00993	Azathioprine	myocardial ischemia	43	0.05
DB00993	Azathioprine	sarcoma	25	0.06
DB00993	Azathioprine	arteriosclerosis	38	0.07
DB00993	Azathioprine	motor neuron disease	31	0.07
DB00993	Azathioprine	arterial occlusive diseases	44	0.11
DB00993	Azathioprine	hypersensitivity	45	0.12
DB00993	Azathioprine	lymphoma	24	0.13
DB00993	Azathioprine	breast neoplasms	40	0.20
DB00993	Azathioprine	dementia	42	0.21
DB00993	Azathioprine	diabetes mellitus type 2	72	0.24
DB00993	Azathioprine	arthritis rheumatoid	42	0.24
DB00993	Azathioprine	prostatic neoplasms	61	0.28
DB00993	Azathioprine	crohn disease	71	0.30
DB00993	Azathioprine	rheumatic diseases	59	0.31
DB00993	Azathioprine	colorectal neoplasms	42	0.33
DB00993	Azathioprine	diabetes mellitus type 1	82	0.35
DB00993	Azathioprine	intestinal neoplasms	42	0.35
DB00993	Azathioprine	spinal cord diseases	59	0.35
DB00993	Azathioprine	arthritis	76	0.37
DB00993	Azathioprine	joint diseases	79	0.40
DB00993	Azathioprine	lung diseases	71	0.40
DB00993	Azathioprine	leukemia myeloid acute	43	0.41
DB00993	Azathioprine	leukemia lymphoid	66	0.50
DB00993	Azathioprine	gastrointestinal neoplasms	72	0.55
DB00993	Azathioprine	diabetes mellitus	162	0.56
DB00993	Azathioprine	bone diseases	144	0.64
DB00993	Azathioprine	heart diseases	167	0.65
DB00993	Azathioprine	leukemia	117	0.71
DB00993	Azathioprine	endocrine system diseases	291	0.93
DB01195	Flecainide	arrhythmias cardiac	30	-4.76
DB01195	Flecainide	heart diseases	167	-4.09
DB01195	Flecainide	cardiomyopathy dilated	29	-3.56
DB01195	Flecainide	cardiovascular diseases	330	-3.12
DB01195	Flecainide	metabolism inborn errors	289	-2.19
DB01195	Flecainide	thyroid diseases	30	-2.17
DB01195	Flecainide	varicose veins	20	-1.22
DB01195	Flecainide	leukemia	117	-1.02
DB01195	Flecainide	epilepsy	25	-0.94
DB01195	Flecainide	macular degeneration	44	-0.78
DB01195	Flecainide	keratosis	21	-0.78
DB01195	Flecainide	hematologic diseases	188	-0.68
DB01195	Flecainide	parkinson disease	30	-0.67
DB01195	Flecainide	parkinsonian disorders	31	-0.65
DB01195	Flecainide	anemia hemolytic	29	-0.58
DB01195	Flecainide	endocrine system diseases	291	-0.58
DB01195	Flecainide	asthma	36	-0.56
DB01195	Flecainide	pancreatic diseases	24	-0.55
DB01195	Flecainide	neuroendocrine tumors	24	-0.53
DB01195	Flecainide	alzheimer disease	29	-0.48
DB01195	Flecainide	arterial occlusive diseases	44	-0.45
DB01195	Flecainide	blood coagulation disorders	40	-0.41
DB01195	Flecainide	hypersensitivity	45	-0.41
DB01195	Flecainide	arthritis rheumatoid	42	-0.36
DB01195	Flecainide	colitis ulcerative	55	-0.31
DB01195	Flecainide	adenocarcinoma	32	-0.29
DB01195	Flecainide	psoriasis	54	-0.27
DB01195	Flecainide	colitis	55	-0.26
DB01195	Flecainide	dementia	42	-0.21
DB01195	Flecainide	prostatic neoplasms	61	-0.19
DB01195	Flecainide	breast neoplasms	40	-0.19
DB01195	Flecainide	rheumatic diseases	59	-0.12
DB01195	Flecainide	leukemia myeloid acute	43	-0.08
DB01195	Flecainide	intestinal neoplasms	42	-0.06
DB01195	Flecainide	colorectal neoplasms	42	-0.06
DB01195	Flecainide	crohn disease	71	-0.04
DB01195	Flecainide	multiple sclerosis	69	-0.04
DB01195	Flecainide	joint diseases	79	0.01
DB01195	Flecainide	spinal cord diseases	59	0.03
DB01195	Flecainide	arthritis	76	0.03
DB01195	Flecainide	lung diseases	71	0.05
DB01195	Flecainide	anemia	58	0.09
DB01195	Flecainide	neoplasms	482	0.13
DB01195	Flecainide	leukemia lymphoid	66	0.16
DB01195	Flecainide	gastrointestinal neoplasms	72	0.22
DB01195	Flecainide	inflammatory bowel diseases	119	0.26
DB01195	Flecainide	gastroenteritis	122	0.28
DB01195	Flecainide	diabetes mellitus	162	0.33
DB01195	Flecainide	kidney diseases	144	0.37
DB01195	Flecainide	bone diseases	144	0.38
DB01195	Flecainide	insulin resistance	26	0.38
DB01195	Flecainide	hyperinsulinism	26	0.45
DB01195	Flecainide	bone diseases metabolic	27	0.45
DB01195	Flecainide	eye diseases	231	0.49
DB01195	Flecainide	vascular diseases	181	0.51
DB01195	Flecainide	mycobacterium infections	22	0.61
DB01195	Flecainide	autoimmune diseases	243	0.67
DB01195	Flecainide	bacterial infections	26	0.73
DB01195	Flecainide	kidney neoplasms	20	0.76
DB01195	Flecainide	coronary disease	37	0.79
DB01195	Flecainide	liver cirrhosis biliary	23	0.79
DB01195	Flecainide	amyotrophic lateral sclerosis	21	0.81
DB01195	Flecainide	skin diseases	278	0.82
DB01195	Flecainide	hypopigmentation	22	0.87
DB01195	Flecainide	malabsorption syndromes	34	0.89
DB01195	Flecainide	liver cirrhosis	24	0.90
DB01195	Flecainide	myocardial ischemia	43	0.93
DB01195	Flecainide	arteriosclerosis	38	0.95
DB01195	Flecainide	sarcoma	25	1.04
DB01195	Flecainide	lymphoma non hodgkin	22	1.13
DB01195	Flecainide	lymphoma	24	1.16
DB01195	Flecainide	motor neuron disease	31	1.26
DB01195	Flecainide	head and neck neoplasms	35	1.40
DB01195	Flecainide	diabetes mellitus type 2	72	1.53
DB01195	Flecainide	lupus erythematosus systemic	75	1.55
DB01195	Flecainide	diabetes mellitus type 1	82	1.60
DB01195	Flecainide	collagen diseases	25	1.89
DB01195	Flecainide	coronary artery disease	31	2.05
DB01196	Estramustine	cardiovascular diseases	330	-2.22
DB01196	Estramustine	heart diseases	167	-1.91
DB01196	Estramustine	arteriosclerosis	38	-1.79
DB01196	Estramustine	cardiomyopathy dilated	29	-1.71
DB01196	Estramustine	breast neoplasms	40	-1.70
DB01196	Estramustine	alzheimer disease	29	-1.65
DB01196	Estramustine	asthma	36	-1.52
DB01196	Estramustine	arterial occlusive diseases	44	-1.51
DB01196	Estramustine	arrhythmias cardiac	30	-1.48
DB01196	Estramustine	pancreatic diseases	24	-1.44
DB01196	Estramustine	epilepsy	25	-1.44
DB01196	Estramustine	hypersensitivity	45	-1.38
DB01196	Estramustine	sarcoma	25	-1.29
DB01196	Estramustine	skin diseases	278	-1.15
DB01196	Estramustine	dementia	42	-1.11
DB01196	Estramustine	coronary artery disease	31	-1.08
DB01196	Estramustine	prostatic neoplasms	61	-1.02
DB01196	Estramustine	colitis ulcerative	55	-0.98
DB01196	Estramustine	colitis	55	-0.92
DB01196	Estramustine	myocardial ischemia	43	-0.90
DB01196	Estramustine	coronary disease	37	-0.87
DB01196	Estramustine	vascular diseases	181	-0.81
DB01196	Estramustine	diabetes mellitus type 2	72	-0.79
DB01196	Estramustine	diabetes mellitus type 1	82	-0.73
DB01196	Estramustine	intestinal neoplasms	42	-0.68
DB01196	Estramustine	colorectal neoplasms	42	-0.64
DB01196	Estramustine	leukemia	117	-0.62
DB01196	Estramustine	kidney neoplasms	20	-0.57
DB01196	Estramustine	crohn disease	71	-0.55
DB01196	Estramustine	spinal cord diseases	59	-0.55
DB01196	Estramustine	multiple sclerosis	69	-0.54
DB01196	Estramustine	metabolism inborn errors	289	-0.53
DB01196	Estramustine	varicose veins	20	-0.47
DB01196	Estramustine	leukemia myeloid acute	43	-0.47
DB01196	Estramustine	neuroendocrine tumors	24	-0.36
DB01196	Estramustine	thyroid diseases	30	-0.36
DB01196	Estramustine	lung diseases	71	-0.36
DB01196	Estramustine	autoimmune diseases	243	-0.35
DB01196	Estramustine	collagen diseases	25	-0.33
DB01196	Estramustine	liver cirrhosis biliary	23	-0.28
DB01196	Estramustine	neoplasms	482	-0.27
DB01196	Estramustine	liver cirrhosis	24	-0.27
DB01196	Estramustine	macular degeneration	44	-0.25
DB01196	Estramustine	bone diseases metabolic	27	-0.22
DB01196	Estramustine	kidney diseases	144	-0.21
DB01196	Estramustine	hyperinsulinism	26	-0.20
DB01196	Estramustine	insulin resistance	26	-0.20
DB01196	Estramustine	lymphoma non hodgkin	22	-0.09
DB01196	Estramustine	gastrointestinal neoplasms	72	-0.08
DB01196	Estramustine	lymphoma	24	-0.04
DB01196	Estramustine	inflammatory bowel diseases	119	0.03
DB01196	Estramustine	gastroenteritis	122	0.06
DB01196	Estramustine	keratosis	21	0.09
DB01196	Estramustine	motor neuron disease	31	0.10
DB01196	Estramustine	anemia hemolytic	29	0.10
DB01196	Estramustine	diabetes mellitus	162	0.13
DB01196	Estramustine	parkinsonian disorders	31	0.15
DB01196	Estramustine	adenocarcinoma	32	0.16
DB01196	Estramustine	parkinson disease	30	0.19
DB01196	Estramustine	eye diseases	231	0.25
DB01196	Estramustine	mycobacterium infections	22	0.29
DB01196	Estramustine	bone diseases	144	0.33
DB01196	Estramustine	lupus erythematosus systemic	75	0.35
DB01196	Estramustine	head and neck neoplasms	35	0.36
DB01196	Estramustine	hypopigmentation	22	0.41
DB01196	Estramustine	malabsorption syndromes	34	0.46
DB01196	Estramustine	bacterial infections	26	0.56
DB01196	Estramustine	blood coagulation disorders	40	0.60
DB01196	Estramustine	amyotrophic lateral sclerosis	21	0.66
DB01196	Estramustine	leukemia lymphoid	66	0.82
DB01196	Estramustine	hematologic diseases	188	0.92
DB01196	Estramustine	anemia	58	1.00
DB01196	Estramustine	arthritis rheumatoid	42	1.20
DB01196	Estramustine	endocrine system diseases	291	1.21
DB01196	Estramustine	psoriasis	54	1.37
DB01196	Estramustine	rheumatic diseases	59	1.70
DB01196	Estramustine	arthritis	76	1.85
DB01196	Estramustine	joint diseases	79	1.90
DB01219	Dantrolene	heart diseases	167	-3.08
DB01219	Dantrolene	hyperinsulinism	26	-2.87
DB01219	Dantrolene	insulin resistance	26	-2.66
DB01219	Dantrolene	eye diseases	231	-2.52
DB01219	Dantrolene	cardiovascular diseases	330	-2.42
DB01219	Dantrolene	kidney diseases	144	-1.21
DB01219	Dantrolene	metabolism inborn errors	289	-0.83
DB01219	Dantrolene	varicose veins	20	-0.27
DB01219	Dantrolene	epilepsy	25	-0.25
DB01219	Dantrolene	collagen diseases	25	-0.13
DB01219	Dantrolene	arrhythmias cardiac	30	-0.13
DB01219	Dantrolene	bone diseases metabolic	27	-0.10
DB01219	Dantrolene	keratosis	21	0.00
DB01219	Dantrolene	mycobacterium infections	22	0.02
DB01219	Dantrolene	coronary artery disease	31	0.04
DB01219	Dantrolene	thyroid diseases	30	0.06
DB01219	Dantrolene	macular degeneration	44	0.08
DB01219	Dantrolene	kidney neoplasms	20	0.09
DB01219	Dantrolene	malabsorption syndromes	34	0.11
DB01219	Dantrolene	bacterial infections	26	0.11
DB01219	Dantrolene	parkinsonian disorders	31	0.12
DB01219	Dantrolene	liver cirrhosis biliary	23	0.14
DB01219	Dantrolene	amyotrophic lateral sclerosis	21	0.14
DB01219	Dantrolene	pancreatic diseases	24	0.14
DB01219	Dantrolene	hypopigmentation	22	0.16
DB01219	Dantrolene	anemia hemolytic	29	0.16
DB01219	Dantrolene	asthma	36	0.17
DB01219	Dantrolene	coronary disease	37	0.18
DB01219	Dantrolene	alzheimer disease	29	0.18
DB01219	Dantrolene	liver cirrhosis	24	0.18
DB01219	Dantrolene	neuroendocrine tumors	24	0.19
DB01219	Dantrolene	sarcoma	25	0.20
DB01219	Dantrolene	arteriosclerosis	38	0.21
DB01219	Dantrolene	myocardial ischemia	43	0.21
DB01219	Dantrolene	cardiomyopathy dilated	29	0.22
DB01219	Dantrolene	parkinson disease	30	0.23
DB01219	Dantrolene	arterial occlusive diseases	44	0.24
DB01219	Dantrolene	hypersensitivity	45	0.27
DB01219	Dantrolene	motor neuron disease	31	0.28
DB01219	Dantrolene	lymphoma	24	0.29
DB01219	Dantrolene	colitis ulcerative	55	0.32
DB01219	Dantrolene	arthritis rheumatoid	42	0.34
DB01219	Dantrolene	blood coagulation disorders	40	0.34
DB01219	Dantrolene	lymphoma non hodgkin	22	0.34
DB01219	Dantrolene	head and neck neoplasms	35	0.36
DB01219	Dantrolene	prostatic neoplasms	61	0.36
DB01219	Dantrolene	adenocarcinoma	32	0.36
DB01219	Dantrolene	rheumatic diseases	59	0.37
DB01219	Dantrolene	colitis	55	0.38
DB01219	Dantrolene	dementia	42	0.38
DB01219	Dantrolene	psoriasis	54	0.39
DB01219	Dantrolene	diabetes mellitus type 2	72	0.40
DB01219	Dantrolene	breast neoplasms	40	0.42
DB01219	Dantrolene	lupus erythematosus systemic	75	0.45
DB01219	Dantrolene	crohn disease	71	0.46
DB01219	Dantrolene	multiple sclerosis	69	0.47
DB01219	Dantrolene	colorectal neoplasms	42	0.48
DB01219	Dantrolene	intestinal neoplasms	42	0.50
DB01219	Dantrolene	spinal cord diseases	59	0.50
DB01219	Dantrolene	leukemia myeloid acute	43	0.51
DB01219	Dantrolene	joint diseases	79	0.52
DB01219	Dantrolene	diabetes mellitus type 1	82	0.52
DB01219	Dantrolene	lung diseases	71	0.53
DB01219	Dantrolene	anemia	58	0.54
DB01219	Dantrolene	arthritis	76	0.55
DB01219	Dantrolene	leukemia lymphoid	66	0.57
DB01219	Dantrolene	gastroenteritis	122	0.63
DB01219	Dantrolene	inflammatory bowel diseases	119	0.64
DB01219	Dantrolene	gastrointestinal neoplasms	72	0.68
DB01219	Dantrolene	diabetes mellitus	162	0.71
DB01219	Dantrolene	bone diseases	144	0.76
DB01219	Dantrolene	leukemia	117	0.87
DB01219	Dantrolene	vascular diseases	181	0.87
DB01219	Dantrolene	autoimmune diseases	243	1.02
DB01219	Dantrolene	hematologic diseases	188	1.07
DB01219	Dantrolene	endocrine system diseases	291	1.19
DB01219	Dantrolene	skin diseases	278	1.25
DB01219	Dantrolene	neoplasms	482	2.31
DB00852	Pseudoephedrine	arrhythmias cardiac	30	-2.35
DB00852	Pseudoephedrine	diabetes mellitus type 2	72	-2.04
DB00852	Pseudoephedrine	parkinsonian disorders	31	-1.95
DB00852	Pseudoephedrine	parkinson disease	30	-1.91
DB00852	Pseudoephedrine	dementia	42	-1.15
DB00852	Pseudoephedrine	amyotrophic lateral sclerosis	21	-1.11
DB00852	Pseudoephedrine	neuroendocrine tumors	24	-1.01
DB00852	Pseudoephedrine	pancreatic diseases	24	-1.00
DB00852	Pseudoephedrine	cardiomyopathy dilated	29	-1.00
DB00852	Pseudoephedrine	diabetes mellitus	162	-0.98
DB00852	Pseudoephedrine	intestinal neoplasms	42	-0.87
DB00852	Pseudoephedrine	colorectal neoplasms	42	-0.85
DB00852	Pseudoephedrine	sarcoma	25	-0.84
DB00852	Pseudoephedrine	multiple sclerosis	69	-0.81
DB00852	Pseudoephedrine	crohn disease	71	-0.80
DB00852	Pseudoephedrine	spinal cord diseases	59	-0.79
DB00852	Pseudoephedrine	arthritis	76	-0.74
DB00852	Pseudoephedrine	bone diseases	144	-0.70
DB00852	Pseudoephedrine	joint diseases	79	-0.70
DB00852	Pseudoephedrine	mycobacterium infections	22	-0.68
DB00852	Pseudoephedrine	lung diseases	71	-0.66
DB00852	Pseudoephedrine	motor neuron disease	31	-0.58
DB00852	Pseudoephedrine	epilepsy	25	-0.46
DB00852	Pseudoephedrine	adenocarcinoma	32	-0.46
DB00852	Pseudoephedrine	bacterial infections	26	-0.41
DB00852	Pseudoephedrine	head and neck neoplasms	35	-0.40
DB00852	Pseudoephedrine	psoriasis	54	-0.35
DB00852	Pseudoephedrine	inflammatory bowel diseases	119	-0.29
DB00852	Pseudoephedrine	breast neoplasms	40	-0.28
DB00852	Pseudoephedrine	gastroenteritis	122	-0.27
DB00852	Pseudoephedrine	collagen diseases	25	-0.27
DB00852	Pseudoephedrine	gastrointestinal neoplasms	72	-0.25
DB00852	Pseudoephedrine	alzheimer disease	29	-0.20
DB00852	Pseudoephedrine	asthma	36	-0.19
DB00852	Pseudoephedrine	lymphoma	24	0.02
DB00852	Pseudoephedrine	arterial occlusive diseases	44	0.03
DB00852	Pseudoephedrine	lymphoma non hodgkin	22	0.05
DB00852	Pseudoephedrine	keratosis	21	0.07
DB00852	Pseudoephedrine	varicose veins	20	0.09
DB00852	Pseudoephedrine	hypersensitivity	45	0.09
DB00852	Pseudoephedrine	endocrine system diseases	291	0.13
DB00852	Pseudoephedrine	heart diseases	167	0.13
DB00852	Pseudoephedrine	thyroid diseases	30	0.22
DB00852	Pseudoephedrine	skin diseases	278	0.23
DB00852	Pseudoephedrine	kidney neoplasms	20	0.27
DB00852	Pseudoephedrine	anemia hemolytic	29	0.31
DB00852	Pseudoephedrine	hypopigmentation	22	0.32
DB00852	Pseudoephedrine	colitis	55	0.33
DB00852	Pseudoephedrine	vascular diseases	181	0.33
DB00852	Pseudoephedrine	cardiovascular diseases	330	0.35
DB00852	Pseudoephedrine	colitis ulcerative	55	0.37
DB00852	Pseudoephedrine	liver cirrhosis biliary	23	0.40
DB00852	Pseudoephedrine	insulin resistance	26	0.42
DB00852	Pseudoephedrine	liver cirrhosis	24	0.43
DB00852	Pseudoephedrine	hyperinsulinism	26	0.44
DB00852	Pseudoephedrine	malabsorption syndromes	34	0.50
DB00852	Pseudoephedrine	prostatic neoplasms	61	0.53
DB00852	Pseudoephedrine	bone diseases metabolic	27	0.55
DB00852	Pseudoephedrine	kidney diseases	144	0.63
DB00852	Pseudoephedrine	autoimmune diseases	243	0.66
DB00852	Pseudoephedrine	rheumatic diseases	59	0.68
DB00852	Pseudoephedrine	coronary artery disease	31	0.76
DB00852	Pseudoephedrine	lupus erythematosus systemic	75	0.77
DB00852	Pseudoephedrine	diabetes mellitus type 1	82	0.81
DB00852	Pseudoephedrine	leukemia myeloid acute	43	0.82
DB00852	Pseudoephedrine	blood coagulation disorders	40	0.85
DB00852	Pseudoephedrine	arthritis rheumatoid	42	1.08
DB00852	Pseudoephedrine	leukemia	117	1.10
DB00852	Pseudoephedrine	coronary disease	37	1.11
DB00852	Pseudoephedrine	leukemia lymphoid	66	1.13
DB00852	Pseudoephedrine	eye diseases	231	1.14
DB00852	Pseudoephedrine	myocardial ischemia	43	1.22
DB00852	Pseudoephedrine	metabolism inborn errors	289	1.24
DB00852	Pseudoephedrine	arteriosclerosis	38	1.31
DB00852	Pseudoephedrine	neoplasms	482	1.33
DB00852	Pseudoephedrine	hematologic diseases	188	1.52
DB00852	Pseudoephedrine	macular degeneration	44	1.59
DB00852	Pseudoephedrine	anemia	58	1.88
DB00999	Hydrochlorothiazide	kidney diseases	144	-3.37
DB00999	Hydrochlorothiazide	metabolism inborn errors	289	-3.22
DB00999	Hydrochlorothiazide	anemia hemolytic	29	-2.20
DB00999	Hydrochlorothiazide	heart diseases	167	-1.70
DB00999	Hydrochlorothiazide	anemia	58	-1.68
DB00999	Hydrochlorothiazide	head and neck neoplasms	35	-1.56
DB00999	Hydrochlorothiazide	cardiovascular diseases	330	-1.55
DB00999	Hydrochlorothiazide	eye diseases	231	-1.39
DB00999	Hydrochlorothiazide	neuroendocrine tumors	24	-1.33
DB00999	Hydrochlorothiazide	hematologic diseases	188	-1.18
DB00999	Hydrochlorothiazide	multiple sclerosis	69	-1.12
DB00999	Hydrochlorothiazide	bone diseases	144	-1.08
DB00999	Hydrochlorothiazide	endocrine system diseases	291	-1.02
DB00999	Hydrochlorothiazide	adenocarcinoma	32	-0.92
DB00999	Hydrochlorothiazide	bone diseases metabolic	27	-0.65
DB00999	Hydrochlorothiazide	gastrointestinal neoplasms	72	-0.61
DB00999	Hydrochlorothiazide	cardiomyopathy dilated	29	-0.59
DB00999	Hydrochlorothiazide	asthma	36	-0.56
DB00999	Hydrochlorothiazide	colorectal neoplasms	42	-0.49
DB00999	Hydrochlorothiazide	intestinal neoplasms	42	-0.47
DB00999	Hydrochlorothiazide	keratosis	21	-0.44
DB00999	Hydrochlorothiazide	lupus erythematosus systemic	75	-0.43
DB00999	Hydrochlorothiazide	diabetes mellitus	162	-0.43
DB00999	Hydrochlorothiazide	arterial occlusive diseases	44	-0.43
DB00999	Hydrochlorothiazide	lymphoma	24	-0.42
DB00999	Hydrochlorothiazide	coronary artery disease	31	-0.39
DB00999	Hydrochlorothiazide	lymphoma non hodgkin	22	-0.36
DB00999	Hydrochlorothiazide	diabetes mellitus type 1	82	-0.34
DB00999	Hydrochlorothiazide	hypersensitivity	45	-0.33
DB00999	Hydrochlorothiazide	varicose veins	20	-0.32
DB00999	Hydrochlorothiazide	hypopigmentation	22	-0.24
DB00999	Hydrochlorothiazide	epilepsy	25	-0.19
DB00999	Hydrochlorothiazide	kidney neoplasms	20	-0.18
DB00999	Hydrochlorothiazide	coronary disease	37	-0.15
DB00999	Hydrochlorothiazide	vascular diseases	181	-0.13
DB00999	Hydrochlorothiazide	liver cirrhosis biliary	23	-0.11
DB00999	Hydrochlorothiazide	dementia	42	-0.09
DB00999	Hydrochlorothiazide	colitis ulcerative	55	-0.09
DB00999	Hydrochlorothiazide	colitis	55	-0.08
DB00999	Hydrochlorothiazide	hyperinsulinism	26	-0.08
DB00999	Hydrochlorothiazide	liver cirrhosis	24	-0.07
DB00999	Hydrochlorothiazide	neoplasms	482	-0.06
DB00999	Hydrochlorothiazide	insulin resistance	26	-0.05
DB00999	Hydrochlorothiazide	arrhythmias cardiac	30	-0.03
DB00999	Hydrochlorothiazide	breast neoplasms	40	-0.01
DB00999	Hydrochlorothiazide	myocardial ischemia	43	0.00
DB00999	Hydrochlorothiazide	arteriosclerosis	38	0.00
DB00999	Hydrochlorothiazide	prostatic neoplasms	61	0.01
DB00999	Hydrochlorothiazide	diabetes mellitus type 2	72	0.04
DB00999	Hydrochlorothiazide	alzheimer disease	29	0.09
DB00999	Hydrochlorothiazide	mycobacterium infections	22	0.20
DB00999	Hydrochlorothiazide	autoimmune diseases	243	0.24
DB00999	Hydrochlorothiazide	crohn disease	71	0.26
DB00999	Hydrochlorothiazide	leukemia myeloid acute	43	0.27
DB00999	Hydrochlorothiazide	motor neuron disease	31	0.39
DB00999	Hydrochlorothiazide	bacterial infections	26	0.50
DB00999	Hydrochlorothiazide	leukemia lymphoid	66	0.53
DB00999	Hydrochlorothiazide	lung diseases	71	0.55
DB00999	Hydrochlorothiazide	malabsorption syndromes	34	0.61
DB00999	Hydrochlorothiazide	collagen diseases	25	0.61
DB00999	Hydrochlorothiazide	pancreatic diseases	24	0.63
DB00999	Hydrochlorothiazide	psoriasis	54	0.71
DB00999	Hydrochlorothiazide	gastroenteritis	122	0.78
DB00999	Hydrochlorothiazide	inflammatory bowel diseases	119	0.85
DB00999	Hydrochlorothiazide	sarcoma	25	0.85
DB00999	Hydrochlorothiazide	macular degeneration	44	0.89
DB00999	Hydrochlorothiazide	blood coagulation disorders	40	1.01
DB00999	Hydrochlorothiazide	thyroid diseases	30	1.06
DB00999	Hydrochlorothiazide	spinal cord diseases	59	1.07
DB00999	Hydrochlorothiazide	skin diseases	278	1.12
DB00999	Hydrochlorothiazide	joint diseases	79	1.20
DB00999	Hydrochlorothiazide	arthritis	76	1.20
DB00999	Hydrochlorothiazide	arthritis rheumatoid	42	1.21
DB00999	Hydrochlorothiazide	leukemia	117	1.28
DB00999	Hydrochlorothiazide	parkinson disease	30	1.28
DB00999	Hydrochlorothiazide	amyotrophic lateral sclerosis	21	1.30
DB00999	Hydrochlorothiazide	parkinsonian disorders	31	1.31
DB00999	Hydrochlorothiazide	rheumatic diseases	59	1.70
DB00851	Dacarbazine	arrhythmias cardiac	30	-1.95
DB00851	Dacarbazine	hypopigmentation	22	-1.83
DB00851	Dacarbazine	keratosis	21	-1.79
DB00851	Dacarbazine	asthma	36	-1.78
DB00851	Dacarbazine	vascular diseases	181	-1.67
DB00851	Dacarbazine	hypersensitivity	45	-1.64
DB00851	Dacarbazine	hematologic diseases	188	-1.40
DB00851	Dacarbazine	cardiovascular diseases	330	-1.34
DB00851	Dacarbazine	rheumatic diseases	59	-1.25
DB00851	Dacarbazine	lupus erythematosus systemic	75	-1.23
DB00851	Dacarbazine	skin diseases	278	-1.21
DB00851	Dacarbazine	head and neck neoplasms	35	-1.12
DB00851	Dacarbazine	psoriasis	54	-1.10
DB00851	Dacarbazine	multiple sclerosis	69	-1.08
DB00851	Dacarbazine	prostatic neoplasms	61	-1.06
DB00851	Dacarbazine	arthritis	76	-1.01
DB00851	Dacarbazine	joint diseases	79	-0.96
DB00851	Dacarbazine	lung diseases	71	-0.90
DB00851	Dacarbazine	varicose veins	20	-0.62
DB00851	Dacarbazine	neoplasms	482	-0.56
DB00851	Dacarbazine	insulin resistance	26	-0.51
DB00851	Dacarbazine	epilepsy	25	-0.51
DB00851	Dacarbazine	gastrointestinal neoplasms	72	-0.50
DB00851	Dacarbazine	heart diseases	167	-0.45
DB00851	Dacarbazine	hyperinsulinism	26	-0.45
DB00851	Dacarbazine	bone diseases	144	-0.41
DB00851	Dacarbazine	collagen diseases	25	-0.31
DB00851	Dacarbazine	mycobacterium infections	22	-0.27
DB00851	Dacarbazine	coronary artery disease	31	-0.23
DB00851	Dacarbazine	anemia hemolytic	29	-0.18
DB00851	Dacarbazine	liver cirrhosis biliary	23	-0.14
DB00851	Dacarbazine	bacterial infections	26	-0.13
DB00851	Dacarbazine	liver cirrhosis	24	-0.13
DB00851	Dacarbazine	eye diseases	231	-0.12
DB00851	Dacarbazine	coronary disease	37	-0.11
DB00851	Dacarbazine	metabolism inborn errors	289	-0.10
DB00851	Dacarbazine	kidney neoplasms	20	-0.08
DB00851	Dacarbazine	malabsorption syndromes	34	-0.05
DB00851	Dacarbazine	myocardial ischemia	43	-0.05
DB00851	Dacarbazine	thyroid diseases	30	-0.01
DB00851	Dacarbazine	neuroendocrine tumors	24	-0.01
DB00851	Dacarbazine	autoimmune diseases	243	-0.01
DB00851	Dacarbazine	pancreatic diseases	24	0.01
DB00851	Dacarbazine	arteriosclerosis	38	0.01
DB00851	Dacarbazine	amyotrophic lateral sclerosis	21	0.08
DB00851	Dacarbazine	cardiomyopathy dilated	29	0.09
DB00851	Dacarbazine	blood coagulation disorders	40	0.12
DB00851	Dacarbazine	parkinson disease	30	0.15
DB00851	Dacarbazine	sarcoma	25	0.15
DB00851	Dacarbazine	arterial occlusive diseases	44	0.15
DB00851	Dacarbazine	lymphoma	24	0.18
DB00851	Dacarbazine	parkinsonian disorders	31	0.18
DB00851	Dacarbazine	lymphoma non hodgkin	22	0.22
DB00851	Dacarbazine	alzheimer disease	29	0.26
DB00851	Dacarbazine	arthritis rheumatoid	42	0.27
DB00851	Dacarbazine	motor neuron disease	31	0.34
DB00851	Dacarbazine	adenocarcinoma	32	0.39
DB00851	Dacarbazine	diabetes mellitus type 2	72	0.43
DB00851	Dacarbazine	colitis ulcerative	55	0.43
DB00851	Dacarbazine	colitis	55	0.43
DB00851	Dacarbazine	dementia	42	0.45
DB00851	Dacarbazine	breast neoplasms	40	0.45
DB00851	Dacarbazine	crohn disease	71	0.54
DB00851	Dacarbazine	leukemia myeloid acute	43	0.56
DB00851	Dacarbazine	anemia	58	0.60
DB00851	Dacarbazine	spinal cord diseases	59	0.65
DB00851	Dacarbazine	diabetes mellitus type 1	82	0.65
DB00851	Dacarbazine	colorectal neoplasms	42	0.70
DB00851	Dacarbazine	intestinal neoplasms	42	0.72
DB00851	Dacarbazine	leukemia lymphoid	66	0.73
DB00851	Dacarbazine	kidney diseases	144	0.90
DB00851	Dacarbazine	inflammatory bowel diseases	119	0.91
DB00851	Dacarbazine	gastroenteritis	122	0.92
DB00851	Dacarbazine	diabetes mellitus	162	0.99
DB00851	Dacarbazine	leukemia	117	1.20
DB00851	Dacarbazine	bone diseases metabolic	27	1.27
DB00851	Dacarbazine	macular degeneration	44	1.35
DB00851	Dacarbazine	endocrine system diseases	291	1.68
DB00337	Pimecrolimus	adenocarcinoma	32	-2.78
DB00337	Pimecrolimus	anemia	58	-2.40
DB00337	Pimecrolimus	intestinal neoplasms	42	-2.09
DB00337	Pimecrolimus	varicose veins	20	-2.06
DB00337	Pimecrolimus	colorectal neoplasms	42	-1.93
DB00337	Pimecrolimus	coronary disease	37	-1.92
DB00337	Pimecrolimus	mycobacterium infections	22	-1.86
DB00337	Pimecrolimus	heart diseases	167	-1.84
DB00337	Pimecrolimus	coronary artery disease	31	-1.79
DB00337	Pimecrolimus	anemia hemolytic	29	-1.73
DB00337	Pimecrolimus	gastrointestinal neoplasms	72	-1.70
DB00337	Pimecrolimus	kidney neoplasms	20	-1.64
DB00337	Pimecrolimus	bacterial infections	26	-1.64
DB00337	Pimecrolimus	neuroendocrine tumors	24	-1.63
DB00337	Pimecrolimus	myocardial ischemia	43	-1.61
DB00337	Pimecrolimus	arteriosclerosis	38	-1.61
DB00337	Pimecrolimus	arterial occlusive diseases	44	-1.50
DB00337	Pimecrolimus	vascular diseases	181	-1.43
DB00337	Pimecrolimus	bone diseases	144	-1.39
DB00337	Pimecrolimus	metabolism inborn errors	289	-1.17
DB00337	Pimecrolimus	prostatic neoplasms	61	-1.08
DB00337	Pimecrolimus	diabetes mellitus type 2	72	-1.07
DB00337	Pimecrolimus	colitis ulcerative	55	-1.07
DB00337	Pimecrolimus	hematologic diseases	188	-1.06
DB00337	Pimecrolimus	colitis	55	-1.05
DB00337	Pimecrolimus	rheumatic diseases	59	-1.03
DB00337	Pimecrolimus	cardiovascular diseases	330	-1.01
DB00337	Pimecrolimus	multiple sclerosis	69	-0.93
DB00337	Pimecrolimus	head and neck neoplasms	35	-0.89
DB00337	Pimecrolimus	crohn disease	71	-0.89
DB00337	Pimecrolimus	arthritis	76	-0.77
DB00337	Pimecrolimus	joint diseases	79	-0.76
DB00337	Pimecrolimus	spinal cord diseases	59	-0.75
DB00337	Pimecrolimus	breast neoplasms	40	-0.74
DB00337	Pimecrolimus	lung diseases	71	-0.73
DB00337	Pimecrolimus	inflammatory bowel diseases	119	-0.52
DB00337	Pimecrolimus	kidney diseases	144	-0.41
DB00337	Pimecrolimus	gastroenteritis	122	-0.40
DB00337	Pimecrolimus	epilepsy	25	-0.31
DB00337	Pimecrolimus	diabetes mellitus	162	-0.30
DB00337	Pimecrolimus	hyperinsulinism	26	-0.28
DB00337	Pimecrolimus	insulin resistance	26	-0.24
DB00337	Pimecrolimus	arrhythmias cardiac	30	-0.17
DB00337	Pimecrolimus	neoplasms	482	-0.16
DB00337	Pimecrolimus	macular degeneration	44	-0.15
DB00337	Pimecrolimus	bone diseases metabolic	27	-0.14
DB00337	Pimecrolimus	collagen diseases	25	-0.07
DB00337	Pimecrolimus	eye diseases	231	-0.03
DB00337	Pimecrolimus	leukemia	117	0.01
DB00337	Pimecrolimus	liver cirrhosis	24	0.10
DB00337	Pimecrolimus	keratosis	21	0.10
DB00337	Pimecrolimus	liver cirrhosis biliary	23	0.10
DB00337	Pimecrolimus	hypopigmentation	22	0.14
DB00337	Pimecrolimus	malabsorption syndromes	34	0.14
DB00337	Pimecrolimus	thyroid diseases	30	0.16
DB00337	Pimecrolimus	pancreatic diseases	24	0.18
DB00337	Pimecrolimus	asthma	36	0.26
DB00337	Pimecrolimus	parkinson disease	30	0.26
DB00337	Pimecrolimus	autoimmune diseases	243	0.28
DB00337	Pimecrolimus	parkinsonian disorders	31	0.29
DB00337	Pimecrolimus	amyotrophic lateral sclerosis	21	0.29
DB00337	Pimecrolimus	cardiomyopathy dilated	29	0.30
DB00337	Pimecrolimus	hypersensitivity	45	0.32
DB00337	Pimecrolimus	blood coagulation disorders	40	0.33
DB00337	Pimecrolimus	alzheimer disease	29	0.39
DB00337	Pimecrolimus	lymphoma	24	0.40
DB00337	Pimecrolimus	sarcoma	25	0.41
DB00337	Pimecrolimus	lymphoma non hodgkin	22	0.42
DB00337	Pimecrolimus	endocrine system diseases	291	0.46
DB00337	Pimecrolimus	arthritis rheumatoid	42	0.50
DB00337	Pimecrolimus	skin diseases	278	0.53
DB00337	Pimecrolimus	motor neuron disease	31	0.55
DB00337	Pimecrolimus	dementia	42	0.62
DB00337	Pimecrolimus	psoriasis	54	0.63
DB00337	Pimecrolimus	lupus erythematosus systemic	75	0.66
DB00337	Pimecrolimus	leukemia myeloid acute	43	0.75
DB00337	Pimecrolimus	diabetes mellitus type 1	82	0.76
DB00337	Pimecrolimus	leukemia lymphoid	66	0.93
DB01248	Docetaxel	neoplasms	482	-3.10
DB01248	Docetaxel	leukemia	117	-2.63
DB01248	Docetaxel	leukemia lymphoid	66	-2.37
DB01248	Docetaxel	diabetes mellitus type 2	72	-2.06
DB01248	Docetaxel	varicose veins	20	-1.76
DB01248	Docetaxel	arthritis rheumatoid	42	-1.37
DB01248	Docetaxel	lymphoma	24	-1.32
DB01248	Docetaxel	lymphoma non hodgkin	22	-1.32
DB01248	Docetaxel	rheumatic diseases	59	-1.01
DB01248	Docetaxel	keratosis	21	-0.98
DB01248	Docetaxel	leukemia myeloid acute	43	-0.94
DB01248	Docetaxel	diabetes mellitus	162	-0.86
DB01248	Docetaxel	cardiomyopathy dilated	29	-0.81
DB01248	Docetaxel	thyroid diseases	30	-0.77
DB01248	Docetaxel	arthritis	76	-0.76
DB01248	Docetaxel	joint diseases	79	-0.75
DB01248	Docetaxel	hypopigmentation	22	-0.69
DB01248	Docetaxel	alzheimer disease	29	-0.55
DB01248	Docetaxel	amyotrophic lateral sclerosis	21	-0.53
DB01248	Docetaxel	bone diseases	144	-0.45
DB01248	Docetaxel	bacterial infections	26	-0.33
DB01248	Docetaxel	asthma	36	-0.30
DB01248	Docetaxel	liver cirrhosis biliary	23	-0.23
DB01248	Docetaxel	liver cirrhosis	24	-0.23
DB01248	Docetaxel	dementia	42	-0.14
DB01248	Docetaxel	hypersensitivity	45	-0.12
DB01248	Docetaxel	autoimmune diseases	243	-0.10
DB01248	Docetaxel	hematologic diseases	188	-0.07
DB01248	Docetaxel	psoriasis	54	-0.02
DB01248	Docetaxel	skin diseases	278	-0.01
DB01248	Docetaxel	prostatic neoplasms	61	0.02
DB01248	Docetaxel	head and neck neoplasms	35	0.02
DB01248	Docetaxel	endocrine system diseases	291	0.03
DB01248	Docetaxel	adenocarcinoma	32	0.14
DB01248	Docetaxel	motor neuron disease	31	0.15
DB01248	Docetaxel	lupus erythematosus systemic	75	0.26
DB01248	Docetaxel	arrhythmias cardiac	30	0.34
DB01248	Docetaxel	crohn disease	71	0.42
DB01248	Docetaxel	epilepsy	25	0.42
DB01248	Docetaxel	collagen diseases	25	0.47
DB01248	Docetaxel	bone diseases metabolic	27	0.48
DB01248	Docetaxel	macular degeneration	44	0.54
DB01248	Docetaxel	hyperinsulinism	26	0.62
DB01248	Docetaxel	parkinson disease	30	0.62
DB01248	Docetaxel	multiple sclerosis	69	0.64
DB01248	Docetaxel	insulin resistance	26	0.65
DB01248	Docetaxel	parkinsonian disorders	31	0.66
DB01248	Docetaxel	inflammatory bowel diseases	119	0.69
DB01248	Docetaxel	gastroenteritis	122	0.69
DB01248	Docetaxel	coronary artery disease	31	0.71
DB01248	Docetaxel	anemia hemolytic	29	0.74
DB01248	Docetaxel	spinal cord diseases	59	0.75
DB01248	Docetaxel	coronary disease	37	0.76
DB01248	Docetaxel	myocardial ischemia	43	0.79
DB01248	Docetaxel	blood coagulation disorders	40	0.85
DB01248	Docetaxel	malabsorption syndromes	34	0.86
DB01248	Docetaxel	arteriosclerosis	38	0.86
DB01248	Docetaxel	heart diseases	167	0.91
DB01248	Docetaxel	kidney neoplasms	20	0.94
DB01248	Docetaxel	colitis	55	0.95
DB01248	Docetaxel	lung diseases	71	0.95
DB01248	Docetaxel	metabolism inborn errors	289	0.96
DB01248	Docetaxel	colitis ulcerative	55	0.96
DB01248	Docetaxel	mycobacterium infections	22	0.98
DB01248	Docetaxel	anemia	58	0.98
DB01248	Docetaxel	arterial occlusive diseases	44	0.98
DB01248	Docetaxel	neuroendocrine tumors	24	1.12
DB01248	Docetaxel	sarcoma	25	1.18
DB01248	Docetaxel	pancreatic diseases	24	1.25
DB01248	Docetaxel	gastrointestinal neoplasms	72	1.41
DB01248	Docetaxel	diabetes mellitus type 1	82	1.44
DB01248	Docetaxel	breast neoplasms	40	1.79
DB01248	Docetaxel	vascular diseases	181	1.86
DB01248	Docetaxel	eye diseases	231	1.88
DB01248	Docetaxel	kidney diseases	144	2.18
DB01248	Docetaxel	colorectal neoplasms	42	2.27
DB01248	Docetaxel	intestinal neoplasms	42	2.29
DB01248	Docetaxel	cardiovascular diseases	330	3.11
DB00627	Niacin	anemia hemolytic	29	-1.65
DB00627	Niacin	hypopigmentation	22	-1.64
DB00627	Niacin	neuroendocrine tumors	24	-1.37
DB00627	Niacin	adenocarcinoma	32	-1.24
DB00627	Niacin	psoriasis	54	-1.14
DB00627	Niacin	multiple sclerosis	69	-0.98
DB00627	Niacin	lupus erythematosus systemic	75	-0.94
DB00627	Niacin	anemia	58	-0.92
DB00627	Niacin	neoplasms	482	-0.90
DB00627	Niacin	gastrointestinal neoplasms	72	-0.74
DB00627	Niacin	epilepsy	25	-0.69
DB00627	Niacin	collagen diseases	25	-0.57
DB00627	Niacin	arrhythmias cardiac	30	-0.55
DB00627	Niacin	keratosis	21	-0.50
DB00627	Niacin	vascular diseases	181	-0.43
DB00627	Niacin	kidney neoplasms	20	-0.43
DB00627	Niacin	macular degeneration	44	-0.40
DB00627	Niacin	thyroid diseases	30	-0.36
DB00627	Niacin	eye diseases	231	-0.34
DB00627	Niacin	liver cirrhosis biliary	23	-0.33
DB00627	Niacin	hematologic diseases	188	-0.33
DB00627	Niacin	liver cirrhosis	24	-0.30
DB00627	Niacin	metabolism inborn errors	289	-0.30
DB00627	Niacin	autoimmune diseases	243	-0.26
DB00627	Niacin	cardiomyopathy dilated	29	-0.25
DB00627	Niacin	alzheimer disease	29	-0.17
DB00627	Niacin	sarcoma	25	-0.15
DB00627	Niacin	lymphoma non hodgkin	22	-0.14
DB00627	Niacin	skin diseases	278	-0.13
DB00627	Niacin	lymphoma	24	-0.11
DB00627	Niacin	arterial occlusive diseases	44	-0.11
DB00627	Niacin	endocrine system diseases	291	-0.09
DB00627	Niacin	cardiovascular diseases	330	-0.01
DB00627	Niacin	arthritis rheumatoid	42	0.01
DB00627	Niacin	colitis	55	0.02
DB00627	Niacin	head and neck neoplasms	35	0.05
DB00627	Niacin	dementia	42	0.08
DB00627	Niacin	colitis ulcerative	55	0.11
DB00627	Niacin	prostatic neoplasms	61	0.11
DB00627	Niacin	intestinal neoplasms	42	0.20
DB00627	Niacin	diabetes mellitus type 2	72	0.22
DB00627	Niacin	leukemia myeloid acute	43	0.22
DB00627	Niacin	rheumatic diseases	59	0.22
DB00627	Niacin	crohn disease	71	0.25
DB00627	Niacin	colorectal neoplasms	42	0.26
DB00627	Niacin	diabetes mellitus type 1	82	0.29
DB00627	Niacin	joint diseases	79	0.35
DB00627	Niacin	arthritis	76	0.38
DB00627	Niacin	lung diseases	71	0.38
DB00627	Niacin	leukemia lymphoid	66	0.41
DB00627	Niacin	varicose veins	20	0.47
DB00627	Niacin	gastroenteritis	122	0.54
DB00627	Niacin	hyperinsulinism	26	0.57
DB00627	Niacin	inflammatory bowel diseases	119	0.60
DB00627	Niacin	insulin resistance	26	0.60
DB00627	Niacin	kidney diseases	144	0.63
DB00627	Niacin	diabetes mellitus	162	0.65
DB00627	Niacin	bone diseases metabolic	27	0.66
DB00627	Niacin	bone diseases	144	0.71
DB00627	Niacin	coronary artery disease	31	0.71
DB00627	Niacin	heart diseases	167	0.75
DB00627	Niacin	leukemia	117	0.76
DB00627	Niacin	mycobacterium infections	22	0.77
DB00627	Niacin	bacterial infections	26	0.84
DB00627	Niacin	coronary disease	37	0.88
DB00627	Niacin	parkinson disease	30	0.89
DB00627	Niacin	pancreatic diseases	24	0.90
DB00627	Niacin	malabsorption syndromes	34	0.91
DB00627	Niacin	myocardial ischemia	43	0.93
DB00627	Niacin	parkinsonian disorders	31	0.94
DB00627	Niacin	amyotrophic lateral sclerosis	21	0.95
DB00627	Niacin	arteriosclerosis	38	0.99
DB00627	Niacin	asthma	36	0.99
DB00627	Niacin	hypersensitivity	45	1.17
DB00627	Niacin	motor neuron disease	31	1.18
DB00627	Niacin	breast neoplasms	40	1.38
DB00627	Niacin	spinal cord diseases	59	1.54
DB00627	Niacin	blood coagulation disorders	40	2.42
DB00883	Isosorbide.Dinitrate	bacterial infections	26	-2.70
DB00883	Isosorbide.Dinitrate	arrhythmias cardiac	30	-2.65
DB00883	Isosorbide.Dinitrate	varicose veins	20	-2.63
DB00883	Isosorbide.Dinitrate	asthma	36	-2.57
DB00883	Isosorbide.Dinitrate	alzheimer disease	29	-2.53
DB00883	Isosorbide.Dinitrate	hypersensitivity	45	-2.50
DB00883	Isosorbide.Dinitrate	cardiomyopathy dilated	29	-2.43
DB00883	Isosorbide.Dinitrate	dementia	42	-2.22
DB00883	Isosorbide.Dinitrate	diabetes mellitus type 2	72	-1.98
DB00883	Isosorbide.Dinitrate	head and neck neoplasms	35	-1.92
DB00883	Isosorbide.Dinitrate	spinal cord diseases	59	-1.87
DB00883	Isosorbide.Dinitrate	lung diseases	71	-1.77
DB00883	Isosorbide.Dinitrate	gastrointestinal neoplasms	72	-1.44
DB00883	Isosorbide.Dinitrate	diabetes mellitus	162	-1.15
DB00883	Isosorbide.Dinitrate	heart diseases	167	-1.10
DB00883	Isosorbide.Dinitrate	vascular diseases	181	-0.88
DB00883	Isosorbide.Dinitrate	eye diseases	231	-0.80
DB00883	Isosorbide.Dinitrate	skin diseases	278	-0.76
DB00883	Isosorbide.Dinitrate	endocrine system diseases	291	-0.61
DB00883	Isosorbide.Dinitrate	cardiovascular diseases	330	-0.60
DB00883	Isosorbide.Dinitrate	neoplasms	482	-0.27
DB00883	Isosorbide.Dinitrate	insulin resistance	26	-0.16
DB00883	Isosorbide.Dinitrate	hyperinsulinism	26	-0.14
DB00883	Isosorbide.Dinitrate	bone diseases metabolic	27	-0.14
DB00883	Isosorbide.Dinitrate	collagen diseases	25	-0.10
DB00883	Isosorbide.Dinitrate	epilepsy	25	-0.09
DB00883	Isosorbide.Dinitrate	macular degeneration	44	0.02
DB00883	Isosorbide.Dinitrate	keratosis	21	0.02
DB00883	Isosorbide.Dinitrate	coronary artery disease	31	0.04
DB00883	Isosorbide.Dinitrate	kidney neoplasms	20	0.09
DB00883	Isosorbide.Dinitrate	thyroid diseases	30	0.11
DB00883	Isosorbide.Dinitrate	amyotrophic lateral sclerosis	21	0.12
DB00883	Isosorbide.Dinitrate	malabsorption syndromes	34	0.14
DB00883	Isosorbide.Dinitrate	coronary disease	37	0.14
DB00883	Isosorbide.Dinitrate	pancreatic diseases	24	0.14
DB00883	Isosorbide.Dinitrate	parkinsonian disorders	31	0.15
DB00883	Isosorbide.Dinitrate	liver cirrhosis biliary	23	0.16
DB00883	Isosorbide.Dinitrate	hypopigmentation	22	0.17
DB00883	Isosorbide.Dinitrate	anemia hemolytic	29	0.17
DB00883	Isosorbide.Dinitrate	parkinson disease	30	0.18
DB00883	Isosorbide.Dinitrate	neuroendocrine tumors	24	0.18
DB00883	Isosorbide.Dinitrate	myocardial ischemia	43	0.21
DB00883	Isosorbide.Dinitrate	liver cirrhosis	24	0.21
DB00883	Isosorbide.Dinitrate	arteriosclerosis	38	0.23
DB00883	Isosorbide.Dinitrate	lymphoma non hodgkin	22	0.24
DB00883	Isosorbide.Dinitrate	sarcoma	25	0.25
DB00883	Isosorbide.Dinitrate	arterial occlusive diseases	44	0.27
DB00883	Isosorbide.Dinitrate	motor neuron disease	31	0.29
DB00883	Isosorbide.Dinitrate	lymphoma	24	0.31
DB00883	Isosorbide.Dinitrate	blood coagulation disorders	40	0.32
DB00883	Isosorbide.Dinitrate	colitis	55	0.35
DB00883	Isosorbide.Dinitrate	arthritis rheumatoid	42	0.35
DB00883	Isosorbide.Dinitrate	adenocarcinoma	32	0.36
DB00883	Isosorbide.Dinitrate	breast neoplasms	40	0.39
DB00883	Isosorbide.Dinitrate	rheumatic diseases	59	0.39
DB00883	Isosorbide.Dinitrate	colitis ulcerative	55	0.39
DB00883	Isosorbide.Dinitrate	prostatic neoplasms	61	0.39
DB00883	Isosorbide.Dinitrate	lupus erythematosus systemic	75	0.45
DB00883	Isosorbide.Dinitrate	psoriasis	54	0.45
DB00883	Isosorbide.Dinitrate	multiple sclerosis	69	0.47
DB00883	Isosorbide.Dinitrate	diabetes mellitus type 1	82	0.48
DB00883	Isosorbide.Dinitrate	leukemia myeloid acute	43	0.50
DB00883	Isosorbide.Dinitrate	crohn disease	71	0.50
DB00883	Isosorbide.Dinitrate	joint diseases	79	0.50
DB00883	Isosorbide.Dinitrate	intestinal neoplasms	42	0.51
DB00883	Isosorbide.Dinitrate	colorectal neoplasms	42	0.51
DB00883	Isosorbide.Dinitrate	leukemia lymphoid	66	0.54
DB00883	Isosorbide.Dinitrate	arthritis	76	0.55
DB00883	Isosorbide.Dinitrate	anemia	58	0.59
DB00883	Isosorbide.Dinitrate	inflammatory bowel diseases	119	0.63
DB00883	Isosorbide.Dinitrate	gastroenteritis	122	0.63
DB00883	Isosorbide.Dinitrate	kidney diseases	144	0.67
DB00883	Isosorbide.Dinitrate	bone diseases	144	0.74
DB00883	Isosorbide.Dinitrate	leukemia	117	0.84
DB00883	Isosorbide.Dinitrate	metabolism inborn errors	289	0.96
DB00883	Isosorbide.Dinitrate	autoimmune diseases	243	1.07
DB00883	Isosorbide.Dinitrate	hematologic diseases	188	1.11
DB00883	Isosorbide.Dinitrate	mycobacterium infections	22	2.84
DB00620	Triamcinolone	coronary artery disease	31	-1.69
DB00620	Triamcinolone	arteriosclerosis	38	-1.45
DB00620	Triamcinolone	myocardial ischemia	43	-1.42
DB00620	Triamcinolone	coronary disease	37	-1.40
DB00620	Triamcinolone	malabsorption syndromes	34	-1.35
DB00620	Triamcinolone	kidney neoplasms	20	-1.31
DB00620	Triamcinolone	colitis ulcerative	55	-1.31
DB00620	Triamcinolone	colitis	55	-1.24
DB00620	Triamcinolone	arterial occlusive diseases	44	-1.18
DB00620	Triamcinolone	neuroendocrine tumors	24	-1.16
DB00620	Triamcinolone	alzheimer disease	29	-1.16
DB00620	Triamcinolone	mycobacterium infections	22	-1.08
DB00620	Triamcinolone	bacterial infections	26	-1.07
DB00620	Triamcinolone	asthma	36	-1.01
DB00620	Triamcinolone	hypersensitivity	45	-0.97
DB00620	Triamcinolone	dementia	42	-0.93
DB00620	Triamcinolone	prostatic neoplasms	61	-0.88
DB00620	Triamcinolone	sarcoma	25	-0.86
DB00620	Triamcinolone	head and neck neoplasms	35	-0.84
DB00620	Triamcinolone	adenocarcinoma	32	-0.83
DB00620	Triamcinolone	arthritis rheumatoid	42	-0.76
DB00620	Triamcinolone	motor neuron disease	31	-0.75
DB00620	Triamcinolone	liver cirrhosis biliary	23	-0.75
DB00620	Triamcinolone	liver cirrhosis	24	-0.72
DB00620	Triamcinolone	lymphoma non hodgkin	22	-0.71
DB00620	Triamcinolone	diabetes mellitus type 1	82	-0.71
DB00620	Triamcinolone	lymphoma	24	-0.70
DB00620	Triamcinolone	lupus erythematosus systemic	75	-0.70
DB00620	Triamcinolone	breast neoplasms	40	-0.62
DB00620	Triamcinolone	crohn disease	71	-0.61
DB00620	Triamcinolone	rheumatic diseases	59	-0.59
DB00620	Triamcinolone	leukemia myeloid acute	43	-0.55
DB00620	Triamcinolone	kidney diseases	144	-0.53
DB00620	Triamcinolone	leukemia lymphoid	66	-0.53
DB00620	Triamcinolone	diabetes mellitus	162	-0.51
DB00620	Triamcinolone	inflammatory bowel diseases	119	-0.47
DB00620	Triamcinolone	gastroenteritis	122	-0.46
DB00620	Triamcinolone	joint diseases	79	-0.45
DB00620	Triamcinolone	intestinal neoplasms	42	-0.45
DB00620	Triamcinolone	colorectal neoplasms	42	-0.42
DB00620	Triamcinolone	arthritis	76	-0.42
DB00620	Triamcinolone	heart diseases	167	-0.37
DB00620	Triamcinolone	multiple sclerosis	69	-0.34
DB00620	Triamcinolone	spinal cord diseases	59	-0.31
DB00620	Triamcinolone	lung diseases	71	-0.30
DB00620	Triamcinolone	metabolism inborn errors	289	-0.30
DB00620	Triamcinolone	bone diseases	144	-0.28
DB00620	Triamcinolone	gastrointestinal neoplasms	72	-0.24
DB00620	Triamcinolone	leukemia	117	-0.12
DB00620	Triamcinolone	eye diseases	231	-0.02
DB00620	Triamcinolone	skin diseases	278	0.02
DB00620	Triamcinolone	vascular diseases	181	0.06
DB00620	Triamcinolone	autoimmune diseases	243	0.11
DB00620	Triamcinolone	hematologic diseases	188	0.12
DB00620	Triamcinolone	cardiovascular diseases	330	0.15
DB00620	Triamcinolone	endocrine system diseases	291	0.17
DB00620	Triamcinolone	neoplasms	482	0.21
DB00620	Triamcinolone	arrhythmias cardiac	30	0.32
DB00620	Triamcinolone	collagen diseases	25	0.34
DB00620	Triamcinolone	varicose veins	20	0.34
DB00620	Triamcinolone	epilepsy	25	0.36
DB00620	Triamcinolone	macular degeneration	44	0.40
DB00620	Triamcinolone	bone diseases metabolic	27	0.40
DB00620	Triamcinolone	parkinsonian disorders	31	0.47
DB00620	Triamcinolone	parkinson disease	30	0.48
DB00620	Triamcinolone	hyperinsulinism	26	0.59
DB00620	Triamcinolone	insulin resistance	26	0.59
DB00620	Triamcinolone	blood coagulation disorders	40	0.61
DB00620	Triamcinolone	cardiomyopathy dilated	29	0.61
DB00620	Triamcinolone	keratosis	21	0.66
DB00620	Triamcinolone	anemia hemolytic	29	0.69
DB00620	Triamcinolone	hypopigmentation	22	0.73
DB00620	Triamcinolone	thyroid diseases	30	0.76
DB00620	Triamcinolone	amyotrophic lateral sclerosis	21	0.78
DB00620	Triamcinolone	diabetes mellitus type 2	72	0.83
DB00620	Triamcinolone	psoriasis	54	1.10
DB00620	Triamcinolone	pancreatic diseases	24	1.15
DB00620	Triamcinolone	anemia	58	2.58
DB00184	Nicotine	epilepsy	25	-8.00
DB00184	Nicotine	macular degeneration	44	-2.83
DB00184	Nicotine	lung diseases	71	-2.71
DB00184	Nicotine	dementia	42	-1.32
DB00184	Nicotine	collagen diseases	25	-1.27
DB00184	Nicotine	neoplasms	482	-1.25
DB00184	Nicotine	arrhythmias cardiac	30	-1.24
DB00184	Nicotine	alzheimer disease	29	-1.23
DB00184	Nicotine	bacterial infections	26	-0.76
DB00184	Nicotine	amyotrophic lateral sclerosis	21	-0.69
DB00184	Nicotine	insulin resistance	26	-0.66
DB00184	Nicotine	pancreatic diseases	24	-0.63
DB00184	Nicotine	hyperinsulinism	26	-0.56
DB00184	Nicotine	cardiomyopathy dilated	29	-0.53
DB00184	Nicotine	prostatic neoplasms	61	-0.49
DB00184	Nicotine	diabetes mellitus type 2	72	-0.42
DB00184	Nicotine	eye diseases	231	-0.37
DB00184	Nicotine	lupus erythematosus systemic	75	-0.24
DB00184	Nicotine	motor neuron disease	31	-0.17
DB00184	Nicotine	spinal cord diseases	59	-0.12
DB00184	Nicotine	adenocarcinoma	32	-0.08
DB00184	Nicotine	colitis	55	0.00
DB00184	Nicotine	colitis ulcerative	55	0.02
DB00184	Nicotine	psoriasis	54	0.14
DB00184	Nicotine	vascular diseases	181	0.20
DB00184	Nicotine	coronary artery disease	31	0.33
DB00184	Nicotine	intestinal neoplasms	42	0.41
DB00184	Nicotine	crohn disease	71	0.44
DB00184	Nicotine	colorectal neoplasms	42	0.44
DB00184	Nicotine	coronary disease	37	0.54
DB00184	Nicotine	diabetes mellitus	162	0.61
DB00184	Nicotine	myocardial ischemia	43	0.69
DB00184	Nicotine	heart diseases	167	0.70
DB00184	Nicotine	arteriosclerosis	38	0.71
DB00184	Nicotine	leukemia lymphoid	66	0.73
DB00184	Nicotine	cardiovascular diseases	330	0.80
DB00184	Nicotine	arterial occlusive diseases	44	0.98
DB00184	Nicotine	gastroenteritis	122	1.04
DB00184	Nicotine	gastrointestinal neoplasms	72	1.05
DB00184	Nicotine	varicose veins	20	1.06
DB00184	Nicotine	inflammatory bowel diseases	119	1.16
DB00184	Nicotine	autoimmune diseases	243	1.21
DB00184	Nicotine	parkinsonian disorders	31	1.22
DB00184	Nicotine	parkinson disease	30	1.26
DB00184	Nicotine	bone diseases	144	1.43
DB00184	Nicotine	skin diseases	278	1.46
DB00184	Nicotine	endocrine system diseases	291	1.47
DB00184	Nicotine	leukemia	117	1.47
DB00184	Nicotine	breast neoplasms	40	1.51
DB00184	Nicotine	keratosis	21	1.58
DB00184	Nicotine	diabetes mellitus type 1	82	1.88
DB00184	Nicotine	malabsorption syndromes	34	1.93
DB00184	Nicotine	hematologic diseases	188	1.97
DB00184	Nicotine	neuroendocrine tumors	24	2.01
DB00184	Nicotine	bone diseases metabolic	27	2.03
DB00184	Nicotine	asthma	36	2.08
DB00184	Nicotine	lymphoma	24	2.18
DB00184	Nicotine	sarcoma	25	2.18
DB00184	Nicotine	mycobacterium infections	22	2.18
DB00184	Nicotine	lymphoma non hodgkin	22	2.24
DB00184	Nicotine	blood coagulation disorders	40	2.24
DB00184	Nicotine	anemia hemolytic	29	2.32
DB00184	Nicotine	kidney neoplasms	20	2.33
DB00184	Nicotine	hypersensitivity	45	2.38
DB00184	Nicotine	thyroid diseases	30	2.42
DB00184	Nicotine	hypopigmentation	22	2.42
DB00184	Nicotine	arthritis rheumatoid	42	2.44
DB00184	Nicotine	head and neck neoplasms	35	2.64
DB00184	Nicotine	rheumatic diseases	59	3.02
DB00184	Nicotine	liver cirrhosis biliary	23	3.08
DB00184	Nicotine	multiple sclerosis	69	3.09
DB00184	Nicotine	kidney diseases	144	3.14
DB00184	Nicotine	leukemia myeloid acute	43	3.15
DB00184	Nicotine	liver cirrhosis	24	3.22
DB00184	Nicotine	metabolism inborn errors	289	3.28
DB00184	Nicotine	arthritis	76	3.30
DB00184	Nicotine	joint diseases	79	3.36
DB00184	Nicotine	anemia	58	3.42
DB00357	Aminoglutethimide	keratosis	21	-2.25
DB00357	Aminoglutethimide	hypersensitivity	45	-1.90
DB00357	Aminoglutethimide	skin diseases	278	-1.89
DB00357	Aminoglutethimide	asthma	36	-1.86
DB00357	Aminoglutethimide	metabolism inborn errors	289	-1.83
DB00357	Aminoglutethimide	endocrine system diseases	291	-1.76
DB00357	Aminoglutethimide	crohn disease	71	-1.51
DB00357	Aminoglutethimide	colorectal neoplasms	42	-1.39
DB00357	Aminoglutethimide	intestinal neoplasms	42	-1.33
DB00357	Aminoglutethimide	anemia	58	-1.33
DB00357	Aminoglutethimide	gastroenteritis	122	-1.28
DB00357	Aminoglutethimide	lung diseases	71	-1.27
DB00357	Aminoglutethimide	inflammatory bowel diseases	119	-1.25
DB00357	Aminoglutethimide	gastrointestinal neoplasms	72	-1.04
DB00357	Aminoglutethimide	bone diseases metabolic	27	-0.95
DB00357	Aminoglutethimide	vascular diseases	181	-0.77
DB00357	Aminoglutethimide	coronary artery disease	31	-0.76
DB00357	Aminoglutethimide	anemia hemolytic	29	-0.75
DB00357	Aminoglutethimide	thyroid diseases	30	-0.71
DB00357	Aminoglutethimide	malabsorption syndromes	34	-0.66
DB00357	Aminoglutethimide	eye diseases	231	-0.64
DB00357	Aminoglutethimide	coronary disease	37	-0.61
DB00357	Aminoglutethimide	kidney neoplasms	20	-0.59
DB00357	Aminoglutethimide	hematologic diseases	188	-0.57
DB00357	Aminoglutethimide	amyotrophic lateral sclerosis	21	-0.56
DB00357	Aminoglutethimide	pancreatic diseases	24	-0.53
DB00357	Aminoglutethimide	alzheimer disease	29	-0.52
DB00357	Aminoglutethimide	neuroendocrine tumors	24	-0.52
DB00357	Aminoglutethimide	myocardial ischemia	43	-0.50
DB00357	Aminoglutethimide	arteriosclerosis	38	-0.49
DB00357	Aminoglutethimide	cardiomyopathy dilated	29	-0.46
DB00357	Aminoglutethimide	sarcoma	25	-0.45
DB00357	Aminoglutethimide	lymphoma	24	-0.44
DB00357	Aminoglutethimide	arterial occlusive diseases	44	-0.43
DB00357	Aminoglutethimide	lymphoma non hodgkin	22	-0.43
DB00357	Aminoglutethimide	motor neuron disease	31	-0.32
DB00357	Aminoglutethimide	colitis	55	-0.28
DB00357	Aminoglutethimide	colitis ulcerative	55	-0.26
DB00357	Aminoglutethimide	head and neck neoplasms	35	-0.25
DB00357	Aminoglutethimide	cardiovascular diseases	330	-0.23
DB00357	Aminoglutethimide	dementia	42	-0.18
DB00357	Aminoglutethimide	adenocarcinoma	32	-0.17
DB00357	Aminoglutethimide	prostatic neoplasms	61	-0.16
DB00357	Aminoglutethimide	psoriasis	54	-0.16
DB00357	Aminoglutethimide	breast neoplasms	40	-0.15
DB00357	Aminoglutethimide	arthritis rheumatoid	42	-0.14
DB00357	Aminoglutethimide	diabetes mellitus type 2	72	-0.12
DB00357	Aminoglutethimide	lupus erythematosus systemic	75	-0.11
DB00357	Aminoglutethimide	multiple sclerosis	69	-0.05
DB00357	Aminoglutethimide	diabetes mellitus type 1	82	-0.02
DB00357	Aminoglutethimide	rheumatic diseases	59	0.01
DB00357	Aminoglutethimide	leukemia myeloid acute	43	0.06
DB00357	Aminoglutethimide	arthritis	76	0.09
DB00357	Aminoglutethimide	spinal cord diseases	59	0.09
DB00357	Aminoglutethimide	leukemia lymphoid	66	0.14
DB00357	Aminoglutethimide	joint diseases	79	0.14
DB00357	Aminoglutethimide	neoplasms	482	0.19
DB00357	Aminoglutethimide	varicose veins	20	0.32
DB00357	Aminoglutethimide	diabetes mellitus	162	0.36
DB00357	Aminoglutethimide	kidney diseases	144	0.37
DB00357	Aminoglutethimide	bone diseases	144	0.48
DB00357	Aminoglutethimide	heart diseases	167	0.48
DB00357	Aminoglutethimide	arrhythmias cardiac	30	0.49
DB00357	Aminoglutethimide	collagen diseases	25	0.52
DB00357	Aminoglutethimide	mycobacterium infections	22	0.64
DB00357	Aminoglutethimide	leukemia	117	0.65
DB00357	Aminoglutethimide	macular degeneration	44	0.66
DB00357	Aminoglutethimide	bacterial infections	26	0.81
DB00357	Aminoglutethimide	hypopigmentation	22	0.84
DB00357	Aminoglutethimide	autoimmune diseases	243	0.84
DB00357	Aminoglutethimide	parkinsonian disorders	31	0.85
DB00357	Aminoglutethimide	parkinson disease	30	0.93
DB00357	Aminoglutethimide	blood coagulation disorders	40	1.02
DB00357	Aminoglutethimide	epilepsy	25	1.86
DB00357	Aminoglutethimide	hyperinsulinism	26	1.93
DB00357	Aminoglutethimide	insulin resistance	26	1.93
DB00357	Aminoglutethimide	liver cirrhosis	24	2.45
DB00357	Aminoglutethimide	liver cirrhosis biliary	23	2.48
DB00351	Megestrol	hypersensitivity	45	-2.15
DB00351	Megestrol	asthma	36	-2.13
DB00351	Megestrol	sarcoma	25	-1.89
DB00351	Megestrol	prostatic neoplasms	61	-1.80
DB00351	Megestrol	breast neoplasms	40	-1.70
DB00351	Megestrol	diabetes mellitus type 1	82	-1.57
DB00351	Megestrol	multiple sclerosis	69	-1.49
DB00351	Megestrol	lung diseases	71	-1.22
DB00351	Megestrol	coronary artery disease	31	-1.15
DB00351	Megestrol	diabetes mellitus	162	-1.13
DB00351	Megestrol	myocardial ischemia	43	-1.06
DB00351	Megestrol	cardiomyopathy dilated	29	-1.03
DB00351	Megestrol	coronary disease	37	-1.00
DB00351	Megestrol	heart diseases	167	-0.92
DB00351	Megestrol	arteriosclerosis	38	-0.91
DB00351	Megestrol	mycobacterium infections	22	-0.89
DB00351	Megestrol	bone diseases	144	-0.89
DB00351	Megestrol	kidney neoplasms	20	-0.83
DB00351	Megestrol	metabolism inborn errors	289	-0.80
DB00351	Megestrol	malabsorption syndromes	34	-0.78
DB00351	Megestrol	alzheimer disease	29	-0.76
DB00351	Megestrol	bacterial infections	26	-0.76
DB00351	Megestrol	neuroendocrine tumors	24	-0.76
DB00351	Megestrol	colitis ulcerative	55	-0.67
DB00351	Megestrol	arterial occlusive diseases	44	-0.66
DB00351	Megestrol	colitis	55	-0.65
DB00351	Megestrol	autoimmune diseases	243	-0.59
DB00351	Megestrol	liver cirrhosis biliary	23	-0.50
DB00351	Megestrol	liver cirrhosis	24	-0.49
DB00351	Megestrol	dementia	42	-0.41
DB00351	Megestrol	skin diseases	278	-0.40
DB00351	Megestrol	endocrine system diseases	291	-0.36
DB00351	Megestrol	cardiovascular diseases	330	-0.34
DB00351	Megestrol	motor neuron disease	31	-0.34
DB00351	Megestrol	lymphoma	24	-0.33
DB00351	Megestrol	lymphoma non hodgkin	22	-0.30
DB00351	Megestrol	arthritis rheumatoid	42	-0.30
DB00351	Megestrol	head and neck neoplasms	35	-0.28
DB00351	Megestrol	adenocarcinoma	32	-0.24
DB00351	Megestrol	lupus erythematosus systemic	75	-0.17
DB00351	Megestrol	rheumatic diseases	59	-0.08
DB00351	Megestrol	neoplasms	482	0.09
DB00351	Megestrol	crohn disease	71	0.09
DB00351	Megestrol	leukemia myeloid acute	43	0.12
DB00351	Megestrol	colorectal neoplasms	42	0.13
DB00351	Megestrol	intestinal neoplasms	42	0.19
DB00351	Megestrol	varicose veins	20	0.21
DB00351	Megestrol	spinal cord diseases	59	0.22
DB00351	Megestrol	arthritis	76	0.23
DB00351	Megestrol	epilepsy	25	0.25
DB00351	Megestrol	joint diseases	79	0.25
DB00351	Megestrol	leukemia lymphoid	66	0.26
DB00351	Megestrol	arrhythmias cardiac	30	0.27
DB00351	Megestrol	gastroenteritis	122	0.29
DB00351	Megestrol	kidney diseases	144	0.37
DB00351	Megestrol	inflammatory bowel diseases	119	0.39
DB00351	Megestrol	bone diseases metabolic	27	0.39
DB00351	Megestrol	macular degeneration	44	0.42
DB00351	Megestrol	collagen diseases	25	0.42
DB00351	Megestrol	hyperinsulinism	26	0.48
DB00351	Megestrol	insulin resistance	26	0.56
DB00351	Megestrol	parkinsonian disorders	31	0.59
DB00351	Megestrol	parkinson disease	30	0.60
DB00351	Megestrol	gastrointestinal neoplasms	72	0.63
DB00351	Megestrol	keratosis	21	0.70
DB00351	Megestrol	hypopigmentation	22	0.72
DB00351	Megestrol	anemia hemolytic	29	0.73
DB00351	Megestrol	thyroid diseases	30	0.76
DB00351	Megestrol	blood coagulation disorders	40	0.79
DB00351	Megestrol	amyotrophic lateral sclerosis	21	0.85
DB00351	Megestrol	leukemia	117	0.96
DB00351	Megestrol	eye diseases	231	0.99
DB00351	Megestrol	vascular diseases	181	1.00
DB00351	Megestrol	diabetes mellitus type 2	72	1.00
DB00351	Megestrol	pancreatic diseases	24	1.14
DB00351	Megestrol	psoriasis	54	1.22
DB00351	Megestrol	hematologic diseases	188	1.42
DB00351	Megestrol	anemia	58	2.06
DB00181	Baclofen	parkinson disease	30	-3.39
DB00181	Baclofen	parkinsonian disorders	31	-3.24
DB00181	Baclofen	epilepsy	25	-2.32
DB00181	Baclofen	thyroid diseases	30	-2.06
DB00181	Baclofen	kidney diseases	144	-1.40
DB00181	Baclofen	leukemia	117	-0.97
DB00181	Baclofen	keratosis	21	-0.67
DB00181	Baclofen	hematologic diseases	188	-0.64
DB00181	Baclofen	malabsorption syndromes	34	-0.53
DB00181	Baclofen	amyotrophic lateral sclerosis	21	-0.52
DB00181	Baclofen	endocrine system diseases	291	-0.48
DB00181	Baclofen	neuroendocrine tumors	24	-0.47
DB00181	Baclofen	alzheimer disease	29	-0.43
DB00181	Baclofen	sarcoma	25	-0.41
DB00181	Baclofen	lymphoma non hodgkin	22	-0.36
DB00181	Baclofen	lymphoma	24	-0.32
DB00181	Baclofen	dementia	42	-0.23
DB00181	Baclofen	motor neuron disease	31	-0.21
DB00181	Baclofen	adenocarcinoma	32	-0.20
DB00181	Baclofen	breast neoplasms	40	-0.17
DB00181	Baclofen	prostatic neoplasms	61	-0.09
DB00181	Baclofen	diabetes mellitus type 2	72	-0.09
DB00181	Baclofen	leukemia myeloid acute	43	-0.03
DB00181	Baclofen	colorectal neoplasms	42	0.02
DB00181	Baclofen	crohn disease	71	0.06
DB00181	Baclofen	intestinal neoplasms	42	0.06
DB00181	Baclofen	multiple sclerosis	69	0.07
DB00181	Baclofen	spinal cord diseases	59	0.07
DB00181	Baclofen	neoplasms	482	0.12
DB00181	Baclofen	leukemia lymphoid	66	0.20
DB00181	Baclofen	anemia	58	0.22
DB00181	Baclofen	varicose veins	20	0.32
DB00181	Baclofen	gastrointestinal neoplasms	72	0.32
DB00181	Baclofen	inflammatory bowel diseases	119	0.34
DB00181	Baclofen	gastroenteritis	122	0.35
DB00181	Baclofen	hyperinsulinism	26	0.43
DB00181	Baclofen	diabetes mellitus	162	0.45
DB00181	Baclofen	insulin resistance	26	0.48
DB00181	Baclofen	bone diseases	144	0.49
DB00181	Baclofen	arrhythmias cardiac	30	0.49
DB00181	Baclofen	collagen diseases	25	0.51
DB00181	Baclofen	bone diseases metabolic	27	0.55
DB00181	Baclofen	eye diseases	231	0.61
DB00181	Baclofen	vascular diseases	181	0.63
DB00181	Baclofen	metabolism inborn errors	289	0.64
DB00181	Baclofen	coronary artery disease	31	0.68
DB00181	Baclofen	mycobacterium infections	22	0.68
DB00181	Baclofen	macular degeneration	44	0.71
DB00181	Baclofen	autoimmune diseases	243	0.75
DB00181	Baclofen	coronary disease	37	0.78
DB00181	Baclofen	kidney neoplasms	20	0.82
DB00181	Baclofen	bacterial infections	26	0.86
DB00181	Baclofen	anemia hemolytic	29	0.87
DB00181	Baclofen	hypopigmentation	22	0.88
DB00181	Baclofen	skin diseases	278	0.90
DB00181	Baclofen	liver cirrhosis	24	0.93
DB00181	Baclofen	cardiovascular diseases	330	0.94
DB00181	Baclofen	myocardial ischemia	43	0.95
DB00181	Baclofen	liver cirrhosis biliary	23	0.96
DB00181	Baclofen	pancreatic diseases	24	1.00
DB00181	Baclofen	asthma	36	1.00
DB00181	Baclofen	arteriosclerosis	38	1.01
DB00181	Baclofen	cardiomyopathy dilated	29	1.10
DB00181	Baclofen	hypersensitivity	45	1.20
DB00181	Baclofen	arterial occlusive diseases	44	1.22
DB00181	Baclofen	blood coagulation disorders	40	1.30
DB00181	Baclofen	colitis ulcerative	55	1.45
DB00181	Baclofen	colitis	55	1.47
DB00181	Baclofen	arthritis rheumatoid	42	1.51
DB00181	Baclofen	head and neck neoplasms	35	1.51
DB00181	Baclofen	psoriasis	54	1.52
DB00181	Baclofen	rheumatic diseases	59	1.75
DB00181	Baclofen	diabetes mellitus type 1	82	1.76
DB00181	Baclofen	lupus erythematosus systemic	75	1.77
DB00181	Baclofen	arthritis	76	1.84
DB00181	Baclofen	joint diseases	79	1.88
DB00181	Baclofen	lung diseases	71	1.88
DB00181	Baclofen	heart diseases	167	2.12
DB00421	Spironolactone	kidney diseases	144	-3.16
DB00421	Spironolactone	metabolism inborn errors	289	-3.00
DB00421	Spironolactone	sarcoma	25	-2.22
DB00421	Spironolactone	neoplasms	482	-2.10
DB00421	Spironolactone	motor neuron disease	31	-2.08
DB00421	Spironolactone	prostatic neoplasms	61	-2.05
DB00421	Spironolactone	spinal cord diseases	59	-2.03
DB00421	Spironolactone	varicose veins	20	-1.72
DB00421	Spironolactone	vascular diseases	181	-1.56
DB00421	Spironolactone	parkinson disease	30	-1.27
DB00421	Spironolactone	parkinsonian disorders	31	-1.25
DB00421	Spironolactone	endocrine system diseases	291	-1.16
DB00421	Spironolactone	keratosis	21	-1.15
DB00421	Spironolactone	coronary artery disease	31	-1.13
DB00421	Spironolactone	coronary disease	37	-1.07
DB00421	Spironolactone	skin diseases	278	-1.05
DB00421	Spironolactone	cardiovascular diseases	330	-1.03
DB00421	Spironolactone	myocardial ischemia	43	-1.01
DB00421	Spironolactone	arteriosclerosis	38	-0.96
DB00421	Spironolactone	kidney neoplasms	20	-0.95
DB00421	Spironolactone	malabsorption syndromes	34	-0.92
DB00421	Spironolactone	amyotrophic lateral sclerosis	21	-0.85
DB00421	Spironolactone	liver cirrhosis biliary	23	-0.76
DB00421	Spironolactone	colitis	55	-0.75
DB00421	Spironolactone	arterial occlusive diseases	44	-0.74
DB00421	Spironolactone	colitis ulcerative	55	-0.73
DB00421	Spironolactone	liver cirrhosis	24	-0.72
DB00421	Spironolactone	asthma	36	-0.69
DB00421	Spironolactone	diabetes mellitus type 2	72	-0.68
DB00421	Spironolactone	pancreatic diseases	24	-0.65
DB00421	Spironolactone	hypersensitivity	45	-0.52
DB00421	Spironolactone	lymphoma non hodgkin	22	-0.51
DB00421	Spironolactone	head and neck neoplasms	35	-0.49
DB00421	Spironolactone	lymphoma	24	-0.48
DB00421	Spironolactone	adenocarcinoma	32	-0.44
DB00421	Spironolactone	diabetes mellitus type 1	82	-0.26
DB00421	Spironolactone	breast neoplasms	40	-0.25
DB00421	Spironolactone	lupus erythematosus systemic	75	-0.24
DB00421	Spironolactone	crohn disease	71	-0.22
DB00421	Spironolactone	arrhythmias cardiac	30	-0.16
DB00421	Spironolactone	epilepsy	25	-0.13
DB00421	Spironolactone	multiple sclerosis	69	-0.10
DB00421	Spironolactone	leukemia myeloid acute	43	-0.09
DB00421	Spironolactone	bone diseases metabolic	27	-0.08
DB00421	Spironolactone	colorectal neoplasms	42	-0.08
DB00421	Spironolactone	intestinal neoplasms	42	-0.04
DB00421	Spironolactone	leukemia lymphoid	66	-0.02
DB00421	Spironolactone	inflammatory bowel diseases	119	0.02
DB00421	Spironolactone	gastroenteritis	122	0.05
DB00421	Spironolactone	lung diseases	71	0.08
DB00421	Spironolactone	diabetes mellitus	162	0.14
DB00421	Spironolactone	gastrointestinal neoplasms	72	0.26
DB00421	Spironolactone	heart diseases	167	0.29
DB00421	Spironolactone	anemia hemolytic	29	0.32
DB00421	Spironolactone	bone diseases	144	0.36
DB00421	Spironolactone	thyroid diseases	30	0.40
DB00421	Spironolactone	leukemia	117	0.47
DB00421	Spironolactone	eye diseases	231	0.49
DB00421	Spironolactone	hypopigmentation	22	0.52
DB00421	Spironolactone	mycobacterium infections	22	0.52
DB00421	Spironolactone	autoimmune diseases	243	0.55
DB00421	Spironolactone	cardiomyopathy dilated	29	0.59
DB00421	Spironolactone	alzheimer disease	29	0.62
DB00421	Spironolactone	hematologic diseases	188	0.63
DB00421	Spironolactone	bacterial infections	26	0.69
DB00421	Spironolactone	neuroendocrine tumors	24	0.89
DB00421	Spironolactone	dementia	42	1.14
DB00421	Spironolactone	arthritis rheumatoid	42	1.21
DB00421	Spironolactone	collagen diseases	25	1.35
DB00421	Spironolactone	psoriasis	54	1.40
DB00421	Spironolactone	hyperinsulinism	26	1.40
DB00421	Spironolactone	insulin resistance	26	1.43
DB00421	Spironolactone	macular degeneration	44	1.58
DB00421	Spironolactone	rheumatic diseases	59	1.67
DB00421	Spironolactone	arthritis	76	1.73
DB00421	Spironolactone	joint diseases	79	1.82
DB00421	Spironolactone	anemia	58	1.94
DB00421	Spironolactone	blood coagulation disorders	40	2.18
DB00549	Zafirlukast	mycobacterium infections	22	-1.65
DB00549	Zafirlukast	malabsorption syndromes	34	-1.56
DB00549	Zafirlukast	coronary artery disease	31	-1.55
DB00549	Zafirlukast	keratosis	21	-1.54
DB00549	Zafirlukast	bacterial infections	26	-1.54
DB00549	Zafirlukast	parkinsonian disorders	31	-1.49
DB00549	Zafirlukast	arteriosclerosis	38	-1.49
DB00549	Zafirlukast	asthma	36	-1.49
DB00549	Zafirlukast	parkinson disease	30	-1.48
DB00549	Zafirlukast	coronary disease	37	-1.47
DB00549	Zafirlukast	sarcoma	25	-1.46
DB00549	Zafirlukast	myocardial ischemia	43	-1.43
DB00549	Zafirlukast	hypersensitivity	45	-1.35
DB00549	Zafirlukast	arterial occlusive diseases	44	-1.24
DB00549	Zafirlukast	dementia	42	-1.23
DB00549	Zafirlukast	prostatic neoplasms	61	-1.23
DB00549	Zafirlukast	colitis ulcerative	55	-1.23
DB00549	Zafirlukast	colitis	55	-1.18
DB00549	Zafirlukast	psoriasis	54	-1.18
DB00549	Zafirlukast	diabetes mellitus type 2	72	-1.09
DB00549	Zafirlukast	lupus erythematosus systemic	75	-1.08
DB00549	Zafirlukast	joint diseases	79	-1.07
DB00549	Zafirlukast	multiple sclerosis	69	-1.07
DB00549	Zafirlukast	crohn disease	71	-1.05
DB00549	Zafirlukast	diabetes mellitus type 1	82	-0.99
DB00549	Zafirlukast	arthritis	76	-0.99
DB00549	Zafirlukast	lung diseases	71	-0.95
DB00549	Zafirlukast	gastroenteritis	122	-0.87
DB00549	Zafirlukast	gastrointestinal neoplasms	72	-0.87
DB00549	Zafirlukast	inflammatory bowel diseases	119	-0.85
DB00549	Zafirlukast	kidney diseases	144	-0.82
DB00549	Zafirlukast	heart diseases	167	-0.74
DB00549	Zafirlukast	bone diseases	144	-0.72
DB00549	Zafirlukast	diabetes mellitus	162	-0.67
DB00549	Zafirlukast	vascular diseases	181	-0.64
DB00549	Zafirlukast	eye diseases	231	-0.59
DB00549	Zafirlukast	hematologic diseases	188	-0.58
DB00549	Zafirlukast	metabolism inborn errors	289	-0.54
DB00549	Zafirlukast	skin diseases	278	-0.49
DB00549	Zafirlukast	autoimmune diseases	243	-0.47
DB00549	Zafirlukast	cardiovascular diseases	330	-0.42
DB00549	Zafirlukast	endocrine system diseases	291	-0.39
DB00549	Zafirlukast	neoplasms	482	-0.23
DB00549	Zafirlukast	varicose veins	20	-0.16
DB00549	Zafirlukast	bone diseases metabolic	27	-0.07
DB00549	Zafirlukast	epilepsy	25	-0.07
DB00549	Zafirlukast	arrhythmias cardiac	30	-0.06
DB00549	Zafirlukast	insulin resistance	26	-0.04
DB00549	Zafirlukast	hyperinsulinism	26	-0.04
DB00549	Zafirlukast	collagen diseases	25	0.01
DB00549	Zafirlukast	macular degeneration	44	0.06
DB00549	Zafirlukast	anemia hemolytic	29	0.07
DB00549	Zafirlukast	hypopigmentation	22	0.09
DB00549	Zafirlukast	amyotrophic lateral sclerosis	21	0.10
DB00549	Zafirlukast	thyroid diseases	30	0.10
DB00549	Zafirlukast	kidney neoplasms	20	0.10
DB00549	Zafirlukast	neuroendocrine tumors	24	0.12
DB00549	Zafirlukast	liver cirrhosis biliary	23	0.13
DB00549	Zafirlukast	liver cirrhosis	24	0.13
DB00549	Zafirlukast	pancreatic diseases	24	0.13
DB00549	Zafirlukast	alzheimer disease	29	0.16
DB00549	Zafirlukast	cardiomyopathy dilated	29	0.18
DB00549	Zafirlukast	lymphoma non hodgkin	22	0.20
DB00549	Zafirlukast	lymphoma	24	0.25
DB00549	Zafirlukast	blood coagulation disorders	40	0.26
DB00549	Zafirlukast	arthritis rheumatoid	42	0.27
DB00549	Zafirlukast	adenocarcinoma	32	0.28
DB00549	Zafirlukast	motor neuron disease	31	0.29
DB00549	Zafirlukast	head and neck neoplasms	35	0.34
DB00549	Zafirlukast	breast neoplasms	40	0.43
DB00549	Zafirlukast	leukemia myeloid acute	43	0.46
DB00549	Zafirlukast	rheumatic diseases	59	0.47
DB00549	Zafirlukast	colorectal neoplasms	42	0.48
DB00549	Zafirlukast	intestinal neoplasms	42	0.49
DB00549	Zafirlukast	spinal cord diseases	59	0.51
DB00549	Zafirlukast	anemia	58	0.58
DB00549	Zafirlukast	leukemia lymphoid	66	0.58
DB00549	Zafirlukast	leukemia	117	0.85
DB01039	Fenofibrate	sarcoma	25	-2.05
DB01039	Fenofibrate	colitis	55	-1.99
DB01039	Fenofibrate	colitis ulcerative	55	-1.91
DB01039	Fenofibrate	breast neoplasms	40	-1.82
DB01039	Fenofibrate	diabetes mellitus type 2	72	-1.80
DB01039	Fenofibrate	multiple sclerosis	69	-1.70
DB01039	Fenofibrate	crohn disease	71	-1.62
DB01039	Fenofibrate	diabetes mellitus type 1	82	-1.55
DB01039	Fenofibrate	leukemia myeloid acute	43	-1.43
DB01039	Fenofibrate	gastroenteritis	122	-1.21
DB01039	Fenofibrate	inflammatory bowel diseases	119	-1.18
DB01039	Fenofibrate	diabetes mellitus	162	-1.16
DB01039	Fenofibrate	bone diseases	144	-0.96
DB01039	Fenofibrate	leukemia	117	-0.83
DB01039	Fenofibrate	autoimmune diseases	243	-0.61
DB01039	Fenofibrate	skin diseases	278	-0.48
DB01039	Fenofibrate	endocrine system diseases	291	-0.47
DB01039	Fenofibrate	varicose veins	20	-0.04
DB01039	Fenofibrate	epilepsy	25	0.03
DB01039	Fenofibrate	neoplasms	482	0.05
DB01039	Fenofibrate	insulin resistance	26	0.10
DB01039	Fenofibrate	collagen diseases	25	0.11
DB01039	Fenofibrate	arrhythmias cardiac	30	0.11
DB01039	Fenofibrate	hyperinsulinism	26	0.13
DB01039	Fenofibrate	mycobacterium infections	22	0.16
DB01039	Fenofibrate	bone diseases metabolic	27	0.18
DB01039	Fenofibrate	macular degeneration	44	0.23
DB01039	Fenofibrate	coronary artery disease	31	0.23
DB01039	Fenofibrate	bacterial infections	26	0.27
DB01039	Fenofibrate	coronary disease	37	0.27
DB01039	Fenofibrate	keratosis	21	0.28
DB01039	Fenofibrate	anemia hemolytic	29	0.29
DB01039	Fenofibrate	liver cirrhosis	24	0.29
DB01039	Fenofibrate	liver cirrhosis biliary	23	0.29
DB01039	Fenofibrate	thyroid diseases	30	0.30
DB01039	Fenofibrate	hypopigmentation	22	0.33
DB01039	Fenofibrate	pancreatic diseases	24	0.33
DB01039	Fenofibrate	parkinson disease	30	0.34
DB01039	Fenofibrate	alzheimer disease	29	0.34
DB01039	Fenofibrate	malabsorption syndromes	34	0.35
DB01039	Fenofibrate	parkinsonian disorders	31	0.35
DB01039	Fenofibrate	myocardial ischemia	43	0.35
DB01039	Fenofibrate	arteriosclerosis	38	0.36
DB01039	Fenofibrate	asthma	36	0.36
DB01039	Fenofibrate	kidney neoplasms	20	0.36
DB01039	Fenofibrate	cardiomyopathy dilated	29	0.36
DB01039	Fenofibrate	arterial occlusive diseases	44	0.37
DB01039	Fenofibrate	amyotrophic lateral sclerosis	21	0.37
DB01039	Fenofibrate	lymphoma non hodgkin	22	0.40
DB01039	Fenofibrate	neuroendocrine tumors	24	0.41
DB01039	Fenofibrate	hypersensitivity	45	0.42
DB01039	Fenofibrate	lymphoma	24	0.42
DB01039	Fenofibrate	blood coagulation disorders	40	0.43
DB01039	Fenofibrate	motor neuron disease	31	0.44
DB01039	Fenofibrate	arthritis rheumatoid	42	0.46
DB01039	Fenofibrate	prostatic neoplasms	61	0.50
DB01039	Fenofibrate	adenocarcinoma	32	0.51
DB01039	Fenofibrate	head and neck neoplasms	35	0.54
DB01039	Fenofibrate	psoriasis	54	0.55
DB01039	Fenofibrate	dementia	42	0.56
DB01039	Fenofibrate	intestinal neoplasms	42	0.58
DB01039	Fenofibrate	rheumatic diseases	59	0.58
DB01039	Fenofibrate	colorectal neoplasms	42	0.61
DB01039	Fenofibrate	lupus erythematosus systemic	75	0.62
DB01039	Fenofibrate	anemia	58	0.64
DB01039	Fenofibrate	arthritis	76	0.65
DB01039	Fenofibrate	spinal cord diseases	59	0.66
DB01039	Fenofibrate	leukemia lymphoid	66	0.67
DB01039	Fenofibrate	joint diseases	79	0.67
DB01039	Fenofibrate	lung diseases	71	0.70
DB01039	Fenofibrate	kidney diseases	144	0.83
DB01039	Fenofibrate	gastrointestinal neoplasms	72	0.85
DB01039	Fenofibrate	heart diseases	167	1.01
DB01039	Fenofibrate	eye diseases	231	1.08
DB01039	Fenofibrate	vascular diseases	181	1.19
DB01039	Fenofibrate	metabolism inborn errors	289	1.28
DB01039	Fenofibrate	hematologic diseases	188	1.48
DB01039	Fenofibrate	cardiovascular diseases	330	1.72
DB00482	Celecoxib	adenocarcinoma	32	-2.42
DB00482	Celecoxib	varicose veins	20	-1.85
DB00482	Celecoxib	macular degeneration	44	-1.81
DB00482	Celecoxib	coronary artery disease	31	-1.67
DB00482	Celecoxib	gastrointestinal neoplasms	72	-1.63
DB00482	Celecoxib	myocardial ischemia	43	-1.62
DB00482	Celecoxib	coronary disease	37	-1.61
DB00482	Celecoxib	malabsorption syndromes	34	-1.40
DB00482	Celecoxib	kidney neoplasms	20	-1.37
DB00482	Celecoxib	arteriosclerosis	38	-1.37
DB00482	Celecoxib	neuroendocrine tumors	24	-1.29
DB00482	Celecoxib	eye diseases	231	-1.25
DB00482	Celecoxib	metabolism inborn errors	289	-1.23
DB00482	Celecoxib	arterial occlusive diseases	44	-1.12
DB00482	Celecoxib	colitis ulcerative	55	-1.00
DB00482	Celecoxib	colitis	55	-0.99
DB00482	Celecoxib	arthritis rheumatoid	42	-0.98
DB00482	Celecoxib	endocrine system diseases	291	-0.95
DB00482	Celecoxib	psoriasis	54	-0.88
DB00482	Celecoxib	skin diseases	278	-0.84
DB00482	Celecoxib	head and neck neoplasms	35	-0.82
DB00482	Celecoxib	breast neoplasms	40	-0.76
DB00482	Celecoxib	diabetes mellitus type 2	72	-0.76
DB00482	Celecoxib	rheumatic diseases	59	-0.70
DB00482	Celecoxib	lupus erythematosus systemic	75	-0.66
DB00482	Celecoxib	diabetes mellitus type 1	82	-0.65
DB00482	Celecoxib	crohn disease	71	-0.65
DB00482	Celecoxib	multiple sclerosis	69	-0.61
DB00482	Celecoxib	spinal cord diseases	59	-0.57
DB00482	Celecoxib	intestinal neoplasms	42	-0.55
DB00482	Celecoxib	joint diseases	79	-0.54
DB00482	Celecoxib	colorectal neoplasms	42	-0.51
DB00482	Celecoxib	arthritis	76	-0.48
DB00482	Celecoxib	lung diseases	71	-0.38
DB00482	Celecoxib	anemia	58	-0.36
DB00482	Celecoxib	inflammatory bowel diseases	119	-0.29
DB00482	Celecoxib	gastroenteritis	122	-0.27
DB00482	Celecoxib	neoplasms	482	-0.27
DB00482	Celecoxib	kidney diseases	144	-0.21
DB00482	Celecoxib	arrhythmias cardiac	30	-0.15
DB00482	Celecoxib	insulin resistance	26	-0.13
DB00482	Celecoxib	diabetes mellitus	162	-0.11
DB00482	Celecoxib	hyperinsulinism	26	-0.10
DB00482	Celecoxib	heart diseases	167	-0.06
DB00482	Celecoxib	collagen diseases	25	-0.06
DB00482	Celecoxib	bone diseases metabolic	27	-0.02
DB00482	Celecoxib	bone diseases	144	0.01
DB00482	Celecoxib	keratosis	21	0.14
DB00482	Celecoxib	anemia hemolytic	29	0.16
DB00482	Celecoxib	parkinson disease	30	0.25
DB00482	Celecoxib	thyroid diseases	30	0.26
DB00482	Celecoxib	parkinsonian disorders	31	0.29
DB00482	Celecoxib	vascular diseases	181	0.29
DB00482	Celecoxib	amyotrophic lateral sclerosis	21	0.34
DB00482	Celecoxib	alzheimer disease	29	0.39
DB00482	Celecoxib	pancreatic diseases	24	0.41
DB00482	Celecoxib	cardiomyopathy dilated	29	0.43
DB00482	Celecoxib	blood coagulation disorders	40	0.45
DB00482	Celecoxib	asthma	36	0.46
DB00482	Celecoxib	hypersensitivity	45	0.50
DB00482	Celecoxib	hematologic diseases	188	0.53
DB00482	Celecoxib	sarcoma	25	0.53
DB00482	Celecoxib	autoimmune diseases	243	0.56
DB00482	Celecoxib	motor neuron disease	31	0.61
DB00482	Celecoxib	lymphoma non hodgkin	22	0.63
DB00482	Celecoxib	lymphoma	24	0.65
DB00482	Celecoxib	dementia	42	0.71
DB00482	Celecoxib	prostatic neoplasms	61	0.73
DB00482	Celecoxib	cardiovascular diseases	330	0.79
DB00482	Celecoxib	leukemia myeloid acute	43	1.04
DB00482	Celecoxib	leukemia lymphoid	66	1.15
DB00482	Celecoxib	epilepsy	25	1.60
DB00482	Celecoxib	leukemia	117	1.81
DB00482	Celecoxib	mycobacterium infections	22	1.92
DB00482	Celecoxib	bacterial infections	26	1.95
DB00482	Celecoxib	hypopigmentation	22	1.98
DB00482	Celecoxib	liver cirrhosis	24	2.07
DB00482	Celecoxib	liver cirrhosis biliary	23	2.14
DB00641	Simvastatin	vascular diseases	181	-1.71
DB00641	Simvastatin	hematologic diseases	188	-1.43
DB00641	Simvastatin	diabetes mellitus type 2	72	-1.21
DB00641	Simvastatin	cardiovascular diseases	330	-1.21
DB00641	Simvastatin	skin diseases	278	-1.19
DB00641	Simvastatin	lupus erythematosus systemic	75	-0.94
DB00641	Simvastatin	spinal cord diseases	59	-0.87
DB00641	Simvastatin	multiple sclerosis	69	-0.87
DB00641	Simvastatin	diabetes mellitus type 1	82	-0.86
DB00641	Simvastatin	neoplasms	482	-0.61
DB00641	Simvastatin	kidney diseases	144	-0.55
DB00641	Simvastatin	insulin resistance	26	-0.43
DB00641	Simvastatin	hyperinsulinism	26	-0.41
DB00641	Simvastatin	epilepsy	25	-0.38
DB00641	Simvastatin	diabetes mellitus	162	-0.38
DB00641	Simvastatin	heart diseases	167	-0.34
DB00641	Simvastatin	arrhythmias cardiac	30	-0.34
DB00641	Simvastatin	bone diseases metabolic	27	-0.33
DB00641	Simvastatin	collagen diseases	25	-0.31
DB00641	Simvastatin	coronary artery disease	31	-0.19
DB00641	Simvastatin	mycobacterium infections	22	-0.17
DB00641	Simvastatin	leukemia	117	-0.12
DB00641	Simvastatin	keratosis	21	-0.11
DB00641	Simvastatin	coronary disease	37	-0.08
DB00641	Simvastatin	metabolism inborn errors	289	-0.07
DB00641	Simvastatin	malabsorption syndromes	34	-0.05
DB00641	Simvastatin	bacterial infections	26	-0.03
DB00641	Simvastatin	anemia hemolytic	29	-0.03
DB00641	Simvastatin	kidney neoplasms	20	0.00
DB00641	Simvastatin	liver cirrhosis biliary	23	0.00
DB00641	Simvastatin	myocardial ischemia	43	0.02
DB00641	Simvastatin	hypopigmentation	22	0.02
DB00641	Simvastatin	liver cirrhosis	24	0.04
DB00641	Simvastatin	parkinsonian disorders	31	0.04
DB00641	Simvastatin	arteriosclerosis	38	0.06
DB00641	Simvastatin	parkinson disease	30	0.07
DB00641	Simvastatin	pancreatic diseases	24	0.07
DB00641	Simvastatin	alzheimer disease	29	0.11
DB00641	Simvastatin	neuroendocrine tumors	24	0.13
DB00641	Simvastatin	amyotrophic lateral sclerosis	21	0.16
DB00641	Simvastatin	asthma	36	0.19
DB00641	Simvastatin	cardiomyopathy dilated	29	0.19
DB00641	Simvastatin	autoimmune diseases	243	0.20
DB00641	Simvastatin	sarcoma	25	0.22
DB00641	Simvastatin	arterial occlusive diseases	44	0.24
DB00641	Simvastatin	blood coagulation disorders	40	0.25
DB00641	Simvastatin	hypersensitivity	45	0.26
DB00641	Simvastatin	endocrine system diseases	291	0.32
DB00641	Simvastatin	lymphoma non hodgkin	22	0.34
DB00641	Simvastatin	lymphoma	24	0.38
DB00641	Simvastatin	colitis ulcerative	55	0.38
DB00641	Simvastatin	arthritis rheumatoid	42	0.38
DB00641	Simvastatin	colitis	55	0.41
DB00641	Simvastatin	motor neuron disease	31	0.41
DB00641	Simvastatin	adenocarcinoma	32	0.45
DB00641	Simvastatin	head and neck neoplasms	35	0.50
DB00641	Simvastatin	prostatic neoplasms	61	0.51
DB00641	Simvastatin	dementia	42	0.51
DB00641	Simvastatin	breast neoplasms	40	0.53
DB00641	Simvastatin	rheumatic diseases	59	0.59
DB00641	Simvastatin	crohn disease	71	0.67
DB00641	Simvastatin	intestinal neoplasms	42	0.69
DB00641	Simvastatin	colorectal neoplasms	42	0.75
DB00641	Simvastatin	joint diseases	79	0.78
DB00641	Simvastatin	leukemia myeloid acute	43	0.80
DB00641	Simvastatin	arthritis	76	0.82
DB00641	Simvastatin	anemia	58	0.84
DB00641	Simvastatin	lung diseases	71	0.85
DB00641	Simvastatin	leukemia lymphoid	66	0.89
DB00641	Simvastatin	gastroenteritis	122	0.97
DB00641	Simvastatin	inflammatory bowel diseases	119	1.02
DB00641	Simvastatin	varicose veins	20	1.13
DB00641	Simvastatin	gastrointestinal neoplasms	72	1.14
DB00641	Simvastatin	bone diseases	144	1.18
DB00641	Simvastatin	eye diseases	231	1.42
DB00641	Simvastatin	macular degeneration	44	1.44
DB00641	Simvastatin	thyroid diseases	30	1.49
DB00641	Simvastatin	psoriasis	54	2.26
DB01033	Mercaptopurine	metabolism inborn errors	289	-2.88
DB01033	Mercaptopurine	neuroendocrine tumors	24	-2.57
DB01033	Mercaptopurine	kidney neoplasms	20	-2.53
DB01033	Mercaptopurine	adenocarcinoma	32	-2.51
DB01033	Mercaptopurine	anemia hemolytic	29	-2.39
DB01033	Mercaptopurine	lupus erythematosus systemic	75	-2.27
DB01033	Mercaptopurine	psoriasis	54	-2.16
DB01033	Mercaptopurine	colitis ulcerative	55	-2.15
DB01033	Mercaptopurine	hypopigmentation	22	-2.15
DB01033	Mercaptopurine	colitis	55	-2.13
DB01033	Mercaptopurine	head and neck neoplasms	35	-2.11
DB01033	Mercaptopurine	multiple sclerosis	69	-1.89
DB01033	Mercaptopurine	anemia	58	-1.86
DB01033	Mercaptopurine	kidney diseases	144	-1.76
DB01033	Mercaptopurine	inflammatory bowel diseases	119	-1.51
DB01033	Mercaptopurine	gastroenteritis	122	-1.48
DB01033	Mercaptopurine	vascular diseases	181	-1.18
DB01033	Mercaptopurine	eye diseases	231	-1.17
DB01033	Mercaptopurine	hematologic diseases	188	-0.97
DB01033	Mercaptopurine	autoimmune diseases	243	-0.93
DB01033	Mercaptopurine	skin diseases	278	-0.80
DB01033	Mercaptopurine	cardiovascular diseases	330	-0.77
DB01033	Mercaptopurine	epilepsy	25	-0.35
DB01033	Mercaptopurine	neoplasms	482	-0.34
DB01033	Mercaptopurine	varicose veins	20	-0.34
DB01033	Mercaptopurine	arrhythmias cardiac	30	-0.25
DB01033	Mercaptopurine	bone diseases metabolic	27	-0.22
DB01033	Mercaptopurine	collagen diseases	25	-0.21
DB01033	Mercaptopurine	insulin resistance	26	-0.17
DB01033	Mercaptopurine	hyperinsulinism	26	-0.17
DB01033	Mercaptopurine	keratosis	21	-0.16
DB01033	Mercaptopurine	macular degeneration	44	-0.15
DB01033	Mercaptopurine	mycobacterium infections	22	-0.12
DB01033	Mercaptopurine	coronary artery disease	31	-0.10
DB01033	Mercaptopurine	liver cirrhosis	24	-0.08
DB01033	Mercaptopurine	thyroid diseases	30	-0.08
DB01033	Mercaptopurine	bacterial infections	26	-0.05
DB01033	Mercaptopurine	amyotrophic lateral sclerosis	21	-0.04
DB01033	Mercaptopurine	pancreatic diseases	24	-0.04
DB01033	Mercaptopurine	coronary disease	37	-0.02
DB01033	Mercaptopurine	liver cirrhosis biliary	23	-0.02
DB01033	Mercaptopurine	alzheimer disease	29	0.02
DB01033	Mercaptopurine	myocardial ischemia	43	0.02
DB01033	Mercaptopurine	arteriosclerosis	38	0.03
DB01033	Mercaptopurine	cardiomyopathy dilated	29	0.04
DB01033	Mercaptopurine	parkinson disease	30	0.04
DB01033	Mercaptopurine	malabsorption syndromes	34	0.04
DB01033	Mercaptopurine	parkinsonian disorders	31	0.05
DB01033	Mercaptopurine	sarcoma	25	0.06
DB01033	Mercaptopurine	asthma	36	0.06
DB01033	Mercaptopurine	lymphoma	24	0.07
DB01033	Mercaptopurine	arterial occlusive diseases	44	0.08
DB01033	Mercaptopurine	blood coagulation disorders	40	0.10
DB01033	Mercaptopurine	lymphoma non hodgkin	22	0.11
DB01033	Mercaptopurine	motor neuron disease	31	0.12
DB01033	Mercaptopurine	hypersensitivity	45	0.13
DB01033	Mercaptopurine	dementia	42	0.20
DB01033	Mercaptopurine	arthritis rheumatoid	42	0.21
DB01033	Mercaptopurine	prostatic neoplasms	61	0.24
DB01033	Mercaptopurine	breast neoplasms	40	0.27
DB01033	Mercaptopurine	diabetes mellitus type 2	72	0.29
DB01033	Mercaptopurine	spinal cord diseases	59	0.31
DB01033	Mercaptopurine	rheumatic diseases	59	0.32
DB01033	Mercaptopurine	crohn disease	71	0.33
DB01033	Mercaptopurine	colorectal neoplasms	42	0.34
DB01033	Mercaptopurine	intestinal neoplasms	42	0.34
DB01033	Mercaptopurine	leukemia myeloid acute	43	0.36
DB01033	Mercaptopurine	diabetes mellitus type 1	82	0.36
DB01033	Mercaptopurine	arthritis	76	0.38
DB01033	Mercaptopurine	lung diseases	71	0.40
DB01033	Mercaptopurine	joint diseases	79	0.40
DB01033	Mercaptopurine	leukemia lymphoid	66	0.43
DB01033	Mercaptopurine	diabetes mellitus	162	0.53
DB01033	Mercaptopurine	gastrointestinal neoplasms	72	0.59
DB01033	Mercaptopurine	heart diseases	167	0.64
DB01033	Mercaptopurine	bone diseases	144	0.65
DB01033	Mercaptopurine	leukemia	117	0.73
DB01033	Mercaptopurine	endocrine system diseases	291	1.01
DB01037	Selegiline	coronary artery disease	31	-3.78
DB01037	Selegiline	coronary disease	37	-3.78
DB01037	Selegiline	myocardial ischemia	43	-3.74
DB01037	Selegiline	keratosis	21	-3.66
DB01037	Selegiline	bone diseases metabolic	27	-3.53
DB01037	Selegiline	arteriosclerosis	38	-3.49
DB01037	Selegiline	arterial occlusive diseases	44	-3.17
DB01037	Selegiline	head and neck neoplasms	35	-2.69
DB01037	Selegiline	heart diseases	167	-1.56
DB01037	Selegiline	gastrointestinal neoplasms	72	-1.51
DB01037	Selegiline	bone diseases	144	-1.46
DB01037	Selegiline	vascular diseases	181	-1.16
DB01037	Selegiline	metabolism inborn errors	289	-1.08
DB01037	Selegiline	diabetes mellitus type 2	72	-0.87
DB01037	Selegiline	cardiovascular diseases	330	-0.75
DB01037	Selegiline	skin diseases	278	-0.75
DB01037	Selegiline	diabetes mellitus	162	-0.18
DB01037	Selegiline	neoplasms	482	-0.10
DB01037	Selegiline	mycobacterium infections	22	0.13
DB01037	Selegiline	kidney neoplasms	20	0.25
DB01037	Selegiline	anemia hemolytic	29	0.25
DB01037	Selegiline	malabsorption syndromes	34	0.30
DB01037	Selegiline	bacterial infections	26	0.31
DB01037	Selegiline	liver cirrhosis biliary	23	0.32
DB01037	Selegiline	hypopigmentation	22	0.34
DB01037	Selegiline	liver cirrhosis	24	0.35
DB01037	Selegiline	asthma	36	0.35
DB01037	Selegiline	neuroendocrine tumors	24	0.36
DB01037	Selegiline	parkinsonian disorders	31	0.38
DB01037	Selegiline	parkinson disease	30	0.39
DB01037	Selegiline	amyotrophic lateral sclerosis	21	0.42
DB01037	Selegiline	hypersensitivity	45	0.42
DB01037	Selegiline	sarcoma	25	0.47
DB01037	Selegiline	lymphoma non hodgkin	22	0.48
DB01037	Selegiline	alzheimer disease	29	0.48
DB01037	Selegiline	motor neuron disease	31	0.51
DB01037	Selegiline	lymphoma	24	0.53
DB01037	Selegiline	arthritis rheumatoid	42	0.60
DB01037	Selegiline	colitis	55	0.63
DB01037	Selegiline	colitis ulcerative	55	0.63
DB01037	Selegiline	prostatic neoplasms	61	0.64
DB01037	Selegiline	adenocarcinoma	32	0.65
DB01037	Selegiline	psoriasis	54	0.68
DB01037	Selegiline	breast neoplasms	40	0.71
DB01037	Selegiline	dementia	42	0.71
DB01037	Selegiline	endocrine system diseases	291	0.72
DB01037	Selegiline	rheumatic diseases	59	0.74
DB01037	Selegiline	lupus erythematosus systemic	75	0.78
DB01037	Selegiline	multiple sclerosis	69	0.78
DB01037	Selegiline	crohn disease	71	0.79
DB01037	Selegiline	leukemia myeloid acute	43	0.81
DB01037	Selegiline	diabetes mellitus type 1	82	0.83
DB01037	Selegiline	intestinal neoplasms	42	0.85
DB01037	Selegiline	spinal cord diseases	59	0.86
DB01037	Selegiline	joint diseases	79	0.87
DB01037	Selegiline	arthritis	76	0.89
DB01037	Selegiline	colorectal neoplasms	42	0.91
DB01037	Selegiline	lung diseases	71	0.93
DB01037	Selegiline	leukemia lymphoid	66	0.95
DB01037	Selegiline	anemia	58	1.01
DB01037	Selegiline	inflammatory bowel diseases	119	1.08
DB01037	Selegiline	gastroenteritis	122	1.10
DB01037	Selegiline	kidney diseases	144	1.11
DB01037	Selegiline	leukemia	117	1.47
DB01037	Selegiline	eye diseases	231	1.51
DB01037	Selegiline	varicose veins	20	1.72
DB01037	Selegiline	autoimmune diseases	243	1.80
DB01037	Selegiline	hematologic diseases	188	1.87
DB01037	Selegiline	arrhythmias cardiac	30	1.87
DB01037	Selegiline	hyperinsulinism	26	1.88
DB01037	Selegiline	insulin resistance	26	1.88
DB01037	Selegiline	collagen diseases	25	1.90
DB01037	Selegiline	pancreatic diseases	24	2.15
DB01037	Selegiline	blood coagulation disorders	40	2.17
DB01037	Selegiline	cardiomyopathy dilated	29	2.18
DB01037	Selegiline	macular degeneration	44	2.20
DB01037	Selegiline	thyroid diseases	30	2.29
DB01037	Selegiline	epilepsy	25	3.66
DB01035	Procainamide	arrhythmias cardiac	30	-3.31
DB01035	Procainamide	cardiomyopathy dilated	29	-3.09
DB01035	Procainamide	cardiovascular diseases	330	-2.34
DB01035	Procainamide	thyroid diseases	30	-1.75
DB01035	Procainamide	heart diseases	167	-1.71
DB01035	Procainamide	autoimmune diseases	243	-1.54
DB01035	Procainamide	colitis	55	-1.45
DB01035	Procainamide	colitis ulcerative	55	-1.45
DB01035	Procainamide	sarcoma	25	-1.38
DB01035	Procainamide	hematologic diseases	188	-1.32
DB01035	Procainamide	lupus erythematosus systemic	75	-1.26
DB01035	Procainamide	multiple sclerosis	69	-1.17
DB01035	Procainamide	crohn disease	71	-0.97
DB01035	Procainamide	gastroenteritis	122	-0.67
DB01035	Procainamide	inflammatory bowel diseases	119	-0.61
DB01035	Procainamide	kidney diseases	144	-0.58
DB01035	Procainamide	neoplasms	482	-0.45
DB01035	Procainamide	varicose veins	20	-0.44
DB01035	Procainamide	epilepsy	25	-0.41
DB01035	Procainamide	hyperinsulinism	26	-0.31
DB01035	Procainamide	insulin resistance	26	-0.27
DB01035	Procainamide	vascular diseases	181	-0.23
DB01035	Procainamide	eye diseases	231	-0.22
DB01035	Procainamide	bone diseases metabolic	27	-0.19
DB01035	Procainamide	leukemia	117	-0.16
DB01035	Procainamide	mycobacterium infections	22	-0.15
DB01035	Procainamide	macular degeneration	44	-0.13
DB01035	Procainamide	keratosis	21	-0.04
DB01035	Procainamide	metabolism inborn errors	289	-0.04
DB01035	Procainamide	parkinson disease	30	0.00
DB01035	Procainamide	hypopigmentation	22	0.01
DB01035	Procainamide	coronary disease	37	0.02
DB01035	Procainamide	anemia hemolytic	29	0.03
DB01035	Procainamide	kidney neoplasms	20	0.04
DB01035	Procainamide	arteriosclerosis	38	0.04
DB01035	Procainamide	parkinsonian disorders	31	0.04
DB01035	Procainamide	liver cirrhosis biliary	23	0.05
DB01035	Procainamide	malabsorption syndromes	34	0.05
DB01035	Procainamide	myocardial ischemia	43	0.06
DB01035	Procainamide	bacterial infections	26	0.06
DB01035	Procainamide	pancreatic diseases	24	0.07
DB01035	Procainamide	amyotrophic lateral sclerosis	21	0.08
DB01035	Procainamide	liver cirrhosis	24	0.10
DB01035	Procainamide	asthma	36	0.11
DB01035	Procainamide	neuroendocrine tumors	24	0.16
DB01035	Procainamide	endocrine system diseases	291	0.20
DB01035	Procainamide	alzheimer disease	29	0.21
DB01035	Procainamide	arterial occlusive diseases	44	0.23
DB01035	Procainamide	lymphoma	24	0.25
DB01035	Procainamide	blood coagulation disorders	40	0.26
DB01035	Procainamide	lymphoma non hodgkin	22	0.28
DB01035	Procainamide	hypersensitivity	45	0.31
DB01035	Procainamide	adenocarcinoma	32	0.33
DB01035	Procainamide	arthritis rheumatoid	42	0.34
DB01035	Procainamide	motor neuron disease	31	0.34
DB01035	Procainamide	breast neoplasms	40	0.46
DB01035	Procainamide	prostatic neoplasms	61	0.47
DB01035	Procainamide	psoriasis	54	0.48
DB01035	Procainamide	head and neck neoplasms	35	0.49
DB01035	Procainamide	dementia	42	0.50
DB01035	Procainamide	diabetes mellitus type 2	72	0.51
DB01035	Procainamide	rheumatic diseases	59	0.54
DB01035	Procainamide	diabetes mellitus type 1	82	0.57
DB01035	Procainamide	colorectal neoplasms	42	0.59
DB01035	Procainamide	leukemia myeloid acute	43	0.60
DB01035	Procainamide	spinal cord diseases	59	0.62
DB01035	Procainamide	joint diseases	79	0.65
DB01035	Procainamide	anemia	58	0.67
DB01035	Procainamide	arthritis	76	0.67
DB01035	Procainamide	intestinal neoplasms	42	0.69
DB01035	Procainamide	lung diseases	71	0.73
DB01035	Procainamide	leukemia lymphoid	66	0.75
DB01035	Procainamide	gastrointestinal neoplasms	72	0.89
DB01035	Procainamide	diabetes mellitus	162	0.98
DB01035	Procainamide	bone diseases	144	1.04
DB01035	Procainamide	collagen diseases	25	1.46
DB01035	Procainamide	coronary artery disease	31	1.61
DB01035	Procainamide	skin diseases	278	1.62
DB00615	Rifabutin	coronary artery disease	31	-2.53
DB00615	Rifabutin	myocardial ischemia	43	-2.34
DB00615	Rifabutin	coronary disease	37	-2.33
DB00615	Rifabutin	arteriosclerosis	38	-2.20
DB00615	Rifabutin	diabetes mellitus type 2	72	-2.00
DB00615	Rifabutin	arterial occlusive diseases	44	-1.93
DB00615	Rifabutin	lymphoma	24	-1.84
DB00615	Rifabutin	lymphoma non hodgkin	22	-1.83
DB00615	Rifabutin	prostatic neoplasms	61	-1.60
DB00615	Rifabutin	arthritis rheumatoid	42	-1.56
DB00615	Rifabutin	macular degeneration	44	-1.44
DB00615	Rifabutin	anemia	58	-1.41
DB00615	Rifabutin	lung diseases	71	-1.38
DB00615	Rifabutin	rheumatic diseases	59	-1.38
DB00615	Rifabutin	arthritis	76	-1.37
DB00615	Rifabutin	leukemia lymphoid	66	-1.32
DB00615	Rifabutin	joint diseases	79	-1.29
DB00615	Rifabutin	diabetes mellitus	162	-1.19
DB00615	Rifabutin	kidney diseases	144	-1.16
DB00615	Rifabutin	heart diseases	167	-1.06
DB00615	Rifabutin	gastrointestinal neoplasms	72	-1.04
DB00615	Rifabutin	bone diseases	144	-1.02
DB00615	Rifabutin	eye diseases	231	-0.86
DB00615	Rifabutin	thyroid diseases	30	-0.85
DB00615	Rifabutin	leukemia	117	-0.78
DB00615	Rifabutin	metabolism inborn errors	289	-0.76
DB00615	Rifabutin	vascular diseases	181	-0.73
DB00615	Rifabutin	mycobacterium infections	22	-0.65
DB00615	Rifabutin	blood coagulation disorders	40	-0.61
DB00615	Rifabutin	autoimmune diseases	243	-0.60
DB00615	Rifabutin	amyotrophic lateral sclerosis	21	-0.58
DB00615	Rifabutin	hematologic diseases	188	-0.55
DB00615	Rifabutin	endocrine system diseases	291	-0.55
DB00615	Rifabutin	alzheimer disease	29	-0.54
DB00615	Rifabutin	bacterial infections	26	-0.54
DB00615	Rifabutin	liver cirrhosis biliary	23	-0.45
DB00615	Rifabutin	pancreatic diseases	24	-0.44
DB00615	Rifabutin	liver cirrhosis	24	-0.42
DB00615	Rifabutin	colitis	55	-0.41
DB00615	Rifabutin	skin diseases	278	-0.37
DB00615	Rifabutin	cardiovascular diseases	330	-0.37
DB00615	Rifabutin	colitis ulcerative	55	-0.34
DB00615	Rifabutin	neuroendocrine tumors	24	-0.32
DB00615	Rifabutin	dementia	42	-0.23
DB00615	Rifabutin	motor neuron disease	31	-0.09
DB00615	Rifabutin	head and neck neoplasms	35	-0.08
DB00615	Rifabutin	psoriasis	54	-0.05
DB00615	Rifabutin	adenocarcinoma	32	-0.05
DB00615	Rifabutin	breast neoplasms	40	0.13
DB00615	Rifabutin	neoplasms	482	0.16
DB00615	Rifabutin	crohn disease	71	0.21
DB00615	Rifabutin	leukemia myeloid acute	43	0.22
DB00615	Rifabutin	multiple sclerosis	69	0.24
DB00615	Rifabutin	varicose veins	20	0.25
DB00615	Rifabutin	arrhythmias cardiac	30	0.25
DB00615	Rifabutin	spinal cord diseases	59	0.28
DB00615	Rifabutin	intestinal neoplasms	42	0.30
DB00615	Rifabutin	colorectal neoplasms	42	0.33
DB00615	Rifabutin	collagen diseases	25	0.36
DB00615	Rifabutin	epilepsy	25	0.38
DB00615	Rifabutin	bone diseases metabolic	27	0.39
DB00615	Rifabutin	hyperinsulinism	26	0.42
DB00615	Rifabutin	insulin resistance	26	0.50
DB00615	Rifabutin	gastroenteritis	122	0.55
DB00615	Rifabutin	inflammatory bowel diseases	119	0.58
DB00615	Rifabutin	parkinson disease	30	0.61
DB00615	Rifabutin	parkinsonian disorders	31	0.63
DB00615	Rifabutin	anemia hemolytic	29	0.69
DB00615	Rifabutin	keratosis	21	0.74
DB00615	Rifabutin	malabsorption syndromes	34	0.89
DB00615	Rifabutin	hypopigmentation	22	0.90
DB00615	Rifabutin	kidney neoplasms	20	0.99
DB00615	Rifabutin	cardiomyopathy dilated	29	1.01
DB00615	Rifabutin	asthma	36	1.17
DB00615	Rifabutin	sarcoma	25	1.24
DB00615	Rifabutin	hypersensitivity	45	1.38
DB00615	Rifabutin	diabetes mellitus type 1	82	1.70
DB00615	Rifabutin	lupus erythematosus systemic	75	1.83
DB00459	Acitretin	thyroid diseases	30	-4.47
DB00459	Acitretin	leukemia myeloid acute	43	-3.97
DB00459	Acitretin	sarcoma	25	-3.68
DB00459	Acitretin	bone diseases metabolic	27	-3.02
DB00459	Acitretin	leukemia	117	-2.38
DB00459	Acitretin	colitis ulcerative	55	-1.73
DB00459	Acitretin	neoplasms	482	-1.62
DB00459	Acitretin	colitis	55	-1.61
DB00459	Acitretin	crohn disease	71	-1.58
DB00459	Acitretin	gastroenteritis	122	-1.05
DB00459	Acitretin	endocrine system diseases	291	-0.99
DB00459	Acitretin	inflammatory bowel diseases	119	-0.96
DB00459	Acitretin	metabolism inborn errors	289	-0.94
DB00459	Acitretin	bone diseases	144	-0.56
DB00459	Acitretin	dementia	42	-0.52
DB00459	Acitretin	leukemia lymphoid	66	-0.49
DB00459	Acitretin	motor neuron disease	31	-0.49
DB00459	Acitretin	head and neck neoplasms	35	-0.43
DB00459	Acitretin	liver cirrhosis biliary	23	-0.30
DB00459	Acitretin	amyotrophic lateral sclerosis	21	-0.28
DB00459	Acitretin	liver cirrhosis	24	-0.25
DB00459	Acitretin	kidney diseases	144	-0.24
DB00459	Acitretin	breast neoplasms	40	-0.21
DB00459	Acitretin	eye diseases	231	-0.13
DB00459	Acitretin	diabetes mellitus	162	-0.12
DB00459	Acitretin	diabetes mellitus type 1	82	-0.11
DB00459	Acitretin	skin diseases	278	-0.05
DB00459	Acitretin	coronary artery disease	31	0.09
DB00459	Acitretin	colorectal neoplasms	42	0.13
DB00459	Acitretin	intestinal neoplasms	42	0.16
DB00459	Acitretin	mycobacterium infections	22	0.17
DB00459	Acitretin	spinal cord diseases	59	0.21
DB00459	Acitretin	anemia hemolytic	29	0.23
DB00459	Acitretin	varicose veins	20	0.32
DB00459	Acitretin	parkinson disease	30	0.33
DB00459	Acitretin	diabetes mellitus type 2	72	0.33
DB00459	Acitretin	coronary disease	37	0.34
DB00459	Acitretin	myocardial ischemia	43	0.34
DB00459	Acitretin	parkinsonian disorders	31	0.36
DB00459	Acitretin	prostatic neoplasms	61	0.40
DB00459	Acitretin	lung diseases	71	0.41
DB00459	Acitretin	kidney neoplasms	20	0.42
DB00459	Acitretin	bacterial infections	26	0.44
DB00459	Acitretin	malabsorption syndromes	34	0.44
DB00459	Acitretin	arteriosclerosis	38	0.48
DB00459	Acitretin	lupus erythematosus systemic	75	0.56
DB00459	Acitretin	cardiomyopathy dilated	29	0.56
DB00459	Acitretin	neuroendocrine tumors	24	0.60
DB00459	Acitretin	alzheimer disease	29	0.62
DB00459	Acitretin	collagen diseases	25	0.62
DB00459	Acitretin	blood coagulation disorders	40	0.63
DB00459	Acitretin	pancreatic diseases	24	0.68
DB00459	Acitretin	asthma	36	0.70
DB00459	Acitretin	arterial occlusive diseases	44	0.72
DB00459	Acitretin	macular degeneration	44	0.83
DB00459	Acitretin	gastrointestinal neoplasms	72	0.83
DB00459	Acitretin	multiple sclerosis	69	0.85
DB00459	Acitretin	hypersensitivity	45	0.88
DB00459	Acitretin	heart diseases	167	1.01
DB00459	Acitretin	lymphoma	24	1.08
DB00459	Acitretin	keratosis	21	1.09
DB00459	Acitretin	lymphoma non hodgkin	22	1.13
DB00459	Acitretin	arthritis rheumatoid	42	1.16
DB00459	Acitretin	hematologic diseases	188	1.17
DB00459	Acitretin	adenocarcinoma	32	1.23
DB00459	Acitretin	hypopigmentation	22	1.28
DB00459	Acitretin	psoriasis	54	1.31
DB00459	Acitretin	arrhythmias cardiac	30	1.40
DB00459	Acitretin	rheumatic diseases	59	1.49
DB00459	Acitretin	insulin resistance	26	1.51
DB00459	Acitretin	hyperinsulinism	26	1.56
DB00459	Acitretin	arthritis	76	1.85
DB00459	Acitretin	autoimmune diseases	243	1.89
DB00459	Acitretin	joint diseases	79	1.94
DB00459	Acitretin	anemia	58	2.01
DB00459	Acitretin	epilepsy	25	2.21
DB00459	Acitretin	cardiovascular diseases	330	2.45
DB00459	Acitretin	vascular diseases	181	3.00
DB00908	Quinidine	heart diseases	167	-4.34
DB00908	Quinidine	arrhythmias cardiac	30	-4.27
DB00908	Quinidine	cardiovascular diseases	330	-3.26
DB00908	Quinidine	cardiomyopathy dilated	29	-3.00
DB00908	Quinidine	thyroid diseases	30	-1.97
DB00908	Quinidine	coronary disease	37	-1.90
DB00908	Quinidine	myocardial ischemia	43	-1.88
DB00908	Quinidine	lymphoma	24	-1.73
DB00908	Quinidine	arteriosclerosis	38	-1.73
DB00908	Quinidine	arterial occlusive diseases	44	-1.68
DB00908	Quinidine	lymphoma non hodgkin	22	-1.67
DB00908	Quinidine	head and neck neoplasms	35	-1.66
DB00908	Quinidine	varicose veins	20	-1.41
DB00908	Quinidine	endocrine system diseases	291	-1.35
DB00908	Quinidine	bone diseases metabolic	27	-1.07
DB00908	Quinidine	keratosis	21	-1.00
DB00908	Quinidine	coronary artery disease	31	-0.92
DB00908	Quinidine	macular degeneration	44	-0.89
DB00908	Quinidine	kidney neoplasms	20	-0.86
DB00908	Quinidine	hypopigmentation	22	-0.82
DB00908	Quinidine	parkinson disease	30	-0.79
DB00908	Quinidine	parkinsonian disorders	31	-0.79
DB00908	Quinidine	bone diseases	144	-0.74
DB00908	Quinidine	bacterial infections	26	-0.73
DB00908	Quinidine	amyotrophic lateral sclerosis	21	-0.72
DB00908	Quinidine	malabsorption syndromes	34	-0.72
DB00908	Quinidine	pancreatic diseases	24	-0.68
DB00908	Quinidine	liver cirrhosis	24	-0.67
DB00908	Quinidine	alzheimer disease	29	-0.66
DB00908	Quinidine	asthma	36	-0.66
DB00908	Quinidine	leukemia	117	-0.65
DB00908	Quinidine	liver cirrhosis biliary	23	-0.65
DB00908	Quinidine	vascular diseases	181	-0.58
DB00908	Quinidine	sarcoma	25	-0.53
DB00908	Quinidine	hypersensitivity	45	-0.51
DB00908	Quinidine	eye diseases	231	-0.49
DB00908	Quinidine	neoplasms	482	-0.48
DB00908	Quinidine	motor neuron disease	31	-0.41
DB00908	Quinidine	autoimmune diseases	243	-0.37
DB00908	Quinidine	adenocarcinoma	32	-0.36
DB00908	Quinidine	arthritis rheumatoid	42	-0.36
DB00908	Quinidine	colitis ulcerative	55	-0.35
DB00908	Quinidine	dementia	42	-0.30
DB00908	Quinidine	colitis	55	-0.29
DB00908	Quinidine	breast neoplasms	40	-0.26
DB00908	Quinidine	psoriasis	54	-0.23
DB00908	Quinidine	prostatic neoplasms	61	-0.21
DB00908	Quinidine	diabetes mellitus type 2	72	-0.19
DB00908	Quinidine	epilepsy	25	-0.18
DB00908	Quinidine	hematologic diseases	188	-0.17
DB00908	Quinidine	lupus erythematosus systemic	75	-0.08
DB00908	Quinidine	rheumatic diseases	59	-0.07
DB00908	Quinidine	leukemia myeloid acute	43	-0.04
DB00908	Quinidine	multiple sclerosis	69	-0.03
DB00908	Quinidine	insulin resistance	26	-0.03
DB00908	Quinidine	diabetes mellitus type 1	82	-0.03
DB00908	Quinidine	spinal cord diseases	59	-0.02
DB00908	Quinidine	hyperinsulinism	26	-0.01
DB00908	Quinidine	crohn disease	71	-0.01
DB00908	Quinidine	intestinal neoplasms	42	0.00
DB00908	Quinidine	colorectal neoplasms	42	0.02
DB00908	Quinidine	collagen diseases	25	0.02
DB00908	Quinidine	arthritis	76	0.03
DB00908	Quinidine	joint diseases	79	0.04
DB00908	Quinidine	lung diseases	71	0.08
DB00908	Quinidine	leukemia lymphoid	66	0.11
DB00908	Quinidine	mycobacterium infections	22	0.15
DB00908	Quinidine	inflammatory bowel diseases	119	0.23
DB00908	Quinidine	gastrointestinal neoplasms	72	0.29
DB00908	Quinidine	gastroenteritis	122	0.30
DB00908	Quinidine	anemia hemolytic	29	0.38
DB00908	Quinidine	kidney diseases	144	0.38
DB00908	Quinidine	diabetes mellitus	162	0.45
DB00908	Quinidine	neuroendocrine tumors	24	0.58
DB00908	Quinidine	metabolism inborn errors	289	0.79
DB00908	Quinidine	blood coagulation disorders	40	0.81
DB00908	Quinidine	skin diseases	278	0.97
DB00908	Quinidine	anemia	58	1.43
DB00799	Tazarotene	sarcoma	25	-3.93
DB00799	Tazarotene	leukemia myeloid acute	43	-3.74
DB00799	Tazarotene	leukemia	117	-2.65
DB00799	Tazarotene	thyroid diseases	30	-2.15
DB00799	Tazarotene	crohn disease	71	-1.96
DB00799	Tazarotene	neoplasms	482	-1.53
DB00799	Tazarotene	colitis ulcerative	55	-1.42
DB00799	Tazarotene	colitis	55	-1.32
DB00799	Tazarotene	inflammatory bowel diseases	119	-1.30
DB00799	Tazarotene	gastroenteritis	122	-1.29
DB00799	Tazarotene	bone diseases metabolic	27	-1.22
DB00799	Tazarotene	metabolism inborn errors	289	-0.66
DB00799	Tazarotene	leukemia lymphoid	66	-0.64
DB00799	Tazarotene	amyotrophic lateral sclerosis	21	-0.61
DB00799	Tazarotene	blood coagulation disorders	40	-0.54
DB00799	Tazarotene	varicose veins	20	-0.36
DB00799	Tazarotene	motor neuron disease	31	-0.26
DB00799	Tazarotene	prostatic neoplasms	61	-0.22
DB00799	Tazarotene	dementia	42	-0.22
DB00799	Tazarotene	diabetes mellitus	162	-0.20
DB00799	Tazarotene	endocrine system diseases	291	-0.18
DB00799	Tazarotene	head and neck neoplasms	35	-0.09
DB00799	Tazarotene	skin diseases	278	-0.05
DB00799	Tazarotene	diabetes mellitus type 2	72	-0.04
DB00799	Tazarotene	bone diseases	144	0.01
DB00799	Tazarotene	diabetes mellitus type 1	82	0.03
DB00799	Tazarotene	coronary artery disease	31	0.05
DB00799	Tazarotene	macular degeneration	44	0.06
DB00799	Tazarotene	breast neoplasms	40	0.06
DB00799	Tazarotene	keratosis	21	0.11
DB00799	Tazarotene	mycobacterium infections	22	0.13
DB00799	Tazarotene	eye diseases	231	0.16
DB00799	Tazarotene	intestinal neoplasms	42	0.18
DB00799	Tazarotene	anemia hemolytic	29	0.20
DB00799	Tazarotene	colorectal neoplasms	42	0.20
DB00799	Tazarotene	coronary disease	37	0.24
DB00799	Tazarotene	spinal cord diseases	59	0.27
DB00799	Tazarotene	malabsorption syndromes	34	0.29
DB00799	Tazarotene	myocardial ischemia	43	0.30
DB00799	Tazarotene	hypopigmentation	22	0.32
DB00799	Tazarotene	bacterial infections	26	0.33
DB00799	Tazarotene	lung diseases	71	0.33
DB00799	Tazarotene	arteriosclerosis	38	0.35
DB00799	Tazarotene	parkinson disease	30	0.37
DB00799	Tazarotene	parkinsonian disorders	31	0.39
DB00799	Tazarotene	kidney neoplasms	20	0.40
DB00799	Tazarotene	pancreatic diseases	24	0.48
DB00799	Tazarotene	liver cirrhosis	24	0.48
DB00799	Tazarotene	alzheimer disease	29	0.50
DB00799	Tazarotene	cardiomyopathy dilated	29	0.51
DB00799	Tazarotene	neuroendocrine tumors	24	0.51
DB00799	Tazarotene	liver cirrhosis biliary	23	0.53
DB00799	Tazarotene	asthma	36	0.54
DB00799	Tazarotene	arterial occlusive diseases	44	0.57
DB00799	Tazarotene	kidney diseases	144	0.59
DB00799	Tazarotene	hypersensitivity	45	0.65
DB00799	Tazarotene	hematologic diseases	188	0.70
DB00799	Tazarotene	lymphoma non hodgkin	22	0.72
DB00799	Tazarotene	gastrointestinal neoplasms	72	0.74
DB00799	Tazarotene	lymphoma	24	0.78
DB00799	Tazarotene	arthritis rheumatoid	42	0.83
DB00799	Tazarotene	adenocarcinoma	32	0.87
DB00799	Tazarotene	heart diseases	167	0.89
DB00799	Tazarotene	arrhythmias cardiac	30	1.00
DB00799	Tazarotene	psoriasis	54	1.02
DB00799	Tazarotene	lupus erythematosus systemic	75	1.05
DB00799	Tazarotene	hyperinsulinism	26	1.10
DB00799	Tazarotene	insulin resistance	26	1.12
DB00799	Tazarotene	collagen diseases	25	1.13
DB00799	Tazarotene	rheumatic diseases	59	1.13
DB00799	Tazarotene	multiple sclerosis	69	1.13
DB00799	Tazarotene	joint diseases	79	1.25
DB00799	Tazarotene	arthritis	76	1.32
DB00799	Tazarotene	anemia	58	1.39
DB00799	Tazarotene	autoimmune diseases	243	1.72
DB00799	Tazarotene	epilepsy	25	2.22
DB00799	Tazarotene	cardiovascular diseases	330	2.25
DB00799	Tazarotene	vascular diseases	181	2.28
DB00903	Ethacrynic.acid	endocrine system diseases	291	-2.95
DB00903	Ethacrynic.acid	gastrointestinal neoplasms	72	-2.38
DB00903	Ethacrynic.acid	kidney diseases	144	-2.24
DB00903	Ethacrynic.acid	liver cirrhosis	24	-2.23
DB00903	Ethacrynic.acid	liver cirrhosis biliary	23	-2.16
DB00903	Ethacrynic.acid	prostatic neoplasms	61	-1.75
DB00903	Ethacrynic.acid	adenocarcinoma	32	-1.63
DB00903	Ethacrynic.acid	intestinal neoplasms	42	-1.56
DB00903	Ethacrynic.acid	colorectal neoplasms	42	-1.42
DB00903	Ethacrynic.acid	neoplasms	482	-1.32
DB00903	Ethacrynic.acid	leukemia lymphoid	66	-1.26
DB00903	Ethacrynic.acid	lung diseases	71	-1.26
DB00903	Ethacrynic.acid	varicose veins	20	-1.20
DB00903	Ethacrynic.acid	arrhythmias cardiac	30	-1.05
DB00903	Ethacrynic.acid	anemia hemolytic	29	-0.86
DB00903	Ethacrynic.acid	keratosis	21	-0.84
DB00903	Ethacrynic.acid	leukemia	117	-0.72
DB00903	Ethacrynic.acid	pancreatic diseases	24	-0.70
DB00903	Ethacrynic.acid	lymphoma	24	-0.55
DB00903	Ethacrynic.acid	lymphoma non hodgkin	22	-0.54
DB00903	Ethacrynic.acid	metabolism inborn errors	289	-0.53
DB00903	Ethacrynic.acid	autoimmune diseases	243	-0.53
DB00903	Ethacrynic.acid	arthritis rheumatoid	42	-0.35
DB00903	Ethacrynic.acid	colitis	55	-0.33
DB00903	Ethacrynic.acid	skin diseases	278	-0.31
DB00903	Ethacrynic.acid	colitis ulcerative	55	-0.30
DB00903	Ethacrynic.acid	head and neck neoplasms	35	-0.25
DB00903	Ethacrynic.acid	diabetes mellitus type 2	72	-0.24
DB00903	Ethacrynic.acid	rheumatic diseases	59	-0.19
DB00903	Ethacrynic.acid	diabetes mellitus type 1	82	-0.12
DB00903	Ethacrynic.acid	lupus erythematosus systemic	75	-0.12
DB00903	Ethacrynic.acid	multiple sclerosis	69	-0.10
DB00903	Ethacrynic.acid	leukemia myeloid acute	43	-0.10
DB00903	Ethacrynic.acid	arthritis	76	-0.06
DB00903	Ethacrynic.acid	anemia	58	-0.05
DB00903	Ethacrynic.acid	joint diseases	79	0.00
DB00903	Ethacrynic.acid	inflammatory bowel diseases	119	0.18
DB00903	Ethacrynic.acid	gastroenteritis	122	0.20
DB00903	Ethacrynic.acid	epilepsy	25	0.33
DB00903	Ethacrynic.acid	diabetes mellitus	162	0.36
DB00903	Ethacrynic.acid	insulin resistance	26	0.36
DB00903	Ethacrynic.acid	hyperinsulinism	26	0.42
DB00903	Ethacrynic.acid	heart diseases	167	0.44
DB00903	Ethacrynic.acid	bone diseases	144	0.45
DB00903	Ethacrynic.acid	collagen diseases	25	0.47
DB00903	Ethacrynic.acid	bone diseases metabolic	27	0.49
DB00903	Ethacrynic.acid	mycobacterium infections	22	0.57
DB00903	Ethacrynic.acid	coronary artery disease	31	0.58
DB00903	Ethacrynic.acid	macular degeneration	44	0.59
DB00903	Ethacrynic.acid	eye diseases	231	0.60
DB00903	Ethacrynic.acid	vascular diseases	181	0.61
DB00903	Ethacrynic.acid	kidney neoplasms	20	0.64
DB00903	Ethacrynic.acid	bacterial infections	26	0.65
DB00903	Ethacrynic.acid	thyroid diseases	30	0.65
DB00903	Ethacrynic.acid	hypopigmentation	22	0.67
DB00903	Ethacrynic.acid	parkinsonian disorders	31	0.69
DB00903	Ethacrynic.acid	myocardial ischemia	43	0.69
DB00903	Ethacrynic.acid	parkinson disease	30	0.70
DB00903	Ethacrynic.acid	amyotrophic lateral sclerosis	21	0.71
DB00903	Ethacrynic.acid	asthma	36	0.72
DB00903	Ethacrynic.acid	coronary disease	37	0.73
DB00903	Ethacrynic.acid	malabsorption syndromes	34	0.75
DB00903	Ethacrynic.acid	neuroendocrine tumors	24	0.77
DB00903	Ethacrynic.acid	sarcoma	25	0.78
DB00903	Ethacrynic.acid	alzheimer disease	29	0.79
DB00903	Ethacrynic.acid	arteriosclerosis	38	0.79
DB00903	Ethacrynic.acid	hematologic diseases	188	0.80
DB00903	Ethacrynic.acid	cardiomyopathy dilated	29	0.83
DB00903	Ethacrynic.acid	hypersensitivity	45	0.86
DB00903	Ethacrynic.acid	blood coagulation disorders	40	0.86
DB00903	Ethacrynic.acid	arterial occlusive diseases	44	0.87
DB00903	Ethacrynic.acid	motor neuron disease	31	0.94
DB00903	Ethacrynic.acid	psoriasis	54	1.03
DB00903	Ethacrynic.acid	dementia	42	1.04
DB00903	Ethacrynic.acid	cardiovascular diseases	330	1.08
DB00903	Ethacrynic.acid	breast neoplasms	40	1.08
DB00903	Ethacrynic.acid	spinal cord diseases	59	1.25
DB00903	Ethacrynic.acid	crohn disease	71	1.29
DB01200	Bromocriptine	colitis	55	-2.61
DB01200	Bromocriptine	bone diseases	144	-2.57
DB01200	Bromocriptine	colitis ulcerative	55	-2.55
DB01200	Bromocriptine	varicose veins	20	-2.38
DB01200	Bromocriptine	epilepsy	25	-2.14
DB01200	Bromocriptine	arrhythmias cardiac	30	-1.83
DB01200	Bromocriptine	cardiovascular diseases	330	-1.75
DB01200	Bromocriptine	gastroenteritis	122	-1.64
DB01200	Bromocriptine	inflammatory bowel diseases	119	-1.60
DB01200	Bromocriptine	thyroid diseases	30	-1.59
DB01200	Bromocriptine	heart diseases	167	-1.55
DB01200	Bromocriptine	crohn disease	71	-1.49
DB01200	Bromocriptine	psoriasis	54	-1.44
DB01200	Bromocriptine	multiple sclerosis	69	-0.93
DB01200	Bromocriptine	vascular diseases	181	-0.74
DB01200	Bromocriptine	breast neoplasms	40	-0.48
DB01200	Bromocriptine	arthritis	76	-0.22
DB01200	Bromocriptine	joint diseases	79	-0.21
DB01200	Bromocriptine	bacterial infections	26	-0.15
DB01200	Bromocriptine	mycobacterium infections	22	-0.14
DB01200	Bromocriptine	intestinal neoplasms	42	-0.08
DB01200	Bromocriptine	colorectal neoplasms	42	-0.01
DB01200	Bromocriptine	spinal cord diseases	59	0.07
DB01200	Bromocriptine	adenocarcinoma	32	0.13
DB01200	Bromocriptine	insulin resistance	26	0.16
DB01200	Bromocriptine	hyperinsulinism	26	0.18
DB01200	Bromocriptine	neuroendocrine tumors	24	0.22
DB01200	Bromocriptine	alzheimer disease	29	0.24
DB01200	Bromocriptine	cardiomyopathy dilated	29	0.31
DB01200	Bromocriptine	eye diseases	231	0.31
DB01200	Bromocriptine	gastrointestinal neoplasms	72	0.32
DB01200	Bromocriptine	hematologic diseases	188	0.33
DB01200	Bromocriptine	amyotrophic lateral sclerosis	21	0.41
DB01200	Bromocriptine	leukemia myeloid acute	43	0.42
DB01200	Bromocriptine	liver cirrhosis	24	0.42
DB01200	Bromocriptine	liver cirrhosis biliary	23	0.42
DB01200	Bromocriptine	endocrine system diseases	291	0.58
DB01200	Bromocriptine	anemia hemolytic	29	0.61
DB01200	Bromocriptine	skin diseases	278	0.69
DB01200	Bromocriptine	collagen diseases	25	0.69
DB01200	Bromocriptine	keratosis	21	0.70
DB01200	Bromocriptine	autoimmune diseases	243	0.71
DB01200	Bromocriptine	parkinson disease	30	0.75
DB01200	Bromocriptine	dementia	42	0.78
DB01200	Bromocriptine	lung diseases	71	0.80
DB01200	Bromocriptine	parkinsonian disorders	31	0.83
DB01200	Bromocriptine	pancreatic diseases	24	0.84
DB01200	Bromocriptine	malabsorption syndromes	34	0.88
DB01200	Bromocriptine	myocardial ischemia	43	0.94
DB01200	Bromocriptine	kidney neoplasms	20	1.00
DB01200	Bromocriptine	leukemia	117	1.02
DB01200	Bromocriptine	diabetes mellitus type 2	72	1.05
DB01200	Bromocriptine	arterial occlusive diseases	44	1.10
DB01200	Bromocriptine	hypopigmentation	22	1.14
DB01200	Bromocriptine	motor neuron disease	31	1.35
DB01200	Bromocriptine	diabetes mellitus type 1	82	1.42
DB01200	Bromocriptine	arteriosclerosis	38	1.50
DB01200	Bromocriptine	blood coagulation disorders	40	1.56
DB01200	Bromocriptine	diabetes mellitus	162	1.62
DB01200	Bromocriptine	macular degeneration	44	1.65
DB01200	Bromocriptine	anemia	58	1.71
DB01200	Bromocriptine	sarcoma	25	1.74
DB01200	Bromocriptine	lymphoma non hodgkin	22	1.89
DB01200	Bromocriptine	metabolism inborn errors	289	1.92
DB01200	Bromocriptine	asthma	36	1.94
DB01200	Bromocriptine	arthritis rheumatoid	42	1.98
DB01200	Bromocriptine	lymphoma	24	1.99
DB01200	Bromocriptine	coronary artery disease	31	2.03
DB01200	Bromocriptine	head and neck neoplasms	35	2.11
DB01200	Bromocriptine	kidney diseases	144	2.35
DB01200	Bromocriptine	lupus erythematosus systemic	75	2.35
DB01200	Bromocriptine	leukemia lymphoid	66	2.37
DB01200	Bromocriptine	coronary disease	37	2.46
DB01200	Bromocriptine	hypersensitivity	45	2.47
DB01200	Bromocriptine	neoplasms	482	2.53
DB01200	Bromocriptine	rheumatic diseases	59	2.64
DB01200	Bromocriptine	prostatic neoplasms	61	2.83
DB01200	Bromocriptine	bone diseases metabolic	27	2.86
DB01202	Levetiracetam	malabsorption syndromes	34	-2.58
DB01202	Levetiracetam	intestinal neoplasms	42	-2.09
DB01202	Levetiracetam	colorectal neoplasms	42	-2.07
DB01202	Levetiracetam	lupus erythematosus systemic	75	-2.04
DB01202	Levetiracetam	prostatic neoplasms	61	-1.90
DB01202	Levetiracetam	gastrointestinal neoplasms	72	-1.74
DB01202	Levetiracetam	neoplasms	482	-1.70
DB01202	Levetiracetam	collagen diseases	25	-1.48
DB01202	Levetiracetam	bone diseases metabolic	27	-1.44
DB01202	Levetiracetam	eye diseases	231	-1.29
DB01202	Levetiracetam	thyroid diseases	30	-1.25
DB01202	Levetiracetam	autoimmune diseases	243	-1.23
DB01202	Levetiracetam	bacterial infections	26	-1.17
DB01202	Levetiracetam	pancreatic diseases	24	-1.17
DB01202	Levetiracetam	liver cirrhosis	24	-1.15
DB01202	Levetiracetam	liver cirrhosis biliary	23	-1.14
DB01202	Levetiracetam	alzheimer disease	29	-1.09
DB01202	Levetiracetam	cardiomyopathy dilated	29	-1.04
DB01202	Levetiracetam	blood coagulation disorders	40	-0.94
DB01202	Levetiracetam	motor neuron disease	31	-0.91
DB01202	Levetiracetam	dementia	42	-0.80
DB01202	Levetiracetam	psoriasis	54	-0.73
DB01202	Levetiracetam	breast neoplasms	40	-0.66
DB01202	Levetiracetam	crohn disease	71	-0.62
DB01202	Levetiracetam	leukemia myeloid acute	43	-0.60
DB01202	Levetiracetam	multiple sclerosis	69	-0.57
DB01202	Levetiracetam	spinal cord diseases	59	-0.56
DB01202	Levetiracetam	arthritis	76	-0.50
DB01202	Levetiracetam	leukemia lymphoid	66	-0.49
DB01202	Levetiracetam	lung diseases	71	-0.47
DB01202	Levetiracetam	joint diseases	79	-0.46
DB01202	Levetiracetam	inflammatory bowel diseases	119	-0.32
DB01202	Levetiracetam	varicose veins	20	-0.30
DB01202	Levetiracetam	gastroenteritis	122	-0.29
DB01202	Levetiracetam	kidney diseases	144	-0.26
DB01202	Levetiracetam	heart diseases	167	-0.15
DB01202	Levetiracetam	bone diseases	144	-0.14
DB01202	Levetiracetam	epilepsy	25	-0.12
DB01202	Levetiracetam	arrhythmias cardiac	30	-0.07
DB01202	Levetiracetam	leukemia	117	-0.04
DB01202	Levetiracetam	vascular diseases	181	0.05
DB01202	Levetiracetam	keratosis	21	0.05
DB01202	Levetiracetam	hypopigmentation	22	0.14
DB01202	Levetiracetam	metabolism inborn errors	289	0.16
DB01202	Levetiracetam	amyotrophic lateral sclerosis	21	0.19
DB01202	Levetiracetam	kidney neoplasms	20	0.19
DB01202	Levetiracetam	hematologic diseases	188	0.22
DB01202	Levetiracetam	parkinson disease	30	0.24
DB01202	Levetiracetam	parkinsonian disorders	31	0.25
DB01202	Levetiracetam	endocrine system diseases	291	0.26
DB01202	Levetiracetam	skin diseases	278	0.32
DB01202	Levetiracetam	asthma	36	0.33
DB01202	Levetiracetam	sarcoma	25	0.37
DB01202	Levetiracetam	cardiovascular diseases	330	0.39
DB01202	Levetiracetam	lymphoma	24	0.42
DB01202	Levetiracetam	lymphoma non hodgkin	22	0.42
DB01202	Levetiracetam	hypersensitivity	45	0.47
DB01202	Levetiracetam	adenocarcinoma	32	0.58
DB01202	Levetiracetam	arthritis rheumatoid	42	0.59
DB01202	Levetiracetam	colitis	55	0.61
DB01202	Levetiracetam	colitis ulcerative	55	0.63
DB01202	Levetiracetam	head and neck neoplasms	35	0.64
DB01202	Levetiracetam	diabetes mellitus type 2	72	0.73
DB01202	Levetiracetam	rheumatic diseases	59	0.77
DB01202	Levetiracetam	diabetes mellitus type 1	82	0.83
DB01202	Levetiracetam	insulin resistance	26	1.20
DB01202	Levetiracetam	hyperinsulinism	26	1.26
DB01202	Levetiracetam	diabetes mellitus	162	1.27
DB01202	Levetiracetam	macular degeneration	44	1.39
DB01202	Levetiracetam	coronary artery disease	31	1.40
DB01202	Levetiracetam	mycobacterium infections	22	1.41
DB01202	Levetiracetam	coronary disease	37	1.56
DB01202	Levetiracetam	anemia hemolytic	29	1.56
DB01202	Levetiracetam	arteriosclerosis	38	1.61
DB01202	Levetiracetam	myocardial ischemia	43	1.63
DB01202	Levetiracetam	neuroendocrine tumors	24	1.72
DB01202	Levetiracetam	arterial occlusive diseases	44	1.74
DB01202	Levetiracetam	anemia	58	2.43
DB00987	Cytarabine	varicose veins	20	-0.65
DB00987	Cytarabine	bone diseases metabolic	27	-0.52
DB00987	Cytarabine	collagen diseases	25	-0.52
DB00987	Cytarabine	epilepsy	25	-0.49
DB00987	Cytarabine	mycobacterium infections	22	-0.45
DB00987	Cytarabine	coronary artery disease	31	-0.44
DB00987	Cytarabine	arrhythmias cardiac	30	-0.44
DB00987	Cytarabine	macular degeneration	44	-0.42
DB00987	Cytarabine	amyotrophic lateral sclerosis	21	-0.35
DB00987	Cytarabine	kidney neoplasms	20	-0.35
DB00987	Cytarabine	coronary disease	37	-0.34
DB00987	Cytarabine	bacterial infections	26	-0.33
DB00987	Cytarabine	parkinson disease	30	-0.31
DB00987	Cytarabine	parkinsonian disorders	31	-0.28
DB00987	Cytarabine	liver cirrhosis	24	-0.28
DB00987	Cytarabine	pancreatic diseases	24	-0.28
DB00987	Cytarabine	myocardial ischemia	43	-0.27
DB00987	Cytarabine	hypopigmentation	22	-0.26
DB00987	Cytarabine	malabsorption syndromes	34	-0.26
DB00987	Cytarabine	liver cirrhosis biliary	23	-0.25
DB00987	Cytarabine	anemia hemolytic	29	-0.25
DB00987	Cytarabine	thyroid diseases	30	-0.25
DB00987	Cytarabine	alzheimer disease	29	-0.23
DB00987	Cytarabine	neuroendocrine tumors	24	-0.22
DB00987	Cytarabine	asthma	36	-0.21
DB00987	Cytarabine	arteriosclerosis	38	-0.21
DB00987	Cytarabine	cardiomyopathy dilated	29	-0.20
DB00987	Cytarabine	sarcoma	25	-0.17
DB00987	Cytarabine	lymphoma non hodgkin	22	-0.15
DB00987	Cytarabine	arterial occlusive diseases	44	-0.14
DB00987	Cytarabine	hypersensitivity	45	-0.10
DB00987	Cytarabine	lymphoma	24	-0.08
DB00987	Cytarabine	motor neuron disease	31	-0.07
DB00987	Cytarabine	arthritis rheumatoid	42	-0.07
DB00987	Cytarabine	adenocarcinoma	32	-0.05
DB00987	Cytarabine	colitis	55	-0.03
DB00987	Cytarabine	dementia	42	0.00
DB00987	Cytarabine	breast neoplasms	40	0.01
DB00987	Cytarabine	colitis ulcerative	55	0.02
DB00987	Cytarabine	prostatic neoplasms	61	0.03
DB00987	Cytarabine	head and neck neoplasms	35	0.03
DB00987	Cytarabine	blood coagulation disorders	40	0.05
DB00987	Cytarabine	diabetes mellitus type 2	72	0.09
DB00987	Cytarabine	multiple sclerosis	69	0.10
DB00987	Cytarabine	psoriasis	54	0.11
DB00987	Cytarabine	intestinal neoplasms	42	0.12
DB00987	Cytarabine	leukemia myeloid acute	43	0.12
DB00987	Cytarabine	rheumatic diseases	59	0.14
DB00987	Cytarabine	spinal cord diseases	59	0.15
DB00987	Cytarabine	lupus erythematosus systemic	75	0.15
DB00987	Cytarabine	colorectal neoplasms	42	0.16
DB00987	Cytarabine	crohn disease	71	0.18
DB00987	Cytarabine	arthritis	76	0.18
DB00987	Cytarabine	diabetes mellitus type 1	82	0.19
DB00987	Cytarabine	joint diseases	79	0.20
DB00987	Cytarabine	leukemia lymphoid	66	0.23
DB00987	Cytarabine	lung diseases	71	0.23
DB00987	Cytarabine	anemia	58	0.27
DB00987	Cytarabine	gastroenteritis	122	0.28
DB00987	Cytarabine	inflammatory bowel diseases	119	0.31
DB00987	Cytarabine	gastrointestinal neoplasms	72	0.33
DB00987	Cytarabine	kidney diseases	144	0.33
DB00987	Cytarabine	diabetes mellitus	162	0.34
DB00987	Cytarabine	bone diseases	144	0.41
DB00987	Cytarabine	heart diseases	167	0.41
DB00987	Cytarabine	leukemia	117	0.48
DB00987	Cytarabine	vascular diseases	181	0.49
DB00987	Cytarabine	metabolism inborn errors	289	0.51
DB00987	Cytarabine	eye diseases	231	0.52
DB00987	Cytarabine	autoimmune diseases	243	0.55
DB00987	Cytarabine	hematologic diseases	188	0.66
DB00987	Cytarabine	endocrine system diseases	291	0.69
DB00987	Cytarabine	cardiovascular diseases	330	0.69
DB00987	Cytarabine	skin diseases	278	0.69
DB00987	Cytarabine	neoplasms	482	1.11
DB00987	Cytarabine	hyperinsulinism	26	1.37
DB00987	Cytarabine	insulin resistance	26	1.45
DB00987	Cytarabine	keratosis	21	1.72
DB01204	Mitoxantrone	cardiomyopathy dilated	29	-1.65
DB01204	Mitoxantrone	kidney neoplasms	20	-1.59
DB01204	Mitoxantrone	sarcoma	25	-1.53
DB01204	Mitoxantrone	pancreatic diseases	24	-1.51
DB01204	Mitoxantrone	arthritis rheumatoid	42	-1.33
DB01204	Mitoxantrone	lymphoma non hodgkin	22	-1.24
DB01204	Mitoxantrone	head and neck neoplasms	35	-1.20
DB01204	Mitoxantrone	lymphoma	24	-1.19
DB01204	Mitoxantrone	adenocarcinoma	32	-1.16
DB01204	Mitoxantrone	rheumatic diseases	59	-1.12
DB01204	Mitoxantrone	prostatic neoplasms	61	-1.10
DB01204	Mitoxantrone	breast neoplasms	40	-1.06
DB01204	Mitoxantrone	joint diseases	79	-0.99
DB01204	Mitoxantrone	colorectal neoplasms	42	-0.98
DB01204	Mitoxantrone	spinal cord diseases	59	-0.97
DB01204	Mitoxantrone	arthritis	76	-0.95
DB01204	Mitoxantrone	leukemia myeloid acute	43	-0.95
DB01204	Mitoxantrone	intestinal neoplasms	42	-0.95
DB01204	Mitoxantrone	multiple sclerosis	69	-0.88
DB01204	Mitoxantrone	lung diseases	71	-0.85
DB01204	Mitoxantrone	leukemia lymphoid	66	-0.75
DB01204	Mitoxantrone	kidney diseases	144	-0.74
DB01204	Mitoxantrone	heart diseases	167	-0.66
DB01204	Mitoxantrone	gastrointestinal neoplasms	72	-0.62
DB01204	Mitoxantrone	metabolism inborn errors	289	-0.51
DB01204	Mitoxantrone	eye diseases	231	-0.44
DB01204	Mitoxantrone	vascular diseases	181	-0.34
DB01204	Mitoxantrone	leukemia	117	-0.31
DB01204	Mitoxantrone	hematologic diseases	188	-0.28
DB01204	Mitoxantrone	skin diseases	278	-0.20
DB01204	Mitoxantrone	autoimmune diseases	243	-0.19
DB01204	Mitoxantrone	endocrine system diseases	291	-0.07
DB01204	Mitoxantrone	cardiovascular diseases	330	-0.06
DB01204	Mitoxantrone	varicose veins	20	0.23
DB01204	Mitoxantrone	neoplasms	482	0.24
DB01204	Mitoxantrone	arrhythmias cardiac	30	0.27
DB01204	Mitoxantrone	hyperinsulinism	26	0.28
DB01204	Mitoxantrone	epilepsy	25	0.28
DB01204	Mitoxantrone	collagen diseases	25	0.30
DB01204	Mitoxantrone	bone diseases metabolic	27	0.32
DB01204	Mitoxantrone	macular degeneration	44	0.34
DB01204	Mitoxantrone	insulin resistance	26	0.34
DB01204	Mitoxantrone	coronary artery disease	31	0.41
DB01204	Mitoxantrone	myocardial ischemia	43	0.42
DB01204	Mitoxantrone	anemia hemolytic	29	0.43
DB01204	Mitoxantrone	keratosis	21	0.44
DB01204	Mitoxantrone	coronary disease	37	0.44
DB01204	Mitoxantrone	mycobacterium infections	22	0.48
DB01204	Mitoxantrone	malabsorption syndromes	34	0.50
DB01204	Mitoxantrone	arteriosclerosis	38	0.50
DB01204	Mitoxantrone	parkinson disease	30	0.50
DB01204	Mitoxantrone	hypopigmentation	22	0.51
DB01204	Mitoxantrone	parkinsonian disorders	31	0.51
DB01204	Mitoxantrone	bacterial infections	26	0.51
DB01204	Mitoxantrone	thyroid diseases	30	0.53
DB01204	Mitoxantrone	amyotrophic lateral sclerosis	21	0.55
DB01204	Mitoxantrone	blood coagulation disorders	40	0.56
DB01204	Mitoxantrone	arterial occlusive diseases	44	0.56
DB01204	Mitoxantrone	alzheimer disease	29	0.57
DB01204	Mitoxantrone	liver cirrhosis biliary	23	0.59
DB01204	Mitoxantrone	asthma	36	0.60
DB01204	Mitoxantrone	liver cirrhosis	24	0.60
DB01204	Mitoxantrone	neuroendocrine tumors	24	0.61
DB01204	Mitoxantrone	hypersensitivity	45	0.67
DB01204	Mitoxantrone	colitis	55	0.69
DB01204	Mitoxantrone	colitis ulcerative	55	0.71
DB01204	Mitoxantrone	motor neuron disease	31	0.74
DB01204	Mitoxantrone	dementia	42	0.77
DB01204	Mitoxantrone	diabetes mellitus type 2	72	0.79
DB01204	Mitoxantrone	psoriasis	54	0.82
DB01204	Mitoxantrone	lupus erythematosus systemic	75	0.88
DB01204	Mitoxantrone	diabetes mellitus type 1	82	0.89
DB01204	Mitoxantrone	crohn disease	71	0.95
DB01204	Mitoxantrone	anemia	58	1.17
DB01204	Mitoxantrone	inflammatory bowel diseases	119	1.24
DB01204	Mitoxantrone	gastroenteritis	122	1.29
DB01204	Mitoxantrone	diabetes mellitus	162	1.41
DB01204	Mitoxantrone	bone diseases	144	1.64
DB01206	Lomustine	varicose veins	20	-1.28
DB01206	Lomustine	keratosis	21	-1.10
DB01206	Lomustine	thyroid diseases	30	-1.02
DB01206	Lomustine	hypopigmentation	22	-0.98
DB01206	Lomustine	neuroendocrine tumors	24	-0.87
DB01206	Lomustine	blood coagulation disorders	40	-0.83
DB01206	Lomustine	lymphoma non hodgkin	22	-0.79
DB01206	Lomustine	lymphoma	24	-0.78
DB01206	Lomustine	motor neuron disease	31	-0.74
DB01206	Lomustine	hypersensitivity	45	-0.72
DB01206	Lomustine	adenocarcinoma	32	-0.70
DB01206	Lomustine	dementia	42	-0.67
DB01206	Lomustine	diabetes mellitus type 2	72	-0.63
DB01206	Lomustine	prostatic neoplasms	61	-0.59
DB01206	Lomustine	rheumatic diseases	59	-0.57
DB01206	Lomustine	intestinal neoplasms	42	-0.56
DB01206	Lomustine	leukemia myeloid acute	43	-0.54
DB01206	Lomustine	spinal cord diseases	59	-0.53
DB01206	Lomustine	crohn disease	71	-0.52
DB01206	Lomustine	colorectal neoplasms	42	-0.51
DB01206	Lomustine	lupus erythematosus systemic	75	-0.50
DB01206	Lomustine	anemia	58	-0.48
DB01206	Lomustine	diabetes mellitus type 1	82	-0.46
DB01206	Lomustine	arthritis	76	-0.46
DB01206	Lomustine	multiple sclerosis	69	-0.46
DB01206	Lomustine	lung diseases	71	-0.45
DB01206	Lomustine	joint diseases	79	-0.43
DB01206	Lomustine	gastrointestinal neoplasms	72	-0.33
DB01206	Lomustine	inflammatory bowel diseases	119	-0.33
DB01206	Lomustine	gastroenteritis	122	-0.31
DB01206	Lomustine	bone diseases	144	-0.24
DB01206	Lomustine	kidney diseases	144	-0.23
DB01206	Lomustine	heart diseases	167	-0.23
DB01206	Lomustine	diabetes mellitus	162	-0.22
DB01206	Lomustine	leukemia	117	-0.20
DB01206	Lomustine	vascular diseases	181	-0.15
DB01206	Lomustine	eye diseases	231	-0.10
DB01206	Lomustine	hematologic diseases	188	-0.05
DB01206	Lomustine	autoimmune diseases	243	0.00
DB01206	Lomustine	metabolism inborn errors	289	0.01
DB01206	Lomustine	skin diseases	278	0.05
DB01206	Lomustine	endocrine system diseases	291	0.06
DB01206	Lomustine	cardiovascular diseases	330	0.07
DB01206	Lomustine	neoplasms	482	0.34
DB01206	Lomustine	epilepsy	25	0.55
DB01206	Lomustine	arrhythmias cardiac	30	0.59
DB01206	Lomustine	insulin resistance	26	0.60
DB01206	Lomustine	collagen diseases	25	0.63
DB01206	Lomustine	bone diseases metabolic	27	0.64
DB01206	Lomustine	hyperinsulinism	26	0.64
DB01206	Lomustine	mycobacterium infections	22	0.70
DB01206	Lomustine	coronary artery disease	31	0.71
DB01206	Lomustine	macular degeneration	44	0.75
DB01206	Lomustine	anemia hemolytic	29	0.75
DB01206	Lomustine	kidney neoplasms	20	0.78
DB01206	Lomustine	pancreatic diseases	24	0.79
DB01206	Lomustine	bacterial infections	26	0.79
DB01206	Lomustine	liver cirrhosis	24	0.80
DB01206	Lomustine	parkinson disease	30	0.80
DB01206	Lomustine	parkinsonian disorders	31	0.83
DB01206	Lomustine	amyotrophic lateral sclerosis	21	0.83
DB01206	Lomustine	liver cirrhosis biliary	23	0.84
DB01206	Lomustine	myocardial ischemia	43	0.86
DB01206	Lomustine	coronary disease	37	0.87
DB01206	Lomustine	malabsorption syndromes	34	0.88
DB01206	Lomustine	alzheimer disease	29	0.89
DB01206	Lomustine	arteriosclerosis	38	0.89
DB01206	Lomustine	asthma	36	0.91
DB01206	Lomustine	cardiomyopathy dilated	29	0.91
DB01206	Lomustine	sarcoma	25	0.96
DB01206	Lomustine	arterial occlusive diseases	44	1.00
DB01206	Lomustine	colitis	55	1.10
DB01206	Lomustine	arthritis rheumatoid	42	1.10
DB01206	Lomustine	colitis ulcerative	55	1.13
DB01206	Lomustine	psoriasis	54	1.14
DB01206	Lomustine	breast neoplasms	40	1.15
DB01206	Lomustine	head and neck neoplasms	35	1.18
DB01206	Lomustine	leukemia lymphoid	66	1.37
DB00537	Ciprofloxacin	sarcoma	25	-1.60
DB00537	Ciprofloxacin	kidney neoplasms	20	-1.57
DB00537	Ciprofloxacin	cardiomyopathy dilated	29	-1.54
DB00537	Ciprofloxacin	pancreatic diseases	24	-1.44
DB00537	Ciprofloxacin	lymphoma non hodgkin	22	-1.27
DB00537	Ciprofloxacin	arthritis rheumatoid	42	-1.26
DB00537	Ciprofloxacin	lymphoma	24	-1.21
DB00537	Ciprofloxacin	head and neck neoplasms	35	-1.20
DB00537	Ciprofloxacin	adenocarcinoma	32	-1.17
DB00537	Ciprofloxacin	prostatic neoplasms	61	-1.16
DB00537	Ciprofloxacin	breast neoplasms	40	-1.10
DB00537	Ciprofloxacin	rheumatic diseases	59	-1.02
DB00537	Ciprofloxacin	colorectal neoplasms	42	-1.00
DB00537	Ciprofloxacin	leukemia myeloid acute	43	-0.91
DB00537	Ciprofloxacin	intestinal neoplasms	42	-0.90
DB00537	Ciprofloxacin	spinal cord diseases	59	-0.89
DB00537	Ciprofloxacin	joint diseases	79	-0.89
DB00537	Ciprofloxacin	arthritis	76	-0.86
DB00537	Ciprofloxacin	multiple sclerosis	69	-0.84
DB00537	Ciprofloxacin	lung diseases	71	-0.81
DB00537	Ciprofloxacin	leukemia lymphoid	66	-0.73
DB00537	Ciprofloxacin	kidney diseases	144	-0.72
DB00537	Ciprofloxacin	heart diseases	167	-0.66
DB00537	Ciprofloxacin	gastrointestinal neoplasms	72	-0.63
DB00537	Ciprofloxacin	eye diseases	231	-0.49
DB00537	Ciprofloxacin	metabolism inborn errors	289	-0.48
DB00537	Ciprofloxacin	vascular diseases	181	-0.41
DB00537	Ciprofloxacin	leukemia	117	-0.35
DB00537	Ciprofloxacin	hematologic diseases	188	-0.24
DB00537	Ciprofloxacin	skin diseases	278	-0.24
DB00537	Ciprofloxacin	autoimmune diseases	243	-0.20
DB00537	Ciprofloxacin	cardiovascular diseases	330	-0.12
DB00537	Ciprofloxacin	endocrine system diseases	291	-0.09
DB00537	Ciprofloxacin	neoplasms	482	0.22
DB00537	Ciprofloxacin	insulin resistance	26	0.24
DB00537	Ciprofloxacin	bone diseases metabolic	27	0.26
DB00537	Ciprofloxacin	varicose veins	20	0.27
DB00537	Ciprofloxacin	collagen diseases	25	0.28
DB00537	Ciprofloxacin	arrhythmias cardiac	30	0.28
DB00537	Ciprofloxacin	hyperinsulinism	26	0.32
DB00537	Ciprofloxacin	macular degeneration	44	0.32
DB00537	Ciprofloxacin	epilepsy	25	0.34
DB00537	Ciprofloxacin	coronary artery disease	31	0.37
DB00537	Ciprofloxacin	keratosis	21	0.40
DB00537	Ciprofloxacin	coronary disease	37	0.43
DB00537	Ciprofloxacin	myocardial ischemia	43	0.45
DB00537	Ciprofloxacin	anemia hemolytic	29	0.47
DB00537	Ciprofloxacin	parkinson disease	30	0.47
DB00537	Ciprofloxacin	parkinsonian disorders	31	0.48
DB00537	Ciprofloxacin	malabsorption syndromes	34	0.49
DB00537	Ciprofloxacin	mycobacterium infections	22	0.50
DB00537	Ciprofloxacin	hypopigmentation	22	0.51
DB00537	Ciprofloxacin	alzheimer disease	29	0.52
DB00537	Ciprofloxacin	arteriosclerosis	38	0.53
DB00537	Ciprofloxacin	thyroid diseases	30	0.54
DB00537	Ciprofloxacin	bacterial infections	26	0.56
DB00537	Ciprofloxacin	blood coagulation disorders	40	0.57
DB00537	Ciprofloxacin	amyotrophic lateral sclerosis	21	0.57
DB00537	Ciprofloxacin	neuroendocrine tumors	24	0.58
DB00537	Ciprofloxacin	asthma	36	0.59
DB00537	Ciprofloxacin	arterial occlusive diseases	44	0.59
DB00537	Ciprofloxacin	liver cirrhosis	24	0.61
DB00537	Ciprofloxacin	liver cirrhosis biliary	23	0.65
DB00537	Ciprofloxacin	hypersensitivity	45	0.68
DB00537	Ciprofloxacin	colitis ulcerative	55	0.71
DB00537	Ciprofloxacin	colitis	55	0.71
DB00537	Ciprofloxacin	motor neuron disease	31	0.76
DB00537	Ciprofloxacin	dementia	42	0.76
DB00537	Ciprofloxacin	diabetes mellitus type 2	72	0.78
DB00537	Ciprofloxacin	psoriasis	54	0.84
DB00537	Ciprofloxacin	diabetes mellitus type 1	82	0.90
DB00537	Ciprofloxacin	lupus erythematosus systemic	75	0.92
DB00537	Ciprofloxacin	crohn disease	71	0.94
DB00537	Ciprofloxacin	gastroenteritis	122	1.23
DB00537	Ciprofloxacin	anemia	58	1.26
DB00537	Ciprofloxacin	diabetes mellitus	162	1.33
DB00537	Ciprofloxacin	inflammatory bowel diseases	119	1.36
DB00537	Ciprofloxacin	bone diseases	144	1.63
DB01261	Sitagliptin	coronary artery disease	31	-2.74
DB01261	Sitagliptin	arteriosclerosis	38	-2.50
DB01261	Sitagliptin	myocardial ischemia	43	-2.44
DB01261	Sitagliptin	arterial occlusive diseases	44	-2.44
DB01261	Sitagliptin	multiple sclerosis	69	-2.42
DB01261	Sitagliptin	coronary disease	37	-2.27
DB01261	Sitagliptin	heart diseases	167	-1.47
DB01261	Sitagliptin	autoimmune diseases	243	-1.33
DB01261	Sitagliptin	vascular diseases	181	-1.10
DB01261	Sitagliptin	cardiovascular diseases	330	-0.81
DB01261	Sitagliptin	collagen diseases	25	-0.45
DB01261	Sitagliptin	varicose veins	20	-0.43
DB01261	Sitagliptin	mycobacterium infections	22	-0.39
DB01261	Sitagliptin	bone diseases metabolic	27	-0.32
DB01261	Sitagliptin	macular degeneration	44	-0.32
DB01261	Sitagliptin	kidney neoplasms	20	-0.29
DB01261	Sitagliptin	liver cirrhosis	24	-0.28
DB01261	Sitagliptin	liver cirrhosis biliary	23	-0.27
DB01261	Sitagliptin	thyroid diseases	30	-0.27
DB01261	Sitagliptin	bacterial infections	26	-0.25
DB01261	Sitagliptin	anemia hemolytic	29	-0.25
DB01261	Sitagliptin	malabsorption syndromes	34	-0.24
DB01261	Sitagliptin	pancreatic diseases	24	-0.23
DB01261	Sitagliptin	parkinson disease	30	-0.21
DB01261	Sitagliptin	parkinsonian disorders	31	-0.20
DB01261	Sitagliptin	hypopigmentation	22	-0.18
DB01261	Sitagliptin	asthma	36	-0.17
DB01261	Sitagliptin	lymphoma	24	-0.13
DB01261	Sitagliptin	lymphoma non hodgkin	22	-0.09
DB01261	Sitagliptin	hypersensitivity	45	-0.08
DB01261	Sitagliptin	blood coagulation disorders	40	-0.06
DB01261	Sitagliptin	arthritis rheumatoid	42	-0.03
DB01261	Sitagliptin	adenocarcinoma	32	0.02
DB01261	Sitagliptin	colitis	55	0.04
DB01261	Sitagliptin	colitis ulcerative	55	0.05
DB01261	Sitagliptin	head and neck neoplasms	35	0.07
DB01261	Sitagliptin	psoriasis	54	0.08
DB01261	Sitagliptin	prostatic neoplasms	61	0.10
DB01261	Sitagliptin	diabetes mellitus type 2	72	0.13
DB01261	Sitagliptin	crohn disease	71	0.14
DB01261	Sitagliptin	rheumatic diseases	59	0.14
DB01261	Sitagliptin	lupus erythematosus systemic	75	0.16
DB01261	Sitagliptin	leukemia myeloid acute	43	0.18
DB01261	Sitagliptin	lung diseases	71	0.19
DB01261	Sitagliptin	diabetes mellitus type 1	82	0.20
DB01261	Sitagliptin	spinal cord diseases	59	0.20
DB01261	Sitagliptin	colorectal neoplasms	42	0.21
DB01261	Sitagliptin	joint diseases	79	0.22
DB01261	Sitagliptin	intestinal neoplasms	42	0.22
DB01261	Sitagliptin	anemia	58	0.23
DB01261	Sitagliptin	leukemia lymphoid	66	0.26
DB01261	Sitagliptin	arthritis	76	0.26
DB01261	Sitagliptin	kidney diseases	144	0.33
DB01261	Sitagliptin	gastroenteritis	122	0.34
DB01261	Sitagliptin	inflammatory bowel diseases	119	0.34
DB01261	Sitagliptin	diabetes mellitus	162	0.43
DB01261	Sitagliptin	gastrointestinal neoplasms	72	0.43
DB01261	Sitagliptin	bone diseases	144	0.45
DB01261	Sitagliptin	eye diseases	231	0.54
DB01261	Sitagliptin	leukemia	117	0.57
DB01261	Sitagliptin	metabolism inborn errors	289	0.63
DB01261	Sitagliptin	hematologic diseases	188	0.67
DB01261	Sitagliptin	skin diseases	278	0.78
DB01261	Sitagliptin	endocrine system diseases	291	0.82
DB01261	Sitagliptin	insulin resistance	26	1.35
DB01261	Sitagliptin	neoplasms	482	1.37
DB01261	Sitagliptin	hyperinsulinism	26	1.38
DB01261	Sitagliptin	epilepsy	25	1.40
DB01261	Sitagliptin	arrhythmias cardiac	30	1.54
DB01261	Sitagliptin	keratosis	21	1.78
DB01261	Sitagliptin	amyotrophic lateral sclerosis	21	2.09
DB01261	Sitagliptin	alzheimer disease	29	2.19
DB01261	Sitagliptin	cardiomyopathy dilated	29	2.20
DB01261	Sitagliptin	sarcoma	25	2.25
DB01261	Sitagliptin	neuroendocrine tumors	24	2.36
DB01261	Sitagliptin	motor neuron disease	31	2.44
DB01261	Sitagliptin	dementia	42	2.52
DB01261	Sitagliptin	breast neoplasms	40	2.55
DB00530	Erlotinib	lung diseases	71	-3.53
DB00530	Erlotinib	cardiomyopathy dilated	29	-2.46
DB00530	Erlotinib	asthma	36	-2.21
DB00530	Erlotinib	hypersensitivity	45	-1.99
DB00530	Erlotinib	neoplasms	482	-1.98
DB00530	Erlotinib	arrhythmias cardiac	30	-1.61
DB00530	Erlotinib	heart diseases	167	-1.60
DB00530	Erlotinib	macular degeneration	44	-1.52
DB00530	Erlotinib	metabolism inborn errors	289	-1.31
DB00530	Erlotinib	coronary artery disease	31	-1.25
DB00530	Erlotinib	parkinsonian disorders	31	-1.21
DB00530	Erlotinib	parkinson disease	30	-1.15
DB00530	Erlotinib	coronary disease	37	-1.12
DB00530	Erlotinib	anemia hemolytic	29	-1.11
DB00530	Erlotinib	thyroid diseases	30	-1.05
DB00530	Erlotinib	myocardial ischemia	43	-1.04
DB00530	Erlotinib	arteriosclerosis	38	-1.00
DB00530	Erlotinib	mycobacterium infections	22	-0.94
DB00530	Erlotinib	cardiovascular diseases	330	-0.91
DB00530	Erlotinib	malabsorption syndromes	34	-0.90
DB00530	Erlotinib	kidney neoplasms	20	-0.86
DB00530	Erlotinib	arterial occlusive diseases	44	-0.85
DB00530	Erlotinib	blood coagulation disorders	40	-0.84
DB00530	Erlotinib	alzheimer disease	29	-0.84
DB00530	Erlotinib	bacterial infections	26	-0.73
DB00530	Erlotinib	colitis	55	-0.71
DB00530	Erlotinib	colitis ulcerative	55	-0.61
DB00530	Erlotinib	sarcoma	25	-0.61
DB00530	Erlotinib	diabetes mellitus type 2	72	-0.61
DB00530	Erlotinib	dementia	42	-0.51
DB00530	Erlotinib	prostatic neoplasms	61	-0.42
DB00530	Erlotinib	head and neck neoplasms	35	-0.39
DB00530	Erlotinib	motor neuron disease	31	-0.34
DB00530	Erlotinib	arthritis rheumatoid	42	-0.29
DB00530	Erlotinib	adenocarcinoma	32	-0.27
DB00530	Erlotinib	diabetes mellitus type 1	82	-0.23
DB00530	Erlotinib	lupus erythematosus systemic	75	-0.17
DB00530	Erlotinib	breast neoplasms	40	-0.14
DB00530	Erlotinib	crohn disease	71	-0.09
DB00530	Erlotinib	intestinal neoplasms	42	-0.09
DB00530	Erlotinib	varicose veins	20	-0.08
DB00530	Erlotinib	multiple sclerosis	69	-0.08
DB00530	Erlotinib	rheumatic diseases	59	-0.07
DB00530	Erlotinib	leukemia myeloid acute	43	-0.04
DB00530	Erlotinib	spinal cord diseases	59	-0.01
DB00530	Erlotinib	colorectal neoplasms	42	0.02
DB00530	Erlotinib	arthritis	76	0.06
DB00530	Erlotinib	bone diseases metabolic	27	0.09
DB00530	Erlotinib	joint diseases	79	0.10
DB00530	Erlotinib	insulin resistance	26	0.10
DB00530	Erlotinib	leukemia lymphoid	66	0.12
DB00530	Erlotinib	gastroenteritis	122	0.12
DB00530	Erlotinib	kidney diseases	144	0.15
DB00530	Erlotinib	hyperinsulinism	26	0.16
DB00530	Erlotinib	inflammatory bowel diseases	119	0.19
DB00530	Erlotinib	anemia	58	0.20
DB00530	Erlotinib	diabetes mellitus	162	0.20
DB00530	Erlotinib	gastrointestinal neoplasms	72	0.31
DB00530	Erlotinib	keratosis	21	0.41
DB00530	Erlotinib	bone diseases	144	0.46
DB00530	Erlotinib	leukemia	117	0.54
DB00530	Erlotinib	eye diseases	231	0.56
DB00530	Erlotinib	vascular diseases	181	0.59
DB00530	Erlotinib	amyotrophic lateral sclerosis	21	0.69
DB00530	Erlotinib	autoimmune diseases	243	0.71
DB00530	Erlotinib	hematologic diseases	188	0.74
DB00530	Erlotinib	endocrine system diseases	291	0.74
DB00530	Erlotinib	skin diseases	278	0.80
DB00530	Erlotinib	liver cirrhosis	24	0.88
DB00530	Erlotinib	liver cirrhosis biliary	23	0.95
DB00530	Erlotinib	pancreatic diseases	24	0.96
DB00530	Erlotinib	neuroendocrine tumors	24	0.96
DB00530	Erlotinib	lymphoma non hodgkin	22	1.30
DB00530	Erlotinib	lymphoma	24	1.31
DB00530	Erlotinib	psoriasis	54	1.42
DB00530	Erlotinib	epilepsy	25	1.51
DB00530	Erlotinib	collagen diseases	25	1.66
DB00530	Erlotinib	hypopigmentation	22	2.09
DB01124	Tolbutamide	pancreatic diseases	24	-4.88
DB01124	Tolbutamide	endocrine system diseases	291	-4.75
DB01124	Tolbutamide	diabetes mellitus type 2	72	-3.18
DB01124	Tolbutamide	kidney diseases	144	-3.15
DB01124	Tolbutamide	diabetes mellitus	162	-3.01
DB01124	Tolbutamide	arrhythmias cardiac	30	-2.32
DB01124	Tolbutamide	arthritis	76	-1.82
DB01124	Tolbutamide	rheumatic diseases	59	-1.77
DB01124	Tolbutamide	joint diseases	79	-1.69
DB01124	Tolbutamide	heart diseases	167	-1.46
DB01124	Tolbutamide	metabolism inborn errors	289	-0.99
DB01124	Tolbutamide	bacterial infections	26	-0.90
DB01124	Tolbutamide	cardiomyopathy dilated	29	-0.87
DB01124	Tolbutamide	cardiovascular diseases	330	-0.83
DB01124	Tolbutamide	alzheimer disease	29	-0.76
DB01124	Tolbutamide	arthritis rheumatoid	42	-0.55
DB01124	Tolbutamide	dementia	42	-0.54
DB01124	Tolbutamide	spinal cord diseases	59	-0.27
DB01124	Tolbutamide	lung diseases	71	-0.23
DB01124	Tolbutamide	varicose veins	20	-0.06
DB01124	Tolbutamide	epilepsy	25	-0.03
DB01124	Tolbutamide	insulin resistance	26	0.05
DB01124	Tolbutamide	hyperinsulinism	26	0.05
DB01124	Tolbutamide	collagen diseases	25	0.07
DB01124	Tolbutamide	bone diseases metabolic	27	0.10
DB01124	Tolbutamide	coronary artery disease	31	0.19
DB01124	Tolbutamide	keratosis	21	0.26
DB01124	Tolbutamide	mycobacterium infections	22	0.27
DB01124	Tolbutamide	macular degeneration	44	0.29
DB01124	Tolbutamide	hypopigmentation	22	0.33
DB01124	Tolbutamide	thyroid diseases	30	0.34
DB01124	Tolbutamide	kidney neoplasms	20	0.35
DB01124	Tolbutamide	anemia hemolytic	29	0.37
DB01124	Tolbutamide	coronary disease	37	0.39
DB01124	Tolbutamide	malabsorption syndromes	34	0.41
DB01124	Tolbutamide	liver cirrhosis biliary	23	0.43
DB01124	Tolbutamide	parkinsonian disorders	31	0.44
DB01124	Tolbutamide	autoimmune diseases	243	0.45
DB01124	Tolbutamide	liver cirrhosis	24	0.45
DB01124	Tolbutamide	amyotrophic lateral sclerosis	21	0.45
DB01124	Tolbutamide	parkinson disease	30	0.46
DB01124	Tolbutamide	neuroendocrine tumors	24	0.47
DB01124	Tolbutamide	myocardial ischemia	43	0.51
DB01124	Tolbutamide	asthma	36	0.52
DB01124	Tolbutamide	skin diseases	278	0.55
DB01124	Tolbutamide	sarcoma	25	0.58
DB01124	Tolbutamide	arteriosclerosis	38	0.58
DB01124	Tolbutamide	arterial occlusive diseases	44	0.68
DB01124	Tolbutamide	lymphoma	24	0.68
DB01124	Tolbutamide	lymphoma non hodgkin	22	0.68
DB01124	Tolbutamide	blood coagulation disorders	40	0.69
DB01124	Tolbutamide	hypersensitivity	45	0.75
DB01124	Tolbutamide	motor neuron disease	31	0.82
DB01124	Tolbutamide	adenocarcinoma	32	0.86
DB01124	Tolbutamide	colitis ulcerative	55	0.87
DB01124	Tolbutamide	colitis	55	0.89
DB01124	Tolbutamide	neoplasms	482	0.93
DB01124	Tolbutamide	breast neoplasms	40	0.94
DB01124	Tolbutamide	head and neck neoplasms	35	0.94
DB01124	Tolbutamide	prostatic neoplasms	61	0.95
DB01124	Tolbutamide	psoriasis	54	0.97
DB01124	Tolbutamide	lupus erythematosus systemic	75	1.16
DB01124	Tolbutamide	crohn disease	71	1.17
DB01124	Tolbutamide	multiple sclerosis	69	1.18
DB01124	Tolbutamide	diabetes mellitus type 1	82	1.21
DB01124	Tolbutamide	colorectal neoplasms	42	1.22
DB01124	Tolbutamide	intestinal neoplasms	42	1.23
DB01124	Tolbutamide	leukemia myeloid acute	43	1.23
DB01124	Tolbutamide	leukemia lymphoid	66	1.36
DB01124	Tolbutamide	anemia	58	1.42
DB01124	Tolbutamide	gastroenteritis	122	1.53
DB01124	Tolbutamide	inflammatory bowel diseases	119	1.54
DB01124	Tolbutamide	gastrointestinal neoplasms	72	1.68
DB01124	Tolbutamide	bone diseases	144	1.75
DB01124	Tolbutamide	eye diseases	231	1.77
DB01124	Tolbutamide	leukemia	117	1.82
DB01124	Tolbutamide	vascular diseases	181	1.85
DB01124	Tolbutamide	hematologic diseases	188	1.94
DB01120	Gliclazide	diabetes mellitus	162	-5.62
DB01120	Gliclazide	endocrine system diseases	291	-5.15
DB01120	Gliclazide	pancreatic diseases	24	-3.51
DB01120	Gliclazide	diabetes mellitus type 2	72	-3.34
DB01120	Gliclazide	kidney diseases	144	-2.78
DB01120	Gliclazide	macular degeneration	44	-2.32
DB01120	Gliclazide	colitis	55	-1.94
DB01120	Gliclazide	colitis ulcerative	55	-1.86
DB01120	Gliclazide	inflammatory bowel diseases	119	-1.40
DB01120	Gliclazide	gastroenteritis	122	-1.34
DB01120	Gliclazide	eye diseases	231	-0.87
DB01120	Gliclazide	bacterial infections	26	-0.82
DB01120	Gliclazide	autoimmune diseases	243	-0.77
DB01120	Gliclazide	alzheimer disease	29	-0.73
DB01120	Gliclazide	cardiomyopathy dilated	29	-0.65
DB01120	Gliclazide	skin diseases	278	-0.49
DB01120	Gliclazide	arthritis rheumatoid	42	-0.39
DB01120	Gliclazide	dementia	42	-0.38
DB01120	Gliclazide	psoriasis	54	-0.26
DB01120	Gliclazide	rheumatic diseases	59	-0.25
DB01120	Gliclazide	lupus erythematosus systemic	75	-0.18
DB01120	Gliclazide	diabetes mellitus type 1	82	-0.15
DB01120	Gliclazide	spinal cord diseases	59	-0.13
DB01120	Gliclazide	multiple sclerosis	69	-0.11
DB01120	Gliclazide	joint diseases	79	-0.04
DB01120	Gliclazide	arthritis	76	0.00
DB01120	Gliclazide	neoplasms	482	0.08
DB01120	Gliclazide	varicose veins	20	0.19
DB01120	Gliclazide	epilepsy	25	0.27
DB01120	Gliclazide	heart diseases	167	0.29
DB01120	Gliclazide	insulin resistance	26	0.30
DB01120	Gliclazide	arrhythmias cardiac	30	0.31
DB01120	Gliclazide	hyperinsulinism	26	0.36
DB01120	Gliclazide	bone diseases metabolic	27	0.37
DB01120	Gliclazide	collagen diseases	25	0.40
DB01120	Gliclazide	mycobacterium infections	22	0.43
DB01120	Gliclazide	keratosis	21	0.50
DB01120	Gliclazide	coronary artery disease	31	0.51
DB01120	Gliclazide	metabolism inborn errors	289	0.55
DB01120	Gliclazide	kidney neoplasms	20	0.60
DB01120	Gliclazide	hypopigmentation	22	0.62
DB01120	Gliclazide	thyroid diseases	30	0.63
DB01120	Gliclazide	anemia hemolytic	29	0.64
DB01120	Gliclazide	amyotrophic lateral sclerosis	21	0.69
DB01120	Gliclazide	liver cirrhosis biliary	23	0.70
DB01120	Gliclazide	coronary disease	37	0.70
DB01120	Gliclazide	malabsorption syndromes	34	0.72
DB01120	Gliclazide	myocardial ischemia	43	0.73
DB01120	Gliclazide	liver cirrhosis	24	0.73
DB01120	Gliclazide	asthma	36	0.75
DB01120	Gliclazide	arteriosclerosis	38	0.80
DB01120	Gliclazide	neuroendocrine tumors	24	0.82
DB01120	Gliclazide	cardiovascular diseases	330	0.83
DB01120	Gliclazide	sarcoma	25	0.86
DB01120	Gliclazide	arterial occlusive diseases	44	0.89
DB01120	Gliclazide	blood coagulation disorders	40	0.90
DB01120	Gliclazide	hypersensitivity	45	0.93
DB01120	Gliclazide	lymphoma	24	0.95
DB01120	Gliclazide	lymphoma non hodgkin	22	0.98
DB01120	Gliclazide	motor neuron disease	31	1.07
DB01120	Gliclazide	adenocarcinoma	32	1.10
DB01120	Gliclazide	head and neck neoplasms	35	1.10
DB01120	Gliclazide	breast neoplasms	40	1.21
DB01120	Gliclazide	prostatic neoplasms	61	1.23
DB01120	Gliclazide	leukemia myeloid acute	43	1.28
DB01120	Gliclazide	intestinal neoplasms	42	1.37
DB01120	Gliclazide	colorectal neoplasms	42	1.37
DB01120	Gliclazide	leukemia lymphoid	66	1.53
DB01120	Gliclazide	crohn disease	71	1.54
DB01120	Gliclazide	anemia	58	1.55
DB01120	Gliclazide	lung diseases	71	1.57
DB01120	Gliclazide	gastrointestinal neoplasms	72	1.75
DB01120	Gliclazide	leukemia	117	1.83
DB01120	Gliclazide	bone diseases	144	1.85
DB01120	Gliclazide	vascular diseases	181	1.99
DB01120	Gliclazide	hematologic diseases	188	2.06
DB01120	Gliclazide	parkinsonian disorders	31	2.14
DB01120	Gliclazide	parkinson disease	30	2.17
DB00635	Prednisone	coronary disease	37	-3.53
DB00635	Prednisone	myocardial ischemia	43	-3.27
DB00635	Prednisone	vascular diseases	181	-2.16
DB00635	Prednisone	heart diseases	167	-2.13
DB00635	Prednisone	hematologic diseases	188	-2.08
DB00635	Prednisone	blood coagulation disorders	40	-2.04
DB00635	Prednisone	cardiovascular diseases	330	-2.03
DB00635	Prednisone	sarcoma	25	-1.70
DB00635	Prednisone	prostatic neoplasms	61	-1.53
DB00635	Prednisone	collagen diseases	25	-1.28
DB00635	Prednisone	bone diseases metabolic	27	-1.14
DB00635	Prednisone	coronary artery disease	31	-0.93
DB00635	Prednisone	bone diseases	144	-0.82
DB00635	Prednisone	mycobacterium infections	22	-0.75
DB00635	Prednisone	kidney neoplasms	20	-0.74
DB00635	Prednisone	malabsorption syndromes	34	-0.68
DB00635	Prednisone	arteriosclerosis	38	-0.67
DB00635	Prednisone	metabolism inborn errors	289	-0.61
DB00635	Prednisone	bacterial infections	26	-0.61
DB00635	Prednisone	neuroendocrine tumors	24	-0.60
DB00635	Prednisone	alzheimer disease	29	-0.59
DB00635	Prednisone	arterial occlusive diseases	44	-0.57
DB00635	Prednisone	asthma	36	-0.55
DB00635	Prednisone	colitis ulcerative	55	-0.51
DB00635	Prednisone	skin diseases	278	-0.51
DB00635	Prednisone	colitis	55	-0.44
DB00635	Prednisone	hypersensitivity	45	-0.43
DB00635	Prednisone	liver cirrhosis	24	-0.43
DB00635	Prednisone	liver cirrhosis biliary	23	-0.41
DB00635	Prednisone	dementia	42	-0.31
DB00635	Prednisone	lymphoma	24	-0.30
DB00635	Prednisone	motor neuron disease	31	-0.28
DB00635	Prednisone	lymphoma non hodgkin	22	-0.27
DB00635	Prednisone	head and neck neoplasms	35	-0.25
DB00635	Prednisone	adenocarcinoma	32	-0.24
DB00635	Prednisone	arthritis rheumatoid	42	-0.23
DB00635	Prednisone	neoplasms	482	-0.18
DB00635	Prednisone	lupus erythematosus systemic	75	-0.06
DB00635	Prednisone	diabetes mellitus type 1	82	-0.05
DB00635	Prednisone	breast neoplasms	40	-0.03
DB00635	Prednisone	rheumatic diseases	59	-0.02
DB00635	Prednisone	varicose veins	20	0.02
DB00635	Prednisone	crohn disease	71	0.08
DB00635	Prednisone	intestinal neoplasms	42	0.12
DB00635	Prednisone	colorectal neoplasms	42	0.13
DB00635	Prednisone	arrhythmias cardiac	30	0.14
DB00635	Prednisone	epilepsy	25	0.15
DB00635	Prednisone	leukemia myeloid acute	43	0.15
DB00635	Prednisone	multiple sclerosis	69	0.22
DB00635	Prednisone	leukemia lymphoid	66	0.24
DB00635	Prednisone	spinal cord diseases	59	0.25
DB00635	Prednisone	macular degeneration	44	0.25
DB00635	Prednisone	arthritis	76	0.25
DB00635	Prednisone	joint diseases	79	0.27
DB00635	Prednisone	hyperinsulinism	26	0.29
DB00635	Prednisone	insulin resistance	26	0.30
DB00635	Prednisone	inflammatory bowel diseases	119	0.35
DB00635	Prednisone	lung diseases	71	0.35
DB00635	Prednisone	parkinsonian disorders	31	0.36
DB00635	Prednisone	kidney diseases	144	0.36
DB00635	Prednisone	gastroenteritis	122	0.37
DB00635	Prednisone	parkinson disease	30	0.37
DB00635	Prednisone	diabetes mellitus	162	0.43
DB00635	Prednisone	hypopigmentation	22	0.47
DB00635	Prednisone	anemia hemolytic	29	0.49
DB00635	Prednisone	cardiomyopathy dilated	29	0.51
DB00635	Prednisone	gastrointestinal neoplasms	72	0.53
DB00635	Prednisone	thyroid diseases	30	0.55
DB00635	Prednisone	amyotrophic lateral sclerosis	21	0.59
DB00635	Prednisone	leukemia	117	0.79
DB00635	Prednisone	eye diseases	231	0.80
DB00635	Prednisone	pancreatic diseases	24	0.82
DB00635	Prednisone	diabetes mellitus type 2	72	0.92
DB00635	Prednisone	autoimmune diseases	243	1.01
DB00635	Prednisone	endocrine system diseases	291	1.05
DB00635	Prednisone	psoriasis	54	1.07
DB00635	Prednisone	anemia	58	1.68
DB00635	Prednisone	keratosis	21	1.79
DB00434	Cyproheptadine	colitis	55	-1.71
DB00434	Cyproheptadine	colitis ulcerative	55	-1.66
DB00434	Cyproheptadine	varicose veins	20	-1.50
DB00434	Cyproheptadine	liver cirrhosis biliary	23	-1.39
DB00434	Cyproheptadine	pancreatic diseases	24	-1.39
DB00434	Cyproheptadine	epilepsy	25	-1.38
DB00434	Cyproheptadine	liver cirrhosis	24	-1.38
DB00434	Cyproheptadine	crohn disease	71	-1.35
DB00434	Cyproheptadine	leukemia myeloid acute	43	-1.34
DB00434	Cyproheptadine	arthritis	76	-1.21
DB00434	Cyproheptadine	joint diseases	79	-1.12
DB00434	Cyproheptadine	vascular diseases	181	-1.00
DB00434	Cyproheptadine	gastroenteritis	122	-0.85
DB00434	Cyproheptadine	dementia	42	-0.85
DB00434	Cyproheptadine	inflammatory bowel diseases	119	-0.85
DB00434	Cyproheptadine	hypopigmentation	22	-0.76
DB00434	Cyproheptadine	thyroid diseases	30	-0.73
DB00434	Cyproheptadine	parkinsonian disorders	31	-0.69
DB00434	Cyproheptadine	parkinson disease	30	-0.67
DB00434	Cyproheptadine	psoriasis	54	-0.65
DB00434	Cyproheptadine	hyperinsulinism	26	-0.53
DB00434	Cyproheptadine	diabetes mellitus type 1	82	-0.52
DB00434	Cyproheptadine	insulin resistance	26	-0.52
DB00434	Cyproheptadine	arteriosclerosis	38	-0.50
DB00434	Cyproheptadine	neuroendocrine tumors	24	-0.49
DB00434	Cyproheptadine	skin diseases	278	-0.43
DB00434	Cyproheptadine	leukemia	117	-0.35
DB00434	Cyproheptadine	cardiovascular diseases	330	-0.31
DB00434	Cyproheptadine	arterial occlusive diseases	44	-0.30
DB00434	Cyproheptadine	lung diseases	71	-0.23
DB00434	Cyproheptadine	eye diseases	231	-0.23
DB00434	Cyproheptadine	keratosis	21	-0.22
DB00434	Cyproheptadine	head and neck neoplasms	35	-0.07
DB00434	Cyproheptadine	adenocarcinoma	32	-0.04
DB00434	Cyproheptadine	autoimmune diseases	243	-0.02
DB00434	Cyproheptadine	anemia hemolytic	29	0.01
DB00434	Cyproheptadine	hematologic diseases	188	0.05
DB00434	Cyproheptadine	bacterial infections	26	0.05
DB00434	Cyproheptadine	gastrointestinal neoplasms	72	0.07
DB00434	Cyproheptadine	breast neoplasms	40	0.10
DB00434	Cyproheptadine	myocardial ischemia	43	0.17
DB00434	Cyproheptadine	diabetes mellitus	162	0.19
DB00434	Cyproheptadine	kidney diseases	144	0.20
DB00434	Cyproheptadine	arrhythmias cardiac	30	0.27
DB00434	Cyproheptadine	bone diseases	144	0.28
DB00434	Cyproheptadine	asthma	36	0.33
DB00434	Cyproheptadine	alzheimer disease	29	0.33
DB00434	Cyproheptadine	bone diseases metabolic	27	0.36
DB00434	Cyproheptadine	lupus erythematosus systemic	75	0.38
DB00434	Cyproheptadine	multiple sclerosis	69	0.38
DB00434	Cyproheptadine	cardiomyopathy dilated	29	0.39
DB00434	Cyproheptadine	colorectal neoplasms	42	0.41
DB00434	Cyproheptadine	intestinal neoplasms	42	0.42
DB00434	Cyproheptadine	neoplasms	482	0.45
DB00434	Cyproheptadine	spinal cord diseases	59	0.50
DB00434	Cyproheptadine	lymphoma non hodgkin	22	0.53
DB00434	Cyproheptadine	lymphoma	24	0.53
DB00434	Cyproheptadine	blood coagulation disorders	40	0.54
DB00434	Cyproheptadine	anemia	58	0.60
DB00434	Cyproheptadine	hypersensitivity	45	0.60
DB00434	Cyproheptadine	macular degeneration	44	0.65
DB00434	Cyproheptadine	leukemia lymphoid	66	0.68
DB00434	Cyproheptadine	metabolism inborn errors	289	0.78
DB00434	Cyproheptadine	malabsorption syndromes	34	0.96
DB00434	Cyproheptadine	endocrine system diseases	291	1.00
DB00434	Cyproheptadine	amyotrophic lateral sclerosis	21	1.02
DB00434	Cyproheptadine	diabetes mellitus type 2	72	1.09
DB00434	Cyproheptadine	mycobacterium infections	22	1.27
DB00434	Cyproheptadine	heart diseases	167	1.27
DB00434	Cyproheptadine	coronary artery disease	31	1.33
DB00434	Cyproheptadine	motor neuron disease	31	1.52
DB00434	Cyproheptadine	arthritis rheumatoid	42	1.59
DB00434	Cyproheptadine	kidney neoplasms	20	1.63
DB00434	Cyproheptadine	coronary disease	37	1.67
DB00434	Cyproheptadine	collagen diseases	25	1.83
DB00434	Cyproheptadine	prostatic neoplasms	61	1.93
DB00434	Cyproheptadine	sarcoma	25	2.07
DB00434	Cyproheptadine	rheumatic diseases	59	2.07
DB00343	Diltiazem	liver cirrhosis biliary	23	-1.57
DB00343	Diltiazem	parkinson disease	30	-1.56
DB00343	Diltiazem	liver cirrhosis	24	-1.52
DB00343	Diltiazem	amyotrophic lateral sclerosis	21	-1.50
DB00343	Diltiazem	parkinsonian disorders	31	-1.38
DB00343	Diltiazem	motor neuron disease	31	-1.29
DB00343	Diltiazem	breast neoplasms	40	-1.19
DB00343	Diltiazem	prostatic neoplasms	61	-1.13
DB00343	Diltiazem	multiple sclerosis	69	-1.09
DB00343	Diltiazem	spinal cord diseases	59	-1.05
DB00343	Diltiazem	lung diseases	71	-1.05
DB00343	Diltiazem	skin diseases	278	-0.50
DB00343	Diltiazem	autoimmune diseases	243	-0.48
DB00343	Diltiazem	neoplasms	482	-0.21
DB00343	Diltiazem	varicose veins	20	-0.14
DB00343	Diltiazem	epilepsy	25	-0.07
DB00343	Diltiazem	arrhythmias cardiac	30	-0.05
DB00343	Diltiazem	hyperinsulinism	26	-0.05
DB00343	Diltiazem	collagen diseases	25	-0.04
DB00343	Diltiazem	bone diseases metabolic	27	-0.03
DB00343	Diltiazem	mycobacterium infections	22	-0.02
DB00343	Diltiazem	insulin resistance	26	0.00
DB00343	Diltiazem	keratosis	21	0.02
DB00343	Diltiazem	coronary artery disease	31	0.03
DB00343	Diltiazem	kidney neoplasms	20	0.07
DB00343	Diltiazem	anemia hemolytic	29	0.08
DB00343	Diltiazem	hypopigmentation	22	0.08
DB00343	Diltiazem	thyroid diseases	30	0.09
DB00343	Diltiazem	macular degeneration	44	0.10
DB00343	Diltiazem	myocardial ischemia	43	0.11
DB00343	Diltiazem	bacterial infections	26	0.11
DB00343	Diltiazem	malabsorption syndromes	34	0.12
DB00343	Diltiazem	cardiomyopathy dilated	29	0.14
DB00343	Diltiazem	arteriosclerosis	38	0.15
DB00343	Diltiazem	asthma	36	0.15
DB00343	Diltiazem	coronary disease	37	0.16
DB00343	Diltiazem	alzheimer disease	29	0.19
DB00343	Diltiazem	lymphoma non hodgkin	22	0.20
DB00343	Diltiazem	lymphoma	24	0.20
DB00343	Diltiazem	arterial occlusive diseases	44	0.20
DB00343	Diltiazem	blood coagulation disorders	40	0.23
DB00343	Diltiazem	hypersensitivity	45	0.29
DB00343	Diltiazem	colitis ulcerative	55	0.31
DB00343	Diltiazem	arthritis rheumatoid	42	0.33
DB00343	Diltiazem	adenocarcinoma	32	0.33
DB00343	Diltiazem	head and neck neoplasms	35	0.35
DB00343	Diltiazem	dementia	42	0.36
DB00343	Diltiazem	diabetes mellitus type 2	72	0.38
DB00343	Diltiazem	colitis	55	0.39
DB00343	Diltiazem	psoriasis	54	0.40
DB00343	Diltiazem	rheumatic diseases	59	0.43
DB00343	Diltiazem	lupus erythematosus systemic	75	0.43
DB00343	Diltiazem	intestinal neoplasms	42	0.46
DB00343	Diltiazem	colorectal neoplasms	42	0.47
DB00343	Diltiazem	leukemia myeloid acute	43	0.49
DB00343	Diltiazem	crohn disease	71	0.51
DB00343	Diltiazem	diabetes mellitus type 1	82	0.52
DB00343	Diltiazem	anemia	58	0.53
DB00343	Diltiazem	arthritis	76	0.54
DB00343	Diltiazem	leukemia lymphoid	66	0.56
DB00343	Diltiazem	joint diseases	79	0.56
DB00343	Diltiazem	inflammatory bowel diseases	119	0.65
DB00343	Diltiazem	gastrointestinal neoplasms	72	0.69
DB00343	Diltiazem	kidney diseases	144	0.70
DB00343	Diltiazem	gastroenteritis	122	0.72
DB00343	Diltiazem	bone diseases	144	0.79
DB00343	Diltiazem	diabetes mellitus	162	0.79
DB00343	Diltiazem	heart diseases	167	0.81
DB00343	Diltiazem	leukemia	117	0.84
DB00343	Diltiazem	vascular diseases	181	0.88
DB00343	Diltiazem	eye diseases	231	0.89
DB00343	Diltiazem	metabolism inborn errors	289	0.99
DB00343	Diltiazem	hematologic diseases	188	1.03
DB00343	Diltiazem	endocrine system diseases	291	1.07
DB00343	Diltiazem	cardiovascular diseases	330	1.15
DB00343	Diltiazem	neuroendocrine tumors	24	1.71
DB00343	Diltiazem	pancreatic diseases	24	1.84
DB00343	Diltiazem	sarcoma	25	1.89
DB00437	Allopurinol	lupus erythematosus systemic	75	-2.79
DB00437	Allopurinol	autoimmune diseases	243	-2.14
DB00437	Allopurinol	varicose veins	20	-0.18
DB00437	Allopurinol	hyperinsulinism	26	-0.08
DB00437	Allopurinol	insulin resistance	26	-0.03
DB00437	Allopurinol	mycobacterium infections	22	-0.01
DB00437	Allopurinol	macular degeneration	44	0.06
DB00437	Allopurinol	bacterial infections	26	0.09
DB00437	Allopurinol	parkinsonian disorders	31	0.09
DB00437	Allopurinol	pancreatic diseases	24	0.12
DB00437	Allopurinol	malabsorption syndromes	34	0.12
DB00437	Allopurinol	amyotrophic lateral sclerosis	21	0.12
DB00437	Allopurinol	arteriosclerosis	38	0.14
DB00437	Allopurinol	parkinson disease	30	0.15
DB00437	Allopurinol	lymphoma non hodgkin	22	0.19
DB00437	Allopurinol	sarcoma	25	0.19
DB00437	Allopurinol	arterial occlusive diseases	44	0.21
DB00437	Allopurinol	lymphoma	24	0.21
DB00437	Allopurinol	motor neuron disease	31	0.29
DB00437	Allopurinol	adenocarcinoma	32	0.30
DB00437	Allopurinol	breast neoplasms	40	0.35
DB00437	Allopurinol	head and neck neoplasms	35	0.36
DB00437	Allopurinol	dementia	42	0.36
DB00437	Allopurinol	psoriasis	54	0.37
DB00437	Allopurinol	prostatic neoplasms	61	0.40
DB00437	Allopurinol	intestinal neoplasms	42	0.44
DB00437	Allopurinol	diabetes mellitus type 2	72	0.44
DB00437	Allopurinol	colorectal neoplasms	42	0.47
DB00437	Allopurinol	leukemia myeloid acute	43	0.48
DB00437	Allopurinol	spinal cord diseases	59	0.48
DB00437	Allopurinol	crohn disease	71	0.49
DB00437	Allopurinol	multiple sclerosis	69	0.49
DB00437	Allopurinol	diabetes mellitus type 1	82	0.50
DB00437	Allopurinol	lung diseases	71	0.54
DB00437	Allopurinol	leukemia lymphoid	66	0.55
DB00437	Allopurinol	gastrointestinal neoplasms	72	0.66
DB00437	Allopurinol	gastroenteritis	122	0.68
DB00437	Allopurinol	inflammatory bowel diseases	119	0.69
DB00437	Allopurinol	diabetes mellitus	162	0.72
DB00437	Allopurinol	bone diseases	144	0.78
DB00437	Allopurinol	leukemia	117	0.83
DB00437	Allopurinol	vascular diseases	181	0.92
DB00437	Allopurinol	eye diseases	231	0.94
DB00437	Allopurinol	metabolism inborn errors	289	0.96
DB00437	Allopurinol	hematologic diseases	188	1.00
DB00437	Allopurinol	endocrine system diseases	291	1.06
DB00437	Allopurinol	cardiovascular diseases	330	1.09
DB00437	Allopurinol	skin diseases	278	1.12
DB00437	Allopurinol	neoplasms	482	1.41
DB00437	Allopurinol	epilepsy	25	1.52
DB00437	Allopurinol	arrhythmias cardiac	30	1.56
DB00437	Allopurinol	collagen diseases	25	1.59
DB00437	Allopurinol	bone diseases metabolic	27	1.59
DB00437	Allopurinol	coronary artery disease	31	1.61
DB00437	Allopurinol	keratosis	21	1.68
DB00437	Allopurinol	thyroid diseases	30	1.70
DB00437	Allopurinol	anemia hemolytic	29	1.71
DB00437	Allopurinol	hypopigmentation	22	1.73
DB00437	Allopurinol	coronary disease	37	1.75
DB00437	Allopurinol	myocardial ischemia	43	1.76
DB00437	Allopurinol	alzheimer disease	29	1.76
DB00437	Allopurinol	asthma	36	1.77
DB00437	Allopurinol	kidney neoplasms	20	1.78
DB00437	Allopurinol	liver cirrhosis biliary	23	1.82
DB00437	Allopurinol	cardiomyopathy dilated	29	1.83
DB00437	Allopurinol	neuroendocrine tumors	24	1.85
DB00437	Allopurinol	liver cirrhosis	24	1.85
DB00437	Allopurinol	blood coagulation disorders	40	1.88
DB00437	Allopurinol	hypersensitivity	45	1.90
DB00437	Allopurinol	arthritis rheumatoid	42	1.92
DB00437	Allopurinol	colitis	55	1.93
DB00437	Allopurinol	colitis ulcerative	55	1.94
DB00437	Allopurinol	rheumatic diseases	59	2.01
DB00437	Allopurinol	joint diseases	79	2.12
DB00437	Allopurinol	arthritis	76	2.14
DB00437	Allopurinol	anemia	58	2.18
DB00437	Allopurinol	kidney diseases	144	2.27
DB00437	Allopurinol	heart diseases	167	2.38
DB01128	Bicalutamide	endocrine system diseases	291	-5.33
DB01128	Bicalutamide	skin diseases	278	-4.19
DB01128	Bicalutamide	spinal cord diseases	59	-3.52
DB01128	Bicalutamide	motor neuron disease	31	-2.83
DB01128	Bicalutamide	neoplasms	482	-2.82
DB01128	Bicalutamide	prostatic neoplasms	61	-2.71
DB01128	Bicalutamide	parkinsonian disorders	31	-1.48
DB01128	Bicalutamide	parkinson disease	30	-1.48
DB01128	Bicalutamide	coronary artery disease	31	-1.28
DB01128	Bicalutamide	myocardial ischemia	43	-1.21
DB01128	Bicalutamide	keratosis	21	-1.19
DB01128	Bicalutamide	coronary disease	37	-1.18
DB01128	Bicalutamide	arteriosclerosis	38	-1.08
DB01128	Bicalutamide	malabsorption syndromes	34	-0.92
DB01128	Bicalutamide	arterial occlusive diseases	44	-0.92
DB01128	Bicalutamide	colitis ulcerative	55	-0.88
DB01128	Bicalutamide	kidney neoplasms	20	-0.87
DB01128	Bicalutamide	amyotrophic lateral sclerosis	21	-0.86
DB01128	Bicalutamide	colitis	55	-0.84
DB01128	Bicalutamide	diabetes mellitus type 2	72	-0.82
DB01128	Bicalutamide	liver cirrhosis	24	-0.75
DB01128	Bicalutamide	liver cirrhosis biliary	23	-0.70
DB01128	Bicalutamide	pancreatic diseases	24	-0.68
DB01128	Bicalutamide	sarcoma	25	-0.67
DB01128	Bicalutamide	asthma	36	-0.66
DB01128	Bicalutamide	hypersensitivity	45	-0.57
DB01128	Bicalutamide	lymphoma non hodgkin	22	-0.54
DB01128	Bicalutamide	diabetes mellitus type 1	82	-0.54
DB01128	Bicalutamide	lymphoma	24	-0.52
DB01128	Bicalutamide	head and neck neoplasms	35	-0.51
DB01128	Bicalutamide	adenocarcinoma	32	-0.45
DB01128	Bicalutamide	lupus erythematosus systemic	75	-0.43
DB01128	Bicalutamide	breast neoplasms	40	-0.38
DB01128	Bicalutamide	crohn disease	71	-0.36
DB01128	Bicalutamide	diabetes mellitus	162	-0.29
DB01128	Bicalutamide	leukemia myeloid acute	43	-0.27
DB01128	Bicalutamide	metabolism inborn errors	289	-0.27
DB01128	Bicalutamide	multiple sclerosis	69	-0.26
DB01128	Bicalutamide	gastroenteritis	122	-0.25
DB01128	Bicalutamide	colorectal neoplasms	42	-0.24
DB01128	Bicalutamide	intestinal neoplasms	42	-0.24
DB01128	Bicalutamide	kidney diseases	144	-0.22
DB01128	Bicalutamide	inflammatory bowel diseases	119	-0.21
DB01128	Bicalutamide	heart diseases	167	-0.21
DB01128	Bicalutamide	leukemia lymphoid	66	-0.20
DB01128	Bicalutamide	lung diseases	71	-0.13
DB01128	Bicalutamide	gastrointestinal neoplasms	72	-0.02
DB01128	Bicalutamide	bone diseases	144	0.02
DB01128	Bicalutamide	vascular diseases	181	0.03
DB01128	Bicalutamide	eye diseases	231	0.09
DB01128	Bicalutamide	cardiovascular diseases	330	0.12
DB01128	Bicalutamide	leukemia	117	0.15
DB01128	Bicalutamide	autoimmune diseases	243	0.16
DB01128	Bicalutamide	hematologic diseases	188	0.18
DB01128	Bicalutamide	arrhythmias cardiac	30	0.47
DB01128	Bicalutamide	varicose veins	20	0.52
DB01128	Bicalutamide	macular degeneration	44	0.53
DB01128	Bicalutamide	collagen diseases	25	0.56
DB01128	Bicalutamide	epilepsy	25	0.56
DB01128	Bicalutamide	bone diseases metabolic	27	0.62
DB01128	Bicalutamide	insulin resistance	26	0.70
DB01128	Bicalutamide	hyperinsulinism	26	0.72
DB01128	Bicalutamide	anemia hemolytic	29	0.81
DB01128	Bicalutamide	thyroid diseases	30	0.87
DB01128	Bicalutamide	cardiomyopathy dilated	29	0.98
DB01128	Bicalutamide	hypopigmentation	22	1.02
DB01128	Bicalutamide	blood coagulation disorders	40	1.05
DB01128	Bicalutamide	mycobacterium infections	22	1.05
DB01128	Bicalutamide	alzheimer disease	29	1.06
DB01128	Bicalutamide	bacterial infections	26	1.25
DB01128	Bicalutamide	dementia	42	1.41
DB01128	Bicalutamide	neuroendocrine tumors	24	1.43
DB01128	Bicalutamide	psoriasis	54	1.72
DB01128	Bicalutamide	arthritis rheumatoid	42	1.82
DB01128	Bicalutamide	rheumatic diseases	59	2.33
DB01128	Bicalutamide	arthritis	76	2.79
DB01128	Bicalutamide	joint diseases	79	3.08
DB01128	Bicalutamide	anemia	58	3.57
DB01029	Irbesartan	kidney diseases	144	-3.35
DB01029	Irbesartan	metabolism inborn errors	289	-2.97
DB01029	Irbesartan	thyroid diseases	30	-2.32
DB01029	Irbesartan	colitis ulcerative	55	-2.24
DB01029	Irbesartan	colitis	55	-2.18
DB01029	Irbesartan	multiple sclerosis	69	-1.84
DB01029	Irbesartan	crohn disease	71	-1.82
DB01029	Irbesartan	head and neck neoplasms	35	-1.77
DB01029	Irbesartan	leukemia myeloid acute	43	-1.67
DB01029	Irbesartan	lung diseases	71	-1.63
DB01029	Irbesartan	arrhythmias cardiac	30	-1.53
DB01029	Irbesartan	gastroenteritis	122	-1.53
DB01029	Irbesartan	inflammatory bowel diseases	119	-1.52
DB01029	Irbesartan	bone diseases metabolic	27	-1.45
DB01029	Irbesartan	macular degeneration	44	-1.44
DB01029	Irbesartan	heart diseases	167	-1.22
DB01029	Irbesartan	coronary artery disease	31	-1.16
DB01029	Irbesartan	vascular diseases	181	-1.15
DB01029	Irbesartan	parkinson disease	30	-1.14
DB01029	Irbesartan	parkinsonian disorders	31	-1.12
DB01029	Irbesartan	eye diseases	231	-1.10
DB01029	Irbesartan	myocardial ischemia	43	-1.06
DB01029	Irbesartan	keratosis	21	-1.06
DB01029	Irbesartan	leukemia	117	-1.05
DB01029	Irbesartan	coronary disease	37	-0.99
DB01029	Irbesartan	autoimmune diseases	243	-0.96
DB01029	Irbesartan	hematologic diseases	188	-0.94
DB01029	Irbesartan	arteriosclerosis	38	-0.93
DB01029	Irbesartan	blood coagulation disorders	40	-0.83
DB01029	Irbesartan	cardiomyopathy dilated	29	-0.80
DB01029	Irbesartan	skin diseases	278	-0.78
DB01029	Irbesartan	mycobacterium infections	22	-0.78
DB01029	Irbesartan	arterial occlusive diseases	44	-0.77
DB01029	Irbesartan	alzheimer disease	29	-0.75
DB01029	Irbesartan	endocrine system diseases	291	-0.74
DB01029	Irbesartan	cardiovascular diseases	330	-0.70
DB01029	Irbesartan	malabsorption syndromes	34	-0.68
DB01029	Irbesartan	bacterial infections	26	-0.66
DB01029	Irbesartan	liver cirrhosis	24	-0.59
DB01029	Irbesartan	pancreatic diseases	24	-0.58
DB01029	Irbesartan	liver cirrhosis biliary	23	-0.57
DB01029	Irbesartan	diabetes mellitus type 2	72	-0.55
DB01029	Irbesartan	neuroendocrine tumors	24	-0.54
DB01029	Irbesartan	asthma	36	-0.52
DB01029	Irbesartan	sarcoma	25	-0.51
DB01029	Irbesartan	dementia	42	-0.43
DB01029	Irbesartan	hypersensitivity	45	-0.39
DB01029	Irbesartan	lymphoma	24	-0.37
DB01029	Irbesartan	lymphoma non hodgkin	22	-0.36
DB01029	Irbesartan	motor neuron disease	31	-0.25
DB01029	Irbesartan	arthritis rheumatoid	42	-0.23
DB01029	Irbesartan	prostatic neoplasms	61	-0.22
DB01029	Irbesartan	diabetes mellitus type 1	82	-0.21
DB01029	Irbesartan	adenocarcinoma	32	-0.20
DB01029	Irbesartan	psoriasis	54	-0.19
DB01029	Irbesartan	lupus erythematosus systemic	75	-0.17
DB01029	Irbesartan	neoplasms	482	-0.12
DB01029	Irbesartan	breast neoplasms	40	-0.09
DB01029	Irbesartan	rheumatic diseases	59	-0.05
DB01029	Irbesartan	varicose veins	20	-0.04
DB01029	Irbesartan	intestinal neoplasms	42	0.10
DB01029	Irbesartan	spinal cord diseases	59	0.11
DB01029	Irbesartan	colorectal neoplasms	42	0.13
DB01029	Irbesartan	collagen diseases	25	0.13
DB01029	Irbesartan	joint diseases	79	0.16
DB01029	Irbesartan	leukemia lymphoid	66	0.17
DB01029	Irbesartan	arthritis	76	0.17
DB01029	Irbesartan	anemia	58	0.21
DB01029	Irbesartan	diabetes mellitus	162	0.25
DB01029	Irbesartan	insulin resistance	26	0.25
DB01029	Irbesartan	hyperinsulinism	26	0.29
DB01029	Irbesartan	gastrointestinal neoplasms	72	0.45
DB01029	Irbesartan	anemia hemolytic	29	0.45
DB01029	Irbesartan	bone diseases	144	0.55
DB01029	Irbesartan	hypopigmentation	22	0.72
DB01029	Irbesartan	amyotrophic lateral sclerosis	21	0.76
DB01029	Irbesartan	kidney neoplasms	20	0.81
DB01029	Irbesartan	epilepsy	25	1.64
DB00086	Streptokinase	eye diseases	231	-2.90
DB00086	Streptokinase	blood coagulation disorders	40	-2.76
DB00086	Streptokinase	vascular diseases	181	-2.70
DB00086	Streptokinase	cardiovascular diseases	330	-2.38
DB00086	Streptokinase	hematologic diseases	188	-2.29
DB00086	Streptokinase	hypersensitivity	45	-1.71
DB00086	Streptokinase	colitis ulcerative	55	-1.24
DB00086	Streptokinase	colitis	55	-1.18
DB00086	Streptokinase	dementia	42	-1.14
DB00086	Streptokinase	prostatic neoplasms	61	-1.08
DB00086	Streptokinase	diabetes mellitus type 1	82	-1.00
DB00086	Streptokinase	intestinal neoplasms	42	-0.79
DB00086	Streptokinase	gastroenteritis	122	-0.73
DB00086	Streptokinase	colorectal neoplasms	42	-0.71
DB00086	Streptokinase	inflammatory bowel diseases	119	-0.66
DB00086	Streptokinase	insulin resistance	26	-0.57
DB00086	Streptokinase	diabetes mellitus	162	-0.56
DB00086	Streptokinase	hyperinsulinism	26	-0.53
DB00086	Streptokinase	bone diseases metabolic	27	-0.46
DB00086	Streptokinase	collagen diseases	25	-0.42
DB00086	Streptokinase	macular degeneration	44	-0.41
DB00086	Streptokinase	bone diseases	144	-0.41
DB00086	Streptokinase	gastrointestinal neoplasms	72	-0.35
DB00086	Streptokinase	heart diseases	167	-0.34
DB00086	Streptokinase	mycobacterium infections	22	-0.30
DB00086	Streptokinase	bacterial infections	26	-0.26
DB00086	Streptokinase	coronary artery disease	31	-0.26
DB00086	Streptokinase	keratosis	21	-0.23
DB00086	Streptokinase	kidney neoplasms	20	-0.18
DB00086	Streptokinase	liver cirrhosis biliary	23	-0.18
DB00086	Streptokinase	anemia hemolytic	29	-0.16
DB00086	Streptokinase	hypopigmentation	22	-0.14
DB00086	Streptokinase	malabsorption syndromes	34	-0.13
DB00086	Streptokinase	coronary disease	37	-0.11
DB00086	Streptokinase	asthma	36	-0.10
DB00086	Streptokinase	neuroendocrine tumors	24	-0.09
DB00086	Streptokinase	pancreatic diseases	24	-0.09
DB00086	Streptokinase	myocardial ischemia	43	-0.08
DB00086	Streptokinase	liver cirrhosis	24	-0.08
DB00086	Streptokinase	thyroid diseases	30	-0.08
DB00086	Streptokinase	arteriosclerosis	38	-0.01
DB00086	Streptokinase	amyotrophic lateral sclerosis	21	0.00
DB00086	Streptokinase	autoimmune diseases	243	0.06
DB00086	Streptokinase	parkinsonian disorders	31	0.08
DB00086	Streptokinase	cardiomyopathy dilated	29	0.11
DB00086	Streptokinase	parkinson disease	30	0.13
DB00086	Streptokinase	alzheimer disease	29	0.14
DB00086	Streptokinase	sarcoma	25	0.14
DB00086	Streptokinase	arterial occlusive diseases	44	0.14
DB00086	Streptokinase	lymphoma	24	0.17
DB00086	Streptokinase	arthritis rheumatoid	42	0.17
DB00086	Streptokinase	lymphoma non hodgkin	22	0.23
DB00086	Streptokinase	endocrine system diseases	291	0.27
DB00086	Streptokinase	skin diseases	278	0.30
DB00086	Streptokinase	motor neuron disease	31	0.31
DB00086	Streptokinase	rheumatic diseases	59	0.34
DB00086	Streptokinase	diabetes mellitus type 2	72	0.36
DB00086	Streptokinase	lupus erythematosus systemic	75	0.39
DB00086	Streptokinase	psoriasis	54	0.40
DB00086	Streptokinase	adenocarcinoma	32	0.41
DB00086	Streptokinase	multiple sclerosis	69	0.47
DB00086	Streptokinase	crohn disease	71	0.51
DB00086	Streptokinase	head and neck neoplasms	35	0.53
DB00086	Streptokinase	joint diseases	79	0.54
DB00086	Streptokinase	anemia	58	0.54
DB00086	Streptokinase	leukemia myeloid acute	43	0.55
DB00086	Streptokinase	spinal cord diseases	59	0.56
DB00086	Streptokinase	arthritis	76	0.56
DB00086	Streptokinase	breast neoplasms	40	0.56
DB00086	Streptokinase	lung diseases	71	0.71
DB00086	Streptokinase	leukemia lymphoid	66	0.73
DB00086	Streptokinase	varicose veins	20	0.77
DB00086	Streptokinase	kidney diseases	144	0.82
DB00086	Streptokinase	epilepsy	25	0.85
DB00086	Streptokinase	arrhythmias cardiac	30	1.02
DB00086	Streptokinase	neoplasms	482	1.05
DB00086	Streptokinase	leukemia	117	1.14
DB00086	Streptokinase	metabolism inborn errors	289	1.42
DB00328	Indomethacin	eye diseases	231	-2.13
DB00328	Indomethacin	multiple sclerosis	69	-1.64
DB00328	Indomethacin	skin diseases	278	-1.41
DB00328	Indomethacin	lung diseases	71	-1.33
DB00328	Indomethacin	bone diseases metabolic	27	-1.01
DB00328	Indomethacin	gastrointestinal neoplasms	72	-0.95
DB00328	Indomethacin	coronary artery disease	31	-0.90
DB00328	Indomethacin	psoriasis	54	-0.85
DB00328	Indomethacin	dementia	42	-0.81
DB00328	Indomethacin	endocrine system diseases	291	-0.71
DB00328	Indomethacin	coronary disease	37	-0.65
DB00328	Indomethacin	diabetes mellitus type 1	82	-0.62
DB00328	Indomethacin	malabsorption syndromes	34	-0.61
DB00328	Indomethacin	myocardial ischemia	43	-0.61
DB00328	Indomethacin	neoplasms	482	-0.60
DB00328	Indomethacin	lupus erythematosus systemic	75	-0.60
DB00328	Indomethacin	spinal cord diseases	59	-0.57
DB00328	Indomethacin	arteriosclerosis	38	-0.55
DB00328	Indomethacin	amyotrophic lateral sclerosis	21	-0.48
DB00328	Indomethacin	alzheimer disease	29	-0.39
DB00328	Indomethacin	vascular diseases	181	-0.37
DB00328	Indomethacin	arterial occlusive diseases	44	-0.32
DB00328	Indomethacin	hyperinsulinism	26	-0.26
DB00328	Indomethacin	metabolism inborn errors	289	-0.21
DB00328	Indomethacin	lymphoma non hodgkin	22	-0.21
DB00328	Indomethacin	lymphoma	24	-0.21
DB00328	Indomethacin	insulin resistance	26	-0.19
DB00328	Indomethacin	collagen diseases	25	-0.18
DB00328	Indomethacin	colitis	55	-0.05
DB00328	Indomethacin	motor neuron disease	31	-0.04
DB00328	Indomethacin	adenocarcinoma	32	-0.04
DB00328	Indomethacin	arthritis rheumatoid	42	-0.03
DB00328	Indomethacin	autoimmune diseases	243	-0.02
DB00328	Indomethacin	colitis ulcerative	55	-0.02
DB00328	Indomethacin	head and neck neoplasms	35	0.09
DB00328	Indomethacin	keratosis	21	0.10
DB00328	Indomethacin	diabetes mellitus	162	0.11
DB00328	Indomethacin	diabetes mellitus type 2	72	0.17
DB00328	Indomethacin	breast neoplasms	40	0.22
DB00328	Indomethacin	bone diseases	144	0.25
DB00328	Indomethacin	thyroid diseases	30	0.27
DB00328	Indomethacin	heart diseases	167	0.29
DB00328	Indomethacin	rheumatic diseases	59	0.29
DB00328	Indomethacin	cardiovascular diseases	330	0.31
DB00328	Indomethacin	crohn disease	71	0.39
DB00328	Indomethacin	parkinson disease	30	0.41
DB00328	Indomethacin	varicose veins	20	0.44
DB00328	Indomethacin	leukemia myeloid acute	43	0.45
DB00328	Indomethacin	parkinsonian disorders	31	0.47
DB00328	Indomethacin	neuroendocrine tumors	24	0.50
DB00328	Indomethacin	leukemia	117	0.51
DB00328	Indomethacin	arthritis	76	0.53
DB00328	Indomethacin	joint diseases	79	0.54
DB00328	Indomethacin	epilepsy	25	0.57
DB00328	Indomethacin	sarcoma	25	0.64
DB00328	Indomethacin	leukemia lymphoid	66	0.68
DB00328	Indomethacin	inflammatory bowel diseases	119	0.88
DB00328	Indomethacin	gastroenteritis	122	0.90
DB00328	Indomethacin	kidney diseases	144	0.95
DB00328	Indomethacin	macular degeneration	44	1.01
DB00328	Indomethacin	prostatic neoplasms	61	1.21
DB00328	Indomethacin	kidney neoplasms	20	1.26
DB00328	Indomethacin	liver cirrhosis biliary	23	1.31
DB00328	Indomethacin	pancreatic diseases	24	1.38
DB00328	Indomethacin	liver cirrhosis	24	1.39
DB00328	Indomethacin	intestinal neoplasms	42	1.44
DB00328	Indomethacin	colorectal neoplasms	42	1.48
DB00328	Indomethacin	asthma	36	1.51
DB00328	Indomethacin	anemia	58	1.57
DB00328	Indomethacin	cardiomyopathy dilated	29	1.59
DB00328	Indomethacin	arrhythmias cardiac	30	1.64
DB00328	Indomethacin	hypersensitivity	45	1.76
DB00328	Indomethacin	hematologic diseases	188	1.78
DB00328	Indomethacin	mycobacterium infections	22	1.85
DB00328	Indomethacin	bacterial infections	26	2.14
DB00328	Indomethacin	anemia hemolytic	29	2.17
DB00328	Indomethacin	hypopigmentation	22	3.04
DB00328	Indomethacin	blood coagulation disorders	40	3.60
DB00651	Dyphylline	eye diseases	231	-2.29
DB00651	Dyphylline	arrhythmias cardiac	30	-1.23
DB00651	Dyphylline	asthma	36	-1.14
DB00651	Dyphylline	bone diseases metabolic	27	-1.10
DB00651	Dyphylline	endocrine system diseases	291	-0.95
DB00651	Dyphylline	hypersensitivity	45	-0.94
DB00651	Dyphylline	gastrointestinal neoplasms	72	-0.94
DB00651	Dyphylline	lung diseases	71	-0.70
DB00651	Dyphylline	head and neck neoplasms	35	-0.59
DB00651	Dyphylline	pancreatic diseases	24	-0.49
DB00651	Dyphylline	cardiomyopathy dilated	29	-0.20
DB00651	Dyphylline	intestinal neoplasms	42	-0.13
DB00651	Dyphylline	diabetes mellitus	162	-0.07
DB00651	Dyphylline	colorectal neoplasms	42	-0.07
DB00651	Dyphylline	varicose veins	20	0.01
DB00651	Dyphylline	bacterial infections	26	0.18
DB00651	Dyphylline	insulin resistance	26	0.35
DB00651	Dyphylline	hyperinsulinism	26	0.40
DB00651	Dyphylline	vascular diseases	181	0.40
DB00651	Dyphylline	diabetes mellitus type 2	72	0.42
DB00651	Dyphylline	alzheimer disease	29	0.58
DB00651	Dyphylline	metabolism inborn errors	289	0.59
DB00651	Dyphylline	cardiovascular diseases	330	0.62
DB00651	Dyphylline	spinal cord diseases	59	0.68
DB00651	Dyphylline	bone diseases	144	0.72
DB00651	Dyphylline	heart diseases	167	0.82
DB00651	Dyphylline	dementia	42	1.15
DB00651	Dyphylline	neoplasms	482	1.24
DB00651	Dyphylline	epilepsy	25	1.55
DB00651	Dyphylline	anemia hemolytic	29	1.66
DB00651	Dyphylline	liver cirrhosis biliary	23	1.82
DB00651	Dyphylline	thyroid diseases	30	1.85
DB00651	Dyphylline	liver cirrhosis	24	1.96
DB00651	Dyphylline	malabsorption syndromes	34	1.99
DB00651	Dyphylline	kidney diseases	144	2.02
DB00651	Dyphylline	arteriosclerosis	38	2.08
DB00651	Dyphylline	keratosis	21	2.26
DB00651	Dyphylline	sarcoma	25	2.30
DB00651	Dyphylline	multiple sclerosis	69	2.34
DB00651	Dyphylline	joint diseases	79	2.43
DB00651	Dyphylline	lymphoma	24	2.44
DB00651	Dyphylline	skin diseases	278	2.47
DB00651	Dyphylline	arterial occlusive diseases	44	2.47
DB00651	Dyphylline	arthritis	76	2.56
DB00651	Dyphylline	motor neuron disease	31	2.57
DB00651	Dyphylline	coronary disease	37	2.58
DB00651	Dyphylline	lymphoma non hodgkin	22	2.63
DB00651	Dyphylline	hypopigmentation	22	2.64
DB00651	Dyphylline	arthritis rheumatoid	42	2.70
DB00651	Dyphylline	autoimmune diseases	243	2.70
DB00651	Dyphylline	kidney neoplasms	20	2.71
DB00651	Dyphylline	collagen diseases	25	2.81
DB00651	Dyphylline	hematologic diseases	188	2.81
DB00651	Dyphylline	myocardial ischemia	43	2.82
DB00651	Dyphylline	amyotrophic lateral sclerosis	21	2.84
DB00651	Dyphylline	parkinsonian disorders	31	2.85
DB00651	Dyphylline	colitis	55	2.91
DB00651	Dyphylline	neuroendocrine tumors	24	2.92
DB00651	Dyphylline	colitis ulcerative	55	2.93
DB00651	Dyphylline	psoriasis	54	2.93
DB00651	Dyphylline	parkinson disease	30	2.96
DB00651	Dyphylline	rheumatic diseases	59	2.97
DB00651	Dyphylline	mycobacterium infections	22	2.98
DB00651	Dyphylline	coronary artery disease	31	3.01
DB00651	Dyphylline	lupus erythematosus systemic	75	3.02
DB00651	Dyphylline	macular degeneration	44	3.04
DB00651	Dyphylline	crohn disease	71	3.16
DB00651	Dyphylline	diabetes mellitus type 1	82	3.16
DB00651	Dyphylline	leukemia myeloid acute	43	3.20
DB00651	Dyphylline	blood coagulation disorders	40	3.27
DB00651	Dyphylline	anemia	58	3.31
DB00651	Dyphylline	leukemia	117	3.32
DB00651	Dyphylline	gastroenteritis	122	3.39
DB00651	Dyphylline	leukemia lymphoid	66	3.49
DB00651	Dyphylline	adenocarcinoma	32	3.52
DB00651	Dyphylline	inflammatory bowel diseases	119	3.56
DB00651	Dyphylline	breast neoplasms	40	3.74
DB00651	Dyphylline	prostatic neoplasms	61	3.76
DB00499	Flutamide	spinal cord diseases	59	-3.32
DB00499	Flutamide	coronary artery disease	31	-2.54
DB00499	Flutamide	myocardial ischemia	43	-2.50
DB00499	Flutamide	coronary disease	37	-2.48
DB00499	Flutamide	arteriosclerosis	38	-2.45
DB00499	Flutamide	skin diseases	278	-2.35
DB00499	Flutamide	endocrine system diseases	291	-2.23
DB00499	Flutamide	arterial occlusive diseases	44	-2.13
DB00499	Flutamide	neoplasms	482	-2.12
DB00499	Flutamide	sarcoma	25	-1.92
DB00499	Flutamide	colitis ulcerative	55	-1.88
DB00499	Flutamide	colitis	55	-1.86
DB00499	Flutamide	motor neuron disease	31	-1.73
DB00499	Flutamide	prostatic neoplasms	61	-1.73
DB00499	Flutamide	breast neoplasms	40	-1.61
DB00499	Flutamide	leukemia myeloid acute	43	-1.55
DB00499	Flutamide	crohn disease	71	-1.45
DB00499	Flutamide	colorectal neoplasms	42	-1.42
DB00499	Flutamide	intestinal neoplasms	42	-1.34
DB00499	Flutamide	gastroenteritis	122	-1.12
DB00499	Flutamide	inflammatory bowel diseases	119	-1.11
DB00499	Flutamide	parkinsonian disorders	31	-1.11
DB00499	Flutamide	heart diseases	167	-1.06
DB00499	Flutamide	parkinson disease	30	-1.04
DB00499	Flutamide	gastrointestinal neoplasms	72	-1.04
DB00499	Flutamide	keratosis	21	-0.94
DB00499	Flutamide	eye diseases	231	-0.92
DB00499	Flutamide	vascular diseases	181	-0.88
DB00499	Flutamide	thyroid diseases	30	-0.85
DB00499	Flutamide	leukemia	117	-0.80
DB00499	Flutamide	bone diseases	144	-0.79
DB00499	Flutamide	hematologic diseases	188	-0.63
DB00499	Flutamide	kidney neoplasms	20	-0.60
DB00499	Flutamide	malabsorption syndromes	34	-0.59
DB00499	Flutamide	amyotrophic lateral sclerosis	21	-0.55
DB00499	Flutamide	cardiovascular diseases	330	-0.53
DB00499	Flutamide	liver cirrhosis	24	-0.44
DB00499	Flutamide	liver cirrhosis biliary	23	-0.43
DB00499	Flutamide	pancreatic diseases	24	-0.41
DB00499	Flutamide	asthma	36	-0.36
DB00499	Flutamide	diabetes mellitus type 2	72	-0.29
DB00499	Flutamide	hypersensitivity	45	-0.29
DB00499	Flutamide	lymphoma non hodgkin	22	-0.23
DB00499	Flutamide	lymphoma	24	-0.15
DB00499	Flutamide	head and neck neoplasms	35	-0.06
DB00499	Flutamide	adenocarcinoma	32	-0.01
DB00499	Flutamide	diabetes mellitus type 1	82	0.06
DB00499	Flutamide	lupus erythematosus systemic	75	0.10
DB00499	Flutamide	multiple sclerosis	69	0.24
DB00499	Flutamide	varicose veins	20	0.26
DB00499	Flutamide	arrhythmias cardiac	30	0.26
DB00499	Flutamide	collagen diseases	25	0.34
DB00499	Flutamide	epilepsy	25	0.38
DB00499	Flutamide	macular degeneration	44	0.38
DB00499	Flutamide	bone diseases metabolic	27	0.39
DB00499	Flutamide	lung diseases	71	0.42
DB00499	Flutamide	leukemia lymphoid	66	0.43
DB00499	Flutamide	kidney diseases	144	0.45
DB00499	Flutamide	hyperinsulinism	26	0.48
DB00499	Flutamide	insulin resistance	26	0.51
DB00499	Flutamide	diabetes mellitus	162	0.54
DB00499	Flutamide	anemia hemolytic	29	0.69
DB00499	Flutamide	metabolism inborn errors	289	0.80
DB00499	Flutamide	hypopigmentation	22	0.86
DB00499	Flutamide	mycobacterium infections	22	0.92
DB00499	Flutamide	blood coagulation disorders	40	0.96
DB00499	Flutamide	cardiomyopathy dilated	29	1.00
DB00499	Flutamide	alzheimer disease	29	1.03
DB00499	Flutamide	bacterial infections	26	1.07
DB00499	Flutamide	autoimmune diseases	243	1.18
DB00499	Flutamide	neuroendocrine tumors	24	1.28
DB00499	Flutamide	dementia	42	1.40
DB00499	Flutamide	arthritis rheumatoid	42	1.57
DB00499	Flutamide	psoriasis	54	1.61
DB00499	Flutamide	rheumatic diseases	59	1.86
DB00499	Flutamide	arthritis	76	2.01
DB00499	Flutamide	joint diseases	79	2.13
DB00499	Flutamide	anemia	58	2.20
DB01020	Isosorbide.Mononitrate	hypersensitivity	45	-2.56
DB01020	Isosorbide.Mononitrate	asthma	36	-2.50
DB01020	Isosorbide.Mononitrate	varicose veins	20	-2.47
DB01020	Isosorbide.Mononitrate	head and neck neoplasms	35	-2.13
DB01020	Isosorbide.Mononitrate	diabetes mellitus type 2	72	-1.93
DB01020	Isosorbide.Mononitrate	lung diseases	71	-1.83
DB01020	Isosorbide.Mononitrate	spinal cord diseases	59	-1.78
DB01020	Isosorbide.Mononitrate	gastrointestinal neoplasms	72	-1.32
DB01020	Isosorbide.Mononitrate	diabetes mellitus	162	-1.25
DB01020	Isosorbide.Mononitrate	eye diseases	231	-1.20
DB01020	Isosorbide.Mononitrate	vascular diseases	181	-1.01
DB01020	Isosorbide.Mononitrate	endocrine system diseases	291	-0.78
DB01020	Isosorbide.Mononitrate	cardiovascular diseases	330	-0.63
DB01020	Isosorbide.Mononitrate	neoplasms	482	-0.29
DB01020	Isosorbide.Mononitrate	epilepsy	25	-0.21
DB01020	Isosorbide.Mononitrate	arrhythmias cardiac	30	-0.15
DB01020	Isosorbide.Mononitrate	collagen diseases	25	-0.12
DB01020	Isosorbide.Mononitrate	bone diseases metabolic	27	-0.11
DB01020	Isosorbide.Mononitrate	macular degeneration	44	-0.02
DB01020	Isosorbide.Mononitrate	coronary artery disease	31	0.00
DB01020	Isosorbide.Mononitrate	mycobacterium infections	22	0.01
DB01020	Isosorbide.Mononitrate	anemia hemolytic	29	0.01
DB01020	Isosorbide.Mononitrate	hypopigmentation	22	0.03
DB01020	Isosorbide.Mononitrate	thyroid diseases	30	0.04
DB01020	Isosorbide.Mononitrate	bacterial infections	26	0.05
DB01020	Isosorbide.Mononitrate	pancreatic diseases	24	0.08
DB01020	Isosorbide.Mononitrate	parkinson disease	30	0.10
DB01020	Isosorbide.Mononitrate	coronary disease	37	0.11
DB01020	Isosorbide.Mononitrate	liver cirrhosis biliary	23	0.13
DB01020	Isosorbide.Mononitrate	kidney neoplasms	20	0.13
DB01020	Isosorbide.Mononitrate	liver cirrhosis	24	0.14
DB01020	Isosorbide.Mononitrate	arteriosclerosis	38	0.15
DB01020	Isosorbide.Mononitrate	myocardial ischemia	43	0.15
DB01020	Isosorbide.Mononitrate	parkinsonian disorders	31	0.16
DB01020	Isosorbide.Mononitrate	amyotrophic lateral sclerosis	21	0.18
DB01020	Isosorbide.Mononitrate	neuroendocrine tumors	24	0.20
DB01020	Isosorbide.Mononitrate	cardiomyopathy dilated	29	0.22
DB01020	Isosorbide.Mononitrate	alzheimer disease	29	0.22
DB01020	Isosorbide.Mononitrate	arterial occlusive diseases	44	0.22
DB01020	Isosorbide.Mononitrate	sarcoma	25	0.23
DB01020	Isosorbide.Mononitrate	blood coagulation disorders	40	0.23
DB01020	Isosorbide.Mononitrate	lymphoma	24	0.24
DB01020	Isosorbide.Mononitrate	lymphoma non hodgkin	22	0.25
DB01020	Isosorbide.Mononitrate	motor neuron disease	31	0.28
DB01020	Isosorbide.Mononitrate	adenocarcinoma	32	0.33
DB01020	Isosorbide.Mononitrate	colitis ulcerative	55	0.33
DB01020	Isosorbide.Mononitrate	colitis	55	0.35
DB01020	Isosorbide.Mononitrate	arthritis rheumatoid	42	0.36
DB01020	Isosorbide.Mononitrate	prostatic neoplasms	61	0.36
DB01020	Isosorbide.Mononitrate	psoriasis	54	0.37
DB01020	Isosorbide.Mononitrate	dementia	42	0.38
DB01020	Isosorbide.Mononitrate	breast neoplasms	40	0.41
DB01020	Isosorbide.Mononitrate	diabetes mellitus type 1	82	0.42
DB01020	Isosorbide.Mononitrate	multiple sclerosis	69	0.43
DB01020	Isosorbide.Mononitrate	joint diseases	79	0.45
DB01020	Isosorbide.Mononitrate	rheumatic diseases	59	0.46
DB01020	Isosorbide.Mononitrate	arthritis	76	0.48
DB01020	Isosorbide.Mononitrate	crohn disease	71	0.48
DB01020	Isosorbide.Mononitrate	leukemia myeloid acute	43	0.49
DB01020	Isosorbide.Mononitrate	intestinal neoplasms	42	0.49
DB01020	Isosorbide.Mononitrate	colorectal neoplasms	42	0.52
DB01020	Isosorbide.Mononitrate	anemia	58	0.55
DB01020	Isosorbide.Mononitrate	leukemia lymphoid	66	0.56
DB01020	Isosorbide.Mononitrate	gastroenteritis	122	0.59
DB01020	Isosorbide.Mononitrate	inflammatory bowel diseases	119	0.65
DB01020	Isosorbide.Mononitrate	kidney diseases	144	0.65
DB01020	Isosorbide.Mononitrate	bone diseases	144	0.76
DB01020	Isosorbide.Mononitrate	heart diseases	167	0.79
DB01020	Isosorbide.Mononitrate	leukemia	117	0.82
DB01020	Isosorbide.Mononitrate	metabolism inborn errors	289	0.90
DB01020	Isosorbide.Mononitrate	hematologic diseases	188	1.03
DB01020	Isosorbide.Mononitrate	autoimmune diseases	243	1.06
DB01020	Isosorbide.Mononitrate	skin diseases	278	1.25
DB01020	Isosorbide.Mononitrate	hyperinsulinism	26	2.43
DB01020	Isosorbide.Mononitrate	insulin resistance	26	2.54
DB01020	Isosorbide.Mononitrate	malabsorption syndromes	34	2.64
DB01020	Isosorbide.Mononitrate	keratosis	21	2.84
DB01020	Isosorbide.Mononitrate	lupus erythematosus systemic	75	3.02
DB00494	Entacapone	adenocarcinoma	32	-2.67
DB00494	Entacapone	kidney diseases	144	-1.78
DB00494	Entacapone	diabetes mellitus	162	-1.70
DB00494	Entacapone	vascular diseases	181	-1.37
DB00494	Entacapone	metabolism inborn errors	289	-1.14
DB00494	Entacapone	cardiovascular diseases	330	-0.98
DB00494	Entacapone	endocrine system diseases	291	-0.93
DB00494	Entacapone	varicose veins	20	-0.46
DB00494	Entacapone	epilepsy	25	-0.37
DB00494	Entacapone	neoplasms	482	-0.36
DB00494	Entacapone	arrhythmias cardiac	30	-0.33
DB00494	Entacapone	bone diseases metabolic	27	-0.30
DB00494	Entacapone	collagen diseases	25	-0.25
DB00494	Entacapone	macular degeneration	44	-0.21
DB00494	Entacapone	coronary artery disease	31	-0.20
DB00494	Entacapone	mycobacterium infections	22	-0.16
DB00494	Entacapone	keratosis	21	-0.12
DB00494	Entacapone	kidney neoplasms	20	-0.10
DB00494	Entacapone	anemia hemolytic	29	-0.10
DB00494	Entacapone	pancreatic diseases	24	-0.10
DB00494	Entacapone	hypopigmentation	22	-0.10
DB00494	Entacapone	coronary disease	37	-0.08
DB00494	Entacapone	amyotrophic lateral sclerosis	21	-0.08
DB00494	Entacapone	parkinsonian disorders	31	-0.08
DB00494	Entacapone	myocardial ischemia	43	-0.07
DB00494	Entacapone	liver cirrhosis biliary	23	-0.07
DB00494	Entacapone	parkinson disease	30	-0.07
DB00494	Entacapone	liver cirrhosis	24	-0.07
DB00494	Entacapone	thyroid diseases	30	-0.04
DB00494	Entacapone	malabsorption syndromes	34	-0.03
DB00494	Entacapone	alzheimer disease	29	-0.03
DB00494	Entacapone	asthma	36	-0.01
DB00494	Entacapone	bacterial infections	26	-0.01
DB00494	Entacapone	neuroendocrine tumors	24	0.02
DB00494	Entacapone	arteriosclerosis	38	0.02
DB00494	Entacapone	cardiomyopathy dilated	29	0.02
DB00494	Entacapone	arterial occlusive diseases	44	0.04
DB00494	Entacapone	hypersensitivity	45	0.07
DB00494	Entacapone	lymphoma	24	0.07
DB00494	Entacapone	sarcoma	25	0.08
DB00494	Entacapone	lymphoma non hodgkin	22	0.11
DB00494	Entacapone	motor neuron disease	31	0.16
DB00494	Entacapone	colitis	55	0.17
DB00494	Entacapone	head and neck neoplasms	35	0.18
DB00494	Entacapone	arthritis rheumatoid	42	0.19
DB00494	Entacapone	dementia	42	0.22
DB00494	Entacapone	colitis ulcerative	55	0.22
DB00494	Entacapone	prostatic neoplasms	61	0.22
DB00494	Entacapone	psoriasis	54	0.23
DB00494	Entacapone	multiple sclerosis	69	0.26
DB00494	Entacapone	diabetes mellitus type 2	72	0.29
DB00494	Entacapone	rheumatic diseases	59	0.30
DB00494	Entacapone	crohn disease	71	0.31
DB00494	Entacapone	intestinal neoplasms	42	0.32
DB00494	Entacapone	lupus erythematosus systemic	75	0.34
DB00494	Entacapone	spinal cord diseases	59	0.34
DB00494	Entacapone	leukemia myeloid acute	43	0.34
DB00494	Entacapone	diabetes mellitus type 1	82	0.35
DB00494	Entacapone	joint diseases	79	0.38
DB00494	Entacapone	lung diseases	71	0.38
DB00494	Entacapone	colorectal neoplasms	42	0.38
DB00494	Entacapone	arthritis	76	0.41
DB00494	Entacapone	anemia	58	0.41
DB00494	Entacapone	leukemia lymphoid	66	0.43
DB00494	Entacapone	inflammatory bowel diseases	119	0.46
DB00494	Entacapone	gastroenteritis	122	0.47
DB00494	Entacapone	gastrointestinal neoplasms	72	0.50
DB00494	Entacapone	heart diseases	167	0.56
DB00494	Entacapone	bone diseases	144	0.59
DB00494	Entacapone	leukemia	117	0.65
DB00494	Entacapone	eye diseases	231	0.69
DB00494	Entacapone	autoimmune diseases	243	0.79
DB00494	Entacapone	hematologic diseases	188	0.82
DB00494	Entacapone	skin diseases	278	0.89
DB00494	Entacapone	hyperinsulinism	26	1.84
DB00494	Entacapone	insulin resistance	26	1.91
DB00494	Entacapone	blood coagulation disorders	40	2.65
DB00494	Entacapone	breast neoplasms	40	2.74
DB06710	Methyltestosterone	endocrine system diseases	291	-6.24
DB06710	Methyltestosterone	skin diseases	278	-5.50
DB06710	Methyltestosterone	spinal cord diseases	59	-3.54
DB06710	Methyltestosterone	neoplasms	482	-2.84
DB06710	Methyltestosterone	motor neuron disease	31	-2.82
DB06710	Methyltestosterone	prostatic neoplasms	61	-2.70
DB06710	Methyltestosterone	parkinsonian disorders	31	-1.53
DB06710	Methyltestosterone	parkinson disease	30	-1.47
DB06710	Methyltestosterone	coronary artery disease	31	-1.28
DB06710	Methyltestosterone	coronary disease	37	-1.22
DB06710	Methyltestosterone	myocardial ischemia	43	-1.21
DB06710	Methyltestosterone	keratosis	21	-1.13
DB06710	Methyltestosterone	arteriosclerosis	38	-1.09
DB06710	Methyltestosterone	malabsorption syndromes	34	-0.99
DB06710	Methyltestosterone	arterial occlusive diseases	44	-0.96
DB06710	Methyltestosterone	kidney neoplasms	20	-0.90
DB06710	Methyltestosterone	colitis ulcerative	55	-0.87
DB06710	Methyltestosterone	colitis	55	-0.87
DB06710	Methyltestosterone	amyotrophic lateral sclerosis	21	-0.83
DB06710	Methyltestosterone	diabetes mellitus type 2	72	-0.78
DB06710	Methyltestosterone	liver cirrhosis	24	-0.71
DB06710	Methyltestosterone	sarcoma	25	-0.68
DB06710	Methyltestosterone	pancreatic diseases	24	-0.66
DB06710	Methyltestosterone	liver cirrhosis biliary	23	-0.64
DB06710	Methyltestosterone	asthma	36	-0.63
DB06710	Methyltestosterone	hypersensitivity	45	-0.60
DB06710	Methyltestosterone	diabetes mellitus type 1	82	-0.54
DB06710	Methyltestosterone	head and neck neoplasms	35	-0.52
DB06710	Methyltestosterone	lymphoma non hodgkin	22	-0.47
DB06710	Methyltestosterone	lymphoma	24	-0.47
DB06710	Methyltestosterone	lupus erythematosus systemic	75	-0.44
DB06710	Methyltestosterone	adenocarcinoma	32	-0.42
DB06710	Methyltestosterone	breast neoplasms	40	-0.38
DB06710	Methyltestosterone	crohn disease	71	-0.36
DB06710	Methyltestosterone	diabetes mellitus	162	-0.29
DB06710	Methyltestosterone	leukemia myeloid acute	43	-0.28
DB06710	Methyltestosterone	inflammatory bowel diseases	119	-0.28
DB06710	Methyltestosterone	multiple sclerosis	69	-0.28
DB06710	Methyltestosterone	metabolism inborn errors	289	-0.27
DB06710	Methyltestosterone	leukemia lymphoid	66	-0.27
DB06710	Methyltestosterone	kidney diseases	144	-0.24
DB06710	Methyltestosterone	gastroenteritis	122	-0.24
DB06710	Methyltestosterone	colorectal neoplasms	42	-0.23
DB06710	Methyltestosterone	intestinal neoplasms	42	-0.21
DB06710	Methyltestosterone	heart diseases	167	-0.21
DB06710	Methyltestosterone	lung diseases	71	-0.13
DB06710	Methyltestosterone	bone diseases	144	-0.08
DB06710	Methyltestosterone	gastrointestinal neoplasms	72	-0.07
DB06710	Methyltestosterone	vascular diseases	181	0.06
DB06710	Methyltestosterone	eye diseases	231	0.09
DB06710	Methyltestosterone	cardiovascular diseases	330	0.14
DB06710	Methyltestosterone	leukemia	117	0.15
DB06710	Methyltestosterone	autoimmune diseases	243	0.16
DB06710	Methyltestosterone	hematologic diseases	188	0.17
DB06710	Methyltestosterone	arrhythmias cardiac	30	0.50
DB06710	Methyltestosterone	varicose veins	20	0.50
DB06710	Methyltestosterone	collagen diseases	25	0.52
DB06710	Methyltestosterone	epilepsy	25	0.57
DB06710	Methyltestosterone	macular degeneration	44	0.57
DB06710	Methyltestosterone	bone diseases metabolic	27	0.61
DB06710	Methyltestosterone	hyperinsulinism	26	0.69
DB06710	Methyltestosterone	insulin resistance	26	0.70
DB06710	Methyltestosterone	anemia hemolytic	29	0.81
DB06710	Methyltestosterone	thyroid diseases	30	0.83
DB06710	Methyltestosterone	cardiomyopathy dilated	29	0.96
DB06710	Methyltestosterone	blood coagulation disorders	40	1.01
DB06710	Methyltestosterone	hypopigmentation	22	1.05
DB06710	Methyltestosterone	alzheimer disease	29	1.09
DB06710	Methyltestosterone	mycobacterium infections	22	1.13
DB06710	Methyltestosterone	bacterial infections	26	1.22
DB06710	Methyltestosterone	dementia	42	1.50
DB06710	Methyltestosterone	neuroendocrine tumors	24	1.53
DB06710	Methyltestosterone	psoriasis	54	1.81
DB06710	Methyltestosterone	arthritis rheumatoid	42	1.94
DB06710	Methyltestosterone	rheumatic diseases	59	2.31
DB06710	Methyltestosterone	arthritis	76	2.95
DB06710	Methyltestosterone	joint diseases	79	3.06
DB06710	Methyltestosterone	anemia	58	3.36
DB01024	Mycophenolic.acid	anemia hemolytic	29	-3.56
DB01024	Mycophenolic.acid	eye diseases	231	-3.35
DB01024	Mycophenolic.acid	anemia	58	-3.04
DB01024	Mycophenolic.acid	leukemia myeloid acute	43	-2.88
DB01024	Mycophenolic.acid	leukemia	117	-2.16
DB01024	Mycophenolic.acid	hematologic diseases	188	-1.84
DB01024	Mycophenolic.acid	asthma	36	-1.84
DB01024	Mycophenolic.acid	hypersensitivity	45	-1.81
DB01024	Mycophenolic.acid	psoriasis	54	-1.77
DB01024	Mycophenolic.acid	metabolism inborn errors	289	-1.76
DB01024	Mycophenolic.acid	breast neoplasms	40	-1.66
DB01024	Mycophenolic.acid	multiple sclerosis	69	-1.46
DB01024	Mycophenolic.acid	diabetes mellitus type 1	82	-1.46
DB01024	Mycophenolic.acid	joint diseases	79	-1.36
DB01024	Mycophenolic.acid	arthritis	76	-1.33
DB01024	Mycophenolic.acid	lupus erythematosus systemic	75	-1.32
DB01024	Mycophenolic.acid	lung diseases	71	-1.27
DB01024	Mycophenolic.acid	kidney diseases	144	-1.07
DB01024	Mycophenolic.acid	diabetes mellitus	162	-0.94
DB01024	Mycophenolic.acid	neoplasms	482	-0.91
DB01024	Mycophenolic.acid	bone diseases	144	-0.90
DB01024	Mycophenolic.acid	arrhythmias cardiac	30	-0.78
DB01024	Mycophenolic.acid	vascular diseases	181	-0.54
DB01024	Mycophenolic.acid	hypopigmentation	22	-0.44
DB01024	Mycophenolic.acid	kidney neoplasms	20	-0.40
DB01024	Mycophenolic.acid	pancreatic diseases	24	-0.37
DB01024	Mycophenolic.acid	neuroendocrine tumors	24	-0.30
DB01024	Mycophenolic.acid	autoimmune diseases	243	-0.30
DB01024	Mycophenolic.acid	endocrine system diseases	291	-0.24
DB01024	Mycophenolic.acid	skin diseases	278	-0.19
DB01024	Mycophenolic.acid	cardiovascular diseases	330	-0.15
DB01024	Mycophenolic.acid	adenocarcinoma	32	-0.07
DB01024	Mycophenolic.acid	head and neck neoplasms	35	-0.03
DB01024	Mycophenolic.acid	intestinal neoplasms	42	0.26
DB01024	Mycophenolic.acid	colorectal neoplasms	42	0.29
DB01024	Mycophenolic.acid	leukemia lymphoid	66	0.38
DB01024	Mycophenolic.acid	epilepsy	25	0.55
DB01024	Mycophenolic.acid	gastrointestinal neoplasms	72	0.56
DB01024	Mycophenolic.acid	varicose veins	20	0.57
DB01024	Mycophenolic.acid	heart diseases	167	0.67
DB01024	Mycophenolic.acid	insulin resistance	26	0.69
DB01024	Mycophenolic.acid	hyperinsulinism	26	0.75
DB01024	Mycophenolic.acid	bone diseases metabolic	27	0.76
DB01024	Mycophenolic.acid	collagen diseases	25	0.81
DB01024	Mycophenolic.acid	keratosis	21	0.85
DB01024	Mycophenolic.acid	mycobacterium infections	22	0.86
DB01024	Mycophenolic.acid	macular degeneration	44	0.86
DB01024	Mycophenolic.acid	coronary artery disease	31	0.88
DB01024	Mycophenolic.acid	bacterial infections	26	1.01
DB01024	Mycophenolic.acid	thyroid diseases	30	1.08
DB01024	Mycophenolic.acid	amyotrophic lateral sclerosis	21	1.13
DB01024	Mycophenolic.acid	myocardial ischemia	43	1.16
DB01024	Mycophenolic.acid	liver cirrhosis biliary	23	1.18
DB01024	Mycophenolic.acid	malabsorption syndromes	34	1.18
DB01024	Mycophenolic.acid	coronary disease	37	1.19
DB01024	Mycophenolic.acid	liver cirrhosis	24	1.19
DB01024	Mycophenolic.acid	parkinsonian disorders	31	1.20
DB01024	Mycophenolic.acid	arteriosclerosis	38	1.24
DB01024	Mycophenolic.acid	parkinson disease	30	1.24
DB01024	Mycophenolic.acid	cardiomyopathy dilated	29	1.29
DB01024	Mycophenolic.acid	alzheimer disease	29	1.32
DB01024	Mycophenolic.acid	arterial occlusive diseases	44	1.36
DB01024	Mycophenolic.acid	blood coagulation disorders	40	1.36
DB01024	Mycophenolic.acid	sarcoma	25	1.37
DB01024	Mycophenolic.acid	lymphoma	24	1.37
DB01024	Mycophenolic.acid	lymphoma non hodgkin	22	1.40
DB01024	Mycophenolic.acid	arthritis rheumatoid	42	1.51
DB01024	Mycophenolic.acid	motor neuron disease	31	1.53
DB01024	Mycophenolic.acid	colitis ulcerative	55	1.60
DB01024	Mycophenolic.acid	colitis	55	1.61
DB01024	Mycophenolic.acid	prostatic neoplasms	61	1.65
DB01024	Mycophenolic.acid	dementia	42	1.67
DB01024	Mycophenolic.acid	spinal cord diseases	59	1.77
DB01024	Mycophenolic.acid	rheumatic diseases	59	1.81
DB01024	Mycophenolic.acid	diabetes mellitus type 2	72	1.84
DB01024	Mycophenolic.acid	crohn disease	71	1.92
DB01024	Mycophenolic.acid	gastroenteritis	122	2.08
DB01024	Mycophenolic.acid	inflammatory bowel diseases	119	2.12
DB00322	Floxuridine	myocardial ischemia	43	-2.58
DB00322	Floxuridine	anemia hemolytic	29	-2.50
DB00322	Floxuridine	alzheimer disease	29	-2.49
DB00322	Floxuridine	coronary disease	37	-2.45
DB00322	Floxuridine	dementia	42	-2.07
DB00322	Floxuridine	colorectal neoplasms	42	-2.04
DB00322	Floxuridine	intestinal neoplasms	42	-1.93
DB00322	Floxuridine	anemia	58	-1.89
DB00322	Floxuridine	gastrointestinal neoplasms	72	-1.48
DB00322	Floxuridine	heart diseases	167	-1.26
DB00322	Floxuridine	vascular diseases	181	-1.20
DB00322	Floxuridine	metabolism inborn errors	289	-1.12
DB00322	Floxuridine	hematologic diseases	188	-1.09
DB00322	Floxuridine	cardiovascular diseases	330	-0.80
DB00322	Floxuridine	varicose veins	20	-0.38
DB00322	Floxuridine	neoplasms	482	-0.31
DB00322	Floxuridine	arrhythmias cardiac	30	-0.30
DB00322	Floxuridine	collagen diseases	25	-0.24
DB00322	Floxuridine	bone diseases metabolic	27	-0.23
DB00322	Floxuridine	hyperinsulinism	26	-0.20
DB00322	Floxuridine	coronary artery disease	31	-0.19
DB00322	Floxuridine	mycobacterium infections	22	-0.16
DB00322	Floxuridine	keratosis	21	-0.15
DB00322	Floxuridine	insulin resistance	26	-0.15
DB00322	Floxuridine	thyroid diseases	30	-0.09
DB00322	Floxuridine	kidney neoplasms	20	-0.07
DB00322	Floxuridine	bacterial infections	26	-0.06
DB00322	Floxuridine	macular degeneration	44	-0.05
DB00322	Floxuridine	parkinson disease	30	-0.04
DB00322	Floxuridine	liver cirrhosis	24	-0.03
DB00322	Floxuridine	pancreatic diseases	24	-0.03
DB00322	Floxuridine	liver cirrhosis biliary	23	-0.03
DB00322	Floxuridine	hypopigmentation	22	-0.02
DB00322	Floxuridine	amyotrophic lateral sclerosis	21	0.00
DB00322	Floxuridine	arteriosclerosis	38	0.00
DB00322	Floxuridine	neuroendocrine tumors	24	0.02
DB00322	Floxuridine	asthma	36	0.02
DB00322	Floxuridine	malabsorption syndromes	34	0.03
DB00322	Floxuridine	parkinsonian disorders	31	0.03
DB00322	Floxuridine	cardiomyopathy dilated	29	0.06
DB00322	Floxuridine	sarcoma	25	0.08
DB00322	Floxuridine	arterial occlusive diseases	44	0.09
DB00322	Floxuridine	hypersensitivity	45	0.10
DB00322	Floxuridine	lymphoma non hodgkin	22	0.10
DB00322	Floxuridine	lymphoma	24	0.14
DB00322	Floxuridine	motor neuron disease	31	0.14
DB00322	Floxuridine	blood coagulation disorders	40	0.15
DB00322	Floxuridine	adenocarcinoma	32	0.17
DB00322	Floxuridine	colitis	55	0.18
DB00322	Floxuridine	colitis ulcerative	55	0.20
DB00322	Floxuridine	prostatic neoplasms	61	0.23
DB00322	Floxuridine	breast neoplasms	40	0.23
DB00322	Floxuridine	diabetes mellitus type 2	72	0.25
DB00322	Floxuridine	arthritis rheumatoid	42	0.25
DB00322	Floxuridine	psoriasis	54	0.26
DB00322	Floxuridine	head and neck neoplasms	35	0.26
DB00322	Floxuridine	rheumatic diseases	59	0.28
DB00322	Floxuridine	multiple sclerosis	69	0.32
DB00322	Floxuridine	lupus erythematosus systemic	75	0.34
DB00322	Floxuridine	spinal cord diseases	59	0.34
DB00322	Floxuridine	diabetes mellitus type 1	82	0.37
DB00322	Floxuridine	arthritis	76	0.38
DB00322	Floxuridine	leukemia myeloid acute	43	0.38
DB00322	Floxuridine	joint diseases	79	0.39
DB00322	Floxuridine	crohn disease	71	0.39
DB00322	Floxuridine	leukemia lymphoid	66	0.43
DB00322	Floxuridine	lung diseases	71	0.43
DB00322	Floxuridine	inflammatory bowel diseases	119	0.48
DB00322	Floxuridine	gastroenteritis	122	0.51
DB00322	Floxuridine	diabetes mellitus	162	0.53
DB00322	Floxuridine	kidney diseases	144	0.55
DB00322	Floxuridine	bone diseases	144	0.64
DB00322	Floxuridine	leukemia	117	0.74
DB00322	Floxuridine	eye diseases	231	0.75
DB00322	Floxuridine	autoimmune diseases	243	0.89
DB00322	Floxuridine	endocrine system diseases	291	1.00
DB00322	Floxuridine	skin diseases	278	1.06
DB00322	Floxuridine	epilepsy	25	1.99
DB00491	Miglitol	diabetes mellitus type 1	82	-5.04
DB00491	Miglitol	bone diseases metabolic	27	-4.36
DB00491	Miglitol	parkinson disease	30	-4.14
DB00491	Miglitol	parkinsonian disorders	31	-4.05
DB00491	Miglitol	bone diseases	144	-4.04
DB00491	Miglitol	metabolism inborn errors	289	-4.03
DB00491	Miglitol	alzheimer disease	29	-4.00
DB00491	Miglitol	malabsorption syndromes	34	-3.99
DB00491	Miglitol	diabetes mellitus	162	-3.98
DB00491	Miglitol	dementia	42	-3.61
DB00491	Miglitol	autoimmune diseases	243	-3.14
DB00491	Miglitol	endocrine system diseases	291	-2.61
DB00491	Miglitol	hematologic diseases	188	-2.23
DB00491	Miglitol	lymphoma non hodgkin	22	-1.72
DB00491	Miglitol	lymphoma	24	-1.64
DB00491	Miglitol	prostatic neoplasms	61	-1.42
DB00491	Miglitol	rheumatic diseases	59	-1.32
DB00491	Miglitol	lupus erythematosus systemic	75	-1.17
DB00491	Miglitol	arthritis	76	-1.10
DB00491	Miglitol	joint diseases	79	-1.09
DB00491	Miglitol	leukemia lymphoid	66	-0.99
DB00491	Miglitol	kidney diseases	144	-0.73
DB00491	Miglitol	heart diseases	167	-0.59
DB00491	Miglitol	arthritis rheumatoid	42	-0.50
DB00491	Miglitol	leukemia	117	-0.39
DB00491	Miglitol	diabetes mellitus type 2	72	-0.32
DB00491	Miglitol	cardiovascular diseases	330	0.17
DB00491	Miglitol	arrhythmias cardiac	30	0.45
DB00491	Miglitol	neoplasms	482	0.91
DB00491	Miglitol	hypopigmentation	22	0.92
DB00491	Miglitol	kidney neoplasms	20	1.00
DB00491	Miglitol	varicose veins	20	1.14
DB00491	Miglitol	asthma	36	1.22
DB00491	Miglitol	epilepsy	25	1.26
DB00491	Miglitol	sarcoma	25	1.27
DB00491	Miglitol	hypersensitivity	45	1.47
DB00491	Miglitol	collagen diseases	25	1.53
DB00491	Miglitol	adenocarcinoma	32	1.60
DB00491	Miglitol	mycobacterium infections	22	1.65
DB00491	Miglitol	keratosis	21	1.67
DB00491	Miglitol	macular degeneration	44	1.77
DB00491	Miglitol	coronary artery disease	31	1.77
DB00491	Miglitol	head and neck neoplasms	35	1.79
DB00491	Miglitol	thyroid diseases	30	1.87
DB00491	Miglitol	anemia hemolytic	29	1.90
DB00491	Miglitol	bacterial infections	26	1.95
DB00491	Miglitol	psoriasis	54	1.96
DB00491	Miglitol	pancreatic diseases	24	2.01
DB00491	Miglitol	multiple sclerosis	69	2.06
DB00491	Miglitol	coronary disease	37	2.06
DB00491	Miglitol	liver cirrhosis	24	2.06
DB00491	Miglitol	myocardial ischemia	43	2.09
DB00491	Miglitol	amyotrophic lateral sclerosis	21	2.11
DB00491	Miglitol	crohn disease	71	2.13
DB00491	Miglitol	liver cirrhosis biliary	23	2.15
DB00491	Miglitol	arteriosclerosis	38	2.23
DB00491	Miglitol	hyperinsulinism	26	2.24
DB00491	Miglitol	neuroendocrine tumors	24	2.29
DB00491	Miglitol	lung diseases	71	2.29
DB00491	Miglitol	cardiomyopathy dilated	29	2.40
DB00491	Miglitol	arterial occlusive diseases	44	2.42
DB00491	Miglitol	insulin resistance	26	2.45
DB00491	Miglitol	gastroenteritis	122	2.47
DB00491	Miglitol	blood coagulation disorders	40	2.53
DB00491	Miglitol	inflammatory bowel diseases	119	2.53
DB00491	Miglitol	motor neuron disease	31	2.66
DB00491	Miglitol	eye diseases	231	2.77
DB00491	Miglitol	colitis	55	2.77
DB00491	Miglitol	vascular diseases	181	2.86
DB00491	Miglitol	colitis ulcerative	55	2.91
DB00491	Miglitol	skin diseases	278	2.92
DB00491	Miglitol	breast neoplasms	40	2.92
DB00491	Miglitol	colorectal neoplasms	42	3.22
DB00491	Miglitol	leukemia myeloid acute	43	3.27
DB00491	Miglitol	intestinal neoplasms	42	3.32
DB00491	Miglitol	anemia	58	3.43
DB00491	Miglitol	spinal cord diseases	59	3.48
DB00491	Miglitol	gastrointestinal neoplasms	72	3.56
DB00936	Salicyclic.acid	psoriasis	54	-1.51
DB00936	Salicyclic.acid	eye diseases	231	-1.44
DB00936	Salicyclic.acid	lung diseases	71	-1.19
DB00936	Salicyclic.acid	skin diseases	278	-1.15
DB00936	Salicyclic.acid	gastrointestinal neoplasms	72	-1.01
DB00936	Salicyclic.acid	malabsorption syndromes	34	-0.73
DB00936	Salicyclic.acid	alzheimer disease	29	-0.69
DB00936	Salicyclic.acid	lymphoma	24	-0.59
DB00936	Salicyclic.acid	lymphoma non hodgkin	22	-0.57
DB00936	Salicyclic.acid	head and neck neoplasms	35	-0.41
DB00936	Salicyclic.acid	adenocarcinoma	32	-0.37
DB00936	Salicyclic.acid	dementia	42	-0.34
DB00936	Salicyclic.acid	metabolism inborn errors	289	-0.30
DB00936	Salicyclic.acid	breast neoplasms	40	-0.29
DB00936	Salicyclic.acid	diabetes mellitus type 2	72	-0.27
DB00936	Salicyclic.acid	prostatic neoplasms	61	-0.22
DB00936	Salicyclic.acid	varicose veins	20	-0.20
DB00936	Salicyclic.acid	lupus erythematosus systemic	75	-0.15
DB00936	Salicyclic.acid	intestinal neoplasms	42	-0.11
DB00936	Salicyclic.acid	multiple sclerosis	69	-0.07
DB00936	Salicyclic.acid	diabetes mellitus type 1	82	-0.06
DB00936	Salicyclic.acid	colorectal neoplasms	42	-0.06
DB00936	Salicyclic.acid	endocrine system diseases	291	-0.04
DB00936	Salicyclic.acid	collagen diseases	25	-0.03
DB00936	Salicyclic.acid	arrhythmias cardiac	30	-0.01
DB00936	Salicyclic.acid	bone diseases metabolic	27	0.02
DB00936	Salicyclic.acid	spinal cord diseases	59	0.03
DB00936	Salicyclic.acid	leukemia lymphoid	66	0.08
DB00936	Salicyclic.acid	anemia	58	0.15
DB00936	Salicyclic.acid	keratosis	21	0.18
DB00936	Salicyclic.acid	macular degeneration	44	0.24
DB00936	Salicyclic.acid	thyroid diseases	30	0.34
DB00936	Salicyclic.acid	amyotrophic lateral sclerosis	21	0.38
DB00936	Salicyclic.acid	kidney neoplasms	20	0.38
DB00936	Salicyclic.acid	diabetes mellitus	162	0.39
DB00936	Salicyclic.acid	parkinson disease	30	0.41
DB00936	Salicyclic.acid	asthma	36	0.44
DB00936	Salicyclic.acid	parkinsonian disorders	31	0.45
DB00936	Salicyclic.acid	pancreatic diseases	24	0.45
DB00936	Salicyclic.acid	bone diseases	144	0.46
DB00936	Salicyclic.acid	neuroendocrine tumors	24	0.48
DB00936	Salicyclic.acid	heart diseases	167	0.50
DB00936	Salicyclic.acid	leukemia	117	0.56
DB00936	Salicyclic.acid	sarcoma	25	0.60
DB00936	Salicyclic.acid	vascular diseases	181	0.62
DB00936	Salicyclic.acid	neoplasms	482	0.71
DB00936	Salicyclic.acid	hypersensitivity	45	0.73
DB00936	Salicyclic.acid	motor neuron disease	31	0.79
DB00936	Salicyclic.acid	autoimmune diseases	243	0.86
DB00936	Salicyclic.acid	arthritis rheumatoid	42	0.88
DB00936	Salicyclic.acid	colitis ulcerative	55	0.91
DB00936	Salicyclic.acid	hematologic diseases	188	0.91
DB00936	Salicyclic.acid	colitis	55	0.92
DB00936	Salicyclic.acid	insulin resistance	26	1.09
DB00936	Salicyclic.acid	rheumatic diseases	59	1.10
DB00936	Salicyclic.acid	cardiovascular diseases	330	1.11
DB00936	Salicyclic.acid	leukemia myeloid acute	43	1.12
DB00936	Salicyclic.acid	hyperinsulinism	26	1.12
DB00936	Salicyclic.acid	mycobacterium infections	22	1.22
DB00936	Salicyclic.acid	crohn disease	71	1.25
DB00936	Salicyclic.acid	joint diseases	79	1.28
DB00936	Salicyclic.acid	arthritis	76	1.32
DB00936	Salicyclic.acid	coronary artery disease	31	1.36
DB00936	Salicyclic.acid	anemia hemolytic	29	1.49
DB00936	Salicyclic.acid	bacterial infections	26	1.51
DB00936	Salicyclic.acid	liver cirrhosis biliary	23	1.51
DB00936	Salicyclic.acid	gastroenteritis	122	1.52
DB00936	Salicyclic.acid	coronary disease	37	1.52
DB00936	Salicyclic.acid	kidney diseases	144	1.54
DB00936	Salicyclic.acid	liver cirrhosis	24	1.54
DB00936	Salicyclic.acid	inflammatory bowel diseases	119	1.61
DB00936	Salicyclic.acid	myocardial ischemia	43	1.72
DB00936	Salicyclic.acid	arteriosclerosis	38	1.72
DB00936	Salicyclic.acid	arterial occlusive diseases	44	1.86
DB00936	Salicyclic.acid	blood coagulation disorders	40	1.91
DB00936	Salicyclic.acid	epilepsy	25	2.15
DB00936	Salicyclic.acid	hypopigmentation	22	2.63
DB00936	Salicyclic.acid	cardiomyopathy dilated	29	2.91
DB06212	Tolvaptan	kidney diseases	144	-4.15
DB06212	Tolvaptan	bone diseases metabolic	27	-2.58
DB06212	Tolvaptan	endocrine system diseases	291	-2.38
DB06212	Tolvaptan	intestinal neoplasms	42	-1.98
DB06212	Tolvaptan	colorectal neoplasms	42	-1.93
DB06212	Tolvaptan	multiple sclerosis	69	-1.85
DB06212	Tolvaptan	gastrointestinal neoplasms	72	-1.80
DB06212	Tolvaptan	varicose veins	20	-1.60
DB06212	Tolvaptan	epilepsy	25	-1.56
DB06212	Tolvaptan	bone diseases	144	-1.45
DB06212	Tolvaptan	arrhythmias cardiac	30	-1.42
DB06212	Tolvaptan	collagen diseases	25	-1.40
DB06212	Tolvaptan	coronary artery disease	31	-1.29
DB06212	Tolvaptan	autoimmune diseases	243	-1.19
DB06212	Tolvaptan	parkinsonian disorders	31	-1.17
DB06212	Tolvaptan	hypopigmentation	22	-1.17
DB06212	Tolvaptan	kidney neoplasms	20	-1.15
DB06212	Tolvaptan	macular degeneration	44	-1.15
DB06212	Tolvaptan	parkinson disease	30	-1.14
DB06212	Tolvaptan	bacterial infections	26	-1.13
DB06212	Tolvaptan	amyotrophic lateral sclerosis	21	-1.12
DB06212	Tolvaptan	pancreatic diseases	24	-1.12
DB06212	Tolvaptan	metabolism inborn errors	289	-1.12
DB06212	Tolvaptan	coronary disease	37	-1.10
DB06212	Tolvaptan	liver cirrhosis	24	-1.09
DB06212	Tolvaptan	liver cirrhosis biliary	23	-1.09
DB06212	Tolvaptan	alzheimer disease	29	-1.06
DB06212	Tolvaptan	malabsorption syndromes	34	-1.03
DB06212	Tolvaptan	sarcoma	25	-1.02
DB06212	Tolvaptan	myocardial ischemia	43	-1.01
DB06212	Tolvaptan	cardiomyopathy dilated	29	-0.97
DB06212	Tolvaptan	arteriosclerosis	38	-0.95
DB06212	Tolvaptan	lymphoma non hodgkin	22	-0.94
DB06212	Tolvaptan	arterial occlusive diseases	44	-0.89
DB06212	Tolvaptan	blood coagulation disorders	40	-0.88
DB06212	Tolvaptan	motor neuron disease	31	-0.85
DB06212	Tolvaptan	lymphoma	24	-0.84
DB06212	Tolvaptan	arthritis rheumatoid	42	-0.82
DB06212	Tolvaptan	dementia	42	-0.77
DB06212	Tolvaptan	adenocarcinoma	32	-0.75
DB06212	Tolvaptan	head and neck neoplasms	35	-0.74
DB06212	Tolvaptan	prostatic neoplasms	61	-0.73
DB06212	Tolvaptan	breast neoplasms	40	-0.71
DB06212	Tolvaptan	diabetes mellitus type 2	72	-0.68
DB06212	Tolvaptan	colitis ulcerative	55	-0.68
DB06212	Tolvaptan	colitis	55	-0.67
DB06212	Tolvaptan	psoriasis	54	-0.64
DB06212	Tolvaptan	rheumatic diseases	59	-0.62
DB06212	Tolvaptan	leukemia myeloid acute	43	-0.58
DB06212	Tolvaptan	diabetes mellitus type 1	82	-0.56
DB06212	Tolvaptan	spinal cord diseases	59	-0.56
DB06212	Tolvaptan	crohn disease	71	-0.52
DB06212	Tolvaptan	neoplasms	482	-0.48
DB06212	Tolvaptan	joint diseases	79	-0.47
DB06212	Tolvaptan	arthritis	76	-0.43
DB06212	Tolvaptan	anemia	58	-0.40
DB06212	Tolvaptan	leukemia lymphoid	66	-0.40
DB06212	Tolvaptan	lung diseases	71	-0.36
DB06212	Tolvaptan	inflammatory bowel diseases	119	-0.26
DB06212	Tolvaptan	gastroenteritis	122	-0.26
DB06212	Tolvaptan	hyperinsulinism	26	-0.24
DB06212	Tolvaptan	diabetes mellitus	162	-0.15
DB06212	Tolvaptan	insulin resistance	26	-0.14
DB06212	Tolvaptan	mycobacterium infections	22	-0.07
DB06212	Tolvaptan	keratosis	21	-0.04
DB06212	Tolvaptan	leukemia	117	0.02
DB06212	Tolvaptan	heart diseases	167	0.04
DB06212	Tolvaptan	vascular diseases	181	0.06
DB06212	Tolvaptan	thyroid diseases	30	0.07
DB06212	Tolvaptan	eye diseases	231	0.09
DB06212	Tolvaptan	anemia hemolytic	29	0.10
DB06212	Tolvaptan	neuroendocrine tumors	24	0.19
DB06212	Tolvaptan	hematologic diseases	188	0.22
DB06212	Tolvaptan	asthma	36	0.25
DB06212	Tolvaptan	skin diseases	278	0.30
DB06212	Tolvaptan	cardiovascular diseases	330	0.40
DB06212	Tolvaptan	hypersensitivity	45	0.43
DB06212	Tolvaptan	lupus erythematosus systemic	75	0.85
DB00839	Tolazamide	kidney diseases	144	-4.71
DB00839	Tolazamide	endocrine system diseases	291	-3.25
DB00839	Tolazamide	arthritis	76	-2.61
DB00839	Tolazamide	pancreatic diseases	24	-2.53
DB00839	Tolazamide	lung diseases	71	-2.49
DB00839	Tolazamide	joint diseases	79	-2.47
DB00839	Tolazamide	rheumatic diseases	59	-2.42
DB00839	Tolazamide	arrhythmias cardiac	30	-2.30
DB00839	Tolazamide	heart diseases	167	-1.92
DB00839	Tolazamide	metabolism inborn errors	289	-1.80
DB00839	Tolazamide	cardiovascular diseases	330	-1.26
DB00839	Tolazamide	epilepsy	25	-0.75
DB00839	Tolazamide	bone diseases metabolic	27	-0.73
DB00839	Tolazamide	collagen diseases	25	-0.72
DB00839	Tolazamide	hyperinsulinism	26	-0.72
DB00839	Tolazamide	insulin resistance	26	-0.70
DB00839	Tolazamide	varicose veins	20	-0.68
DB00839	Tolazamide	coronary artery disease	31	-0.57
DB00839	Tolazamide	mycobacterium infections	22	-0.56
DB00839	Tolazamide	macular degeneration	44	-0.55
DB00839	Tolazamide	keratosis	21	-0.54
DB00839	Tolazamide	kidney neoplasms	20	-0.50
DB00839	Tolazamide	coronary disease	37	-0.48
DB00839	Tolazamide	thyroid diseases	30	-0.48
DB00839	Tolazamide	hypopigmentation	22	-0.47
DB00839	Tolazamide	parkinson disease	30	-0.47
DB00839	Tolazamide	parkinsonian disorders	31	-0.47
DB00839	Tolazamide	myocardial ischemia	43	-0.44
DB00839	Tolazamide	anemia hemolytic	29	-0.44
DB00839	Tolazamide	amyotrophic lateral sclerosis	21	-0.44
DB00839	Tolazamide	bacterial infections	26	-0.43
DB00839	Tolazamide	neuroendocrine tumors	24	-0.41
DB00839	Tolazamide	malabsorption syndromes	34	-0.41
DB00839	Tolazamide	liver cirrhosis biliary	23	-0.40
DB00839	Tolazamide	cardiomyopathy dilated	29	-0.39
DB00839	Tolazamide	liver cirrhosis	24	-0.38
DB00839	Tolazamide	alzheimer disease	29	-0.37
DB00839	Tolazamide	arteriosclerosis	38	-0.36
DB00839	Tolazamide	arterial occlusive diseases	44	-0.36
DB00839	Tolazamide	asthma	36	-0.35
DB00839	Tolazamide	lymphoma	24	-0.30
DB00839	Tolazamide	sarcoma	25	-0.30
DB00839	Tolazamide	blood coagulation disorders	40	-0.29
DB00839	Tolazamide	arthritis rheumatoid	42	-0.28
DB00839	Tolazamide	lymphoma non hodgkin	22	-0.27
DB00839	Tolazamide	colitis	55	-0.22
DB00839	Tolazamide	motor neuron disease	31	-0.22
DB00839	Tolazamide	adenocarcinoma	32	-0.21
DB00839	Tolazamide	hypersensitivity	45	-0.20
DB00839	Tolazamide	colitis ulcerative	55	-0.20
DB00839	Tolazamide	prostatic neoplasms	61	-0.16
DB00839	Tolazamide	head and neck neoplasms	35	-0.13
DB00839	Tolazamide	dementia	42	-0.11
DB00839	Tolazamide	breast neoplasms	40	-0.11
DB00839	Tolazamide	diabetes mellitus type 2	72	-0.06
DB00839	Tolazamide	psoriasis	54	-0.06
DB00839	Tolazamide	intestinal neoplasms	42	-0.01
DB00839	Tolazamide	lupus erythematosus systemic	75	-0.01
DB00839	Tolazamide	crohn disease	71	-0.01
DB00839	Tolazamide	spinal cord diseases	59	0.00
DB00839	Tolazamide	multiple sclerosis	69	0.02
DB00839	Tolazamide	leukemia myeloid acute	43	0.03
DB00839	Tolazamide	colorectal neoplasms	42	0.05
DB00839	Tolazamide	diabetes mellitus type 1	82	0.06
DB00839	Tolazamide	leukemia lymphoid	66	0.09
DB00839	Tolazamide	anemia	58	0.12
DB00839	Tolazamide	gastroenteritis	122	0.18
DB00839	Tolazamide	gastrointestinal neoplasms	72	0.23
DB00839	Tolazamide	inflammatory bowel diseases	119	0.24
DB00839	Tolazamide	diabetes mellitus	162	0.28
DB00839	Tolazamide	bone diseases	144	0.29
DB00839	Tolazamide	leukemia	117	0.39
DB00839	Tolazamide	eye diseases	231	0.42
DB00839	Tolazamide	vascular diseases	181	0.45
DB00839	Tolazamide	autoimmune diseases	243	0.48
DB00839	Tolazamide	hematologic diseases	188	0.50
DB00839	Tolazamide	skin diseases	278	0.56
DB00839	Tolazamide	neoplasms	482	0.85
DB00242	Cladribine	head and neck neoplasms	35	-3.39
DB00242	Cladribine	adenocarcinoma	32	-2.72
DB00242	Cladribine	lung diseases	71	-2.51
DB00242	Cladribine	eye diseases	231	-2.44
DB00242	Cladribine	neuroendocrine tumors	24	-2.43
DB00242	Cladribine	asthma	36	-2.36
DB00242	Cladribine	hypersensitivity	45	-2.22
DB00242	Cladribine	psoriasis	54	-1.86
DB00242	Cladribine	hypopigmentation	22	-1.83
DB00242	Cladribine	lupus erythematosus systemic	75	-1.64
DB00242	Cladribine	macular degeneration	44	-1.57
DB00242	Cladribine	lymphoma	24	-1.55
DB00242	Cladribine	lymphoma non hodgkin	22	-1.46
DB00242	Cladribine	gastrointestinal neoplasms	72	-1.23
DB00242	Cladribine	arrhythmias cardiac	30	-1.15
DB00242	Cladribine	prostatic neoplasms	61	-1.14
DB00242	Cladribine	hematologic diseases	188	-1.10
DB00242	Cladribine	sarcoma	25	-0.78
DB00242	Cladribine	neoplasms	482	-0.77
DB00242	Cladribine	mycobacterium infections	22	-0.76
DB00242	Cladribine	multiple sclerosis	69	-0.76
DB00242	Cladribine	coronary artery disease	31	-0.75
DB00242	Cladribine	keratosis	21	-0.65
DB00242	Cladribine	anemia hemolytic	29	-0.53
DB00242	Cladribine	bacterial infections	26	-0.49
DB00242	Cladribine	kidney neoplasms	20	-0.46
DB00242	Cladribine	coronary disease	37	-0.40
DB00242	Cladribine	arthritis rheumatoid	42	-0.35
DB00242	Cladribine	leukemia lymphoid	66	-0.35
DB00242	Cladribine	arteriosclerosis	38	-0.32
DB00242	Cladribine	myocardial ischemia	43	-0.30
DB00242	Cladribine	endocrine system diseases	291	-0.28
DB00242	Cladribine	parkinsonian disorders	31	-0.27
DB00242	Cladribine	pancreatic diseases	24	-0.27
DB00242	Cladribine	bone diseases metabolic	27	-0.26
DB00242	Cladribine	amyotrophic lateral sclerosis	21	-0.25
DB00242	Cladribine	parkinson disease	30	-0.24
DB00242	Cladribine	diabetes mellitus type 2	72	-0.18
DB00242	Cladribine	cardiomyopathy dilated	29	-0.13
DB00242	Cladribine	autoimmune diseases	243	-0.02
DB00242	Cladribine	rheumatic diseases	59	-0.01
DB00242	Cladribine	arterial occlusive diseases	44	0.01
DB00242	Cladribine	diabetes mellitus type 1	82	0.02
DB00242	Cladribine	vascular diseases	181	0.13
DB00242	Cladribine	epilepsy	25	0.15
DB00242	Cladribine	diabetes mellitus	162	0.16
DB00242	Cladribine	colorectal neoplasms	42	0.17
DB00242	Cladribine	intestinal neoplasms	42	0.18
DB00242	Cladribine	thyroid diseases	30	0.23
DB00242	Cladribine	arthritis	76	0.24
DB00242	Cladribine	motor neuron disease	31	0.26
DB00242	Cladribine	colitis ulcerative	55	0.27
DB00242	Cladribine	joint diseases	79	0.27
DB00242	Cladribine	hyperinsulinism	26	0.29
DB00242	Cladribine	insulin resistance	26	0.33
DB00242	Cladribine	anemia	58	0.37
DB00242	Cladribine	colitis	55	0.37
DB00242	Cladribine	liver cirrhosis	24	0.43
DB00242	Cladribine	liver cirrhosis biliary	23	0.45
DB00242	Cladribine	cardiovascular diseases	330	0.50
DB00242	Cladribine	breast neoplasms	40	0.52
DB00242	Cladribine	alzheimer disease	29	0.67
DB00242	Cladribine	leukemia	117	0.69
DB00242	Cladribine	crohn disease	71	0.78
DB00242	Cladribine	leukemia myeloid acute	43	0.84
DB00242	Cladribine	spinal cord diseases	59	0.87
DB00242	Cladribine	skin diseases	278	0.91
DB00242	Cladribine	bone diseases	144	1.02
DB00242	Cladribine	heart diseases	167	1.08
DB00242	Cladribine	dementia	42	1.22
DB00242	Cladribine	malabsorption syndromes	34	1.24
DB00242	Cladribine	gastroenteritis	122	1.28
DB00242	Cladribine	inflammatory bowel diseases	119	1.31
DB00242	Cladribine	kidney diseases	144	1.40
DB00242	Cladribine	metabolism inborn errors	289	1.54
DB00242	Cladribine	collagen diseases	25	1.92
DB00242	Cladribine	varicose veins	20	2.74
DB00242	Cladribine	blood coagulation disorders	40	3.14
DB01235	Levodopa	epilepsy	25	-3.44
DB01235	Levodopa	heart diseases	167	-3.22
DB01235	Levodopa	arrhythmias cardiac	30	-2.38
DB01235	Levodopa	bone diseases	144	-2.30
DB01235	Levodopa	anemia hemolytic	29	-2.09
DB01235	Levodopa	cardiovascular diseases	330	-2.02
DB01235	Levodopa	varicose veins	20	-1.93
DB01235	Levodopa	thyroid diseases	30	-1.15
DB01235	Levodopa	anemia	58	-0.94
DB01235	Levodopa	hyperinsulinism	26	-0.86
DB01235	Levodopa	gastroenteritis	122	-0.81
DB01235	Levodopa	hematologic diseases	188	-0.75
DB01235	Levodopa	insulin resistance	26	-0.74
DB01235	Levodopa	inflammatory bowel diseases	119	-0.68
DB01235	Levodopa	collagen diseases	25	-0.65
DB01235	Levodopa	colitis	55	-0.55
DB01235	Levodopa	colitis ulcerative	55	-0.55
DB01235	Levodopa	endocrine system diseases	291	-0.52
DB01235	Levodopa	kidney neoplasms	20	-0.33
DB01235	Levodopa	hypopigmentation	22	-0.25
DB01235	Levodopa	pancreatic diseases	24	-0.20
DB01235	Levodopa	malabsorption syndromes	34	-0.19
DB01235	Levodopa	amyotrophic lateral sclerosis	21	-0.19
DB01235	Levodopa	eye diseases	231	-0.16
DB01235	Levodopa	myocardial ischemia	43	-0.15
DB01235	Levodopa	intestinal neoplasms	42	-0.14
DB01235	Levodopa	vascular diseases	181	-0.13
DB01235	Levodopa	colorectal neoplasms	42	-0.12
DB01235	Levodopa	spinal cord diseases	59	-0.11
DB01235	Levodopa	alzheimer disease	29	-0.08
DB01235	Levodopa	asthma	36	-0.06
DB01235	Levodopa	neuroendocrine tumors	24	-0.05
DB01235	Levodopa	cardiomyopathy dilated	29	0.01
DB01235	Levodopa	lymphoma	24	0.07
DB01235	Levodopa	lymphoma non hodgkin	22	0.12
DB01235	Levodopa	blood coagulation disorders	40	0.14
DB01235	Levodopa	hypersensitivity	45	0.17
DB01235	Levodopa	motor neuron disease	31	0.31
DB01235	Levodopa	gastrointestinal neoplasms	72	0.32
DB01235	Levodopa	mycobacterium infections	22	0.35
DB01235	Levodopa	arthritis rheumatoid	42	0.38
DB01235	Levodopa	adenocarcinoma	32	0.40
DB01235	Levodopa	head and neck neoplasms	35	0.42
DB01235	Levodopa	dementia	42	0.45
DB01235	Levodopa	prostatic neoplasms	61	0.53
DB01235	Levodopa	breast neoplasms	40	0.54
DB01235	Levodopa	bacterial infections	26	0.56
DB01235	Levodopa	psoriasis	54	0.58
DB01235	Levodopa	diabetes mellitus type 2	72	0.65
DB01235	Levodopa	rheumatic diseases	59	0.68
DB01235	Levodopa	liver cirrhosis biliary	23	0.69
DB01235	Levodopa	parkinson disease	30	0.69
DB01235	Levodopa	parkinsonian disorders	31	0.70
DB01235	Levodopa	liver cirrhosis	24	0.72
DB01235	Levodopa	leukemia myeloid acute	43	0.78
DB01235	Levodopa	arteriosclerosis	38	0.79
DB01235	Levodopa	lupus erythematosus systemic	75	0.79
DB01235	Levodopa	multiple sclerosis	69	0.82
DB01235	Levodopa	diabetes mellitus type 1	82	0.87
DB01235	Levodopa	crohn disease	71	0.88
DB01235	Levodopa	arthritis	76	0.97
DB01235	Levodopa	lung diseases	71	0.99
DB01235	Levodopa	joint diseases	79	1.00
DB01235	Levodopa	autoimmune diseases	243	1.00
DB01235	Levodopa	sarcoma	25	1.01
DB01235	Levodopa	leukemia lymphoid	66	1.05
DB01235	Levodopa	arterial occlusive diseases	44	1.06
DB01235	Levodopa	coronary artery disease	31	1.27
DB01235	Levodopa	kidney diseases	144	1.28
DB01235	Levodopa	macular degeneration	44	1.32
DB01235	Levodopa	keratosis	21	1.32
DB01235	Levodopa	diabetes mellitus	162	1.37
DB01235	Levodopa	coronary disease	37	1.56
DB01235	Levodopa	leukemia	117	1.63
DB01235	Levodopa	metabolism inborn errors	289	1.76
DB01235	Levodopa	bone diseases metabolic	27	1.80
DB01235	Levodopa	neoplasms	482	1.95
DB01235	Levodopa	skin diseases	278	2.02
DB00523	Alitretinoin	leukemia myeloid acute	43	-4.15
DB00523	Alitretinoin	sarcoma	25	-3.74
DB00523	Alitretinoin	thyroid diseases	30	-3.56
DB00523	Alitretinoin	bone diseases metabolic	27	-3.17
DB00523	Alitretinoin	leukemia	117	-2.85
DB00523	Alitretinoin	colitis	55	-1.75
DB00523	Alitretinoin	crohn disease	71	-1.74
DB00523	Alitretinoin	colitis ulcerative	55	-1.72
DB00523	Alitretinoin	neoplasms	482	-1.39
DB00523	Alitretinoin	metabolism inborn errors	289	-1.19
DB00523	Alitretinoin	inflammatory bowel diseases	119	-1.19
DB00523	Alitretinoin	gastroenteritis	122	-1.18
DB00523	Alitretinoin	amyotrophic lateral sclerosis	21	-1.16
DB00523	Alitretinoin	bone diseases	144	-0.71
DB00523	Alitretinoin	leukemia lymphoid	66	-0.62
DB00523	Alitretinoin	dementia	42	-0.60
DB00523	Alitretinoin	motor neuron disease	31	-0.55
DB00523	Alitretinoin	endocrine system diseases	291	-0.45
DB00523	Alitretinoin	skin diseases	278	-0.36
DB00523	Alitretinoin	varicose veins	20	-0.36
DB00523	Alitretinoin	kidney diseases	144	-0.34
DB00523	Alitretinoin	diabetes mellitus type 1	82	-0.23
DB00523	Alitretinoin	blood coagulation disorders	40	-0.23
DB00523	Alitretinoin	diabetes mellitus	162	-0.22
DB00523	Alitretinoin	breast neoplasms	40	-0.18
DB00523	Alitretinoin	liver cirrhosis	24	-0.14
DB00523	Alitretinoin	liver cirrhosis biliary	23	-0.11
DB00523	Alitretinoin	colorectal neoplasms	42	0.12
DB00523	Alitretinoin	intestinal neoplasms	42	0.14
DB00523	Alitretinoin	spinal cord diseases	59	0.16
DB00523	Alitretinoin	lung diseases	71	0.23
DB00523	Alitretinoin	coronary artery disease	31	0.28
DB00523	Alitretinoin	diabetes mellitus type 2	72	0.33
DB00523	Alitretinoin	prostatic neoplasms	61	0.37
DB00523	Alitretinoin	keratosis	21	0.40
DB00523	Alitretinoin	anemia hemolytic	29	0.40
DB00523	Alitretinoin	eye diseases	231	0.45
DB00523	Alitretinoin	head and neck neoplasms	35	0.46
DB00523	Alitretinoin	mycobacterium infections	22	0.46
DB00523	Alitretinoin	parkinson disease	30	0.49
DB00523	Alitretinoin	coronary disease	37	0.50
DB00523	Alitretinoin	myocardial ischemia	43	0.54
DB00523	Alitretinoin	parkinsonian disorders	31	0.55
DB00523	Alitretinoin	lupus erythematosus systemic	75	0.57
DB00523	Alitretinoin	kidney neoplasms	20	0.62
DB00523	Alitretinoin	arteriosclerosis	38	0.63
DB00523	Alitretinoin	malabsorption syndromes	34	0.64
DB00523	Alitretinoin	bacterial infections	26	0.64
DB00523	Alitretinoin	cardiomyopathy dilated	29	0.65
DB00523	Alitretinoin	gastrointestinal neoplasms	72	0.78
DB00523	Alitretinoin	neuroendocrine tumors	24	0.80
DB00523	Alitretinoin	arterial occlusive diseases	44	0.81
DB00523	Alitretinoin	pancreatic diseases	24	0.82
DB00523	Alitretinoin	alzheimer disease	29	0.85
DB00523	Alitretinoin	heart diseases	167	0.87
DB00523	Alitretinoin	asthma	36	0.87
DB00523	Alitretinoin	multiple sclerosis	69	0.90
DB00523	Alitretinoin	collagen diseases	25	0.94
DB00523	Alitretinoin	hypersensitivity	45	1.01
DB00523	Alitretinoin	hematologic diseases	188	1.03
DB00523	Alitretinoin	macular degeneration	44	1.15
DB00523	Alitretinoin	lymphoma non hodgkin	22	1.16
DB00523	Alitretinoin	lymphoma	24	1.20
DB00523	Alitretinoin	arthritis rheumatoid	42	1.23
DB00523	Alitretinoin	adenocarcinoma	32	1.28
DB00523	Alitretinoin	psoriasis	54	1.41
DB00523	Alitretinoin	hypopigmentation	22	1.56
DB00523	Alitretinoin	rheumatic diseases	59	1.63
DB00523	Alitretinoin	arthritis	76	1.90
DB00523	Alitretinoin	joint diseases	79	1.90
DB00523	Alitretinoin	arrhythmias cardiac	30	1.95
DB00523	Alitretinoin	hyperinsulinism	26	1.99
DB00523	Alitretinoin	autoimmune diseases	243	1.99
DB00523	Alitretinoin	insulin resistance	26	2.06
DB00523	Alitretinoin	anemia	58	2.09
DB00523	Alitretinoin	cardiovascular diseases	330	2.32
DB00523	Alitretinoin	epilepsy	25	2.91
DB00523	Alitretinoin	vascular diseases	181	3.14
DB01118	Amiodarone	epilepsy	25	-3.05
DB01118	Amiodarone	arrhythmias cardiac	30	-2.76
DB01118	Amiodarone	thyroid diseases	30	-2.45
DB01118	Amiodarone	arterial occlusive diseases	44	-2.24
DB01118	Amiodarone	bone diseases metabolic	27	-1.94
DB01118	Amiodarone	keratosis	21	-1.85
DB01118	Amiodarone	alzheimer disease	29	-1.56
DB01118	Amiodarone	arteriosclerosis	38	-1.52
DB01118	Amiodarone	lymphoma non hodgkin	22	-1.38
DB01118	Amiodarone	blood coagulation disorders	40	-1.38
DB01118	Amiodarone	lymphoma	24	-1.36
DB01118	Amiodarone	endocrine system diseases	291	-1.33
DB01118	Amiodarone	cardiovascular diseases	330	-1.31
DB01118	Amiodarone	motor neuron disease	31	-1.23
DB01118	Amiodarone	adenocarcinoma	32	-1.19
DB01118	Amiodarone	dementia	42	-1.19
DB01118	Amiodarone	head and neck neoplasms	35	-1.18
DB01118	Amiodarone	colitis	55	-1.18
DB01118	Amiodarone	colitis ulcerative	55	-1.12
DB01118	Amiodarone	heart diseases	167	-1.10
DB01118	Amiodarone	collagen diseases	25	-1.04
DB01118	Amiodarone	insulin resistance	26	-1.02
DB01118	Amiodarone	hyperinsulinism	26	-1.02
DB01118	Amiodarone	diabetes mellitus type 2	72	-1.02
DB01118	Amiodarone	intestinal neoplasms	42	-0.94
DB01118	Amiodarone	vascular diseases	181	-0.90
DB01118	Amiodarone	colorectal neoplasms	42	-0.86
DB01118	Amiodarone	rheumatic diseases	59	-0.85
DB01118	Amiodarone	coronary artery disease	31	-0.84
DB01118	Amiodarone	anemia hemolytic	29	-0.78
DB01118	Amiodarone	spinal cord diseases	59	-0.78
DB01118	Amiodarone	kidney neoplasms	20	-0.75
DB01118	Amiodarone	bacterial infections	26	-0.72
DB01118	Amiodarone	eye diseases	231	-0.71
DB01118	Amiodarone	joint diseases	79	-0.70
DB01118	Amiodarone	arthritis	76	-0.69
DB01118	Amiodarone	coronary disease	37	-0.69
DB01118	Amiodarone	neoplasms	482	-0.64
DB01118	Amiodarone	neuroendocrine tumors	24	-0.63
DB01118	Amiodarone	parkinson disease	30	-0.63
DB01118	Amiodarone	parkinsonian disorders	31	-0.61
DB01118	Amiodarone	myocardial ischemia	43	-0.61
DB01118	Amiodarone	amyotrophic lateral sclerosis	21	-0.61
DB01118	Amiodarone	liver cirrhosis biliary	23	-0.59
DB01118	Amiodarone	malabsorption syndromes	34	-0.58
DB01118	Amiodarone	liver cirrhosis	24	-0.58
DB01118	Amiodarone	cardiomyopathy dilated	29	-0.56
DB01118	Amiodarone	pancreatic diseases	24	-0.52
DB01118	Amiodarone	asthma	36	-0.50
DB01118	Amiodarone	gastrointestinal neoplasms	72	-0.49
DB01118	Amiodarone	gastroenteritis	122	-0.45
DB01118	Amiodarone	sarcoma	25	-0.43
DB01118	Amiodarone	inflammatory bowel diseases	119	-0.43
DB01118	Amiodarone	varicose veins	20	-0.36
DB01118	Amiodarone	kidney diseases	144	-0.36
DB01118	Amiodarone	hypersensitivity	45	-0.31
DB01118	Amiodarone	diabetes mellitus	162	-0.26
DB01118	Amiodarone	bone diseases	144	-0.19
DB01118	Amiodarone	arthritis rheumatoid	42	-0.17
DB01118	Amiodarone	prostatic neoplasms	61	-0.02
DB01118	Amiodarone	breast neoplasms	40	-0.01
DB01118	Amiodarone	leukemia myeloid acute	43	0.14
DB01118	Amiodarone	crohn disease	71	0.15
DB01118	Amiodarone	macular degeneration	44	0.15
DB01118	Amiodarone	lupus erythematosus systemic	75	0.17
DB01118	Amiodarone	metabolism inborn errors	289	0.18
DB01118	Amiodarone	diabetes mellitus type 1	82	0.19
DB01118	Amiodarone	multiple sclerosis	69	0.19
DB01118	Amiodarone	hypopigmentation	22	0.24
DB01118	Amiodarone	autoimmune diseases	243	0.28
DB01118	Amiodarone	hematologic diseases	188	0.33
DB01118	Amiodarone	leukemia lymphoid	66	0.35
DB01118	Amiodarone	anemia	58	0.36
DB01118	Amiodarone	lung diseases	71	0.36
DB01118	Amiodarone	skin diseases	278	0.45
DB01118	Amiodarone	leukemia	117	0.87
DB01118	Amiodarone	mycobacterium infections	22	0.98
DB01118	Amiodarone	psoriasis	54	1.01
DB00836	Loperamide	spinal cord diseases	59	-2.90
DB00836	Loperamide	mycobacterium infections	22	-2.39
DB00836	Loperamide	bacterial infections	26	-2.25
DB00836	Loperamide	epilepsy	25	-2.18
DB00836	Loperamide	prostatic neoplasms	61	-1.50
DB00836	Loperamide	breast neoplasms	40	-1.40
DB00836	Loperamide	bone diseases metabolic	27	-1.25
DB00836	Loperamide	neuroendocrine tumors	24	-1.15
DB00836	Loperamide	multiple sclerosis	69	-1.06
DB00836	Loperamide	skin diseases	278	-1.05
DB00836	Loperamide	lymphoma non hodgkin	22	-0.89
DB00836	Loperamide	lymphoma	24	-0.85
DB00836	Loperamide	parkinson disease	30	-0.76
DB00836	Loperamide	thyroid diseases	30	-0.72
DB00836	Loperamide	parkinsonian disorders	31	-0.71
DB00836	Loperamide	hypopigmentation	22	-0.61
DB00836	Loperamide	psoriasis	54	-0.56
DB00836	Loperamide	arrhythmias cardiac	30	-0.50
DB00836	Loperamide	arteriosclerosis	38	-0.45
DB00836	Loperamide	lupus erythematosus systemic	75	-0.40
DB00836	Loperamide	liver cirrhosis	24	-0.38
DB00836	Loperamide	bone diseases	144	-0.37
DB00836	Loperamide	diabetes mellitus type 1	82	-0.35
DB00836	Loperamide	liver cirrhosis biliary	23	-0.28
DB00836	Loperamide	heart diseases	167	-0.26
DB00836	Loperamide	sarcoma	25	-0.21
DB00836	Loperamide	arterial occlusive diseases	44	-0.20
DB00836	Loperamide	macular degeneration	44	-0.14
DB00836	Loperamide	keratosis	21	-0.07
DB00836	Loperamide	coronary artery disease	31	-0.06
DB00836	Loperamide	cardiovascular diseases	330	-0.03
DB00836	Loperamide	leukemia lymphoid	66	-0.02
DB00836	Loperamide	colitis ulcerative	55	0.01
DB00836	Loperamide	vascular diseases	181	0.03
DB00836	Loperamide	colitis	55	0.05
DB00836	Loperamide	eye diseases	231	0.05
DB00836	Loperamide	varicose veins	20	0.13
DB00836	Loperamide	arthritis rheumatoid	42	0.17
DB00836	Loperamide	kidney neoplasms	20	0.19
DB00836	Loperamide	coronary disease	37	0.20
DB00836	Loperamide	myocardial ischemia	43	0.22
DB00836	Loperamide	kidney diseases	144	0.27
DB00836	Loperamide	inflammatory bowel diseases	119	0.28
DB00836	Loperamide	gastroenteritis	122	0.29
DB00836	Loperamide	diabetes mellitus	162	0.31
DB00836	Loperamide	hematologic diseases	188	0.33
DB00836	Loperamide	malabsorption syndromes	34	0.33
DB00836	Loperamide	autoimmune diseases	243	0.35
DB00836	Loperamide	cardiomyopathy dilated	29	0.38
DB00836	Loperamide	gastrointestinal neoplasms	72	0.41
DB00836	Loperamide	pancreatic diseases	24	0.46
DB00836	Loperamide	asthma	36	0.53
DB00836	Loperamide	rheumatic diseases	59	0.56
DB00836	Loperamide	neoplasms	482	0.65
DB00836	Loperamide	leukemia myeloid acute	43	0.67
DB00836	Loperamide	crohn disease	71	0.68
DB00836	Loperamide	intestinal neoplasms	42	0.72
DB00836	Loperamide	hypersensitivity	45	0.75
DB00836	Loperamide	colorectal neoplasms	42	0.78
DB00836	Loperamide	leukemia	117	0.80
DB00836	Loperamide	arthritis	76	0.84
DB00836	Loperamide	anemia hemolytic	29	0.90
DB00836	Loperamide	joint diseases	79	0.91
DB00836	Loperamide	lung diseases	71	0.97
DB00836	Loperamide	metabolism inborn errors	289	0.97
DB00836	Loperamide	motor neuron disease	31	0.98
DB00836	Loperamide	diabetes mellitus type 2	72	1.03
DB00836	Loperamide	dementia	42	1.03
DB00836	Loperamide	adenocarcinoma	32	1.06
DB00836	Loperamide	amyotrophic lateral sclerosis	21	1.07
DB00836	Loperamide	head and neck neoplasms	35	1.14
DB00836	Loperamide	collagen diseases	25	1.21
DB00836	Loperamide	insulin resistance	26	1.25
DB00836	Loperamide	hyperinsulinism	26	1.27
DB00836	Loperamide	endocrine system diseases	291	1.32
DB00836	Loperamide	alzheimer disease	29	1.36
DB00836	Loperamide	blood coagulation disorders	40	1.42
DB00836	Loperamide	anemia	58	2.73
DB01132	Pioglitazone	neoplasms	482	-3.08
DB01132	Pioglitazone	skin diseases	278	-2.75
DB01132	Pioglitazone	coronary artery disease	31	-2.35
DB01132	Pioglitazone	coronary disease	37	-2.23
DB01132	Pioglitazone	myocardial ischemia	43	-2.04
DB01132	Pioglitazone	arteriosclerosis	38	-1.94
DB01132	Pioglitazone	amyotrophic lateral sclerosis	21	-1.94
DB01132	Pioglitazone	alzheimer disease	29	-1.83
DB01132	Pioglitazone	arterial occlusive diseases	44	-1.77
DB01132	Pioglitazone	sarcoma	25	-1.74
DB01132	Pioglitazone	colitis ulcerative	55	-1.56
DB01132	Pioglitazone	colitis	55	-1.54
DB01132	Pioglitazone	motor neuron disease	31	-1.46
DB01132	Pioglitazone	dementia	42	-1.30
DB01132	Pioglitazone	multiple sclerosis	69	-1.29
DB01132	Pioglitazone	crohn disease	71	-1.16
DB01132	Pioglitazone	spinal cord diseases	59	-1.14
DB01132	Pioglitazone	leukemia myeloid acute	43	-1.12
DB01132	Pioglitazone	inflammatory bowel diseases	119	-0.96
DB01132	Pioglitazone	gastroenteritis	122	-0.91
DB01132	Pioglitazone	bone diseases	144	-0.78
DB01132	Pioglitazone	heart diseases	167	-0.75
DB01132	Pioglitazone	gastrointestinal neoplasms	72	-0.72
DB01132	Pioglitazone	leukemia	117	-0.61
DB01132	Pioglitazone	vascular diseases	181	-0.60
DB01132	Pioglitazone	eye diseases	231	-0.50
DB01132	Pioglitazone	autoimmune diseases	243	-0.37
DB01132	Pioglitazone	endocrine system diseases	291	-0.25
DB01132	Pioglitazone	cardiovascular diseases	330	-0.25
DB01132	Pioglitazone	varicose veins	20	0.06
DB01132	Pioglitazone	epilepsy	25	0.12
DB01132	Pioglitazone	hyperinsulinism	26	0.13
DB01132	Pioglitazone	insulin resistance	26	0.14
DB01132	Pioglitazone	bone diseases metabolic	27	0.17
DB01132	Pioglitazone	arrhythmias cardiac	30	0.18
DB01132	Pioglitazone	macular degeneration	44	0.19
DB01132	Pioglitazone	collagen diseases	25	0.20
DB01132	Pioglitazone	anemia hemolytic	29	0.29
DB01132	Pioglitazone	bacterial infections	26	0.32
DB01132	Pioglitazone	liver cirrhosis	24	0.32
DB01132	Pioglitazone	hypopigmentation	22	0.33
DB01132	Pioglitazone	keratosis	21	0.33
DB01132	Pioglitazone	mycobacterium infections	22	0.34
DB01132	Pioglitazone	kidney neoplasms	20	0.35
DB01132	Pioglitazone	malabsorption syndromes	34	0.35
DB01132	Pioglitazone	thyroid diseases	30	0.36
DB01132	Pioglitazone	liver cirrhosis biliary	23	0.38
DB01132	Pioglitazone	asthma	36	0.39
DB01132	Pioglitazone	pancreatic diseases	24	0.40
DB01132	Pioglitazone	neuroendocrine tumors	24	0.40
DB01132	Pioglitazone	parkinsonian disorders	31	0.42
DB01132	Pioglitazone	parkinson disease	30	0.46
DB01132	Pioglitazone	hypersensitivity	45	0.50
DB01132	Pioglitazone	cardiomyopathy dilated	29	0.50
DB01132	Pioglitazone	blood coagulation disorders	40	0.51
DB01132	Pioglitazone	lymphoma	24	0.53
DB01132	Pioglitazone	lymphoma non hodgkin	22	0.56
DB01132	Pioglitazone	arthritis rheumatoid	42	0.57
DB01132	Pioglitazone	adenocarcinoma	32	0.61
DB01132	Pioglitazone	prostatic neoplasms	61	0.63
DB01132	Pioglitazone	psoriasis	54	0.66
DB01132	Pioglitazone	diabetes mellitus type 2	72	0.67
DB01132	Pioglitazone	head and neck neoplasms	35	0.67
DB01132	Pioglitazone	rheumatic diseases	59	0.69
DB01132	Pioglitazone	breast neoplasms	40	0.72
DB01132	Pioglitazone	lupus erythematosus systemic	75	0.73
DB01132	Pioglitazone	diabetes mellitus type 1	82	0.79
DB01132	Pioglitazone	arthritis	76	0.84
DB01132	Pioglitazone	intestinal neoplasms	42	0.85
DB01132	Pioglitazone	anemia	58	0.86
DB01132	Pioglitazone	joint diseases	79	0.86
DB01132	Pioglitazone	lung diseases	71	0.89
DB01132	Pioglitazone	colorectal neoplasms	42	0.90
DB01132	Pioglitazone	kidney diseases	144	1.00
DB01132	Pioglitazone	leukemia lymphoid	66	1.00
DB01132	Pioglitazone	diabetes mellitus	162	1.10
DB01132	Pioglitazone	metabolism inborn errors	289	1.56
DB01132	Pioglitazone	hematologic diseases	188	2.11
DB00489	Sotalol	arrhythmias cardiac	30	-4.34
DB00489	Sotalol	diabetes mellitus type 2	72	-2.48
DB00489	Sotalol	heart diseases	167	-2.44
DB00489	Sotalol	coronary artery disease	31	-1.72
DB00489	Sotalol	bone diseases metabolic	27	-1.72
DB00489	Sotalol	endocrine system diseases	291	-1.64
DB00489	Sotalol	coronary disease	37	-1.63
DB00489	Sotalol	diabetes mellitus	162	-1.56
DB00489	Sotalol	arteriosclerosis	38	-1.51
DB00489	Sotalol	myocardial ischemia	43	-1.51
DB00489	Sotalol	cardiovascular diseases	330	-1.50
DB00489	Sotalol	pancreatic diseases	24	-1.47
DB00489	Sotalol	thyroid diseases	30	-1.41
DB00489	Sotalol	lymphoma	24	-1.39
DB00489	Sotalol	arterial occlusive diseases	44	-1.39
DB00489	Sotalol	lymphoma non hodgkin	22	-1.31
DB00489	Sotalol	bone diseases	144	-1.28
DB00489	Sotalol	head and neck neoplasms	35	-1.09
DB00489	Sotalol	breast neoplasms	40	-0.99
DB00489	Sotalol	colorectal neoplasms	42	-0.84
DB00489	Sotalol	neoplasms	482	-0.81
DB00489	Sotalol	varicose veins	20	-0.79
DB00489	Sotalol	intestinal neoplasms	42	-0.73
DB00489	Sotalol	epilepsy	25	-0.73
DB00489	Sotalol	hyperinsulinism	26	-0.63
DB00489	Sotalol	collagen diseases	25	-0.57
DB00489	Sotalol	insulin resistance	26	-0.57
DB00489	Sotalol	lung diseases	71	-0.51
DB00489	Sotalol	keratosis	21	-0.37
DB00489	Sotalol	macular degeneration	44	-0.34
DB00489	Sotalol	gastrointestinal neoplasms	72	-0.32
DB00489	Sotalol	bacterial infections	26	-0.27
DB00489	Sotalol	anemia hemolytic	29	-0.24
DB00489	Sotalol	kidney neoplasms	20	-0.22
DB00489	Sotalol	parkinsonian disorders	31	-0.22
DB00489	Sotalol	hypopigmentation	22	-0.19
DB00489	Sotalol	liver cirrhosis	24	-0.16
DB00489	Sotalol	malabsorption syndromes	34	-0.16
DB00489	Sotalol	amyotrophic lateral sclerosis	21	-0.12
DB00489	Sotalol	parkinson disease	30	-0.11
DB00489	Sotalol	cardiomyopathy dilated	29	-0.10
DB00489	Sotalol	liver cirrhosis biliary	23	-0.09
DB00489	Sotalol	neuroendocrine tumors	24	-0.08
DB00489	Sotalol	asthma	36	-0.05
DB00489	Sotalol	alzheimer disease	29	-0.03
DB00489	Sotalol	sarcoma	25	0.04
DB00489	Sotalol	blood coagulation disorders	40	0.06
DB00489	Sotalol	vascular diseases	181	0.11
DB00489	Sotalol	hypersensitivity	45	0.12
DB00489	Sotalol	eye diseases	231	0.15
DB00489	Sotalol	motor neuron disease	31	0.19
DB00489	Sotalol	colitis ulcerative	55	0.25
DB00489	Sotalol	colitis	55	0.25
DB00489	Sotalol	adenocarcinoma	32	0.25
DB00489	Sotalol	arthritis rheumatoid	42	0.26
DB00489	Sotalol	dementia	42	0.33
DB00489	Sotalol	prostatic neoplasms	61	0.34
DB00489	Sotalol	autoimmune diseases	243	0.39
DB00489	Sotalol	psoriasis	54	0.39
DB00489	Sotalol	rheumatic diseases	59	0.48
DB00489	Sotalol	multiple sclerosis	69	0.48
DB00489	Sotalol	lupus erythematosus systemic	75	0.50
DB00489	Sotalol	diabetes mellitus type 1	82	0.50
DB00489	Sotalol	crohn disease	71	0.54
DB00489	Sotalol	joint diseases	79	0.58
DB00489	Sotalol	skin diseases	278	0.59
DB00489	Sotalol	spinal cord diseases	59	0.59
DB00489	Sotalol	leukemia myeloid acute	43	0.59
DB00489	Sotalol	arthritis	76	0.66
DB00489	Sotalol	anemia	58	0.69
DB00489	Sotalol	leukemia lymphoid	66	0.71
DB00489	Sotalol	gastroenteritis	122	0.83
DB00489	Sotalol	mycobacterium infections	22	0.84
DB00489	Sotalol	inflammatory bowel diseases	119	0.88
DB00489	Sotalol	kidney diseases	144	0.96
DB00489	Sotalol	leukemia	117	1.24
DB00489	Sotalol	metabolism inborn errors	289	1.35
DB00489	Sotalol	hematologic diseases	188	1.57
DB01137	Levofloxacin	kidney neoplasms	20	-1.73
DB01137	Levofloxacin	cardiomyopathy dilated	29	-1.69
DB01137	Levofloxacin	sarcoma	25	-1.51
DB01137	Levofloxacin	pancreatic diseases	24	-1.41
DB01137	Levofloxacin	arthritis rheumatoid	42	-1.30
DB01137	Levofloxacin	head and neck neoplasms	35	-1.25
DB01137	Levofloxacin	lymphoma	24	-1.21
DB01137	Levofloxacin	lymphoma non hodgkin	22	-1.21
DB01137	Levofloxacin	adenocarcinoma	32	-1.20
DB01137	Levofloxacin	rheumatic diseases	59	-1.15
DB01137	Levofloxacin	prostatic neoplasms	61	-1.09
DB01137	Levofloxacin	breast neoplasms	40	-1.01
DB01137	Levofloxacin	leukemia myeloid acute	43	-1.00
DB01137	Levofloxacin	colorectal neoplasms	42	-0.98
DB01137	Levofloxacin	multiple sclerosis	69	-0.96
DB01137	Levofloxacin	intestinal neoplasms	42	-0.92
DB01137	Levofloxacin	joint diseases	79	-0.92
DB01137	Levofloxacin	spinal cord diseases	59	-0.90
DB01137	Levofloxacin	arthritis	76	-0.87
DB01137	Levofloxacin	lung diseases	71	-0.84
DB01137	Levofloxacin	leukemia lymphoid	66	-0.73
DB01137	Levofloxacin	kidney diseases	144	-0.73
DB01137	Levofloxacin	heart diseases	167	-0.67
DB01137	Levofloxacin	gastrointestinal neoplasms	72	-0.65
DB01137	Levofloxacin	metabolism inborn errors	289	-0.50
DB01137	Levofloxacin	eye diseases	231	-0.47
DB01137	Levofloxacin	vascular diseases	181	-0.34
DB01137	Levofloxacin	leukemia	117	-0.31
DB01137	Levofloxacin	autoimmune diseases	243	-0.26
DB01137	Levofloxacin	hematologic diseases	188	-0.25
DB01137	Levofloxacin	skin diseases	278	-0.20
DB01137	Levofloxacin	endocrine system diseases	291	-0.09
DB01137	Levofloxacin	cardiovascular diseases	330	-0.03
DB01137	Levofloxacin	neoplasms	482	0.21
DB01137	Levofloxacin	arrhythmias cardiac	30	0.22
DB01137	Levofloxacin	varicose veins	20	0.26
DB01137	Levofloxacin	insulin resistance	26	0.27
DB01137	Levofloxacin	bone diseases metabolic	27	0.29
DB01137	Levofloxacin	hyperinsulinism	26	0.29
DB01137	Levofloxacin	collagen diseases	25	0.30
DB01137	Levofloxacin	epilepsy	25	0.33
DB01137	Levofloxacin	macular degeneration	44	0.33
DB01137	Levofloxacin	coronary disease	37	0.41
DB01137	Levofloxacin	anemia hemolytic	29	0.41
DB01137	Levofloxacin	coronary artery disease	31	0.42
DB01137	Levofloxacin	parkinson disease	30	0.42
DB01137	Levofloxacin	keratosis	21	0.44
DB01137	Levofloxacin	myocardial ischemia	43	0.44
DB01137	Levofloxacin	malabsorption syndromes	34	0.48
DB01137	Levofloxacin	mycobacterium infections	22	0.49
DB01137	Levofloxacin	parkinsonian disorders	31	0.49
DB01137	Levofloxacin	arteriosclerosis	38	0.50
DB01137	Levofloxacin	thyroid diseases	30	0.50
DB01137	Levofloxacin	hypopigmentation	22	0.52
DB01137	Levofloxacin	bacterial infections	26	0.55
DB01137	Levofloxacin	alzheimer disease	29	0.57
DB01137	Levofloxacin	amyotrophic lateral sclerosis	21	0.57
DB01137	Levofloxacin	neuroendocrine tumors	24	0.58
DB01137	Levofloxacin	liver cirrhosis biliary	23	0.59
DB01137	Levofloxacin	arterial occlusive diseases	44	0.59
DB01137	Levofloxacin	blood coagulation disorders	40	0.60
DB01137	Levofloxacin	liver cirrhosis	24	0.61
DB01137	Levofloxacin	asthma	36	0.61
DB01137	Levofloxacin	hypersensitivity	45	0.62
DB01137	Levofloxacin	colitis	55	0.69
DB01137	Levofloxacin	dementia	42	0.70
DB01137	Levofloxacin	colitis ulcerative	55	0.72
DB01137	Levofloxacin	diabetes mellitus type 2	72	0.75
DB01137	Levofloxacin	motor neuron disease	31	0.82
DB01137	Levofloxacin	psoriasis	54	0.84
DB01137	Levofloxacin	lupus erythematosus systemic	75	0.87
DB01137	Levofloxacin	diabetes mellitus type 1	82	0.88
DB01137	Levofloxacin	crohn disease	71	1.00
DB01137	Levofloxacin	gastroenteritis	122	1.22
DB01137	Levofloxacin	anemia	58	1.23
DB01137	Levofloxacin	diabetes mellitus	162	1.28
DB01137	Levofloxacin	inflammatory bowel diseases	119	1.30
DB01137	Levofloxacin	bone diseases	144	1.86
DB00230	Pregabalin	spinal cord diseases	59	-4.37
DB00230	Pregabalin	epilepsy	25	-2.75
DB00230	Pregabalin	lymphoma	24	-2.51
DB00230	Pregabalin	lymphoma non hodgkin	22	-2.44
DB00230	Pregabalin	leukemia lymphoid	66	-2.31
DB00230	Pregabalin	leukemia	117	-1.97
DB00230	Pregabalin	varicose veins	20	-1.03
DB00230	Pregabalin	neoplasms	482	-1.01
DB00230	Pregabalin	arrhythmias cardiac	30	-0.92
DB00230	Pregabalin	bone diseases metabolic	27	-0.82
DB00230	Pregabalin	coronary artery disease	31	-0.78
DB00230	Pregabalin	mycobacterium infections	22	-0.76
DB00230	Pregabalin	thyroid diseases	30	-0.74
DB00230	Pregabalin	coronary disease	37	-0.70
DB00230	Pregabalin	myocardial ischemia	43	-0.68
DB00230	Pregabalin	arteriosclerosis	38	-0.68
DB00230	Pregabalin	liver cirrhosis	24	-0.66
DB00230	Pregabalin	liver cirrhosis biliary	23	-0.61
DB00230	Pregabalin	bacterial infections	26	-0.61
DB00230	Pregabalin	sarcoma	25	-0.55
DB00230	Pregabalin	arterial occlusive diseases	44	-0.48
DB00230	Pregabalin	arthritis rheumatoid	42	-0.43
DB00230	Pregabalin	colitis ulcerative	55	-0.39
DB00230	Pregabalin	psoriasis	54	-0.39
DB00230	Pregabalin	breast neoplasms	40	-0.36
DB00230	Pregabalin	colitis	55	-0.34
DB00230	Pregabalin	prostatic neoplasms	61	-0.31
DB00230	Pregabalin	diabetes mellitus type 2	72	-0.30
DB00230	Pregabalin	rheumatic diseases	59	-0.27
DB00230	Pregabalin	crohn disease	71	-0.26
DB00230	Pregabalin	colorectal neoplasms	42	-0.24
DB00230	Pregabalin	multiple sclerosis	69	-0.23
DB00230	Pregabalin	diabetes mellitus type 1	82	-0.22
DB00230	Pregabalin	intestinal neoplasms	42	-0.22
DB00230	Pregabalin	lupus erythematosus systemic	75	-0.22
DB00230	Pregabalin	leukemia myeloid acute	43	-0.21
DB00230	Pregabalin	joint diseases	79	-0.19
DB00230	Pregabalin	arthritis	76	-0.13
DB00230	Pregabalin	gastroenteritis	122	-0.08
DB00230	Pregabalin	inflammatory bowel diseases	119	-0.04
DB00230	Pregabalin	gastrointestinal neoplasms	72	-0.04
DB00230	Pregabalin	kidney diseases	144	0.03
DB00230	Pregabalin	diabetes mellitus	162	0.05
DB00230	Pregabalin	bone diseases	144	0.07
DB00230	Pregabalin	heart diseases	167	0.09
DB00230	Pregabalin	eye diseases	231	0.16
DB00230	Pregabalin	vascular diseases	181	0.17
DB00230	Pregabalin	autoimmune diseases	243	0.26
DB00230	Pregabalin	hematologic diseases	188	0.27
DB00230	Pregabalin	metabolism inborn errors	289	0.29
DB00230	Pregabalin	endocrine system diseases	291	0.35
DB00230	Pregabalin	skin diseases	278	0.39
DB00230	Pregabalin	cardiovascular diseases	330	0.45
DB00230	Pregabalin	insulin resistance	26	0.96
DB00230	Pregabalin	hyperinsulinism	26	0.99
DB00230	Pregabalin	collagen diseases	25	1.05
DB00230	Pregabalin	macular degeneration	44	1.07
DB00230	Pregabalin	keratosis	21	1.15
DB00230	Pregabalin	kidney neoplasms	20	1.19
DB00230	Pregabalin	pancreatic diseases	24	1.19
DB00230	Pregabalin	anemia hemolytic	29	1.21
DB00230	Pregabalin	parkinson disease	30	1.25
DB00230	Pregabalin	amyotrophic lateral sclerosis	21	1.25
DB00230	Pregabalin	parkinsonian disorders	31	1.27
DB00230	Pregabalin	alzheimer disease	29	1.28
DB00230	Pregabalin	malabsorption syndromes	34	1.28
DB00230	Pregabalin	neuroendocrine tumors	24	1.29
DB00230	Pregabalin	hypopigmentation	22	1.29
DB00230	Pregabalin	asthma	36	1.31
DB00230	Pregabalin	cardiomyopathy dilated	29	1.44
DB00230	Pregabalin	blood coagulation disorders	40	1.46
DB00230	Pregabalin	hypersensitivity	45	1.50
DB00230	Pregabalin	adenocarcinoma	32	1.52
DB00230	Pregabalin	motor neuron disease	31	1.63
DB00230	Pregabalin	head and neck neoplasms	35	1.65
DB00230	Pregabalin	dementia	42	1.66
DB00230	Pregabalin	lung diseases	71	1.95
DB00230	Pregabalin	anemia	58	2.02
DB01138	Sulfinpyrazone	metabolism inborn errors	289	-3.88
DB01138	Sulfinpyrazone	bone diseases metabolic	27	-1.08
DB01138	Sulfinpyrazone	insulin resistance	26	-1.06
DB01138	Sulfinpyrazone	hyperinsulinism	26	-1.05
DB01138	Sulfinpyrazone	mycobacterium infections	22	-0.98
DB01138	Sulfinpyrazone	coronary artery disease	31	-0.93
DB01138	Sulfinpyrazone	thyroid diseases	30	-0.90
DB01138	Sulfinpyrazone	keratosis	21	-0.89
DB01138	Sulfinpyrazone	liver cirrhosis biliary	23	-0.88
DB01138	Sulfinpyrazone	anemia hemolytic	29	-0.87
DB01138	Sulfinpyrazone	hypopigmentation	22	-0.86
DB01138	Sulfinpyrazone	bacterial infections	26	-0.85
DB01138	Sulfinpyrazone	parkinson disease	30	-0.82
DB01138	Sulfinpyrazone	coronary disease	37	-0.82
DB01138	Sulfinpyrazone	liver cirrhosis	24	-0.81
DB01138	Sulfinpyrazone	neuroendocrine tumors	24	-0.80
DB01138	Sulfinpyrazone	kidney neoplasms	20	-0.80
DB01138	Sulfinpyrazone	pancreatic diseases	24	-0.80
DB01138	Sulfinpyrazone	parkinsonian disorders	31	-0.78
DB01138	Sulfinpyrazone	arteriosclerosis	38	-0.72
DB01138	Sulfinpyrazone	myocardial ischemia	43	-0.71
DB01138	Sulfinpyrazone	blood coagulation disorders	40	-0.68
DB01138	Sulfinpyrazone	arterial occlusive diseases	44	-0.67
DB01138	Sulfinpyrazone	colitis ulcerative	55	-0.59
DB01138	Sulfinpyrazone	head and neck neoplasms	35	-0.59
DB01138	Sulfinpyrazone	motor neuron disease	31	-0.58
DB01138	Sulfinpyrazone	adenocarcinoma	32	-0.58
DB01138	Sulfinpyrazone	colitis	55	-0.55
DB01138	Sulfinpyrazone	breast neoplasms	40	-0.53
DB01138	Sulfinpyrazone	arthritis rheumatoid	42	-0.52
DB01138	Sulfinpyrazone	prostatic neoplasms	61	-0.50
DB01138	Sulfinpyrazone	multiple sclerosis	69	-0.45
DB01138	Sulfinpyrazone	psoriasis	54	-0.45
DB01138	Sulfinpyrazone	leukemia myeloid acute	43	-0.44
DB01138	Sulfinpyrazone	diabetes mellitus type 2	72	-0.43
DB01138	Sulfinpyrazone	colorectal neoplasms	42	-0.42
DB01138	Sulfinpyrazone	intestinal neoplasms	42	-0.41
DB01138	Sulfinpyrazone	lupus erythematosus systemic	75	-0.40
DB01138	Sulfinpyrazone	crohn disease	71	-0.39
DB01138	Sulfinpyrazone	rheumatic diseases	59	-0.37
DB01138	Sulfinpyrazone	anemia	58	-0.35
DB01138	Sulfinpyrazone	arthritis	76	-0.33
DB01138	Sulfinpyrazone	spinal cord diseases	59	-0.31
DB01138	Sulfinpyrazone	lung diseases	71	-0.30
DB01138	Sulfinpyrazone	leukemia lymphoid	66	-0.27
DB01138	Sulfinpyrazone	joint diseases	79	-0.27
DB01138	Sulfinpyrazone	gastrointestinal neoplasms	72	-0.19
DB01138	Sulfinpyrazone	gastroenteritis	122	-0.16
DB01138	Sulfinpyrazone	inflammatory bowel diseases	119	-0.15
DB01138	Sulfinpyrazone	kidney diseases	144	-0.11
DB01138	Sulfinpyrazone	diabetes mellitus	162	-0.09
DB01138	Sulfinpyrazone	heart diseases	167	-0.07
DB01138	Sulfinpyrazone	bone diseases	144	-0.07
DB01138	Sulfinpyrazone	leukemia	117	-0.03
DB01138	Sulfinpyrazone	vascular diseases	181	0.00
DB01138	Sulfinpyrazone	eye diseases	231	0.06
DB01138	Sulfinpyrazone	hematologic diseases	188	0.15
DB01138	Sulfinpyrazone	autoimmune diseases	243	0.17
DB01138	Sulfinpyrazone	skin diseases	278	0.19
DB01138	Sulfinpyrazone	cardiovascular diseases	330	0.23
DB01138	Sulfinpyrazone	endocrine system diseases	291	0.23
DB01138	Sulfinpyrazone	neoplasms	482	0.52
DB01138	Sulfinpyrazone	varicose veins	20	0.68
DB01138	Sulfinpyrazone	epilepsy	25	0.69
DB01138	Sulfinpyrazone	arrhythmias cardiac	30	0.76
DB01138	Sulfinpyrazone	collagen diseases	25	0.81
DB01138	Sulfinpyrazone	macular degeneration	44	0.83
DB01138	Sulfinpyrazone	amyotrophic lateral sclerosis	21	0.98
DB01138	Sulfinpyrazone	malabsorption syndromes	34	0.98
DB01138	Sulfinpyrazone	asthma	36	1.05
DB01138	Sulfinpyrazone	cardiomyopathy dilated	29	1.07
DB01138	Sulfinpyrazone	alzheimer disease	29	1.07
DB01138	Sulfinpyrazone	lymphoma	24	1.15
DB01138	Sulfinpyrazone	lymphoma non hodgkin	22	1.15
DB01138	Sulfinpyrazone	hypersensitivity	45	1.17
DB01138	Sulfinpyrazone	sarcoma	25	1.18
DB01138	Sulfinpyrazone	dementia	42	1.39
DB01138	Sulfinpyrazone	diabetes mellitus type 1	82	1.62
DB00104	Octreotide	kidney diseases	144	-1.16
DB00104	Octreotide	neuroendocrine tumors	24	-1.04
DB00104	Octreotide	lymphoma	24	-1.01
DB00104	Octreotide	lymphoma non hodgkin	22	-0.99
DB00104	Octreotide	motor neuron disease	31	-0.81
DB00104	Octreotide	colitis ulcerative	55	-0.77
DB00104	Octreotide	colitis	55	-0.72
DB00104	Octreotide	diabetes mellitus type 2	72	-0.70
DB00104	Octreotide	metabolism inborn errors	289	-0.68
DB00104	Octreotide	varicose veins	20	-0.66
DB00104	Octreotide	colorectal neoplasms	42	-0.52
DB00104	Octreotide	intestinal neoplasms	42	-0.49
DB00104	Octreotide	diabetes mellitus type 1	82	-0.47
DB00104	Octreotide	spinal cord diseases	59	-0.43
DB00104	Octreotide	anemia	58	-0.38
DB00104	Octreotide	keratosis	21	-0.34
DB00104	Octreotide	leukemia lymphoid	66	-0.31
DB00104	Octreotide	gastroenteritis	122	-0.17
DB00104	Octreotide	kidney neoplasms	20	-0.16
DB00104	Octreotide	inflammatory bowel diseases	119	-0.13
DB00104	Octreotide	gastrointestinal neoplasms	72	-0.10
DB00104	Octreotide	amyotrophic lateral sclerosis	21	-0.08
DB00104	Octreotide	liver cirrhosis	24	-0.07
DB00104	Octreotide	liver cirrhosis biliary	23	-0.07
DB00104	Octreotide	diabetes mellitus	162	-0.06
DB00104	Octreotide	pancreatic diseases	24	-0.04
DB00104	Octreotide	asthma	36	-0.01
DB00104	Octreotide	bone diseases	144	0.05
DB00104	Octreotide	heart diseases	167	0.07
DB00104	Octreotide	neoplasms	482	0.12
DB00104	Octreotide	leukemia	117	0.15
DB00104	Octreotide	hypersensitivity	45	0.19
DB00104	Octreotide	blood coagulation disorders	40	0.21
DB00104	Octreotide	eye diseases	231	0.25
DB00104	Octreotide	vascular diseases	181	0.26
DB00104	Octreotide	arthritis rheumatoid	42	0.32
DB00104	Octreotide	hematologic diseases	188	0.37
DB00104	Octreotide	adenocarcinoma	32	0.38
DB00104	Octreotide	autoimmune diseases	243	0.43
DB00104	Octreotide	psoriasis	54	0.44
DB00104	Octreotide	head and neck neoplasms	35	0.45
DB00104	Octreotide	arrhythmias cardiac	30	0.51
DB00104	Octreotide	insulin resistance	26	0.51
DB00104	Octreotide	endocrine system diseases	291	0.52
DB00104	Octreotide	hyperinsulinism	26	0.52
DB00104	Octreotide	collagen diseases	25	0.56
DB00104	Octreotide	bone diseases metabolic	27	0.59
DB00104	Octreotide	cardiovascular diseases	330	0.61
DB00104	Octreotide	rheumatic diseases	59	0.65
DB00104	Octreotide	lupus erythematosus systemic	75	0.66
DB00104	Octreotide	mycobacterium infections	22	0.71
DB00104	Octreotide	coronary artery disease	31	0.72
DB00104	Octreotide	leukemia myeloid acute	43	0.73
DB00104	Octreotide	crohn disease	71	0.74
DB00104	Octreotide	multiple sclerosis	69	0.74
DB00104	Octreotide	anemia hemolytic	29	0.84
DB00104	Octreotide	arthritis	76	0.85
DB00104	Octreotide	lung diseases	71	0.87
DB00104	Octreotide	joint diseases	79	0.87
DB00104	Octreotide	thyroid diseases	30	0.88
DB00104	Octreotide	hypopigmentation	22	0.96
DB00104	Octreotide	parkinsonian disorders	31	0.96
DB00104	Octreotide	bacterial infections	26	0.97
DB00104	Octreotide	myocardial ischemia	43	0.99
DB00104	Octreotide	coronary disease	37	0.99
DB00104	Octreotide	parkinson disease	30	1.00
DB00104	Octreotide	arteriosclerosis	38	1.03
DB00104	Octreotide	malabsorption syndromes	34	1.05
DB00104	Octreotide	alzheimer disease	29	1.13
DB00104	Octreotide	cardiomyopathy dilated	29	1.13
DB00104	Octreotide	sarcoma	25	1.24
DB00104	Octreotide	arterial occlusive diseases	44	1.32
DB00104	Octreotide	epilepsy	25	1.48
DB00104	Octreotide	dementia	42	1.52
DB00104	Octreotide	breast neoplasms	40	1.71
DB00104	Octreotide	skin diseases	278	1.74
DB00104	Octreotide	prostatic neoplasms	61	1.78
DB00104	Octreotide	macular degeneration	44	1.90
DB01234	Dexamethasone	skin diseases	278	-2.88
DB01234	Dexamethasone	motor neuron disease	31	-2.11
DB01234	Dexamethasone	psoriasis	54	-2.06
DB01234	Dexamethasone	arterial occlusive diseases	44	-1.78
DB01234	Dexamethasone	varicose veins	20	-1.76
DB01234	Dexamethasone	spinal cord diseases	59	-1.69
DB01234	Dexamethasone	colitis	55	-1.51
DB01234	Dexamethasone	colitis ulcerative	55	-1.49
DB01234	Dexamethasone	lymphoma non hodgkin	22	-1.15
DB01234	Dexamethasone	prostatic neoplasms	61	-1.13
DB01234	Dexamethasone	coronary artery disease	31	-1.10
DB01234	Dexamethasone	lymphoma	24	-1.06
DB01234	Dexamethasone	metabolism inborn errors	289	-0.96
DB01234	Dexamethasone	coronary disease	37	-0.91
DB01234	Dexamethasone	myocardial ischemia	43	-0.90
DB01234	Dexamethasone	breast neoplasms	40	-0.89
DB01234	Dexamethasone	eye diseases	231	-0.85
DB01234	Dexamethasone	mycobacterium infections	22	-0.81
DB01234	Dexamethasone	kidney neoplasms	20	-0.79
DB01234	Dexamethasone	arteriosclerosis	38	-0.76
DB01234	Dexamethasone	crohn disease	71	-0.72
DB01234	Dexamethasone	malabsorption syndromes	34	-0.72
DB01234	Dexamethasone	amyotrophic lateral sclerosis	21	-0.69
DB01234	Dexamethasone	alzheimer disease	29	-0.68
DB01234	Dexamethasone	autoimmune diseases	243	-0.60
DB01234	Dexamethasone	leukemia myeloid acute	43	-0.59
DB01234	Dexamethasone	bacterial infections	26	-0.58
DB01234	Dexamethasone	endocrine system diseases	291	-0.52
DB01234	Dexamethasone	leukemia lymphoid	66	-0.44
DB01234	Dexamethasone	liver cirrhosis biliary	23	-0.41
DB01234	Dexamethasone	liver cirrhosis	24	-0.40
DB01234	Dexamethasone	asthma	36	-0.40
DB01234	Dexamethasone	joint diseases	79	-0.39
DB01234	Dexamethasone	arthritis	76	-0.37
DB01234	Dexamethasone	lung diseases	71	-0.34
DB01234	Dexamethasone	cardiovascular diseases	330	-0.34
DB01234	Dexamethasone	sarcoma	25	-0.32
DB01234	Dexamethasone	neuroendocrine tumors	24	-0.32
DB01234	Dexamethasone	gastroenteritis	122	-0.30
DB01234	Dexamethasone	inflammatory bowel diseases	119	-0.28
DB01234	Dexamethasone	kidney diseases	144	-0.24
DB01234	Dexamethasone	hypersensitivity	45	-0.19
DB01234	Dexamethasone	dementia	42	-0.18
DB01234	Dexamethasone	head and neck neoplasms	35	-0.06
DB01234	Dexamethasone	heart diseases	167	-0.03
DB01234	Dexamethasone	adenocarcinoma	32	0.03
DB01234	Dexamethasone	parkinsonian disorders	31	0.04
DB01234	Dexamethasone	keratosis	21	0.04
DB01234	Dexamethasone	arthritis rheumatoid	42	0.06
DB01234	Dexamethasone	parkinson disease	30	0.07
DB01234	Dexamethasone	bone diseases	144	0.13
DB01234	Dexamethasone	thyroid diseases	30	0.17
DB01234	Dexamethasone	diabetes mellitus type 1	82	0.22
DB01234	Dexamethasone	neoplasms	482	0.27
DB01234	Dexamethasone	lupus erythematosus systemic	75	0.27
DB01234	Dexamethasone	cardiomyopathy dilated	29	0.35
DB01234	Dexamethasone	leukemia	117	0.36
DB01234	Dexamethasone	rheumatic diseases	59	0.43
DB01234	Dexamethasone	vascular diseases	181	0.45
DB01234	Dexamethasone	multiple sclerosis	69	0.58
DB01234	Dexamethasone	pancreatic diseases	24	0.63
DB01234	Dexamethasone	intestinal neoplasms	42	0.65
DB01234	Dexamethasone	arrhythmias cardiac	30	0.67
DB01234	Dexamethasone	hematologic diseases	188	0.70
DB01234	Dexamethasone	collagen diseases	25	0.70
DB01234	Dexamethasone	colorectal neoplasms	42	0.72
DB01234	Dexamethasone	epilepsy	25	0.72
DB01234	Dexamethasone	diabetes mellitus type 2	72	0.78
DB01234	Dexamethasone	bone diseases metabolic	27	0.79
DB01234	Dexamethasone	insulin resistance	26	0.82
DB01234	Dexamethasone	hyperinsulinism	26	0.85
DB01234	Dexamethasone	diabetes mellitus	162	0.85
DB01234	Dexamethasone	anemia	58	0.86
DB01234	Dexamethasone	macular degeneration	44	0.99
DB01234	Dexamethasone	anemia hemolytic	29	1.20
DB01234	Dexamethasone	gastrointestinal neoplasms	72	1.22
DB01234	Dexamethasone	hypopigmentation	22	1.33
DB01234	Dexamethasone	blood coagulation disorders	40	1.60
DB00091	Cyclosporine	vascular diseases	181	-1.79
DB00091	Cyclosporine	eye diseases	231	-1.72
DB00091	Cyclosporine	lupus erythematosus systemic	75	-1.62
DB00091	Cyclosporine	autoimmune diseases	243	-1.56
DB00091	Cyclosporine	bone diseases metabolic	27	-1.45
DB00091	Cyclosporine	collagen diseases	25	-1.42
DB00091	Cyclosporine	lung diseases	71	-1.37
DB00091	Cyclosporine	cardiovascular diseases	330	-1.24
DB00091	Cyclosporine	neuroendocrine tumors	24	-1.01
DB00091	Cyclosporine	alzheimer disease	29	-0.96
DB00091	Cyclosporine	bone diseases	144	-0.93
DB00091	Cyclosporine	heart diseases	167	-0.91
DB00091	Cyclosporine	sarcoma	25	-0.90
DB00091	Cyclosporine	asthma	36	-0.89
DB00091	Cyclosporine	blood coagulation disorders	40	-0.88
DB00091	Cyclosporine	hypersensitivity	45	-0.76
DB00091	Cyclosporine	adenocarcinoma	32	-0.75
DB00091	Cyclosporine	leukemia	117	-0.70
DB00091	Cyclosporine	colitis	55	-0.65
DB00091	Cyclosporine	colitis ulcerative	55	-0.61
DB00091	Cyclosporine	dementia	42	-0.60
DB00091	Cyclosporine	head and neck neoplasms	35	-0.59
DB00091	Cyclosporine	neoplasms	482	-0.56
DB00091	Cyclosporine	diabetes mellitus type 2	72	-0.51
DB00091	Cyclosporine	psoriasis	54	-0.48
DB00091	Cyclosporine	varicose veins	20	-0.44
DB00091	Cyclosporine	epilepsy	25	-0.36
DB00091	Cyclosporine	hematologic diseases	188	-0.36
DB00091	Cyclosporine	leukemia myeloid acute	43	-0.36
DB00091	Cyclosporine	diabetes mellitus type 1	82	-0.32
DB00091	Cyclosporine	crohn disease	71	-0.30
DB00091	Cyclosporine	hyperinsulinism	26	-0.28
DB00091	Cyclosporine	multiple sclerosis	69	-0.26
DB00091	Cyclosporine	insulin resistance	26	-0.21
DB00091	Cyclosporine	arrhythmias cardiac	30	-0.17
DB00091	Cyclosporine	anemia	58	-0.15
DB00091	Cyclosporine	keratosis	21	-0.07
DB00091	Cyclosporine	coronary artery disease	31	-0.04
DB00091	Cyclosporine	mycobacterium infections	22	-0.02
DB00091	Cyclosporine	gastroenteritis	122	0.00
DB00091	Cyclosporine	kidney diseases	144	0.01
DB00091	Cyclosporine	macular degeneration	44	0.02
DB00091	Cyclosporine	inflammatory bowel diseases	119	0.04
DB00091	Cyclosporine	thyroid diseases	30	0.08
DB00091	Cyclosporine	kidney neoplasms	20	0.09
DB00091	Cyclosporine	anemia hemolytic	29	0.10
DB00091	Cyclosporine	hypopigmentation	22	0.12
DB00091	Cyclosporine	diabetes mellitus	162	0.12
DB00091	Cyclosporine	coronary disease	37	0.14
DB00091	Cyclosporine	bacterial infections	26	0.15
DB00091	Cyclosporine	liver cirrhosis biliary	23	0.15
DB00091	Cyclosporine	parkinson disease	30	0.17
DB00091	Cyclosporine	pancreatic diseases	24	0.20
DB00091	Cyclosporine	amyotrophic lateral sclerosis	21	0.20
DB00091	Cyclosporine	malabsorption syndromes	34	0.21
DB00091	Cyclosporine	liver cirrhosis	24	0.23
DB00091	Cyclosporine	myocardial ischemia	43	0.24
DB00091	Cyclosporine	arteriosclerosis	38	0.25
DB00091	Cyclosporine	cardiomyopathy dilated	29	0.31
DB00091	Cyclosporine	parkinsonian disorders	31	0.31
DB00091	Cyclosporine	arterial occlusive diseases	44	0.40
DB00091	Cyclosporine	lymphoma	24	0.42
DB00091	Cyclosporine	lymphoma non hodgkin	22	0.44
DB00091	Cyclosporine	motor neuron disease	31	0.54
DB00091	Cyclosporine	metabolism inborn errors	289	0.58
DB00091	Cyclosporine	arthritis rheumatoid	42	0.59
DB00091	Cyclosporine	breast neoplasms	40	0.70
DB00091	Cyclosporine	prostatic neoplasms	61	0.74
DB00091	Cyclosporine	endocrine system diseases	291	0.83
DB00091	Cyclosporine	colorectal neoplasms	42	0.83
DB00091	Cyclosporine	skin diseases	278	0.85
DB00091	Cyclosporine	rheumatic diseases	59	0.85
DB00091	Cyclosporine	intestinal neoplasms	42	0.90
DB00091	Cyclosporine	spinal cord diseases	59	0.96
DB00091	Cyclosporine	arthritis	76	0.99
DB00091	Cyclosporine	joint diseases	79	1.01
DB00091	Cyclosporine	leukemia lymphoid	66	1.10
DB00091	Cyclosporine	gastrointestinal neoplasms	72	1.20
DB00667	Histamine.Phosphate	insulin resistance	26	-1.04
DB00667	Histamine.Phosphate	hyperinsulinism	26	-1.03
DB00667	Histamine.Phosphate	bone diseases	144	-0.91
DB00667	Histamine.Phosphate	hypopigmentation	22	-0.66
DB00667	Histamine.Phosphate	malabsorption syndromes	34	-0.50
DB00667	Histamine.Phosphate	epilepsy	25	-0.29
DB00667	Histamine.Phosphate	arthritis rheumatoid	42	-0.17
DB00667	Histamine.Phosphate	arrhythmias cardiac	30	-0.17
DB00667	Histamine.Phosphate	bone diseases metabolic	27	-0.12
DB00667	Histamine.Phosphate	dementia	42	-0.07
DB00667	Histamine.Phosphate	heart diseases	167	0.00
DB00667	Histamine.Phosphate	psoriasis	54	0.00
DB00667	Histamine.Phosphate	breast neoplasms	40	0.02
DB00667	Histamine.Phosphate	diabetes mellitus type 2	72	0.10
DB00667	Histamine.Phosphate	anemia hemolytic	29	0.14
DB00667	Histamine.Phosphate	rheumatic diseases	59	0.14
DB00667	Histamine.Phosphate	kidney neoplasms	20	0.16
DB00667	Histamine.Phosphate	thyroid diseases	30	0.19
DB00667	Histamine.Phosphate	eye diseases	231	0.20
DB00667	Histamine.Phosphate	lupus erythematosus systemic	75	0.21
DB00667	Histamine.Phosphate	crohn disease	71	0.22
DB00667	Histamine.Phosphate	spinal cord diseases	59	0.23
DB00667	Histamine.Phosphate	bacterial infections	26	0.23
DB00667	Histamine.Phosphate	diabetes mellitus type 1	82	0.25
DB00667	Histamine.Phosphate	liver cirrhosis	24	0.26
DB00667	Histamine.Phosphate	pancreatic diseases	24	0.27
DB00667	Histamine.Phosphate	liver cirrhosis biliary	23	0.27
DB00667	Histamine.Phosphate	amyotrophic lateral sclerosis	21	0.28
DB00667	Histamine.Phosphate	myocardial ischemia	43	0.31
DB00667	Histamine.Phosphate	arthritis	76	0.33
DB00667	Histamine.Phosphate	joint diseases	79	0.34
DB00667	Histamine.Phosphate	cardiomyopathy dilated	29	0.35
DB00667	Histamine.Phosphate	asthma	36	0.37
DB00667	Histamine.Phosphate	autoimmune diseases	243	0.41
DB00667	Histamine.Phosphate	alzheimer disease	29	0.42
DB00667	Histamine.Phosphate	sarcoma	25	0.44
DB00667	Histamine.Phosphate	varicose veins	20	0.45
DB00667	Histamine.Phosphate	lymphoma non hodgkin	22	0.48
DB00667	Histamine.Phosphate	blood coagulation disorders	40	0.51
DB00667	Histamine.Phosphate	lymphoma	24	0.56
DB00667	Histamine.Phosphate	hypersensitivity	45	0.58
DB00667	Histamine.Phosphate	cardiovascular diseases	330	0.63
DB00667	Histamine.Phosphate	inflammatory bowel diseases	119	0.63
DB00667	Histamine.Phosphate	gastroenteritis	122	0.64
DB00667	Histamine.Phosphate	adenocarcinoma	32	0.66
DB00667	Histamine.Phosphate	motor neuron disease	31	0.66
DB00667	Histamine.Phosphate	colitis ulcerative	55	0.71
DB00667	Histamine.Phosphate	collagen diseases	25	0.73
DB00667	Histamine.Phosphate	head and neck neoplasms	35	0.75
DB00667	Histamine.Phosphate	colitis	55	0.80
DB00667	Histamine.Phosphate	diabetes mellitus	162	0.81
DB00667	Histamine.Phosphate	mycobacterium infections	22	0.82
DB00667	Histamine.Phosphate	keratosis	21	0.84
DB00667	Histamine.Phosphate	prostatic neoplasms	61	0.85
DB00667	Histamine.Phosphate	coronary artery disease	31	0.91
DB00667	Histamine.Phosphate	macular degeneration	44	0.94
DB00667	Histamine.Phosphate	coronary disease	37	1.03
DB00667	Histamine.Phosphate	vascular diseases	181	1.03
DB00667	Histamine.Phosphate	intestinal neoplasms	42	1.04
DB00667	Histamine.Phosphate	multiple sclerosis	69	1.10
DB00667	Histamine.Phosphate	parkinsonian disorders	31	1.10
DB00667	Histamine.Phosphate	parkinson disease	30	1.10
DB00667	Histamine.Phosphate	colorectal neoplasms	42	1.10
DB00667	Histamine.Phosphate	leukemia myeloid acute	43	1.10
DB00667	Histamine.Phosphate	neoplasms	482	1.12
DB00667	Histamine.Phosphate	neuroendocrine tumors	24	1.18
DB00667	Histamine.Phosphate	anemia	58	1.23
DB00667	Histamine.Phosphate	metabolism inborn errors	289	1.26
DB00667	Histamine.Phosphate	arteriosclerosis	38	1.26
DB00667	Histamine.Phosphate	lung diseases	71	1.29
DB00667	Histamine.Phosphate	leukemia lymphoid	66	1.29
DB00667	Histamine.Phosphate	hematologic diseases	188	1.31
DB00667	Histamine.Phosphate	arterial occlusive diseases	44	1.32
DB00667	Histamine.Phosphate	endocrine system diseases	291	1.37
DB00667	Histamine.Phosphate	skin diseases	278	1.45
DB00667	Histamine.Phosphate	gastrointestinal neoplasms	72	1.50
DB00667	Histamine.Phosphate	kidney diseases	144	1.62
DB00667	Histamine.Phosphate	leukemia	117	1.83
DB00313	Valproic.Acid	coronary disease	37	-3.11
DB00313	Valproic.Acid	myocardial ischemia	43	-2.86
DB00313	Valproic.Acid	arteriosclerosis	38	-2.77
DB00313	Valproic.Acid	metabolism inborn errors	289	-2.68
DB00313	Valproic.Acid	kidney diseases	144	-2.68
DB00313	Valproic.Acid	colitis	55	-2.52
DB00313	Valproic.Acid	arterial occlusive diseases	44	-2.51
DB00313	Valproic.Acid	colitis ulcerative	55	-2.46
DB00313	Valproic.Acid	head and neck neoplasms	35	-2.20
DB00313	Valproic.Acid	coronary artery disease	31	-1.58
DB00313	Valproic.Acid	inflammatory bowel diseases	119	-1.44
DB00313	Valproic.Acid	gastroenteritis	122	-1.35
DB00313	Valproic.Acid	gastrointestinal neoplasms	72	-1.32
DB00313	Valproic.Acid	heart diseases	167	-1.15
DB00313	Valproic.Acid	lymphoma non hodgkin	22	-1.04
DB00313	Valproic.Acid	lymphoma	24	-1.02
DB00313	Valproic.Acid	vascular diseases	181	-0.66
DB00313	Valproic.Acid	leukemia myeloid acute	43	-0.61
DB00313	Valproic.Acid	spinal cord diseases	59	-0.57
DB00313	Valproic.Acid	neoplasms	482	-0.54
DB00313	Valproic.Acid	leukemia lymphoid	66	-0.36
DB00313	Valproic.Acid	skin diseases	278	-0.23
DB00313	Valproic.Acid	bone diseases metabolic	27	-0.22
DB00313	Valproic.Acid	keratosis	21	-0.17
DB00313	Valproic.Acid	cardiovascular diseases	330	-0.03
DB00313	Valproic.Acid	diabetes mellitus	162	-0.02
DB00313	Valproic.Acid	pancreatic diseases	24	0.03
DB00313	Valproic.Acid	malabsorption syndromes	34	0.04
DB00313	Valproic.Acid	bone diseases	144	0.06
DB00313	Valproic.Acid	hypopigmentation	22	0.09
DB00313	Valproic.Acid	amyotrophic lateral sclerosis	21	0.15
DB00313	Valproic.Acid	asthma	36	0.18
DB00313	Valproic.Acid	neuroendocrine tumors	24	0.18
DB00313	Valproic.Acid	cardiomyopathy dilated	29	0.20
DB00313	Valproic.Acid	leukemia	117	0.22
DB00313	Valproic.Acid	hypersensitivity	45	0.31
DB00313	Valproic.Acid	sarcoma	25	0.32
DB00313	Valproic.Acid	arthritis rheumatoid	42	0.39
DB00313	Valproic.Acid	motor neuron disease	31	0.40
DB00313	Valproic.Acid	adenocarcinoma	32	0.41
DB00313	Valproic.Acid	prostatic neoplasms	61	0.53
DB00313	Valproic.Acid	psoriasis	54	0.55
DB00313	Valproic.Acid	diabetes mellitus type 2	72	0.55
DB00313	Valproic.Acid	breast neoplasms	40	0.58
DB00313	Valproic.Acid	autoimmune diseases	243	0.61
DB00313	Valproic.Acid	hematologic diseases	188	0.63
DB00313	Valproic.Acid	multiple sclerosis	69	0.65
DB00313	Valproic.Acid	lupus erythematosus systemic	75	0.65
DB00313	Valproic.Acid	rheumatic diseases	59	0.68
DB00313	Valproic.Acid	crohn disease	71	0.70
DB00313	Valproic.Acid	intestinal neoplasms	42	0.72
DB00313	Valproic.Acid	varicose veins	20	0.72
DB00313	Valproic.Acid	colorectal neoplasms	42	0.74
DB00313	Valproic.Acid	joint diseases	79	0.77
DB00313	Valproic.Acid	endocrine system diseases	291	0.77
DB00313	Valproic.Acid	arthritis	76	0.79
DB00313	Valproic.Acid	lung diseases	71	0.83
DB00313	Valproic.Acid	anemia	58	0.87
DB00313	Valproic.Acid	insulin resistance	26	0.94
DB00313	Valproic.Acid	hyperinsulinism	26	0.97
DB00313	Valproic.Acid	mycobacterium infections	22	1.20
DB00313	Valproic.Acid	macular degeneration	44	1.29
DB00313	Valproic.Acid	eye diseases	231	1.39
DB00313	Valproic.Acid	anemia hemolytic	29	1.40
DB00313	Valproic.Acid	liver cirrhosis biliary	23	1.47
DB00313	Valproic.Acid	thyroid diseases	30	1.47
DB00313	Valproic.Acid	parkinson disease	30	1.50
DB00313	Valproic.Acid	kidney neoplasms	20	1.51
DB00313	Valproic.Acid	bacterial infections	26	1.52
DB00313	Valproic.Acid	liver cirrhosis	24	1.53
DB00313	Valproic.Acid	parkinsonian disorders	31	1.54
DB00313	Valproic.Acid	alzheimer disease	29	1.67
DB00313	Valproic.Acid	dementia	42	1.81
DB00313	Valproic.Acid	blood coagulation disorders	40	1.87
DB00313	Valproic.Acid	diabetes mellitus type 1	82	2.05
DB00313	Valproic.Acid	epilepsy	25	2.08
DB00313	Valproic.Acid	arrhythmias cardiac	30	2.21
DB00313	Valproic.Acid	collagen diseases	25	2.34
DB01427	Amrinone	psoriasis	54	-2.16
DB01427	Amrinone	multiple sclerosis	69	-2.00
DB01427	Amrinone	eye diseases	231	-1.80
DB01427	Amrinone	joint diseases	79	-1.61
DB01427	Amrinone	arthritis	76	-1.60
DB01427	Amrinone	autoimmune diseases	243	-1.57
DB01427	Amrinone	liver cirrhosis	24	-1.51
DB01427	Amrinone	keratosis	21	-1.51
DB01427	Amrinone	liver cirrhosis biliary	23	-1.42
DB01427	Amrinone	malabsorption syndromes	34	-1.14
DB01427	Amrinone	colitis ulcerative	55	-1.01
DB01427	Amrinone	colitis	55	-0.95
DB01427	Amrinone	adenocarcinoma	32	-0.90
DB01427	Amrinone	arthritis rheumatoid	42	-0.89
DB01427	Amrinone	bone diseases	144	-0.85
DB01427	Amrinone	lupus erythematosus systemic	75	-0.75
DB01427	Amrinone	rheumatic diseases	59	-0.71
DB01427	Amrinone	varicose veins	20	-0.50
DB01427	Amrinone	anemia	58	-0.44
DB01427	Amrinone	epilepsy	25	-0.43
DB01427	Amrinone	arrhythmias cardiac	30	-0.34
DB01427	Amrinone	hyperinsulinism	26	-0.30
DB01427	Amrinone	insulin resistance	26	-0.27
DB01427	Amrinone	collagen diseases	25	-0.23
DB01427	Amrinone	bone diseases metabolic	27	-0.23
DB01427	Amrinone	inflammatory bowel diseases	119	-0.22
DB01427	Amrinone	macular degeneration	44	-0.20
DB01427	Amrinone	gastroenteritis	122	-0.19
DB01427	Amrinone	coronary artery disease	31	-0.17
DB01427	Amrinone	endocrine system diseases	291	-0.17
DB01427	Amrinone	skin diseases	278	-0.12
DB01427	Amrinone	cardiovascular diseases	330	-0.10
DB01427	Amrinone	bacterial infections	26	0.01
DB01427	Amrinone	anemia hemolytic	29	0.02
DB01427	Amrinone	kidney neoplasms	20	0.04
DB01427	Amrinone	coronary disease	37	0.04
DB01427	Amrinone	hypopigmentation	22	0.05
DB01427	Amrinone	pancreatic diseases	24	0.05
DB01427	Amrinone	myocardial ischemia	43	0.07
DB01427	Amrinone	thyroid diseases	30	0.08
DB01427	Amrinone	arteriosclerosis	38	0.11
DB01427	Amrinone	amyotrophic lateral sclerosis	21	0.12
DB01427	Amrinone	parkinson disease	30	0.12
DB01427	Amrinone	parkinsonian disorders	31	0.12
DB01427	Amrinone	asthma	36	0.20
DB01427	Amrinone	heart diseases	167	0.20
DB01427	Amrinone	alzheimer disease	29	0.22
DB01427	Amrinone	neuroendocrine tumors	24	0.24
DB01427	Amrinone	cardiomyopathy dilated	29	0.26
DB01427	Amrinone	blood coagulation disorders	40	0.26
DB01427	Amrinone	lymphoma non hodgkin	22	0.29
DB01427	Amrinone	hypersensitivity	45	0.31
DB01427	Amrinone	lymphoma	24	0.34
DB01427	Amrinone	sarcoma	25	0.36
DB01427	Amrinone	arterial occlusive diseases	44	0.36
DB01427	Amrinone	motor neuron disease	31	0.41
DB01427	Amrinone	metabolism inborn errors	289	0.43
DB01427	Amrinone	dementia	42	0.49
DB01427	Amrinone	head and neck neoplasms	35	0.55
DB01427	Amrinone	prostatic neoplasms	61	0.56
DB01427	Amrinone	breast neoplasms	40	0.59
DB01427	Amrinone	diabetes mellitus type 2	72	0.62
DB01427	Amrinone	leukemia myeloid acute	43	0.71
DB01427	Amrinone	spinal cord diseases	59	0.71
DB01427	Amrinone	hematologic diseases	188	0.72
DB01427	Amrinone	colorectal neoplasms	42	0.74
DB01427	Amrinone	diabetes mellitus type 1	82	0.75
DB01427	Amrinone	intestinal neoplasms	42	0.75
DB01427	Amrinone	crohn disease	71	0.79
DB01427	Amrinone	lung diseases	71	0.81
DB01427	Amrinone	neoplasms	482	0.90
DB01427	Amrinone	leukemia lymphoid	66	0.92
DB01427	Amrinone	kidney diseases	144	1.07
DB01427	Amrinone	gastrointestinal neoplasms	72	1.10
DB01427	Amrinone	diabetes mellitus	162	1.13
DB01427	Amrinone	mycobacterium infections	22	1.33
DB01427	Amrinone	leukemia	117	1.44
DB01427	Amrinone	vascular diseases	181	1.57
DB05271	Rotigotine	epilepsy	25	-2.97
DB05271	Rotigotine	heart diseases	167	-2.62
DB05271	Rotigotine	bone diseases	144	-1.99
DB05271	Rotigotine	varicose veins	20	-1.61
DB05271	Rotigotine	thyroid diseases	30	-1.50
DB05271	Rotigotine	cardiovascular diseases	330	-1.47
DB05271	Rotigotine	insulin resistance	26	-1.39
DB05271	Rotigotine	arrhythmias cardiac	30	-1.28
DB05271	Rotigotine	hyperinsulinism	26	-1.28
DB05271	Rotigotine	anemia hemolytic	29	-0.89
DB05271	Rotigotine	colitis ulcerative	55	-0.86
DB05271	Rotigotine	colitis	55	-0.82
DB05271	Rotigotine	inflammatory bowel diseases	119	-0.72
DB05271	Rotigotine	gastroenteritis	122	-0.63
DB05271	Rotigotine	collagen diseases	25	-0.56
DB05271	Rotigotine	hematologic diseases	188	-0.45
DB05271	Rotigotine	spinal cord diseases	59	-0.37
DB05271	Rotigotine	intestinal neoplasms	42	-0.37
DB05271	Rotigotine	endocrine system diseases	291	-0.30
DB05271	Rotigotine	colorectal neoplasms	42	-0.29
DB05271	Rotigotine	kidney neoplasms	20	-0.10
DB05271	Rotigotine	anemia	58	-0.08
DB05271	Rotigotine	vascular diseases	181	-0.02
DB05271	Rotigotine	amyotrophic lateral sclerosis	21	0.04
DB05271	Rotigotine	eye diseases	231	0.04
DB05271	Rotigotine	malabsorption syndromes	34	0.05
DB05271	Rotigotine	pancreatic diseases	24	0.06
DB05271	Rotigotine	myocardial ischemia	43	0.07
DB05271	Rotigotine	breast neoplasms	40	0.16
DB05271	Rotigotine	alzheimer disease	29	0.18
DB05271	Rotigotine	neuroendocrine tumors	24	0.20
DB05271	Rotigotine	gastrointestinal neoplasms	72	0.20
DB05271	Rotigotine	psoriasis	54	0.21
DB05271	Rotigotine	cardiomyopathy dilated	29	0.25
DB05271	Rotigotine	diabetes mellitus type 2	72	0.26
DB05271	Rotigotine	mycobacterium infections	22	0.36
DB05271	Rotigotine	crohn disease	71	0.42
DB05271	Rotigotine	lymphoma non hodgkin	22	0.44
DB05271	Rotigotine	lupus erythematosus systemic	75	0.45
DB05271	Rotigotine	multiple sclerosis	69	0.45
DB05271	Rotigotine	blood coagulation disorders	40	0.45
DB05271	Rotigotine	diabetes mellitus type 1	82	0.45
DB05271	Rotigotine	leukemia myeloid acute	43	0.45
DB05271	Rotigotine	lymphoma	24	0.46
DB05271	Rotigotine	motor neuron disease	31	0.61
DB05271	Rotigotine	bacterial infections	26	0.65
DB05271	Rotigotine	hypopigmentation	22	0.66
DB05271	Rotigotine	lung diseases	71	0.67
DB05271	Rotigotine	leukemia lymphoid	66	0.67
DB05271	Rotigotine	adenocarcinoma	32	0.69
DB05271	Rotigotine	arthritis rheumatoid	42	0.71
DB05271	Rotigotine	liver cirrhosis biliary	23	0.72
DB05271	Rotigotine	parkinson disease	30	0.73
DB05271	Rotigotine	parkinsonian disorders	31	0.78
DB05271	Rotigotine	head and neck neoplasms	35	0.79
DB05271	Rotigotine	liver cirrhosis	24	0.79
DB05271	Rotigotine	dementia	42	0.80
DB05271	Rotigotine	asthma	36	0.93
DB05271	Rotigotine	arteriosclerosis	38	0.96
DB05271	Rotigotine	prostatic neoplasms	61	0.97
DB05271	Rotigotine	autoimmune diseases	243	1.01
DB05271	Rotigotine	sarcoma	25	1.13
DB05271	Rotigotine	coronary artery disease	31	1.13
DB05271	Rotigotine	rheumatic diseases	59	1.14
DB05271	Rotigotine	keratosis	21	1.17
DB05271	Rotigotine	diabetes mellitus	162	1.19
DB05271	Rotigotine	arterial occlusive diseases	44	1.20
DB05271	Rotigotine	hypersensitivity	45	1.27
DB05271	Rotigotine	coronary disease	37	1.38
DB05271	Rotigotine	joint diseases	79	1.43
DB05271	Rotigotine	arthritis	76	1.48
DB05271	Rotigotine	leukemia	117	1.50
DB05271	Rotigotine	metabolism inborn errors	289	1.60
DB05271	Rotigotine	kidney diseases	144	1.79
DB05271	Rotigotine	macular degeneration	44	1.86
DB05271	Rotigotine	skin diseases	278	1.97
DB05271	Rotigotine	neoplasms	482	2.17
DB05271	Rotigotine	bone diseases metabolic	27	2.31
DB00146	Calcidiol	bone diseases metabolic	27	-4.04
DB00146	Calcidiol	kidney diseases	144	-2.68
DB00146	Calcidiol	bone diseases	144	-2.67
DB00146	Calcidiol	metabolism inborn errors	289	-2.67
DB00146	Calcidiol	coronary artery disease	31	-2.32
DB00146	Calcidiol	mycobacterium infections	22	-2.31
DB00146	Calcidiol	coronary disease	37	-2.16
DB00146	Calcidiol	myocardial ischemia	43	-2.11
DB00146	Calcidiol	arteriosclerosis	38	-2.08
DB00146	Calcidiol	bacterial infections	26	-2.04
DB00146	Calcidiol	asthma	36	-1.98
DB00146	Calcidiol	arterial occlusive diseases	44	-1.78
DB00146	Calcidiol	hypersensitivity	45	-1.74
DB00146	Calcidiol	neuroendocrine tumors	24	-1.69
DB00146	Calcidiol	sarcoma	25	-1.56
DB00146	Calcidiol	adenocarcinoma	32	-1.38
DB00146	Calcidiol	colitis	55	-1.30
DB00146	Calcidiol	colitis ulcerative	55	-1.25
DB00146	Calcidiol	diabetes mellitus type 1	82	-1.23
DB00146	Calcidiol	head and neck neoplasms	35	-1.21
DB00146	Calcidiol	intestinal neoplasms	42	-1.09
DB00146	Calcidiol	colorectal neoplasms	42	-1.08
DB00146	Calcidiol	lung diseases	71	-1.01
DB00146	Calcidiol	crohn disease	71	-0.98
DB00146	Calcidiol	leukemia myeloid acute	43	-0.93
DB00146	Calcidiol	gastrointestinal neoplasms	72	-0.83
DB00146	Calcidiol	leukemia lymphoid	66	-0.81
DB00146	Calcidiol	heart diseases	167	-0.74
DB00146	Calcidiol	gastroenteritis	122	-0.71
DB00146	Calcidiol	inflammatory bowel diseases	119	-0.67
DB00146	Calcidiol	eye diseases	231	-0.66
DB00146	Calcidiol	diabetes mellitus	162	-0.64
DB00146	Calcidiol	vascular diseases	181	-0.54
DB00146	Calcidiol	leukemia	117	-0.36
DB00146	Calcidiol	cardiovascular diseases	330	-0.31
DB00146	Calcidiol	autoimmune diseases	243	-0.30
DB00146	Calcidiol	hematologic diseases	188	-0.30
DB00146	Calcidiol	skin diseases	278	-0.17
DB00146	Calcidiol	endocrine system diseases	291	-0.13
DB00146	Calcidiol	varicose veins	20	0.05
DB00146	Calcidiol	arrhythmias cardiac	30	0.08
DB00146	Calcidiol	insulin resistance	26	0.09
DB00146	Calcidiol	hyperinsulinism	26	0.09
DB00146	Calcidiol	epilepsy	25	0.09
DB00146	Calcidiol	macular degeneration	44	0.11
DB00146	Calcidiol	collagen diseases	25	0.13
DB00146	Calcidiol	neoplasms	482	0.20
DB00146	Calcidiol	anemia hemolytic	29	0.22
DB00146	Calcidiol	keratosis	21	0.28
DB00146	Calcidiol	malabsorption syndromes	34	0.35
DB00146	Calcidiol	parkinson disease	30	0.35
DB00146	Calcidiol	hypopigmentation	22	0.37
DB00146	Calcidiol	parkinsonian disorders	31	0.37
DB00146	Calcidiol	alzheimer disease	29	0.43
DB00146	Calcidiol	blood coagulation disorders	40	0.43
DB00146	Calcidiol	cardiomyopathy dilated	29	0.44
DB00146	Calcidiol	kidney neoplasms	20	0.45
DB00146	Calcidiol	thyroid diseases	30	0.47
DB00146	Calcidiol	liver cirrhosis biliary	23	0.49
DB00146	Calcidiol	pancreatic diseases	24	0.50
DB00146	Calcidiol	amyotrophic lateral sclerosis	21	0.50
DB00146	Calcidiol	liver cirrhosis	24	0.53
DB00146	Calcidiol	lymphoma	24	0.63
DB00146	Calcidiol	arthritis rheumatoid	42	0.64
DB00146	Calcidiol	lymphoma non hodgkin	22	0.67
DB00146	Calcidiol	motor neuron disease	31	0.69
DB00146	Calcidiol	prostatic neoplasms	61	0.70
DB00146	Calcidiol	dementia	42	0.74
DB00146	Calcidiol	psoriasis	54	0.78
DB00146	Calcidiol	lupus erythematosus systemic	75	0.79
DB00146	Calcidiol	rheumatic diseases	59	0.81
DB00146	Calcidiol	diabetes mellitus type 2	72	0.81
DB00146	Calcidiol	multiple sclerosis	69	0.82
DB00146	Calcidiol	breast neoplasms	40	0.89
DB00146	Calcidiol	spinal cord diseases	59	0.94
DB00146	Calcidiol	joint diseases	79	0.96
DB00146	Calcidiol	arthritis	76	0.99
DB00146	Calcidiol	anemia	58	1.11
DB00390	Digoxin	liver cirrhosis	24	-2.82
DB00390	Digoxin	liver cirrhosis biliary	23	-2.66
DB00390	Digoxin	keratosis	21	-2.45
DB00390	Digoxin	lymphoma non hodgkin	22	-2.36
DB00390	Digoxin	lymphoma	24	-2.08
DB00390	Digoxin	adenocarcinoma	32	-2.00
DB00390	Digoxin	prostatic neoplasms	61	-1.87
DB00390	Digoxin	lupus erythematosus systemic	75	-1.83
DB00390	Digoxin	colorectal neoplasms	42	-1.67
DB00390	Digoxin	multiple sclerosis	69	-1.64
DB00390	Digoxin	intestinal neoplasms	42	-1.58
DB00390	Digoxin	lung diseases	71	-1.30
DB00390	Digoxin	leukemia lymphoid	66	-1.20
DB00390	Digoxin	gastrointestinal neoplasms	72	-0.97
DB00390	Digoxin	leukemia	117	-0.81
DB00390	Digoxin	eye diseases	231	-0.76
DB00390	Digoxin	metabolism inborn errors	289	-0.72
DB00390	Digoxin	autoimmune diseases	243	-0.65
DB00390	Digoxin	endocrine system diseases	291	-0.51
DB00390	Digoxin	skin diseases	278	-0.44
DB00390	Digoxin	varicose veins	20	-0.06
DB00390	Digoxin	neoplasms	482	0.01
DB00390	Digoxin	hyperinsulinism	26	0.03
DB00390	Digoxin	epilepsy	25	0.04
DB00390	Digoxin	collagen diseases	25	0.06
DB00390	Digoxin	arrhythmias cardiac	30	0.12
DB00390	Digoxin	insulin resistance	26	0.12
DB00390	Digoxin	bone diseases metabolic	27	0.14
DB00390	Digoxin	mycobacterium infections	22	0.16
DB00390	Digoxin	macular degeneration	44	0.19
DB00390	Digoxin	coronary artery disease	31	0.19
DB00390	Digoxin	bacterial infections	26	0.24
DB00390	Digoxin	coronary disease	37	0.26
DB00390	Digoxin	hypopigmentation	22	0.28
DB00390	Digoxin	anemia hemolytic	29	0.29
DB00390	Digoxin	kidney neoplasms	20	0.31
DB00390	Digoxin	parkinson disease	30	0.31
DB00390	Digoxin	neuroendocrine tumors	24	0.32
DB00390	Digoxin	arteriosclerosis	38	0.33
DB00390	Digoxin	thyroid diseases	30	0.33
DB00390	Digoxin	myocardial ischemia	43	0.34
DB00390	Digoxin	pancreatic diseases	24	0.34
DB00390	Digoxin	asthma	36	0.34
DB00390	Digoxin	malabsorption syndromes	34	0.34
DB00390	Digoxin	amyotrophic lateral sclerosis	21	0.35
DB00390	Digoxin	parkinsonian disorders	31	0.37
DB00390	Digoxin	alzheimer disease	29	0.39
DB00390	Digoxin	hypersensitivity	45	0.39
DB00390	Digoxin	cardiomyopathy dilated	29	0.39
DB00390	Digoxin	sarcoma	25	0.42
DB00390	Digoxin	arterial occlusive diseases	44	0.42
DB00390	Digoxin	blood coagulation disorders	40	0.43
DB00390	Digoxin	arthritis rheumatoid	42	0.44
DB00390	Digoxin	motor neuron disease	31	0.45
DB00390	Digoxin	colitis ulcerative	55	0.46
DB00390	Digoxin	rheumatic diseases	59	0.52
DB00390	Digoxin	dementia	42	0.53
DB00390	Digoxin	colitis	55	0.54
DB00390	Digoxin	head and neck neoplasms	35	0.54
DB00390	Digoxin	breast neoplasms	40	0.54
DB00390	Digoxin	psoriasis	54	0.54
DB00390	Digoxin	diabetes mellitus type 2	72	0.57
DB00390	Digoxin	diabetes mellitus type 1	82	0.58
DB00390	Digoxin	crohn disease	71	0.64
DB00390	Digoxin	joint diseases	79	0.64
DB00390	Digoxin	arthritis	76	0.64
DB00390	Digoxin	leukemia myeloid acute	43	0.67
DB00390	Digoxin	spinal cord diseases	59	0.69
DB00390	Digoxin	anemia	58	0.69
DB00390	Digoxin	gastroenteritis	122	0.78
DB00390	Digoxin	kidney diseases	144	0.81
DB00390	Digoxin	inflammatory bowel diseases	119	0.85
DB00390	Digoxin	bone diseases	144	0.91
DB00390	Digoxin	diabetes mellitus	162	0.92
DB00390	Digoxin	heart diseases	167	0.95
DB00390	Digoxin	vascular diseases	181	1.16
DB00390	Digoxin	hematologic diseases	188	1.45
DB00390	Digoxin	cardiovascular diseases	330	1.62
DB00806	Pentoxifylline	eye diseases	231	-1.58
DB00806	Pentoxifylline	thyroid diseases	30	-1.56
DB00806	Pentoxifylline	anemia hemolytic	29	-1.38
DB00806	Pentoxifylline	arrhythmias cardiac	30	-1.07
DB00806	Pentoxifylline	bone diseases metabolic	27	-0.93
DB00806	Pentoxifylline	pancreatic diseases	24	-0.42
DB00806	Pentoxifylline	leukemia myeloid acute	43	-0.34
DB00806	Pentoxifylline	malabsorption syndromes	34	-0.34
DB00806	Pentoxifylline	multiple sclerosis	69	-0.34
DB00806	Pentoxifylline	colorectal neoplasms	42	-0.33
DB00806	Pentoxifylline	intestinal neoplasms	42	-0.32
DB00806	Pentoxifylline	arteriosclerosis	38	-0.27
DB00806	Pentoxifylline	spinal cord diseases	59	-0.25
DB00806	Pentoxifylline	heart diseases	167	-0.24
DB00806	Pentoxifylline	endocrine system diseases	291	-0.21
DB00806	Pentoxifylline	cardiomyopathy dilated	29	-0.20
DB00806	Pentoxifylline	sarcoma	25	-0.17
DB00806	Pentoxifylline	insulin resistance	26	-0.14
DB00806	Pentoxifylline	lymphoma	24	-0.11
DB00806	Pentoxifylline	anemia	58	-0.11
DB00806	Pentoxifylline	leukemia lymphoid	66	-0.10
DB00806	Pentoxifylline	arterial occlusive diseases	44	-0.10
DB00806	Pentoxifylline	hyperinsulinism	26	-0.09
DB00806	Pentoxifylline	lymphoma non hodgkin	22	-0.08
DB00806	Pentoxifylline	cardiovascular diseases	330	0.04
DB00806	Pentoxifylline	motor neuron disease	31	0.06
DB00806	Pentoxifylline	metabolism inborn errors	289	0.14
DB00806	Pentoxifylline	kidney diseases	144	0.17
DB00806	Pentoxifylline	colitis ulcerative	55	0.23
DB00806	Pentoxifylline	colitis	55	0.25
DB00806	Pentoxifylline	gastrointestinal neoplasms	72	0.29
DB00806	Pentoxifylline	diabetes mellitus type 2	72	0.34
DB00806	Pentoxifylline	psoriasis	54	0.38
DB00806	Pentoxifylline	kidney neoplasms	20	0.41
DB00806	Pentoxifylline	varicose veins	20	0.43
DB00806	Pentoxifylline	hypopigmentation	22	0.47
DB00806	Pentoxifylline	coronary disease	37	0.47
DB00806	Pentoxifylline	lupus erythematosus systemic	75	0.48
DB00806	Pentoxifylline	liver cirrhosis	24	0.50
DB00806	Pentoxifylline	bone diseases	144	0.52
DB00806	Pentoxifylline	epilepsy	25	0.52
DB00806	Pentoxifylline	liver cirrhosis biliary	23	0.53
DB00806	Pentoxifylline	diabetes mellitus type 1	82	0.54
DB00806	Pentoxifylline	myocardial ischemia	43	0.55
DB00806	Pentoxifylline	crohn disease	71	0.56
DB00806	Pentoxifylline	parkinson disease	30	0.57
DB00806	Pentoxifylline	amyotrophic lateral sclerosis	21	0.58
DB00806	Pentoxifylline	parkinsonian disorders	31	0.59
DB00806	Pentoxifylline	neuroendocrine tumors	24	0.67
DB00806	Pentoxifylline	asthma	36	0.68
DB00806	Pentoxifylline	vascular diseases	181	0.73
DB00806	Pentoxifylline	alzheimer disease	29	0.73
DB00806	Pentoxifylline	leukemia	117	0.73
DB00806	Pentoxifylline	joint diseases	79	0.73
DB00806	Pentoxifylline	lung diseases	71	0.75
DB00806	Pentoxifylline	arthritis	76	0.76
DB00806	Pentoxifylline	collagen diseases	25	0.87
DB00806	Pentoxifylline	blood coagulation disorders	40	0.89
DB00806	Pentoxifylline	hypersensitivity	45	0.94
DB00806	Pentoxifylline	gastroenteritis	122	0.97
DB00806	Pentoxifylline	inflammatory bowel diseases	119	1.03
DB00806	Pentoxifylline	adenocarcinoma	32	1.06
DB00806	Pentoxifylline	coronary artery disease	31	1.06
DB00806	Pentoxifylline	neoplasms	482	1.10
DB00806	Pentoxifylline	hematologic diseases	188	1.11
DB00806	Pentoxifylline	keratosis	21	1.14
DB00806	Pentoxifylline	autoimmune diseases	243	1.14
DB00806	Pentoxifylline	diabetes mellitus	162	1.16
DB00806	Pentoxifylline	head and neck neoplasms	35	1.16
DB00806	Pentoxifylline	dementia	42	1.22
DB00806	Pentoxifylline	bacterial infections	26	1.28
DB00806	Pentoxifylline	breast neoplasms	40	1.29
DB00806	Pentoxifylline	prostatic neoplasms	61	1.36
DB00806	Pentoxifylline	macular degeneration	44	1.99
DB00806	Pentoxifylline	arthritis rheumatoid	42	2.05
DB00806	Pentoxifylline	skin diseases	278	2.11
DB00806	Pentoxifylline	rheumatic diseases	59	2.40
DB00806	Pentoxifylline	mycobacterium infections	22	2.83
DB00661	Verapamil	arrhythmias cardiac	30	-8.36
DB00661	Verapamil	heart diseases	167	-6.21
DB00661	Verapamil	cardiovascular diseases	330	-4.95
DB00661	Verapamil	epilepsy	25	-3.95
DB00661	Verapamil	cardiomyopathy dilated	29	-3.66
DB00661	Verapamil	thyroid diseases	30	-3.25
DB00661	Verapamil	spinal cord diseases	59	-3.21
DB00661	Verapamil	eye diseases	231	-2.49
DB00661	Verapamil	alzheimer disease	29	-2.25
DB00661	Verapamil	metabolism inborn errors	289	-2.22
DB00661	Verapamil	pancreatic diseases	24	-1.97
DB00661	Verapamil	kidney diseases	144	-1.94
DB00661	Verapamil	lymphoma	24	-1.88
DB00661	Verapamil	lymphoma non hodgkin	22	-1.80
DB00661	Verapamil	insulin resistance	26	-1.63
DB00661	Verapamil	hyperinsulinism	26	-1.54
DB00661	Verapamil	dementia	42	-1.42
DB00661	Verapamil	crohn disease	71	-1.37
DB00661	Verapamil	diabetes mellitus type 2	72	-1.24
DB00661	Verapamil	bacterial infections	26	-1.16
DB00661	Verapamil	varicose veins	20	-1.13
DB00661	Verapamil	autoimmune diseases	243	-1.11
DB00661	Verapamil	gastroenteritis	122	-1.07
DB00661	Verapamil	liver cirrhosis	24	-1.07
DB00661	Verapamil	inflammatory bowel diseases	119	-1.06
DB00661	Verapamil	liver cirrhosis biliary	23	-1.05
DB00661	Verapamil	leukemia	117	-0.91
DB00661	Verapamil	endocrine system diseases	291	-0.84
DB00661	Verapamil	prostatic neoplasms	61	-0.82
DB00661	Verapamil	breast neoplasms	40	-0.77
DB00661	Verapamil	parkinson disease	30	-0.75
DB00661	Verapamil	parkinsonian disorders	31	-0.71
DB00661	Verapamil	bone diseases	144	-0.64
DB00661	Verapamil	bone diseases metabolic	27	-0.61
DB00661	Verapamil	colitis	55	-0.57
DB00661	Verapamil	colitis ulcerative	55	-0.53
DB00661	Verapamil	leukemia lymphoid	66	-0.52
DB00661	Verapamil	leukemia myeloid acute	43	-0.46
DB00661	Verapamil	lupus erythematosus systemic	75	-0.46
DB00661	Verapamil	anemia hemolytic	29	-0.39
DB00661	Verapamil	multiple sclerosis	69	-0.36
DB00661	Verapamil	motor neuron disease	31	-0.35
DB00661	Verapamil	psoriasis	54	-0.34
DB00661	Verapamil	diabetes mellitus type 1	82	-0.34
DB00661	Verapamil	diabetes mellitus	162	-0.33
DB00661	Verapamil	coronary disease	37	-0.28
DB00661	Verapamil	vascular diseases	181	-0.23
DB00661	Verapamil	arthritis rheumatoid	42	-0.20
DB00661	Verapamil	arthritis	76	-0.16
DB00661	Verapamil	myocardial ischemia	43	-0.11
DB00661	Verapamil	joint diseases	79	-0.10
DB00661	Verapamil	arterial occlusive diseases	44	-0.09
DB00661	Verapamil	arteriosclerosis	38	0.02
DB00661	Verapamil	mycobacterium infections	22	0.12
DB00661	Verapamil	neoplasms	482	0.15
DB00661	Verapamil	sarcoma	25	0.16
DB00661	Verapamil	keratosis	21	0.19
DB00661	Verapamil	amyotrophic lateral sclerosis	21	0.24
DB00661	Verapamil	coronary artery disease	31	0.24
DB00661	Verapamil	hematologic diseases	188	0.26
DB00661	Verapamil	macular degeneration	44	0.31
DB00661	Verapamil	rheumatic diseases	59	0.38
DB00661	Verapamil	lung diseases	71	0.42
DB00661	Verapamil	blood coagulation disorders	40	0.43
DB00661	Verapamil	colorectal neoplasms	42	0.53
DB00661	Verapamil	hypopigmentation	22	0.54
DB00661	Verapamil	intestinal neoplasms	42	0.58
DB00661	Verapamil	collagen diseases	25	0.74
DB00661	Verapamil	malabsorption syndromes	34	0.75
DB00661	Verapamil	head and neck neoplasms	35	0.85
DB00661	Verapamil	neuroendocrine tumors	24	0.88
DB00661	Verapamil	kidney neoplasms	20	0.92
DB00661	Verapamil	asthma	36	0.95
DB00661	Verapamil	anemia	58	0.95
DB00661	Verapamil	gastrointestinal neoplasms	72	0.96
DB00661	Verapamil	skin diseases	278	1.06
DB00661	Verapamil	adenocarcinoma	32	1.26
DB00661	Verapamil	hypersensitivity	45	1.49
DB00331	Metformin	arrhythmias cardiac	30	-2.63
DB00331	Metformin	varicose veins	20	-2.47
DB00331	Metformin	parkinson disease	30	-2.19
DB00331	Metformin	parkinsonian disorders	31	-2.04
DB00331	Metformin	insulin resistance	26	-1.80
DB00331	Metformin	hyperinsulinism	26	-1.78
DB00331	Metformin	blood coagulation disorders	40	-1.64
DB00331	Metformin	kidney neoplasms	20	-1.35
DB00331	Metformin	thyroid diseases	30	-1.35
DB00331	Metformin	diabetes mellitus type 2	72	-1.18
DB00331	Metformin	sarcoma	25	-0.90
DB00331	Metformin	psoriasis	54	-0.87
DB00331	Metformin	arthritis rheumatoid	42	-0.82
DB00331	Metformin	liver cirrhosis biliary	23	-0.78
DB00331	Metformin	adenocarcinoma	32	-0.77
DB00331	Metformin	liver cirrhosis	24	-0.76
DB00331	Metformin	lupus erythematosus systemic	75	-0.70
DB00331	Metformin	rheumatic diseases	59	-0.56
DB00331	Metformin	crohn disease	71	-0.55
DB00331	Metformin	leukemia myeloid acute	43	-0.54
DB00331	Metformin	kidney diseases	144	-0.49
DB00331	Metformin	diabetes mellitus	162	-0.47
DB00331	Metformin	colorectal neoplasms	42	-0.47
DB00331	Metformin	arthritis	76	-0.47
DB00331	Metformin	joint diseases	79	-0.46
DB00331	Metformin	intestinal neoplasms	42	-0.43
DB00331	Metformin	inflammatory bowel diseases	119	-0.42
DB00331	Metformin	gastroenteritis	122	-0.40
DB00331	Metformin	heart diseases	167	-0.38
DB00331	Metformin	anemia	58	-0.30
DB00331	Metformin	metabolism inborn errors	289	-0.30
DB00331	Metformin	gastrointestinal neoplasms	72	-0.24
DB00331	Metformin	leukemia	117	-0.11
DB00331	Metformin	vascular diseases	181	0.00
DB00331	Metformin	skin diseases	278	0.02
DB00331	Metformin	eye diseases	231	0.04
DB00331	Metformin	autoimmune diseases	243	0.09
DB00331	Metformin	hematologic diseases	188	0.12
DB00331	Metformin	cardiovascular diseases	330	0.14
DB00331	Metformin	endocrine system diseases	291	0.16
DB00331	Metformin	neoplasms	482	0.20
DB00331	Metformin	collagen diseases	25	0.36
DB00331	Metformin	epilepsy	25	0.37
DB00331	Metformin	bone diseases metabolic	27	0.38
DB00331	Metformin	macular degeneration	44	0.40
DB00331	Metformin	coronary artery disease	31	0.56
DB00331	Metformin	cardiomyopathy dilated	29	0.61
DB00331	Metformin	keratosis	21	0.64
DB00331	Metformin	coronary disease	37	0.68
DB00331	Metformin	myocardial ischemia	43	0.70
DB00331	Metformin	anemia hemolytic	29	0.70
DB00331	Metformin	hypopigmentation	22	0.75
DB00331	Metformin	colitis ulcerative	55	0.75
DB00331	Metformin	amyotrophic lateral sclerosis	21	0.76
DB00331	Metformin	malabsorption syndromes	34	0.77
DB00331	Metformin	colitis	55	0.77
DB00331	Metformin	arteriosclerosis	38	0.77
DB00331	Metformin	alzheimer disease	29	0.82
DB00331	Metformin	arterial occlusive diseases	44	0.82
DB00331	Metformin	mycobacterium infections	22	0.83
DB00331	Metformin	neuroendocrine tumors	24	0.88
DB00331	Metformin	asthma	36	0.93
DB00331	Metformin	bacterial infections	26	0.93
DB00331	Metformin	hypersensitivity	45	0.96
DB00331	Metformin	dementia	42	1.01
DB00331	Metformin	prostatic neoplasms	61	1.12
DB00331	Metformin	head and neck neoplasms	35	1.13
DB00331	Metformin	pancreatic diseases	24	1.14
DB00331	Metformin	lymphoma	24	1.26
DB00331	Metformin	lymphoma non hodgkin	22	1.29
DB00331	Metformin	motor neuron disease	31	1.34
DB00331	Metformin	diabetes mellitus type 1	82	1.40
DB00331	Metformin	breast neoplasms	40	1.56
DB00331	Metformin	leukemia lymphoid	66	1.80
DB00331	Metformin	multiple sclerosis	69	2.12
DB00331	Metformin	spinal cord diseases	59	2.21
DB00331	Metformin	lung diseases	71	2.42
DB00331	Metformin	bone diseases	144	3.59
DB00396	Progesterone	metabolism inborn errors	289	-4.12
DB00396	Progesterone	sarcoma	25	-2.66
DB00396	Progesterone	breast neoplasms	40	-2.28
DB00396	Progesterone	cardiomyopathy dilated	29	-1.86
DB00396	Progesterone	endocrine system diseases	291	-1.58
DB00396	Progesterone	asthma	36	-1.54
DB00396	Progesterone	skin diseases	278	-1.47
DB00396	Progesterone	kidney diseases	144	-1.40
DB00396	Progesterone	cardiovascular diseases	330	-1.39
DB00396	Progesterone	hypersensitivity	45	-1.39
DB00396	Progesterone	heart diseases	167	-1.21
DB00396	Progesterone	prostatic neoplasms	61	-1.17
DB00396	Progesterone	bone diseases	144	-1.05
DB00396	Progesterone	coronary artery disease	31	-1.04
DB00396	Progesterone	diabetes mellitus type 1	82	-0.97
DB00396	Progesterone	multiple sclerosis	69	-0.91
DB00396	Progesterone	keratosis	21	-0.84
DB00396	Progesterone	coronary disease	37	-0.81
DB00396	Progesterone	thyroid diseases	30	-0.77
DB00396	Progesterone	myocardial ischemia	43	-0.73
DB00396	Progesterone	kidney neoplasms	20	-0.64
DB00396	Progesterone	arteriosclerosis	38	-0.64
DB00396	Progesterone	lung diseases	71	-0.55
DB00396	Progesterone	neoplasms	482	-0.54
DB00396	Progesterone	alzheimer disease	29	-0.52
DB00396	Progesterone	liver cirrhosis	24	-0.45
DB00396	Progesterone	pancreatic diseases	24	-0.45
DB00396	Progesterone	liver cirrhosis biliary	23	-0.42
DB00396	Progesterone	arterial occlusive diseases	44	-0.42
DB00396	Progesterone	varicose veins	20	-0.40
DB00396	Progesterone	diabetes mellitus	162	-0.35
DB00396	Progesterone	neuroendocrine tumors	24	-0.35
DB00396	Progesterone	epilepsy	25	-0.31
DB00396	Progesterone	arrhythmias cardiac	30	-0.26
DB00396	Progesterone	colitis ulcerative	55	-0.26
DB00396	Progesterone	colitis	55	-0.22
DB00396	Progesterone	lymphoma non hodgkin	22	-0.19
DB00396	Progesterone	bone diseases metabolic	27	-0.17
DB00396	Progesterone	lymphoma	24	-0.15
DB00396	Progesterone	diabetes mellitus type 2	72	-0.08
DB00396	Progesterone	motor neuron disease	31	-0.04
DB00396	Progesterone	dementia	42	-0.03
DB00396	Progesterone	adenocarcinoma	32	0.00
DB00396	Progesterone	head and neck neoplasms	35	0.11
DB00396	Progesterone	vascular diseases	181	0.14
DB00396	Progesterone	eye diseases	231	0.20
DB00396	Progesterone	parkinson disease	30	0.25
DB00396	Progesterone	parkinsonian disorders	31	0.26
DB00396	Progesterone	anemia hemolytic	29	0.27
DB00396	Progesterone	lupus erythematosus systemic	75	0.32
DB00396	Progesterone	mycobacterium infections	22	0.32
DB00396	Progesterone	crohn disease	71	0.45
DB00396	Progesterone	hypopigmentation	22	0.47
DB00396	Progesterone	intestinal neoplasms	42	0.48
DB00396	Progesterone	colorectal neoplasms	42	0.49
DB00396	Progesterone	spinal cord diseases	59	0.50
DB00396	Progesterone	malabsorption syndromes	34	0.51
DB00396	Progesterone	autoimmune diseases	243	0.51
DB00396	Progesterone	hematologic diseases	188	0.52
DB00396	Progesterone	leukemia myeloid acute	43	0.52
DB00396	Progesterone	bacterial infections	26	0.60
DB00396	Progesterone	anemia	58	0.64
DB00396	Progesterone	amyotrophic lateral sclerosis	21	0.65
DB00396	Progesterone	leukemia lymphoid	66	0.69
DB00396	Progesterone	inflammatory bowel diseases	119	0.79
DB00396	Progesterone	gastroenteritis	122	0.80
DB00396	Progesterone	gastrointestinal neoplasms	72	0.90
DB00396	Progesterone	collagen diseases	25	0.97
DB00396	Progesterone	hyperinsulinism	26	1.02
DB00396	Progesterone	insulin resistance	26	1.04
DB00396	Progesterone	macular degeneration	44	1.11
DB00396	Progesterone	arthritis rheumatoid	42	1.26
DB00396	Progesterone	leukemia	117	1.28
DB00396	Progesterone	psoriasis	54	1.34
DB00396	Progesterone	rheumatic diseases	59	1.50
DB00396	Progesterone	joint diseases	79	1.75
DB00396	Progesterone	arthritis	76	1.81
DB00396	Progesterone	blood coagulation disorders	40	1.87
DB00399	Zoledronate	spinal cord diseases	59	-1.78
DB00399	Zoledronate	bone diseases	144	-1.20
DB00399	Zoledronate	macular degeneration	44	-0.93
DB00399	Zoledronate	hematologic diseases	188	-0.85
DB00399	Zoledronate	endocrine system diseases	291	-0.81
DB00399	Zoledronate	lymphoma	24	-0.58
DB00399	Zoledronate	lymphoma non hodgkin	22	-0.57
DB00399	Zoledronate	motor neuron disease	31	-0.56
DB00399	Zoledronate	leukemia lymphoid	66	-0.01
DB00399	Zoledronate	varicose veins	20	0.06
DB00399	Zoledronate	epilepsy	25	0.12
DB00399	Zoledronate	leukemia	117	0.33
DB00399	Zoledronate	mycobacterium infections	22	0.36
DB00399	Zoledronate	coronary artery disease	31	0.37
DB00399	Zoledronate	eye diseases	231	0.38
DB00399	Zoledronate	keratosis	21	0.41
DB00399	Zoledronate	thyroid diseases	30	0.46
DB00399	Zoledronate	coronary disease	37	0.54
DB00399	Zoledronate	metabolism inborn errors	289	0.55
DB00399	Zoledronate	liver cirrhosis biliary	23	0.55
DB00399	Zoledronate	parkinson disease	30	0.58
DB00399	Zoledronate	myocardial ischemia	43	0.58
DB00399	Zoledronate	liver cirrhosis	24	0.58
DB00399	Zoledronate	parkinsonian disorders	31	0.58
DB00399	Zoledronate	bacterial infections	26	0.59
DB00399	Zoledronate	amyotrophic lateral sclerosis	21	0.60
DB00399	Zoledronate	malabsorption syndromes	34	0.65
DB00399	Zoledronate	arteriosclerosis	38	0.66
DB00399	Zoledronate	asthma	36	0.70
DB00399	Zoledronate	skin diseases	278	0.72
DB00399	Zoledronate	alzheimer disease	29	0.73
DB00399	Zoledronate	sarcoma	25	0.74
DB00399	Zoledronate	cardiomyopathy dilated	29	0.76
DB00399	Zoledronate	arterial occlusive diseases	44	0.77
DB00399	Zoledronate	blood coagulation disorders	40	0.80
DB00399	Zoledronate	hypersensitivity	45	0.89
DB00399	Zoledronate	adenocarcinoma	32	0.99
DB00399	Zoledronate	arthritis rheumatoid	42	1.05
DB00399	Zoledronate	colitis	55	1.07
DB00399	Zoledronate	dementia	42	1.07
DB00399	Zoledronate	prostatic neoplasms	61	1.09
DB00399	Zoledronate	neoplasms	482	1.09
DB00399	Zoledronate	head and neck neoplasms	35	1.14
DB00399	Zoledronate	colitis ulcerative	55	1.16
DB00399	Zoledronate	breast neoplasms	40	1.20
DB00399	Zoledronate	diabetes mellitus type 2	72	1.25
DB00399	Zoledronate	rheumatic diseases	59	1.26
DB00399	Zoledronate	psoriasis	54	1.28
DB00399	Zoledronate	lupus erythematosus systemic	75	1.36
DB00399	Zoledronate	colorectal neoplasms	42	1.37
DB00399	Zoledronate	multiple sclerosis	69	1.38
DB00399	Zoledronate	crohn disease	71	1.39
DB00399	Zoledronate	leukemia myeloid acute	43	1.41
DB00399	Zoledronate	intestinal neoplasms	42	1.41
DB00399	Zoledronate	diabetes mellitus type 1	82	1.47
DB00399	Zoledronate	hyperinsulinism	26	1.48
DB00399	Zoledronate	arrhythmias cardiac	30	1.48
DB00399	Zoledronate	lung diseases	71	1.50
DB00399	Zoledronate	insulin resistance	26	1.52
DB00399	Zoledronate	arthritis	76	1.54
DB00399	Zoledronate	joint diseases	79	1.56
DB00399	Zoledronate	anemia	58	1.57
DB00399	Zoledronate	collagen diseases	25	1.60
DB00399	Zoledronate	kidney diseases	144	1.72
DB00399	Zoledronate	gastroenteritis	122	1.74
DB00399	Zoledronate	inflammatory bowel diseases	119	1.84
DB00399	Zoledronate	anemia hemolytic	29	1.88
DB00399	Zoledronate	gastrointestinal neoplasms	72	1.88
DB00399	Zoledronate	heart diseases	167	1.90
DB00399	Zoledronate	vascular diseases	181	1.92
DB00399	Zoledronate	kidney neoplasms	20	1.94
DB00399	Zoledronate	diabetes mellitus	162	1.97
DB00399	Zoledronate	pancreatic diseases	24	1.98
DB00399	Zoledronate	cardiovascular diseases	330	1.99
DB00399	Zoledronate	autoimmune diseases	243	2.07
DB00399	Zoledronate	neuroendocrine tumors	24	2.10
DB00399	Zoledronate	bone diseases metabolic	27	2.90
DB00399	Zoledronate	hypopigmentation	22	3.09
DB00121	Biotin	metabolism inborn errors	289	-5.60
DB00121	Biotin	gastrointestinal neoplasms	72	-1.83
DB00121	Biotin	spinal cord diseases	59	-1.69
DB00121	Biotin	parkinsonian disorders	31	-1.65
DB00121	Biotin	parkinson disease	30	-1.55
DB00121	Biotin	kidney neoplasms	20	-1.02
DB00121	Biotin	liver cirrhosis	24	-0.91
DB00121	Biotin	liver cirrhosis biliary	23	-0.85
DB00121	Biotin	pancreatic diseases	24	-0.79
DB00121	Biotin	breast neoplasms	40	-0.64
DB00121	Biotin	sarcoma	25	-0.62
DB00121	Biotin	lymphoma	24	-0.49
DB00121	Biotin	lymphoma non hodgkin	22	-0.48
DB00121	Biotin	adenocarcinoma	32	-0.22
DB00121	Biotin	arthritis rheumatoid	42	-0.16
DB00121	Biotin	head and neck neoplasms	35	-0.16
DB00121	Biotin	colitis	55	-0.16
DB00121	Biotin	colitis ulcerative	55	-0.13
DB00121	Biotin	prostatic neoplasms	61	0.01
DB00121	Biotin	rheumatic diseases	59	0.19
DB00121	Biotin	amyotrophic lateral sclerosis	21	0.36
DB00121	Biotin	neoplasms	482	0.37
DB00121	Biotin	diabetes mellitus	162	0.40
DB00121	Biotin	arthritis	76	0.48
DB00121	Biotin	mycobacterium infections	22	0.52
DB00121	Biotin	neuroendocrine tumors	24	0.52
DB00121	Biotin	joint diseases	79	0.54
DB00121	Biotin	keratosis	21	0.58
DB00121	Biotin	endocrine system diseases	291	0.61
DB00121	Biotin	cardiomyopathy dilated	29	0.65
DB00121	Biotin	varicose veins	20	0.69
DB00121	Biotin	leukemia lymphoid	66	0.71
DB00121	Biotin	vascular diseases	181	0.84
DB00121	Biotin	gastroenteritis	122	0.90
DB00121	Biotin	lupus erythematosus systemic	75	0.93
DB00121	Biotin	bacterial infections	26	0.94
DB00121	Biotin	motor neuron disease	31	0.96
DB00121	Biotin	inflammatory bowel diseases	119	0.97
DB00121	Biotin	kidney diseases	144	1.03
DB00121	Biotin	diabetes mellitus type 1	82	1.06
DB00121	Biotin	autoimmune diseases	243	1.12
DB00121	Biotin	arteriosclerosis	38	1.18
DB00121	Biotin	bone diseases	144	1.29
DB00121	Biotin	heart diseases	167	1.32
DB00121	Biotin	diabetes mellitus type 2	72	1.37
DB00121	Biotin	skin diseases	278	1.41
DB00121	Biotin	leukemia	117	1.45
DB00121	Biotin	cardiovascular diseases	330	1.46
DB00121	Biotin	arterial occlusive diseases	44	1.49
DB00121	Biotin	arrhythmias cardiac	30	1.66
DB00121	Biotin	epilepsy	25	2.02
DB00121	Biotin	macular degeneration	44	2.03
DB00121	Biotin	hypopigmentation	22	2.16
DB00121	Biotin	coronary disease	37	2.21
DB00121	Biotin	malabsorption syndromes	34	2.30
DB00121	Biotin	myocardial ischemia	43	2.38
DB00121	Biotin	coronary artery disease	31	2.41
DB00121	Biotin	lung diseases	71	2.59
DB00121	Biotin	anemia hemolytic	29	2.72
DB00121	Biotin	hyperinsulinism	26	2.77
DB00121	Biotin	insulin resistance	26	2.78
DB00121	Biotin	bone diseases metabolic	27	2.84
DB00121	Biotin	collagen diseases	25	2.91
DB00121	Biotin	asthma	36	2.94
DB00121	Biotin	multiple sclerosis	69	3.07
DB00121	Biotin	dementia	42	3.07
DB00121	Biotin	hematologic diseases	188	3.18
DB00121	Biotin	alzheimer disease	29	3.28
DB00121	Biotin	thyroid diseases	30	3.36
DB00121	Biotin	hypersensitivity	45	3.39
DB00121	Biotin	psoriasis	54	3.40
DB00121	Biotin	blood coagulation disorders	40	3.53
DB00121	Biotin	eye diseases	231	3.57
DB00121	Biotin	intestinal neoplasms	42	3.62
DB00121	Biotin	crohn disease	71	3.75
DB00121	Biotin	leukemia myeloid acute	43	3.76
DB00121	Biotin	colorectal neoplasms	42	3.79
DB00121	Biotin	anemia	58	4.16
DB00007	Leuprolide	endocrine system diseases	291	-3.99
DB00007	Leuprolide	hematologic diseases	188	-1.61
DB00007	Leuprolide	varicose veins	20	-0.85
DB00007	Leuprolide	neoplasms	482	-0.85
DB00007	Leuprolide	hyperinsulinism	26	-0.82
DB00007	Leuprolide	epilepsy	25	-0.81
DB00007	Leuprolide	insulin resistance	26	-0.76
DB00007	Leuprolide	arrhythmias cardiac	30	-0.72
DB00007	Leuprolide	bone diseases metabolic	27	-0.70
DB00007	Leuprolide	mycobacterium infections	22	-0.66
DB00007	Leuprolide	keratosis	21	-0.65
DB00007	Leuprolide	macular degeneration	44	-0.61
DB00007	Leuprolide	coronary artery disease	31	-0.60
DB00007	Leuprolide	thyroid diseases	30	-0.59
DB00007	Leuprolide	kidney neoplasms	20	-0.54
DB00007	Leuprolide	bacterial infections	26	-0.53
DB00007	Leuprolide	malabsorption syndromes	34	-0.52
DB00007	Leuprolide	parkinsonian disorders	31	-0.52
DB00007	Leuprolide	hypopigmentation	22	-0.51
DB00007	Leuprolide	liver cirrhosis	24	-0.50
DB00007	Leuprolide	cardiomyopathy dilated	29	-0.49
DB00007	Leuprolide	pancreatic diseases	24	-0.49
DB00007	Leuprolide	coronary disease	37	-0.47
DB00007	Leuprolide	parkinson disease	30	-0.47
DB00007	Leuprolide	myocardial ischemia	43	-0.47
DB00007	Leuprolide	neuroendocrine tumors	24	-0.46
DB00007	Leuprolide	alzheimer disease	29	-0.46
DB00007	Leuprolide	arteriosclerosis	38	-0.45
DB00007	Leuprolide	liver cirrhosis biliary	23	-0.45
DB00007	Leuprolide	sarcoma	25	-0.43
DB00007	Leuprolide	asthma	36	-0.40
DB00007	Leuprolide	lymphoma	24	-0.38
DB00007	Leuprolide	lymphoma non hodgkin	22	-0.38
DB00007	Leuprolide	motor neuron disease	31	-0.33
DB00007	Leuprolide	arthritis rheumatoid	42	-0.31
DB00007	Leuprolide	dementia	42	-0.31
DB00007	Leuprolide	arterial occlusive diseases	44	-0.31
DB00007	Leuprolide	blood coagulation disorders	40	-0.30
DB00007	Leuprolide	hypersensitivity	45	-0.29
DB00007	Leuprolide	head and neck neoplasms	35	-0.29
DB00007	Leuprolide	adenocarcinoma	32	-0.27
DB00007	Leuprolide	breast neoplasms	40	-0.22
DB00007	Leuprolide	psoriasis	54	-0.22
DB00007	Leuprolide	diabetes mellitus type 2	72	-0.20
DB00007	Leuprolide	colitis	55	-0.19
DB00007	Leuprolide	prostatic neoplasms	61	-0.18
DB00007	Leuprolide	colitis ulcerative	55	-0.18
DB00007	Leuprolide	intestinal neoplasms	42	-0.12
DB00007	Leuprolide	diabetes mellitus type 1	82	-0.10
DB00007	Leuprolide	multiple sclerosis	69	-0.10
DB00007	Leuprolide	rheumatic diseases	59	-0.09
DB00007	Leuprolide	lupus erythematosus systemic	75	-0.09
DB00007	Leuprolide	spinal cord diseases	59	-0.08
DB00007	Leuprolide	colorectal neoplasms	42	-0.07
DB00007	Leuprolide	leukemia myeloid acute	43	-0.06
DB00007	Leuprolide	crohn disease	71	-0.06
DB00007	Leuprolide	joint diseases	79	-0.03
DB00007	Leuprolide	arthritis	76	-0.02
DB00007	Leuprolide	lung diseases	71	0.02
DB00007	Leuprolide	anemia	58	0.03
DB00007	Leuprolide	leukemia lymphoid	66	0.09
DB00007	Leuprolide	gastroenteritis	122	0.12
DB00007	Leuprolide	gastrointestinal neoplasms	72	0.13
DB00007	Leuprolide	inflammatory bowel diseases	119	0.15
DB00007	Leuprolide	kidney diseases	144	0.17
DB00007	Leuprolide	diabetes mellitus	162	0.19
DB00007	Leuprolide	bone diseases	144	0.27
DB00007	Leuprolide	heart diseases	167	0.27
DB00007	Leuprolide	leukemia	117	0.30
DB00007	Leuprolide	eye diseases	231	0.34
DB00007	Leuprolide	vascular diseases	181	0.38
DB00007	Leuprolide	metabolism inborn errors	289	0.43
DB00007	Leuprolide	autoimmune diseases	243	0.48
DB00007	Leuprolide	skin diseases	278	0.54
DB00007	Leuprolide	cardiovascular diseases	330	0.60
DB00007	Leuprolide	collagen diseases	25	1.18
DB00007	Leuprolide	anemia hemolytic	29	1.44
DB00007	Leuprolide	amyotrophic lateral sclerosis	21	1.65
DB00920	Ketotifen	eye diseases	231	-3.54
DB00920	Ketotifen	varicose veins	20	-2.81
DB00920	Ketotifen	head and neck neoplasms	35	-1.98
DB00920	Ketotifen	asthma	36	-1.85
DB00920	Ketotifen	hypersensitivity	45	-1.61
DB00920	Ketotifen	arrhythmias cardiac	30	-1.34
DB00920	Ketotifen	diabetes mellitus	162	-1.13
DB00920	Ketotifen	diabetes mellitus type 2	72	-1.03
DB00920	Ketotifen	vascular diseases	181	-1.01
DB00920	Ketotifen	endocrine system diseases	291	-0.96
DB00920	Ketotifen	bacterial infections	26	-0.72
DB00920	Ketotifen	spinal cord diseases	59	-0.66
DB00920	Ketotifen	lung diseases	71	-0.60
DB00920	Ketotifen	pancreatic diseases	24	-0.59
DB00920	Ketotifen	bone diseases metabolic	27	-0.51
DB00920	Ketotifen	cardiomyopathy dilated	29	-0.33
DB00920	Ketotifen	alzheimer disease	29	-0.33
DB00920	Ketotifen	cardiovascular diseases	330	-0.03
DB00920	Ketotifen	gastrointestinal neoplasms	72	0.05
DB00920	Ketotifen	dementia	42	0.29
DB00920	Ketotifen	intestinal neoplasms	42	0.64
DB00920	Ketotifen	colorectal neoplasms	42	0.78
DB00920	Ketotifen	metabolism inborn errors	289	0.89
DB00920	Ketotifen	hyperinsulinism	26	1.28
DB00920	Ketotifen	insulin resistance	26	1.31
DB00920	Ketotifen	bone diseases	144	1.52
DB00920	Ketotifen	heart diseases	167	1.59
DB00920	Ketotifen	epilepsy	25	1.66
DB00920	Ketotifen	neoplasms	482	1.94
DB00920	Ketotifen	hypopigmentation	22	1.98
DB00920	Ketotifen	collagen diseases	25	1.98
DB00920	Ketotifen	skin diseases	278	2.05
DB00920	Ketotifen	arthritis rheumatoid	42	2.31
DB00920	Ketotifen	keratosis	21	2.39
DB00920	Ketotifen	rheumatic diseases	59	2.67
DB00920	Ketotifen	anemia hemolytic	29	2.68
DB00920	Ketotifen	kidney neoplasms	20	2.82
DB00920	Ketotifen	coronary disease	37	2.85
DB00920	Ketotifen	multiple sclerosis	69	2.86
DB00920	Ketotifen	arthritis	76	2.86
DB00920	Ketotifen	autoimmune diseases	243	2.89
DB00920	Ketotifen	joint diseases	79	2.89
DB00920	Ketotifen	liver cirrhosis biliary	23	2.94
DB00920	Ketotifen	liver cirrhosis	24	2.96
DB00920	Ketotifen	parkinson disease	30	2.97
DB00920	Ketotifen	myocardial ischemia	43	3.02
DB00920	Ketotifen	malabsorption syndromes	34	3.10
DB00920	Ketotifen	arteriosclerosis	38	3.14
DB00920	Ketotifen	parkinsonian disorders	31	3.16
DB00920	Ketotifen	coronary artery disease	31	3.20
DB00920	Ketotifen	neuroendocrine tumors	24	3.22
DB00920	Ketotifen	thyroid diseases	30	3.32
DB00920	Ketotifen	psoriasis	54	3.39
DB00920	Ketotifen	sarcoma	25	3.40
DB00920	Ketotifen	lupus erythematosus systemic	75	3.44
DB00920	Ketotifen	lymphoma non hodgkin	22	3.44
DB00920	Ketotifen	hematologic diseases	188	3.49
DB00920	Ketotifen	lymphoma	24	3.55
DB00920	Ketotifen	blood coagulation disorders	40	3.56
DB00920	Ketotifen	mycobacterium infections	22	3.63
DB00920	Ketotifen	arterial occlusive diseases	44	3.69
DB00920	Ketotifen	motor neuron disease	31	3.74
DB00920	Ketotifen	amyotrophic lateral sclerosis	21	3.78
DB00920	Ketotifen	macular degeneration	44	3.82
DB00920	Ketotifen	adenocarcinoma	32	3.88
DB00920	Ketotifen	kidney diseases	144	3.95
DB00920	Ketotifen	breast neoplasms	40	3.99
DB00920	Ketotifen	prostatic neoplasms	61	4.01
DB00920	Ketotifen	colitis	55	4.12
DB00920	Ketotifen	colitis ulcerative	55	4.14
DB00920	Ketotifen	leukemia	117	4.17
DB00920	Ketotifen	crohn disease	71	4.24
DB00920	Ketotifen	diabetes mellitus type 1	82	4.27
DB00920	Ketotifen	anemia	58	4.32
DB00920	Ketotifen	leukemia myeloid acute	43	4.34
DB00920	Ketotifen	leukemia lymphoid	66	4.59
DB00920	Ketotifen	inflammatory bowel diseases	119	4.71
DB00920	Ketotifen	gastroenteritis	122	4.77
DB00317	Gefitinib	lung diseases	71	-3.65
DB00317	Gefitinib	neoplasms	482	-2.80
DB00317	Gefitinib	arrhythmias cardiac	30	-2.09
DB00317	Gefitinib	varicose veins	20	-1.82
DB00317	Gefitinib	macular degeneration	44	-1.80
DB00317	Gefitinib	parkinsonian disorders	31	-1.52
DB00317	Gefitinib	insulin resistance	26	-1.51
DB00317	Gefitinib	parkinson disease	30	-1.47
DB00317	Gefitinib	hyperinsulinism	26	-1.45
DB00317	Gefitinib	coronary artery disease	31	-1.32
DB00317	Gefitinib	coronary disease	37	-1.32
DB00317	Gefitinib	keratosis	21	-1.26
DB00317	Gefitinib	anemia hemolytic	29	-1.25
DB00317	Gefitinib	myocardial ischemia	43	-1.22
DB00317	Gefitinib	thyroid diseases	30	-1.11
DB00317	Gefitinib	arteriosclerosis	38	-1.08
DB00317	Gefitinib	cardiomyopathy dilated	29	-1.04
DB00317	Gefitinib	blood coagulation disorders	40	-0.96
DB00317	Gefitinib	malabsorption syndromes	34	-0.96
DB00317	Gefitinib	arterial occlusive diseases	44	-0.95
DB00317	Gefitinib	alzheimer disease	29	-0.92
DB00317	Gefitinib	mycobacterium infections	22	-0.88
DB00317	Gefitinib	kidney neoplasms	20	-0.87
DB00317	Gefitinib	diabetes mellitus type 2	72	-0.84
DB00317	Gefitinib	colitis ulcerative	55	-0.83
DB00317	Gefitinib	colitis	55	-0.83
DB00317	Gefitinib	bacterial infections	26	-0.79
DB00317	Gefitinib	asthma	36	-0.70
DB00317	Gefitinib	dementia	42	-0.68
DB00317	Gefitinib	hypersensitivity	45	-0.57
DB00317	Gefitinib	head and neck neoplasms	35	-0.54
DB00317	Gefitinib	diabetes mellitus type 1	82	-0.50
DB00317	Gefitinib	prostatic neoplasms	61	-0.49
DB00317	Gefitinib	motor neuron disease	31	-0.48
DB00317	Gefitinib	adenocarcinoma	32	-0.47
DB00317	Gefitinib	lupus erythematosus systemic	75	-0.44
DB00317	Gefitinib	arthritis rheumatoid	42	-0.38
DB00317	Gefitinib	breast neoplasms	40	-0.36
DB00317	Gefitinib	crohn disease	71	-0.35
DB00317	Gefitinib	rheumatic diseases	59	-0.31
DB00317	Gefitinib	kidney diseases	144	-0.30
DB00317	Gefitinib	diabetes mellitus	162	-0.29
DB00317	Gefitinib	leukemia myeloid acute	43	-0.28
DB00317	Gefitinib	multiple sclerosis	69	-0.27
DB00317	Gefitinib	joint diseases	79	-0.26
DB00317	Gefitinib	metabolism inborn errors	289	-0.26
DB00317	Gefitinib	leukemia lymphoid	66	-0.26
DB00317	Gefitinib	gastroenteritis	122	-0.25
DB00317	Gefitinib	inflammatory bowel diseases	119	-0.25
DB00317	Gefitinib	heart diseases	167	-0.25
DB00317	Gefitinib	spinal cord diseases	59	-0.24
DB00317	Gefitinib	colorectal neoplasms	42	-0.24
DB00317	Gefitinib	arthritis	76	-0.21
DB00317	Gefitinib	intestinal neoplasms	42	-0.20
DB00317	Gefitinib	anemia	58	-0.18
DB00317	Gefitinib	gastrointestinal neoplasms	72	-0.08
DB00317	Gefitinib	bone diseases	144	-0.02
DB00317	Gefitinib	vascular diseases	181	0.03
DB00317	Gefitinib	eye diseases	231	0.07
DB00317	Gefitinib	cardiovascular diseases	330	0.13
DB00317	Gefitinib	autoimmune diseases	243	0.14
DB00317	Gefitinib	hematologic diseases	188	0.16
DB00317	Gefitinib	endocrine system diseases	291	0.16
DB00317	Gefitinib	leukemia	117	0.17
DB00317	Gefitinib	skin diseases	278	0.18
DB00317	Gefitinib	collagen diseases	25	0.52
DB00317	Gefitinib	bone diseases metabolic	27	0.56
DB00317	Gefitinib	epilepsy	25	0.57
DB00317	Gefitinib	hypopigmentation	22	0.99
DB00317	Gefitinib	amyotrophic lateral sclerosis	21	1.08
DB00317	Gefitinib	sarcoma	25	1.38
DB00317	Gefitinib	liver cirrhosis biliary	23	1.42
DB00317	Gefitinib	pancreatic diseases	24	1.42
DB00317	Gefitinib	neuroendocrine tumors	24	1.44
DB00317	Gefitinib	liver cirrhosis	24	1.45
DB00317	Gefitinib	lymphoma non hodgkin	22	1.65
DB00317	Gefitinib	psoriasis	54	1.72
DB00317	Gefitinib	lymphoma	24	1.76
DB00412	Rosiglitazone	coronary artery disease	31	-1.88
DB00412	Rosiglitazone	macular degeneration	44	-1.82
DB00412	Rosiglitazone	coronary disease	37	-1.80
DB00412	Rosiglitazone	myocardial ischemia	43	-1.77
DB00412	Rosiglitazone	amyotrophic lateral sclerosis	21	-1.62
DB00412	Rosiglitazone	eye diseases	231	-1.61
DB00412	Rosiglitazone	alzheimer disease	29	-1.60
DB00412	Rosiglitazone	sarcoma	25	-1.51
DB00412	Rosiglitazone	arteriosclerosis	38	-1.51
DB00412	Rosiglitazone	arterial occlusive diseases	44	-1.40
DB00412	Rosiglitazone	motor neuron disease	31	-1.35
DB00412	Rosiglitazone	colitis ulcerative	55	-1.24
DB00412	Rosiglitazone	skin diseases	278	-1.24
DB00412	Rosiglitazone	dementia	42	-1.23
DB00412	Rosiglitazone	colitis	55	-1.18
DB00412	Rosiglitazone	crohn disease	71	-1.01
DB00412	Rosiglitazone	spinal cord diseases	59	-0.93
DB00412	Rosiglitazone	leukemia myeloid acute	43	-0.92
DB00412	Rosiglitazone	neoplasms	482	-0.79
DB00412	Rosiglitazone	varicose veins	20	-0.66
DB00412	Rosiglitazone	gastroenteritis	122	-0.59
DB00412	Rosiglitazone	inflammatory bowel diseases	119	-0.57
DB00412	Rosiglitazone	collagen diseases	25	-0.51
DB00412	Rosiglitazone	gastrointestinal neoplasms	72	-0.47
DB00412	Rosiglitazone	bone diseases	144	-0.45
DB00412	Rosiglitazone	heart diseases	167	-0.41
DB00412	Rosiglitazone	keratosis	21	-0.33
DB00412	Rosiglitazone	mycobacterium infections	22	-0.27
DB00412	Rosiglitazone	malabsorption syndromes	34	-0.18
DB00412	Rosiglitazone	leukemia	117	-0.14
DB00412	Rosiglitazone	bacterial infections	26	-0.13
DB00412	Rosiglitazone	kidney neoplasms	20	-0.10
DB00412	Rosiglitazone	vascular diseases	181	-0.10
DB00412	Rosiglitazone	parkinson disease	30	-0.08
DB00412	Rosiglitazone	parkinsonian disorders	31	-0.06
DB00412	Rosiglitazone	cardiomyopathy dilated	29	0.00
DB00412	Rosiglitazone	autoimmune diseases	243	0.06
DB00412	Rosiglitazone	lymphoma	24	0.08
DB00412	Rosiglitazone	lymphoma non hodgkin	22	0.09
DB00412	Rosiglitazone	blood coagulation disorders	40	0.14
DB00412	Rosiglitazone	arthritis rheumatoid	42	0.21
DB00412	Rosiglitazone	endocrine system diseases	291	0.22
DB00412	Rosiglitazone	adenocarcinoma	32	0.24
DB00412	Rosiglitazone	head and neck neoplasms	35	0.30
DB00412	Rosiglitazone	prostatic neoplasms	61	0.33
DB00412	Rosiglitazone	diabetes mellitus type 2	72	0.35
DB00412	Rosiglitazone	cardiovascular diseases	330	0.37
DB00412	Rosiglitazone	psoriasis	54	0.38
DB00412	Rosiglitazone	rheumatic diseases	59	0.42
DB00412	Rosiglitazone	breast neoplasms	40	0.46
DB00412	Rosiglitazone	lupus erythematosus systemic	75	0.52
DB00412	Rosiglitazone	multiple sclerosis	69	0.53
DB00412	Rosiglitazone	diabetes mellitus type 1	82	0.55
DB00412	Rosiglitazone	intestinal neoplasms	42	0.57
DB00412	Rosiglitazone	joint diseases	79	0.61
DB00412	Rosiglitazone	colorectal neoplasms	42	0.61
DB00412	Rosiglitazone	lung diseases	71	0.68
DB00412	Rosiglitazone	anemia	58	0.68
DB00412	Rosiglitazone	arthritis	76	0.69
DB00412	Rosiglitazone	leukemia lymphoid	66	0.70
DB00412	Rosiglitazone	epilepsy	25	0.93
DB00412	Rosiglitazone	hyperinsulinism	26	0.99
DB00412	Rosiglitazone	kidney diseases	144	1.00
DB00412	Rosiglitazone	insulin resistance	26	1.00
DB00412	Rosiglitazone	bone diseases metabolic	27	1.03
DB00412	Rosiglitazone	arrhythmias cardiac	30	1.05
DB00412	Rosiglitazone	diabetes mellitus	162	1.08
DB00412	Rosiglitazone	anemia hemolytic	29	1.26
DB00412	Rosiglitazone	hypopigmentation	22	1.26
DB00412	Rosiglitazone	metabolism inborn errors	289	1.34
DB00412	Rosiglitazone	thyroid diseases	30	1.36
DB00412	Rosiglitazone	pancreatic diseases	24	1.39
DB00412	Rosiglitazone	liver cirrhosis	24	1.40
DB00412	Rosiglitazone	liver cirrhosis biliary	23	1.45
DB00412	Rosiglitazone	neuroendocrine tumors	24	1.46
DB00412	Rosiglitazone	asthma	36	1.47
DB00412	Rosiglitazone	hypersensitivity	45	1.53
DB00412	Rosiglitazone	hematologic diseases	188	1.59
DB00989	Rivastigmine	coronary artery disease	31	-1.15
DB00989	Rivastigmine	coronary disease	37	-0.98
DB00989	Rivastigmine	arteriosclerosis	38	-0.94
DB00989	Rivastigmine	alzheimer disease	29	-0.94
DB00989	Rivastigmine	myocardial ischemia	43	-0.87
DB00989	Rivastigmine	asthma	36	-0.82
DB00989	Rivastigmine	arterial occlusive diseases	44	-0.76
DB00989	Rivastigmine	hypersensitivity	45	-0.72
DB00989	Rivastigmine	dementia	42	-0.64
DB00989	Rivastigmine	lung diseases	71	-0.32
DB00989	Rivastigmine	heart diseases	167	0.10
DB00989	Rivastigmine	vascular diseases	181	0.23
DB00989	Rivastigmine	cardiovascular diseases	330	0.55
DB00989	Rivastigmine	spinal cord diseases	59	1.05
DB00989	Rivastigmine	epilepsy	25	1.28
DB00989	Rivastigmine	bone diseases metabolic	27	1.33
DB00989	Rivastigmine	collagen diseases	25	1.33
DB00989	Rivastigmine	insulin resistance	26	1.34
DB00989	Rivastigmine	hyperinsulinism	26	1.37
DB00989	Rivastigmine	macular degeneration	44	1.50
DB00989	Rivastigmine	mycobacterium infections	22	1.54
DB00989	Rivastigmine	anemia hemolytic	29	1.60
DB00989	Rivastigmine	bacterial infections	26	1.65
DB00989	Rivastigmine	parkinson disease	30	1.65
DB00989	Rivastigmine	amyotrophic lateral sclerosis	21	1.70
DB00989	Rivastigmine	kidney neoplasms	20	1.72
DB00989	Rivastigmine	liver cirrhosis biliary	23	1.72
DB00989	Rivastigmine	pancreatic diseases	24	1.72
DB00989	Rivastigmine	liver cirrhosis	24	1.74
DB00989	Rivastigmine	parkinsonian disorders	31	1.75
DB00989	Rivastigmine	cardiomyopathy dilated	29	1.82
DB00989	Rivastigmine	neuroendocrine tumors	24	1.88
DB00989	Rivastigmine	sarcoma	25	1.93
DB00989	Rivastigmine	lymphoma	24	1.94
DB00989	Rivastigmine	lymphoma non hodgkin	22	1.99
DB00989	Rivastigmine	blood coagulation disorders	40	2.00
DB00989	Rivastigmine	motor neuron disease	31	2.07
DB00989	Rivastigmine	head and neck neoplasms	35	2.10
DB00989	Rivastigmine	adenocarcinoma	32	2.15
DB00989	Rivastigmine	psoriasis	54	2.15
DB00989	Rivastigmine	colitis	55	2.18
DB00989	Rivastigmine	diabetes mellitus type 2	72	2.21
DB00989	Rivastigmine	colitis ulcerative	55	2.22
DB00989	Rivastigmine	breast neoplasms	40	2.29
DB00989	Rivastigmine	prostatic neoplasms	61	2.32
DB00989	Rivastigmine	diabetes mellitus type 1	82	2.36
DB00989	Rivastigmine	intestinal neoplasms	42	2.37
DB00989	Rivastigmine	anemia	58	2.37
DB00989	Rivastigmine	multiple sclerosis	69	2.41
DB00989	Rivastigmine	colorectal neoplasms	42	2.41
DB00989	Rivastigmine	leukemia myeloid acute	43	2.42
DB00989	Rivastigmine	crohn disease	71	2.46
DB00989	Rivastigmine	joint diseases	79	2.47
DB00989	Rivastigmine	leukemia lymphoid	66	2.47
DB00989	Rivastigmine	arthritis	76	2.48
DB00989	Rivastigmine	diabetes mellitus	162	2.59
DB00989	Rivastigmine	kidney diseases	144	2.61
DB00989	Rivastigmine	gastrointestinal neoplasms	72	2.69
DB00989	Rivastigmine	gastroenteritis	122	2.71
DB00989	Rivastigmine	inflammatory bowel diseases	119	2.72
DB00989	Rivastigmine	leukemia	117	2.79
DB00989	Rivastigmine	bone diseases	144	2.79
DB00989	Rivastigmine	keratosis	21	2.80
DB00989	Rivastigmine	eye diseases	231	2.85
DB00989	Rivastigmine	metabolism inborn errors	289	2.92
DB00989	Rivastigmine	autoimmune diseases	243	2.97
DB00989	Rivastigmine	skin diseases	278	2.99
DB00989	Rivastigmine	hematologic diseases	188	3.04
DB00989	Rivastigmine	hypopigmentation	22	3.06
DB00989	Rivastigmine	endocrine system diseases	291	3.08
DB00989	Rivastigmine	neoplasms	482	3.46
DB00989	Rivastigmine	rheumatic diseases	59	3.54
DB00989	Rivastigmine	varicose veins	20	3.57
DB00989	Rivastigmine	arrhythmias cardiac	30	4.04
DB00989	Rivastigmine	thyroid diseases	30	4.48
DB00989	Rivastigmine	malabsorption syndromes	34	4.64
DB00989	Rivastigmine	arthritis rheumatoid	42	4.74
DB00989	Rivastigmine	lupus erythematosus systemic	75	5.01
DB00795	Sulfasalazine	bone diseases	144	-2.88
DB00795	Sulfasalazine	skin diseases	278	-2.48
DB00795	Sulfasalazine	bone diseases metabolic	27	-2.41
DB00795	Sulfasalazine	multiple sclerosis	69	-2.29
DB00795	Sulfasalazine	psoriasis	54	-2.20
DB00795	Sulfasalazine	head and neck neoplasms	35	-1.48
DB00795	Sulfasalazine	varicose veins	20	-1.22
DB00795	Sulfasalazine	vascular diseases	181	-0.97
DB00795	Sulfasalazine	gastrointestinal neoplasms	72	-0.96
DB00795	Sulfasalazine	collagen diseases	25	-0.87
DB00795	Sulfasalazine	amyotrophic lateral sclerosis	21	-0.85
DB00795	Sulfasalazine	malabsorption syndromes	34	-0.82
DB00795	Sulfasalazine	arthritis rheumatoid	42	-0.77
DB00795	Sulfasalazine	neoplasms	482	-0.73
DB00795	Sulfasalazine	joint diseases	79	-0.63
DB00795	Sulfasalazine	arthritis	76	-0.57
DB00795	Sulfasalazine	autoimmune diseases	243	-0.53
DB00795	Sulfasalazine	keratosis	21	-0.45
DB00795	Sulfasalazine	gastroenteritis	122	-0.37
DB00795	Sulfasalazine	lupus erythematosus systemic	75	-0.35
DB00795	Sulfasalazine	colitis ulcerative	55	-0.33
DB00795	Sulfasalazine	colitis	55	-0.33
DB00795	Sulfasalazine	rheumatic diseases	59	-0.28
DB00795	Sulfasalazine	eye diseases	231	-0.24
DB00795	Sulfasalazine	diabetes mellitus type 1	82	-0.22
DB00795	Sulfasalazine	metabolism inborn errors	289	-0.18
DB00795	Sulfasalazine	endocrine system diseases	291	-0.14
DB00795	Sulfasalazine	cardiovascular diseases	330	-0.14
DB00795	Sulfasalazine	lymphoma non hodgkin	22	-0.13
DB00795	Sulfasalazine	diabetes mellitus type 2	72	-0.13
DB00795	Sulfasalazine	myocardial ischemia	43	-0.10
DB00795	Sulfasalazine	lymphoma	24	-0.07
DB00795	Sulfasalazine	colorectal neoplasms	42	-0.02
DB00795	Sulfasalazine	intestinal neoplasms	42	0.00
DB00795	Sulfasalazine	heart diseases	167	0.04
DB00795	Sulfasalazine	adenocarcinoma	32	0.07
DB00795	Sulfasalazine	motor neuron disease	31	0.08
DB00795	Sulfasalazine	neuroendocrine tumors	24	0.10
DB00795	Sulfasalazine	spinal cord diseases	59	0.11
DB00795	Sulfasalazine	alzheimer disease	29	0.16
DB00795	Sulfasalazine	arterial occlusive diseases	44	0.21
DB00795	Sulfasalazine	coronary artery disease	31	0.26
DB00795	Sulfasalazine	anemia	58	0.32
DB00795	Sulfasalazine	lung diseases	71	0.36
DB00795	Sulfasalazine	inflammatory bowel diseases	119	0.39
DB00795	Sulfasalazine	sarcoma	25	0.41
DB00795	Sulfasalazine	breast neoplasms	40	0.44
DB00795	Sulfasalazine	leukemia	117	0.49
DB00795	Sulfasalazine	mycobacterium infections	22	0.52
DB00795	Sulfasalazine	arrhythmias cardiac	30	0.53
DB00795	Sulfasalazine	coronary disease	37	0.57
DB00795	Sulfasalazine	kidney neoplasms	20	0.60
DB00795	Sulfasalazine	leukemia myeloid acute	43	0.62
DB00795	Sulfasalazine	diabetes mellitus	162	0.63
DB00795	Sulfasalazine	crohn disease	71	0.66
DB00795	Sulfasalazine	insulin resistance	26	0.68
DB00795	Sulfasalazine	hyperinsulinism	26	0.69
DB00795	Sulfasalazine	dementia	42	0.73
DB00795	Sulfasalazine	arteriosclerosis	38	0.74
DB00795	Sulfasalazine	bacterial infections	26	0.77
DB00795	Sulfasalazine	leukemia lymphoid	66	0.88
DB00795	Sulfasalazine	liver cirrhosis	24	0.97
DB00795	Sulfasalazine	liver cirrhosis biliary	23	1.00
DB00795	Sulfasalazine	kidney diseases	144	1.13
DB00795	Sulfasalazine	epilepsy	25	1.25
DB00795	Sulfasalazine	parkinson disease	30	1.27
DB00795	Sulfasalazine	parkinsonian disorders	31	1.29
DB00795	Sulfasalazine	anemia hemolytic	29	1.32
DB00795	Sulfasalazine	thyroid diseases	30	1.34
DB00795	Sulfasalazine	hypopigmentation	22	1.43
DB00795	Sulfasalazine	blood coagulation disorders	40	1.62
DB00795	Sulfasalazine	prostatic neoplasms	61	1.62
DB00795	Sulfasalazine	macular degeneration	44	1.70
DB00795	Sulfasalazine	asthma	36	1.73
DB00795	Sulfasalazine	hematologic diseases	188	1.78
DB00795	Sulfasalazine	pancreatic diseases	24	1.78
DB00795	Sulfasalazine	hypersensitivity	45	1.89
DB00795	Sulfasalazine	cardiomyopathy dilated	29	2.29
DB00794	Primidone	epilepsy	25	-7.28
DB00794	Primidone	spinal cord diseases	59	-1.82
DB00794	Primidone	varicose veins	20	-1.34
DB00794	Primidone	collagen diseases	25	-0.94
DB00794	Primidone	cardiomyopathy dilated	29	-0.72
DB00794	Primidone	sarcoma	25	-0.62
DB00794	Primidone	rheumatic diseases	59	-0.47
DB00794	Primidone	arrhythmias cardiac	30	-0.42
DB00794	Primidone	motor neuron disease	31	-0.36
DB00794	Primidone	cardiovascular diseases	330	-0.24
DB00794	Primidone	pancreatic diseases	24	-0.22
DB00794	Primidone	arthritis	76	-0.20
DB00794	Primidone	malabsorption syndromes	34	-0.19
DB00794	Primidone	joint diseases	79	-0.18
DB00794	Primidone	adenocarcinoma	32	-0.17
DB00794	Primidone	dementia	42	-0.08
DB00794	Primidone	keratosis	21	-0.05
DB00794	Primidone	heart diseases	167	-0.04
DB00794	Primidone	alzheimer disease	29	-0.04
DB00794	Primidone	prostatic neoplasms	61	0.02
DB00794	Primidone	blood coagulation disorders	40	0.11
DB00794	Primidone	lymphoma	24	0.12
DB00794	Primidone	lymphoma non hodgkin	22	0.13
DB00794	Primidone	hyperinsulinism	26	0.18
DB00794	Primidone	diabetes mellitus type 2	72	0.20
DB00794	Primidone	vascular diseases	181	0.21
DB00794	Primidone	insulin resistance	26	0.22
DB00794	Primidone	kidney neoplasms	20	0.25
DB00794	Primidone	bacterial infections	26	0.25
DB00794	Primidone	hypopigmentation	22	0.26
DB00794	Primidone	gastrointestinal neoplasms	72	0.27
DB00794	Primidone	leukemia myeloid acute	43	0.31
DB00794	Primidone	multiple sclerosis	69	0.33
DB00794	Primidone	intestinal neoplasms	42	0.34
DB00794	Primidone	colorectal neoplasms	42	0.36
DB00794	Primidone	amyotrophic lateral sclerosis	21	0.41
DB00794	Primidone	arthritis rheumatoid	42	0.44
DB00794	Primidone	metabolism inborn errors	289	0.45
DB00794	Primidone	asthma	36	0.53
DB00794	Primidone	colitis	55	0.55
DB00794	Primidone	colitis ulcerative	55	0.56
DB00794	Primidone	coronary artery disease	31	0.58
DB00794	Primidone	neuroendocrine tumors	24	0.58
DB00794	Primidone	lung diseases	71	0.60
DB00794	Primidone	macular degeneration	44	0.64
DB00794	Primidone	psoriasis	54	0.72
DB00794	Primidone	breast neoplasms	40	0.77
DB00794	Primidone	bone diseases metabolic	27	0.89
DB00794	Primidone	arterial occlusive diseases	44	0.89
DB00794	Primidone	coronary disease	37	0.89
DB00794	Primidone	hypersensitivity	45	0.89
DB00794	Primidone	parkinsonian disorders	31	0.96
DB00794	Primidone	lupus erythematosus systemic	75	1.01
DB00794	Primidone	parkinson disease	30	1.03
DB00794	Primidone	myocardial ischemia	43	1.10
DB00794	Primidone	diabetes mellitus type 1	82	1.11
DB00794	Primidone	mycobacterium infections	22	1.11
DB00794	Primidone	crohn disease	71	1.13
DB00794	Primidone	arteriosclerosis	38	1.13
DB00794	Primidone	diabetes mellitus	162	1.20
DB00794	Primidone	autoimmune diseases	243	1.22
DB00794	Primidone	head and neck neoplasms	35	1.28
DB00794	Primidone	bone diseases	144	1.28
DB00794	Primidone	leukemia lymphoid	66	1.42
DB00794	Primidone	endocrine system diseases	291	1.43
DB00794	Primidone	leukemia	117	1.51
DB00794	Primidone	eye diseases	231	1.56
DB00794	Primidone	inflammatory bowel diseases	119	1.74
DB00794	Primidone	gastroenteritis	122	1.78
DB00794	Primidone	kidney diseases	144	1.84
DB00794	Primidone	hematologic diseases	188	1.98
DB00794	Primidone	anemia	58	2.13
DB00794	Primidone	anemia hemolytic	29	2.16
DB00794	Primidone	thyroid diseases	30	2.18
DB00794	Primidone	skin diseases	278	2.20
DB00794	Primidone	neoplasms	482	2.45
DB00794	Primidone	liver cirrhosis	24	2.87
DB00794	Primidone	liver cirrhosis biliary	23	2.90
DB00790	Perindopril	kidney diseases	144	-4.08
DB00790	Perindopril	diabetes mellitus	162	-3.95
DB00790	Perindopril	vascular diseases	181	-3.90
DB00790	Perindopril	endocrine system diseases	291	-3.75
DB00790	Perindopril	metabolism inborn errors	289	-3.68
DB00790	Perindopril	cardiovascular diseases	330	-3.56
DB00790	Perindopril	varicose veins	20	-1.19
DB00790	Perindopril	collagen diseases	25	-1.04
DB00790	Perindopril	bone diseases metabolic	27	-1.03
DB00790	Perindopril	mycobacterium infections	22	-0.96
DB00790	Perindopril	coronary artery disease	31	-0.92
DB00790	Perindopril	thyroid diseases	30	-0.92
DB00790	Perindopril	keratosis	21	-0.92
DB00790	Perindopril	macular degeneration	44	-0.91
DB00790	Perindopril	anemia hemolytic	29	-0.85
DB00790	Perindopril	bacterial infections	26	-0.85
DB00790	Perindopril	coronary disease	37	-0.84
DB00790	Perindopril	liver cirrhosis biliary	23	-0.82
DB00790	Perindopril	myocardial ischemia	43	-0.82
DB00790	Perindopril	parkinsonian disorders	31	-0.80
DB00790	Perindopril	liver cirrhosis	24	-0.80
DB00790	Perindopril	amyotrophic lateral sclerosis	21	-0.79
DB00790	Perindopril	alzheimer disease	29	-0.79
DB00790	Perindopril	parkinson disease	30	-0.79
DB00790	Perindopril	asthma	36	-0.78
DB00790	Perindopril	arteriosclerosis	38	-0.74
DB00790	Perindopril	pancreatic diseases	24	-0.74
DB00790	Perindopril	malabsorption syndromes	34	-0.74
DB00790	Perindopril	blood coagulation disorders	40	-0.74
DB00790	Perindopril	cardiomyopathy dilated	29	-0.72
DB00790	Perindopril	neuroendocrine tumors	24	-0.71
DB00790	Perindopril	lymphoma non hodgkin	22	-0.69
DB00790	Perindopril	sarcoma	25	-0.68
DB00790	Perindopril	lymphoma	24	-0.67
DB00790	Perindopril	arterial occlusive diseases	44	-0.67
DB00790	Perindopril	hypersensitivity	45	-0.66
DB00790	Perindopril	adenocarcinoma	32	-0.62
DB00790	Perindopril	motor neuron disease	31	-0.61
DB00790	Perindopril	colitis ulcerative	55	-0.59
DB00790	Perindopril	dementia	42	-0.56
DB00790	Perindopril	head and neck neoplasms	35	-0.56
DB00790	Perindopril	prostatic neoplasms	61	-0.55
DB00790	Perindopril	colitis	55	-0.53
DB00790	Perindopril	breast neoplasms	40	-0.51
DB00790	Perindopril	psoriasis	54	-0.50
DB00790	Perindopril	colorectal neoplasms	42	-0.46
DB00790	Perindopril	lupus erythematosus systemic	75	-0.46
DB00790	Perindopril	intestinal neoplasms	42	-0.44
DB00790	Perindopril	leukemia myeloid acute	43	-0.43
DB00790	Perindopril	multiple sclerosis	69	-0.42
DB00790	Perindopril	diabetes mellitus type 2	72	-0.42
DB00790	Perindopril	crohn disease	71	-0.40
DB00790	Perindopril	spinal cord diseases	59	-0.39
DB00790	Perindopril	diabetes mellitus type 1	82	-0.39
DB00790	Perindopril	lung diseases	71	-0.35
DB00790	Perindopril	arthritis	76	-0.33
DB00790	Perindopril	joint diseases	79	-0.32
DB00790	Perindopril	leukemia lymphoid	66	-0.30
DB00790	Perindopril	anemia	58	-0.29
DB00790	Perindopril	inflammatory bowel diseases	119	-0.22
DB00790	Perindopril	gastrointestinal neoplasms	72	-0.19
DB00790	Perindopril	gastroenteritis	122	-0.15
DB00790	Perindopril	heart diseases	167	-0.11
DB00790	Perindopril	bone diseases	144	-0.04
DB00790	Perindopril	leukemia	117	0.00
DB00790	Perindopril	eye diseases	231	0.06
DB00790	Perindopril	hematologic diseases	188	0.09
DB00790	Perindopril	autoimmune diseases	243	0.09
DB00790	Perindopril	skin diseases	278	0.19
DB00790	Perindopril	neoplasms	482	0.46
DB00790	Perindopril	hyperinsulinism	26	0.62
DB00790	Perindopril	arrhythmias cardiac	30	0.65
DB00790	Perindopril	insulin resistance	26	0.65
DB00790	Perindopril	epilepsy	25	0.66
DB00790	Perindopril	kidney neoplasms	20	0.85
DB00790	Perindopril	hypopigmentation	22	0.87
DB00790	Perindopril	arthritis rheumatoid	42	1.16
DB00790	Perindopril	rheumatic diseases	59	1.42
DB01224	Quetiapine	colitis	55	-2.87
DB01224	Quetiapine	colitis ulcerative	55	-2.82
DB01224	Quetiapine	bone diseases	144	-2.80
DB01224	Quetiapine	epilepsy	25	-2.48
DB01224	Quetiapine	thyroid diseases	30	-1.78
DB01224	Quetiapine	psoriasis	54	-1.73
DB01224	Quetiapine	arrhythmias cardiac	30	-1.58
DB01224	Quetiapine	gastroenteritis	122	-1.48
DB01224	Quetiapine	inflammatory bowel diseases	119	-1.46
DB01224	Quetiapine	joint diseases	79	-1.43
DB01224	Quetiapine	arthritis	76	-1.40
DB01224	Quetiapine	crohn disease	71	-1.31
DB01224	Quetiapine	varicose veins	20	-1.15
DB01224	Quetiapine	heart diseases	167	-0.85
DB01224	Quetiapine	hyperinsulinism	26	-0.62
DB01224	Quetiapine	insulin resistance	26	-0.61
DB01224	Quetiapine	colorectal neoplasms	42	-0.60
DB01224	Quetiapine	bacterial infections	26	-0.59
DB01224	Quetiapine	intestinal neoplasms	42	-0.58
DB01224	Quetiapine	cardiovascular diseases	330	-0.58
DB01224	Quetiapine	multiple sclerosis	69	-0.55
DB01224	Quetiapine	mycobacterium infections	22	-0.45
DB01224	Quetiapine	adenocarcinoma	32	-0.35
DB01224	Quetiapine	gastrointestinal neoplasms	72	-0.30
DB01224	Quetiapine	leukemia myeloid acute	43	-0.29
DB01224	Quetiapine	dementia	42	-0.20
DB01224	Quetiapine	amyotrophic lateral sclerosis	21	-0.15
DB01224	Quetiapine	liver cirrhosis	24	-0.12
DB01224	Quetiapine	liver cirrhosis biliary	23	-0.09
DB01224	Quetiapine	spinal cord diseases	59	-0.08
DB01224	Quetiapine	pancreatic diseases	24	-0.07
DB01224	Quetiapine	vascular diseases	181	-0.01
DB01224	Quetiapine	breast neoplasms	40	0.01
DB01224	Quetiapine	eye diseases	231	0.13
DB01224	Quetiapine	neuroendocrine tumors	24	0.15
DB01224	Quetiapine	autoimmune diseases	243	0.15
DB01224	Quetiapine	diabetes mellitus type 2	72	0.17
DB01224	Quetiapine	lung diseases	71	0.21
DB01224	Quetiapine	alzheimer disease	29	0.22
DB01224	Quetiapine	anemia hemolytic	29	0.30
DB01224	Quetiapine	myocardial ischemia	43	0.36
DB01224	Quetiapine	hematologic diseases	188	0.50
DB01224	Quetiapine	endocrine system diseases	291	0.52
DB01224	Quetiapine	keratosis	21	0.60
DB01224	Quetiapine	diabetes mellitus type 1	82	0.60
DB01224	Quetiapine	cardiomyopathy dilated	29	0.60
DB01224	Quetiapine	kidney neoplasms	20	0.63
DB01224	Quetiapine	arterial occlusive diseases	44	0.64
DB01224	Quetiapine	skin diseases	278	0.66
DB01224	Quetiapine	hypopigmentation	22	0.70
DB01224	Quetiapine	sarcoma	25	0.71
DB01224	Quetiapine	arthritis rheumatoid	42	0.73
DB01224	Quetiapine	arteriosclerosis	38	0.80
DB01224	Quetiapine	asthma	36	0.80
DB01224	Quetiapine	motor neuron disease	31	0.82
DB01224	Quetiapine	head and neck neoplasms	35	0.84
DB01224	Quetiapine	lymphoma non hodgkin	22	0.85
DB01224	Quetiapine	parkinson disease	30	0.85
DB01224	Quetiapine	anemia	58	0.89
DB01224	Quetiapine	leukemia	117	0.89
DB01224	Quetiapine	malabsorption syndromes	34	0.90
DB01224	Quetiapine	lymphoma	24	0.91
DB01224	Quetiapine	parkinsonian disorders	31	0.95
DB01224	Quetiapine	blood coagulation disorders	40	1.04
DB01224	Quetiapine	kidney diseases	144	1.06
DB01224	Quetiapine	leukemia lymphoid	66	1.07
DB01224	Quetiapine	diabetes mellitus	162	1.15
DB01224	Quetiapine	bone diseases metabolic	27	1.16
DB01224	Quetiapine	collagen diseases	25	1.16
DB01224	Quetiapine	metabolism inborn errors	289	1.18
DB01224	Quetiapine	lupus erythematosus systemic	75	1.23
DB01224	Quetiapine	coronary artery disease	31	1.32
DB01224	Quetiapine	rheumatic diseases	59	1.42
DB01224	Quetiapine	hypersensitivity	45	1.45
DB01224	Quetiapine	macular degeneration	44	1.50
DB01224	Quetiapine	coronary disease	37	1.52
DB01224	Quetiapine	neoplasms	482	2.06
DB01224	Quetiapine	prostatic neoplasms	61	2.28
DB01225	Enoxaparin	blood coagulation disorders	40	-6.46
DB01225	Enoxaparin	hematologic diseases	188	-4.98
DB01225	Enoxaparin	prostatic neoplasms	61	-3.26
DB01225	Enoxaparin	vascular diseases	181	-2.47
DB01225	Enoxaparin	eye diseases	231	-2.21
DB01225	Enoxaparin	cardiovascular diseases	330	-1.81
DB01225	Enoxaparin	insulin resistance	26	-0.99
DB01225	Enoxaparin	hyperinsulinism	26	-0.95
DB01225	Enoxaparin	neoplasms	482	-0.90
DB01225	Enoxaparin	bone diseases metabolic	27	-0.87
DB01225	Enoxaparin	coronary artery disease	31	-0.83
DB01225	Enoxaparin	thyroid diseases	30	-0.67
DB01225	Enoxaparin	amyotrophic lateral sclerosis	21	-0.65
DB01225	Enoxaparin	anemia hemolytic	29	-0.65
DB01225	Enoxaparin	parkinson disease	30	-0.65
DB01225	Enoxaparin	coronary disease	37	-0.63
DB01225	Enoxaparin	kidney neoplasms	20	-0.61
DB01225	Enoxaparin	myocardial ischemia	43	-0.61
DB01225	Enoxaparin	arteriosclerosis	38	-0.60
DB01225	Enoxaparin	parkinsonian disorders	31	-0.55
DB01225	Enoxaparin	pancreatic diseases	24	-0.53
DB01225	Enoxaparin	arterial occlusive diseases	44	-0.46
DB01225	Enoxaparin	hypersensitivity	45	-0.41
DB01225	Enoxaparin	motor neuron disease	31	-0.35
DB01225	Enoxaparin	arthritis rheumatoid	42	-0.29
DB01225	Enoxaparin	colitis	55	-0.24
DB01225	Enoxaparin	adenocarcinoma	32	-0.23
DB01225	Enoxaparin	dementia	42	-0.23
DB01225	Enoxaparin	colitis ulcerative	55	-0.22
DB01225	Enoxaparin	diabetes mellitus type 2	72	-0.21
DB01225	Enoxaparin	head and neck neoplasms	35	-0.21
DB01225	Enoxaparin	psoriasis	54	-0.17
DB01225	Enoxaparin	breast neoplasms	40	-0.15
DB01225	Enoxaparin	crohn disease	71	-0.06
DB01225	Enoxaparin	lupus erythematosus systemic	75	-0.05
DB01225	Enoxaparin	rheumatic diseases	59	-0.03
DB01225	Enoxaparin	colorectal neoplasms	42	-0.03
DB01225	Enoxaparin	intestinal neoplasms	42	0.00
DB01225	Enoxaparin	diabetes mellitus type 1	82	0.01
DB01225	Enoxaparin	multiple sclerosis	69	0.02
DB01225	Enoxaparin	leukemia myeloid acute	43	0.02
DB01225	Enoxaparin	spinal cord diseases	59	0.03
DB01225	Enoxaparin	anemia	58	0.05
DB01225	Enoxaparin	arthritis	76	0.09
DB01225	Enoxaparin	leukemia lymphoid	66	0.10
DB01225	Enoxaparin	joint diseases	79	0.13
DB01225	Enoxaparin	lung diseases	71	0.17
DB01225	Enoxaparin	inflammatory bowel diseases	119	0.22
DB01225	Enoxaparin	gastroenteritis	122	0.28
DB01225	Enoxaparin	varicose veins	20	0.29
DB01225	Enoxaparin	kidney diseases	144	0.30
DB01225	Enoxaparin	gastrointestinal neoplasms	72	0.30
DB01225	Enoxaparin	diabetes mellitus	162	0.33
DB01225	Enoxaparin	heart diseases	167	0.45
DB01225	Enoxaparin	bone diseases	144	0.48
DB01225	Enoxaparin	arrhythmias cardiac	30	0.48
DB01225	Enoxaparin	collagen diseases	25	0.52
DB01225	Enoxaparin	leukemia	117	0.55
DB01225	Enoxaparin	mycobacterium infections	22	0.57
DB01225	Enoxaparin	metabolism inborn errors	289	0.64
DB01225	Enoxaparin	keratosis	21	0.68
DB01225	Enoxaparin	autoimmune diseases	243	0.74
DB01225	Enoxaparin	bacterial infections	26	0.82
DB01225	Enoxaparin	endocrine system diseases	291	0.84
DB01225	Enoxaparin	liver cirrhosis	24	0.85
DB01225	Enoxaparin	skin diseases	278	0.86
DB01225	Enoxaparin	hypopigmentation	22	0.86
DB01225	Enoxaparin	malabsorption syndromes	34	0.87
DB01225	Enoxaparin	liver cirrhosis biliary	23	0.97
DB01225	Enoxaparin	neuroendocrine tumors	24	0.97
DB01225	Enoxaparin	cardiomyopathy dilated	29	1.01
DB01225	Enoxaparin	sarcoma	25	1.03
DB01225	Enoxaparin	alzheimer disease	29	1.05
DB01225	Enoxaparin	lymphoma non hodgkin	22	1.10
DB01225	Enoxaparin	lymphoma	24	1.18
DB01225	Enoxaparin	epilepsy	25	1.72
DB01225	Enoxaparin	macular degeneration	44	2.05
DB01225	Enoxaparin	asthma	36	2.48
DB00714	Apomorphine	varicose veins	20	-3.28
DB00714	Apomorphine	cardiovascular diseases	330	-2.33
DB00714	Apomorphine	epilepsy	25	-2.29
DB00714	Apomorphine	heart diseases	167	-1.87
DB00714	Apomorphine	thyroid diseases	30	-1.30
DB00714	Apomorphine	bone diseases	144	-1.26
DB00714	Apomorphine	arrhythmias cardiac	30	-1.03
DB00714	Apomorphine	vascular diseases	181	-1.01
DB00714	Apomorphine	colitis ulcerative	55	-0.53
DB00714	Apomorphine	colitis	55	-0.52
DB00714	Apomorphine	leukemia myeloid acute	43	-0.47
DB00714	Apomorphine	spinal cord diseases	59	-0.36
DB00714	Apomorphine	breast neoplasms	40	-0.31
DB00714	Apomorphine	gastroenteritis	122	-0.21
DB00714	Apomorphine	inflammatory bowel diseases	119	-0.20
DB00714	Apomorphine	hyperinsulinism	26	-0.15
DB00714	Apomorphine	insulin resistance	26	-0.10
DB00714	Apomorphine	hematologic diseases	188	0.05
DB00714	Apomorphine	intestinal neoplasms	42	0.07
DB00714	Apomorphine	crohn disease	71	0.10
DB00714	Apomorphine	colorectal neoplasms	42	0.11
DB00714	Apomorphine	neuroendocrine tumors	24	0.12
DB00714	Apomorphine	psoriasis	54	0.16
DB00714	Apomorphine	alzheimer disease	29	0.19
DB00714	Apomorphine	eye diseases	231	0.22
DB00714	Apomorphine	anemia hemolytic	29	0.22
DB00714	Apomorphine	bacterial infections	26	0.22
DB00714	Apomorphine	mycobacterium infections	22	0.27
DB00714	Apomorphine	gastrointestinal neoplasms	72	0.27
DB00714	Apomorphine	adenocarcinoma	32	0.37
DB00714	Apomorphine	lung diseases	71	0.38
DB00714	Apomorphine	liver cirrhosis	24	0.39
DB00714	Apomorphine	pancreatic diseases	24	0.41
DB00714	Apomorphine	liver cirrhosis biliary	23	0.41
DB00714	Apomorphine	amyotrophic lateral sclerosis	21	0.42
DB00714	Apomorphine	myocardial ischemia	43	0.47
DB00714	Apomorphine	collagen diseases	25	0.48
DB00714	Apomorphine	malabsorption syndromes	34	0.50
DB00714	Apomorphine	diabetes mellitus type 1	82	0.60
DB00714	Apomorphine	multiple sclerosis	69	0.61
DB00714	Apomorphine	cardiomyopathy dilated	29	0.68
DB00714	Apomorphine	kidney neoplasms	20	0.69
DB00714	Apomorphine	hypopigmentation	22	0.69
DB00714	Apomorphine	keratosis	21	0.83
DB00714	Apomorphine	endocrine system diseases	291	0.84
DB00714	Apomorphine	anemia	58	0.90
DB00714	Apomorphine	leukemia	117	1.01
DB00714	Apomorphine	blood coagulation disorders	40	1.01
DB00714	Apomorphine	dementia	42	1.09
DB00714	Apomorphine	motor neuron disease	31	1.26
DB00714	Apomorphine	arthritis rheumatoid	42	1.31
DB00714	Apomorphine	arthritis	76	1.32
DB00714	Apomorphine	parkinson disease	30	1.32
DB00714	Apomorphine	diabetes mellitus type 2	72	1.35
DB00714	Apomorphine	joint diseases	79	1.38
DB00714	Apomorphine	parkinsonian disorders	31	1.38
DB00714	Apomorphine	lymphoma non hodgkin	22	1.45
DB00714	Apomorphine	lymphoma	24	1.46
DB00714	Apomorphine	asthma	36	1.54
DB00714	Apomorphine	arteriosclerosis	38	1.55
DB00714	Apomorphine	leukemia lymphoid	66	1.56
DB00714	Apomorphine	diabetes mellitus	162	1.61
DB00714	Apomorphine	sarcoma	25	1.73
DB00714	Apomorphine	skin diseases	278	1.85
DB00714	Apomorphine	arterial occlusive diseases	44	1.86
DB00714	Apomorphine	metabolism inborn errors	289	1.91
DB00714	Apomorphine	rheumatic diseases	59	1.92
DB00714	Apomorphine	head and neck neoplasms	35	2.00
DB00714	Apomorphine	autoimmune diseases	243	2.01
DB00714	Apomorphine	macular degeneration	44	2.02
DB00714	Apomorphine	hypersensitivity	45	2.05
DB00714	Apomorphine	lupus erythematosus systemic	75	2.13
DB00714	Apomorphine	coronary artery disease	31	2.21
DB00714	Apomorphine	prostatic neoplasms	61	2.25
DB00714	Apomorphine	coronary disease	37	2.63
DB00714	Apomorphine	kidney diseases	144	2.69
DB00714	Apomorphine	neoplasms	482	2.71
DB00714	Apomorphine	bone diseases metabolic	27	3.13
DB00716	Nedocromil	gastrointestinal neoplasms	72	-2.12
DB00716	Nedocromil	bone diseases	144	-1.88
DB00716	Nedocromil	coronary artery disease	31	-1.81
DB00716	Nedocromil	mycobacterium infections	22	-1.74
DB00716	Nedocromil	neoplasms	482	-1.67
DB00716	Nedocromil	coronary disease	37	-1.66
DB00716	Nedocromil	intestinal neoplasms	42	-1.63
DB00716	Nedocromil	metabolism inborn errors	289	-1.60
DB00716	Nedocromil	amyotrophic lateral sclerosis	21	-1.58
DB00716	Nedocromil	malabsorption syndromes	34	-1.54
DB00716	Nedocromil	myocardial ischemia	43	-1.51
DB00716	Nedocromil	bacterial infections	26	-1.51
DB00716	Nedocromil	arteriosclerosis	38	-1.50
DB00716	Nedocromil	colorectal neoplasms	42	-1.48
DB00716	Nedocromil	lung diseases	71	-1.44
DB00716	Nedocromil	endocrine system diseases	291	-1.33
DB00716	Nedocromil	bone diseases metabolic	27	-1.30
DB00716	Nedocromil	arterial occlusive diseases	44	-1.25
DB00716	Nedocromil	colitis	55	-1.09
DB00716	Nedocromil	colitis ulcerative	55	-1.08
DB00716	Nedocromil	kidney diseases	144	-1.08
DB00716	Nedocromil	motor neuron disease	31	-1.07
DB00716	Nedocromil	dementia	42	-1.02
DB00716	Nedocromil	heart diseases	167	-0.95
DB00716	Nedocromil	diabetes mellitus type 2	72	-0.89
DB00716	Nedocromil	psoriasis	54	-0.87
DB00716	Nedocromil	parkinson disease	30	-0.86
DB00716	Nedocromil	parkinsonian disorders	31	-0.85
DB00716	Nedocromil	thyroid diseases	30	-0.83
DB00716	Nedocromil	eye diseases	231	-0.69
DB00716	Nedocromil	lupus erythematosus systemic	75	-0.68
DB00716	Nedocromil	multiple sclerosis	69	-0.64
DB00716	Nedocromil	spinal cord diseases	59	-0.63
DB00716	Nedocromil	crohn disease	71	-0.61
DB00716	Nedocromil	autoimmune diseases	243	-0.59
DB00716	Nedocromil	liver cirrhosis biliary	23	-0.54
DB00716	Nedocromil	liver cirrhosis	24	-0.53
DB00716	Nedocromil	varicose veins	20	-0.49
DB00716	Nedocromil	neuroendocrine tumors	24	-0.47
DB00716	Nedocromil	joint diseases	79	-0.46
DB00716	Nedocromil	arthritis	76	-0.45
DB00716	Nedocromil	asthma	36	-0.45
DB00716	Nedocromil	arrhythmias cardiac	30	-0.33
DB00716	Nedocromil	cardiovascular diseases	330	-0.33
DB00716	Nedocromil	lymphoma non hodgkin	22	-0.32
DB00716	Nedocromil	lymphoma	24	-0.30
DB00716	Nedocromil	insulin resistance	26	-0.26
DB00716	Nedocromil	hypersensitivity	45	-0.26
DB00716	Nedocromil	hyperinsulinism	26	-0.23
DB00716	Nedocromil	inflammatory bowel diseases	119	-0.23
DB00716	Nedocromil	gastroenteritis	122	-0.19
DB00716	Nedocromil	diabetes mellitus	162	-0.09
DB00716	Nedocromil	arthritis rheumatoid	42	-0.06
DB00716	Nedocromil	keratosis	21	-0.02
DB00716	Nedocromil	prostatic neoplasms	61	-0.01
DB00716	Nedocromil	breast neoplasms	40	0.10
DB00716	Nedocromil	vascular diseases	181	0.16
DB00716	Nedocromil	rheumatic diseases	59	0.23
DB00716	Nedocromil	diabetes mellitus type 1	82	0.24
DB00716	Nedocromil	cardiomyopathy dilated	29	0.27
DB00716	Nedocromil	leukemia myeloid acute	43	0.29
DB00716	Nedocromil	hematologic diseases	188	0.33
DB00716	Nedocromil	alzheimer disease	29	0.36
DB00716	Nedocromil	pancreatic diseases	24	0.37
DB00716	Nedocromil	sarcoma	25	0.46
DB00716	Nedocromil	anemia	58	0.47
DB00716	Nedocromil	epilepsy	25	0.47
DB00716	Nedocromil	leukemia lymphoid	66	0.49
DB00716	Nedocromil	skin diseases	278	0.54
DB00716	Nedocromil	collagen diseases	25	0.54
DB00716	Nedocromil	adenocarcinoma	32	0.80
DB00716	Nedocromil	head and neck neoplasms	35	0.82
DB00716	Nedocromil	anemia hemolytic	29	0.89
DB00716	Nedocromil	hypopigmentation	22	1.02
DB00716	Nedocromil	kidney neoplasms	20	1.02
DB00716	Nedocromil	leukemia	117	1.08
DB00716	Nedocromil	blood coagulation disorders	40	1.27
DB00716	Nedocromil	macular degeneration	44	1.59
DB00245	Benzatropine	dementia	42	-1.88
DB00245	Benzatropine	joint diseases	79	-1.74
DB00245	Benzatropine	arthritis	76	-1.67
DB00245	Benzatropine	parkinson disease	30	-1.43
DB00245	Benzatropine	parkinsonian disorders	31	-1.39
DB00245	Benzatropine	liver cirrhosis	24	-1.36
DB00245	Benzatropine	liver cirrhosis biliary	23	-1.28
DB00245	Benzatropine	pancreatic diseases	24	-1.24
DB00245	Benzatropine	lymphoma	24	-1.13
DB00245	Benzatropine	arterial occlusive diseases	44	-1.07
DB00245	Benzatropine	lymphoma non hodgkin	22	-1.06
DB00245	Benzatropine	autoimmune diseases	243	-1.00
DB00245	Benzatropine	epilepsy	25	-0.84
DB00245	Benzatropine	psoriasis	54	-0.82
DB00245	Benzatropine	diabetes mellitus type 2	72	-0.81
DB00245	Benzatropine	insulin resistance	26	-0.77
DB00245	Benzatropine	hyperinsulinism	26	-0.72
DB00245	Benzatropine	arrhythmias cardiac	30	-0.69
DB00245	Benzatropine	rheumatic diseases	59	-0.67
DB00245	Benzatropine	crohn disease	71	-0.58
DB00245	Benzatropine	leukemia myeloid acute	43	-0.58
DB00245	Benzatropine	diabetes mellitus type 1	82	-0.57
DB00245	Benzatropine	anemia	58	-0.53
DB00245	Benzatropine	lung diseases	71	-0.51
DB00245	Benzatropine	leukemia lymphoid	66	-0.47
DB00245	Benzatropine	anemia hemolytic	29	-0.39
DB00245	Benzatropine	kidney neoplasms	20	-0.38
DB00245	Benzatropine	amyotrophic lateral sclerosis	21	-0.34
DB00245	Benzatropine	gastroenteritis	122	-0.33
DB00245	Benzatropine	bacterial infections	26	-0.31
DB00245	Benzatropine	inflammatory bowel diseases	119	-0.28
DB00245	Benzatropine	malabsorption syndromes	34	-0.26
DB00245	Benzatropine	kidney diseases	144	-0.20
DB00245	Benzatropine	arteriosclerosis	38	-0.19
DB00245	Benzatropine	neuroendocrine tumors	24	-0.19
DB00245	Benzatropine	bone diseases	144	-0.17
DB00245	Benzatropine	cardiomyopathy dilated	29	-0.16
DB00245	Benzatropine	alzheimer disease	29	-0.16
DB00245	Benzatropine	asthma	36	-0.14
DB00245	Benzatropine	diabetes mellitus	162	-0.11
DB00245	Benzatropine	sarcoma	25	-0.10
DB00245	Benzatropine	hypersensitivity	45	0.02
DB00245	Benzatropine	leukemia	117	0.03
DB00245	Benzatropine	motor neuron disease	31	0.06
DB00245	Benzatropine	vascular diseases	181	0.12
DB00245	Benzatropine	arthritis rheumatoid	42	0.14
DB00245	Benzatropine	eye diseases	231	0.14
DB00245	Benzatropine	adenocarcinoma	32	0.17
DB00245	Benzatropine	varicose veins	20	0.18
DB00245	Benzatropine	colitis ulcerative	55	0.19
DB00245	Benzatropine	head and neck neoplasms	35	0.23
DB00245	Benzatropine	colitis	55	0.23
DB00245	Benzatropine	hematologic diseases	188	0.26
DB00245	Benzatropine	metabolism inborn errors	289	0.26
DB00245	Benzatropine	prostatic neoplasms	61	0.29
DB00245	Benzatropine	collagen diseases	25	0.39
DB00245	Benzatropine	skin diseases	278	0.39
DB00245	Benzatropine	bone diseases metabolic	27	0.39
DB00245	Benzatropine	endocrine system diseases	291	0.47
DB00245	Benzatropine	mycobacterium infections	22	0.48
DB00245	Benzatropine	multiple sclerosis	69	0.48
DB00245	Benzatropine	cardiovascular diseases	330	0.49
DB00245	Benzatropine	intestinal neoplasms	42	0.50
DB00245	Benzatropine	lupus erythematosus systemic	75	0.52
DB00245	Benzatropine	coronary artery disease	31	0.53
DB00245	Benzatropine	spinal cord diseases	59	0.54
DB00245	Benzatropine	colorectal neoplasms	42	0.55
DB00245	Benzatropine	keratosis	21	0.56
DB00245	Benzatropine	macular degeneration	44	0.58
DB00245	Benzatropine	thyroid diseases	30	0.61
DB00245	Benzatropine	hypopigmentation	22	0.69
DB00245	Benzatropine	coronary disease	37	0.71
DB00245	Benzatropine	myocardial ischemia	43	0.78
DB00245	Benzatropine	gastrointestinal neoplasms	72	0.89
DB00245	Benzatropine	neoplasms	482	0.95
DB00245	Benzatropine	blood coagulation disorders	40	1.05
DB00245	Benzatropine	heart diseases	167	1.16
DB00245	Benzatropine	breast neoplasms	40	1.42
DB00244	Mesalazine	skin diseases	278	-2.12
DB00244	Mesalazine	psoriasis	54	-1.34
DB00244	Mesalazine	gastrointestinal neoplasms	72	-0.93
DB00244	Mesalazine	varicose veins	20	-0.87
DB00244	Mesalazine	keratosis	21	-0.87
DB00244	Mesalazine	diabetes mellitus type 2	72	-0.78
DB00244	Mesalazine	heart diseases	167	-0.73
DB00244	Mesalazine	myocardial ischemia	43	-0.67
DB00244	Mesalazine	multiple sclerosis	69	-0.65
DB00244	Mesalazine	bone diseases	144	-0.60
DB00244	Mesalazine	arthritis rheumatoid	42	-0.56
DB00244	Mesalazine	bone diseases metabolic	27	-0.55
DB00244	Mesalazine	malabsorption syndromes	34	-0.54
DB00244	Mesalazine	head and neck neoplasms	35	-0.52
DB00244	Mesalazine	adenocarcinoma	32	-0.47
DB00244	Mesalazine	lung diseases	71	-0.37
DB00244	Mesalazine	eye diseases	231	-0.34
DB00244	Mesalazine	neoplasms	482	-0.33
DB00244	Mesalazine	arterial occlusive diseases	44	-0.26
DB00244	Mesalazine	vascular diseases	181	-0.22
DB00244	Mesalazine	coronary artery disease	31	-0.19
DB00244	Mesalazine	colitis ulcerative	55	-0.14
DB00244	Mesalazine	colitis	55	-0.08
DB00244	Mesalazine	rheumatic diseases	59	-0.08
DB00244	Mesalazine	coronary disease	37	0.09
DB00244	Mesalazine	lymphoma non hodgkin	22	0.13
DB00244	Mesalazine	lymphoma	24	0.17
DB00244	Mesalazine	leukemia lymphoid	66	0.22
DB00244	Mesalazine	arteriosclerosis	38	0.27
DB00244	Mesalazine	collagen diseases	25	0.29
DB00244	Mesalazine	motor neuron disease	31	0.31
DB00244	Mesalazine	amyotrophic lateral sclerosis	21	0.32
DB00244	Mesalazine	spinal cord diseases	59	0.33
DB00244	Mesalazine	arthritis	76	0.36
DB00244	Mesalazine	joint diseases	79	0.37
DB00244	Mesalazine	endocrine system diseases	291	0.43
DB00244	Mesalazine	alzheimer disease	29	0.50
DB00244	Mesalazine	gastroenteritis	122	0.52
DB00244	Mesalazine	metabolism inborn errors	289	0.54
DB00244	Mesalazine	leukemia	117	0.57
DB00244	Mesalazine	cardiovascular diseases	330	0.57
DB00244	Mesalazine	lupus erythematosus systemic	75	0.62
DB00244	Mesalazine	diabetes mellitus	162	0.68
DB00244	Mesalazine	diabetes mellitus type 1	82	0.73
DB00244	Mesalazine	breast neoplasms	40	0.73
DB00244	Mesalazine	leukemia myeloid acute	43	0.93
DB00244	Mesalazine	mycobacterium infections	22	0.94
DB00244	Mesalazine	autoimmune diseases	243	1.00
DB00244	Mesalazine	intestinal neoplasms	42	1.00
DB00244	Mesalazine	arrhythmias cardiac	30	1.02
DB00244	Mesalazine	dementia	42	1.03
DB00244	Mesalazine	colorectal neoplasms	42	1.06
DB00244	Mesalazine	kidney neoplasms	20	1.07
DB00244	Mesalazine	insulin resistance	26	1.13
DB00244	Mesalazine	bacterial infections	26	1.13
DB00244	Mesalazine	hyperinsulinism	26	1.21
DB00244	Mesalazine	neuroendocrine tumors	24	1.28
DB00244	Mesalazine	inflammatory bowel diseases	119	1.34
DB00244	Mesalazine	liver cirrhosis biliary	23	1.34
DB00244	Mesalazine	asthma	36	1.35
DB00244	Mesalazine	liver cirrhosis	24	1.38
DB00244	Mesalazine	macular degeneration	44	1.38
DB00244	Mesalazine	anemia	58	1.49
DB00244	Mesalazine	hypersensitivity	45	1.54
DB00244	Mesalazine	sarcoma	25	1.61
DB00244	Mesalazine	parkinson disease	30	1.72
DB00244	Mesalazine	parkinsonian disorders	31	1.76
DB00244	Mesalazine	crohn disease	71	1.77
DB00244	Mesalazine	thyroid diseases	30	1.78
DB00244	Mesalazine	hematologic diseases	188	1.95
DB00244	Mesalazine	prostatic neoplasms	61	1.97
DB00244	Mesalazine	blood coagulation disorders	40	2.12
DB00244	Mesalazine	pancreatic diseases	24	2.28
DB00244	Mesalazine	anemia hemolytic	29	2.56
DB00244	Mesalazine	hypopigmentation	22	2.59
DB00244	Mesalazine	epilepsy	25	2.65
DB00244	Mesalazine	cardiomyopathy dilated	29	2.80
DB00244	Mesalazine	kidney diseases	144	2.99
DB00555	Lamotrigine	epilepsy	25	-4.90
DB00555	Lamotrigine	arrhythmias cardiac	30	-2.82
DB00555	Lamotrigine	heart diseases	167	-2.06
DB00555	Lamotrigine	cardiovascular diseases	330	-1.89
DB00555	Lamotrigine	keratosis	21	-0.96
DB00555	Lamotrigine	coronary artery disease	31	-0.94
DB00555	Lamotrigine	amyotrophic lateral sclerosis	21	-0.84
DB00555	Lamotrigine	coronary disease	37	-0.81
DB00555	Lamotrigine	arteriosclerosis	38	-0.77
DB00555	Lamotrigine	asthma	36	-0.75
DB00555	Lamotrigine	myocardial ischemia	43	-0.74
DB00555	Lamotrigine	arterial occlusive diseases	44	-0.68
DB00555	Lamotrigine	hypersensitivity	45	-0.65
DB00555	Lamotrigine	motor neuron disease	31	-0.55
DB00555	Lamotrigine	crohn disease	71	-0.43
DB00555	Lamotrigine	colorectal neoplasms	42	-0.42
DB00555	Lamotrigine	intestinal neoplasms	42	-0.40
DB00555	Lamotrigine	spinal cord diseases	59	-0.38
DB00555	Lamotrigine	lung diseases	71	-0.32
DB00555	Lamotrigine	gastrointestinal neoplasms	72	-0.20
DB00555	Lamotrigine	gastroenteritis	122	-0.19
DB00555	Lamotrigine	inflammatory bowel diseases	119	-0.17
DB00555	Lamotrigine	kidney diseases	144	-0.15
DB00555	Lamotrigine	bone diseases	144	-0.14
DB00555	Lamotrigine	vascular diseases	181	-0.02
DB00555	Lamotrigine	hematologic diseases	188	0.08
DB00555	Lamotrigine	autoimmune diseases	243	0.09
DB00555	Lamotrigine	metabolism inborn errors	289	0.14
DB00555	Lamotrigine	skin diseases	278	0.22
DB00555	Lamotrigine	neoplasms	482	0.44
DB00555	Lamotrigine	varicose veins	20	0.61
DB00555	Lamotrigine	insulin resistance	26	0.66
DB00555	Lamotrigine	hyperinsulinism	26	0.69
DB00555	Lamotrigine	collagen diseases	25	0.74
DB00555	Lamotrigine	bone diseases metabolic	27	0.77
DB00555	Lamotrigine	mycobacterium infections	22	0.82
DB00555	Lamotrigine	macular degeneration	44	0.84
DB00555	Lamotrigine	kidney neoplasms	20	0.86
DB00555	Lamotrigine	hypopigmentation	22	0.88
DB00555	Lamotrigine	bacterial infections	26	0.88
DB00555	Lamotrigine	anemia hemolytic	29	0.92
DB00555	Lamotrigine	liver cirrhosis biliary	23	0.92
DB00555	Lamotrigine	malabsorption syndromes	34	0.93
DB00555	Lamotrigine	thyroid diseases	30	0.93
DB00555	Lamotrigine	parkinson disease	30	0.94
DB00555	Lamotrigine	liver cirrhosis	24	0.94
DB00555	Lamotrigine	pancreatic diseases	24	0.94
DB00555	Lamotrigine	neuroendocrine tumors	24	0.99
DB00555	Lamotrigine	parkinsonian disorders	31	0.99
DB00555	Lamotrigine	sarcoma	25	1.04
DB00555	Lamotrigine	alzheimer disease	29	1.05
DB00555	Lamotrigine	cardiomyopathy dilated	29	1.05
DB00555	Lamotrigine	lymphoma non hodgkin	22	1.08
DB00555	Lamotrigine	lymphoma	24	1.09
DB00555	Lamotrigine	blood coagulation disorders	40	1.12
DB00555	Lamotrigine	arthritis rheumatoid	42	1.12
DB00555	Lamotrigine	colitis	55	1.24
DB00555	Lamotrigine	adenocarcinoma	32	1.26
DB00555	Lamotrigine	breast neoplasms	40	1.30
DB00555	Lamotrigine	colitis ulcerative	55	1.31
DB00555	Lamotrigine	head and neck neoplasms	35	1.32
DB00555	Lamotrigine	dementia	42	1.33
DB00555	Lamotrigine	diabetes mellitus type 2	72	1.33
DB00555	Lamotrigine	prostatic neoplasms	61	1.40
DB00555	Lamotrigine	psoriasis	54	1.40
DB00555	Lamotrigine	leukemia myeloid acute	43	1.45
DB00555	Lamotrigine	rheumatic diseases	59	1.49
DB00555	Lamotrigine	multiple sclerosis	69	1.50
DB00555	Lamotrigine	lupus erythematosus systemic	75	1.52
DB00555	Lamotrigine	diabetes mellitus type 1	82	1.52
DB00555	Lamotrigine	anemia	58	1.53
DB00555	Lamotrigine	leukemia lymphoid	66	1.54
DB00555	Lamotrigine	arthritis	76	1.56
DB00555	Lamotrigine	joint diseases	79	1.64
DB00555	Lamotrigine	diabetes mellitus	162	1.86
DB00555	Lamotrigine	leukemia	117	1.99
DB00555	Lamotrigine	eye diseases	231	2.05
DB00555	Lamotrigine	endocrine system diseases	291	2.14
DB00248	Cabergoline	varicose veins	20	-2.80
DB00248	Cabergoline	epilepsy	25	-2.20
DB00248	Cabergoline	cardiovascular diseases	330	-1.77
DB00248	Cabergoline	heart diseases	167	-1.35
DB00248	Cabergoline	bone diseases	144	-1.31
DB00248	Cabergoline	thyroid diseases	30	-1.24
DB00248	Cabergoline	colitis ulcerative	55	-1.09
DB00248	Cabergoline	colitis	55	-1.06
DB00248	Cabergoline	arrhythmias cardiac	30	-0.96
DB00248	Cabergoline	vascular diseases	181	-0.89
DB00248	Cabergoline	leukemia myeloid acute	43	-0.51
DB00248	Cabergoline	spinal cord diseases	59	-0.36
DB00248	Cabergoline	breast neoplasms	40	-0.30
DB00248	Cabergoline	inflammatory bowel diseases	119	-0.18
DB00248	Cabergoline	gastroenteritis	122	-0.18
DB00248	Cabergoline	hyperinsulinism	26	-0.17
DB00248	Cabergoline	insulin resistance	26	-0.14
DB00248	Cabergoline	liver cirrhosis biliary	23	-0.09
DB00248	Cabergoline	hematologic diseases	188	-0.01
DB00248	Cabergoline	liver cirrhosis	24	0.00
DB00248	Cabergoline	colorectal neoplasms	42	0.08
DB00248	Cabergoline	intestinal neoplasms	42	0.08
DB00248	Cabergoline	crohn disease	71	0.08
DB00248	Cabergoline	psoriasis	54	0.17
DB00248	Cabergoline	alzheimer disease	29	0.18
DB00248	Cabergoline	anemia hemolytic	29	0.21
DB00248	Cabergoline	adenocarcinoma	32	0.28
DB00248	Cabergoline	bacterial infections	26	0.28
DB00248	Cabergoline	mycobacterium infections	22	0.31
DB00248	Cabergoline	gastrointestinal neoplasms	72	0.33
DB00248	Cabergoline	keratosis	21	0.38
DB00248	Cabergoline	amyotrophic lateral sclerosis	21	0.40
DB00248	Cabergoline	lung diseases	71	0.42
DB00248	Cabergoline	myocardial ischemia	43	0.42
DB00248	Cabergoline	malabsorption syndromes	34	0.44
DB00248	Cabergoline	pancreatic diseases	24	0.45
DB00248	Cabergoline	dementia	42	0.48
DB00248	Cabergoline	diabetes mellitus type 1	82	0.57
DB00248	Cabergoline	multiple sclerosis	69	0.59
DB00248	Cabergoline	neuroendocrine tumors	24	0.60
DB00248	Cabergoline	eye diseases	231	0.64
DB00248	Cabergoline	kidney neoplasms	20	0.68
DB00248	Cabergoline	hypopigmentation	22	0.73
DB00248	Cabergoline	cardiomyopathy dilated	29	0.74
DB00248	Cabergoline	endocrine system diseases	291	0.83
DB00248	Cabergoline	parkinson disease	30	0.83
DB00248	Cabergoline	parkinsonian disorders	31	0.87
DB00248	Cabergoline	anemia	58	0.88
DB00248	Cabergoline	collagen diseases	25	0.89
DB00248	Cabergoline	leukemia	117	1.04
DB00248	Cabergoline	blood coagulation disorders	40	1.05
DB00248	Cabergoline	arteriosclerosis	38	1.07
DB00248	Cabergoline	motor neuron disease	31	1.14
DB00248	Cabergoline	diabetes mellitus type 2	72	1.31
DB00248	Cabergoline	arthritis	76	1.33
DB00248	Cabergoline	joint diseases	79	1.33
DB00248	Cabergoline	arthritis rheumatoid	42	1.35
DB00248	Cabergoline	lymphoma	24	1.36
DB00248	Cabergoline	macular degeneration	44	1.41
DB00248	Cabergoline	lymphoma non hodgkin	22	1.45
DB00248	Cabergoline	arterial occlusive diseases	44	1.46
DB00248	Cabergoline	leukemia lymphoid	66	1.52
DB00248	Cabergoline	asthma	36	1.53
DB00248	Cabergoline	diabetes mellitus	162	1.72
DB00248	Cabergoline	coronary artery disease	31	1.75
DB00248	Cabergoline	sarcoma	25	1.78
DB00248	Cabergoline	skin diseases	278	1.93
DB00248	Cabergoline	hypersensitivity	45	1.97
DB00248	Cabergoline	head and neck neoplasms	35	1.97
DB00248	Cabergoline	autoimmune diseases	243	1.98
DB00248	Cabergoline	rheumatic diseases	59	1.99
DB00248	Cabergoline	metabolism inborn errors	289	1.99
DB00248	Cabergoline	lupus erythematosus systemic	75	2.08
DB00248	Cabergoline	prostatic neoplasms	61	2.17
DB00248	Cabergoline	coronary disease	37	2.21
DB00248	Cabergoline	neoplasms	482	2.24
DB00248	Cabergoline	kidney diseases	144	2.60
DB00248	Cabergoline	bone diseases metabolic	27	3.15
DB01303	Oxtriphylline	bone diseases metabolic	27	-1.61
DB01303	Oxtriphylline	insulin resistance	26	-1.54
DB01303	Oxtriphylline	hyperinsulinism	26	-1.52
DB01303	Oxtriphylline	endocrine system diseases	291	-1.36
DB01303	Oxtriphylline	anemia hemolytic	29	-1.13
DB01303	Oxtriphylline	heart diseases	167	-1.08
DB01303	Oxtriphylline	arteriosclerosis	38	-0.93
DB01303	Oxtriphylline	eye diseases	231	-0.89
DB01303	Oxtriphylline	intestinal neoplasms	42	-0.86
DB01303	Oxtriphylline	colorectal neoplasms	42	-0.85
DB01303	Oxtriphylline	liver cirrhosis biliary	23	-0.78
DB01303	Oxtriphylline	malabsorption syndromes	34	-0.78
DB01303	Oxtriphylline	liver cirrhosis	24	-0.77
DB01303	Oxtriphylline	arrhythmias cardiac	30	-0.71
DB01303	Oxtriphylline	pancreatic diseases	24	-0.70
DB01303	Oxtriphylline	arterial occlusive diseases	44	-0.67
DB01303	Oxtriphylline	sarcoma	25	-0.57
DB01303	Oxtriphylline	lymphoma non hodgkin	22	-0.47
DB01303	Oxtriphylline	colitis ulcerative	55	-0.47
DB01303	Oxtriphylline	kidney diseases	144	-0.45
DB01303	Oxtriphylline	colitis	55	-0.44
DB01303	Oxtriphylline	lymphoma	24	-0.40
DB01303	Oxtriphylline	gastrointestinal neoplasms	72	-0.32
DB01303	Oxtriphylline	mycobacterium infections	22	-0.23
DB01303	Oxtriphylline	neoplasms	482	-0.22
DB01303	Oxtriphylline	cardiovascular diseases	330	-0.20
DB01303	Oxtriphylline	thyroid diseases	30	-0.16
DB01303	Oxtriphylline	parkinson disease	30	-0.11
DB01303	Oxtriphylline	bone diseases	144	-0.08
DB01303	Oxtriphylline	coronary disease	37	-0.08
DB01303	Oxtriphylline	parkinsonian disorders	31	-0.04
DB01303	Oxtriphylline	myocardial ischemia	43	-0.01
DB01303	Oxtriphylline	kidney neoplasms	20	0.02
DB01303	Oxtriphylline	lupus erythematosus systemic	75	0.02
DB01303	Oxtriphylline	diabetes mellitus type 1	82	0.07
DB01303	Oxtriphylline	bacterial infections	26	0.09
DB01303	Oxtriphylline	epilepsy	25	0.10
DB01303	Oxtriphylline	cardiomyopathy dilated	29	0.17
DB01303	Oxtriphylline	crohn disease	71	0.20
DB01303	Oxtriphylline	spinal cord diseases	59	0.24
DB01303	Oxtriphylline	multiple sclerosis	69	0.24
DB01303	Oxtriphylline	leukemia myeloid acute	43	0.25
DB01303	Oxtriphylline	neuroendocrine tumors	24	0.33
DB01303	Oxtriphylline	asthma	36	0.33
DB01303	Oxtriphylline	joint diseases	79	0.35
DB01303	Oxtriphylline	arthritis	76	0.39
DB01303	Oxtriphylline	leukemia lymphoid	66	0.41
DB01303	Oxtriphylline	lung diseases	71	0.43
DB01303	Oxtriphylline	anemia	58	0.45
DB01303	Oxtriphylline	autoimmune diseases	243	0.45
DB01303	Oxtriphylline	gastroenteritis	122	0.56
DB01303	Oxtriphylline	hypersensitivity	45	0.57
DB01303	Oxtriphylline	inflammatory bowel diseases	119	0.60
DB01303	Oxtriphylline	coronary artery disease	31	0.63
DB01303	Oxtriphylline	diabetes mellitus type 2	72	0.69
DB01303	Oxtriphylline	diabetes mellitus	162	0.70
DB01303	Oxtriphylline	keratosis	21	0.70
DB01303	Oxtriphylline	motor neuron disease	31	0.74
DB01303	Oxtriphylline	head and neck neoplasms	35	0.79
DB01303	Oxtriphylline	adenocarcinoma	32	0.81
DB01303	Oxtriphylline	arthritis rheumatoid	42	0.83
DB01303	Oxtriphylline	prostatic neoplasms	61	0.90
DB01303	Oxtriphylline	psoriasis	54	0.97
DB01303	Oxtriphylline	varicose veins	20	0.97
DB01303	Oxtriphylline	hypopigmentation	22	1.02
DB01303	Oxtriphylline	breast neoplasms	40	1.04
DB01303	Oxtriphylline	amyotrophic lateral sclerosis	21	1.09
DB01303	Oxtriphylline	vascular diseases	181	1.10
DB01303	Oxtriphylline	leukemia	117	1.10
DB01303	Oxtriphylline	metabolism inborn errors	289	1.11
DB01303	Oxtriphylline	rheumatic diseases	59	1.16
DB01303	Oxtriphylline	collagen diseases	25	1.27
DB01303	Oxtriphylline	blood coagulation disorders	40	1.30
DB01303	Oxtriphylline	alzheimer disease	29	1.34
DB01303	Oxtriphylline	hematologic diseases	188	1.34
DB01303	Oxtriphylline	macular degeneration	44	1.48
DB01303	Oxtriphylline	skin diseases	278	1.59
DB01303	Oxtriphylline	dementia	42	1.83
DB01306	Insulin.Aspart	skin diseases	278	-3.83
DB01306	Insulin.Aspart	pancreatic diseases	24	-3.52
DB01306	Insulin.Aspart	endocrine system diseases	291	-3.24
DB01306	Insulin.Aspart	diabetes mellitus type 2	72	-2.95
DB01306	Insulin.Aspart	hyperinsulinism	26	-2.94
DB01306	Insulin.Aspart	insulin resistance	26	-2.88
DB01306	Insulin.Aspart	arrhythmias cardiac	30	-2.55
DB01306	Insulin.Aspart	bone diseases metabolic	27	-2.44
DB01306	Insulin.Aspart	varicose veins	20	-2.39
DB01306	Insulin.Aspart	diabetes mellitus	162	-2.33
DB01306	Insulin.Aspart	malabsorption syndromes	34	-1.99
DB01306	Insulin.Aspart	thyroid diseases	30	-1.82
DB01306	Insulin.Aspart	blood coagulation disorders	40	-1.80
DB01306	Insulin.Aspart	colitis	55	-1.40
DB01306	Insulin.Aspart	colitis ulcerative	55	-1.39
DB01306	Insulin.Aspart	head and neck neoplasms	35	-1.24
DB01306	Insulin.Aspart	crohn disease	71	-1.06
DB01306	Insulin.Aspart	diabetes mellitus type 1	82	-1.03
DB01306	Insulin.Aspart	leukemia myeloid acute	43	-0.93
DB01306	Insulin.Aspart	spinal cord diseases	59	-0.92
DB01306	Insulin.Aspart	multiple sclerosis	69	-0.88
DB01306	Insulin.Aspart	kidney diseases	144	-0.71
DB01306	Insulin.Aspart	gastroenteritis	122	-0.71
DB01306	Insulin.Aspart	inflammatory bowel diseases	119	-0.66
DB01306	Insulin.Aspart	heart diseases	167	-0.66
DB01306	Insulin.Aspart	bone diseases	144	-0.59
DB01306	Insulin.Aspart	metabolism inborn errors	289	-0.53
DB01306	Insulin.Aspart	eye diseases	231	-0.47
DB01306	Insulin.Aspart	vascular diseases	181	-0.41
DB01306	Insulin.Aspart	hematologic diseases	188	-0.29
DB01306	Insulin.Aspart	leukemia	117	-0.28
DB01306	Insulin.Aspart	autoimmune diseases	243	-0.20
DB01306	Insulin.Aspart	cardiovascular diseases	330	-0.12
DB01306	Insulin.Aspart	neoplasms	482	0.25
DB01306	Insulin.Aspart	epilepsy	25	0.30
DB01306	Insulin.Aspart	collagen diseases	25	0.31
DB01306	Insulin.Aspart	macular degeneration	44	0.32
DB01306	Insulin.Aspart	coronary artery disease	31	0.38
DB01306	Insulin.Aspart	anemia hemolytic	29	0.41
DB01306	Insulin.Aspart	keratosis	21	0.43
DB01306	Insulin.Aspart	parkinson disease	30	0.44
DB01306	Insulin.Aspart	coronary disease	37	0.45
DB01306	Insulin.Aspart	myocardial ischemia	43	0.47
DB01306	Insulin.Aspart	mycobacterium infections	22	0.48
DB01306	Insulin.Aspart	parkinsonian disorders	31	0.48
DB01306	Insulin.Aspart	arteriosclerosis	38	0.50
DB01306	Insulin.Aspart	hypopigmentation	22	0.53
DB01306	Insulin.Aspart	bacterial infections	26	0.53
DB01306	Insulin.Aspart	cardiomyopathy dilated	29	0.55
DB01306	Insulin.Aspart	alzheimer disease	29	0.56
DB01306	Insulin.Aspart	amyotrophic lateral sclerosis	21	0.57
DB01306	Insulin.Aspart	kidney neoplasms	20	0.58
DB01306	Insulin.Aspart	arterial occlusive diseases	44	0.59
DB01306	Insulin.Aspart	liver cirrhosis	24	0.60
DB01306	Insulin.Aspart	neuroendocrine tumors	24	0.61
DB01306	Insulin.Aspart	asthma	36	0.64
DB01306	Insulin.Aspart	liver cirrhosis biliary	23	0.64
DB01306	Insulin.Aspart	sarcoma	25	0.68
DB01306	Insulin.Aspart	dementia	42	0.68
DB01306	Insulin.Aspart	hypersensitivity	45	0.70
DB01306	Insulin.Aspart	lymphoma	24	0.74
DB01306	Insulin.Aspart	lymphoma non hodgkin	22	0.77
DB01306	Insulin.Aspart	prostatic neoplasms	61	0.78
DB01306	Insulin.Aspart	arthritis rheumatoid	42	0.79
DB01306	Insulin.Aspart	motor neuron disease	31	0.81
DB01306	Insulin.Aspart	psoriasis	54	0.81
DB01306	Insulin.Aspart	adenocarcinoma	32	0.84
DB01306	Insulin.Aspart	lupus erythematosus systemic	75	0.87
DB01306	Insulin.Aspart	rheumatic diseases	59	0.93
DB01306	Insulin.Aspart	breast neoplasms	40	0.99
DB01306	Insulin.Aspart	intestinal neoplasms	42	1.04
DB01306	Insulin.Aspart	arthritis	76	1.05
DB01306	Insulin.Aspart	colorectal neoplasms	42	1.05
DB01306	Insulin.Aspart	joint diseases	79	1.10
DB01306	Insulin.Aspart	lung diseases	71	1.17
DB01306	Insulin.Aspart	leukemia lymphoid	66	1.18
DB01306	Insulin.Aspart	anemia	58	1.21
DB01306	Insulin.Aspart	gastrointestinal neoplasms	72	1.49